<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:1f63046d-a77a-465e-aed4-1fd7d331378a,g:f755fa79-e9ed-4360-88c0-9c62587f0bf5,d:5fed483d9c7e4f3cbba3a62c53226cd7--><html xml:lang="en-US" xmlns="http://www.w3.org/1999/xhtml" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:lly="http://www.lilly.com/20220930" xmlns:srt="http://fasb.org/srt/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><head><meta content="text/html" http-equiv="Content-Type"/>
<title>lly-20220930</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonnumeric contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180L2ZyYWc6ZjA3ZDU1NzE1NmRmNGQ5N2EzYzgzZDUxMGI0NWIxNzQvdGFibGU6MDYwZDA0Mzk1MDFhNDAyNWJhODgzODY0ZDdjMDk2ZjEvdGFibGVyYW5nZTowNjBkMDQzOTUwMWE0MDI1YmE4ODM4NjRkN2MwOTZmMV8zLTEtMS0xLTE1OTU0MA_582a62c1-1ee7-48d5-940c-9bc41e37fa54" name="dei:AmendmentFlag">FALSE</ix:nonnumeric><ix:nonnumeric contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180L2ZyYWc6ZjA3ZDU1NzE1NmRmNGQ5N2EzYzgzZDUxMGI0NWIxNzQvdGFibGU6MDYwZDA0Mzk1MDFhNDAyNWJhODgzODY0ZDdjMDk2ZjEvdGFibGVyYW5nZTowNjBkMDQzOTUwMWE0MDI1YmE4ODM4NjRkN2MwOTZmMV80LTEtMS0xLTE1OTU0MA_d1904b85-d2d2-4d0f-b9cb-92fb32c5a711" name="dei:DocumentFiscalYearFocus">2022</ix:nonnumeric><ix:nonnumeric contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180L2ZyYWc6ZjA3ZDU1NzE1NmRmNGQ5N2EzYzgzZDUxMGI0NWIxNzQvdGFibGU6MDYwZDA0Mzk1MDFhNDAyNWJhODgzODY0ZDdjMDk2ZjEvdGFibGVyYW5nZTowNjBkMDQzOTUwMWE0MDI1YmE4ODM4NjRkN2MwOTZmMV81LTEtMS0xLTE1OTU0MA_eb986dfe-7a49-49a0-a37d-1798f409ef8a" name="dei:DocumentFiscalPeriodFocus">Q3</ix:nonnumeric><ix:nonnumeric contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180L2ZyYWc6ZjA3ZDU1NzE1NmRmNGQ5N2EzYzgzZDUxMGI0NWIxNzQvdGFibGU6MDYwZDA0Mzk1MDFhNDAyNWJhODgzODY0ZDdjMDk2ZjEvdGFibGVyYW5nZTowNjBkMDQzOTUwMWE0MDI1YmE4ODM4NjRkN2MwOTZmMV82LTEtMS0xLTE1OTU0MA_3c9cc8c2-a16e-432e-92f2-c55e9d7a051d" name="dei:EntityCentralIndexKey">0000059478</ix:nonnumeric><ix:nonnumeric contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" format="ixt:date-month-day" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180L2ZyYWc6ZjA3ZDU1NzE1NmRmNGQ5N2EzYzgzZDUxMGI0NWIxNzQvdGFibGU6MDYwZDA0Mzk1MDFhNDAyNWJhODgzODY0ZDdjMDk2ZjEvdGFibGVyYW5nZTowNjBkMDQzOTUwMWE0MDI1YmE4ODM4NjRkN2MwOTZmMV83LTEtMS0xLTE1OTU0MA_c6179d16-4bd6-492e-8406-ea9ff242a47a" name="dei:CurrentFiscalYearEndDate">12/31</ix:nonnumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaref xlink:href="lly-20220930.xsd" xlink:type="simple"></link:schemaref></ix:references><ix:resources><xbrli:context id="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i71f35536970d471db55131eae57d8a56_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i928ac777ff9b4d2c901021ddb94de4b4_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">lly:A718NotesDueJune12025Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i47d1aafe63fc4d6a8af84bd5fc7ec42a_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">lly:A1.625NotesDueJune22026Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ifbf789a7a75f4a94b1ecc8e7f5692048_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">lly:A2.125NotesDueJune32030Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i37d6cf7d3d9642f7887a8b59cb2a9056_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">lly:A625NotesDue2031Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ia2c9b0358abd4ac1849fbad87ceaf6b2_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">lly:A500NotesDue2033Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ib18e156e215841b180cc7996ffae9682_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">lly:A6.77NotesDueJanuary12036Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i80ad5b0231594dcca53dbf943886b1f2_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">lly:A1625NotesDue2043Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i8e27869f09004f868cb336c53f59bddd_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">lly:A1700NotesDue2049Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i94f283ca5ff741c39e115f9c18564a88_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">lly:A1125NotesDue2051Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i9b0db4c7708642f7a34b06aae1404242_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">lly:A1375NotesDue2061Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i465e2cbbe1e444108f9f7bdae9a93ca5_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i19fc0325c48543008ea71e1fdcf11d86_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="ie4fa4f6b472a4f269297591b44aba572_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitnumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitnumerator><xbrli:unitdenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitdenominator></xbrli:divide></xbrli:unit><xbrli:context id="i08ccb35f6ad24d7793c9c91b74ca2ea1_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0973ba0c1d894ceaa494709a13f814fb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ff8d0839ef74b87b0394c920e9dfa82_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9a5e6caa6224a1a95516222bf3644c0_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9fbf406305be444e87d56294647b476e_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab7ebbcbace541c5b7a8ee0e0e859b97_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TrustForBenefitOfEmployeesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19336abc2d9f44a7a6562598fdd26074_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i880a0df9a6d245b9a11c009232dc11c9_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d264417b4674277a12ca8c8f571f6da_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice03038a88b14398a99843ecea77cf17_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i37f1eff7c147431d9904c45abe8087de_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i28729f1c595d49408f9bc75addee5dce_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ieabf4a292fa6473cb378b3091605b996_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ia0caea5b6e2742c49986260609ac8cb2_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i5d0c3b9efde1461b8e305f2507573310_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied5972defca747b08dfeb7847dcbf9b1_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e2b4f10aa894a52a243db283dd48374_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d24641160994798813313583b8c5313_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TrustForBenefitOfEmployeesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib38bda0500864764be978f7cbb680740_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b19ed61f4414f2e89fb8677352c10c6_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6809dd88ee6440e8b81974c0682727a5_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1796d16ca7c4cf0894522a6f064e12e_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia172fdb106784793868c32f3fe4a033a_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13cf184e02084806adfd29b238e3b85d_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i044825e6cd0d4decafdaae3baf84a330_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TrustForBenefitOfEmployeesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9cff35c3c8c34c0fb04c18abeacebca6_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21c6412f9d1948d19b3452207237dadd_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28fcba67335d4eeeb35e767ac7467d7b_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib48f338ea64a4a6ab71c4d7e3fd06673_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i55ef102ce6314f71bbad20789a340a44_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="idb26ceb80a3d4067ad9572aeb3904905_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i97b74653944e4f17928c61ac64c196ad_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i1b27ad5aed11494a84032093fe25e25c_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i5c81da162e9a42e2a66c2c1a06d48dd5_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice411cf446b842b893447accbe09511a_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ebf10616d0b4419a14703502b215705_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i422ef8f62e714031b35d70b78011fe07_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TrustForBenefitOfEmployeesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i405731ae56194b5ab8d7ef0f5a2a4501_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7890664142234b2cba495545e31cf06b_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i874cf6e76f6143ffbd4b62dbb7d9d39b_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e4e65510f9e48218be4e6b56cc6a8e6_I20210531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id40dc90365d54458840dc95bd54da311_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13a4d036feb14d029728aad2602198e3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89632ef2fab645e59b17e0d04998f005_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03ad855e73c7425c82de6d5bf47f2c5c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TrustForBenefitOfEmployeesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f26207c7675459eb15f8af1fa1954bd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i475ce37d989c466ca8d104299897d8b5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd150ac2b08f457b820ab337af8f787a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaae84e0e259740269afbdc32023935d8_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="if4b3bbe2d1454aa7b635ddfa117d7690_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i53f6912753594605b21dd0402024a8d0_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i0f7811d1ec7f49e2b3619fe9097a5c81_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i43c09d3fa78d4c5e896029e6ef10d475_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ieb70d5cf9dee4eaa8c659c22eeb4ea9e_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i272cf8c25ebe4484a64e58f12187ad1b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf8140dd5b59491da9ea91218accebc6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d075318dc464943b61778b509358518_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1b20bf098e647cbbe9a5c1797e3b7a9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TrustForBenefitOfEmployeesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i016472e8315c436a845438f1b48dc880_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39c60ea04aef49b0830a61d60786759c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a1a2f4319ea49c8a9891d557b01b308_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53fe950833774c68a3cffa46aff8f74b_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i78ac3ae89d8a4e4b9b5634d9c24f6a88_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i318f185707b94171a8496548525b0a43_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i5fb9024f659a4c12b2ddd5ecc6dd8e7f_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i668d06cad6064c9488359f57b6460125_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i1e65888bb572465d96d1a55aaa12d167_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i82811f99128e46738e63b2b2f09a72ef_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5fcc694940794a94a960d8f1f9315381_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if42877c131ac415eb21599c372b78f90_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i80d1b089c2a644458859200e15f563c8_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="id3dd0ce52c8549c58e5d29bb1bb1c197_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i1962268fe5e4415bbcb7e76b2f694425_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ie24dcfd7665d4948a6b3ea63d1979c25_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:CollaborationandOtherRevenueMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i28f16eccfa8b45c9b2f74cc6235732b4_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:CollaborationandOtherRevenueMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i3ebb89e75b934815a2a398afa3315ad4_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:CollaborationandOtherRevenueMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i0707295b42774a95baab2b522f5925a8_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:CollaborationandOtherRevenueMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i34aeabd3620f4de8ad8c2efefc863807_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ia0d2323337da484fb1444b8262ff7a7e_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i16836baff9c344308700232bb53196d6_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ib6db6b88271640b7be37a4c3c9f838c6_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i46e52d8ad0e14ebf9fa7c9ecc503bbfa_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:ChangeInAccountingEstimateByTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i72b37618b2b848e48b6d7a66628d0ea0_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:ChangeInAccountingEstimateByTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i19f0f8e72ada412eb34eae9afa79a051_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:ChangeInAccountingEstimateByTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i7685d8873a9b40f5bab0b11fa36b225d_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:ChangeInAccountingEstimateByTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i28a49a83c479441f905c7cffa76d0d1e_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:TrulicityMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i7ce64df6d312430cadd360079f217dd5_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:TrulicityMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i345b235e6d564f1bb6f06b9ed8319a72_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:TrulicityMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i89ca472eabec43fd814b3653fab15181_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:TrulicityMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i7bbccd7a5a8e4837a3a85f1a2b3d2ef1_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:TrulicityMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i46a90cbffcd647a5801317b946ab5209_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:TrulicityMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i5546f63545a844a085ff12b7f2497571_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:JardianceMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i348983749551494ba7808729a9dd6254_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:JardianceMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="idfba5b60fbbe4370bad16f003f72e3c1_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:JardianceMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i669b22e2d64c487fb8bd01c345ab7f38_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:JardianceMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i4ab46b2a51674189a54630451735b250_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:JardianceMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ia28641f7c767406eacaa8089e13a2e77_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:JardianceMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i233675fe0cc34caa880f2ae73fa95cad_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:HumalogMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i404df183ca794e64b829a2993c89673f_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:HumalogMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i6069340928544f1d98e220d601c0ccf7_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:HumalogMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i4b145726bc2c4ed78a3c2ec12b53c5c2_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:HumalogMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="id28218d7550a4cf4be526f83ae1c7332_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:HumalogMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ie59d14500008412ea099e2c09441a042_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:HumalogMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ib99bd175ff46428092a6e96c970b94c5_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:HumulinMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i644d2f1188e14878aaa508d910b54dde_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:HumulinMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i7cc0d4df5329427cb7da48ad36cb2efb_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:HumulinMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i02d6e02b9e20402bb506e5e37520efdb_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:HumulinMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i40d7116b6c0a470195c3ab9234e5bb0e_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:HumulinMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="iec80f91e475941f1abdc131fd14d868d_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:HumulinMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i529518415079475fa56a8916e119480c_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:BasaglarMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ie34f0db27136443ca391ec67d20f46cc_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:BasaglarMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="id6f3b41d10de4dfb99b809554e15f4ca_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:BasaglarMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="idcd8ed6a0f624997876200ae1a53d3ff_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:BasaglarMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i1981e978a66e4861b39ec95f950a699c_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:BasaglarMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ieef95d1c0c4643f8a5a104c9301c56f6_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:BasaglarMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i7992fe4fc5774bd6aa8b55cf4d326364_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:MounjaroMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i47be57988ea94c92b33e106ae820b8f7_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:MounjaroMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i22fcf936becc4b56b4c435b41fdfd4c7_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:MounjaroMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i866b02b106bf4510aa3acc82ee4887a0_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:MounjaroMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i99914bb8f18546f78ea8cdcaa7af2939_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:MounjaroMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i9094ecfcbf9c4d8bbe63fc38a5f24df0_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:MounjaroMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="iceaf7dbcd2d8486cb982fc3658598e56_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherDiabetesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i05fc368927fd409998e10fd8a8626ff3_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherDiabetesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="iadb96dab5219493a8a09e4ef5a30b381_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherDiabetesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i26f16b68de674d2592c2cd9ee9755295_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherDiabetesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ib4a6a3281a6e41eda8915c8ed31cf4c4_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherDiabetesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ib01598d835464cac82cecfbe826de92d_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherDiabetesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="id8862697b08648bcb4c7b9ad3dff39c3_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:DiabetesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="if00d7a9221f04fe68817babf35f51ebf_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:DiabetesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ic1a606c172db416288ba0bbd8baa9966_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:DiabetesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i9d79583b71134ad5b1affaf7d3c9e867_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:DiabetesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i74d4b85fd2a346fb93493d49de1c2bce_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:DiabetesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i42ad32bd431444b189dab3e866f14dce_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:DiabetesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i0c515dd1cd2b453686e3e31d8c9a32d3_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:VerzenioMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="id154bceb5f3a4af7bf7c046f1608e110_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:VerzenioMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ifb827f745b3b446f900ce979a433b71f_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:VerzenioMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i1f8a0004521c4a0ab278bcec0c67c5bd_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:VerzenioMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="iaf75ab0eae484bb4b01f61ae25f750c5_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:VerzenioMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i6b3d0e422c9640ab9313c19640d9fd90_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:VerzenioMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i46e236388c73464e81b03a5d53c0dd53_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:CyramzaMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i5b6d4e4158744aaa95ee5bf00acb80cb_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:CyramzaMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i4c1435377d2042d39e6953c271d4585b_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:CyramzaMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i176af1ca7219458c851326db4f5f0e18_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:CyramzaMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ie4ca284b63654c0bbf5fc3646e324b1b_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:CyramzaMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i48871c7176154dbb971dc8a40b431eca_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:CyramzaMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ifc30105eafd9459d81eaf411eb4da357_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:ErbituxMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i84fe5c0fb05340ce93ab592130765d86_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:ErbituxMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i75db1e7f9d154c588f6bfd88b08dacf2_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:ErbituxMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ifb220bd49b9b4fee9a08cf2aba4811ff_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:ErbituxMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="if441e31221c74fb7b06ce4acda75a1ac_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:ErbituxMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i74ebe2d40f834c6aaed2f9503f82b5c2_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:ErbituxMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i51fae75c655f4c9db22deca064e1d22a_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:AlimtaMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i814e9ebeca8f4359b602b1c4116691fa_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:AlimtaMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i093d47ca61034ea8b9f0303b73074f6e_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:AlimtaMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i5b8a2c0676cd456a958892b0fdc5f275_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:AlimtaMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i01f53de517814e9fae0973ed84a89508_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:AlimtaMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i91b98892233a42579bec90b2f1f07fad_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:AlimtaMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i578736c37abd4751958301e188d9a111_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:TYVYTMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ic105c32b09d5439ab48f1ea47e388e5c_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:TYVYTMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ifc8fc5f6c1924a46b0d88ad7ea894f53_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:TYVYTMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i326cec97451b4c0fa64fb496bcc0d262_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:TYVYTMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="id6f0f8b1cbb14fe5bc88c77765723cdc_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:TYVYTMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i9da960751fa245d8bf93fa1681ead439_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:TYVYTMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i4280b008d25146138bb9937941f505ac_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherOncologyMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ib83a82fddc51484f973f835759a83951_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherOncologyMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i7add942c6a224625b4aa726843340e48_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherOncologyMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i010a412d535641f895d21d4765b984db_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherOncologyMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i9a1ab61d480a42babad1c189210b4f6f_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherOncologyMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i3d24e8995a5a4ced9875b8b9174e8096_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherOncologyMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="if7ca1b1b8ebc4b97a61e679591aa9aa4_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OncologyMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i98dec2ee927948db8ae6249a13fbc06a_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OncologyMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="idacb7a7257294fe689d448659352e301_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OncologyMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i573f860cee384e44a092723fc9aaea21_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OncologyMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ic45235af254e414c87819d6a61117897_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OncologyMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i3490b47c9d914a7a80f4c441455b8ead_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OncologyMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="id3ed2240ab2944e1a3695929ccce3c61_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:TaltzMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="iec46bce8b1474abc9815b6e1b2d7a169_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:TaltzMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i800167f3776142a4bf399d8f51830c78_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:TaltzMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ia22b346dd2a54714a0f4ba483559b116_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:TaltzMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i0852df9f516e48b4a9af370971f46a78_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:TaltzMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ia60c521d441f43a2b5801e09809d0abe_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:TaltzMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i16529d5d29744762b0746672c1ef5cbf_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OlumiantMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i2456bc73ed7d4b8b8bc891900fd86004_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OlumiantMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i65843c3594444a24be3c2dd715fb25e8_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OlumiantMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="idef6b1951baa49b98d6da883dd4d89b9_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OlumiantMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ia1eb3846894a440d9b3b08cf8304da43_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OlumiantMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i342e7e7b465546ffa22256042c6bf573_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OlumiantMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="id0dbce0c2a604a12ab2550f876430b73_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherImmunologyMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i32547c688b2942bb9648bd77d09fed5d_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherImmunologyMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ic666c0215c174e0da07f4d1e09afbca8_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherImmunologyMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i24578a0bb60d41509dae6c91cf840cf4_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherImmunologyMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i797465f9dcae46679ecb0c162248cdbf_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherImmunologyMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i01bedd14598d4bef97fe5433a5abe2ec_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherImmunologyMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i0bca0633651d410a8f37cdc991be5df2_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:ImmunologyMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i0952e420996041498b88ed77f880c508_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:ImmunologyMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i6386f383c2e5484da28e805bf356222b_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:ImmunologyMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i4d8dd9cfbda345988f0d1cea4fac4546_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:ImmunologyMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="icff9e13bc98e41938e743e7a4e4fd6de_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:ImmunologyMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i5adbec8a8b6b48f7a5d1e48f49bf3411_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:ImmunologyMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i358dff328e02486cae97aaae267517fd_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:EmgalityMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i9c4b3d872761408cb58a702f02c9d3dd_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:EmgalityMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i88720be3d2b447b38eacb349e966b957_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:EmgalityMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i306f66892e60463a9440dd8625f955f2_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:EmgalityMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i830b5f4dd99f475f892c9b95d9c74688_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:EmgalityMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i04f1fa38b33d409c95edc1ca5dddc792_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:EmgalityMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ib3165ffc22844091b6dfdb6536ee8f81_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:ZyprexaMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i93ab8179e11b4f23a7909ff2a1a2042f_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:ZyprexaMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ia17da4c4f6b642d596703193f6afe6b9_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:ZyprexaMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i870e9a03322b437eab5ad616b9b96c9f_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:ZyprexaMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i119d9834ae424e7fa424cf206e1fa0fa_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:ZyprexaMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i9028e0822d8749e59ae82cba528438af_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:ZyprexaMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ib6ab25c06067493bbca70a4e7597fdb8_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:CymbaltaMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i85be7a9452cb426a90fedddc2f455b01_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:CymbaltaMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i2b6eac789003419ebceebcc13f624925_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:CymbaltaMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ibd3368429e0140009581d9d510f8d8ff_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:CymbaltaMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i734fc13568954b75bd88b7375fbfa00d_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:CymbaltaMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i53769ba188564f8a86965473de7ac7a2_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:CymbaltaMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ic8c180d54e944d17bbbf0438a4c8f563_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherNeuroscienceMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i31bc9c1361964102bc7f26ff4a6390ee_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherNeuroscienceMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="icf97b2cc85a442f5bc488f333e264c43_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherNeuroscienceMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i7434dc344c6b4a99973bac3fef8d4f3a_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherNeuroscienceMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i3ed4e34eaaf642748b03cff5ec59a742_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherNeuroscienceMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ifdd2b94511c147b0aa78edfbd1578f35_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherNeuroscienceMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i75c76b5ae8b04d0694593c6b670f2a70_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:NeuroscienceMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="if373b9f49fe74bdbbcaeb90bdcf2de8e_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:NeuroscienceMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i1f4a20a3083448aabf8de47a307ae3fc_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:NeuroscienceMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i9aabeac82be44155a967c8ced0c3a972_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:NeuroscienceMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i6d31ef68d52e4c1680dc7d71063a6777_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:NeuroscienceMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i6cb7b465f1794abdb49eb28db9903a03_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:NeuroscienceMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i0fe5df95a127467ea05981672b21cdba_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:COVID19AntibodiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ib4b9aa980cc940d3870c8d9e4046840e_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:COVID19AntibodiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ic89265df487544d48f864b30c7c12762_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:COVID19AntibodiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i136c9d207de14e89bbae2b72e3112e4a_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:COVID19AntibodiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ic05b3db77dcf4e66b1e09c07f79fd579_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:COVID19AntibodiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i05b4b2fd75f8488cafa80162074dca18_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:COVID19AntibodiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i78e14fd2e59849538d2032aed3e9bb0c_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:ForteoMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ic73ca51c96f5471cb91194277c299762_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:ForteoMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i29d5f03b98014ea7af366d7dbec08cc2_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:ForteoMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i5b6529d5d56e42959333a8689a171264_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:ForteoMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i99005918fc524bff85805ac964cb5794_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:ForteoMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i6ec8ff4aa32b406db0037636d5d11b91_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:ForteoMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="id253637b6dc04f4593c5389197fd1ed5_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:CialisMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i9b5c45eac140477aa0acc064ef0011ea_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:CialisMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i57e0cd27dd3c4483afca4b02ab1ab2ea_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:CialisMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i71526b83a9b84d10a6e1ab1807ab8e18_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:CialisMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i04e727dddbbd447c91777ca002cf2367_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:CialisMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i01198f0de24240588ceb005e3647087b_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:CialisMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="if0fe66e11e054c0a85bb68ff7d7f2857_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherProductMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i347c502b181c4a13a94b72d8e2a383bf_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherProductMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ic32c291337714cc290c1dac418f4d40a_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherProductMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i4760c4e663814ba4816919d7cf1c133d_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherProductMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i0b57a14b81924b58a902d121891b42eb_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherProductMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ib28a57467090415586ea5d4a46d5a6ff_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherProductMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i3bfde2172ab44bdb98ffec5b7744d66c_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherProductTotalMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i4e976e03f8b7452b97fe7c6fa5a98acb_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherProductTotalMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ibb8a914c841d467289183242e217e8c8_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherProductTotalMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i23b21b36e578436fa92bcc41739470c2_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherProductTotalMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ibe9720e656b242efa27c155f58ea5690_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherProductTotalMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i9af8cc7ddb614c4d8a4d4ce694795736_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherProductTotalMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i5ef4c6628ee44bfaba7f2e062c3984ca_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i553eac0570bc41a68be3130cb9383387_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ib7200d1730974b7f929910230bd89187_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i8bdc66e6dc0c4330955f23ef9a18d769_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ie25d63c812ca4ba5bcb202b4ef3da925_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:TrulicityMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i91615b3923a04f6a8fd92d711866d588_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:TrulicityMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i9623881a23db40a3b62885fe7a43e0c9_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:TrulicityMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i46ce2dc33fb14a94972b38a4c73c48ee_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:TrulicityMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i9d256a84bdcc43939ac6114642c9df5a_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:TrulicityMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="idb96fc34e7f1409fb5661213f97e7f9d_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:TrulicityMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i29b3721d52314523b933748df1c86126_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:HumalogMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i50fdff0f3f64436b8220edeb6c5da6b9_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:HumalogMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i2bbcd6ec5faf46bc81ff607368bdd5ab_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:HumalogMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i5f2bb68aeed244a48b9a5b9fe2b0b039_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:HumalogMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ib6a78f62d5834a11a82558249ee89a7a_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:HumalogMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i6afc7019eb204b20bc59d3a19fef7f74_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:HumalogMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i1e18d072344643ada09a2e6559995804_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:JardianceMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="idb016f4e6a094b91ac0aee6fd832f15c_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:JardianceMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i1c01691865ed49fc84902886c99bbbdf_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:JardianceMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ia2d8d981e4314247892b22b49b01d418_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:JardianceMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ie65c118c7eb54da8b92e056d23b07e85_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:JardianceMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i46099dfb95b0484ab5891f186d350f52_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:JardianceMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i3ad9a3d1e7704c9f8a4c92e4f18248ef_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:HumulinMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ib4c358f120c14431858d22fd921cdb1a_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:HumulinMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i97453ba9a92b4601b70738c5fd865a63_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:HumulinMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i9a4be59d818242b8a5d6e29a133e78b3_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:HumulinMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i74ac58ad376e44179242350ff8091245_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:HumulinMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i4d442db3854641bb9c50b1533223b1bf_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:HumulinMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i9b84a7f78d3743f383680162b1a79677_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:BasaglarMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="if1fd51de24bf4269a3f10390a0eb16b8_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:BasaglarMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i1f95ba5af9c24c3eb20dc2c5a3979588_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:BasaglarMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i9df6a30c7e76498dbe8e2c10556551c7_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:BasaglarMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ifc6cb890a5e04ad3ab5d2c0f4a2935cb_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:BasaglarMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="id065d1641c8b4bc19bda4f978edc7f70_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:BasaglarMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ie9c6e93828454ef795aef5751d0352fd_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:MounjaroMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i844e2c3c4d3c4a4eb90a291b6edaa117_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:MounjaroMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i8d0e3b68ad424288aedc96a1c3c5e2d2_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:MounjaroMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ibd146a846a384a1cbb7ed3016e2cb317_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:MounjaroMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="idea0b040a90e4c93ababd4c0d4f02647_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:MounjaroMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ie993c12313da41f38573f6bc42f10868_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:MounjaroMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i1ed26a3d9a8b45559192c48d5bb034d4_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherDiabetesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i4cfbe889964e44e3a453aa644188647d_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherDiabetesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i1414ede1c78a462e95bd1b8346592f8b_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherDiabetesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i20194883f2624f82b663260d5199fa21_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherDiabetesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i820e5b799761449bbbf32e97e1e019fa_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherDiabetesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="iab636b5286134cd7875bd3dfdf73353a_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherDiabetesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i1356cd272fa54029ba0f0c21fab222b4_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:DiabetesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i19fb57248d6f41d19ef8485870fa08f3_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:DiabetesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i2a4c43c5e76a47ceb09387d84fc5d358_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:DiabetesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ifc6e032f5a9d4001ba9413713acf7354_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:DiabetesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="iabf6366b8c134597b8ac64603a6cb066_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:DiabetesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i44a3630aeb244ec2ab5204f6c1650459_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:DiabetesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i630ed70ef3804cddb8e7bd6a2c884284_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:VerzenioMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="id50357546429495db587cbaca50bd352_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:VerzenioMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i20c536a6925e49838b17da59e54c92aa_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:VerzenioMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="if8fd3622c0c34f5f942c2bcf19a84b1b_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:VerzenioMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i08e4bcea32b741f3ad619cb7789236d1_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:VerzenioMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i6ea3180802c144d4924a8a4b8a919abd_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:VerzenioMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ia0759c0458d14fac885984f8686a83c3_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:CyramzaMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i234acbdded404fc5bcf21a6ea711e9ef_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:CyramzaMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ib28d65608ad54ff9b7e45a5c0298b338_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:CyramzaMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i98867991ccbb44078d309a9dd8539a71_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:CyramzaMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ib811fbcdfc1241359475319e63db4106_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:CyramzaMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ieb20b9b0be4f46bfb05c7b12f39a6a9e_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:CyramzaMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i64bc0872b6e94aa7bf69b1268d189134_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:AlimtaMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="id1a6ba9c9b6a42638bdfdbee6e6f2758_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:AlimtaMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i07ddaa6f5dd549048da689638ae982f5_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:AlimtaMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i9571c6749464454692162cefb3bb7738_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:AlimtaMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i546701dbe3cb400c84bc62c598271f8b_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:AlimtaMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i70cb0ea9b68f4680b98801d50a608b14_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:AlimtaMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i40507b3da3804796ace099350f243c27_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:ErbituxMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i680ed22913654e2ead217f9b5989504b_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:ErbituxMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i0088a078fdd54003819037635cb52f70_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:ErbituxMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i27e99c349c3a48dcb14b9a15ed3dafe5_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:ErbituxMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="if0246564d9bc4f02a5441b1f2566bf51_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:ErbituxMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ic3c22691b22448eca997f30d1f1366e2_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:ErbituxMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i0302245b5cc5492d85c394bdbd9a59c3_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:TYVYTMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="iab104518f25b49a4b922a68ba94e910b_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:TYVYTMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i6633f1ca883b4a32962bcd825ba66bfc_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:TYVYTMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i6761a6ec70464bd2bba2e8b31d7dfb55_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:TYVYTMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i68cac27afeeb4c6ca2de0e2af5aeecd2_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:TYVYTMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i3a42a2407e7046519687e4401e714180_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:TYVYTMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ib89a61de2c8542719d727ea9b2e4d288_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherOncologyMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ie1753f6d5c4044468226ef9a5f59457c_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherOncologyMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="iffc444b9d88245d5a3bdb35b82ef0d55_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherOncologyMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i85c317c4af504382b28dfedc3facb2dc_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherOncologyMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i6290305d31574c06901b06e6eacfd414_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherOncologyMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i7bf748b95e7a45cf9e722167434f1385_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherOncologyMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i240fc921c5ef4622986756418d0b3d39_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OncologyMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i5db5d222d3da4495a3cd1481fae9b1eb_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OncologyMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="id3038a6b1fd04b43a1855095f482ffd4_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OncologyMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="idf34cf4a2aae43eda96963b778a49168_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OncologyMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ib71c38ea0818475aa548176344240c72_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OncologyMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i7cc9d1bb283d475d915f7fcb4f945c8c_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OncologyMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i08907695f17c4fe487c0f59792752c89_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:TaltzMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i4d2d7d0cc9e04232b6d62adfc3777b93_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:TaltzMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i7453a607ad674e25bbab08ef19e88d3c_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:TaltzMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="iccd3059fecb04f1d94d0044c6e3c7e32_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:TaltzMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i3036c3ea47bd4c89bafa4bdba1320abf_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:TaltzMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ifea4d8eb21b94b0ca8248b42f02b49e9_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:TaltzMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ia4036604f9c945e1a19be8b3aa38e334_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OlumiantMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i381560b71db64644aa7adbc056fac279_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OlumiantMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i5da2c0b8af014f4085d9e2a62f64ccc7_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OlumiantMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i9a1215ba2eae4c7da8010b728800b4d3_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OlumiantMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ife8cad1b8c0f45d89f7c79beb6a9506c_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OlumiantMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i681b00cc06e740d5afd240016ce29efc_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OlumiantMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i8cdc5308202645dfa9f06b53e46a162b_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherImmunologyMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i6010298ee7bc433e8bebac5a5efc972e_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherImmunologyMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i659d2c39bfc34df8bd9f7d944a3822a2_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherImmunologyMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i61df0f1a279148aa9e8254f5980c32dc_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherImmunologyMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i1e4c4171e5c3493aa1885a72fe4cfa14_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherImmunologyMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ic9a4f1d7373649528e8dfb81328134a4_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherImmunologyMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ibb0659e3898241ecbd83bdbf9dc59c78_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:ImmunologyMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i4e251958291a42a3a1c5447458b86d15_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:ImmunologyMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i8aaae8dc85e144a6a4bf886fd061d950_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:ImmunologyMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i2d035bb38a454213828a14551e6edea5_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:ImmunologyMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i71c9047535fe473ba6d96eba16066ad6_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:ImmunologyMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i4cef6079bf0146839ee9f000bdcfe3c4_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:ImmunologyMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="iaf50cba6df584b358ccfd1c552ac603a_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:EmgalityMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ife6ede2d6f41458f8f350cd5f6ddeb17_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:EmgalityMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i0b7c20f1ff97494783d6f4579ff8f7f8_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:EmgalityMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i2892d650df3349fe9ae882f6ae942d58_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:EmgalityMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ibc4bdc96c6434cc8b53a24c987e9c41e_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:EmgalityMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i5d73674530f248b5a702b835849253ef_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:EmgalityMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ibd5454cbe2de4d0ea429015722b20f15_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:ZyprexaMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="id7ad299a8b764bb9813cbf2dcae42919_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:ZyprexaMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ic3a68db7fa3b428995899c0bf854ba94_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:ZyprexaMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i006ca6ec8c3c4717aef2b19d419c92a3_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:ZyprexaMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ib90b244e7d0040c68677396984559ec8_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:ZyprexaMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="iedfe879bea3a496bb3766920c821c198_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:ZyprexaMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i3f91e524972e42a98fc9b5abba31e458_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:CymbaltaMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ic3c6fe2019a042c4909c317b26cdf477_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:CymbaltaMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="iee5d9669f4b344499cebdffb37f32030_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:CymbaltaMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i3f307f23d1de4f80bbe2e59ea610ff7f_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:CymbaltaMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i526c0b4d4b3140cfaf92e5209854bd78_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:CymbaltaMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i733173c6b1a342488769f27288f96647_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:CymbaltaMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i00d29df7fc444a888bd8f1ac7c7fcd63_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherNeuroscienceMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="id5a61b3abda849d981158a33cc123750_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherNeuroscienceMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i4894a69792984d28b5bd70bdcb925593_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherNeuroscienceMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i2af7293d556c4ac189783fd3d7bfa089_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherNeuroscienceMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="id7dd70175fc2484e9291653ca9b5bcd0_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherNeuroscienceMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="iaffd646b91554c9fbd55b7373a9ab9f2_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherNeuroscienceMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i177e8ff27d1b444d8032f9fd6e71b86e_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:NeuroscienceMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i20063c304d1142018b211b53b3a1c50b_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:NeuroscienceMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i7a5789bb5ddb493385ae07bb301aa500_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:NeuroscienceMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i8c8cfb5bc4ac42dba8e3851f39bd2683_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:NeuroscienceMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ib59bf69a9b284970b3b6642f7e4b795c_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:NeuroscienceMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i84bebc50684e4e1b90500bbb83bb79a6_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:NeuroscienceMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i0e5b50746e074ddabe26161b8cf97195_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:COVID19AntibodiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i2ce72c9f883a452ca19b57204999df16_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:COVID19AntibodiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ie674d270134f4cffaff8f7a15471b73e_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:COVID19AntibodiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i62f7a17973be46d9bf4530c993775bef_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:COVID19AntibodiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ifb238d01fbaa4761a5fe7a7c91587c74_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:COVID19AntibodiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ic06f11244a5a4b88822809b3b3941ffe_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:COVID19AntibodiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ifa18b54c7e0f4330b37b5256dc5dffac_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:CialisMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i8a49509981cc41bbafe688a08ea538c6_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:CialisMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="iac7de63087cb4fa28c15d4fe01f12460_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:CialisMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i80c0d99bb34b42e1adce6dce3134630a_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:CialisMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i6dd390f6ff6a43b49662e266d7334459_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:CialisMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i51c31c17a15244248305698502760153_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:CialisMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i3c39dd39688f4abb8ddb719a2260f6bf_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:ForteoMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i56ac4d65faa946aaaebabc3dc7ca99f9_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:ForteoMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i185dafd0ab80405eb3f78281a2098c9f_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:ForteoMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ice1d37ac1886488088492ea4c957a118_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:ForteoMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i33b45d6e796b4bab93b3906f52ced571_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:ForteoMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i606443bf75d84de3b93c88a5d2c2a9c5_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:ForteoMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i62be4d98bd454dbea6bd3764ddcdacb4_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherProductMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i774d30363ab447e4b7b6985e99b6de0d_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherProductMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i238722e1d54440828f51f9f11854afaf_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherProductMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ib4554ea5474043e5b51ccd4cca5610ae_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherProductMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i1a25265d56d04bc481727001f1d55ecc_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherProductMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i1fc264d1cb9b42cd927c0bbd387866cc_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherProductMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i13e5988f996e48299f0ddef7dd648213_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherProductTotalMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i3b007283f3094ae08f3a1b5eca4a7fb8_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherProductTotalMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i5b6298a19c0a4c5da470fa7e5e3e967a_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherProductTotalMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="idcc7138275c74437be6ca40f1474b509_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherProductTotalMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i7efeaf621a9e448fa08571db01806cd3_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherProductTotalMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i7fe3dcab54b44eaf90f9f242c2fe0f52_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OtherProductTotalMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i60c5eb8ff51d4d9fa0a74c53c73aa0dd_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="if326645430854a2d9ac96495205c029f_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i2783a40327b64633b6abee19f7b4ca30_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i9ff1711a07ba45ffadc911d350d44f94_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i812f3d20a1af4d92924e0bbe1371c71e_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i973b61d370734fa5bcf42303b4a667df_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i4cf771cc163e44ed8acdd62a65cc8b4c_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="id0ffca9720f342dbbe64a17e04c55d84_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ib92bd7160fd94961b7bba02ffbd18490_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i25019079a8464a91a3cf96012fcc0d52_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ib37e987842e2478dab07f58a5f789a49_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="if9ff4ce3b7704faaa359e30df99f2b54_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ic678bb62bdef4faea88b4e3dfd6a7971_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ib648672815904a56b3a3874c085884b6_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="id085508ee8c24a36a655eea7d3096500_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i4b2b1ef297534a4a801da2637a1d37e4_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ib2c80ff08a384ec7a8c6dd07798b9efd_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">lly:OtherForeignCountriesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i59dcfcfb04c94ad588f473c50147a921_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">lly:OtherForeignCountriesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i20e09a0b7eb34ffbbc4057f306b92c3d_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">lly:OtherForeignCountriesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i3c8b51c823f54bb1a2efb0592f5476a3_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">lly:OtherForeignCountriesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="id1a51594b8b04df48cf5b7eff20f7e6d_I20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">lly:PrevailTherapeuticsIncMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28f89248cda04bd08a5c9d722de7c1db_D20210101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">lly:PrevailTherapeuticsIncMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-01-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:unit id="right"><xbrli:measure>lly:right</xbrli:measure></xbrli:unit><xbrli:context id="ie6db4c7ca7af4463afc62347bd8b3a94_I20210122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">lly:PrevailTherapeuticsIncMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10a5ee4bd0c64813b300c5389565a056_D20210122-20210122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">lly:PrevailTherapeuticsIncMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-22</xbrli:startdate><xbrli:enddate>2021-01-22</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i3b190c0fcac94cb9b4d37191d35b87bb_D20220201-20220228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:AssetAcquisitionAxis">lly:BioMarinPharmaceuticalIncMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-02-01</xbrli:startdate><xbrli:enddate>2022-02-28</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ifa2b520f9b26403ca1dfc59f5150bb2a_D20210301-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:AssetAcquisitionAxis">lly:RigelPharmaceuticalsIncMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-03-01</xbrli:startdate><xbrli:enddate>2021-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i2a70d59a929b499ca4d9201b21544293_D20210101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:AssetAcquisitionAxis">lly:PrecisionBiosciencesIncMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-01-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ieacc700b698842408fe2f8c736054aa3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">lly:AkouosAcquisitionMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d940f045f1243808212f82e48b91487_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">lly:AkouosAcquisitionMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-10-01</xbrli:startdate><xbrli:enddate>2022-12-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="if142129c01ca4ea0b352f378c8bc9899_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:JardianceMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:TypeOfArrangementAxis">lly:MilestonePaymentsDevelopmentandRegulatoryCapitalizedDeferredCumulativeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i744124019ee24c83852d6d07406b514c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:JardianceMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:TypeOfArrangementAxis">lly:MilestonePaymentsDevelopmentandRegulatoryCapitalizedDeferredCumulativeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a19b281bf8a4f059256a5bba91d053c_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:TypeOfArrangementAxis">lly:MilestonePaymentsDevelopmentandRegulatoryCapitalizedDeferredCumulativeMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:TrajentaBIMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic00807c6a67343bd9b77d66d8f53542e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:TypeOfArrangementAxis">lly:MilestonePaymentsDevelopmentandRegulatoryCapitalizedDeferredCumulativeMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:TrajentaBIMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2eb6b846c0e477a94f57d35ebf60943_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:BasaglarMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:TypeOfArrangementAxis">lly:MilestonePaymentsDevelopmentandRegulatoryCapitalizedDeferredCumulativeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6657690bf5241ba82f0d73292ac9ea7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:BasaglarMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:TypeOfArrangementAxis">lly:MilestonePaymentsDevelopmentandRegulatoryCapitalizedDeferredCumulativeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91e1bea218144eab958a68c72b25b13d_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:TrajentaBIMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i9fe7212a81994bafa9e83b419cfb489f_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:TrajentaBIMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i4cbfd23e4f9c474bac8535d65c4695e8_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:TrajentaBIMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i57c459014f2c4c2797423bd9e7eff879_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:TrajentaBIMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="idfc0a5f22fb44537835f6510caaa9fa5_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OlumiantMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:RoyaltyAgreementTermsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i46a25e2e10224815a8f7d26777b2eb48_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:TypeOfArrangementAxis">lly:MilestonePaymentsCapitalizedAsIntangibleAssetsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OlumiantMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i445e64ca4f7041e49970bead926a789e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:TypeOfArrangementAxis">lly:MilestonePaymentsCapitalizedAsIntangibleAssetsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OlumiantMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i97f0fe2e404740069df426fbe933ed1d_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:TypeOfArrangementAxis">lly:MilestonePaymentsSalesBasedMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:OlumiantMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia361008dd9de45979f0de7611a5df845_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:TYVYTMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:TypeOfArrangementAxis">lly:MilestonePaymentsCapitalizedAsIntangibleAssetsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f82e7316ae6411ea23d0347aa8ad8db_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:TYVYTMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:TypeOfArrangementAxis">lly:MilestonePaymentsCapitalizedAsIntangibleAssetsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e3c0bf77cd749d8b6fec828c354954b_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:TypeOfArrangementAxis">lly:MilestonePaymentsSuccessBasedRegulatoryAndSalesBasedMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:TYVYTMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="dei:LegalEntityAxis">lly:InnoventBiologicsIncMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic7d2b40b9fc943b9bfb247bb3c25f43f_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="dei:LegalEntityAxis">lly:RocheMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:LebrikizumabMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:TypeOfArrangementAxis">lly:MilestonePaymentsDevelopmentAndRegulatoryMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7f02cde7e1c419684772d2d99dda277_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="dei:LegalEntityAxis">lly:RocheMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:LebrikizumabMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:TypeOfArrangementAxis">lly:MilestonePaymentsSalesBasedMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e48d839c4b14a2e953d735b3bb79f88_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:LebrikizumabMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:TypeOfArrangementAxis">lly:MilestonePaymentsDevelopmentAndRegulatoryMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id39a445d06074ecaa26735263645cb4e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:LebrikizumabMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:TypeOfArrangementAxis">lly:MilestonePaymentsSalesBasedMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae28a429ac4b40e2a498a65c7eaaedc6_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:LebrikizumabMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7a3c615db604cd2baec39887078a8e2_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">lly:BuyUsDollarSellEuroMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="eur"><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unit><xbrli:context id="icbc49bb61efe4f65ba8c0e7f0093e86a_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">lly:BuyEuroSellUsDollarMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77c728fb616a42cc8c6b40e0bbdd95d4_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">lly:BuyUSDollarSellChineseYuanMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="cny"><xbrli:measure>iso4217:CNY</xbrli:measure></xbrli:unit><xbrli:context id="i80a649fe7dd9480994358ed2532d905d_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">lly:BuyUSdollarSellJapaneseYenMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="jpy"><xbrli:measure>iso4217:JPY</xbrli:measure></xbrli:unit><xbrli:context id="i04bcb23b9ae84c9c9a64aca2a3cc4a34_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">lly:BuyBritishPoundandSellUSDollarsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="gbp"><xbrli:measure>iso4217:GBP</xbrli:measure></xbrli:unit><xbrli:context id="ifd62109e29474416b9bd4cb46c68e40f_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">lly:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e675ec6e62d42a9bc9b9a5e61226095_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">lly:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b6a7a49e6b543c7a9c9f34217259d0f_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">lly:SwapU.S.DollarsToEuroMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f4cbed09a8d4efbba96a84a21c4f229_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">lly:SwapSwissFrancsToU.S.DollarsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i223b03ef72744bd2b0b10b131126e63e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">lly:SellEuroMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea65a7fd63824506a3ca41c5d51257a3_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i788cd34fd44840639efca67d73c371ff_D20220915-20220915"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">lly:MaturityDate2023Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-09-15</xbrli:startdate><xbrli:enddate>2022-09-15</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i5d53c58f4c7d459489a11fd8bfd27153_I20220914"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">lly:MaturityDate2023Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c071467da4c408bbfd8f27f707626e7_I20220915"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">lly:MaturityDate2023Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17173f194d1742f38780c496d01c1177_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DebtInstrumentAxis">lly:A050NotesDue2033Member</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">lly:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff7c9802a16c4e94a8b83d2c06fbfd30_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DebtInstrumentAxis">lly:A1125NotesDue2051Member</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">lly:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i11a8fe2e658c49ab879c662bd320fc8e_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DebtInstrumentAxis">lly:A1375NotesDue2061Member</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">lly:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea81ed26b993414992722e426a530c04_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DebtInstrumentAxis">lly:A1625NotesDue2043Member</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">lly:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icdfd3853e3eb4a398286b232426b38b1_D20210901-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">lly:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-09-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i96587d4174a14444becf7821313b1347_D20210901-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DebtInstrumentAxis">lly:A395NotesDue2049Member</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">lly:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-09-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i750c23289e514e58bf58ede4855592f4_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DebtInstrumentAxis">lly:A395NotesDue2049Member</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">lly:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice18fb651f95409d813656a157f34daf_D20210901-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DebtInstrumentAxis">lly:A415NotesDue2059Member</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">lly:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-09-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i50894bb5721f4dd58072e6ce75ebf15d_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DebtInstrumentAxis">lly:A415NotesDue2059Member</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">lly:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice022568bdf042618c2c002393cc3c5d_D20210901-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DebtInstrumentAxis">lly:A3375NotesDue2029Member</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">lly:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-09-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="iccc6f8c08fc6454c849c681a4dbe3d01_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DebtInstrumentAxis">lly:A3375NotesDue2029Member</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">lly:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i65012aa62d474ff8af6d08eeb55d206a_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">lly:HedgedFixedRateDebtMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ib627ecf64a434a6b8135da0ac7a5fdf7_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">lly:HedgedFixedRateDebtMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i1d213f8c24344d22ada6f016432acea5_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">lly:HedgedFixedRateDebtMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i41a4fdad9bd748be972c155f2f3acedf_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">lly:HedgedFixedRateDebtMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ic55d4cfd09d8486a8b6e1be77dcc5426_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i519d9df9a61b4cbf87c342e3496785cc_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i7bcae384fb484b6aa3e84e7d484b69e9_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i4cc8664469d846a2b0472f04c7e39442_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ic1eb1816cd7241e7af47383c68f534c0_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="if7cd0109836d43de86e2c830d47c9aec_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i5f64e83e66774562be40774b52732fd5_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i9ed2f279ccc74f238d18ee7977fea9e0_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="iaaffba52583d4dd09213c45974bda81f_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="idb22c9f9ae5f42d5b5d0691a5daa1547_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i00fa96d219234882925d8b07dc0e9a2f_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i5a4ce07ee9fd474a956ccb68a6af4713_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i0803c43adcc2406c8d72a961bdbdb03a_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">lly:HedgedFixedRateDebtMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ifa347bfa67994dfbad7418e0ab44ad66_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">lly:HedgedFixedRateDebtMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i9300bb3fb0c149928c10ce50be156517_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">lly:HedgedFixedRateDebtMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i65cd935c26b44824a9d84d0554032fa4_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">lly:HedgedFixedRateDebtMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ie32852c9ac004e18a40bd3c886375fa2_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ie539446ea66443f18894fe65b477f3f2_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ieb0755f46c634be3a274f37154dcd835_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ib38ae8d2eee24da7b665b5ba4af2fc25_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="iee72a06ebc24478d804a01c9c07503e0_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i847e2e726f374b8997cd2f409d0da50e_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i04964a8dc75f42aeb12d4f04a8c4b0eb_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i735c7ed5628e404298cd5de9565781a5_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i874a4fa6b8034fb7b972ede3e49e5375_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="icc403fcb68ad44ae8c3d0f5675e78f2a_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ic9cf169896e649948e7319fca615da6c_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i792ad77b79a7422690de67f74dc5988f_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ia25fb80ee7f14608ad1bc42cf7dc3d85_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb1b4d0ca2904d3699b0c20378d2d4de_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i909f721d549b4d17b64fd5ef7a64ed65_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida76f129eae2411aac66cefe0c47c6fc_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic34ce18d9ac34702bf22cdc268d8fddc_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice641419095d40b58b1ec413657e5350_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifab6a7669381463baa4bcac0c28cb1ec_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8f3a57231c145049540a666d70b036f_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0bdbf4b6981d423b84e97332dcaf6c1a_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if1140c058291487fa611ebff0a87770b_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i78d99dff74e3423da8f09146d5ccfac9_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i047635964deb4302a146b6e33a2497a8_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2743696771f346c8b079973d11a7071f_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33275a4d21e64200a487dc63563ca001_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a4a874cc47f46a2a264722d13461f46_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b78e10d989e462c8d6d0340d904cc92_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic182ac3c1369411e8483ee598bedbe15_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5db88938a794a79995152d200739e71_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if975bb8107f649de87a30d9d0518813d_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i035b6f8bf7fd4eb2ade6d5c56da79b71_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i313d32c12b5e46a3b70bb355b88d33ae_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia62987f3e7a14b4cba45477046b24356_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81cc2677a958476298d6e691a227d2ef_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibafa8194f14245d092cf8e3fef7acc20_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if5c5c6181311407dbfeb6b2bc5dabd45_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4cd5419a2b1e4f1dae5ad80e024ffbd8_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa5439e6f71a449badc6db614afe1fc0_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7e1bfc7167249e09fd9253c7056e6a4_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i184415738c194fc89b0a1a3ae91e05f6_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99cd69cddcd1432eb41f86a6c107e126_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9351338d7d4b429093117dd87f8b02de_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98487cf76fa84cba948c2fa763c08c17_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i921241c16da34890a377c6cc0f05bf9a_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8c508d73f5d490c991f152f357c2edc_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4fcf6ea2160140fcb9374937bebdf459_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5892dce618474c3397f2f21748d154da_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i839d1d25f31e4a1e8f8686d85cd27d6f_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">lly:OtherEquitySecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66f937e8eb9d439fb99fc1eaf5bb8229_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">lly:OtherEquitySecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d540d6e9952406eae86fcb404c8aa3f_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">lly:OtherEquitySecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac853f32fb164d5dbb16b853b6478ad8_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">lly:OtherEquitySecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d0248c83e9f42aebdedbe45913091c1_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">lly:OtherEquitySecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f00b6f0d7a346a0bbf8ca789b9b4986_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">lly:OtherEquitySecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id469158a1a2340c0b51dedb185916c2c_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">lly:MarketableSecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2330a365ee524585810c28f7dc20e39e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">lly:MarketableSecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb940b9eace84fd38c98429f0f9808ce_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">lly:MarketableSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib28917d514b84c3397d29e8e54a589da_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">lly:MarketableSecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4c3874a92684287bd36704e5ff16e8a_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">lly:MarketableSecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i700bccbf1683474084361d2cee367dc8_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">lly:MarketableSecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7532b4a86304eaf897b92f1ef90f733_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">lly:EquityMethodAndOtherInvestmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3b630730b424a6d8b697cf0362c83d2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d06252e717445c989a037b2b13d0128_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6802f141d8af4b8aa65c6abe305eeed2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i124320eb89ce4dfa87c2f2083ad1e10b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f37875c8bb94fed916b3375076f0703_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52e3293fb124489e844061750e511c35_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i70cd211932aa44d4b6f18e4a94acaa15_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47952f5ad6b1477c8890a2ebe950ab13_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iddfe43e26a024cd3b793575cebd70372_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic82b5cca8a0748c4ad44ff28aa5c8c63_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19bcbbad1685404f997100cdd7ba2b51_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb1ad2dc0cab41488bb60c7f417df54c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb25438d52ac455ba62e9095554c8121_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iabe3e352015e443c90f93e7aee3a5340_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d09607d938a418caf31b9504379627d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i70c1a238fafa4e82bb91738050707531_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94da7f9a237b4f5d92545750475e0865_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iace537990e0345b984d5d9b511dbd56b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i122e96dd9f3645a1845a400915d238b3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2193cdcf640b46f79e5eb9ee0bdb3eb2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb15d5720b2447969c89619f23a52bcd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83fbafd3b87749b69732c68f1032fe86_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if5e4829c2687480ba72b8c79c38602c5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e0c7dd136f94803b44868029c626465_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77a8bad9e7b643b3be999c26e7f341f3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3729e6381590490cad36d5c52a3a9a30_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i65d4f921c43e46389cd396c859835baa_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifea7137c64a940b98bfaf9336e0de8ed_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb1fc1f870e44eb8b489ae050e35d2ec_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5843990a9b9642e089425093f642f011_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d4a6fcb14b84769a71beaa7fadd7543_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib55c35900e8f4879bbab1c3db2b414e6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i514a63925c814a928a17a95e4d93d7cb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e737ad3e2234f028bf65d35bf37f064_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8e9125bc9f34767a3e05b3c767b3498_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0e7cf4206ef42778711f85fddbfe12c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37d081dc80d549d0b7cf06f3dd0f097c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">lly:OtherEquitySecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iebaf7a78928c429596dc216106cd2f95_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">lly:OtherEquitySecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a82bacb2ac843e1b6f6f2fe0be9b508_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">lly:OtherEquitySecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iddd8d40ea4024e44853ebae245c8ff89_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">lly:OtherEquitySecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee09e9df8cb24a98b446ff1b40b49036_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">lly:OtherEquitySecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76efc9c2d361426a8fabf8f468eae443_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">lly:OtherEquitySecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i900be75d24cb4d0e8aaf431324f245f7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">lly:MarketableSecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0829e7b5687473690dec2d117e19409_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">lly:MarketableSecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icdba688916644cc684b154cd319074ad_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">lly:MarketableSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i74870f5304a445feafaa0e95c37df511_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">lly:MarketableSecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec666b23a81840999cae844ee05abaf5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">lly:MarketableSecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4dddf28fc04840efa98b6944bdadf64c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">lly:MarketableSecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89e7fea8ea92492693f830dd7afa0d55_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">lly:EquityMethodAndOtherInvestmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i49af86cdb4774f6da136e21a258b9f38_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b96398a66a144a9aa05b43dea309d1a_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9eb05f2daf0940029ed9c6f6079b072c_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0cbd0bb84e934e18aa8a68f2ed4e3278_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e03886140d04a0f90b726a0b8cb04a2_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1da8e0f672e4bc390cd335a91d4cf83_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7cba691ea8004d118d604043b64cd431_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1657a9a2856448687ac9aaada343dd5_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i020782910cc740779ffa9060458113ba_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f69ca689c7e4d23aa1cab488bb7ed65_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1300d5f8c7d44be79cb93f333746c580_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaca361ecbf3749b7a324afc87754e17e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ac9d317ae404d2ebdc37459bd98e0c0_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6a56ab1b3ed4c26b10443b11b7c0c23_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7268bc376574172920167043f112985_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id872aa3055934897a2abffb3543add56_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idfd9f0975707442aa9a203b7a16441c5_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2eb41ed3d014ed4b273125814f78a0d_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79464644e1f741088bd241cb52754676_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35a8009df6dc423f85c1ef726d565a66_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib616e3ba735b4f66ace91c9075e315e3_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d14a5f5fcc44e8b974f3d717097b500_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7cf0b43a5a854904951946bba3c063dd_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie06f4bbec8ae497db6f7f77940abcf72_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd5c8623b0274f569a6e9cb890fe814d_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id0faa86378a146a48b2256a18f02b7d5_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec96867cd1734fb382b9a966a90c804e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d0b53a09fec472eab66541ef6214321_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1354c03ac64d49b996ad815decc0f6d7_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc6aec644ba74dffa95a469f4848e6bc_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a65232f1fca4f95abbb3167ab435068_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i40ccf9cc0ff7401eab9722772af73854_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4aa9bedfa4ea4600ab40f4f731255ce9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a47a49c720948c3b475ad8f3cf1ff16_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i024a1912186c40c1a4e62a542f42350c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i318612662ee348ca8f4c50e967285c42_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b3448a25ab94a89aef263d03a2bd29a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i841d22572a894c128f4304c5a9d761b0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie51a0fafa7104530b58bfc8df0b750d4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0999361082eb4d43bc2fc7f00ef0bae3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a94f32b7cb642279222210de17f03ed_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab252218731740b9a75cb6728b7b9503_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a6a92fb8f674015b49e7f493a12c723_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee54e09047ba4b21a41fa3c8cc49cec2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf2c03c7d41e4db1941ec3f47533b5ac_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09f8de57c8924dc5916922a278ad4eb1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1339ff825ab84e1292a5f32205bb84fb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iddd7166aae2b440ab53a23a0b63e2aa9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic06c23f16f4443f78411fcbe2a43f013_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6485e6d1b024de18d35df5658693713_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9674dda0210248f68699af728a2b7366_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05396d0962d648b89a38691fab6227da_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i637a8ab6a8a7402880d7c301d82ac216_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47903bc5967647c3ad861c42d533efb5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22af614be29843faa74794b4926362d9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i62df949acd3f4b47ae7d10432a08e2ab_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-12-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i67750cd7b626486fa748e5b71374a667_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-12-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ifea67e1feada4a8c8d0bf25c34910e9a_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i19f7d57c42aa4dde893b82e5f134cfc1_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i0116b5022f7f41b494fd355fe823d76e_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i8a97c43966fd4f6aaf5f8dfb7bba4701_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i238afcd7e9494cbb9f4c68c1cf1dcc2d_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i6b0c929331c241cb98c2a4d85625e2e7_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i60435d86ecc44d56b9b471e301119ba4_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i146fcce3fad6486aa91cf7ba94fd98c8_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ib414aaa5a0174c7fb17ac9898d399d32_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:LitigationCaseAxis">lly:EmgalityPatentLitigationMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="patent"><xbrli:measure>lly:patent</xbrli:measure></xbrli:unit><xbrli:context id="if274934ece0041f487b43797bc8de648_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:LitigationCaseAxis">lly:EmgalityPatentLitigationMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibcc5f2496e02449abe458e54c0a8a61f_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:LitigationCaseAxis">lly:EmgalityPatentLitigationMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58d8155218724e10a6956cdd38ca1bb1_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">lly:ProductLiabilityMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:ByettaMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="lawsuit"><xbrli:measure>lly:lawsuit</xbrli:measure></xbrli:unit><xbrli:context id="i03a0a6037fc44e39af8b9a0fc87cbcbb_D20090301-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">lly:ProductLiabilityMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:ByettaMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2009-03-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:unit id="plaintiff"><xbrli:measure>lly:plaintiff</xbrli:measure></xbrli:unit><xbrli:context id="iedfe8e594f2d4534ba3f7d18996055ec_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:UnfavorableRegulatoryActionMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="site"><xbrli:measure>lly:site</xbrli:measure></xbrli:unit><xbrli:context id="i7b4e96e210ab4559a67ee97574922011_D20180701-20180731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:BR</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:LitigationCaseAxis">lly:EmployeeLitigationMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-07-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:unit id="brl"><xbrli:measure>iso4217:BRL</xbrli:measure></xbrli:unit><xbrli:context id="i983baf60b46f4dc0ab264f727cff1fd1_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:BR</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:LitigationCaseAxis">lly:EmployeeLitigationMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="id52423032e6747898c41a944e3038420_D20190701-20190731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:BR</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:LitigationCaseAxis">lly:EmployeeLitigationMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-07-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i098637113ce84c2f8c583d5aac35942b_D20210601-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:BR</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:LitigationCaseAxis">lly:EmployeeLitigationMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-06-01</xbrli:startdate><xbrli:enddate>2021-06-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i91a11e76b2844622ba08c167af2c1bbd_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:BR</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:LitigationCaseAxis">lly:EmployeeLitigationMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3fd1ac8f6fc9438cb71e216b3246793e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:HumalogHumulinAndForteoMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2605d2b37d747e1b5887703c18e4963_D20210701-20210731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">lly:InsulinMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-07-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:unit id="claim"><xbrli:measure>lly:claim</xbrli:measure></xbrli:unit><xbrli:context id="ia44884b555f84a8bb8c051329b5b483c_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf1cf37660ed42919d552edbdc9ddf29_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib07a74d7836447719291eff28ad65a22_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia3f2ab912d2b47e7862abe56a92bb118_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic22b2460974b4792a24b9b75e0e598d3_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb680e42808d41b587bffa2f35409a91_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ib423da078b9740019ae03257a6ca1320_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i0ddaa7c4639946b1a63ee163ebac9cda_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i9e78a70b50b740909d4bd5980c556e3a_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i603b413215ff4ac0860f74b6a1be9294_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6105e19d65744395aeb2921c7555324a_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ec1c7b3b72549149e283cdff33abeed_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc51fbfd706a4f809013d42ddd4fef8c_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad56c44530dd4208959b336f8d1fe8b1_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b7795dc491c42cbb64812b2b99d2ac9_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ideb9d32d39e441f68ba01504bca2b03c_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec456e1ce7794922919937b65a44561f_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2988484b109649f28736efa0418c49f9_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id29f7d92807d4933b0fb1e960563f81f_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3153def44849420f812d26d82e12f780_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i525ab1d53cfc40b99c19c64b4d032446_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i4b3bb220bf604c6daaf72988d3e20703_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i24f2b962044749c5a2936c59a2f25aa9_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="iab4358396efe4d7f92c5aab447052434_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5be060faaa5146e7a2bf742eb38f7bec_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i894ae4ccbe404068bbc052f007cea48c_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic74e9458c4f44462a21bfd6f33c8c50d_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ed755da42e84ed28970211b57db0d80_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if779a9c74164409ab40929f3c1a22e08_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15e5d118ed234a2f82b7b9a362d215d8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7546d9d8f53446e8b4f3eed0a4210c4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2ce5c439794420c8829fd223a835cd4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic63664fe4e074a5599837d8254019a8b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13abcd536a74422a91f0be2e859c5f11_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ieeda2eb9aa724c2eb2b08a110d5910ca_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i1c0ca46f62b245baa26e2ca939e70c30_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i698e8cd8a6e44a719d0a96611610bdf4_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i4b2bb6e433df4a26acb1d1cfbcc2ce7d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic15a6784d2e64c5b9176f90a12f6b997_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4dbdc6b4ce3472bb83f35a58ba62009_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4084f6774b4344709f32500dfb758be3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61189f333c704d8a9f0dffcd44fd0870_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4def4770d4c9484b9eafab55058f4c06_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="if73a641a34fe4591b395573cedb1bea4_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i71a11ec78f2242498930e393cd63658b_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i314c9492fa9044c3a8d05e0fc3ad2e63_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="iaaff00acdddb497fb5b94bf8d2ff771d_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ia0716cc08360439bb971180db7de8214_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i1e81189c858b4d59b30b2380c8bf756b_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="iafe03a1322e544acb123846499dfb8f0_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="iedc64e6c0ae84f6f8f6f168b1b71f00f_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i02ba7e57b97e4c15aa93cdacb3f05447_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i8d7550b247eb4a90ac3acd3ea2eab6ad_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="if8458e6a1b9b4239b31d01e183c0368d_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i14e2a21089594bfda05e2f482a1a9fdb_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="if60b1262bf5c4116ad9ba0e69b270a48_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i913335a3ccfe4b639f36db1017ae92af_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i7c947211ed8b449b9617f0791f225696_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ib98dca097ce342f1856252087101e534_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">lly:AccumulatedGainLossNetCashFlowHedgeAndForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="if20e319a4c3045b8b0693a8773446ca4_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">lly:AccumulatedGainLossNetCashFlowHedgeAndForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i06f2cc53bd804ced906cc353bccf23bd_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">lly:AccumulatedGainLossNetCashFlowHedgeAndForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i562107a932c943419a75d588f68a7ede_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">lly:AccumulatedGainLossNetCashFlowHedgeAndForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i294aedf137cf40faaba28e6d98a540dc_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="id04bc0ea75e7453daeb27bfa63e91d46_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="id8fcac86ddf342cf954cceefebfd7779_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i741049a232dc40728bbe8ee225522d87_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromrefs="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yOC9mcmFnOmEyNTBjNDBjZWQ3ZDQwZjRhNWUyMTQwZDM3MWNiYjliL3RhYmxlOjU0ZWNlYTRkMjgzZDQ4NTJiZTI1Y2QyYWEzN2M0ZDU0L3RhYmxlcmFuZ2U6NTRlY2VhNGQyODNkNDg1MmJlMjVjZDJhYTM3YzRkNTRfMy0xNS0xLTEtMTU5NTQw_6d92fa6f-1acf-4170-82f2-aac697d0cb4d id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yOC9mcmFnOmEyNTBjNDBjZWQ3ZDQwZjRhNWUyMTQwZDM3MWNiYjliL3RhYmxlOjU0ZWNlYTRkMjgzZDQ4NTJiZTI1Y2QyYWEzN2M0ZDU0L3RhYmxlcmFuZ2U6NTRlY2VhNGQyODNkNDg1MmJlMjVjZDJhYTM3YzRkNTRfMTQtMTUtMS0xLTE1OTU0MA_2900ac5b-f4af-4b04-a084-997e5a9b4ef4 id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yOC9mcmFnOmEyNTBjNDBjZWQ3ZDQwZjRhNWUyMTQwZDM3MWNiYjliL3RhYmxlOjU0ZWNlYTRkMjgzZDQ4NTJiZTI1Y2QyYWEzN2M0ZDU0L3RhYmxlcmFuZ2U6NTRlY2VhNGQyODNkNDg1MmJlMjVjZDJhYTM3YzRkNTRfMTYtMTMtMS0xLTE1OTU0MA_79b6e3ff-9a51-48d4-a405-02f97d7823a6 id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yOC9mcmFnOmEyNTBjNDBjZWQ3ZDQwZjRhNWUyMTQwZDM3MWNiYjliL3RhYmxlOjU0ZWNlYTRkMjgzZDQ4NTJiZTI1Y2QyYWEzN2M0ZDU0L3RhYmxlcmFuZ2U6NTRlY2VhNGQyODNkNDg1MmJlMjVjZDJhYTM3YzRkNTRfMjUtMTMtMS0xLTE1OTU0MA_17f5a50e-d7d3-49ea-ac64-ce1a5539bebc id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yOC9mcmFnOmEyNTBjNDBjZWQ3ZDQwZjRhNWUyMTQwZDM3MWNiYjliL3RhYmxlOjU0ZWNlYTRkMjgzZDQ4NTJiZTI1Y2QyYWEzN2M0ZDU0L3RhYmxlcmFuZ2U6NTRlY2VhNGQyODNkNDg1MmJlMjVjZDJhYTM3YzRkNTRfMy0xMy0xLTEtMTU5NTQw_a0242d52-4853-4826-9c2a-9045ffce7d36 id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yOC9mcmFnOmEyNTBjNDBjZWQ3ZDQwZjRhNWUyMTQwZDM3MWNiYjliL3RhYmxlOjU0ZWNlYTRkMjgzZDQ4NTJiZTI1Y2QyYWEzN2M0ZDU0L3RhYmxlcmFuZ2U6NTRlY2VhNGQyODNkNDg1MmJlMjVjZDJhYTM3YzRkNTRfMTYtMTUtMS0xLTE1OTU0MA_8eb7f85c-86ce-4c28-8769-6fd6765ed5b0 id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yOC9mcmFnOmEyNTBjNDBjZWQ3ZDQwZjRhNWUyMTQwZDM3MWNiYjliL3RhYmxlOjU0ZWNlYTRkMjgzZDQ4NTJiZTI1Y2QyYWEzN2M0ZDU0L3RhYmxlcmFuZ2U6NTRlY2VhNGQyODNkNDg1MmJlMjVjZDJhYTM3YzRkNTRfMTQtMTMtMS0xLTE1OTU0MA_5ba3cacd-6990-4cb0-813c-c9d6994bcad2 id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yOC9mcmFnOmEyNTBjNDBjZWQ3ZDQwZjRhNWUyMTQwZDM3MWNiYjliL3RhYmxlOjU0ZWNlYTRkMjgzZDQ4NTJiZTI1Y2QyYWEzN2M0ZDU0L3RhYmxlcmFuZ2U6NTRlY2VhNGQyODNkNDg1MmJlMjVjZDJhYTM3YzRkNTRfMjUtMTUtMS0xLTE1OTU0MA_7af684c2-0888-4891-a471-aee7fb026ebd" linkrole="http://www.xbrl.org/2003/role/link" order="1" torefs="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yOC9mcmFnOmEyNTBjNDBjZWQ3ZDQwZjRhNWUyMTQwZDM3MWNiYjliL3RleHRyZWdpb246YTI1MGM0MGNlZDdkNDBmNGE1ZTIxNDBkMzcxY2JiOWJfMjYx_2087051d-93f9-4e3e-80d6-ea5e9c10d8dd"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromrefs="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMjAtMTUtMS0xLTE1OTU0MA_90b2c7b9-d4d4-47cb-960d-af52cb5f093c id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMjItMTMtMS0xLTE1OTU0MA_04bc94f9-48f3-42e4-a934-3287c4031747 id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfOS0xNS0xLTEtMTU5NTQw_924c9fdc-7fe9-41c8-80cc-2c3895419a1d id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMjUtMTUtMS0xLTE1OTU0MA_da8ad497-050f-4202-83f7-ba8bfce436f5 id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMy0xNS0xLTEtMTU5NTQw_0c79c58d-ca29-449b-b8c0-a4ce0f3b7eda id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMjUtMTMtMS0xLTE1OTU0MA_8ef29157-deac-4753-beeb-da0b17fe30c7 id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfNy0xMy0xLTEtMTU5NTQw_ac6aaddd-eafb-4ec4-accf-829f59b018fb id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMTQtMTUtMS0xLTE1OTU0MA_47aac1d5-32f2-4222-a223-a804ecf08662 id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMjItMTUtMS0xLTE1OTU0MA_30b3cfe7-2129-4339-a61e-be4bfad21855 id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMy0xMy0xLTEtMTU5NTQw_d1cdfdda-f62e-426c-9a0c-ebd3749b728c id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMTQtMTMtMS0xLTE1OTU0MA_96786cfe-52bc-495f-97eb-53dc1ce2f278 id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfOC0xMy0xLTEtMTU5NTQw_6f9cea00-98ea-47d7-83e7-d75d6037deda id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMTYtMTUtMS0xLTE1OTU0MA_535791d1-15b8-498e-a925-9f7eddc75751 id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMTYtMTMtMS0xLTE1OTU0MA_d0839666-32d6-4ae0-946a-a4c5686bf3ad id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfOC0xNS0xLTEtMTU5NTQw_5b19ff46-59ca-42cb-8ec4-ec729fa0feac id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfNy0xNS0xLTEtMTU5NTQw_86de006e-c527-4c64-8afd-d972d9acad45 id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfOS0xMy0xLTEtMTU5NTQw_3aeef466-3c5f-4743-b85a-183e218f075e id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMjEtMTMtMS0xLTE1OTU0MA_8e9af476-2a91-410a-81c3-a243861cdf43 id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMjAtMTMtMS0xLTE1OTU0MA_72afa8cd-b258-4119-8087-814775c285dd id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMjEtMTUtMS0xLTE1OTU0MA_c8545f5f-37fb-4748-89c4-dbb910bf7e43" linkrole="http://www.xbrl.org/2003/role/link" order="1" torefs="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RleHRyZWdpb246ZTAxODE5ZTcxMTNjNGY2YzkyNjFiNDYyYzIxODNiMjFfMTY0_9553bd20-e2be-4a9d-901f-d34e31f81e7e"></ix:relationship></ix:resources></ix:header></div><div id="i5fed483d9c7e4f3cbba3a62c53226cd7_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:18pt;font-weight:700;line-height:120%">Form <ix:nonnumeric contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xL2ZyYWc6N2FjMGRkOGIzNWQxNDhiNzlmYTVkMTUwOTYwZGFmZWIvdGV4dHJlZ2lvbjo3YWMwZGQ4YjM1ZDE0OGI3OWZhNWQxNTA5NjBkYWZlYl8yMDM2_73d5082c-d8c0-4f73-bd05-2f9a6414fe05" name="dei:DocumentType">10-Q</ix:nonnumeric> </span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><ix:nonnumeric contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xL2ZyYWc6N2FjMGRkOGIzNWQxNDhiNzlmYTVkMTUwOTYwZGFmZWIvdGV4dHJlZ2lvbjo3YWMwZGQ4YjM1ZDE0OGI3OWZhNWQxNTA5NjBkYWZlYl8yMDQx_103acb8c-ca70-4068-acc9-4530f68a6bba" name="dei:DocumentQuarterlyReport"><ix:nonnumeric contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xL2ZyYWc6N2FjMGRkOGIzNWQxNDhiNzlmYTVkMTUwOTYwZGFmZWIvdGV4dHJlZ2lvbjo3YWMwZGQ4YjM1ZDE0OGI3OWZhNWQxNTA5NjBkYWZlYl8yMDQx_87ed946d-d898-44d7-ae4d-ada2ac30381d" name="dei:DocumentTransitionReport">Quarterly</ix:nonnumeric></ix:nonnumeric> Report Pursuant to Section&#160;13 or 15(d) of the</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Securities Exchange Act of 1934</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonnumeric contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xL2ZyYWc6N2FjMGRkOGIzNWQxNDhiNzlmYTVkMTUwOTYwZGFmZWIvdGV4dHJlZ2lvbjo3YWMwZGQ4YjM1ZDE0OGI3OWZhNWQxNTA5NjBkYWZlYl8yMTA_5776ee39-678b-4d2f-9d1e-7a5c35071614" name="dei:DocumentPeriodEndDate">September&#160;30, 2022</ix:nonnumeric></span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COMMISSION FILE NUMBER <ix:nonnumeric contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xL2ZyYWc6N2FjMGRkOGIzNWQxNDhiNzlmYTVkMTUwOTYwZGFmZWIvdGV4dHJlZ2lvbjo3YWMwZGQ4YjM1ZDE0OGI3OWZhNWQxNTA5NjBkYWZlYl8yMDM1_22c99662-191c-4e79-9904-cd9149835d85" name="dei:EntityFileNumber">001-6351</ix:nonnumeric> </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:22pt;font-weight:700;line-height:120%"><ix:nonnumeric contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xL2ZyYWc6N2FjMGRkOGIzNWQxNDhiNzlmYTVkMTUwOTYwZGFmZWIvdGV4dHJlZ2lvbjo3YWMwZGQ4YjM1ZDE0OGI3OWZhNWQxNTA5NjBkYWZlYl8yMDQy_cc5f090c-cab8-4dc3-8289-5f068daef1f4" name="dei:EntityRegistrantName">ELI LILLY AND COMPANY</ix:nonnumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of Registrant as specified in its charter)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:47.948%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.192%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonnumeric contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xL2ZyYWc6N2FjMGRkOGIzNWQxNDhiNzlmYTVkMTUwOTYwZGFmZWIvdGFibGU6ZjI0MWE4MmNiMTRkNDQwZDllNzFmMDkyMTQ1NTE5OTYvdGFibGVyYW5nZTpmMjQxYTgyY2IxNGQ0NDBkOWU3MWYwOTIxNDU1MTk5Nl8wLTAtMS0xLTE1OTU0MA_544edd58-36aa-4953-8559-944f5279d3a0" name="dei:EntityIncorporationStateCountryCode">Indiana</ix:nonnumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonnumeric contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xL2ZyYWc6N2FjMGRkOGIzNWQxNDhiNzlmYTVkMTUwOTYwZGFmZWIvdGFibGU6ZjI0MWE4MmNiMTRkNDQwZDllNzFmMDkyMTQ1NTE5OTYvdGFibGVyYW5nZTpmMjQxYTgyY2IxNGQ0NDBkOWU3MWYwOTIxNDU1MTk5Nl8wLTItMS0xLTE1OTU0MA_18dc1a91-46f8-4a4b-b238-03a6332df688" name="dei:EntityTaxIdentificationNumber">35-0470950</ix:nonnumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(State or other jurisdiction of</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(I.R.S. Employer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Identification No.)</span></td></tr></table></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonnumeric contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xL2ZyYWc6N2FjMGRkOGIzNWQxNDhiNzlmYTVkMTUwOTYwZGFmZWIvdGV4dHJlZ2lvbjo3YWMwZGQ4YjM1ZDE0OGI3OWZhNWQxNTA5NjBkYWZlYl8yMDM3_12745fad-11a6-4bd2-8050-e7644e0fb50c" name="dei:EntityAddressAddressLine1">Lilly Corporate Center</ix:nonnumeric>, <ix:nonnumeric contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xL2ZyYWc6N2FjMGRkOGIzNWQxNDhiNzlmYTVkMTUwOTYwZGFmZWIvdGV4dHJlZ2lvbjo3YWMwZGQ4YjM1ZDE0OGI3OWZhNWQxNTA5NjBkYWZlYl8yMDQz_2ab6411c-9a74-4238-948e-10e986fb63ed" name="dei:EntityAddressCityOrTown">Indianapolis</ix:nonnumeric>, <ix:nonnumeric contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xL2ZyYWc6N2FjMGRkOGIzNWQxNDhiNzlmYTVkMTUwOTYwZGFmZWIvdGV4dHJlZ2lvbjo3YWMwZGQ4YjM1ZDE0OGI3OWZhNWQxNTA5NjBkYWZlYl8yMDM4_6ef11003-a667-4a31-88b5-ad77a11e4b2b" name="dei:EntityAddressStateOrProvince">Indiana</ix:nonnumeric> <ix:nonnumeric contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xL2ZyYWc6N2FjMGRkOGIzNWQxNDhiNzlmYTVkMTUwOTYwZGFmZWIvdGV4dHJlZ2lvbjo3YWMwZGQ4YjM1ZDE0OGI3OWZhNWQxNTA5NjBkYWZlYl8yMDQ2_53080333-60a1-48da-96c8-abf2f245efb0" name="dei:EntityAddressPostalZipCode">46285</ix:nonnumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Address and zip code of principal executive offices)</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Registrant's telephone number, including area code (<ix:nonnumeric contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xL2ZyYWc6N2FjMGRkOGIzNWQxNDhiNzlmYTVkMTUwOTYwZGFmZWIvdGV4dHJlZ2lvbjo3YWMwZGQ4YjM1ZDE0OGI3OWZhNWQxNTA5NjBkYWZlYl8yMDQ0_d89df568-cd87-4970-a2d0-1ac793463acc" name="dei:CityAreaCode">317</ix:nonnumeric>)&#160;<ix:nonnumeric contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xL2ZyYWc6N2FjMGRkOGIzNWQxNDhiNzlmYTVkMTUwOTYwZGFmZWIvdGV4dHJlZ2lvbjo3YWMwZGQ4YjM1ZDE0OGI3OWZhNWQxNTA5NjBkYWZlYl8yMDM5_482405d2-915b-4844-86f0-bfe33594cc69" name="dei:LocalPhoneNumber">276-2000</ix:nonnumeric> </span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Securities registered pursuant to Section&#160;12(b) of the Exchange Act:</span></div><div style="margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:32.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.105%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.313%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%;text-decoration:underline">Title of Each Class</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%;text-decoration:underline">Trading Symbols</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%;text-decoration:underline">Name of Each Exchange On Which Registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonnumeric contextref="i71f35536970d471db55131eae57d8a56_D20220101-20220930" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xL2ZyYWc6N2FjMGRkOGIzNWQxNDhiNzlmYTVkMTUwOTYwZGFmZWIvdGFibGU6Y2UxN2EyYzQ3OWQ4NGQ0NTkyMTc5NDk3NGE2ZDJhMzUvdGFibGVyYW5nZTpjZTE3YTJjNDc5ZDg0ZDQ1OTIxNzk0OTc0YTZkMmEzNV8xLTAtMS0xLTE1OTU0MA_f71fb43d-9e49-4cda-814a-21e6f778f94e" name="dei:Security12bTitle">Common Stock (no par value)</ix:nonnumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonnumeric contextref="i71f35536970d471db55131eae57d8a56_D20220101-20220930" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xL2ZyYWc6N2FjMGRkOGIzNWQxNDhiNzlmYTVkMTUwOTYwZGFmZWIvdGFibGU6Y2UxN2EyYzQ3OWQ4NGQ0NTkyMTc5NDk3NGE2ZDJhMzUvdGFibGVyYW5nZTpjZTE3YTJjNDc5ZDg0ZDQ1OTIxNzk0OTc0YTZkMmEzNV8xLTEtMS0xLTE1OTU0MA_4dfed371-b10d-493b-9463-99477b5265ec" name="dei:TradingSymbol">LLY</ix:nonnumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonnumeric contextref="i71f35536970d471db55131eae57d8a56_D20220101-20220930" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xL2ZyYWc6N2FjMGRkOGIzNWQxNDhiNzlmYTVkMTUwOTYwZGFmZWIvdGFibGU6Y2UxN2EyYzQ3OWQ4NGQ0NTkyMTc5NDk3NGE2ZDJhMzUvdGFibGVyYW5nZTpjZTE3YTJjNDc5ZDg0ZDQ1OTIxNzk0OTc0YTZkMmEzNV8xLTItMS0xLTE1OTU0MA_97eda022-c29e-4a61-b940-00d36daaa181" name="dei:SecurityExchangeName">New York Stock Exchange</ix:nonnumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonnumeric contextref="i928ac777ff9b4d2c901021ddb94de4b4_D20220101-20220930" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xL2ZyYWc6N2FjMGRkOGIzNWQxNDhiNzlmYTVkMTUwOTYwZGFmZWIvdGFibGU6Y2UxN2EyYzQ3OWQ4NGQ0NTkyMTc5NDk3NGE2ZDJhMzUvdGFibGVyYW5nZTpjZTE3YTJjNDc5ZDg0ZDQ1OTIxNzk0OTc0YTZkMmEzNV8yLTAtMS0xLTE1OTU0MA_b7df35ec-565b-4860-97d1-5bd49c0a8bac" name="dei:Security12bTitle">7 1/8% Notes due 2025</ix:nonnumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonnumeric contextref="i928ac777ff9b4d2c901021ddb94de4b4_D20220101-20220930" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xL2ZyYWc6N2FjMGRkOGIzNWQxNDhiNzlmYTVkMTUwOTYwZGFmZWIvdGFibGU6Y2UxN2EyYzQ3OWQ4NGQ0NTkyMTc5NDk3NGE2ZDJhMzUvdGFibGVyYW5nZTpjZTE3YTJjNDc5ZDg0ZDQ1OTIxNzk0OTc0YTZkMmEzNV8yLTEtMS0xLTE1OTU0MA_de65a88d-e01d-4fbc-84cb-fb57e15ebc31" name="dei:TradingSymbol">LLY25</ix:nonnumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonnumeric contextref="i928ac777ff9b4d2c901021ddb94de4b4_D20220101-20220930" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xL2ZyYWc6N2FjMGRkOGIzNWQxNDhiNzlmYTVkMTUwOTYwZGFmZWIvdGFibGU6Y2UxN2EyYzQ3OWQ4NGQ0NTkyMTc5NDk3NGE2ZDJhMzUvdGFibGVyYW5nZTpjZTE3YTJjNDc5ZDg0ZDQ1OTIxNzk0OTc0YTZkMmEzNV8yLTItMS0xLTE1OTU0MA_901b837b-1cbc-4215-87cc-22ae463a38fc" name="dei:SecurityExchangeName">New York Stock Exchange</ix:nonnumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonnumeric contextref="i47d1aafe63fc4d6a8af84bd5fc7ec42a_D20220101-20220930" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xL2ZyYWc6N2FjMGRkOGIzNWQxNDhiNzlmYTVkMTUwOTYwZGFmZWIvdGFibGU6Y2UxN2EyYzQ3OWQ4NGQ0NTkyMTc5NDk3NGE2ZDJhMzUvdGFibGVyYW5nZTpjZTE3YTJjNDc5ZDg0ZDQ1OTIxNzk0OTc0YTZkMmEzNV8zLTAtMS0xLTE1OTU0MA_5da37923-32d2-4be4-b5e5-2c7377898110" name="dei:Security12bTitle">1.625% Notes due 2026</ix:nonnumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonnumeric contextref="i47d1aafe63fc4d6a8af84bd5fc7ec42a_D20220101-20220930" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xL2ZyYWc6N2FjMGRkOGIzNWQxNDhiNzlmYTVkMTUwOTYwZGFmZWIvdGFibGU6Y2UxN2EyYzQ3OWQ4NGQ0NTkyMTc5NDk3NGE2ZDJhMzUvdGFibGVyYW5nZTpjZTE3YTJjNDc5ZDg0ZDQ1OTIxNzk0OTc0YTZkMmEzNV8zLTEtMS0xLTE1OTU0MA_f4eaed6d-249f-4cef-8ee0-54629ceeff1f" name="dei:TradingSymbol">LLY26</ix:nonnumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonnumeric contextref="i47d1aafe63fc4d6a8af84bd5fc7ec42a_D20220101-20220930" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xL2ZyYWc6N2FjMGRkOGIzNWQxNDhiNzlmYTVkMTUwOTYwZGFmZWIvdGFibGU6Y2UxN2EyYzQ3OWQ4NGQ0NTkyMTc5NDk3NGE2ZDJhMzUvdGFibGVyYW5nZTpjZTE3YTJjNDc5ZDg0ZDQ1OTIxNzk0OTc0YTZkMmEzNV8zLTItMS0xLTE1OTU0MA_7c614c28-7332-464d-9027-5e638f6cc8ba" name="dei:SecurityExchangeName">New York Stock Exchange</ix:nonnumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonnumeric contextref="ifbf789a7a75f4a94b1ecc8e7f5692048_D20220101-20220930" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xL2ZyYWc6N2FjMGRkOGIzNWQxNDhiNzlmYTVkMTUwOTYwZGFmZWIvdGFibGU6Y2UxN2EyYzQ3OWQ4NGQ0NTkyMTc5NDk3NGE2ZDJhMzUvdGFibGVyYW5nZTpjZTE3YTJjNDc5ZDg0ZDQ1OTIxNzk0OTc0YTZkMmEzNV80LTAtMS0xLTE1OTU0MA_46b96503-24b6-4a19-8510-753d303f604f" name="dei:Security12bTitle">2.125% Notes due 2030</ix:nonnumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonnumeric contextref="ifbf789a7a75f4a94b1ecc8e7f5692048_D20220101-20220930" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xL2ZyYWc6N2FjMGRkOGIzNWQxNDhiNzlmYTVkMTUwOTYwZGFmZWIvdGFibGU6Y2UxN2EyYzQ3OWQ4NGQ0NTkyMTc5NDk3NGE2ZDJhMzUvdGFibGVyYW5nZTpjZTE3YTJjNDc5ZDg0ZDQ1OTIxNzk0OTc0YTZkMmEzNV80LTEtMS0xLTE1OTU0MA_0e404cc8-ac8c-4df3-b67c-f354b5fac456" name="dei:TradingSymbol">LLY30</ix:nonnumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonnumeric contextref="ifbf789a7a75f4a94b1ecc8e7f5692048_D20220101-20220930" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xL2ZyYWc6N2FjMGRkOGIzNWQxNDhiNzlmYTVkMTUwOTYwZGFmZWIvdGFibGU6Y2UxN2EyYzQ3OWQ4NGQ0NTkyMTc5NDk3NGE2ZDJhMzUvdGFibGVyYW5nZTpjZTE3YTJjNDc5ZDg0ZDQ1OTIxNzk0OTc0YTZkMmEzNV80LTItMS0xLTE1OTU0MA_aef8cbe7-ee4c-40af-8ab0-53dfe96a5193" name="dei:SecurityExchangeName">New York Stock Exchange</ix:nonnumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonnumeric contextref="i37d6cf7d3d9642f7887a8b59cb2a9056_D20220101-20220930" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xL2ZyYWc6N2FjMGRkOGIzNWQxNDhiNzlmYTVkMTUwOTYwZGFmZWIvdGFibGU6Y2UxN2EyYzQ3OWQ4NGQ0NTkyMTc5NDk3NGE2ZDJhMzUvdGFibGVyYW5nZTpjZTE3YTJjNDc5ZDg0ZDQ1OTIxNzk0OTc0YTZkMmEzNV81LTAtMS0xLTE1OTU0MA_913a9fed-3e04-4e4c-807c-67eab2803549" name="dei:Security12bTitle">0.625% Notes due 2031</ix:nonnumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonnumeric contextref="i37d6cf7d3d9642f7887a8b59cb2a9056_D20220101-20220930" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xL2ZyYWc6N2FjMGRkOGIzNWQxNDhiNzlmYTVkMTUwOTYwZGFmZWIvdGFibGU6Y2UxN2EyYzQ3OWQ4NGQ0NTkyMTc5NDk3NGE2ZDJhMzUvdGFibGVyYW5nZTpjZTE3YTJjNDc5ZDg0ZDQ1OTIxNzk0OTc0YTZkMmEzNV81LTEtMS0xLTE1OTU0MA_ffc66a88-c114-447b-b7bc-5bf915ea4017" name="dei:TradingSymbol">LLY31</ix:nonnumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonnumeric contextref="i37d6cf7d3d9642f7887a8b59cb2a9056_D20220101-20220930" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xL2ZyYWc6N2FjMGRkOGIzNWQxNDhiNzlmYTVkMTUwOTYwZGFmZWIvdGFibGU6Y2UxN2EyYzQ3OWQ4NGQ0NTkyMTc5NDk3NGE2ZDJhMzUvdGFibGVyYW5nZTpjZTE3YTJjNDc5ZDg0ZDQ1OTIxNzk0OTc0YTZkMmEzNV81LTItMS0xLTE1OTU0MA_c75a01b5-50fe-43de-8a36-42a017bff4c4" name="dei:SecurityExchangeName">New York Stock Exchange</ix:nonnumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonnumeric contextref="ia2c9b0358abd4ac1849fbad87ceaf6b2_D20220101-20220930" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xL2ZyYWc6N2FjMGRkOGIzNWQxNDhiNzlmYTVkMTUwOTYwZGFmZWIvdGFibGU6Y2UxN2EyYzQ3OWQ4NGQ0NTkyMTc5NDk3NGE2ZDJhMzUvdGFibGVyYW5nZTpjZTE3YTJjNDc5ZDg0ZDQ1OTIxNzk0OTc0YTZkMmEzNV82LTAtMS0xLTE1OTU0MA_9a5b992b-e8f8-4ab7-a40b-3246ba3fb5b5" name="dei:Security12bTitle">0.500% Notes due 2033</ix:nonnumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonnumeric contextref="ia2c9b0358abd4ac1849fbad87ceaf6b2_D20220101-20220930" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xL2ZyYWc6N2FjMGRkOGIzNWQxNDhiNzlmYTVkMTUwOTYwZGFmZWIvdGFibGU6Y2UxN2EyYzQ3OWQ4NGQ0NTkyMTc5NDk3NGE2ZDJhMzUvdGFibGVyYW5nZTpjZTE3YTJjNDc5ZDg0ZDQ1OTIxNzk0OTc0YTZkMmEzNV82LTEtMS0xLTE1OTU0MA_3606775e-049b-4974-81ad-61a808c92e70" name="dei:TradingSymbol">LLY33</ix:nonnumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonnumeric contextref="ia2c9b0358abd4ac1849fbad87ceaf6b2_D20220101-20220930" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xL2ZyYWc6N2FjMGRkOGIzNWQxNDhiNzlmYTVkMTUwOTYwZGFmZWIvdGFibGU6Y2UxN2EyYzQ3OWQ4NGQ0NTkyMTc5NDk3NGE2ZDJhMzUvdGFibGVyYW5nZTpjZTE3YTJjNDc5ZDg0ZDQ1OTIxNzk0OTc0YTZkMmEzNV82LTItMS0xLTE1OTU0MA_81c94f71-d34a-477c-a69c-2a7419c1d02e" name="dei:SecurityExchangeName">New York Stock Exchange</ix:nonnumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonnumeric contextref="ib18e156e215841b180cc7996ffae9682_D20220101-20220930" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xL2ZyYWc6N2FjMGRkOGIzNWQxNDhiNzlmYTVkMTUwOTYwZGFmZWIvdGFibGU6Y2UxN2EyYzQ3OWQ4NGQ0NTkyMTc5NDk3NGE2ZDJhMzUvdGFibGVyYW5nZTpjZTE3YTJjNDc5ZDg0ZDQ1OTIxNzk0OTc0YTZkMmEzNV83LTAtMS0xLTE1OTU0MA_158fa2e6-e28a-47c4-ac49-d1f6607bd5ac" name="dei:Security12bTitle">6.77%&#160;Notes due 2036</ix:nonnumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonnumeric contextref="ib18e156e215841b180cc7996ffae9682_D20220101-20220930" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xL2ZyYWc6N2FjMGRkOGIzNWQxNDhiNzlmYTVkMTUwOTYwZGFmZWIvdGFibGU6Y2UxN2EyYzQ3OWQ4NGQ0NTkyMTc5NDk3NGE2ZDJhMzUvdGFibGVyYW5nZTpjZTE3YTJjNDc5ZDg0ZDQ1OTIxNzk0OTc0YTZkMmEzNV83LTEtMS0xLTE1OTU0MA_41257b97-39d8-456d-bc21-65ea645cf931" name="dei:TradingSymbol">LLY36</ix:nonnumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonnumeric contextref="ib18e156e215841b180cc7996ffae9682_D20220101-20220930" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xL2ZyYWc6N2FjMGRkOGIzNWQxNDhiNzlmYTVkMTUwOTYwZGFmZWIvdGFibGU6Y2UxN2EyYzQ3OWQ4NGQ0NTkyMTc5NDk3NGE2ZDJhMzUvdGFibGVyYW5nZTpjZTE3YTJjNDc5ZDg0ZDQ1OTIxNzk0OTc0YTZkMmEzNV83LTItMS0xLTE1OTU0MA_4a030d73-4c31-42bd-a6b9-36acfdf550a7" name="dei:SecurityExchangeName">New York Stock Exchange</ix:nonnumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonnumeric contextref="i80ad5b0231594dcca53dbf943886b1f2_D20220101-20220930" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xL2ZyYWc6N2FjMGRkOGIzNWQxNDhiNzlmYTVkMTUwOTYwZGFmZWIvdGFibGU6Y2UxN2EyYzQ3OWQ4NGQ0NTkyMTc5NDk3NGE2ZDJhMzUvdGFibGVyYW5nZTpjZTE3YTJjNDc5ZDg0ZDQ1OTIxNzk0OTc0YTZkMmEzNV84LTAtMS0xLTE1OTU0MA_edba796e-a498-4abb-8935-421196db3c36" name="dei:Security12bTitle">1.625% Notes due 2043</ix:nonnumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonnumeric contextref="i80ad5b0231594dcca53dbf943886b1f2_D20220101-20220930" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xL2ZyYWc6N2FjMGRkOGIzNWQxNDhiNzlmYTVkMTUwOTYwZGFmZWIvdGFibGU6Y2UxN2EyYzQ3OWQ4NGQ0NTkyMTc5NDk3NGE2ZDJhMzUvdGFibGVyYW5nZTpjZTE3YTJjNDc5ZDg0ZDQ1OTIxNzk0OTc0YTZkMmEzNV84LTEtMS0xLTE1OTU0MA_922db86d-222b-42ec-835d-78124e46a67f" name="dei:TradingSymbol">LLY43</ix:nonnumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonnumeric contextref="i80ad5b0231594dcca53dbf943886b1f2_D20220101-20220930" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xL2ZyYWc6N2FjMGRkOGIzNWQxNDhiNzlmYTVkMTUwOTYwZGFmZWIvdGFibGU6Y2UxN2EyYzQ3OWQ4NGQ0NTkyMTc5NDk3NGE2ZDJhMzUvdGFibGVyYW5nZTpjZTE3YTJjNDc5ZDg0ZDQ1OTIxNzk0OTc0YTZkMmEzNV84LTItMS0xLTE1OTU0MA_2dcab404-05b5-4a43-a6a0-b89253fa1ac0" name="dei:SecurityExchangeName">New York Stock Exchange</ix:nonnumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonnumeric contextref="i8e27869f09004f868cb336c53f59bddd_D20220101-20220930" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xL2ZyYWc6N2FjMGRkOGIzNWQxNDhiNzlmYTVkMTUwOTYwZGFmZWIvdGFibGU6Y2UxN2EyYzQ3OWQ4NGQ0NTkyMTc5NDk3NGE2ZDJhMzUvdGFibGVyYW5nZTpjZTE3YTJjNDc5ZDg0ZDQ1OTIxNzk0OTc0YTZkMmEzNV85LTAtMS0xLTE1OTU0MA_1cbfcbaf-aa17-4a52-8496-a46348ba3912" name="dei:Security12bTitle">1.700% Notes due 2049</ix:nonnumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonnumeric contextref="i8e27869f09004f868cb336c53f59bddd_D20220101-20220930" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xL2ZyYWc6N2FjMGRkOGIzNWQxNDhiNzlmYTVkMTUwOTYwZGFmZWIvdGFibGU6Y2UxN2EyYzQ3OWQ4NGQ0NTkyMTc5NDk3NGE2ZDJhMzUvdGFibGVyYW5nZTpjZTE3YTJjNDc5ZDg0ZDQ1OTIxNzk0OTc0YTZkMmEzNV85LTEtMS0xLTE1OTU0MA_fd675a67-017c-4ff7-98ea-cb86ef7aad4a" name="dei:TradingSymbol">LLY49A</ix:nonnumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonnumeric contextref="i8e27869f09004f868cb336c53f59bddd_D20220101-20220930" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xL2ZyYWc6N2FjMGRkOGIzNWQxNDhiNzlmYTVkMTUwOTYwZGFmZWIvdGFibGU6Y2UxN2EyYzQ3OWQ4NGQ0NTkyMTc5NDk3NGE2ZDJhMzUvdGFibGVyYW5nZTpjZTE3YTJjNDc5ZDg0ZDQ1OTIxNzk0OTc0YTZkMmEzNV85LTItMS0xLTE1OTU0MA_1e055b99-3d08-4167-9e0c-2384224f0417" name="dei:SecurityExchangeName">New York Stock Exchange</ix:nonnumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonnumeric contextref="i94f283ca5ff741c39e115f9c18564a88_D20220101-20220930" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xL2ZyYWc6N2FjMGRkOGIzNWQxNDhiNzlmYTVkMTUwOTYwZGFmZWIvdGFibGU6Y2UxN2EyYzQ3OWQ4NGQ0NTkyMTc5NDk3NGE2ZDJhMzUvdGFibGVyYW5nZTpjZTE3YTJjNDc5ZDg0ZDQ1OTIxNzk0OTc0YTZkMmEzNV8xMC0wLTEtMS0xNTk1NDA_192914d9-d26f-4adf-9b27-0acbb8c50b5c" name="dei:Security12bTitle">1.125% Notes due 2051</ix:nonnumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonnumeric contextref="i94f283ca5ff741c39e115f9c18564a88_D20220101-20220930" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xL2ZyYWc6N2FjMGRkOGIzNWQxNDhiNzlmYTVkMTUwOTYwZGFmZWIvdGFibGU6Y2UxN2EyYzQ3OWQ4NGQ0NTkyMTc5NDk3NGE2ZDJhMzUvdGFibGVyYW5nZTpjZTE3YTJjNDc5ZDg0ZDQ1OTIxNzk0OTc0YTZkMmEzNV8xMC0xLTEtMS0xNTk1NDA_839eca65-ca4f-4c53-b7a0-b19ed493e5bf" name="dei:TradingSymbol">LLY51</ix:nonnumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonnumeric contextref="i94f283ca5ff741c39e115f9c18564a88_D20220101-20220930" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xL2ZyYWc6N2FjMGRkOGIzNWQxNDhiNzlmYTVkMTUwOTYwZGFmZWIvdGFibGU6Y2UxN2EyYzQ3OWQ4NGQ0NTkyMTc5NDk3NGE2ZDJhMzUvdGFibGVyYW5nZTpjZTE3YTJjNDc5ZDg0ZDQ1OTIxNzk0OTc0YTZkMmEzNV8xMC0yLTEtMS0xNTk1NDA_23309646-379d-4e1b-9bc4-47bb5e26f63b" name="dei:SecurityExchangeName">New York Stock Exchange</ix:nonnumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonnumeric contextref="i9b0db4c7708642f7a34b06aae1404242_D20220101-20220930" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xL2ZyYWc6N2FjMGRkOGIzNWQxNDhiNzlmYTVkMTUwOTYwZGFmZWIvdGFibGU6Y2UxN2EyYzQ3OWQ4NGQ0NTkyMTc5NDk3NGE2ZDJhMzUvdGFibGVyYW5nZTpjZTE3YTJjNDc5ZDg0ZDQ1OTIxNzk0OTc0YTZkMmEzNV8xMS0wLTEtMS0xNTk1NDA_5702da64-e024-4859-9a1e-4046274ee5d2" name="dei:Security12bTitle">1.375% Notes due 2061</ix:nonnumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonnumeric contextref="i9b0db4c7708642f7a34b06aae1404242_D20220101-20220930" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xL2ZyYWc6N2FjMGRkOGIzNWQxNDhiNzlmYTVkMTUwOTYwZGFmZWIvdGFibGU6Y2UxN2EyYzQ3OWQ4NGQ0NTkyMTc5NDk3NGE2ZDJhMzUvdGFibGVyYW5nZTpjZTE3YTJjNDc5ZDg0ZDQ1OTIxNzk0OTc0YTZkMmEzNV8xMS0xLTEtMS0xNTk1NDA_5f72a643-8266-4c5e-9943-3d77ce8a58af" name="dei:TradingSymbol">LLY61</ix:nonnumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonnumeric contextref="i9b0db4c7708642f7a34b06aae1404242_D20220101-20220930" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xL2ZyYWc6N2FjMGRkOGIzNWQxNDhiNzlmYTVkMTUwOTYwZGFmZWIvdGFibGU6Y2UxN2EyYzQ3OWQ4NGQ0NTkyMTc5NDk3NGE2ZDJhMzUvdGFibGVyYW5nZTpjZTE3YTJjNDc5ZDg0ZDQ1OTIxNzk0OTc0YTZkMmEzNV8xMS0yLTEtMS0xNTk1NDA_cf504784-80e3-40fd-99b2-dd1ebd56b735" name="dei:SecurityExchangeName">New York Stock Exchange</ix:nonnumeric></span></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the Registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports) and (2)&#160;has been subject to such filing requirements for the past 90 days.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonnumeric contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xL2ZyYWc6N2FjMGRkOGIzNWQxNDhiNzlmYTVkMTUwOTYwZGFmZWIvdGV4dHJlZ2lvbjo3YWMwZGQ4YjM1ZDE0OGI3OWZhNWQxNTA5NjBkYWZlYl8yMDQ1_6a7ca5a9-5562-4b8b-bf6a-c02708e9a727" name="dei:EntityCurrentReportingStatus">Yes</ix:nonnumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:2pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files).</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonnumeric contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xL2ZyYWc6N2FjMGRkOGIzNWQxNDhiNzlmYTVkMTUwOTYwZGFmZWIvdGV4dHJlZ2lvbjo3YWMwZGQ4YjM1ZDE0OGI3OWZhNWQxNTA5NjBkYWZlYl8yMDQw_35d85772-cc82-4125-8aa9-bbf7cafdb834" name="dei:EntityInteractiveDataCurrent">Yes</ix:nonnumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:2pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.514%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.250%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.582%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonnumeric contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xL2ZyYWc6N2FjMGRkOGIzNWQxNDhiNzlmYTVkMTUwOTYwZGFmZWIvdGFibGU6M2E1NDlmYmRjZTBkNGY4OWEwZjRlMWZmMTIxZmViMWEvdGFibGVyYW5nZTozYTU0OWZiZGNlMGQ0Zjg5YTBmNGUxZmYxMjFmZWIxYV8wLTAtMS0xLTE1OTU0MA_258f7f21-3480-4d34-a73e-6e3169c3d15f" name="dei:EntityFilerCategory">Large accelerated filer</ix:nonnumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accelerated&#160;filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonnumeric contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xL2ZyYWc6N2FjMGRkOGIzNWQxNDhiNzlmYTVkMTUwOTYwZGFmZWIvdGFibGU6M2E1NDlmYmRjZTBkNGY4OWEwZjRlMWZmMTIxZmViMWEvdGFibGVyYW5nZTozYTU0OWZiZGNlMGQ0Zjg5YTBmNGUxZmYxMjFmZWIxYV8xLTctMS0xLTE1OTU0MA_b8a371c6-c7f2-470e-b1ed-82ef822c4d9a" name="dei:EntitySmallBusiness">&#9744;</ix:nonnumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonnumeric contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xL2ZyYWc6N2FjMGRkOGIzNWQxNDhiNzlmYTVkMTUwOTYwZGFmZWIvdGFibGU6M2E1NDlmYmRjZTBkNGY4OWEwZjRlMWZmMTIxZmViMWEvdGFibGVyYW5nZTozYTU0OWZiZGNlMGQ0Zjg5YTBmNGUxZmYxMjFmZWIxYV8yLTctMS0xLTE1OTU0MA_81a36563-09b5-4400-9d80-d9877eb1fe71" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonnumeric></span></td></tr></table></div><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Yes </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonnumeric contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xL2ZyYWc6N2FjMGRkOGIzNWQxNDhiNzlmYTVkMTUwOTYwZGFmZWIvdGV4dHJlZ2lvbjo3YWMwZGQ4YjM1ZDE0OGI3OWZhNWQxNTA5NjBkYWZlYl8yMDQ3_1270cc30-e5a9-4c62-a803-3855ce7db00a" name="dei:EntityShellCompany">&#9744;</ix:nonnumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The number of shares of common stock outstanding as of October&#160;28, 2022:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:47.948%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.192%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Class</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Number of Shares Outstanding</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i465e2cbbe1e444108f9f7bdae9a93ca5_I20221028" decimals="INF" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xL2ZyYWc6N2FjMGRkOGIzNWQxNDhiNzlmYTVkMTUwOTYwZGFmZWIvdGFibGU6ZGRhMzY1NDUzNTc0NDAyN2I5MDY1MDEyMDc5N2NkYWUvdGFibGVyYW5nZTpkZGEzNjU0NTM1NzQ0MDI3YjkwNjUwMTIwNzk3Y2RhZV8xLTItMS0xLTE1OTU0MA_05c6a09b-a3e3-437f-ac0c-7bd4b6763e01" name="dei:EntityCommonStockSharesOutstanding" scale="0" unitref="shares">950,177,900</ix:nonfraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i5fed483d9c7e4f3cbba3a62c53226cd7_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Eli Lilly and Company</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Form 10-Q</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the Quarter Ended September&#160;30, 2022 </span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Table of Contents</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.654%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.334%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i5fed483d9c7e4f3cbba3a62c53226cd7_13" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">PART I. Financial Information</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i5fed483d9c7e4f3cbba3a62c53226cd7_13" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">5</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i5fed483d9c7e4f3cbba3a62c53226cd7_16" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Item 1.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i5fed483d9c7e4f3cbba3a62c53226cd7_16" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Financial Statements</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i5fed483d9c7e4f3cbba3a62c53226cd7_16" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">5</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i5fed483d9c7e4f3cbba3a62c53226cd7_19" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Consolidated Condensed Statements of Operations</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i5fed483d9c7e4f3cbba3a62c53226cd7_19" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">5</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i5fed483d9c7e4f3cbba3a62c53226cd7_22" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Consolidated Condensed Statements of Comprehensive Income</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i5fed483d9c7e4f3cbba3a62c53226cd7_22" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">6</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i5fed483d9c7e4f3cbba3a62c53226cd7_25" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Consolidated Condensed Balance Sheets</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i5fed483d9c7e4f3cbba3a62c53226cd7_25" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">7</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i5fed483d9c7e4f3cbba3a62c53226cd7_28" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Consolidated Condensed Statements of Equity</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i5fed483d9c7e4f3cbba3a62c53226cd7_28" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">8</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i5fed483d9c7e4f3cbba3a62c53226cd7_34" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Consolidated Condensed Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i5fed483d9c7e4f3cbba3a62c53226cd7_34" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">10</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i5fed483d9c7e4f3cbba3a62c53226cd7_37" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Notes to Consolidated Condensed Financial Statements</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i5fed483d9c7e4f3cbba3a62c53226cd7_37" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">11</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i5fed483d9c7e4f3cbba3a62c53226cd7_82" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Item 2.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i5fed483d9c7e4f3cbba3a62c53226cd7_82" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Management's Discussion and Analysis of Results of Operations and Financial Condition</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i5fed483d9c7e4f3cbba3a62c53226cd7_82" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">37</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i5fed483d9c7e4f3cbba3a62c53226cd7_85" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Executive Overview</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i5fed483d9c7e4f3cbba3a62c53226cd7_85" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">37</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i5fed483d9c7e4f3cbba3a62c53226cd7_88" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Revenue</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i5fed483d9c7e4f3cbba3a62c53226cd7_88" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">45</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i5fed483d9c7e4f3cbba3a62c53226cd7_94" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Gross Margin, Costs, and Expenses</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i5fed483d9c7e4f3cbba3a62c53226cd7_94" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">49</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i5fed483d9c7e4f3cbba3a62c53226cd7_100" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Financial Condition and Liquidity</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i5fed483d9c7e4f3cbba3a62c53226cd7_100" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">50</a></span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i5fed483d9c7e4f3cbba3a62c53226cd7_103" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Critical Accounting Estimates</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i5fed483d9c7e4f3cbba3a62c53226cd7_103" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">51</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i5fed483d9c7e4f3cbba3a62c53226cd7_106" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Available Information on our Website</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i5fed483d9c7e4f3cbba3a62c53226cd7_106" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">51</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i5fed483d9c7e4f3cbba3a62c53226cd7_109" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Item 4.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i5fed483d9c7e4f3cbba3a62c53226cd7_109" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i5fed483d9c7e4f3cbba3a62c53226cd7_109" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">52</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i5fed483d9c7e4f3cbba3a62c53226cd7_112" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">PART II. Other Information</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i5fed483d9c7e4f3cbba3a62c53226cd7_112" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">53</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i5fed483d9c7e4f3cbba3a62c53226cd7_115" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Item 1.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i5fed483d9c7e4f3cbba3a62c53226cd7_115" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i5fed483d9c7e4f3cbba3a62c53226cd7_115" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">53</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i5fed483d9c7e4f3cbba3a62c53226cd7_118" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Item 1A.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i5fed483d9c7e4f3cbba3a62c53226cd7_118" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Risk Factors</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i5fed483d9c7e4f3cbba3a62c53226cd7_118" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">53</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i5fed483d9c7e4f3cbba3a62c53226cd7_121" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Item 2.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i5fed483d9c7e4f3cbba3a62c53226cd7_121" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i5fed483d9c7e4f3cbba3a62c53226cd7_121" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">53</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i5fed483d9c7e4f3cbba3a62c53226cd7_124" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Item 6.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i5fed483d9c7e4f3cbba3a62c53226cd7_124" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibits</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i5fed483d9c7e4f3cbba3a62c53226cd7_124" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">54</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i5fed483d9c7e4f3cbba3a62c53226cd7_127" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Signatures</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i5fed483d9c7e4f3cbba3a62c53226cd7_127" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">54</a></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i5fed483d9c7e4f3cbba3a62c53226cd7_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-style:italic;font-weight:400;line-height:120%">Forward-Looking Statements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.9pt;font-weight:400;line-height:120%">This Quarterly Report on Form 10-Q </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and our other publicly available documents include forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 (Exchange Act), and are subject to the safe harbor created thereby under the Private Securities Litigation Reform Act of 1995. In particular, information appearing under "Management's Discussion and Analysis of Results of Operations and Financial Condition" includes forward-looking statements. Forward-looking statements include all statements that do not relate solely to historical or current facts, and generally can be identified by the use of words such as "may," "believe," "will," "expect," "project," "estimate," "intend," "anticipate," "plan," "continue," or similar expressions or future or conditional verbs. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward-looking statements inherently involve many risks and uncertainties that could cause actual results to differ materially from those expressed in forward-looking statements. Where, in any forward-looking statement, we express an expectation or belief as to future results or events, it is based on management's current plans and expectations, expressed in good faith and believed to have a reasonable basis. However, we can give no assurance that any such expectation or belief will result or will be achieved or accomplished. Investors therefore should not place undue reliance on forward-looking statements. The following include some but not all of the factors that could cause actual results or events to differ materially from those anticipated:</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of the evolving COVID-19 pandemic or any future pandemic, epidemic, or similar public health threat and the global response thereto;</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">uncertainties related to our efforts to develop, manufacture, and distribute potential treatments for COVID-19;</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the significant costs and uncertainties in the pharmaceutical research and development process, including with respect to the timing and process of obtaining regulatory approvals;</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact and outcome of acquisitions and business development transactions and related integration costs;</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the expiration of intellectual property protection for certain of our products and competition from generic and/or biosimilar products;</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to protect and enforce patents and other intellectual property;</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in patent law or regulations related to data package exclusivity;</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">competitive developments affecting current products and our pipeline;</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">market uptake of recently launched products;</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">information technology system inadequacies, breaches, or operating failures;</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">unauthorized access, disclosure, misappropriation, or compromise of confidential information or other data stored in our information technology systems, networks, and facilities, or those of third parties with whom we share our data;</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">unexpected safety or efficacy concerns associated with our products;</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">litigation, investigations, or other similar proceedings involving past, current, or future products or commercial activities as we are largely self-insured;</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">issues with product supply and regulatory approvals stemming from manufacturing difficulties, disruptions, or shortages, including as a result of demand, labor shortages, third-party performance, or regulatory actions relating to our facilities;</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reliance on third-party relationships and outsourcing arrangements;</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">regulatory changes or other developments;</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">regulatory actions regarding currently marketed products; </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">continued pricing pressures and the impact of actions of governmental and private payers affecting pricing of, reimbursement for, and access to pharmaceuticals;</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">devaluations in foreign currency exchange rates, changes in interest rates, and inflation;</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in tax law, tax rates, or events that differ from our assumptions related to tax positions; </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">asset impairments and restructuring charges;</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of global macroeconomic conditions, trade disruptions, global disputes, unrest, war, or other costs, uncertainties and risks related to engaging in business in foreign jurisdictions; </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in accounting and reporting standards promulgated by the Financial Accounting Standards Board and the Securities and Exchange Commission (SEC); and</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">regulatory compliance problems or government investigations.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.9pt;font-weight:400;line-height:120%">More information on factors that could cause actual results or events to differ materially from those anticipated is included from time to time in our reports filed with the SEC, including in our Annual Report on </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9.9pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/0000059478/000005947822000068/lly-20211231.htm" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9.9pt;font-weight:400;line-height:120%;text-decoration:underline">Form 10-K</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.9pt;font-weight:400;line-height:120%"> for the year ended December&#160;31, 2021, particularly under the caption "Risk Factors." Investors should understand that it is not possible to predict or identify all such factors and should not consider the risks described above and under Part I, Item 1A, "Risk Factors" of our Annual Report on </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9.9pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/0000059478/000005947822000068/lly-20211231.htm" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9.9pt;font-weight:400;line-height:120%;text-decoration:underline">Form 10-K</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.9pt;font-weight:400;line-height:120%"> to be a complete statement of all potential risks and uncertainties.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.9pt;font-weight:400;line-height:120%">All forward-looking statements speak only as of the date of this Quarterly Report on Form 10-Q and are expressly qualified in their entirety by the cautionary statements included in or incorporated by reference into this Quarterly Report on Form 10-Q. Except as is required by law, we expressly disclaim any obligation to publicly release any revisions to forward-looking statements to reflect events after the date of this Quarterly Report on Form 10-Q. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i5fed483d9c7e4f3cbba3a62c53226cd7_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:16pt;font-weight:400;line-height:120%;text-decoration:underline">PART I. Financial Information</span></div><div id="i5fed483d9c7e4f3cbba3a62c53226cd7_16"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Item&#160;1. Financial Statements</span></div><div id="i5fed483d9c7e4f3cbba3a62c53226cd7_19"></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Condensed Statements of Operations</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ELI LILLY AND COMPANY AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Dollars and shares in millions, except per-share data)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.206%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue (Note 2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i19fc0325c48543008ea71e1fdcf11d86_D20220701-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xOS9mcmFnOjI4Y2NkODJiMTEwZDQzY2Y5ZjE3OWFlZTgwNzBiYmY0L3RhYmxlOmYzNmEyNjIyOTBjMzQ3ZmRhMzU4OTA1MDE2MGM2MDhhL3RhYmxlcmFuZ2U6ZjM2YTI2MjI5MGMzNDdmZGEzNTg5MDUwMTYwYzYwOGFfMi0xLTEtMS0xNTk1NDA_84b2baed-d6a5-43c8-9b22-b1720ffd84cc" name="us-gaap:Revenues" scale="6" unitref="usd">6,941.6</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie4fa4f6b472a4f269297591b44aba572_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xOS9mcmFnOjI4Y2NkODJiMTEwZDQzY2Y5ZjE3OWFlZTgwNzBiYmY0L3RhYmxlOmYzNmEyNjIyOTBjMzQ3ZmRhMzU4OTA1MDE2MGM2MDhhL3RhYmxlcmFuZ2U6ZjM2YTI2MjI5MGMzNDdmZGEzNTg5MDUwMTYwYzYwOGFfMi0zLTEtMS0xNTk1NDA_2e9d205c-5646-45ea-a8f1-00dea195e123" name="us-gaap:Revenues" scale="6" unitref="usd">6,772.8</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xOS9mcmFnOjI4Y2NkODJiMTEwZDQzY2Y5ZjE3OWFlZTgwNzBiYmY0L3RhYmxlOmYzNmEyNjIyOTBjMzQ3ZmRhMzU4OTA1MDE2MGM2MDhhL3RhYmxlcmFuZ2U6ZjM2YTI2MjI5MGMzNDdmZGEzNTg5MDUwMTYwYzYwOGFfMi01LTEtMS0xNTk1NDA_17382a75-1af1-4741-92e1-29f6816e014e" name="us-gaap:Revenues" scale="6" unitref="usd">21,239.6</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xOS9mcmFnOjI4Y2NkODJiMTEwZDQzY2Y5ZjE3OWFlZTgwNzBiYmY0L3RhYmxlOmYzNmEyNjIyOTBjMzQ3ZmRhMzU4OTA1MDE2MGM2MDhhL3RhYmxlcmFuZ2U6ZjM2YTI2MjI5MGMzNDdmZGEzNTg5MDUwMTYwYzYwOGFfMi03LTEtMS0xNTk1NDA_f14d0139-fe56-4a27-8f9a-40cb6b63c480" name="us-gaap:Revenues" scale="6" unitref="usd">20,318.5</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs, expenses, and other:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i19fc0325c48543008ea71e1fdcf11d86_D20220701-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xOS9mcmFnOjI4Y2NkODJiMTEwZDQzY2Y5ZjE3OWFlZTgwNzBiYmY0L3RhYmxlOmYzNmEyNjIyOTBjMzQ3ZmRhMzU4OTA1MDE2MGM2MDhhL3RhYmxlcmFuZ2U6ZjM2YTI2MjI5MGMzNDdmZGEzNTg5MDUwMTYwYzYwOGFfNC0xLTEtMS0xNTk1NDA_613d7d37-4cb7-418c-9328-7863400be6f6" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" unitref="usd">1,579.1</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie4fa4f6b472a4f269297591b44aba572_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xOS9mcmFnOjI4Y2NkODJiMTEwZDQzY2Y5ZjE3OWFlZTgwNzBiYmY0L3RhYmxlOmYzNmEyNjIyOTBjMzQ3ZmRhMzU4OTA1MDE2MGM2MDhhL3RhYmxlcmFuZ2U6ZjM2YTI2MjI5MGMzNDdmZGEzNTg5MDUwMTYwYzYwOGFfNC0zLTEtMS0xNTk1NDA_f4d08199-fc25-4ff1-b97e-ef128b0b0d21" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" unitref="usd">1,430.8</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xOS9mcmFnOjI4Y2NkODJiMTEwZDQzY2Y5ZjE3OWFlZTgwNzBiYmY0L3RhYmxlOmYzNmEyNjIyOTBjMzQ3ZmRhMzU4OTA1MDE2MGM2MDhhL3RhYmxlcmFuZ2U6ZjM2YTI2MjI5MGMzNDdmZGEzNTg5MDUwMTYwYzYwOGFfNC01LTEtMS0xNTk1NDA_10675cf5-06cf-43b2-8e6f-cb3244baaa08" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" unitref="usd">5,081.7</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xOS9mcmFnOjI4Y2NkODJiMTEwZDQzY2Y5ZjE3OWFlZTgwNzBiYmY0L3RhYmxlOmYzNmEyNjIyOTBjMzQ3ZmRhMzU4OTA1MDE2MGM2MDhhL3RhYmxlcmFuZ2U6ZjM2YTI2MjI5MGMzNDdmZGEzNTg5MDUwMTYwYzYwOGFfNC03LTEtMS0xNTk1NDA_f8bcac5c-a235-4a8f-bf87-c90345e34be9" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" unitref="usd">5,262.6</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i19fc0325c48543008ea71e1fdcf11d86_D20220701-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xOS9mcmFnOjI4Y2NkODJiMTEwZDQzY2Y5ZjE3OWFlZTgwNzBiYmY0L3RhYmxlOmYzNmEyNjIyOTBjMzQ3ZmRhMzU4OTA1MDE2MGM2MDhhL3RhYmxlcmFuZ2U6ZjM2YTI2MjI5MGMzNDdmZGEzNTg5MDUwMTYwYzYwOGFfNS0xLTEtMS0xNTk1NDA_a8fa6aeb-cf55-4189-920d-707e4caebbe8" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" unitref="usd">1,802.9</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie4fa4f6b472a4f269297591b44aba572_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xOS9mcmFnOjI4Y2NkODJiMTEwZDQzY2Y5ZjE3OWFlZTgwNzBiYmY0L3RhYmxlOmYzNmEyNjIyOTBjMzQ3ZmRhMzU4OTA1MDE2MGM2MDhhL3RhYmxlcmFuZ2U6ZjM2YTI2MjI5MGMzNDdmZGEzNTg5MDUwMTYwYzYwOGFfNS0zLTEtMS0xNTk1NDA_d70a720b-459b-40df-9ea5-ecc8edc06707" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" unitref="usd">1,705.3</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xOS9mcmFnOjI4Y2NkODJiMTEwZDQzY2Y5ZjE3OWFlZTgwNzBiYmY0L3RhYmxlOmYzNmEyNjIyOTBjMzQ3ZmRhMzU4OTA1MDE2MGM2MDhhL3RhYmxlcmFuZ2U6ZjM2YTI2MjI5MGMzNDdmZGEzNTg5MDUwMTYwYzYwOGFfNS01LTEtMS0xNTk1NDA_2a06c20f-888c-4cbc-91df-a48ea8ae00ff" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" unitref="usd">5,194.9</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xOS9mcmFnOjI4Y2NkODJiMTEwZDQzY2Y5ZjE3OWFlZTgwNzBiYmY0L3RhYmxlOmYzNmEyNjIyOTBjMzQ3ZmRhMzU4OTA1MDE2MGM2MDhhL3RhYmxlcmFuZ2U6ZjM2YTI2MjI5MGMzNDdmZGEzNTg5MDUwMTYwYzYwOGFfNS03LTEtMS0xNTk1NDA_7854caa1-7b76-464d-b7f4-c4101a2e27a2" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" unitref="usd">5,032.4</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, selling, and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i19fc0325c48543008ea71e1fdcf11d86_D20220701-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xOS9mcmFnOjI4Y2NkODJiMTEwZDQzY2Y5ZjE3OWFlZTgwNzBiYmY0L3RhYmxlOmYzNmEyNjIyOTBjMzQ3ZmRhMzU4OTA1MDE2MGM2MDhhL3RhYmxlcmFuZ2U6ZjM2YTI2MjI5MGMzNDdmZGEzNTg5MDUwMTYwYzYwOGFfNi0xLTEtMS0xNTk1NDA_14213355-7ffb-439f-80f4-67242e82ed5d" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" unitref="usd">1,614.2</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie4fa4f6b472a4f269297591b44aba572_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xOS9mcmFnOjI4Y2NkODJiMTEwZDQzY2Y5ZjE3OWFlZTgwNzBiYmY0L3RhYmxlOmYzNmEyNjIyOTBjMzQ3ZmRhMzU4OTA1MDE2MGM2MDhhL3RhYmxlcmFuZ2U6ZjM2YTI2MjI5MGMzNDdmZGEzNTg5MDUwMTYwYzYwOGFfNi0zLTEtMS0xNTk1NDA_35072b4f-0452-4d41-8273-955eed100b0f" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" unitref="usd">1,577.9</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xOS9mcmFnOjI4Y2NkODJiMTEwZDQzY2Y5ZjE3OWFlZTgwNzBiYmY0L3RhYmxlOmYzNmEyNjIyOTBjMzQ3ZmRhMzU4OTA1MDE2MGM2MDhhL3RhYmxlcmFuZ2U6ZjM2YTI2MjI5MGMzNDdmZGEzNTg5MDUwMTYwYzYwOGFfNi01LTEtMS0xNTk1NDA_67f8179b-9bdd-481b-82f9-f6bcd12659f9" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" unitref="usd">4,797.2</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xOS9mcmFnOjI4Y2NkODJiMTEwZDQzY2Y5ZjE3OWFlZTgwNzBiYmY0L3RhYmxlOmYzNmEyNjIyOTBjMzQ3ZmRhMzU4OTA1MDE2MGM2MDhhL3RhYmxlcmFuZ2U6ZjM2YTI2MjI5MGMzNDdmZGEzNTg5MDUwMTYwYzYwOGFfNi03LTEtMS0xNTk1NDA_05d9ca06-addd-46cf-ab12-0e16beb9b4ac" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" unitref="usd">4,839.6</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired in-process research and development and development milestones (Note 3)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i19fc0325c48543008ea71e1fdcf11d86_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xOS9mcmFnOjI4Y2NkODJiMTEwZDQzY2Y5ZjE3OWFlZTgwNzBiYmY0L3RhYmxlOmYzNmEyNjIyOTBjMzQ3ZmRhMzU4OTA1MDE2MGM2MDhhL3RhYmxlcmFuZ2U6ZjM2YTI2MjI5MGMzNDdmZGEzNTg5MDUwMTYwYzYwOGFfNy0xLTEtMS0xNTk1NDA_8b459b38-3dde-4b01-86a3-b90670ef8e72" name="lly:AcquiredInProcessResearchAndDevelopmentAndDevelopmentMilestones" scale="6" unitref="usd">62.4</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie4fa4f6b472a4f269297591b44aba572_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xOS9mcmFnOjI4Y2NkODJiMTEwZDQzY2Y5ZjE3OWFlZTgwNzBiYmY0L3RhYmxlOmYzNmEyNjIyOTBjMzQ3ZmRhMzU4OTA1MDE2MGM2MDhhL3RhYmxlcmFuZ2U6ZjM2YTI2MjI5MGMzNDdmZGEzNTg5MDUwMTYwYzYwOGFfNy0zLTEtMS0xNTk1NDA_930acb16-c7a4-46f2-b4ec-0c4ce1d82bd4" name="lly:AcquiredInProcessResearchAndDevelopmentAndDevelopmentMilestones" scale="6" unitref="usd">177.6</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xOS9mcmFnOjI4Y2NkODJiMTEwZDQzY2Y5ZjE3OWFlZTgwNzBiYmY0L3RhYmxlOmYzNmEyNjIyOTBjMzQ3ZmRhMzU4OTA1MDE2MGM2MDhhL3RhYmxlcmFuZ2U6ZjM2YTI2MjI5MGMzNDdmZGEzNTg5MDUwMTYwYzYwOGFfNy01LTEtMS0xNTk1NDA_814d2bcb-fad1-4171-8df7-5bf614293fde" name="lly:AcquiredInProcessResearchAndDevelopmentAndDevelopmentMilestones" scale="6" unitref="usd">668.4</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xOS9mcmFnOjI4Y2NkODJiMTEwZDQzY2Y5ZjE3OWFlZTgwNzBiYmY0L3RhYmxlOmYzNmEyNjIyOTBjMzQ3ZmRhMzU4OTA1MDE2MGM2MDhhL3RhYmxlcmFuZ2U6ZjM2YTI2MjI5MGMzNDdmZGEzNTg5MDUwMTYwYzYwOGFfNy03LTEtMS0xNTk1NDA_08faa181-0763-4f6c-9031-a7e1539d6611" name="lly:AcquiredInProcessResearchAndDevelopmentAndDevelopmentMilestones" scale="6" unitref="usd">532.4</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairment, restructuring, and other special charges (Note 5)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i19fc0325c48543008ea71e1fdcf11d86_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xOS9mcmFnOjI4Y2NkODJiMTEwZDQzY2Y5ZjE3OWFlZTgwNzBiYmY0L3RhYmxlOmYzNmEyNjIyOTBjMzQ3ZmRhMzU4OTA1MDE2MGM2MDhhL3RhYmxlcmFuZ2U6ZjM2YTI2MjI5MGMzNDdmZGEzNTg5MDUwMTYwYzYwOGFfOC0xLTEtMS0xNTk1NDA_871cfb58-2491-43dc-b184-34f9c6cf822b" name="us-gaap:RestructuringSettlementAndImpairmentProvisions" scale="6" unitref="usd">206.5</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie4fa4f6b472a4f269297591b44aba572_D20210701-20210930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xOS9mcmFnOjI4Y2NkODJiMTEwZDQzY2Y5ZjE3OWFlZTgwNzBiYmY0L3RhYmxlOmYzNmEyNjIyOTBjMzQ3ZmRhMzU4OTA1MDE2MGM2MDhhL3RhYmxlcmFuZ2U6ZjM2YTI2MjI5MGMzNDdmZGEzNTg5MDUwMTYwYzYwOGFfOC0zLTEtMS0xNTk1NDA_440c64be-a839-43d8-afea-b5abbee97a08" name="us-gaap:RestructuringSettlementAndImpairmentProvisions" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xOS9mcmFnOjI4Y2NkODJiMTEwZDQzY2Y5ZjE3OWFlZTgwNzBiYmY0L3RhYmxlOmYzNmEyNjIyOTBjMzQ3ZmRhMzU4OTA1MDE2MGM2MDhhL3RhYmxlcmFuZ2U6ZjM2YTI2MjI5MGMzNDdmZGEzNTg5MDUwMTYwYzYwOGFfOC01LTEtMS0xNTk1NDA_3d999b88-4ddd-4fb1-bbaa-a10090f42bea" name="us-gaap:RestructuringSettlementAndImpairmentProvisions" scale="6" unitref="usd">206.5</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xOS9mcmFnOjI4Y2NkODJiMTEwZDQzY2Y5ZjE3OWFlZTgwNzBiYmY0L3RhYmxlOmYzNmEyNjIyOTBjMzQ3ZmRhMzU4OTA1MDE2MGM2MDhhL3RhYmxlcmFuZ2U6ZjM2YTI2MjI5MGMzNDdmZGEzNTg5MDUwMTYwYzYwOGFfOC03LTEtMS0xNTk1NDA_6408657e-186f-4757-bc29-234f3692c156" name="us-gaap:RestructuringSettlementAndImpairmentProvisions" scale="6" unitref="usd">211.6</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other&#8211;net, (income) expense (Note 11)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i19fc0325c48543008ea71e1fdcf11d86_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xOS9mcmFnOjI4Y2NkODJiMTEwZDQzY2Y5ZjE3OWFlZTgwNzBiYmY0L3RhYmxlOmYzNmEyNjIyOTBjMzQ3ZmRhMzU4OTA1MDE2MGM2MDhhL3RhYmxlcmFuZ2U6ZjM2YTI2MjI5MGMzNDdmZGEzNTg5MDUwMTYwYzYwOGFfOS0xLTEtMS0xNTk1NDA_0a080a2b-b9ee-4570-bc4c-b4a3b0d6dc9c" name="us-gaap:NonoperatingIncomeExpense" scale="6" sign="-" unitref="usd">111.0</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie4fa4f6b472a4f269297591b44aba572_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xOS9mcmFnOjI4Y2NkODJiMTEwZDQzY2Y5ZjE3OWFlZTgwNzBiYmY0L3RhYmxlOmYzNmEyNjIyOTBjMzQ3ZmRhMzU4OTA1MDE2MGM2MDhhL3RhYmxlcmFuZ2U6ZjM2YTI2MjI5MGMzNDdmZGEzNTg5MDUwMTYwYzYwOGFfOS0zLTEtMS0xNTk1NDA_bf168203-185c-4fdc-8ed2-949d74015438" name="us-gaap:NonoperatingIncomeExpense" scale="6" sign="-" unitref="usd">635.9</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xOS9mcmFnOjI4Y2NkODJiMTEwZDQzY2Y5ZjE3OWFlZTgwNzBiYmY0L3RhYmxlOmYzNmEyNjIyOTBjMzQ3ZmRhMzU4OTA1MDE2MGM2MDhhL3RhYmxlcmFuZ2U6ZjM2YTI2MjI5MGMzNDdmZGEzNTg5MDUwMTYwYzYwOGFfOS01LTEtMS0xNTk1NDA_da74eabf-5727-4eaa-92ef-c61d12d89473" name="us-gaap:NonoperatingIncomeExpense" scale="6" sign="-" unitref="usd">580.9</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xOS9mcmFnOjI4Y2NkODJiMTEwZDQzY2Y5ZjE3OWFlZTgwNzBiYmY0L3RhYmxlOmYzNmEyNjIyOTBjMzQ3ZmRhMzU4OTA1MDE2MGM2MDhhL3RhYmxlcmFuZ2U6ZjM2YTI2MjI5MGMzNDdmZGEzNTg5MDUwMTYwYzYwOGFfOS03LTEtMS0xNTk1NDA_0c41ebaa-dad9-4452-984b-fec846c6f7fa" name="us-gaap:NonoperatingIncomeExpense" scale="6" sign="-" unitref="usd">124.3</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i19fc0325c48543008ea71e1fdcf11d86_D20220701-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xOS9mcmFnOjI4Y2NkODJiMTEwZDQzY2Y5ZjE3OWFlZTgwNzBiYmY0L3RhYmxlOmYzNmEyNjIyOTBjMzQ3ZmRhMzU4OTA1MDE2MGM2MDhhL3RhYmxlcmFuZ2U6ZjM2YTI2MjI5MGMzNDdmZGEzNTg5MDUwMTYwYzYwOGFfMTAtMS0xLTEtMTU5NTQw_12970031-5dbe-4849-a3f4-8ffb277f515c" name="lly:CostOfSalesOperatingExpensesAndOtherNet" scale="6" unitref="usd">5,376.1</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie4fa4f6b472a4f269297591b44aba572_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xOS9mcmFnOjI4Y2NkODJiMTEwZDQzY2Y5ZjE3OWFlZTgwNzBiYmY0L3RhYmxlOmYzNmEyNjIyOTBjMzQ3ZmRhMzU4OTA1MDE2MGM2MDhhL3RhYmxlcmFuZ2U6ZjM2YTI2MjI5MGMzNDdmZGEzNTg5MDUwMTYwYzYwOGFfMTAtMy0xLTEtMTU5NTQw_6cc08d87-8577-40d3-8162-b4bfa1f99ae9" name="lly:CostOfSalesOperatingExpensesAndOtherNet" scale="6" unitref="usd">5,527.5</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xOS9mcmFnOjI4Y2NkODJiMTEwZDQzY2Y5ZjE3OWFlZTgwNzBiYmY0L3RhYmxlOmYzNmEyNjIyOTBjMzQ3ZmRhMzU4OTA1MDE2MGM2MDhhL3RhYmxlcmFuZ2U6ZjM2YTI2MjI5MGMzNDdmZGEzNTg5MDUwMTYwYzYwOGFfMTAtNS0xLTEtMTU5NTQw_505cc220-bff5-4c8a-ba7f-c0f9d961bc6e" name="lly:CostOfSalesOperatingExpensesAndOtherNet" scale="6" unitref="usd">16,529.6</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xOS9mcmFnOjI4Y2NkODJiMTEwZDQzY2Y5ZjE3OWFlZTgwNzBiYmY0L3RhYmxlOmYzNmEyNjIyOTBjMzQ3ZmRhMzU4OTA1MDE2MGM2MDhhL3RhYmxlcmFuZ2U6ZjM2YTI2MjI5MGMzNDdmZGEzNTg5MDUwMTYwYzYwOGFfMTAtNy0xLTEtMTU5NTQw_a69242b6-87ed-45d0-9f4f-09653dc3dd7a" name="lly:CostOfSalesOperatingExpensesAndOtherNet" scale="6" unitref="usd">16,002.9</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i19fc0325c48543008ea71e1fdcf11d86_D20220701-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xOS9mcmFnOjI4Y2NkODJiMTEwZDQzY2Y5ZjE3OWFlZTgwNzBiYmY0L3RhYmxlOmYzNmEyNjIyOTBjMzQ3ZmRhMzU4OTA1MDE2MGM2MDhhL3RhYmxlcmFuZ2U6ZjM2YTI2MjI5MGMzNDdmZGEzNTg5MDUwMTYwYzYwOGFfMTEtMS0xLTEtMTU5NTQw_2eef83f2-97e8-4ef0-9ec0-103a268fbf7c" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" unitref="usd">1,565.5</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie4fa4f6b472a4f269297591b44aba572_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xOS9mcmFnOjI4Y2NkODJiMTEwZDQzY2Y5ZjE3OWFlZTgwNzBiYmY0L3RhYmxlOmYzNmEyNjIyOTBjMzQ3ZmRhMzU4OTA1MDE2MGM2MDhhL3RhYmxlcmFuZ2U6ZjM2YTI2MjI5MGMzNDdmZGEzNTg5MDUwMTYwYzYwOGFfMTEtMy0xLTEtMTU5NTQw_aeb046cf-4b29-4557-8997-ab22bb920225" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" unitref="usd">1,245.3</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xOS9mcmFnOjI4Y2NkODJiMTEwZDQzY2Y5ZjE3OWFlZTgwNzBiYmY0L3RhYmxlOmYzNmEyNjIyOTBjMzQ3ZmRhMzU4OTA1MDE2MGM2MDhhL3RhYmxlcmFuZ2U6ZjM2YTI2MjI5MGMzNDdmZGEzNTg5MDUwMTYwYzYwOGFfMTEtNS0xLTEtMTU5NTQw_97d34a5e-dce8-44a7-870d-73f5bcb10b3d" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" unitref="usd">4,710.0</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xOS9mcmFnOjI4Y2NkODJiMTEwZDQzY2Y5ZjE3OWFlZTgwNzBiYmY0L3RhYmxlOmYzNmEyNjIyOTBjMzQ3ZmRhMzU4OTA1MDE2MGM2MDhhL3RhYmxlcmFuZ2U6ZjM2YTI2MjI5MGMzNDdmZGEzNTg5MDUwMTYwYzYwOGFfMTEtNy0xLTEtMTU5NTQw_7f774311-61dc-4ef9-a174-7c15fecd6af8" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" unitref="usd">4,315.6</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes (Note 7)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i19fc0325c48543008ea71e1fdcf11d86_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xOS9mcmFnOjI4Y2NkODJiMTEwZDQzY2Y5ZjE3OWFlZTgwNzBiYmY0L3RhYmxlOmYzNmEyNjIyOTBjMzQ3ZmRhMzU4OTA1MDE2MGM2MDhhL3RhYmxlcmFuZ2U6ZjM2YTI2MjI5MGMzNDdmZGEzNTg5MDUwMTYwYzYwOGFfMTItMS0xLTEtMTU5NTQw_6e1439d1-de64-4386-9f91-bcbf6791b807" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" unitref="usd">113.8</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie4fa4f6b472a4f269297591b44aba572_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xOS9mcmFnOjI4Y2NkODJiMTEwZDQzY2Y5ZjE3OWFlZTgwNzBiYmY0L3RhYmxlOmYzNmEyNjIyOTBjMzQ3ZmRhMzU4OTA1MDE2MGM2MDhhL3RhYmxlcmFuZ2U6ZjM2YTI2MjI5MGMzNDdmZGEzNTg5MDUwMTYwYzYwOGFfMTItMy0xLTEtMTU5NTQw_6969386e-d191-4be3-9609-64ba670cddaa" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" unitref="usd">135.2</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xOS9mcmFnOjI4Y2NkODJiMTEwZDQzY2Y5ZjE3OWFlZTgwNzBiYmY0L3RhYmxlOmYzNmEyNjIyOTBjMzQ3ZmRhMzU4OTA1MDE2MGM2MDhhL3RhYmxlcmFuZ2U6ZjM2YTI2MjI5MGMzNDdmZGEzNTg5MDUwMTYwYzYwOGFfMTItNS0xLTEtMTU5NTQw_19971751-8fac-441f-a382-ebacb1652bdb" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" unitref="usd">402.9</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xOS9mcmFnOjI4Y2NkODJiMTEwZDQzY2Y5ZjE3OWFlZTgwNzBiYmY0L3RhYmxlOmYzNmEyNjIyOTBjMzQ3ZmRhMzU4OTA1MDE2MGM2MDhhL3RhYmxlcmFuZ2U6ZjM2YTI2MjI5MGMzNDdmZGEzNTg5MDUwMTYwYzYwOGFfMTItNy0xLTEtMTU5NTQw_bb0754e4-3dee-4116-b570-59f9086ff5ab" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" unitref="usd">460.0</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i19fc0325c48543008ea71e1fdcf11d86_D20220701-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xOS9mcmFnOjI4Y2NkODJiMTEwZDQzY2Y5ZjE3OWFlZTgwNzBiYmY0L3RhYmxlOmYzNmEyNjIyOTBjMzQ3ZmRhMzU4OTA1MDE2MGM2MDhhL3RhYmxlcmFuZ2U6ZjM2YTI2MjI5MGMzNDdmZGEzNTg5MDUwMTYwYzYwOGFfMTMtMS0xLTEtMTU5NTQw_58d9c5cb-4c5d-40be-a06d-2489d29adc4b" name="us-gaap:NetIncomeLoss" scale="6" unitref="usd">1,451.7</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie4fa4f6b472a4f269297591b44aba572_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xOS9mcmFnOjI4Y2NkODJiMTEwZDQzY2Y5ZjE3OWFlZTgwNzBiYmY0L3RhYmxlOmYzNmEyNjIyOTBjMzQ3ZmRhMzU4OTA1MDE2MGM2MDhhL3RhYmxlcmFuZ2U6ZjM2YTI2MjI5MGMzNDdmZGEzNTg5MDUwMTYwYzYwOGFfMTMtMy0xLTEtMTU5NTQw_c6e26b7d-c614-4b1e-9f5b-889f1187c777" name="us-gaap:NetIncomeLoss" scale="6" unitref="usd">1,110.1</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xOS9mcmFnOjI4Y2NkODJiMTEwZDQzY2Y5ZjE3OWFlZTgwNzBiYmY0L3RhYmxlOmYzNmEyNjIyOTBjMzQ3ZmRhMzU4OTA1MDE2MGM2MDhhL3RhYmxlcmFuZ2U6ZjM2YTI2MjI5MGMzNDdmZGEzNTg5MDUwMTYwYzYwOGFfMTMtNS0xLTEtMTU5NTQw_6d3a5b51-fef7-4442-b0ae-e0b885eeddf5" name="us-gaap:NetIncomeLoss" scale="6" unitref="usd">4,307.1</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xOS9mcmFnOjI4Y2NkODJiMTEwZDQzY2Y5ZjE3OWFlZTgwNzBiYmY0L3RhYmxlOmYzNmEyNjIyOTBjMzQ3ZmRhMzU4OTA1MDE2MGM2MDhhL3RhYmxlcmFuZ2U6ZjM2YTI2MjI5MGMzNDdmZGEzNTg5MDUwMTYwYzYwOGFfMTMtNy0xLTEtMTU5NTQw_b9809708-0d2a-41f9-9bca-7ebbc7febc06" name="us-gaap:NetIncomeLoss" scale="6" unitref="usd">3,855.6</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i19fc0325c48543008ea71e1fdcf11d86_D20220701-20220930" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xOS9mcmFnOjI4Y2NkODJiMTEwZDQzY2Y5ZjE3OWFlZTgwNzBiYmY0L3RhYmxlOmYzNmEyNjIyOTBjMzQ3ZmRhMzU4OTA1MDE2MGM2MDhhL3RhYmxlcmFuZ2U6ZjM2YTI2MjI5MGMzNDdmZGEzNTg5MDUwMTYwYzYwOGFfMTgtMS0xLTEtMTU5NTQw_1788c234-9267-4223-8b6d-ad74cc709e5c" name="us-gaap:EarningsPerShareBasic" scale="0" unitref="usdPerShare">1.61</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie4fa4f6b472a4f269297591b44aba572_D20210701-20210930" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xOS9mcmFnOjI4Y2NkODJiMTEwZDQzY2Y5ZjE3OWFlZTgwNzBiYmY0L3RhYmxlOmYzNmEyNjIyOTBjMzQ3ZmRhMzU4OTA1MDE2MGM2MDhhL3RhYmxlcmFuZ2U6ZjM2YTI2MjI5MGMzNDdmZGEzNTg5MDUwMTYwYzYwOGFfMTgtMy0xLTEtMTU5NTQw_44d673fa-a784-49b3-9a55-f65a3ef4135c" name="us-gaap:EarningsPerShareBasic" scale="0" unitref="usdPerShare">1.22</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xOS9mcmFnOjI4Y2NkODJiMTEwZDQzY2Y5ZjE3OWFlZTgwNzBiYmY0L3RhYmxlOmYzNmEyNjIyOTBjMzQ3ZmRhMzU4OTA1MDE2MGM2MDhhL3RhYmxlcmFuZ2U6ZjM2YTI2MjI5MGMzNDdmZGEzNTg5MDUwMTYwYzYwOGFfMTgtNS0xLTEtMTU5NTQw_ab48a2bc-46bb-46ec-ba3a-6fced6b4efc8" name="us-gaap:EarningsPerShareBasic" scale="0" unitref="usdPerShare">4.78</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xOS9mcmFnOjI4Y2NkODJiMTEwZDQzY2Y5ZjE3OWFlZTgwNzBiYmY0L3RhYmxlOmYzNmEyNjIyOTBjMzQ3ZmRhMzU4OTA1MDE2MGM2MDhhL3RhYmxlcmFuZ2U6ZjM2YTI2MjI5MGMzNDdmZGEzNTg5MDUwMTYwYzYwOGFfMTgtNy0xLTEtMTU5NTQw_e2fe351d-fd87-4ba1-ab7f-45d55f23330a" name="us-gaap:EarningsPerShareBasic" scale="0" unitref="usdPerShare">4.25</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i19fc0325c48543008ea71e1fdcf11d86_D20220701-20220930" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xOS9mcmFnOjI4Y2NkODJiMTEwZDQzY2Y5ZjE3OWFlZTgwNzBiYmY0L3RhYmxlOmYzNmEyNjIyOTBjMzQ3ZmRhMzU4OTA1MDE2MGM2MDhhL3RhYmxlcmFuZ2U6ZjM2YTI2MjI5MGMzNDdmZGEzNTg5MDUwMTYwYzYwOGFfMjAtMS0xLTEtMTU5NTQw_a40aefd9-b793-4ede-a8b5-9ee491bc0d74" name="us-gaap:EarningsPerShareDiluted" scale="0" unitref="usdPerShare">1.61</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie4fa4f6b472a4f269297591b44aba572_D20210701-20210930" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xOS9mcmFnOjI4Y2NkODJiMTEwZDQzY2Y5ZjE3OWFlZTgwNzBiYmY0L3RhYmxlOmYzNmEyNjIyOTBjMzQ3ZmRhMzU4OTA1MDE2MGM2MDhhL3RhYmxlcmFuZ2U6ZjM2YTI2MjI5MGMzNDdmZGEzNTg5MDUwMTYwYzYwOGFfMjAtMy0xLTEtMTU5NTQw_6489d081-a1d5-4648-aa7e-d1fde0d8b14c" name="us-gaap:EarningsPerShareDiluted" scale="0" unitref="usdPerShare">1.22</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xOS9mcmFnOjI4Y2NkODJiMTEwZDQzY2Y5ZjE3OWFlZTgwNzBiYmY0L3RhYmxlOmYzNmEyNjIyOTBjMzQ3ZmRhMzU4OTA1MDE2MGM2MDhhL3RhYmxlcmFuZ2U6ZjM2YTI2MjI5MGMzNDdmZGEzNTg5MDUwMTYwYzYwOGFfMjAtNS0xLTEtMTU5NTQw_1cae5aec-ea4f-4289-8342-edb9c6e419be" name="us-gaap:EarningsPerShareDiluted" scale="0" unitref="usdPerShare">4.76</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xOS9mcmFnOjI4Y2NkODJiMTEwZDQzY2Y5ZjE3OWFlZTgwNzBiYmY0L3RhYmxlOmYzNmEyNjIyOTBjMzQ3ZmRhMzU4OTA1MDE2MGM2MDhhL3RhYmxlcmFuZ2U6ZjM2YTI2MjI5MGMzNDdmZGEzNTg5MDUwMTYwYzYwOGFfMjAtNy0xLTEtMTU5NTQw_9459800a-920f-4ba4-a2ef-6c573174cb5d" name="us-gaap:EarningsPerShareDiluted" scale="0" unitref="usdPerShare">4.23</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used in calculation of earnings per share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i19fc0325c48543008ea71e1fdcf11d86_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xOS9mcmFnOjI4Y2NkODJiMTEwZDQzY2Y5ZjE3OWFlZTgwNzBiYmY0L3RhYmxlOmYzNmEyNjIyOTBjMzQ3ZmRhMzU4OTA1MDE2MGM2MDhhL3RhYmxlcmFuZ2U6ZjM2YTI2MjI5MGMzNDdmZGEzNTg5MDUwMTYwYzYwOGFfMjQtMS0xLTEtMTU5NTQw_a342be05-e5e0-4fb9-9cf0-bf15a8143672" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" unitref="shares">900.7</ix:nonfraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie4fa4f6b472a4f269297591b44aba572_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xOS9mcmFnOjI4Y2NkODJiMTEwZDQzY2Y5ZjE3OWFlZTgwNzBiYmY0L3RhYmxlOmYzNmEyNjIyOTBjMzQ3ZmRhMzU4OTA1MDE2MGM2MDhhL3RhYmxlcmFuZ2U6ZjM2YTI2MjI5MGMzNDdmZGEzNTg5MDUwMTYwYzYwOGFfMjQtMy0xLTEtMTU5NTQw_45f2e109-295f-4292-b653-57a9576a5425" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" unitref="shares">906.7</ix:nonfraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xOS9mcmFnOjI4Y2NkODJiMTEwZDQzY2Y5ZjE3OWFlZTgwNzBiYmY0L3RhYmxlOmYzNmEyNjIyOTBjMzQ3ZmRhMzU4OTA1MDE2MGM2MDhhL3RhYmxlcmFuZ2U6ZjM2YTI2MjI5MGMzNDdmZGEzNTg5MDUwMTYwYzYwOGFfMjQtNS0xLTEtMTU5NTQw_be7c3387-beae-4102-b101-6b8c58663460" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" unitref="shares">901.8</ix:nonfraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xOS9mcmFnOjI4Y2NkODJiMTEwZDQzY2Y5ZjE3OWFlZTgwNzBiYmY0L3RhYmxlOmYzNmEyNjIyOTBjMzQ3ZmRhMzU4OTA1MDE2MGM2MDhhL3RhYmxlcmFuZ2U6ZjM2YTI2MjI5MGMzNDdmZGEzNTg5MDUwMTYwYzYwOGFfMjQtNy0xLTEtMTU5NTQw_12a33f33-8b87-4de1-a2e6-1ffbea5b8339" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" unitref="shares">907.7</ix:nonfraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i19fc0325c48543008ea71e1fdcf11d86_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xOS9mcmFnOjI4Y2NkODJiMTEwZDQzY2Y5ZjE3OWFlZTgwNzBiYmY0L3RhYmxlOmYzNmEyNjIyOTBjMzQ3ZmRhMzU4OTA1MDE2MGM2MDhhL3RhYmxlcmFuZ2U6ZjM2YTI2MjI5MGMzNDdmZGEzNTg5MDUwMTYwYzYwOGFfMjUtMS0xLTEtMTU5NTQw_18dcdabc-0a87-4da1-97d2-dde6115ab295" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" unitref="shares">903.8</ix:nonfraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie4fa4f6b472a4f269297591b44aba572_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xOS9mcmFnOjI4Y2NkODJiMTEwZDQzY2Y5ZjE3OWFlZTgwNzBiYmY0L3RhYmxlOmYzNmEyNjIyOTBjMzQ3ZmRhMzU4OTA1MDE2MGM2MDhhL3RhYmxlcmFuZ2U6ZjM2YTI2MjI5MGMzNDdmZGEzNTg5MDUwMTYwYzYwOGFfMjUtMy0xLTEtMTU5NTQw_80fbbb1b-385c-462c-a772-a2b6929434e8" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" unitref="shares">910.8</ix:nonfraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xOS9mcmFnOjI4Y2NkODJiMTEwZDQzY2Y5ZjE3OWFlZTgwNzBiYmY0L3RhYmxlOmYzNmEyNjIyOTBjMzQ3ZmRhMzU4OTA1MDE2MGM2MDhhL3RhYmxlcmFuZ2U6ZjM2YTI2MjI5MGMzNDdmZGEzNTg5MDUwMTYwYzYwOGFfMjUtNS0xLTEtMTU5NTQw_35c97634-24cf-4189-8d10-a2e1a41b8118" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" unitref="shares">904.5</ix:nonfraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18xOS9mcmFnOjI4Y2NkODJiMTEwZDQzY2Y5ZjE3OWFlZTgwNzBiYmY0L3RhYmxlOmYzNmEyNjIyOTBjMzQ3ZmRhMzU4OTA1MDE2MGM2MDhhL3RhYmxlcmFuZ2U6ZjM2YTI2MjI5MGMzNDdmZGEzNTg5MDUwMTYwYzYwOGFfMjUtNy0xLTEtMTU5NTQw_4eb16921-f47a-45ae-9e75-e4218e04e70c" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" unitref="shares">911.7</ix:nonfraction></span></td></tr></table></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to consolidated condensed financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i5fed483d9c7e4f3cbba3a62c53226cd7_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Condensed Statements of Comprehensive Income</span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ELI LILLY AND COMPANY AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Dollars in millions)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.443%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.500%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i19fc0325c48543008ea71e1fdcf11d86_D20220701-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yMi9mcmFnOmFkY2U4MDk2NmRlYTQzMmM4YTY4MGZlMzYxMGFmYjU2L3RhYmxlOjFhNzM4NWIwZTEyMjRhYTliM2FiNTZlY2Y3Y2VhYzUyL3RhYmxlcmFuZ2U6MWE3Mzg1YjBlMTIyNGFhOWIzYWI1NmVjZjdjZWFjNTJfMi0xLTEtMS0xNTk1NDA_58d9c5cb-4c5d-40be-a06d-2489d29adc4b" name="us-gaap:NetIncomeLoss" scale="6" unitref="usd">1,451.7</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie4fa4f6b472a4f269297591b44aba572_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yMi9mcmFnOmFkY2U4MDk2NmRlYTQzMmM4YTY4MGZlMzYxMGFmYjU2L3RhYmxlOjFhNzM4NWIwZTEyMjRhYTliM2FiNTZlY2Y3Y2VhYzUyL3RhYmxlcmFuZ2U6MWE3Mzg1YjBlMTIyNGFhOWIzYWI1NmVjZjdjZWFjNTJfMi0zLTEtMS0xNTk1NDA_c6e26b7d-c614-4b1e-9f5b-889f1187c777" name="us-gaap:NetIncomeLoss" scale="6" unitref="usd">1,110.1</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yMi9mcmFnOmFkY2U4MDk2NmRlYTQzMmM4YTY4MGZlMzYxMGFmYjU2L3RhYmxlOjFhNzM4NWIwZTEyMjRhYTliM2FiNTZlY2Y3Y2VhYzUyL3RhYmxlcmFuZ2U6MWE3Mzg1YjBlMTIyNGFhOWIzYWI1NmVjZjdjZWFjNTJfMi01LTEtMS0xNTk1NDA_87698447-ba66-4f71-89c1-b28a71c9e82a" name="us-gaap:NetIncomeLoss" scale="6" unitref="usd">4,307.1</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yMi9mcmFnOmFkY2U4MDk2NmRlYTQzMmM4YTY4MGZlMzYxMGFmYjU2L3RhYmxlOjFhNzM4NWIwZTEyMjRhYTliM2FiNTZlY2Y3Y2VhYzUyL3RhYmxlcmFuZ2U6MWE3Mzg1YjBlMTIyNGFhOWIzYWI1NmVjZjdjZWFjNTJfMi03LTEtMS0xNTk1NDA_912d99b5-d76a-4c0a-b3cd-69c00d2c8eed" name="us-gaap:NetIncomeLoss" scale="6" unitref="usd">3,855.6</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax (Note 10)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="i19fc0325c48543008ea71e1fdcf11d86_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yMi9mcmFnOmFkY2U4MDk2NmRlYTQzMmM4YTY4MGZlMzYxMGFmYjU2L3RhYmxlOjFhNzM4NWIwZTEyMjRhYTliM2FiNTZlY2Y3Y2VhYzUyL3RhYmxlcmFuZ2U6MWE3Mzg1YjBlMTIyNGFhOWIzYWI1NmVjZjdjZWFjNTJfMy0xLTEtMS0xNTk1NDA_3492514b-29f6-4a97-b4ba-d4a886cd03bd" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" sign="-" unitref="usd">8.1</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie4fa4f6b472a4f269297591b44aba572_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yMi9mcmFnOmFkY2U4MDk2NmRlYTQzMmM4YTY4MGZlMzYxMGFmYjU2L3RhYmxlOjFhNzM4NWIwZTEyMjRhYTliM2FiNTZlY2Y3Y2VhYzUyL3RhYmxlcmFuZ2U6MWE3Mzg1YjBlMTIyNGFhOWIzYWI1NmVjZjdjZWFjNTJfMy0zLTEtMS0xNTk1NDA_6bd78490-2767-4792-8223-3f77a669bcc7" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" unitref="usd">114.4</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yMi9mcmFnOmFkY2U4MDk2NmRlYTQzMmM4YTY4MGZlMzYxMGFmYjU2L3RhYmxlOjFhNzM4NWIwZTEyMjRhYTliM2FiNTZlY2Y3Y2VhYzUyL3RhYmxlcmFuZ2U6MWE3Mzg1YjBlMTIyNGFhOWIzYWI1NmVjZjdjZWFjNTJfMy01LTEtMS0xNTk1NDA_46404f0d-dab3-4be2-8104-f9f3be52ab8b" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" unitref="usd">47.3</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yMi9mcmFnOmFkY2U4MDk2NmRlYTQzMmM4YTY4MGZlMzYxMGFmYjU2L3RhYmxlOjFhNzM4NWIwZTEyMjRhYTliM2FiNTZlY2Y3Y2VhYzUyL3RhYmxlcmFuZ2U6MWE3Mzg1YjBlMTIyNGFhOWIzYWI1NmVjZjdjZWFjNTJfMy03LTEtMS0xNTk1NDA_0cbe9d9b-064d-4c6e-9258-7ad03c8bc524" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" unitref="usd">323.7</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i19fc0325c48543008ea71e1fdcf11d86_D20220701-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yMi9mcmFnOmFkY2U4MDk2NmRlYTQzMmM4YTY4MGZlMzYxMGFmYjU2L3RhYmxlOjFhNzM4NWIwZTEyMjRhYTliM2FiNTZlY2Y3Y2VhYzUyL3RhYmxlcmFuZ2U6MWE3Mzg1YjBlMTIyNGFhOWIzYWI1NmVjZjdjZWFjNTJfNC0xLTEtMS0xNTk1NDA_d0c29698-24ec-4a7b-92b3-b5188c7deeb1" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" unitref="usd">1,443.6</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie4fa4f6b472a4f269297591b44aba572_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yMi9mcmFnOmFkY2U4MDk2NmRlYTQzMmM4YTY4MGZlMzYxMGFmYjU2L3RhYmxlOjFhNzM4NWIwZTEyMjRhYTliM2FiNTZlY2Y3Y2VhYzUyL3RhYmxlcmFuZ2U6MWE3Mzg1YjBlMTIyNGFhOWIzYWI1NmVjZjdjZWFjNTJfNC0zLTEtMS0xNTk1NDA_966b1a16-2188-439b-aea5-86ccceca6fe0" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" unitref="usd">1,224.5</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yMi9mcmFnOmFkY2U4MDk2NmRlYTQzMmM4YTY4MGZlMzYxMGFmYjU2L3RhYmxlOjFhNzM4NWIwZTEyMjRhYTliM2FiNTZlY2Y3Y2VhYzUyL3RhYmxlcmFuZ2U6MWE3Mzg1YjBlMTIyNGFhOWIzYWI1NmVjZjdjZWFjNTJfNC01LTEtMS0xNTk1NDA_4f365400-8e9d-4a7f-884c-23f8ba2c1acb" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" unitref="usd">4,354.4</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yMi9mcmFnOmFkY2U4MDk2NmRlYTQzMmM4YTY4MGZlMzYxMGFmYjU2L3RhYmxlOjFhNzM4NWIwZTEyMjRhYTliM2FiNTZlY2Y3Y2VhYzUyL3RhYmxlcmFuZ2U6MWE3Mzg1YjBlMTIyNGFhOWIzYWI1NmVjZjdjZWFjNTJfNC03LTEtMS0xNTk1NDA_7a232746-1a31-451a-934c-5845fc79dcf3" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" unitref="usd">4,179.3</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to consolidated condensed financial statements.</span></div><div style="margin-top:9pt"><span><br/></span></div><div style="margin-top:9pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i5fed483d9c7e4f3cbba3a62c53226cd7_25"></div><hr style="page-break-after:always"/><div style="min-height:27pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Condensed Balance Sheets</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ELI LILLY AND COMPANY AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Dollars in millions)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.281%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.512%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.283%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Current Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents (Note 6)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i08ccb35f6ad24d7793c9c91b74ca2ea1_I20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfMy0xLTEtMS0xNTk1NDA_258622be-3365-4a96-91d9-ab61a14403bd" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" unitref="usd">2,617.4</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i0973ba0c1d894ceaa494709a13f814fb_I20211231" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfMy0zLTEtMS0xNTk1NDA_01c2ae74-7f55-4da1-9d57-e13534decca7" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" unitref="usd">3,818.5</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments (Note 6)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i08ccb35f6ad24d7793c9c91b74ca2ea1_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfNC0xLTEtMS0xNTk1NDA_ecc6984c-df33-40de-8131-7c5e04c1b75e" name="us-gaap:ShortTermInvestments" scale="6" unitref="usd">124.7</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i0973ba0c1d894ceaa494709a13f814fb_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfNC0zLTEtMS0xNTk1NDA_f11fce4a-1f0d-43a2-aac0-2a037605ca5a" name="us-gaap:ShortTermInvestments" scale="6" unitref="usd">90.1</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net of allowances of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$<ix:nonfraction contextref="i08ccb35f6ad24d7793c9c91b74ca2ea1_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfNS0wLTEtMS0xNTk1NDAvdGV4dHJlZ2lvbjoxYzg5YmU1NWM2ZWI0NWIyYjdjYjlkMGQzZWMxMmI4OF80Nw_b19a986a-77cb-4977-8e85-31f22483c306" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" unitref="usd">17.7</ix:nonfraction> (2022)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> and $<ix:nonfraction contextref="i0973ba0c1d894ceaa494709a13f814fb_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfNS0wLTEtMS0xNTk1NDAvdGV4dHJlZ2lvbjoxYzg5YmU1NWM2ZWI0NWIyYjdjYjlkMGQzZWMxMmI4OF82Mg_c63e1ac1-475f-4b86-8273-c6e2ce081463" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" unitref="usd">22.5</ix:nonfraction> (2021)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i08ccb35f6ad24d7793c9c91b74ca2ea1_I20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfNS0xLTEtMS0xNTk1NDA_ab5f6710-3431-4d52-9859-e91ab0a14690" name="us-gaap:AccountsReceivableNetCurrent" scale="6" unitref="usd">6,715.3</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i0973ba0c1d894ceaa494709a13f814fb_I20211231" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfNS0zLTEtMS0xNTk1NDA_7bd80223-a9c3-4e22-82d9-4ae6d749a617" name="us-gaap:AccountsReceivableNetCurrent" scale="6" unitref="usd">6,672.8</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i08ccb35f6ad24d7793c9c91b74ca2ea1_I20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfNi0xLTEtMS0xNTk1NDA_0afe3dcd-2806-44d6-ae8b-0fd486f6130b" name="us-gaap:OtherReceivablesNetCurrent" scale="6" unitref="usd">1,609.5</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i0973ba0c1d894ceaa494709a13f814fb_I20211231" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfNi0zLTEtMS0xNTk1NDA_f19b2b00-7b22-4c1f-adb3-eb30d05cebae" name="us-gaap:OtherReceivablesNetCurrent" scale="6" unitref="usd">1,454.4</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i08ccb35f6ad24d7793c9c91b74ca2ea1_I20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfNy0xLTEtMS0xNTk1NDA_12310145-a3d9-418a-8225-fcebb251b589" name="us-gaap:InventoryNet" scale="6" unitref="usd">3,831.1</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i0973ba0c1d894ceaa494709a13f814fb_I20211231" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfNy0zLTEtMS0xNTk1NDA_e2eb9067-78a5-4492-a0c2-ff451113d3f5" name="us-gaap:InventoryNet" scale="6" unitref="usd">3,886.0</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i08ccb35f6ad24d7793c9c91b74ca2ea1_I20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfOC0xLTEtMS0xNTk1NDA_b767a778-61a5-4263-8907-6cf9f455fe1c" name="us-gaap:PrepaidExpenseCurrent" scale="6" unitref="usd">2,741.9</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i0973ba0c1d894ceaa494709a13f814fb_I20211231" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfOC0zLTEtMS0xNTk1NDA_f9f8c975-c9f8-48e5-8fcd-a6223da95da2" name="us-gaap:PrepaidExpenseCurrent" scale="6" unitref="usd">2,530.6</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i08ccb35f6ad24d7793c9c91b74ca2ea1_I20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfOS0xLTEtMS0xNTk1NDA_487d1f4c-a662-4d7c-bbb5-6a3584ea94a9" name="us-gaap:AssetsCurrent" scale="6" unitref="usd">17,639.9</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i0973ba0c1d894ceaa494709a13f814fb_I20211231" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfOS0zLTEtMS0xNTk1NDA_e25e2846-7a93-42e7-bf53-4e9483207b71" name="us-gaap:AssetsCurrent" scale="6" unitref="usd">18,452.4</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments (Note 6)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i08ccb35f6ad24d7793c9c91b74ca2ea1_I20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfMTAtMS0xLTEtMTU5NTQw_d02b5002-7f0a-4246-b2d3-adbc85598ab0" name="us-gaap:LongTermInvestments" scale="6" unitref="usd">2,574.6</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i0973ba0c1d894ceaa494709a13f814fb_I20211231" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfMTAtMy0xLTEtMTU5NTQw_db9a907b-fd01-4b39-a4d1-6860b5de6fd9" name="us-gaap:LongTermInvestments" scale="6" unitref="usd">3,212.6</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i08ccb35f6ad24d7793c9c91b74ca2ea1_I20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfMTEtMS0xLTEtMTU5NTQw_2449ff88-41a8-4515-bf37-fc0dcb15a504" name="us-gaap:Goodwill" scale="6" unitref="usd">3,891.6</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i0973ba0c1d894ceaa494709a13f814fb_I20211231" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfMTEtMy0xLTEtMTU5NTQw_a9b095b2-2468-40f5-8ff3-8c40277c9562" name="us-gaap:Goodwill" scale="6" unitref="usd">3,892.0</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangibles, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i08ccb35f6ad24d7793c9c91b74ca2ea1_I20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfMTItMS0xLTEtMTU5NTQw_7f0bb81c-6fae-484f-a08b-5bbc315de246" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" unitref="usd">7,124.1</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i0973ba0c1d894ceaa494709a13f814fb_I20211231" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfMTItMy0xLTEtMTU5NTQw_c53ab72a-f910-4179-8eb1-77fd6f556736" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" unitref="usd">7,691.9</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i08ccb35f6ad24d7793c9c91b74ca2ea1_I20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfMTMtMS0xLTEtMTU5NTQw_5b0311aa-6873-4375-a34c-678aff44af5b" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" unitref="usd">2,384.3</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i0973ba0c1d894ceaa494709a13f814fb_I20211231" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfMTMtMy0xLTEtMTU5NTQw_b35d82df-9a8a-49ef-9600-44d0a3efd5ad" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" unitref="usd">2,489.3</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net of accumulated depreciation of</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> $<ix:nonfraction contextref="i08ccb35f6ad24d7793c9c91b74ca2ea1_I20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfMTQtMC0xLTEtMTU5NTQwL3RleHRyZWdpb246MjVhYmU4OTliZDE2NDVmNjg1NzlmYzI5NzE1ZjcxN2JfNjM_37543d0e-594d-4d87-b91f-24c9527fea65" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="6" unitref="usd">10,074.0</ix:nonfraction> (2022) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">and $<ix:nonfraction contextref="i0973ba0c1d894ceaa494709a13f814fb_I20211231" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfMTQtMC0xLTEtMTU5NTQwL3RleHRyZWdpb246MjVhYmU4OTliZDE2NDVmNjg1NzlmYzI5NzE1ZjcxN2JfNzc_4f13a435-2b19-460f-a2a6-d1605042b529" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="6" unitref="usd">9,976.7</ix:nonfraction> (2021)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i08ccb35f6ad24d7793c9c91b74ca2ea1_I20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfMTQtMS0xLTEtMTU5NTQw_213ce0f8-6fd8-4311-a364-0f5407540896" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" unitref="usd">9,311.3</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i0973ba0c1d894ceaa494709a13f814fb_I20211231" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfMTQtMy0xLTEtMTU5NTQw_0414288a-182c-42a7-ab08-1a91a27c5615" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" unitref="usd">8,985.1</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other noncurrent assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i08ccb35f6ad24d7793c9c91b74ca2ea1_I20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfMTUtMS0xLTEtMTU5NTQw_5ed6a90d-7bc6-47fc-9c3f-dba9c9afb7dc" name="us-gaap:OtherAssetsNoncurrent" scale="6" unitref="usd">4,535.7</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i0973ba0c1d894ceaa494709a13f814fb_I20211231" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfMTUtMy0xLTEtMTU5NTQw_c7d6b30f-fae9-469f-a365-4fda19a83677" name="us-gaap:OtherAssetsNoncurrent" scale="6" unitref="usd">4,082.7</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i08ccb35f6ad24d7793c9c91b74ca2ea1_I20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfMTYtMS0xLTEtMTU5NTQw_689c1831-07b9-4dbe-b846-098b7f969a0b" name="us-gaap:Assets" scale="6" unitref="usd">47,461.5</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i0973ba0c1d894ceaa494709a13f814fb_I20211231" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfMTYtMy0xLTEtMTU5NTQw_b3c5f9f9-9fd3-441c-901e-bd917b861063" name="us-gaap:Assets" scale="6" unitref="usd">48,806.0</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities and Equity</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Current Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term borrowings and current maturities of long-term debt</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i08ccb35f6ad24d7793c9c91b74ca2ea1_I20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfMTktMS0xLTEtMTU5NTQw_ff2dfb2b-44d7-428e-a06c-ebe3af4d930e" name="us-gaap:DebtCurrent" scale="6" unitref="usd">1,744.6</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i0973ba0c1d894ceaa494709a13f814fb_I20211231" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfMTktMy0xLTEtMTU5NTQw_cf946d35-5928-4872-9b5a-0ebebcfc1f05" name="us-gaap:DebtCurrent" scale="6" unitref="usd">1,538.3</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i08ccb35f6ad24d7793c9c91b74ca2ea1_I20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfMjAtMS0xLTEtMTU5NTQw_954fcb33-4191-48bb-99a8-4b9629c58657" name="us-gaap:AccountsPayableCurrent" scale="6" unitref="usd">1,683.2</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i0973ba0c1d894ceaa494709a13f814fb_I20211231" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfMjAtMy0xLTEtMTU5NTQw_5b49cf70-0aef-416c-975b-821fbc2f8fbf" name="us-gaap:AccountsPayableCurrent" scale="6" unitref="usd">1,670.6</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i08ccb35f6ad24d7793c9c91b74ca2ea1_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfMjEtMS0xLTEtMTU5NTQw_e19513ed-0f2a-422d-b91d-8b64eb3e9d40" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" unitref="usd">984.1</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i0973ba0c1d894ceaa494709a13f814fb_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfMjEtMy0xLTEtMTU5NTQw_5d192ac0-a27d-433d-b1a6-5bb5f3f2cd2b" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" unitref="usd">958.1</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales rebates and discounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i08ccb35f6ad24d7793c9c91b74ca2ea1_I20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfMjItMS0xLTEtMTU5NTQw_4d908b33-c4c7-4482-9bd8-31a66f6e71fa" name="lly:SalesRebatesAndDiscounts" scale="6" unitref="usd">8,568.4</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i0973ba0c1d894ceaa494709a13f814fb_I20211231" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfMjItMy0xLTEtMTU5NTQw_8eff446a-5b64-4c73-b09e-b2abc41f0de0" name="lly:SalesRebatesAndDiscounts" scale="6" unitref="usd">6,845.8</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i08ccb35f6ad24d7793c9c91b74ca2ea1_I20220930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfMjMtMS0xLTEtMTU5NTQw_eb03c580-9581-41db-a876-67f2d5b6a4c5" name="us-gaap:DividendsPayableCurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i0973ba0c1d894ceaa494709a13f814fb_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfMjMtMy0xLTEtMTU5NTQw_effe50b6-40cd-4ead-a898-e5c73a7d302d" name="us-gaap:DividendsPayableCurrent" scale="6" unitref="usd">885.5</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i08ccb35f6ad24d7793c9c91b74ca2ea1_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfMjQtMS0xLTEtMTU5NTQw_91ab8558-880a-4404-b810-128448e6b45f" name="us-gaap:TaxesPayableCurrent" scale="6" unitref="usd">685.6</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i0973ba0c1d894ceaa494709a13f814fb_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfMjQtMy0xLTEtMTU5NTQw_fb66bc51-7140-4992-a237-cfba4951acf9" name="us-gaap:TaxesPayableCurrent" scale="6" unitref="usd">126.9</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i08ccb35f6ad24d7793c9c91b74ca2ea1_I20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfMjUtMS0xLTEtMTU5NTQw_6d0bd9c0-70fc-4a65-a63f-964d21b26333" name="us-gaap:OtherLiabilitiesCurrent" scale="6" unitref="usd">1,986.9</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i0973ba0c1d894ceaa494709a13f814fb_I20211231" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfMjUtMy0xLTEtMTU5NTQw_3913dbb5-0b1b-48e8-b669-9dd7fee45f64" name="us-gaap:OtherLiabilitiesCurrent" scale="6" unitref="usd">3,027.5</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i08ccb35f6ad24d7793c9c91b74ca2ea1_I20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfMjYtMS0xLTEtMTU5NTQw_07f6f68b-cf9c-40a9-a102-373630c1ae79" name="us-gaap:LiabilitiesCurrent" scale="6" unitref="usd">15,652.8</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i0973ba0c1d894ceaa494709a13f814fb_I20211231" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfMjYtMy0xLTEtMTU5NTQw_9952a1da-616c-4a13-b7bf-89d69b907ab8" name="us-gaap:LiabilitiesCurrent" scale="6" unitref="usd">15,052.7</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i08ccb35f6ad24d7793c9c91b74ca2ea1_I20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfMjgtMS0xLTEtMTU5NTQw_2375d25b-5e7c-45b6-87fb-40c0d3ff9593" name="us-gaap:LongTermDebtNoncurrent" scale="6" unitref="usd">14,143.8</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i0973ba0c1d894ceaa494709a13f814fb_I20211231" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfMjgtMy0xLTEtMTU5NTQw_9364e45a-ca83-48de-8185-5195dd23c1f8" name="us-gaap:LongTermDebtNoncurrent" scale="6" unitref="usd">15,346.4</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued retirement benefits (Note 8)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i08ccb35f6ad24d7793c9c91b74ca2ea1_I20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfMjktMS0xLTEtMTU5NTQw_84f3e680-f348-4b2c-b8c0-d7d2f3a7b188" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" unitref="usd">1,832.5</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i0973ba0c1d894ceaa494709a13f814fb_I20211231" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfMjktMy0xLTEtMTU5NTQw_4d5b2baa-6c52-4034-8937-bf54598c3105" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" unitref="usd">1,954.1</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term income taxes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i08ccb35f6ad24d7793c9c91b74ca2ea1_I20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfMzAtMS0xLTEtMTU5NTQw_3a3cec52-0ed0-44f3-8b86-18246f9232f4" name="us-gaap:AccruedIncomeTaxesNoncurrent" scale="6" unitref="usd">3,641.7</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i0973ba0c1d894ceaa494709a13f814fb_I20211231" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfMzAtMy0xLTEtMTU5NTQw_8e4123d4-043f-4d9c-9faa-7c6d3f10c301" name="us-gaap:AccruedIncomeTaxesNoncurrent" scale="6" unitref="usd">3,920.0</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i08ccb35f6ad24d7793c9c91b74ca2ea1_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfMzEtMS0xLTEtMTU5NTQw_716b9b2e-60e2-4313-83e5-7c7522fc48ec" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" unitref="usd">171.9</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i0973ba0c1d894ceaa494709a13f814fb_I20211231" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfMzEtMy0xLTEtMTU5NTQw_0c8cc5fd-214f-4d35-ad7c-e854c8d8ff30" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" unitref="usd">1,733.7</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other noncurrent liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i08ccb35f6ad24d7793c9c91b74ca2ea1_I20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfMzItMS0xLTEtMTU5NTQw_17fb9f7c-9f28-4952-9bb0-3de3f0152828" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" unitref="usd">1,852.9</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i0973ba0c1d894ceaa494709a13f814fb_I20211231" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfMzItMy0xLTEtMTU5NTQw_7143a679-23bf-4c13-a98f-63c79fd198f9" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" unitref="usd">1,644.3</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i08ccb35f6ad24d7793c9c91b74ca2ea1_I20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfMzMtMS0xLTEtMTU5NTQw_5e4ffb82-2719-495f-bb32-824705e9d184" name="us-gaap:LiabilitiesNoncurrent" scale="6" unitref="usd">21,642.8</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i0973ba0c1d894ceaa494709a13f814fb_I20211231" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfMzMtMy0xLTEtMTU5NTQw_926495a8-349c-41e3-a1f0-0f47cf0e52af" name="us-gaap:LiabilitiesNoncurrent" scale="6" unitref="usd">24,598.5</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Commitments and Contingencies (Note 9)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonfraction contextref="i08ccb35f6ad24d7793c9c91b74ca2ea1_I20220930" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfMzQtMS0xLTEtMTU5NTQw_ed2c349c-8615-40f3-b30d-93b05b4cee01" name="us-gaap:CommitmentsAndContingencies" unitref="usd" xsi:nil="true"></ix:nonfraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonfraction contextref="i0973ba0c1d894ceaa494709a13f814fb_I20211231" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfMzQtMy0xLTEtMTU5NTQw_2ee68847-370e-4e54-94f0-08b48156ba8e" name="us-gaap:CommitmentsAndContingencies" unitref="usd" xsi:nil="true"></ix:nonfraction></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Eli Lilly and Company Shareholders' Equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i08ccb35f6ad24d7793c9c91b74ca2ea1_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfMzYtMS0xLTEtMTU5NTQw_6f945256-6a20-49dc-ab4a-6f42cd913251" name="us-gaap:CommonStockValue" scale="6" unitref="usd">594.1</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i0973ba0c1d894ceaa494709a13f814fb_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfMzYtMy0xLTEtMTU5NTQw_9d547d3c-c16e-47a8-b0d0-faaf4ba786bf" name="us-gaap:CommonStockValue" scale="6" unitref="usd">596.3</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i08ccb35f6ad24d7793c9c91b74ca2ea1_I20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfMzctMS0xLTEtMTU5NTQw_30d4db3f-7b5a-4463-8464-28b1b04af3b7" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="6" unitref="usd">6,829.0</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i0973ba0c1d894ceaa494709a13f814fb_I20211231" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfMzctMy0xLTEtMTU5NTQw_0a2fce72-e720-4219-83e7-6cb98505cb5e" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="6" unitref="usd">6,833.4</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i08ccb35f6ad24d7793c9c91b74ca2ea1_I20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfMzgtMS0xLTEtMTU5NTQw_4356b3df-1ebf-4a4d-83c5-97c3221e488e" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" unitref="usd">10,006.5</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i0973ba0c1d894ceaa494709a13f814fb_I20211231" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfMzgtMy0xLTEtMTU5NTQw_f525ed5f-f563-4f8e-ae59-f9ff003f83d0" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" unitref="usd">8,958.5</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee benefit trust</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="i08ccb35f6ad24d7793c9c91b74ca2ea1_I20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfMzktMS0xLTEtMTU5NTQw_41d7b892-cd4c-4d63-847c-8ae7104e5ff5" name="us-gaap:CommonStockSharesHeldInEmployeeTrust" scale="6" unitref="usd">3,013.2</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i0973ba0c1d894ceaa494709a13f814fb_I20211231" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfMzktMy0xLTEtMTU5NTQw_8aa14d69-63ef-4579-b5cf-9f17a80df6c9" name="us-gaap:CommonStockSharesHeldInEmployeeTrust" scale="6" unitref="usd">3,013.2</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss (Note 10)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="i08ccb35f6ad24d7793c9c91b74ca2ea1_I20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfNDAtMS0xLTEtMTU5NTQw_be175668-fed2-4d93-b0a3-7b998489cb07" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" sign="-" unitref="usd">4,295.8</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i0973ba0c1d894ceaa494709a13f814fb_I20211231" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfNDAtMy0xLTEtMTU5NTQw_c48df100-2831-4414-a2d9-74efbb7b6414" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" sign="-" unitref="usd">4,343.1</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of common stock in treasury</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="i08ccb35f6ad24d7793c9c91b74ca2ea1_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfNDEtMS0xLTEtMTU5NTQw_9da404ad-22a5-41ab-acaa-fe21d3bf090b" name="us-gaap:TreasuryStockCommonValue" scale="6" unitref="usd">50.5</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i0973ba0c1d894ceaa494709a13f814fb_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfNDEtMy0xLTEtMTU5NTQw_661952f6-67c9-4250-aa42-fd386e53977b" name="us-gaap:TreasuryStockCommonValue" scale="6" unitref="usd">52.7</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Eli Lilly and Company shareholders' equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i08ccb35f6ad24d7793c9c91b74ca2ea1_I20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfNDItMS0xLTEtMTU5NTQw_f5846b84-be1f-4976-ac40-6226ea648a2b" name="us-gaap:StockholdersEquity" scale="6" unitref="usd">10,070.1</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i0973ba0c1d894ceaa494709a13f814fb_I20211231" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfNDItMy0xLTEtMTU5NTQw_ff9c930e-a404-4170-8b92-38cbfc993039" name="us-gaap:StockholdersEquity" scale="6" unitref="usd">8,979.2</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i08ccb35f6ad24d7793c9c91b74ca2ea1_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfNDMtMS0xLTEtMTU5NTQw_1dd22c49-06ff-4fe7-ad48-6e6fc8568d67" name="us-gaap:MinorityInterest" scale="6" unitref="usd">95.8</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i0973ba0c1d894ceaa494709a13f814fb_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfNDMtMy0xLTEtMTU5NTQw_4d889854-6640-4a18-89bf-513e478707de" name="us-gaap:MinorityInterest" scale="6" unitref="usd">175.6</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i08ccb35f6ad24d7793c9c91b74ca2ea1_I20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfNDQtMS0xLTEtMTU5NTQw_5d8111d7-420a-4d73-98fb-4648d03a68bb" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" unitref="usd">10,165.9</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i0973ba0c1d894ceaa494709a13f814fb_I20211231" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfNDQtMy0xLTEtMTU5NTQw_dc289584-7b58-418a-b3f1-57669e605413" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" unitref="usd">9,154.8</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and equity</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i08ccb35f6ad24d7793c9c91b74ca2ea1_I20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfNDUtMS0xLTEtMTU5NTQw_a3b4d9e9-1e46-4533-bdf9-dd21360c131b" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" unitref="usd">47,461.5</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i0973ba0c1d894ceaa494709a13f814fb_I20211231" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yNS9mcmFnOjhlOTlhYzhjMjM5YzRmZjg5YmQ2ZTM0YzZjMzBjM2UzL3RhYmxlOjdjMDlhN2RjNGUzNDQ5MjViNGY1Yjg3ZDBmN2Y3NzYwL3RhYmxlcmFuZ2U6N2MwOWE3ZGM0ZTM0NDkyNWI0ZjViODdkMGY3Zjc3NjBfNDUtMy0xLTEtMTU5NTQw_40fb6377-8608-4b12-bf8b-d003a00a08f1" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" unitref="usd">48,806.0</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to consolidated condensed financial statements.</span></div><div style="height:31.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="i5fed483d9c7e4f3cbba3a62c53226cd7_28"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Condensed Statements of Equity</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ELI LILLY AND COMPANY AND SUBSIDIARIES</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:24.668%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.927%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.781%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.927%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.074%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.927%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.856%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.927%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.781%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.276%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="45" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Equity of Eli Lilly and Company Shareholders</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:18pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%"><br/></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(Dollars in millions, except per-share data, and shares in thousands)</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Employee Benefit Trust</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Common Stock in Treasury</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td></tr><tr style="height:11pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Balance at July 1, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i3ff8d0839ef74b87b0394c920e9dfa82_I20210630" decimals="-3" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yOC9mcmFnOmEyNTBjNDBjZWQ3ZDQwZjRhNWUyMTQwZDM3MWNiYjliL3RhYmxlOjU0ZWNlYTRkMjgzZDQ4NTJiZTI1Y2QyYWEzN2M0ZDU0L3RhYmxlcmFuZ2U6NTRlY2VhNGQyODNkNDg1MmJlMjVjZDJhYTM3YzRkNTRfMy0xLTEtMS0xNTk1NDA_d99130da-dfa5-4730-b181-c58b7e189e14" name="us-gaap:CommonStockSharesIssued" scale="3" unitref="shares">957,038</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i3ff8d0839ef74b87b0394c920e9dfa82_I20210630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yOC9mcmFnOmEyNTBjNDBjZWQ3ZDQwZjRhNWUyMTQwZDM3MWNiYjliL3RhYmxlOjU0ZWNlYTRkMjgzZDQ4NTJiZTI1Y2QyYWEzN2M0ZDU0L3RhYmxlcmFuZ2U6NTRlY2VhNGQyODNkNDg1MmJlMjVjZDJhYTM3YzRkNTRfMy0zLTEtMS0xNTk1NDA_8a21183e-9e62-4214-8ea3-eaf9bfd9b255" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" unitref="usd">598.1</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ic9a5e6caa6224a1a95516222bf3644c0_I20210630" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yOC9mcmFnOmEyNTBjNDBjZWQ3ZDQwZjRhNWUyMTQwZDM3MWNiYjliL3RhYmxlOjU0ZWNlYTRkMjgzZDQ4NTJiZTI1Y2QyYWEzN2M0ZDU0L3RhYmxlcmFuZ2U6NTRlY2VhNGQyODNkNDg1MmJlMjVjZDJhYTM3YzRkNTRfMy01LTEtMS0xNTk1NDA_d6b5ac1c-e96a-472c-bb49-c9be4b954f46" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" unitref="usd">6,669.2</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i9fbf406305be444e87d56294647b476e_I20210630" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yOC9mcmFnOmEyNTBjNDBjZWQ3ZDQwZjRhNWUyMTQwZDM3MWNiYjliL3RhYmxlOjU0ZWNlYTRkMjgzZDQ4NTJiZTI1Y2QyYWEzN2M0ZDU0L3RhYmxlcmFuZ2U6NTRlY2VhNGQyODNkNDg1MmJlMjVjZDJhYTM3YzRkNTRfMy03LTEtMS0xNTk1NDA_f4eecd7b-57d8-4ca5-8452-f0f41731dd00" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" unitref="usd">8,530.1</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="iab7ebbcbace541c5b7a8ee0e0e859b97_I20210630" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yOC9mcmFnOmEyNTBjNDBjZWQ3ZDQwZjRhNWUyMTQwZDM3MWNiYjliL3RhYmxlOjU0ZWNlYTRkMjgzZDQ4NTJiZTI1Y2QyYWEzN2M0ZDU0L3RhYmxlcmFuZ2U6NTRlY2VhNGQyODNkNDg1MmJlMjVjZDJhYTM3YzRkNTRfMy05LTEtMS0xNTk1NDA_17125689-6af3-4986-ab90-256a19eef300" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" sign="-" unitref="usd">3,013.2</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i19336abc2d9f44a7a6562598fdd26074_I20210630" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yOC9mcmFnOmEyNTBjNDBjZWQ3ZDQwZjRhNWUyMTQwZDM3MWNiYjliL3RhYmxlOjU0ZWNlYTRkMjgzZDQ4NTJiZTI1Y2QyYWEzN2M0ZDU0L3RhYmxlcmFuZ2U6NTRlY2VhNGQyODNkNDg1MmJlMjVjZDJhYTM3YzRkNTRfMy0xMS0xLTEtMTU5NTQw_7fa55e07-b2c9-48c0-bfe6-7a08f6ccee19" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" sign="-" unitref="usd">6,287.1</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i880a0df9a6d245b9a11c009232dc11c9_I20210630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yOC9mcmFnOmEyNTBjNDBjZWQ3ZDQwZjRhNWUyMTQwZDM3MWNiYjliL3RhYmxlOjU0ZWNlYTRkMjgzZDQ4NTJiZTI1Y2QyYWEzN2M0ZDU0L3RhYmxlcmFuZ2U6NTRlY2VhNGQyODNkNDg1MmJlMjVjZDJhYTM3YzRkNTRfMy0xMy0xLTEtMTU5NTQw_a0242d52-4853-4826-9c2a-9045ffce7d36" name="us-gaap:TreasuryStockCommonShares" scale="3" unitref="shares">463</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i880a0df9a6d245b9a11c009232dc11c9_I20210630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yOC9mcmFnOmEyNTBjNDBjZWQ3ZDQwZjRhNWUyMTQwZDM3MWNiYjliL3RhYmxlOjU0ZWNlYTRkMjgzZDQ4NTJiZTI1Y2QyYWEzN2M0ZDU0L3RhYmxlcmFuZ2U6NTRlY2VhNGQyODNkNDg1MmJlMjVjZDJhYTM3YzRkNTRfMy0xNS0xLTEtMTU5NTQw_6d92fa6f-1acf-4170-82f2-aac697d0cb4d" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" sign="-" unitref="usd">52.7</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i4d264417b4674277a12ca8c8f571f6da_I20210630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yOC9mcmFnOmEyNTBjNDBjZWQ3ZDQwZjRhNWUyMTQwZDM3MWNiYjliL3RhYmxlOjU0ZWNlYTRkMjgzZDQ4NTJiZTI1Y2QyYWEzN2M0ZDU0L3RhYmxlcmFuZ2U6NTRlY2VhNGQyODNkNDg1MmJlMjVjZDJhYTM3YzRkNTRfMy0xNy0xLTEtMTU5NTQw_a9acd5e2-5aec-4ba5-9339-48e3f1e2a6d4" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" unitref="usd">219.1</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income (loss) </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ice03038a88b14398a99843ecea77cf17_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yOC9mcmFnOmEyNTBjNDBjZWQ3ZDQwZjRhNWUyMTQwZDM3MWNiYjliL3RhYmxlOjU0ZWNlYTRkMjgzZDQ4NTJiZTI1Y2QyYWEzN2M0ZDU0L3RhYmxlcmFuZ2U6NTRlY2VhNGQyODNkNDg1MmJlMjVjZDJhYTM3YzRkNTRfNC03LTEtMS0xNTk1NDA_9334433b-71f0-482b-b0ed-efc85667419e" name="us-gaap:ProfitLoss" scale="6" unitref="usd">1,110.1</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i37f1eff7c147431d9904c45abe8087de_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yOC9mcmFnOmEyNTBjNDBjZWQ3ZDQwZjRhNWUyMTQwZDM3MWNiYjliL3RhYmxlOjU0ZWNlYTRkMjgzZDQ4NTJiZTI1Y2QyYWEzN2M0ZDU0L3RhYmxlcmFuZ2U6NTRlY2VhNGQyODNkNDg1MmJlMjVjZDJhYTM3YzRkNTRfNC0xNy0xLTEtMTU5NTQw_b302ceb9-0483-4553-b3b0-a7bbfd98d89a" name="us-gaap:ProfitLoss" scale="6" sign="-" unitref="usd">22.6</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i28729f1c595d49408f9bc75addee5dce_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yOC9mcmFnOmEyNTBjNDBjZWQ3ZDQwZjRhNWUyMTQwZDM3MWNiYjliL3RhYmxlOjU0ZWNlYTRkMjgzZDQ4NTJiZTI1Y2QyYWEzN2M0ZDU0L3RhYmxlcmFuZ2U6NTRlY2VhNGQyODNkNDg1MmJlMjVjZDJhYTM3YzRkNTRfNS0xMS0xLTEtMTU5NTQw_b5d34ff5-fdb6-4175-bd8f-8acb0e98fca3" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" unitref="usd">114.4</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of stock under employee stock plans, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ieabf4a292fa6473cb378b3091605b996_D20210701-20210930" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yOC9mcmFnOmEyNTBjNDBjZWQ3ZDQwZjRhNWUyMTQwZDM3MWNiYjliL3RhYmxlOjU0ZWNlYTRkMjgzZDQ4NTJiZTI1Y2QyYWEzN2M0ZDU0L3RhYmxlcmFuZ2U6NTRlY2VhNGQyODNkNDg1MmJlMjVjZDJhYTM3YzRkNTRfMTAtMS0xLTEtMTU5NTQw_4a6e22e0-78b9-4cd9-9fd5-351b6a9d0265" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" unitref="shares">14</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ieabf4a292fa6473cb378b3091605b996_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yOC9mcmFnOmEyNTBjNDBjZWQ3ZDQwZjRhNWUyMTQwZDM3MWNiYjliL3RhYmxlOjU0ZWNlYTRkMjgzZDQ4NTJiZTI1Y2QyYWEzN2M0ZDU0L3RhYmxlcmFuZ2U6NTRlY2VhNGQyODNkNDg1MmJlMjVjZDJhYTM3YzRkNTRfMTAtMy0xLTEtMTU5NTQw_cb5228b7-d2a3-4faa-9075-9e8f7c1e1068" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" unitref="usd">0.1</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="ia0caea5b6e2742c49986260609ac8cb2_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yOC9mcmFnOmEyNTBjNDBjZWQ3ZDQwZjRhNWUyMTQwZDM3MWNiYjliL3RhYmxlOjU0ZWNlYTRkMjgzZDQ4NTJiZTI1Y2QyYWEzN2M0ZDU0L3RhYmxlcmFuZ2U6NTRlY2VhNGQyODNkNDg1MmJlMjVjZDJhYTM3YzRkNTRfMTAtNS0xLTEtMTU5NTQw_5b574dac-02ce-4c68-af74-aed5fe5c9acb" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" sign="-" unitref="usd">1.3</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ia0caea5b6e2742c49986260609ac8cb2_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yOC9mcmFnOmEyNTBjNDBjZWQ3ZDQwZjRhNWUyMTQwZDM3MWNiYjliL3RhYmxlOjU0ZWNlYTRkMjgzZDQ4NTJiZTI1Y2QyYWEzN2M0ZDU0L3RhYmxlcmFuZ2U6NTRlY2VhNGQyODNkNDg1MmJlMjVjZDJhYTM3YzRkNTRfMTEtNS0xLTEtMTU5NTQw_a99ec9e9-a57b-434c-bba8-14bb40e0e4cd" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" unitref="usd">90.1</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="ice03038a88b14398a99843ecea77cf17_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yOC9mcmFnOmEyNTBjNDBjZWQ3ZDQwZjRhNWUyMTQwZDM3MWNiYjliL3RhYmxlOjU0ZWNlYTRkMjgzZDQ4NTJiZTI1Y2QyYWEzN2M0ZDU0L3RhYmxlcmFuZ2U6NTRlY2VhNGQyODNkNDg1MmJlMjVjZDJhYTM3YzRkNTRfMTMtNy0xLTEtMTU5NTQw_500b1be3-576d-4c65-bf20-4f56891e467a" name="us-gaap:StockholdersEquityOther" scale="6" unitref="usd">0.8</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i37f1eff7c147431d9904c45abe8087de_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yOC9mcmFnOmEyNTBjNDBjZWQ3ZDQwZjRhNWUyMTQwZDM3MWNiYjliL3RhYmxlOjU0ZWNlYTRkMjgzZDQ4NTJiZTI1Y2QyYWEzN2M0ZDU0L3RhYmxlcmFuZ2U6NTRlY2VhNGQyODNkNDg1MmJlMjVjZDJhYTM3YzRkNTRfMTMtMTctMS0xLTE1OTU0MA_bc57a8e6-dc10-4b1a-b0c9-05210e9c61e2" name="us-gaap:StockholdersEquityOther" scale="6" sign="-" unitref="usd">0.6</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i5d0c3b9efde1461b8e305f2507573310_I20210930" decimals="-3" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yOC9mcmFnOmEyNTBjNDBjZWQ3ZDQwZjRhNWUyMTQwZDM3MWNiYjliL3RhYmxlOjU0ZWNlYTRkMjgzZDQ4NTJiZTI1Y2QyYWEzN2M0ZDU0L3RhYmxlcmFuZ2U6NTRlY2VhNGQyODNkNDg1MmJlMjVjZDJhYTM3YzRkNTRfMTQtMS0xLTEtMTU5NTQw_ab54cf97-2781-4f63-b704-ce2ff1d7dbe5" name="us-gaap:CommonStockSharesIssued" scale="3" unitref="shares">957,052</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i5d0c3b9efde1461b8e305f2507573310_I20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yOC9mcmFnOmEyNTBjNDBjZWQ3ZDQwZjRhNWUyMTQwZDM3MWNiYjliL3RhYmxlOjU0ZWNlYTRkMjgzZDQ4NTJiZTI1Y2QyYWEzN2M0ZDU0L3RhYmxlcmFuZ2U6NTRlY2VhNGQyODNkNDg1MmJlMjVjZDJhYTM3YzRkNTRfMTQtMy0xLTEtMTU5NTQw_11f051ef-b549-4ebe-974b-408b5096316c" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" unitref="usd">598.2</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ied5972defca747b08dfeb7847dcbf9b1_I20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yOC9mcmFnOmEyNTBjNDBjZWQ3ZDQwZjRhNWUyMTQwZDM3MWNiYjliL3RhYmxlOjU0ZWNlYTRkMjgzZDQ4NTJiZTI1Y2QyYWEzN2M0ZDU0L3RhYmxlcmFuZ2U6NTRlY2VhNGQyODNkNDg1MmJlMjVjZDJhYTM3YzRkNTRfMTQtNS0xLTEtMTU5NTQw_482df404-ec88-40d0-abc2-87feb99b0eb8" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" unitref="usd">6,758.0</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i5e2b4f10aa894a52a243db283dd48374_I20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yOC9mcmFnOmEyNTBjNDBjZWQ3ZDQwZjRhNWUyMTQwZDM3MWNiYjliL3RhYmxlOjU0ZWNlYTRkMjgzZDQ4NTJiZTI1Y2QyYWEzN2M0ZDU0L3RhYmxlcmFuZ2U6NTRlY2VhNGQyODNkNDg1MmJlMjVjZDJhYTM3YzRkNTRfMTQtNy0xLTEtMTU5NTQw_1836dd86-4f61-4760-9272-7bb7b5e860ad" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" unitref="usd">9,639.4</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i5d24641160994798813313583b8c5313_I20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yOC9mcmFnOmEyNTBjNDBjZWQ3ZDQwZjRhNWUyMTQwZDM3MWNiYjliL3RhYmxlOjU0ZWNlYTRkMjgzZDQ4NTJiZTI1Y2QyYWEzN2M0ZDU0L3RhYmxlcmFuZ2U6NTRlY2VhNGQyODNkNDg1MmJlMjVjZDJhYTM3YzRkNTRfMTQtOS0xLTEtMTU5NTQw_f957e044-1a01-42c5-b1dc-fa79bc20b841" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" sign="-" unitref="usd">3,013.2</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="ib38bda0500864764be978f7cbb680740_I20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yOC9mcmFnOmEyNTBjNDBjZWQ3ZDQwZjRhNWUyMTQwZDM3MWNiYjliL3RhYmxlOjU0ZWNlYTRkMjgzZDQ4NTJiZTI1Y2QyYWEzN2M0ZDU0L3RhYmxlcmFuZ2U6NTRlY2VhNGQyODNkNDg1MmJlMjVjZDJhYTM3YzRkNTRfMTQtMTEtMS0xLTE1OTU0MA_93816949-4939-4059-99fa-6aa33d993e70" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" sign="-" unitref="usd">6,172.7</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7b19ed61f4414f2e89fb8677352c10c6_I20210930" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yOC9mcmFnOmEyNTBjNDBjZWQ3ZDQwZjRhNWUyMTQwZDM3MWNiYjliL3RhYmxlOjU0ZWNlYTRkMjgzZDQ4NTJiZTI1Y2QyYWEzN2M0ZDU0L3RhYmxlcmFuZ2U6NTRlY2VhNGQyODNkNDg1MmJlMjVjZDJhYTM3YzRkNTRfMTQtMTMtMS0xLTE1OTU0MA_5ba3cacd-6990-4cb0-813c-c9d6994bcad2" name="us-gaap:TreasuryStockCommonShares" scale="3" unitref="shares">463</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i7b19ed61f4414f2e89fb8677352c10c6_I20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yOC9mcmFnOmEyNTBjNDBjZWQ3ZDQwZjRhNWUyMTQwZDM3MWNiYjliL3RhYmxlOjU0ZWNlYTRkMjgzZDQ4NTJiZTI1Y2QyYWEzN2M0ZDU0L3RhYmxlcmFuZ2U6NTRlY2VhNGQyODNkNDg1MmJlMjVjZDJhYTM3YzRkNTRfMTQtMTUtMS0xLTE1OTU0MA_2900ac5b-f4af-4b04-a084-997e5a9b4ef4" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" sign="-" unitref="usd">52.7</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i6809dd88ee6440e8b81974c0682727a5_I20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yOC9mcmFnOmEyNTBjNDBjZWQ3ZDQwZjRhNWUyMTQwZDM3MWNiYjliL3RhYmxlOjU0ZWNlYTRkMjgzZDQ4NTJiZTI1Y2QyYWEzN2M0ZDU0L3RhYmxlcmFuZ2U6NTRlY2VhNGQyODNkNDg1MmJlMjVjZDJhYTM3YzRkNTRfMTQtMTctMS0xLTE1OTU0MA_a9aff882-9ca0-4a01-a9c9-5793cd0734c9" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" unitref="usd">197.1</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Balance at July 1, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="id1796d16ca7c4cf0894522a6f064e12e_I20220630" decimals="-3" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yOC9mcmFnOmEyNTBjNDBjZWQ3ZDQwZjRhNWUyMTQwZDM3MWNiYjliL3RhYmxlOjU0ZWNlYTRkMjgzZDQ4NTJiZTI1Y2QyYWEzN2M0ZDU0L3RhYmxlcmFuZ2U6NTRlY2VhNGQyODNkNDg1MmJlMjVjZDJhYTM3YzRkNTRfMTYtMS0xLTEtMTU5NTQw_52cdcd29-2525-4ae3-b4d7-2ba5f9c69e58" name="us-gaap:CommonStockSharesIssued" scale="3" unitref="shares">950,619</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="id1796d16ca7c4cf0894522a6f064e12e_I20220630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yOC9mcmFnOmEyNTBjNDBjZWQ3ZDQwZjRhNWUyMTQwZDM3MWNiYjliL3RhYmxlOjU0ZWNlYTRkMjgzZDQ4NTJiZTI1Y2QyYWEzN2M0ZDU0L3RhYmxlcmFuZ2U6NTRlY2VhNGQyODNkNDg1MmJlMjVjZDJhYTM3YzRkNTRfMTYtMy0xLTEtMTU5NTQw_c7933550-6abf-4f37-bdc4-439f9acf1ae4" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" unitref="usd">594.1</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ia172fdb106784793868c32f3fe4a033a_I20220630" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yOC9mcmFnOmEyNTBjNDBjZWQ3ZDQwZjRhNWUyMTQwZDM3MWNiYjliL3RhYmxlOjU0ZWNlYTRkMjgzZDQ4NTJiZTI1Y2QyYWEzN2M0ZDU0L3RhYmxlcmFuZ2U6NTRlY2VhNGQyODNkNDg1MmJlMjVjZDJhYTM3YzRkNTRfMTYtNS0xLTEtMTU5NTQw_e0dcc718-e876-40e3-865d-74e304b026f9" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" unitref="usd">6,746.0</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i13cf184e02084806adfd29b238e3b85d_I20220630" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yOC9mcmFnOmEyNTBjNDBjZWQ3ZDQwZjRhNWUyMTQwZDM3MWNiYjliL3RhYmxlOjU0ZWNlYTRkMjgzZDQ4NTJiZTI1Y2QyYWEzN2M0ZDU0L3RhYmxlcmFuZ2U6NTRlY2VhNGQyODNkNDg1MmJlMjVjZDJhYTM3YzRkNTRfMTYtNy0xLTEtMTU5NTQw_95b3a5c3-92d3-46d8-a0f1-cd1e3723aab2" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" unitref="usd">8,556.0</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="i044825e6cd0d4decafdaae3baf84a330_I20220630" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yOC9mcmFnOmEyNTBjNDBjZWQ3ZDQwZjRhNWUyMTQwZDM3MWNiYjliL3RhYmxlOjU0ZWNlYTRkMjgzZDQ4NTJiZTI1Y2QyYWEzN2M0ZDU0L3RhYmxlcmFuZ2U6NTRlY2VhNGQyODNkNDg1MmJlMjVjZDJhYTM3YzRkNTRfMTYtOS0xLTEtMTU5NTQw_421097d9-14fe-47d2-82c0-b453d549a435" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" sign="-" unitref="usd">3,013.2</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="i9cff35c3c8c34c0fb04c18abeacebca6_I20220630" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yOC9mcmFnOmEyNTBjNDBjZWQ3ZDQwZjRhNWUyMTQwZDM3MWNiYjliL3RhYmxlOjU0ZWNlYTRkMjgzZDQ4NTJiZTI1Y2QyYWEzN2M0ZDU0L3RhYmxlcmFuZ2U6NTRlY2VhNGQyODNkNDg1MmJlMjVjZDJhYTM3YzRkNTRfMTYtMTEtMS0xLTE1OTU0MA_922f799c-ed71-4cf6-873c-182b55de97e1" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" sign="-" unitref="usd">4,287.7</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i21c6412f9d1948d19b3452207237dadd_I20220630" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yOC9mcmFnOmEyNTBjNDBjZWQ3ZDQwZjRhNWUyMTQwZDM3MWNiYjliL3RhYmxlOjU0ZWNlYTRkMjgzZDQ4NTJiZTI1Y2QyYWEzN2M0ZDU0L3RhYmxlcmFuZ2U6NTRlY2VhNGQyODNkNDg1MmJlMjVjZDJhYTM3YzRkNTRfMTYtMTMtMS0xLTE1OTU0MA_79b6e3ff-9a51-48d4-a405-02f97d7823a6" name="us-gaap:TreasuryStockCommonShares" scale="3" unitref="shares">450</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="i21c6412f9d1948d19b3452207237dadd_I20220630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yOC9mcmFnOmEyNTBjNDBjZWQ3ZDQwZjRhNWUyMTQwZDM3MWNiYjliL3RhYmxlOjU0ZWNlYTRkMjgzZDQ4NTJiZTI1Y2QyYWEzN2M0ZDU0L3RhYmxlcmFuZ2U6NTRlY2VhNGQyODNkNDg1MmJlMjVjZDJhYTM3YzRkNTRfMTYtMTUtMS0xLTE1OTU0MA_8eb7f85c-86ce-4c28-8769-6fd6765ed5b0" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" sign="-" unitref="usd">50.5</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i28fcba67335d4eeeb35e767ac7467d7b_I20220630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yOC9mcmFnOmEyNTBjNDBjZWQ3ZDQwZjRhNWUyMTQwZDM3MWNiYjliL3RhYmxlOjU0ZWNlYTRkMjgzZDQ4NTJiZTI1Y2QyYWEzN2M0ZDU0L3RhYmxlcmFuZ2U6NTRlY2VhNGQyODNkNDg1MmJlMjVjZDJhYTM3YzRkNTRfMTYtMTctMS0xLTE1OTU0MA_35553261-2932-45e5-b75b-26a9b8a401f7" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" unitref="usd">114.5</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ib48f338ea64a4a6ab71c4d7e3fd06673_D20220701-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yOC9mcmFnOmEyNTBjNDBjZWQ3ZDQwZjRhNWUyMTQwZDM3MWNiYjliL3RhYmxlOjU0ZWNlYTRkMjgzZDQ4NTJiZTI1Y2QyYWEzN2M0ZDU0L3RhYmxlcmFuZ2U6NTRlY2VhNGQyODNkNDg1MmJlMjVjZDJhYTM3YzRkNTRfMTctNy0xLTEtMTU5NTQw_14ca4ec0-2a9e-440a-b653-8d3cb5cf460a" name="us-gaap:ProfitLoss" scale="6" unitref="usd">1,451.7</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="i55ef102ce6314f71bbad20789a340a44_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yOC9mcmFnOmEyNTBjNDBjZWQ3ZDQwZjRhNWUyMTQwZDM3MWNiYjliL3RhYmxlOjU0ZWNlYTRkMjgzZDQ4NTJiZTI1Y2QyYWEzN2M0ZDU0L3RhYmxlcmFuZ2U6NTRlY2VhNGQyODNkNDg1MmJlMjVjZDJhYTM3YzRkNTRfMTctMTctMS0xLTE1OTU0MA_111cfb83-128b-4931-b704-03735487bcbe" name="us-gaap:ProfitLoss" scale="6" sign="-" unitref="usd">15.7</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="idb26ceb80a3d4067ad9572aeb3904905_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yOC9mcmFnOmEyNTBjNDBjZWQ3ZDQwZjRhNWUyMTQwZDM3MWNiYjliL3RhYmxlOjU0ZWNlYTRkMjgzZDQ4NTJiZTI1Y2QyYWEzN2M0ZDU0L3RhYmxlcmFuZ2U6NTRlY2VhNGQyODNkNDg1MmJlMjVjZDJhYTM3YzRkNTRfMTgtMTEtMS0xLTE1OTU0MA_ac8af636-3dee-4504-82aa-5287e0932a31" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" sign="-" unitref="usd">8.1</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of stock under employee stock plans, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i97b74653944e4f17928c61ac64c196ad_D20220701-20220930" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yOC9mcmFnOmEyNTBjNDBjZWQ3ZDQwZjRhNWUyMTQwZDM3MWNiYjliL3RhYmxlOjU0ZWNlYTRkMjgzZDQ4NTJiZTI1Y2QyYWEzN2M0ZDU0L3RhYmxlcmFuZ2U6NTRlY2VhNGQyODNkNDg1MmJlMjVjZDJhYTM3YzRkNTRfMjItMS0xLTEtMTU5NTQw_cbed6caa-260e-4cf6-bf22-4b4865463975" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" unitref="shares">8</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="i1b27ad5aed11494a84032093fe25e25c_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yOC9mcmFnOmEyNTBjNDBjZWQ3ZDQwZjRhNWUyMTQwZDM3MWNiYjliL3RhYmxlOjU0ZWNlYTRkMjgzZDQ4NTJiZTI1Y2QyYWEzN2M0ZDU0L3RhYmxlcmFuZ2U6NTRlY2VhNGQyODNkNDg1MmJlMjVjZDJhYTM3YzRkNTRfMjItNS0xLTEtMTU5NTQw_dbb85e96-a511-4c5c-b3a8-522111227c0f" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" sign="-" unitref="usd">2.1</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i1b27ad5aed11494a84032093fe25e25c_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yOC9mcmFnOmEyNTBjNDBjZWQ3ZDQwZjRhNWUyMTQwZDM3MWNiYjliL3RhYmxlOjU0ZWNlYTRkMjgzZDQ4NTJiZTI1Y2QyYWEzN2M0ZDU0L3RhYmxlcmFuZ2U6NTRlY2VhNGQyODNkNDg1MmJlMjVjZDJhYTM3YzRkNTRfMjMtNS0xLTEtMTU5NTQw_793dabe7-3c23-40ba-8b7c-01c5fbeae239" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" unitref="usd">85.1</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="ib48f338ea64a4a6ab71c4d7e3fd06673_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yOC9mcmFnOmEyNTBjNDBjZWQ3ZDQwZjRhNWUyMTQwZDM3MWNiYjliL3RhYmxlOjU0ZWNlYTRkMjgzZDQ4NTJiZTI1Y2QyYWEzN2M0ZDU0L3RhYmxlcmFuZ2U6NTRlY2VhNGQyODNkNDg1MmJlMjVjZDJhYTM3YzRkNTRfMjQtNy0xLTEtMTU5NTQw_3052b3ea-5816-42a7-8c61-a84aff3ded87" name="us-gaap:StockholdersEquityOther" scale="6" unitref="usd">1.2</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="i55ef102ce6314f71bbad20789a340a44_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yOC9mcmFnOmEyNTBjNDBjZWQ3ZDQwZjRhNWUyMTQwZDM3MWNiYjliL3RhYmxlOjU0ZWNlYTRkMjgzZDQ4NTJiZTI1Y2QyYWEzN2M0ZDU0L3RhYmxlcmFuZ2U6NTRlY2VhNGQyODNkNDg1MmJlMjVjZDJhYTM3YzRkNTRfMjQtMTctMS0xLTE1OTU0MA_16605fdf-9003-4867-b015-ad4fd8ac69af" name="us-gaap:StockholdersEquityOther" scale="6" unitref="usd">3.0</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i5c81da162e9a42e2a66c2c1a06d48dd5_I20220930" decimals="-3" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yOC9mcmFnOmEyNTBjNDBjZWQ3ZDQwZjRhNWUyMTQwZDM3MWNiYjliL3RhYmxlOjU0ZWNlYTRkMjgzZDQ4NTJiZTI1Y2QyYWEzN2M0ZDU0L3RhYmxlcmFuZ2U6NTRlY2VhNGQyODNkNDg1MmJlMjVjZDJhYTM3YzRkNTRfMjUtMS0xLTEtMTU5NTQw_5f20c68a-bb7e-4c4b-b690-31acc3a6dc64" name="us-gaap:CommonStockSharesIssued" scale="3" unitref="shares">950,627</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i5c81da162e9a42e2a66c2c1a06d48dd5_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yOC9mcmFnOmEyNTBjNDBjZWQ3ZDQwZjRhNWUyMTQwZDM3MWNiYjliL3RhYmxlOjU0ZWNlYTRkMjgzZDQ4NTJiZTI1Y2QyYWEzN2M0ZDU0L3RhYmxlcmFuZ2U6NTRlY2VhNGQyODNkNDg1MmJlMjVjZDJhYTM3YzRkNTRfMjUtMy0xLTEtMTU5NTQw_3c594ee2-1ec7-4dfa-911c-0548180b2f69" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" unitref="usd">594.1</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ice411cf446b842b893447accbe09511a_I20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yOC9mcmFnOmEyNTBjNDBjZWQ3ZDQwZjRhNWUyMTQwZDM3MWNiYjliL3RhYmxlOjU0ZWNlYTRkMjgzZDQ4NTJiZTI1Y2QyYWEzN2M0ZDU0L3RhYmxlcmFuZ2U6NTRlY2VhNGQyODNkNDg1MmJlMjVjZDJhYTM3YzRkNTRfMjUtNS0xLTEtMTU5NTQw_2a7f82f0-e187-410b-8956-11f19497c65e" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" unitref="usd">6,829.0</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i8ebf10616d0b4419a14703502b215705_I20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yOC9mcmFnOmEyNTBjNDBjZWQ3ZDQwZjRhNWUyMTQwZDM3MWNiYjliL3RhYmxlOjU0ZWNlYTRkMjgzZDQ4NTJiZTI1Y2QyYWEzN2M0ZDU0L3RhYmxlcmFuZ2U6NTRlY2VhNGQyODNkNDg1MmJlMjVjZDJhYTM3YzRkNTRfMjUtNy0xLTEtMTU5NTQw_c293efd4-0b90-4e97-b6f9-5d3574699496" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" unitref="usd">10,006.5</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="i422ef8f62e714031b35d70b78011fe07_I20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yOC9mcmFnOmEyNTBjNDBjZWQ3ZDQwZjRhNWUyMTQwZDM3MWNiYjliL3RhYmxlOjU0ZWNlYTRkMjgzZDQ4NTJiZTI1Y2QyYWEzN2M0ZDU0L3RhYmxlcmFuZ2U6NTRlY2VhNGQyODNkNDg1MmJlMjVjZDJhYTM3YzRkNTRfMjUtOS0xLTEtMTU5NTQw_0aca80ce-bca5-4fac-9dab-71b90961a7d1" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" sign="-" unitref="usd">3,013.2</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="i405731ae56194b5ab8d7ef0f5a2a4501_I20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yOC9mcmFnOmEyNTBjNDBjZWQ3ZDQwZjRhNWUyMTQwZDM3MWNiYjliL3RhYmxlOjU0ZWNlYTRkMjgzZDQ4NTJiZTI1Y2QyYWEzN2M0ZDU0L3RhYmxlcmFuZ2U6NTRlY2VhNGQyODNkNDg1MmJlMjVjZDJhYTM3YzRkNTRfMjUtMTEtMS0xLTE1OTU0MA_2e3dcb2f-de3e-4493-8c47-c1a091b32532" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" sign="-" unitref="usd">4,295.8</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i7890664142234b2cba495545e31cf06b_I20220930" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yOC9mcmFnOmEyNTBjNDBjZWQ3ZDQwZjRhNWUyMTQwZDM3MWNiYjliL3RhYmxlOjU0ZWNlYTRkMjgzZDQ4NTJiZTI1Y2QyYWEzN2M0ZDU0L3RhYmxlcmFuZ2U6NTRlY2VhNGQyODNkNDg1MmJlMjVjZDJhYTM3YzRkNTRfMjUtMTMtMS0xLTE1OTU0MA_17f5a50e-d7d3-49ea-ac64-ce1a5539bebc" name="us-gaap:TreasuryStockCommonShares" scale="3" unitref="shares">450</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="i7890664142234b2cba495545e31cf06b_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yOC9mcmFnOmEyNTBjNDBjZWQ3ZDQwZjRhNWUyMTQwZDM3MWNiYjliL3RhYmxlOjU0ZWNlYTRkMjgzZDQ4NTJiZTI1Y2QyYWEzN2M0ZDU0L3RhYmxlcmFuZ2U6NTRlY2VhNGQyODNkNDg1MmJlMjVjZDJhYTM3YzRkNTRfMjUtMTUtMS0xLTE1OTU0MA_7af684c2-0888-4891-a471-aee7fb026ebd" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" sign="-" unitref="usd">50.5</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i874cf6e76f6143ffbd4b62dbb7d9d39b_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yOC9mcmFnOmEyNTBjNDBjZWQ3ZDQwZjRhNWUyMTQwZDM3MWNiYjliL3RhYmxlOjU0ZWNlYTRkMjgzZDQ4NTJiZTI1Y2QyYWEzN2M0ZDU0L3RhYmxlcmFuZ2U6NTRlY2VhNGQyODNkNDg1MmJlMjVjZDJhYTM3YzRkNTRfMjUtMTctMS0xLTE1OTU0MA_9b67932d-c29d-44d6-9029-00b1aaa98c37" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" unitref="usd">95.8</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:4pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:4.55pt;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> <ix:footnote footnoterole="http://www.xbrl.org/2003/role/footnote" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yOC9mcmFnOmEyNTBjNDBjZWQ3ZDQwZjRhNWUyMTQwZDM3MWNiYjliL3RleHRyZWdpb246YTI1MGM0MGNlZDdkNDBmNGE1ZTIxNDBkMzcxY2JiOWJfMjYx_2087051d-93f9-4e3e-80d6-ea5e9c10d8dd">As of September&#160;30, 2022, there was $<ix:nonfraction contextref="i08ccb35f6ad24d7793c9c91b74ca2ea1_I20220930" decimals="-7" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yOC9mcmFnOmEyNTBjNDBjZWQ3ZDQwZjRhNWUyMTQwZDM3MWNiYjliL3RleHRyZWdpb246YTI1MGM0MGNlZDdkNDBmNGE1ZTIxNDBkMzcxY2JiOWJfMTI2_392aac4e-3a4d-409a-9955-2d5861d0f0a4" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" scale="9" unitref="usd">3.25</ix:nonfraction> billion remaining under our $<ix:nonfraction contextref="i9e4e65510f9e48218be4e6b56cc6a8e6_I20210531" decimals="INF" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18yOC9mcmFnOmEyNTBjNDBjZWQ3ZDQwZjRhNWUyMTQwZDM3MWNiYjliL3RleHRyZWdpb246YTI1MGM0MGNlZDdkNDBmNGE1ZTIxNDBkMzcxY2JiOWJfMTQ5_7e916f3f-df34-4731-a795-e9ef2c8472bc" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" scale="9" unitref="usd">5.00</ix:nonfraction> billion share repurchase program authorized in May 2021.</ix:footnote> </span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to consolidated condensed financial statements.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="i5fed483d9c7e4f3cbba3a62c53226cd7_31"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:24.668%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.927%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.781%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.927%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.074%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.927%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.856%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.927%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.781%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.276%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="45" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Equity of Eli Lilly and Company Shareholders</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:17pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%"><br/></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(Dollars in millions, except per-share data, and shares in thousands)</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Employee Benefit Trust</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Common Stock in Treasury</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td></tr><tr style="height:11pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Balance at January 1, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="id40dc90365d54458840dc95bd54da311_I20201231" decimals="-3" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMy0xLTEtMS0xNTk1NDA_2132fa1b-70fd-4e4f-a01f-ffd6b0c714a2" name="us-gaap:CommonStockSharesIssued" scale="3" unitref="shares">957,077</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="id40dc90365d54458840dc95bd54da311_I20201231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMy0zLTEtMS0xNTk1NDA_49513b36-23c6-4302-bc8a-3e7dce9e4f9e" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" unitref="usd">598.2</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i13a4d036feb14d029728aad2602198e3_I20201231" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMy01LTEtMS0xNTk1NDA_24489339-2366-4003-a9ac-0a475443ec09" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" unitref="usd">6,778.5</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i89632ef2fab645e59b17e0d04998f005_I20201231" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMy03LTEtMS0xNTk1NDA_7bf3ad30-99af-4e23-a5db-56723fa12009" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" unitref="usd">7,830.2</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i03ad855e73c7425c82de6d5bf47f2c5c_I20201231" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMy05LTEtMS0xNTk1NDA_97801844-2f7b-4d80-bb1b-ea229c3d9330" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" sign="-" unitref="usd">3,013.2</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i0f26207c7675459eb15f8af1fa1954bd_I20201231" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMy0xMS0xLTEtMTU5NTQw_45563e87-5a11-412c-8815-eb21c40cb120" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" sign="-" unitref="usd">6,496.4</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i475ce37d989c466ca8d104299897d8b5_I20201231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMy0xMy0xLTEtMTU5NTQw_d1cdfdda-f62e-426c-9a0c-ebd3749b728c" name="us-gaap:TreasuryStockCommonShares" scale="3" unitref="shares">487</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i475ce37d989c466ca8d104299897d8b5_I20201231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMy0xNS0xLTEtMTU5NTQw_0c79c58d-ca29-449b-b8c0-a4ce0f3b7eda" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" sign="-" unitref="usd">55.7</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="idd150ac2b08f457b820ab337af8f787a_I20201231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMy0xNy0xLTEtMTU5NTQw_66e66eb1-ec42-4ada-8619-68e242132c1b" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" unitref="usd">183.6</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="iaae84e0e259740269afbdc32023935d8_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfNC03LTEtMS0xNTk1NDA_e666f04c-429b-4790-a01b-808f5cc00ecf" name="us-gaap:ProfitLoss" scale="6" unitref="usd">3,855.6</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="if4b3bbe2d1454aa7b635ddfa117d7690_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfNC0xNy0xLTEtMTU5NTQw_b6af0d50-8257-4a5b-9d1d-90d9faea180c" name="us-gaap:ProfitLoss" scale="6" unitref="usd">25.2</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i53f6912753594605b21dd0402024a8d0_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfNS0xMS0xLTEtMTU5NTQw_15e3426b-e712-410b-886e-979d782b8d05" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" unitref="usd">323.7</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash dividends declared per share: $<ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfNi0wLTEtMS0xNTk1NDAvdGV4dHJlZ2lvbjo2ZTk0NmE3YzUyMzM0ZjRkODAzOTg4ZWIyOWQ5MjkwNl8zOQ_264e7906-d7fe-4127-a93f-53fff8e375aa" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" unitref="usdPerShare">1.70</ix:nonfraction> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="iaae84e0e259740269afbdc32023935d8_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfNi03LTEtMS0xNTk1NDA_20d6bbec-76c2-4d04-a885-ae1b096b0b58" name="us-gaap:Dividends" scale="6" unitref="usd">1,542.9</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Retirement of treasury shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i0f7811d1ec7f49e2b3619fe9097a5c81_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfNy0xLTEtMS0xNTk1NDA_679f571e-3b8e-441e-b62c-bef0449b53d0" name="us-gaap:TreasuryStockSharesRetired" scale="3" unitref="shares">2,467</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i0f7811d1ec7f49e2b3619fe9097a5c81_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfNy0zLTEtMS0xNTk1NDA_6634d471-c170-433b-892b-f6f91955369f" name="us-gaap:TreasuryStockRetiredCostMethodAmount" scale="6" unitref="usd">1.5</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="iaae84e0e259740269afbdc32023935d8_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfNy03LTEtMS0xNTk1NDA_05ec5219-eae0-4cb0-b3bc-4e0ebcca3bdd" name="us-gaap:TreasuryStockRetiredCostMethodAmount" scale="6" unitref="usd">498.5</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i43c09d3fa78d4c5e896029e6ef10d475_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfNy0xMy0xLTEtMTU5NTQw_ac6aaddd-eafb-4ec4-accf-829f59b018fb" name="us-gaap:TreasuryStockSharesRetired" scale="3" unitref="shares">2,467</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i43c09d3fa78d4c5e896029e6ef10d475_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfNy0xNS0xLTEtMTU5NTQw_86de006e-c527-4c64-8afd-d972d9acad45" name="us-gaap:TreasuryStockRetiredCostMethodAmount" scale="6" sign="-" unitref="usd">500.0</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Purchase of treasury shares </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i43c09d3fa78d4c5e896029e6ef10d475_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfOC0xMy0xLTEtMTU5NTQw_6f9cea00-98ea-47d7-83e7-d75d6037deda" name="us-gaap:TreasuryStockSharesAcquired" scale="3" sign="-" unitref="shares">2,467</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i43c09d3fa78d4c5e896029e6ef10d475_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfOC0xNS0xLTEtMTU5NTQw_5b19ff46-59ca-42cb-8ec4-ec729fa0feac" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" unitref="usd">500.0</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of stock under employee stock plans, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i0f7811d1ec7f49e2b3619fe9097a5c81_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfOS0xLTEtMS0xNTk1NDA_ab343927-0015-46ea-b510-e6333f0c1ad8" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" unitref="shares">2,442</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i0f7811d1ec7f49e2b3619fe9097a5c81_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfOS0zLTEtMS0xNTk1NDA_522291f5-add3-4599-a7f5-cb942110c57c" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" unitref="usd">1.5</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="ieb70d5cf9dee4eaa8c659c22eeb4ea9e_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfOS01LTEtMS0xNTk1NDA_747e7374-e678-4bd6-af94-1fc5da0850ed" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" sign="-" unitref="usd">287.1</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i43c09d3fa78d4c5e896029e6ef10d475_D20210101-20210930" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfOS0xMy0xLTEtMTU5NTQw_3aeef466-3c5f-4743-b85a-183e218f075e" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" sign="-" unitref="shares">24</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i43c09d3fa78d4c5e896029e6ef10d475_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfOS0xNS0xLTEtMTU5NTQw_924c9fdc-7fe9-41c8-80cc-2c3895419a1d" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" unitref="usd">3.0</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ieb70d5cf9dee4eaa8c659c22eeb4ea9e_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMTAtNS0xLTEtMTU5NTQw_0ca3d1f2-d08b-4f97-a61b-c64ee132f2bd" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" unitref="usd">267.5</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="ieb70d5cf9dee4eaa8c659c22eeb4ea9e_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMTMtNS0xLTEtMTU5NTQw_8d18c9f1-80ac-4c14-9ad0-8db4ee8e60b0" name="us-gaap:StockholdersEquityOther" scale="6" unitref="usd">0.9</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="iaae84e0e259740269afbdc32023935d8_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMTMtNy0xLTEtMTU5NTQw_4462113d-c8c5-4da1-bee2-1f3244e3b67c" name="us-gaap:StockholdersEquityOther" scale="6" unitref="usd">5.0</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="if4b3bbe2d1454aa7b635ddfa117d7690_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMTMtMTctMS0xLTE1OTU0MA_50b230a8-b9fd-4ed9-a8d8-5d0be38f1d7b" name="us-gaap:StockholdersEquityOther" scale="6" unitref="usd">11.7</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2021</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i5d0c3b9efde1461b8e305f2507573310_I20210930" decimals="-3" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMTQtMS0xLTEtMTU5NTQw_3e600aec-3f0e-47ad-a44f-0061634fd80c" name="us-gaap:CommonStockSharesIssued" scale="3" unitref="shares">957,052</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i5d0c3b9efde1461b8e305f2507573310_I20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMTQtMy0xLTEtMTU5NTQw_42f8db68-04fd-4974-960b-80ceccdfe146" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" unitref="usd">598.2</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ied5972defca747b08dfeb7847dcbf9b1_I20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMTQtNS0xLTEtMTU5NTQw_81633402-28b7-4825-b5b7-6af580ef37f0" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" unitref="usd">6,758.0</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i5e2b4f10aa894a52a243db283dd48374_I20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMTQtNy0xLTEtMTU5NTQw_1836dd86-4f61-4760-9272-7bb7b5e860ad" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" unitref="usd">9,639.4</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i5d24641160994798813313583b8c5313_I20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMTQtOS0xLTEtMTU5NTQw_a0d8388b-c177-44f6-87f3-6df9302cc370" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" sign="-" unitref="usd">3,013.2</ix:nonfraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="ib38bda0500864764be978f7cbb680740_I20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMTQtMTEtMS0xLTE1OTU0MA_30d30615-9381-44eb-9012-907d0f4a9c0d" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" sign="-" unitref="usd">6,172.7</ix:nonfraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7b19ed61f4414f2e89fb8677352c10c6_I20210930" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMTQtMTMtMS0xLTE1OTU0MA_96786cfe-52bc-495f-97eb-53dc1ce2f278" name="us-gaap:TreasuryStockCommonShares" scale="3" unitref="shares">463</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i7b19ed61f4414f2e89fb8677352c10c6_I20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMTQtMTUtMS0xLTE1OTU0MA_47aac1d5-32f2-4222-a223-a804ecf08662" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" sign="-" unitref="usd">52.7</ix:nonfraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i6809dd88ee6440e8b81974c0682727a5_I20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMTQtMTctMS0xLTE1OTU0MA_6e9724f4-a4eb-4b56-a3dc-86a277367c9a" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" unitref="usd">197.1</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Balance at January 1, 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i272cf8c25ebe4484a64e58f12187ad1b_I20211231" decimals="-3" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMTYtMS0xLTEtMTU5NTQw_002454a9-5cd6-4f01-94d5-75379d7bc199" name="us-gaap:CommonStockSharesIssued" scale="3" unitref="shares">954,116</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i272cf8c25ebe4484a64e58f12187ad1b_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMTYtMy0xLTEtMTU5NTQw_0b7c2b3a-07a8-4b4a-90d8-0e708bbf10f9" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" unitref="usd">596.3</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ibf8140dd5b59491da9ea91218accebc6_I20211231" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMTYtNS0xLTEtMTU5NTQw_9bba381a-13d6-494e-839e-38fee9507482" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" unitref="usd">6,833.4</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i9d075318dc464943b61778b509358518_I20211231" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMTYtNy0xLTEtMTU5NTQw_9a0e730b-50ca-4d3b-ac16-d02e04f9bde5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" unitref="usd">8,958.5</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="ib1b20bf098e647cbbe9a5c1797e3b7a9_I20211231" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMTYtOS0xLTEtMTU5NTQw_2193abb6-63f7-4178-b852-58b7a88037af" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" sign="-" unitref="usd">3,013.2</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="i016472e8315c436a845438f1b48dc880_I20211231" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMTYtMTEtMS0xLTE1OTU0MA_5ee7737e-cf3e-43c3-8600-6ff064b2d889" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" sign="-" unitref="usd">4,343.1</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i39c60ea04aef49b0830a61d60786759c_I20211231" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMTYtMTMtMS0xLTE1OTU0MA_d0839666-32d6-4ae0-946a-a4c5686bf3ad" name="us-gaap:TreasuryStockCommonShares" scale="3" unitref="shares">463</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="i39c60ea04aef49b0830a61d60786759c_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMTYtMTUtMS0xLTE1OTU0MA_535791d1-15b8-498e-a925-9f7eddc75751" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" sign="-" unitref="usd">52.7</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i9a1a2f4319ea49c8a9891d557b01b308_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMTYtMTctMS0xLTE1OTU0MA_e563bd3d-bf63-4cdb-8bdc-c615ce3a888c" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" unitref="usd">175.6</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i53fe950833774c68a3cffa46aff8f74b_D20220101-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMTctNy0xLTEtMTU5NTQw_1488f5b1-e72b-42ae-a6a5-54c34666b7f0" name="us-gaap:ProfitLoss" scale="6" unitref="usd">4,307.1</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="i78ac3ae89d8a4e4b9b5634d9c24f6a88_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMTctMTctMS0xLTE1OTU0MA_668f5da5-cd08-4bac-bbb8-61dc5dc13db8" name="us-gaap:ProfitLoss" scale="6" sign="-" unitref="usd">63.7</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i318f185707b94171a8496548525b0a43_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMTgtMTEtMS0xLTE1OTU0MA_2ae23a72-97f8-46ac-ac5d-bda0c1a083b7" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" unitref="usd">47.3</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash dividends declared per share: $<ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMTktMC0xLTEtMTU5NTQwL3RleHRyZWdpb246OTA0ZjZjMzVjZWM2NDE5NWI3ZjgxMjEzMTY2ZTE0YjhfMzk_04551d09-5ce0-4264-b8c4-2f3305475ce9" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" unitref="usdPerShare">1.96</ix:nonfraction> </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="i53fe950833774c68a3cffa46aff8f74b_D20220101-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMTktNy0xLTEtMTU5NTQw_5bea35f8-dc32-4f00-b577-3a633eb5fb8d" name="us-gaap:Dividends" scale="6" unitref="usd">1,765.9</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Retirement of treasury shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="i5fb9024f659a4c12b2ddd5ecc6dd8e7f_D20220101-20220930" decimals="-3" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMjAtMS0xLTEtMTU5NTQw_3c5243b1-f8e1-46ea-965a-2132168277ba" name="us-gaap:TreasuryStockSharesRetired" scale="3" unitref="shares">5,607</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="i5fb9024f659a4c12b2ddd5ecc6dd8e7f_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMjAtMy0xLTEtMTU5NTQw_2539f052-6bd7-4354-bb2d-681a9b76c79e" name="us-gaap:TreasuryStockRetiredCostMethodAmount" scale="6" unitref="usd">3.5</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="i53fe950833774c68a3cffa46aff8f74b_D20220101-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMjAtNy0xLTEtMTU5NTQw_745a80a5-1a69-42c6-b6d4-0533f56e2900" name="us-gaap:TreasuryStockRetiredCostMethodAmount" scale="6" unitref="usd">1,496.5</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="i668d06cad6064c9488359f57b6460125_D20220101-20220930" decimals="-3" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMjAtMTMtMS0xLTE1OTU0MA_72afa8cd-b258-4119-8087-814775c285dd" name="us-gaap:TreasuryStockSharesRetired" scale="3" unitref="shares">5,607</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i668d06cad6064c9488359f57b6460125_D20220101-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMjAtMTUtMS0xLTE1OTU0MA_90b2c7b9-d4d4-47cb-960d-af52cb5f093c" name="us-gaap:TreasuryStockRetiredCostMethodAmount" scale="6" sign="-" unitref="usd">1,500.0</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Purchase of treasury shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i668d06cad6064c9488359f57b6460125_D20220101-20220930" decimals="-3" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMjEtMTMtMS0xLTE1OTU0MA_8e9af476-2a91-410a-81c3-a243861cdf43" name="us-gaap:TreasuryStockSharesAcquired" scale="3" sign="-" unitref="shares">5,607</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="i668d06cad6064c9488359f57b6460125_D20220101-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMjEtMTUtMS0xLTE1OTU0MA_c8545f5f-37fb-4748-89c4-dbb910bf7e43" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" unitref="usd">1,500.0</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of stock under employee stock plans, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i5fb9024f659a4c12b2ddd5ecc6dd8e7f_D20220101-20220930" decimals="-3" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMjItMS0xLTEtMTU5NTQw_fac55b76-b054-47f6-a788-aa8c5e06a9c4" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" unitref="shares">2,118</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i5fb9024f659a4c12b2ddd5ecc6dd8e7f_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMjItMy0xLTEtMTU5NTQw_db2b2906-739a-4b47-8f3e-03022e2495d0" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" unitref="usd">1.3</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="i1e65888bb572465d96d1a55aaa12d167_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMjItNS0xLTEtMTU5NTQw_70c88f5d-6ad0-4bf4-8108-30a01e218cad" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" sign="-" unitref="usd">282.6</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="i668d06cad6064c9488359f57b6460125_D20220101-20220930" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMjItMTMtMS0xLTE1OTU0MA_04bc94f9-48f3-42e4-a934-3287c4031747" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" sign="-" unitref="shares">13</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i668d06cad6064c9488359f57b6460125_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMjItMTUtMS0xLTE1OTU0MA_30b3cfe7-2129-4339-a61e-be4bfad21855" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" unitref="usd">2.2</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i1e65888bb572465d96d1a55aaa12d167_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMjMtNS0xLTEtMTU5NTQw_64053464-fa17-41d1-afbf-9592f2033a17" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" unitref="usd">278.2</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i53fe950833774c68a3cffa46aff8f74b_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMjQtNy0xLTEtMTU5NTQw_bad7e069-fcfc-431e-b524-dfc9eda39d0b" name="us-gaap:StockholdersEquityOther" scale="6" sign="-" unitref="usd">3.3</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="i78ac3ae89d8a4e4b9b5634d9c24f6a88_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMjQtMTctMS0xLTE1OTU0MA_071d8009-b60e-44d6-beb2-633a460171d0" name="us-gaap:StockholdersEquityOther" scale="6" unitref="usd">16.1</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i5c81da162e9a42e2a66c2c1a06d48dd5_I20220930" decimals="-3" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMjUtMS0xLTEtMTU5NTQw_ed8e396f-8fa5-483e-91c7-3849a10db72c" name="us-gaap:CommonStockSharesIssued" scale="3" unitref="shares">950,627</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i5c81da162e9a42e2a66c2c1a06d48dd5_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMjUtMy0xLTEtMTU5NTQw_f8276910-2b59-49de-8393-db14d519ce5c" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" unitref="usd">594.1</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ice411cf446b842b893447accbe09511a_I20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMjUtNS0xLTEtMTU5NTQw_4fb65594-0089-4ee0-b65c-06b622fa0fed" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" unitref="usd">6,829.0</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i8ebf10616d0b4419a14703502b215705_I20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMjUtNy0xLTEtMTU5NTQw_5d85fa14-fa1e-40f8-9ad9-72d2adb9120a" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" unitref="usd">10,006.5</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="i422ef8f62e714031b35d70b78011fe07_I20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMjUtOS0xLTEtMTU5NTQw_67618d32-1f03-47a0-8024-fce4cf6d5902" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" sign="-" unitref="usd">3,013.2</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="i405731ae56194b5ab8d7ef0f5a2a4501_I20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMjUtMTEtMS0xLTE1OTU0MA_850d9ab0-8b71-4991-b214-659011ddcdfb" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" sign="-" unitref="usd">4,295.8</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i7890664142234b2cba495545e31cf06b_I20220930" decimals="-3" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMjUtMTMtMS0xLTE1OTU0MA_8ef29157-deac-4753-beeb-da0b17fe30c7" name="us-gaap:TreasuryStockCommonShares" scale="3" unitref="shares">450</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="i7890664142234b2cba495545e31cf06b_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMjUtMTUtMS0xLTE1OTU0MA_da8ad497-050f-4202-83f7-ba8bfce436f5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" sign="-" unitref="usd">50.5</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i874cf6e76f6143ffbd4b62dbb7d9d39b_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RhYmxlOjZjMDVjYzRiNTlkODQ4Mjg5ODE1ODYwOWFmZTI2M2I2L3RhYmxlcmFuZ2U6NmMwNWNjNGI1OWQ4NDgyODk4MTU4NjA5YWZlMjYzYjZfMjUtMTctMS0xLTE1OTU0MA_2b347a9e-dd04-46fb-8d13-754797bf19ac" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" unitref="usd">95.8</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:4pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:4.55pt;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> <ix:footnote footnoterole="http://www.xbrl.org/2003/role/footnote" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RleHRyZWdpb246ZTAxODE5ZTcxMTNjNGY2YzkyNjFiNDYyYzIxODNiMjFfMTY0_9553bd20-e2be-4a9d-901f-d34e31f81e7e">As of September&#160;30, 2022, there was $<ix:nonfraction contextref="i08ccb35f6ad24d7793c9c91b74ca2ea1_I20220930" decimals="-7" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RleHRyZWdpb246ZTAxODE5ZTcxMTNjNGY2YzkyNjFiNDYyYzIxODNiMjFfMzE_392aac4e-3a4d-409a-9955-2d5861d0f0a4" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" scale="9" unitref="usd">3.25</ix:nonfraction> billion remaining under our $<ix:nonfraction contextref="i9e4e65510f9e48218be4e6b56cc6a8e6_I20210531" decimals="INF" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zMS9mcmFnOmUwMTgxOWU3MTEzYzRmNmM5MjYxYjQ2MmMyMTgzYjIxL3RleHRyZWdpb246ZTAxODE5ZTcxMTNjNGY2YzkyNjFiNDYyYzIxODNiMjFfNTQ_7e916f3f-df34-4731-a795-e9ef2c8472bc" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" scale="9" unitref="usd">5.00</ix:nonfraction> billion share repurchase program authorized in May 2021. </ix:footnote></span></div><div style="margin-bottom:12pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to consolidated condensed financial statements.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><div id="i5fed483d9c7e4f3cbba3a62c53226cd7_34"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Condensed Statements of Cash Flows</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ELI LILLY AND COMPANY AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Dollars in millions)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.145%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flows from Operating Activities</span></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zNC9mcmFnOmUxYWRjYjRiOGNhYTQzYTM5OWY1ZjExNzc3OTQ0YjI2L3RhYmxlOjg5MzlmNDA0NzJkMTQ2ZGViZTg3MzJlMTg4NTU5ZTE0L3RhYmxlcmFuZ2U6ODkzOWY0MDQ3MmQxNDZkZWJlODczMmUxODg1NTllMTRfMy0xLTEtMS0xNTk1NDA_87698447-ba66-4f71-89c1-b28a71c9e82a" name="us-gaap:NetIncomeLoss" scale="6" unitref="usd">4,307.1</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zNC9mcmFnOmUxYWRjYjRiOGNhYTQzYTM5OWY1ZjExNzc3OTQ0YjI2L3RhYmxlOjg5MzlmNDA0NzJkMTQ2ZGViZTg3MzJlMTg4NTU5ZTE0L3RhYmxlcmFuZ2U6ODkzOWY0MDQ3MmQxNDZkZWJlODczMmUxODg1NTllMTRfMy0zLTEtMS0xNTk1NDA_912d99b5-d76a-4c0a-b3cd-69c00d2c8eed" name="us-gaap:NetIncomeLoss" scale="6" unitref="usd">3,855.6</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjustments to Reconcile Net Income to Cash Flows from Operating Activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zNC9mcmFnOmUxYWRjYjRiOGNhYTQzYTM5OWY1ZjExNzc3OTQ0YjI2L3RhYmxlOjg5MzlmNDA0NzJkMTQ2ZGViZTg3MzJlMTg4NTU5ZTE0L3RhYmxlcmFuZ2U6ODkzOWY0MDQ3MmQxNDZkZWJlODczMmUxODg1NTllMTRfNi0xLTEtMS0xNTk1NDA_b9cc748a-9363-4b7b-acb2-159869e22b9f" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" unitref="usd">1,147.5</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zNC9mcmFnOmUxYWRjYjRiOGNhYTQzYTM5OWY1ZjExNzc3OTQ0YjI2L3RhYmxlOjg5MzlmNDA0NzJkMTQ2ZGViZTg3MzJlMTg4NTU5ZTE0L3RhYmxlcmFuZ2U6ODkzOWY0MDQ3MmQxNDZkZWJlODczMmUxODg1NTllMTRfNi0zLTEtMS0xNTk1NDA_9d7d1f9d-c79a-45eb-b5f7-11fbd7b7ea47" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" unitref="usd">1,101.9</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zNC9mcmFnOmUxYWRjYjRiOGNhYTQzYTM5OWY1ZjExNzc3OTQ0YjI2L3RhYmxlOjg5MzlmNDA0NzJkMTQ2ZGViZTg3MzJlMTg4NTU5ZTE0L3RhYmxlcmFuZ2U6ODkzOWY0MDQ3MmQxNDZkZWJlODczMmUxODg1NTllMTRfNy0xLTEtMS0xNTk1NDA_764e659f-8406-4ad2-a060-e1d8421b2f97" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="6" unitref="usd">2,195.6</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zNC9mcmFnOmUxYWRjYjRiOGNhYTQzYTM5OWY1ZjExNzc3OTQ0YjI2L3RhYmxlOjg5MzlmNDA0NzJkMTQ2ZGViZTg3MzJlMTg4NTU5ZTE0L3RhYmxlcmFuZ2U6ODkzOWY0MDQ3MmQxNDZkZWJlODczMmUxODg1NTllMTRfNy0zLTEtMS0xNTk1NDA_87aef963-a7a1-4268-9d2e-d9f86dec1340" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="6" unitref="usd">709.8</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt extinguishment loss (Note 6)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zNC9mcmFnOmUxYWRjYjRiOGNhYTQzYTM5OWY1ZjExNzc3OTQ0YjI2L3RhYmxlOjg5MzlmNDA0NzJkMTQ2ZGViZTg3MzJlMTg4NTU5ZTE0L3RhYmxlcmFuZ2U6ODkzOWY0MDQ3MmQxNDZkZWJlODczMmUxODg1NTllMTRfOC0xLTEtMS0xNTk1NDA_328a2c13-40c1-486c-9761-5b3e0b35c0a0" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" unitref="usd">&#8212;</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zNC9mcmFnOmUxYWRjYjRiOGNhYTQzYTM5OWY1ZjExNzc3OTQ0YjI2L3RhYmxlOjg5MzlmNDA0NzJkMTQ2ZGViZTg3MzJlMTg4NTU5ZTE0L3RhYmxlcmFuZ2U6ODkzOWY0MDQ3MmQxNDZkZWJlODczMmUxODg1NTllMTRfOC0zLTEtMS0xNTk1NDA_569e5a6f-b822-41b5-953f-f9ef17228704" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" sign="-" unitref="usd">405.2</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zNC9mcmFnOmUxYWRjYjRiOGNhYTQzYTM5OWY1ZjExNzc3OTQ0YjI2L3RhYmxlOjg5MzlmNDA0NzJkMTQ2ZGViZTg3MzJlMTg4NTU5ZTE0L3RhYmxlcmFuZ2U6ODkzOWY0MDQ3MmQxNDZkZWJlODczMmUxODg1NTllMTRfOS0xLTEtMS0xNTk1NDA_82ab231b-3959-45a5-8912-96f848fc2b13" name="us-gaap:ShareBasedCompensation" scale="6" unitref="usd">278.2</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zNC9mcmFnOmUxYWRjYjRiOGNhYTQzYTM5OWY1ZjExNzc3OTQ0YjI2L3RhYmxlOjg5MzlmNDA0NzJkMTQ2ZGViZTg3MzJlMTg4NTU5ZTE0L3RhYmxlcmFuZ2U6ODkzOWY0MDQ3MmQxNDZkZWJlODczMmUxODg1NTllMTRfOS0zLTEtMS0xNTk1NDA_f133a8dc-8f7b-4aca-897f-9e1c38bdc39c" name="us-gaap:ShareBasedCompensation" scale="6" unitref="usd">267.5</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment (gains) losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zNC9mcmFnOmUxYWRjYjRiOGNhYTQzYTM5OWY1ZjExNzc3OTQ0YjI2L3RhYmxlOjg5MzlmNDA0NzJkMTQ2ZGViZTg3MzJlMTg4NTU5ZTE0L3RhYmxlcmFuZ2U6ODkzOWY0MDQ3MmQxNDZkZWJlODczMmUxODg1NTllMTRfMTEtMS0xLTEtMTU5NTQw_ec4b44eb-a340-48b1-b0af-46349619b1e5" name="us-gaap:GainLossOnInvestments" scale="6" sign="-" unitref="usd">676.4</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zNC9mcmFnOmUxYWRjYjRiOGNhYTQzYTM5OWY1ZjExNzc3OTQ0YjI2L3RhYmxlOjg5MzlmNDA0NzJkMTQ2ZGViZTg3MzJlMTg4NTU5ZTE0L3RhYmxlcmFuZ2U6ODkzOWY0MDQ3MmQxNDZkZWJlODczMmUxODg1NTllMTRfMTEtMy0xLTEtMTU5NTQw_97a67122-077c-4352-ac30-90f9b59e1868" name="us-gaap:GainLossOnInvestments" scale="6" unitref="usd">271.1</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired in-process research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zNC9mcmFnOmUxYWRjYjRiOGNhYTQzYTM5OWY1ZjExNzc3OTQ0YjI2L3RhYmxlOjg5MzlmNDA0NzJkMTQ2ZGViZTg3MzJlMTg4NTU5ZTE0L3RhYmxlcmFuZ2U6ODkzOWY0MDQ3MmQxNDZkZWJlODczMmUxODg1NTllMTRfMTItMS0xLTEtMTU5NTQw_dcc1f7f6-af8e-4c78-aa45-9ce768437fb3" name="lly:AcquiredInProcessResearchAndDevelopment" scale="6" unitref="usd">252.0</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zNC9mcmFnOmUxYWRjYjRiOGNhYTQzYTM5OWY1ZjExNzc3OTQ0YjI2L3RhYmxlOjg5MzlmNDA0NzJkMTQ2ZGViZTg3MzJlMTg4NTU5ZTE0L3RhYmxlcmFuZ2U6ODkzOWY0MDQ3MmQxNDZkZWJlODczMmUxODg1NTllMTRfMTItMy0xLTEtMTU5NTQw_5c23604b-5a24-410e-b04f-04d7914c0171" name="lly:AcquiredInProcessResearchAndDevelopment" scale="6" unitref="usd">498.3</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other changes in operating assets and liabilities, net of acquisitions and divestitures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zNC9mcmFnOmUxYWRjYjRiOGNhYTQzYTM5OWY1ZjExNzc3OTQ0YjI2L3RhYmxlOjg5MzlmNDA0NzJkMTQ2ZGViZTg3MzJlMTg4NTU5ZTE0L3RhYmxlcmFuZ2U6ODkzOWY0MDQ3MmQxNDZkZWJlODczMmUxODg1NTllMTRfMTMtMS0xLTEtMTU5NTQw_0db44160-12aa-4dd2-82a3-81f847e73113" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" sign="-" unitref="usd">821.5</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zNC9mcmFnOmUxYWRjYjRiOGNhYTQzYTM5OWY1ZjExNzc3OTQ0YjI2L3RhYmxlOjg5MzlmNDA0NzJkMTQ2ZGViZTg3MzJlMTg4NTU5ZTE0L3RhYmxlcmFuZ2U6ODkzOWY0MDQ3MmQxNDZkZWJlODczMmUxODg1NTllMTRfMTMtMy0xLTEtMTU5NTQw_5f6110da-05b6-4d87-afea-962318793b33" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" unitref="usd">548.1</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-cash operating activities, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zNC9mcmFnOmUxYWRjYjRiOGNhYTQzYTM5OWY1ZjExNzc3OTQ0YjI2L3RhYmxlOjg5MzlmNDA0NzJkMTQ2ZGViZTg3MzJlMTg4NTU5ZTE0L3RhYmxlcmFuZ2U6ODkzOWY0MDQ3MmQxNDZkZWJlODczMmUxODg1NTllMTRfMTQtMS0xLTEtMTU5NTQw_288b8c65-33ef-4727-a892-c3f2cde4f247" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="6" unitref="usd">217.6</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zNC9mcmFnOmUxYWRjYjRiOGNhYTQzYTM5OWY1ZjExNzc3OTQ0YjI2L3RhYmxlOjg5MzlmNDA0NzJkMTQ2ZGViZTg3MzJlMTg4NTU5ZTE0L3RhYmxlcmFuZ2U6ODkzOWY0MDQ3MmQxNDZkZWJlODczMmUxODg1NTllMTRfMTQtMy0xLTEtMTU5NTQw_04e1b5bd-99da-47e9-97ff-c13da12b6387" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="6" unitref="usd">504.7</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Cash Provided by Operating Activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zNC9mcmFnOmUxYWRjYjRiOGNhYTQzYTM5OWY1ZjExNzc3OTQ0YjI2L3RhYmxlOjg5MzlmNDA0NzJkMTQ2ZGViZTg3MzJlMTg4NTU5ZTE0L3RhYmxlcmFuZ2U6ODkzOWY0MDQ3MmQxNDZkZWJlODczMmUxODg1NTllMTRfMTUtMS0xLTEtMTU5NTQw_6bb08335-ddfb-4a04-bfcc-447a014d0496" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" unitref="usd">5,504.7</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zNC9mcmFnOmUxYWRjYjRiOGNhYTQzYTM5OWY1ZjExNzc3OTQ0YjI2L3RhYmxlOjg5MzlmNDA0NzJkMTQ2ZGViZTg3MzJlMTg4NTU5ZTE0L3RhYmxlcmFuZ2U6ODkzOWY0MDQ3MmQxNDZkZWJlODczMmUxODg1NTllMTRfMTUtMy0xLTEtMTU5NTQw_f383a937-0b7d-44dc-a557-f5b1f767e627" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" unitref="usd">5,104.2</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flows from Investing Activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net purchases of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zNC9mcmFnOmUxYWRjYjRiOGNhYTQzYTM5OWY1ZjExNzc3OTQ0YjI2L3RhYmxlOjg5MzlmNDA0NzJkMTQ2ZGViZTg3MzJlMTg4NTU5ZTE0L3RhYmxlcmFuZ2U6ODkzOWY0MDQ3MmQxNDZkZWJlODczMmUxODg1NTllMTRfMTctMS0xLTEtMTU5NTQw_ca5d5be9-6d35-47d9-9943-2beaa3ecad9c" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" unitref="usd">1,353.6</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zNC9mcmFnOmUxYWRjYjRiOGNhYTQzYTM5OWY1ZjExNzc3OTQ0YjI2L3RhYmxlOjg5MzlmNDA0NzJkMTQ2ZGViZTg3MzJlMTg4NTU5ZTE0L3RhYmxlcmFuZ2U6ODkzOWY0MDQ3MmQxNDZkZWJlODczMmUxODg1NTllMTRfMTctMy0xLTEtMTU5NTQw_5e9b2339-93ad-42d8-9132-14a123a8ab14" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" unitref="usd">1,018.4</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales and maturities of short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zNC9mcmFnOmUxYWRjYjRiOGNhYTQzYTM5OWY1ZjExNzc3OTQ0YjI2L3RhYmxlOjg5MzlmNDA0NzJkMTQ2ZGViZTg3MzJlMTg4NTU5ZTE0L3RhYmxlcmFuZ2U6ODkzOWY0MDQ3MmQxNDZkZWJlODczMmUxODg1NTllMTRfMTgtMS0xLTEtMTU5NTQw_40c8c0cc-1be7-4e46-a0db-c61e697604bb" name="us-gaap:ProceedsFromSaleOfShortTermInvestments" scale="6" unitref="usd">83.1</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zNC9mcmFnOmUxYWRjYjRiOGNhYTQzYTM5OWY1ZjExNzc3OTQ0YjI2L3RhYmxlOjg5MzlmNDA0NzJkMTQ2ZGViZTg3MzJlMTg4NTU5ZTE0L3RhYmxlcmFuZ2U6ODkzOWY0MDQ3MmQxNDZkZWJlODczMmUxODg1NTllMTRfMTgtMy0xLTEtMTU5NTQw_a4b5ab83-a00f-416f-ae12-62df96c82992" name="us-gaap:ProceedsFromSaleOfShortTermInvestments" scale="6" unitref="usd">46.6</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of short-term investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zNC9mcmFnOmUxYWRjYjRiOGNhYTQzYTM5OWY1ZjExNzc3OTQ0YjI2L3RhYmxlOjg5MzlmNDA0NzJkMTQ2ZGViZTg3MzJlMTg4NTU5ZTE0L3RhYmxlcmFuZ2U6ODkzOWY0MDQ3MmQxNDZkZWJlODczMmUxODg1NTllMTRfMTktMS0xLTEtMTU5NTQw_62d74910-481b-40a4-8d64-e96ed1b818c8" name="us-gaap:PaymentsToAcquireShortTermInvestments" scale="6" unitref="usd">65.0</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zNC9mcmFnOmUxYWRjYjRiOGNhYTQzYTM5OWY1ZjExNzc3OTQ0YjI2L3RhYmxlOjg5MzlmNDA0NzJkMTQ2ZGViZTg3MzJlMTg4NTU5ZTE0L3RhYmxlcmFuZ2U6ODkzOWY0MDQ3MmQxNDZkZWJlODczMmUxODg1NTllMTRfMTktMy0xLTEtMTU5NTQw_74557a09-80f4-473f-aa1a-6dec572a31ca" name="us-gaap:PaymentsToAcquireShortTermInvestments" scale="6" unitref="usd">27.9</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales of noncurrent investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zNC9mcmFnOmUxYWRjYjRiOGNhYTQzYTM5OWY1ZjExNzc3OTQ0YjI2L3RhYmxlOjg5MzlmNDA0NzJkMTQ2ZGViZTg3MzJlMTg4NTU5ZTE0L3RhYmxlcmFuZ2U6ODkzOWY0MDQ3MmQxNDZkZWJlODczMmUxODg1NTllMTRfMjAtMS0xLTEtMTU5NTQw_3434e9b9-5b67-4077-b746-975240c17351" name="us-gaap:ProceedsFromSaleOfLongtermInvestments" scale="6" unitref="usd">251.6</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zNC9mcmFnOmUxYWRjYjRiOGNhYTQzYTM5OWY1ZjExNzc3OTQ0YjI2L3RhYmxlOjg5MzlmNDA0NzJkMTQ2ZGViZTg3MzJlMTg4NTU5ZTE0L3RhYmxlcmFuZ2U6ODkzOWY0MDQ3MmQxNDZkZWJlODczMmUxODg1NTllMTRfMjAtMy0xLTEtMTU5NTQw_f4fef672-2df4-43b0-a0f7-bcd950718d5c" name="us-gaap:ProceedsFromSaleOfLongtermInvestments" scale="6" unitref="usd">537.2</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of noncurrent investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zNC9mcmFnOmUxYWRjYjRiOGNhYTQzYTM5OWY1ZjExNzc3OTQ0YjI2L3RhYmxlOjg5MzlmNDA0NzJkMTQ2ZGViZTg3MzJlMTg4NTU5ZTE0L3RhYmxlcmFuZ2U6ODkzOWY0MDQ3MmQxNDZkZWJlODczMmUxODg1NTllMTRfMjEtMS0xLTEtMTU5NTQw_9bf78d1b-6c1e-45bf-8e24-30fa8d8de78d" name="us-gaap:PaymentsToAcquireLongtermInvestments" scale="6" unitref="usd">474.1</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zNC9mcmFnOmUxYWRjYjRiOGNhYTQzYTM5OWY1ZjExNzc3OTQ0YjI2L3RhYmxlOjg5MzlmNDA0NzJkMTQ2ZGViZTg3MzJlMTg4NTU5ZTE0L3RhYmxlcmFuZ2U6ODkzOWY0MDQ3MmQxNDZkZWJlODczMmUxODg1NTllMTRfMjEtMy0xLTEtMTU5NTQw_75173681-dd0d-4f28-9f64-82e68bbf1f44" name="us-gaap:PaymentsToAcquireLongtermInvestments" scale="6" unitref="usd">710.1</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for acquisitions, net of cash acquired (Note 3)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zNC9mcmFnOmUxYWRjYjRiOGNhYTQzYTM5OWY1ZjExNzc3OTQ0YjI2L3RhYmxlOjg5MzlmNDA0NzJkMTQ2ZGViZTg3MzJlMTg4NTU5ZTE0L3RhYmxlcmFuZ2U6ODkzOWY0MDQ3MmQxNDZkZWJlODczMmUxODg1NTllMTRfMjItMS0xLTEtMTU5NTQw_177676c3-2202-4fa7-a902-2e4cf7a37549" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" unitref="usd">&#8212;</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zNC9mcmFnOmUxYWRjYjRiOGNhYTQzYTM5OWY1ZjExNzc3OTQ0YjI2L3RhYmxlOjg5MzlmNDA0NzJkMTQ2ZGViZTg3MzJlMTg4NTU5ZTE0L3RhYmxlcmFuZ2U6ODkzOWY0MDQ3MmQxNDZkZWJlODczMmUxODg1NTllMTRfMjItMy0xLTEtMTU5NTQw_e1fd174b-e2d1-41fc-9455-45f9c24728a3" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" unitref="usd">747.4</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of in-process research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zNC9mcmFnOmUxYWRjYjRiOGNhYTQzYTM5OWY1ZjExNzc3OTQ0YjI2L3RhYmxlOjg5MzlmNDA0NzJkMTQ2ZGViZTg3MzJlMTg4NTU5ZTE0L3RhYmxlcmFuZ2U6ODkzOWY0MDQ3MmQxNDZkZWJlODczMmUxODg1NTllMTRfMjQtMS0xLTEtMTU5NTQw_b503ab4d-f58f-4069-9818-d2c83c572b70" name="lly:PurchasedInProcessResearchAndDevelopment" scale="6" unitref="usd">574.8</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zNC9mcmFnOmUxYWRjYjRiOGNhYTQzYTM5OWY1ZjExNzc3OTQ0YjI2L3RhYmxlOjg5MzlmNDA0NzJkMTQ2ZGViZTg3MzJlMTg4NTU5ZTE0L3RhYmxlcmFuZ2U6ODkzOWY0MDQ3MmQxNDZkZWJlODczMmUxODg1NTllMTRfMjQtMy0xLTEtMTU5NTQw_1a617613-4c4d-40f3-a2fa-e891430a0c03" name="lly:PurchasedInProcessResearchAndDevelopment" scale="6" unitref="usd">460.6</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investing activities, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zNC9mcmFnOmUxYWRjYjRiOGNhYTQzYTM5OWY1ZjExNzc3OTQ0YjI2L3RhYmxlOjg5MzlmNDA0NzJkMTQ2ZGViZTg3MzJlMTg4NTU5ZTE0L3RhYmxlcmFuZ2U6ODkzOWY0MDQ3MmQxNDZkZWJlODczMmUxODg1NTllMTRfMjUtMS0xLTEtMTU5NTQw_3c8796b1-f1b6-4c64-a938-6142f6b5d666" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" unitref="usd">268.3</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zNC9mcmFnOmUxYWRjYjRiOGNhYTQzYTM5OWY1ZjExNzc3OTQ0YjI2L3RhYmxlOjg5MzlmNDA0NzJkMTQ2ZGViZTg3MzJlMTg4NTU5ZTE0L3RhYmxlcmFuZ2U6ODkzOWY0MDQ3MmQxNDZkZWJlODczMmUxODg1NTllMTRfMjUtMy0xLTEtMTU5NTQw_3ee7f4b3-234c-4fba-b5fe-ee78439318dd" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" unitref="usd">2.7</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Cash Used for Investing Activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zNC9mcmFnOmUxYWRjYjRiOGNhYTQzYTM5OWY1ZjExNzc3OTQ0YjI2L3RhYmxlOjg5MzlmNDA0NzJkMTQ2ZGViZTg3MzJlMTg4NTU5ZTE0L3RhYmxlcmFuZ2U6ODkzOWY0MDQ3MmQxNDZkZWJlODczMmUxODg1NTllMTRfMjYtMS0xLTEtMTU5NTQw_a627cbdc-b668-4f21-925f-cd14613cc17d" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" sign="-" unitref="usd">2,401.1</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zNC9mcmFnOmUxYWRjYjRiOGNhYTQzYTM5OWY1ZjExNzc3OTQ0YjI2L3RhYmxlOjg5MzlmNDA0NzJkMTQ2ZGViZTg3MzJlMTg4NTU5ZTE0L3RhYmxlcmFuZ2U6ODkzOWY0MDQ3MmQxNDZkZWJlODczMmUxODg1NTllMTRfMjYtMy0xLTEtMTU5NTQw_12d7c113-8444-4b2b-915e-8ef9a7e90b16" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" sign="-" unitref="usd">2,383.3</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flows from Financing Activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zNC9mcmFnOmUxYWRjYjRiOGNhYTQzYTM5OWY1ZjExNzc3OTQ0YjI2L3RhYmxlOjg5MzlmNDA0NzJkMTQ2ZGViZTg3MzJlMTg4NTU5ZTE0L3RhYmxlcmFuZ2U6ODkzOWY0MDQ3MmQxNDZkZWJlODczMmUxODg1NTllMTRfMjgtMS0xLTEtMTU5NTQw_2daf73e0-0adb-465b-b461-da3b89a3cb06" name="us-gaap:PaymentsOfDividends" scale="6" unitref="usd">2,651.4</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zNC9mcmFnOmUxYWRjYjRiOGNhYTQzYTM5OWY1ZjExNzc3OTQ0YjI2L3RhYmxlOjg5MzlmNDA0NzJkMTQ2ZGViZTg3MzJlMTg4NTU5ZTE0L3RhYmxlcmFuZ2U6ODkzOWY0MDQ3MmQxNDZkZWJlODczMmUxODg1NTllMTRfMjgtMy0xLTEtMTU5NTQw_b734ad7f-5df0-431d-8cf8-9d7b067f6371" name="us-gaap:PaymentsOfDividends" scale="6" unitref="usd">2,313.5</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in short-term borrowings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zNC9mcmFnOmUxYWRjYjRiOGNhYTQzYTM5OWY1ZjExNzc3OTQ0YjI2L3RhYmxlOjg5MzlmNDA0NzJkMTQ2ZGViZTg3MzJlMTg4NTU5ZTE0L3RhYmxlcmFuZ2U6ODkzOWY0MDQ3MmQxNDZkZWJlODczMmUxODg1NTllMTRfMjktMS0xLTEtMTU5NTQw_0b92accc-d1a4-4611-9c38-36ef0f1c866a" name="us-gaap:ProceedsFromShortTermDebt" scale="6" unitref="usd">1,741.3</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zNC9mcmFnOmUxYWRjYjRiOGNhYTQzYTM5OWY1ZjExNzc3OTQ0YjI2L3RhYmxlOjg5MzlmNDA0NzJkMTQ2ZGViZTg3MzJlMTg4NTU5ZTE0L3RhYmxlcmFuZ2U6ODkzOWY0MDQ3MmQxNDZkZWJlODczMmUxODg1NTllMTRfMjktMy0xLTEtMTU5NTQw_9cf07f1b-dfc4-4c80-93cf-d3aac87aed91" name="us-gaap:ProceedsFromShortTermDebt" scale="6" sign="-" unitref="usd">1.5</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from issuance of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zNC9mcmFnOmUxYWRjYjRiOGNhYTQzYTM5OWY1ZjExNzc3OTQ0YjI2L3RhYmxlOjg5MzlmNDA0NzJkMTQ2ZGViZTg3MzJlMTg4NTU5ZTE0L3RhYmxlcmFuZ2U6ODkzOWY0MDQ3MmQxNDZkZWJlODczMmUxODg1NTllMTRfMzAtMS0xLTEtMTU5NTQw_b707055a-6256-4816-aa37-c3b84c53640d" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="6" unitref="usd">&#8212;</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zNC9mcmFnOmUxYWRjYjRiOGNhYTQzYTM5OWY1ZjExNzc3OTQ0YjI2L3RhYmxlOjg5MzlmNDA0NzJkMTQ2ZGViZTg3MzJlMTg4NTU5ZTE0L3RhYmxlcmFuZ2U6ODkzOWY0MDQ3MmQxNDZkZWJlODczMmUxODg1NTllMTRfMzAtMy0xLTEtMTU5NTQw_4fbebe53-dbe3-46b7-866c-623447a9cb6d" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="6" unitref="usd">2,410.8</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayments of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zNC9mcmFnOmUxYWRjYjRiOGNhYTQzYTM5OWY1ZjExNzc3OTQ0YjI2L3RhYmxlOjg5MzlmNDA0NzJkMTQ2ZGViZTg3MzJlMTg4NTU5ZTE0L3RhYmxlcmFuZ2U6ODkzOWY0MDQ3MmQxNDZkZWJlODczMmUxODg1NTllMTRfMzEtMS0xLTEtMTU5NTQw_fd21dd0d-8e21-4001-8765-84806aa5e6da" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" unitref="usd">1,560.0</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zNC9mcmFnOmUxYWRjYjRiOGNhYTQzYTM5OWY1ZjExNzc3OTQ0YjI2L3RhYmxlOjg5MzlmNDA0NzJkMTQ2ZGViZTg3MzJlMTg4NTU5ZTE0L3RhYmxlcmFuZ2U6ODkzOWY0MDQ3MmQxNDZkZWJlODczMmUxODg1NTllMTRfMzEtMy0xLTEtMTU5NTQw_50c48fb5-0621-4f3a-ba04-a0f7765632dd" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" unitref="usd">1,905.3</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zNC9mcmFnOmUxYWRjYjRiOGNhYTQzYTM5OWY1ZjExNzc3OTQ0YjI2L3RhYmxlOjg5MzlmNDA0NzJkMTQ2ZGViZTg3MzJlMTg4NTU5ZTE0L3RhYmxlcmFuZ2U6ODkzOWY0MDQ3MmQxNDZkZWJlODczMmUxODg1NTllMTRfMzItMS0xLTEtMTU5NTQw_9f31c2fa-6849-4968-92d0-450b156e1d41" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" unitref="usd">1,500.0</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zNC9mcmFnOmUxYWRjYjRiOGNhYTQzYTM5OWY1ZjExNzc3OTQ0YjI2L3RhYmxlOjg5MzlmNDA0NzJkMTQ2ZGViZTg3MzJlMTg4NTU5ZTE0L3RhYmxlcmFuZ2U6ODkzOWY0MDQ3MmQxNDZkZWJlODczMmUxODg1NTllMTRfMzItMy0xLTEtMTU5NTQw_d85bb1cc-71a5-4c31-86ed-c2114e83e792" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" unitref="usd">500.0</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other financing activities, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zNC9mcmFnOmUxYWRjYjRiOGNhYTQzYTM5OWY1ZjExNzc3OTQ0YjI2L3RhYmxlOjg5MzlmNDA0NzJkMTQ2ZGViZTg3MzJlMTg4NTU5ZTE0L3RhYmxlcmFuZ2U6ODkzOWY0MDQ3MmQxNDZkZWJlODczMmUxODg1NTllMTRfMzQtMS0xLTEtMTU5NTQw_3b3c2ed5-5e87-44cf-8e2b-fc522b40f82f" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" sign="-" unitref="usd">295.2</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zNC9mcmFnOmUxYWRjYjRiOGNhYTQzYTM5OWY1ZjExNzc3OTQ0YjI2L3RhYmxlOjg5MzlmNDA0NzJkMTQ2ZGViZTg3MzJlMTg4NTU5ZTE0L3RhYmxlcmFuZ2U6ODkzOWY0MDQ3MmQxNDZkZWJlODczMmUxODg1NTllMTRfMzQtMy0xLTEtMTU5NTQw_38bbeaf7-b915-436b-896c-0da49d08ba69" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" sign="-" unitref="usd">295.3</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Cash Used for Financing Activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zNC9mcmFnOmUxYWRjYjRiOGNhYTQzYTM5OWY1ZjExNzc3OTQ0YjI2L3RhYmxlOjg5MzlmNDA0NzJkMTQ2ZGViZTg3MzJlMTg4NTU5ZTE0L3RhYmxlcmFuZ2U6ODkzOWY0MDQ3MmQxNDZkZWJlODczMmUxODg1NTllMTRfMzUtMS0xLTEtMTU5NTQw_bac41b47-a144-414b-8a24-914f32a3d386" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" sign="-" unitref="usd">4,265.3</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zNC9mcmFnOmUxYWRjYjRiOGNhYTQzYTM5OWY1ZjExNzc3OTQ0YjI2L3RhYmxlOjg5MzlmNDA0NzJkMTQ2ZGViZTg3MzJlMTg4NTU5ZTE0L3RhYmxlcmFuZ2U6ODkzOWY0MDQ3MmQxNDZkZWJlODczMmUxODg1NTllMTRfMzUtMy0xLTEtMTU5NTQw_4f302acd-0901-4703-a1ad-9c60a2cd4eaf" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" sign="-" unitref="usd">2,604.8</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zNC9mcmFnOmUxYWRjYjRiOGNhYTQzYTM5OWY1ZjExNzc3OTQ0YjI2L3RhYmxlOjg5MzlmNDA0NzJkMTQ2ZGViZTg3MzJlMTg4NTU5ZTE0L3RhYmxlcmFuZ2U6ODkzOWY0MDQ3MmQxNDZkZWJlODczMmUxODg1NTllMTRfMzYtMS0xLTEtMTU5NTQw_2e450789-c04d-4f1c-8538-dfe6887b2591" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" sign="-" unitref="usd">39.4</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zNC9mcmFnOmUxYWRjYjRiOGNhYTQzYTM5OWY1ZjExNzc3OTQ0YjI2L3RhYmxlOjg5MzlmNDA0NzJkMTQ2ZGViZTg3MzJlMTg4NTU5ZTE0L3RhYmxlcmFuZ2U6ODkzOWY0MDQ3MmQxNDZkZWJlODczMmUxODg1NTllMTRfMzYtMy0xLTEtMTU5NTQw_1811339c-0279-44cc-a072-6fefee97a6cc" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" unitref="usd">15.0</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net decrease in cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zNC9mcmFnOmUxYWRjYjRiOGNhYTQzYTM5OWY1ZjExNzc3OTQ0YjI2L3RhYmxlOjg5MzlmNDA0NzJkMTQ2ZGViZTg3MzJlMTg4NTU5ZTE0L3RhYmxlcmFuZ2U6ODkzOWY0MDQ3MmQxNDZkZWJlODczMmUxODg1NTllMTRfMzgtMS0xLTEtMTU5NTQw_a28bb36e-7195-40e0-a77f-b14351a55465" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" sign="-" unitref="usd">1,201.1</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zNC9mcmFnOmUxYWRjYjRiOGNhYTQzYTM5OWY1ZjExNzc3OTQ0YjI2L3RhYmxlOjg5MzlmNDA0NzJkMTQ2ZGViZTg3MzJlMTg4NTU5ZTE0L3RhYmxlcmFuZ2U6ODkzOWY0MDQ3MmQxNDZkZWJlODczMmUxODg1NTllMTRfMzgtMy0xLTEtMTU5NTQw_39368642-1b38-4577-a7ee-0f931466ca29" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" unitref="usd">131.1</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents at January&#160;1</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i0973ba0c1d894ceaa494709a13f814fb_I20211231" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zNC9mcmFnOmUxYWRjYjRiOGNhYTQzYTM5OWY1ZjExNzc3OTQ0YjI2L3RhYmxlOjg5MzlmNDA0NzJkMTQ2ZGViZTg3MzJlMTg4NTU5ZTE0L3RhYmxlcmFuZ2U6ODkzOWY0MDQ3MmQxNDZkZWJlODczMmUxODg1NTllMTRfMzktMS0xLTEtMTU5NTQw_4138cde0-d05c-46d1-b55b-3ec64c5b13ec" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" scale="6" unitref="usd">3,818.5</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i82811f99128e46738e63b2b2f09a72ef_I20201231" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zNC9mcmFnOmUxYWRjYjRiOGNhYTQzYTM5OWY1ZjExNzc3OTQ0YjI2L3RhYmxlOjg5MzlmNDA0NzJkMTQ2ZGViZTg3MzJlMTg4NTU5ZTE0L3RhYmxlcmFuZ2U6ODkzOWY0MDQ3MmQxNDZkZWJlODczMmUxODg1NTllMTRfMzktMy0xLTEtMTU5NTQw_803f4814-4572-421f-84d7-fd69fc65f552" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" scale="6" unitref="usd">3,657.1</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and Cash Equivalents at September 30</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i08ccb35f6ad24d7793c9c91b74ca2ea1_I20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zNC9mcmFnOmUxYWRjYjRiOGNhYTQzYTM5OWY1ZjExNzc3OTQ0YjI2L3RhYmxlOjg5MzlmNDA0NzJkMTQ2ZGViZTg3MzJlMTg4NTU5ZTE0L3RhYmxlcmFuZ2U6ODkzOWY0MDQ3MmQxNDZkZWJlODczMmUxODg1NTllMTRfNDAtMS0xLTEtMTU5NTQw_eed9b77a-2738-4fbd-94c1-1605e4fd8402" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" scale="6" unitref="usd">2,617.4</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i5fcc694940794a94a960d8f1f9315381_I20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN18zNC9mcmFnOmUxYWRjYjRiOGNhYTQzYTM5OWY1ZjExNzc3OTQ0YjI2L3RhYmxlOjg5MzlmNDA0NzJkMTQ2ZGViZTg3MzJlMTg4NTU5ZTE0L3RhYmxlcmFuZ2U6ODkzOWY0MDQ3MmQxNDZkZWJlODczMmUxODg1NTllMTRfNDAtMy0xLTEtMTU5NTQw_9b1f9dbb-af91-4ae6-bde0-d3b4eeee6877" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" scale="6" unitref="usd">3,788.2</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to consolidated condensed financial statements.</span></div><div style="margin-top:9pt"><span><br/></span></div><div style="margin-top:9pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><div id="i5fed483d9c7e4f3cbba3a62c53226cd7_37"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Condensed Financial Statements</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(Tables present dollars in millions, except per-share data)</span></div><div id="i5fed483d9c7e4f3cbba3a62c53226cd7_40"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 1: <ix:nonnumeric contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" continuedat="i791f6c3d34404365a97e68b9ae7ec7aa" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180MC9mcmFnOjY1MTIyYTE5YjI4ZjQ1MzNhMjNhNzYyMmI4NDg4MGQ5L3RleHRyZWdpb246NjUxMjJhMTliMjhmNDUzM2EyM2E3NjIyYjg0ODgwZDlfNDE2Nw_fef486b7-2bf9-4243-b1bf-ccb3fd9bb9e8" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">Basis of Presentation and Implementation of New Financial Accounting Standard </ix:nonnumeric></span></div><ix:continuation id="i791f6c3d34404365a97e68b9ae7ec7aa"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have prepared the accompanying unaudited consolidated condensed financial statements in accordance with the requirements of Form 10-Q and, therefore, they do not include all information and footnotes necessary for a fair presentation of financial position, results of operations, and cash flows in conformity with accounting principles generally accepted in the United States (GAAP). In our opinion, the consolidated condensed financial statements reflect all adjustments (including those that are normal and recurring) that are necessary for a fair presentation of the results of operations for the periods shown. In preparing financial statements in conformity with GAAP, we must make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, expenses, and related disclosures at the date of the financial statements and during the reporting period. Actual results could differ from those estimates.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information included in this Quarterly Report on Form 10-Q should be read in conjunction with our consolidated financial statements and accompanying notes included in our Annual Report on </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/0000059478/000005947822000068/lly-20211231.htm" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Form 10-K</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the year ended December&#160;31, 2021. We issue our financial statements by filing them with the Securities and Exchange Commission and have evaluated subsequent events up to the time of the filing of this Quarterly Report on Form 10-Q.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain reclassifications have been made to prior periods in the consolidated condensed financial statements and accompanying notes to conform with the current presentation.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All per-share amounts, unless otherwise noted in the footnotes, are presented on a diluted basis; that is, based on the weighted-average number of common shares outstanding plus the effect of incremental shares from our stock-based compensation programs.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate as a single operating segment engaged in the discovery, development, manufacturing, marketing, and sales of pharmaceutical products worldwide. A global research and development organization and a supply chain organization are responsible for the discovery, development, manufacturing, and supply of our products. Regional commercial organizations market, distribute, and sell the products. The business is also supported by global corporate staff functions. Our determination that we operate as a single segment is consistent with the financial information regularly reviewed by the chief operating decision maker for purposes of evaluating performance, allocating resources, setting incentive compensation targets, and planning and forecasting for future periods.</span></div><ix:nonnumeric contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180MC9mcmFnOjY1MTIyYTE5YjI4ZjQ1MzNhMjNhNzYyMmI4NDg4MGQ5L3RleHRyZWdpb246NjUxMjJhMTliMjhmNDUzM2EyM2E3NjIyYjg0ODgwZDlfNDE3NA_c48d06ff-5e0b-4653-8b6c-1453156fde1e" name="us-gaap:ResearchAndDevelopmentExpensePolicy"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development Expenses and Acquired In-Process Research and Development (IPR&amp;D) and Development Milestones</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development costs are expensed as incurred. Research and development costs consist of expenses incurred in performing research and development activities, including but not limited to, compensation and benefits, facilities and overhead expense, clinical trial expense, and fees paid to contract research organizations.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquired IPR&amp;D and development milestones include the initial costs of externally developed IPR&amp;D projects, acquired directly in a transaction other than a business combination, that do not have an alternative future use. Additionally, milestone payment obligations related to these transactions that are incurred prior to regulatory approval of the compound are expensed when the event triggering an obligation to pay the milestone occurs.</span></div></ix:nonnumeric><ix:nonnumeric contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180MC9mcmFnOjY1MTIyYTE5YjI4ZjQ1MzNhMjNhNzYyMmI4NDg4MGQ5L3RleHRyZWdpb246NjUxMjJhMTliMjhmNDUzM2EyM2E3NjIyYjg0ODgwZDlfNDE2MA_e539ef21-51c4-4a56-93ea-59e5c9426eb5" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Implementation of New Financial Accounting Standard</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounting Standards Update 2021-01, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, provides for temporary optional expedients and exceptions in applying current GAAP to contracts, hedging relationships, and other transactions affected by the transition from the use of the London Interbank Offered Rate (LIBOR) to an alternative reference rate. The standard is currently applicable to contracts entered into before January 1, 2023. We adopted the standard in the first quarter of 2022. The adoption did not have a material impact on our consolidated condensed financial statements.</span></div></ix:nonnumeric></ix:continuation><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><div id="i5fed483d9c7e4f3cbba3a62c53226cd7_43"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 2: <ix:nonnumeric contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" continuedat="i9b6734e2ae1b41aa8072f418713c62dc" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RleHRyZWdpb246MzBhNDczMzUyMjFjNDA4Yjg4MjFiMDVmZmU0MmMzNTdfMzYxMA_932f7981-0408-4c83-94a4-8b2a8211708a" name="us-gaap:RevenueFromContractWithCustomerTextBlock">Revenue</ix:nonnumeric></span></div><ix:continuation continuedat="i7c5afb1018314c73b9913adea27862c1" id="i9b6734e2ae1b41aa8072f418713c62dc"><ix:nonnumeric contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" continuedat="i9bf5f888dbb34effbbdcbb5ca4c84cd0" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RleHRyZWdpb246MzBhNDczMzUyMjFjNDA4Yjg4MjFiMDVmZmU0MmMzNTdfMzYyNg_6ed514c1-a15c-4ee4-b5b9-6c21ca4f5357" name="us-gaap:DisaggregationOfRevenueTableTextBlock"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our revenue recognized in our consolidated condensed statements of operations:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.206%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net product revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="if42877c131ac415eb21599c372b78f90_D20220701-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjA3OWI2OTMzNGFkNDQ5YTBhODFiNGY3ZGZlMDkzN2M0L3RhYmxlcmFuZ2U6MDc5YjY5MzM0YWQ0NDlhMGE4MWI0ZjdkZmUwOTM3YzRfMi0xLTEtMS0xNTk1NDA_7cb2a4c7-1716-45c9-8edc-e1709c8521c6" name="us-gaap:Revenues" scale="6" unitref="usd">6,119.2</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i80d1b089c2a644458859200e15f563c8_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjA3OWI2OTMzNGFkNDQ5YTBhODFiNGY3ZGZlMDkzN2M0L3RhYmxlcmFuZ2U6MDc5YjY5MzM0YWQ0NDlhMGE4MWI0ZjdkZmUwOTM3YzRfMi0zLTEtMS0xNTk1NDA_831ad7c4-6e8a-446d-90a9-8755ba774bc5" name="us-gaap:Revenues" scale="6" unitref="usd">6,189.0</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="id3dd0ce52c8549c58e5d29bb1bb1c197_D20220101-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjA3OWI2OTMzNGFkNDQ5YTBhODFiNGY3ZGZlMDkzN2M0L3RhYmxlcmFuZ2U6MDc5YjY5MzM0YWQ0NDlhMGE4MWI0ZjdkZmUwOTM3YzRfMi01LTEtMS0xNTk1NDA_7f49393a-0299-45f2-a53f-487e0e7b7fc7" name="us-gaap:Revenues" scale="6" unitref="usd">19,123.0</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i1962268fe5e4415bbcb7e76b2f694425_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjA3OWI2OTMzNGFkNDQ5YTBhODFiNGY3ZGZlMDkzN2M0L3RhYmxlcmFuZ2U6MDc5YjY5MzM0YWQ0NDlhMGE4MWI0ZjdkZmUwOTM3YzRfMi03LTEtMS0xNTk1NDA_beeb036d-b623-4bdb-abb4-d6bf219bff19" name="us-gaap:Revenues" scale="6" unitref="usd">18,579.5</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Collaboration and other revenue</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ie24dcfd7665d4948a6b3ea63d1979c25_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjA3OWI2OTMzNGFkNDQ5YTBhODFiNGY3ZGZlMDkzN2M0L3RhYmxlcmFuZ2U6MDc5YjY5MzM0YWQ0NDlhMGE4MWI0ZjdkZmUwOTM3YzRfMy0xLTEtMS0xNTk1NDA_91e45130-eaf7-493d-8c3f-a3da24660c94" name="us-gaap:Revenues" scale="6" unitref="usd">822.4</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i28f16eccfa8b45c9b2f74cc6235732b4_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjA3OWI2OTMzNGFkNDQ5YTBhODFiNGY3ZGZlMDkzN2M0L3RhYmxlcmFuZ2U6MDc5YjY5MzM0YWQ0NDlhMGE4MWI0ZjdkZmUwOTM3YzRfMy0zLTEtMS0xNTk1NDA_f2b10dfd-d1df-4bd2-8e47-05df82f43ef9" name="us-gaap:Revenues" scale="6" unitref="usd">583.8</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i3ebb89e75b934815a2a398afa3315ad4_D20220101-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjA3OWI2OTMzNGFkNDQ5YTBhODFiNGY3ZGZlMDkzN2M0L3RhYmxlcmFuZ2U6MDc5YjY5MzM0YWQ0NDlhMGE4MWI0ZjdkZmUwOTM3YzRfMy01LTEtMS0xNTk1NDA_7b426d53-c29a-46a8-a041-cf93af6fe19d" name="us-gaap:Revenues" scale="6" unitref="usd">2,116.6</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i0707295b42774a95baab2b522f5925a8_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjA3OWI2OTMzNGFkNDQ5YTBhODFiNGY3ZGZlMDkzN2M0L3RhYmxlcmFuZ2U6MDc5YjY5MzM0YWQ0NDlhMGE4MWI0ZjdkZmUwOTM3YzRfMy03LTEtMS0xNTk1NDA_ac06b230-7599-445e-a758-572f515f5955" name="us-gaap:Revenues" scale="6" unitref="usd">1,739.0</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i19fc0325c48543008ea71e1fdcf11d86_D20220701-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjA3OWI2OTMzNGFkNDQ5YTBhODFiNGY3ZGZlMDkzN2M0L3RhYmxlcmFuZ2U6MDc5YjY5MzM0YWQ0NDlhMGE4MWI0ZjdkZmUwOTM3YzRfNC0xLTEtMS0xNTk1NDA_12e03f10-98cf-4b8e-b958-bc063c635ef8" name="us-gaap:Revenues" scale="6" unitref="usd">6,941.6</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie4fa4f6b472a4f269297591b44aba572_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjA3OWI2OTMzNGFkNDQ5YTBhODFiNGY3ZGZlMDkzN2M0L3RhYmxlcmFuZ2U6MDc5YjY5MzM0YWQ0NDlhMGE4MWI0ZjdkZmUwOTM3YzRfNC0zLTEtMS0xNTk1NDA_159989f0-4305-48b1-9340-a92b751ddf73" name="us-gaap:Revenues" scale="6" unitref="usd">6,772.8</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjA3OWI2OTMzNGFkNDQ5YTBhODFiNGY3ZGZlMDkzN2M0L3RhYmxlcmFuZ2U6MDc5YjY5MzM0YWQ0NDlhMGE4MWI0ZjdkZmUwOTM3YzRfNC01LTEtMS0xNTk1NDA_c7f53c2a-97d3-40c1-8e71-3bc264a49ee2" name="us-gaap:Revenues" scale="6" unitref="usd">21,239.6</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjA3OWI2OTMzNGFkNDQ5YTBhODFiNGY3ZGZlMDkzN2M0L3RhYmxlcmFuZ2U6MDc5YjY5MzM0YWQ0NDlhMGE4MWI0ZjdkZmUwOTM3YzRfNC03LTEtMS0xNTk1NDA_ca22ca5b-9b12-4f38-baf1-ba66e3eb63d3" name="us-gaap:Revenues" scale="6" unitref="usd">20,318.5</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Collaboration and other revenue associated with prior period transfers of intellectual property was $<ix:nonfraction contextref="i34aeabd3620f4de8ad8c2efefc863807_D20220701-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RleHRyZWdpb246MzBhNDczMzUyMjFjNDA4Yjg4MjFiMDVmZmU0MmMzNTdfMjM3_f0f2f02c-15ad-4db8-8741-6bed5024e2b6" name="us-gaap:Revenues" scale="6" unitref="usd">43.3</ix:nonfraction> million and $<ix:nonfraction contextref="ia0d2323337da484fb1444b8262ff7a7e_D20220101-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RleHRyZWdpb246MzBhNDczMzUyMjFjNDA4Yjg4MjFiMDVmZmU0MmMzNTdfMjQ0_73540d04-9c94-44c7-8a94-e0acf37c1b39" name="us-gaap:Revenues" scale="6" unitref="usd">130.9</ix:nonfraction> million during the three and nine months ended September&#160;30, 2022, respectively, and $<ix:nonfraction contextref="i16836baff9c344308700232bb53196d6_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RleHRyZWdpb246MzBhNDczMzUyMjFjNDA4Yjg4MjFiMDVmZmU0MmMzNTdfMjk2_74bd2027-e5ee-42ef-9a3c-077af228cbba" name="us-gaap:Revenues" scale="6" unitref="usd">62.1</ix:nonfraction> million and $<ix:nonfraction contextref="ib6db6b88271640b7be37a4c3c9f838c6_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RleHRyZWdpb246MzBhNDczMzUyMjFjNDA4Yjg4MjFiMDVmZmU0MmMzNTdfMzAz_cbd103f3-7e5a-4006-a81f-8fb363caa85a" name="us-gaap:Revenues" scale="6" unitref="usd">136.1</ix:nonfraction> million during the three and nine months ended September&#160;30, 2021, respectively.</span></div></ix:nonnumeric><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue primarily from two different types of contracts, product sales to customers (net product revenue) and collaborations and other arrangements. Revenue recognized from collaborations and other arrangements includes our share of profits from the collaborations, as well as royalties, upfront and milestone payments we receive under these types of contracts. See Note 4 for additional information related to our collaborations and other arrangements. Collaboration and other revenue disclosed above includes the revenue from the Jardiance</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trajenta</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> families of products resulting from our collaboration with Boehringer Ingelheim discussed in Note 4. Substantially all of the remainder of collaboration and other revenue is related to contracts accounted for as contracts with customers.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Adjustments to Revenue</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjustments to increase revenue recognized as a result of changes in estimates for our most significant United States (U.S.) sales returns, rebates, and discounts liability balances for products shipped in previous periods were <ix:nonfraction contextref="i46e52d8ad0e14ebf9fa7c9ecc503bbfa_D20220701-20220930" decimals="2" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RleHRyZWdpb246MzBhNDczMzUyMjFjNDA4Yjg4MjFiMDVmZmU0MmMzNTdfMzI5ODUzNDg4NzE4MA_5b451c14-f56c-4b09-ab4d-34d0986e41c2" name="lly:RevenueInformationUsedToDetermineRevenueRecognizedChangeInAccountingEstimatePercent" scale="-2" unitref="number">3</ix:nonfraction> percent of U.S. revenue for the three months ended September&#160;30, 2022 and less than <ix:nonfraction contextref="i72b37618b2b848e48b6d7a66628d0ea0_D20220101-20220930" decimals="2" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RleHRyZWdpb246MzBhNDczMzUyMjFjNDA4Yjg4MjFiMDVmZmU0MmMzNTdfMTQxMA_0eb796ed-9b9f-4506-8b44-40e03e988f78" name="lly:RevenueInformationUsedToDetermineRevenueRecognizedChangeInAccountingEstimatePercent" scale="-2" unitref="number"><ix:nonfraction contextref="i19f0f8e72ada412eb34eae9afa79a051_D20210701-20210930" decimals="2" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RleHRyZWdpb246MzBhNDczMzUyMjFjNDA4Yjg4MjFiMDVmZmU0MmMzNTdfMTQxMA_6e78608c-d607-4a0e-84f2-ca135f08d9c7" name="lly:RevenueInformationUsedToDetermineRevenueRecognizedChangeInAccountingEstimatePercent" scale="-2" unitref="number"><ix:nonfraction contextref="i7685d8873a9b40f5bab0b11fa36b225d_D20210101-20210930" decimals="2" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RleHRyZWdpb246MzBhNDczMzUyMjFjNDA4Yjg4MjFiMDVmZmU0MmMzNTdfMTQxMA_7e029b78-43ca-4f60-bc29-bad0fcf3e363" name="lly:RevenueInformationUsedToDetermineRevenueRecognizedChangeInAccountingEstimatePercent" scale="-2" unitref="number">1</ix:nonfraction></ix:nonfraction></ix:nonfraction> percent of U.S. revenue during the nine months ended September&#160;30, 2022 and the three and nine months ended September&#160;30, 2021. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Contract Liabilities</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our contract liabilities result from arrangements where we have received payment in advance of performance under the contract and do not include sales returns, rebates, and discounts. Changes in contract liabilities are generally due to either receipt of additional advance payments or our performance under the contract. </span></div><ix:nonnumeric contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RleHRyZWdpb246MzBhNDczMzUyMjFjNDA4Yjg4MjFiMDVmZmU0MmMzNTdfMzYyOA_78254a29-9a46-45f0-a0cb-93d522524262" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes contract liability balances:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.420%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.276%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i08ccb35f6ad24d7793c9c91b74ca2ea1_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjQxNzkzNmNkMjI4MTQwYmU4ZWY0NWY3MjdmZjM5OGMzL3RhYmxlcmFuZ2U6NDE3OTM2Y2QyMjgxNDBiZThlZjQ1ZjcyN2ZmMzk4YzNfMS0xLTEtMS0xNTk1NDA_d65e19dc-0f22-425e-9ad6-e5dd69a060fc" name="us-gaap:ContractWithCustomerLiability" scale="6" unitref="usd">232.5</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i0973ba0c1d894ceaa494709a13f814fb_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjQxNzkzNmNkMjI4MTQwYmU4ZWY0NWY3MjdmZjM5OGMzL3RhYmxlcmFuZ2U6NDE3OTM2Y2QyMjgxNDBiZThlZjQ1ZjcyN2ZmMzk4YzNfMS0zLTEtMS0xNTk1NDA_fecc1ef7-53ac-41e6-ac8d-b31aa7ad7f68" name="us-gaap:ContractWithCustomerLiability" scale="6" unitref="usd">262.6</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonnumeric><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and nine months ended September&#160;30, 2022 and 2021, revenue recognized from contract liabilities as of the beginning of the respective year was not material. Revenue expected to be recognized in the future from contract liabilities as the related performance obligations are satisfied is not expected to be material in any one year.</span></div></ix:continuation><div style="margin-bottom:12pt;margin-top:12pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation continuedat="i8a87bd7f728c4956b4f7b4a382aa7a0a" id="i7c5afb1018314c73b9913adea27862c1"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Disaggregation of Revenue</span></div><ix:continuation continuedat="ia7ddf8304b894ea5ae7ce70c55fcc02c" id="i9bf5f888dbb34effbbdcbb5ca4c84cd0"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes revenue by product for the three months ended September&#160;30, 2022 and 2021:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.577%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S.</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outside U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S.</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outside U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue&#8212;to unaffiliated customers:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diabetes:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Trulicity</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i28a49a83c479441f905c7cffa76d0d1e_D20220701-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfNS0xLTEtMS0xNTk1NDA_0a0e8bf5-a577-4900-b278-d7a04ee80107" name="us-gaap:Revenues" scale="6" unitref="usd">1,418.3</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i7ce64df6d312430cadd360079f217dd5_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfNS0yLTEtMS0xNTk1NDA_1a2199b9-12bd-47bf-ae8a-6c6a69218f5a" name="us-gaap:Revenues" scale="6" unitref="usd">432.0</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i345b235e6d564f1bb6f06b9ed8319a72_D20220701-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfNS0zLTEtMS0xNTk1NDA_c321a335-fcb5-4a1d-9b4d-5f42b3cae5b9" name="us-gaap:Revenues" scale="6" unitref="usd">1,850.4</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i89ca472eabec43fd814b3653fab15181_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfNS01LTEtMS0xNTk1NDA_4dadfefb-6ae4-4196-95d1-5af313320aa4" name="us-gaap:Revenues" scale="6" unitref="usd">1,201.4</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7bbccd7a5a8e4837a3a85f1a2b3d2ef1_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfNS02LTEtMS0xNTk1NDA_09157d41-c628-48ef-bf42-57976969f325" name="us-gaap:Revenues" scale="6" unitref="usd">398.8</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i46a90cbffcd647a5801317b946ab5209_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfNS03LTEtMS0xNTk1NDA_d980fd01-6e83-48ff-aa9c-7000ff03be32" name="us-gaap:Revenues" scale="6" unitref="usd">1,600.1</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Jardiance</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i5546f63545a844a085ff12b7f2497571_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfNi0xLTEtMS0xNTk1NDA_1fcf3759-c56c-4c17-831e-88fc29de45a6" name="us-gaap:Revenues" scale="6" unitref="usd">350.9</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i348983749551494ba7808729a9dd6254_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfNi0yLTEtMS0xNTk1NDA_45a007c0-bd08-45bb-a63e-e154e3b3b4cc" name="us-gaap:Revenues" scale="6" unitref="usd">222.4</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="idfba5b60fbbe4370bad16f003f72e3c1_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfNi0zLTEtMS0xNTk1NDA_4b4062e7-4dbf-476d-b7d9-c49ae88fb823" name="us-gaap:Revenues" scale="6" unitref="usd">573.3</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i669b22e2d64c487fb8bd01c345ab7f38_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfNi01LTEtMS0xNTk1NDA_8b429d89-4e05-479b-920e-bdb91cf04f68" name="us-gaap:Revenues" scale="6" unitref="usd">221.2</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i4ab46b2a51674189a54630451735b250_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfNi02LTEtMS0xNTk1NDA_416e5a77-2473-428d-b4ba-9abd5f7e7ed5" name="us-gaap:Revenues" scale="6" unitref="usd">169.2</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ia28641f7c767406eacaa8089e13a2e77_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfNi03LTEtMS0xNTk1NDA_a6146567-ce3d-4baa-8cc0-7c8b22aba394" name="us-gaap:Revenues" scale="6" unitref="usd">390.4</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Humalog</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; (2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i233675fe0cc34caa880f2ae73fa95cad_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfNy0xLTEtMS0xNTk1NDA_d8c05d8a-7bfe-4a08-809f-8bee6eca013b" name="us-gaap:Revenues" scale="6" unitref="usd">248.1</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i404df183ca794e64b829a2993c89673f_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfNy0yLTEtMS0xNTk1NDA_a425bba8-99ae-4d14-8303-e5eea1502902" name="us-gaap:Revenues" scale="6" unitref="usd">198.8</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i6069340928544f1d98e220d601c0ccf7_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfNy0zLTEtMS0xNTk1NDA_5ab1e631-5e58-4f75-a0df-d43c4b15221a" name="us-gaap:Revenues" scale="6" unitref="usd">447.0</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i4b145726bc2c4ed78a3c2ec12b53c5c2_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfNy01LTEtMS0xNTk1NDA_ef942622-abcd-4639-8d77-6ac8e8a0402a" name="us-gaap:Revenues" scale="6" unitref="usd">347.3</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="id28218d7550a4cf4be526f83ae1c7332_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfNy02LTEtMS0xNTk1NDA_03219981-3fac-4a71-b859-0bf2fc9a5c4f" name="us-gaap:Revenues" scale="6" unitref="usd">279.4</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie59d14500008412ea099e2c09441a042_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfNy03LTEtMS0xNTk1NDA_59269390-f54a-4272-a172-208b9ae465df" name="us-gaap:Revenues" scale="6" unitref="usd">626.7</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Humulin</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ib99bd175ff46428092a6e96c970b94c5_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfOC0xLTEtMS0xNTk1NDA_ef8255d3-ba3a-4fe4-8d53-a7c538c10f08" name="us-gaap:Revenues" scale="6" unitref="usd">169.5</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i644d2f1188e14878aaa508d910b54dde_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfOC0yLTEtMS0xNTk1NDA_d767dbdb-d458-411d-9060-53fea646da55" name="us-gaap:Revenues" scale="6" unitref="usd">68.7</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i7cc0d4df5329427cb7da48ad36cb2efb_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfOC0zLTEtMS0xNTk1NDA_545ab11e-e529-4b1e-8c2d-d5f998327755" name="us-gaap:Revenues" scale="6" unitref="usd">238.2</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i02d6e02b9e20402bb506e5e37520efdb_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfOC01LTEtMS0xNTk1NDA_704ddbb1-ea70-4a79-b949-8e824af7ebe0" name="us-gaap:Revenues" scale="6" unitref="usd">193.4</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i40d7116b6c0a470195c3ab9234e5bb0e_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfOC02LTEtMS0xNTk1NDA_d73b78ed-eec6-4af8-aa8e-7aa015e64068" name="us-gaap:Revenues" scale="6" unitref="usd">93.4</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="iec80f91e475941f1abdc131fd14d868d_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfOC03LTEtMS0xNTk1NDA_e2256e80-7d98-4239-9df7-3cf70d782bad" name="us-gaap:Revenues" scale="6" unitref="usd">286.7</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Basaglar</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i529518415079475fa56a8916e119480c_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfOS0xLTEtMS0xNTk1NDA_0fd4e0cf-7cbe-4944-818b-8ce1563cb87e" name="us-gaap:Revenues" scale="6" unitref="usd">124.8</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ie34f0db27136443ca391ec67d20f46cc_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfOS0yLTEtMS0xNTk1NDA_31691ed2-0cb3-496c-9d57-42567e4ffd19" name="us-gaap:Revenues" scale="6" unitref="usd">68.1</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="id6f3b41d10de4dfb99b809554e15f4ca_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfOS0zLTEtMS0xNTk1NDA_f5a63c3a-96cf-4c8e-978e-398f3ff81c82" name="us-gaap:Revenues" scale="6" unitref="usd">193.0</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="idcd8ed6a0f624997876200ae1a53d3ff_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfOS01LTEtMS0xNTk1NDA_117389a1-ff79-41cc-9127-c5112b157bf9" name="us-gaap:Revenues" scale="6" unitref="usd">114.7</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i1981e978a66e4861b39ec95f950a699c_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfOS02LTEtMS0xNTk1NDA_d6155f67-733f-4420-b723-607036c04867" name="us-gaap:Revenues" scale="6" unitref="usd">78.1</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ieef95d1c0c4643f8a5a104c9301c56f6_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfOS03LTEtMS0xNTk1NDA_f749cbc3-4bf9-40a9-9045-7be859795e51" name="us-gaap:Revenues" scale="6" unitref="usd">192.8</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Mounjaro</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i7992fe4fc5774bd6aa8b55cf4d326364_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMTAtMS0xLTEtMTg5NTI3_8255f582-07e7-413b-8f1b-697aebc72623" name="us-gaap:Revenues" scale="6" unitref="usd">97.3</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i47be57988ea94c92b33e106ae820b8f7_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMTAtMi0xLTEtMTg5NTMw_00c4b87b-fccc-4654-800e-4d61aa4fc78a" name="us-gaap:Revenues" scale="6" unitref="usd">90.0</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i22fcf936becc4b56b4c435b41fdfd4c7_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMTAtMy0xLTEtMTg5NTMz_1a17e772-77e8-424a-b3a8-99bc44d20c89" name="us-gaap:Revenues" scale="6" unitref="usd">187.3</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i866b02b106bf4510aa3acc82ee4887a0_D20210701-20210930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMTAtNS0xLTEtMTg5NTM2_69604ef1-fb87-4640-af77-034a6a0db5ea" name="us-gaap:Revenues" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i99914bb8f18546f78ea8cdcaa7af2939_D20210701-20210930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMTAtNi0xLTEtMTg5NTQz_3ade9baa-dfc0-491a-8c02-258606dc14cc" name="us-gaap:Revenues" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i9094ecfcbf9c4d8bbe63fc38a5f24df0_D20210701-20210930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMTAtNy0xLTEtMTg5NTUw_fb5ffaf4-fc18-4729-9c50-d4c48f4a9343" name="us-gaap:Revenues" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other diabetes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="iceaf7dbcd2d8486cb982fc3658598e56_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMTAtMS0xLTEtMTU5NTQw_5a99f14f-a3eb-4586-a551-935e24cd4316" name="us-gaap:Revenues" scale="6" unitref="usd">79.7</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i05fc368927fd409998e10fd8a8626ff3_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMTAtMi0xLTEtMTU5NTQw_34167a83-898e-4991-8e01-cda06cf1b704" name="us-gaap:Revenues" scale="6" unitref="usd">94.0</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="iadb96dab5219493a8a09e4ef5a30b381_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMTAtMy0xLTEtMTU5NTQw_ace0b04b-86fb-4754-8362-1ff7ca2a5ea6" name="us-gaap:Revenues" scale="6" unitref="usd">173.4</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i26f16b68de674d2592c2cd9ee9755295_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMTAtNS0xLTEtMTU5NTQw_3f38029c-f3ba-449d-beb0-1c07de26c128" name="us-gaap:Revenues" scale="6" unitref="usd">65.0</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ib4a6a3281a6e41eda8915c8ed31cf4c4_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMTAtNi0xLTEtMTU5NTQw_a751d592-9242-4989-a1f9-324525142cd6" name="us-gaap:Revenues" scale="6" unitref="usd">112.2</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ib01598d835464cac82cecfbe826de92d_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMTAtNy0xLTEtMTU5NTQw_eb3e62c9-f150-41d5-8b49-0125b7996564" name="us-gaap:Revenues" scale="6" unitref="usd">177.4</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total diabetes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="id8862697b08648bcb4c7b9ad3dff39c3_D20220701-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMTEtMS0xLTEtMTU5NTQw_9d99bd9f-beb1-41a1-96bb-397628572fd8" name="us-gaap:Revenues" scale="6" unitref="usd">2,488.6</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="if00d7a9221f04fe68817babf35f51ebf_D20220701-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMTEtMi0xLTEtMTU5NTQw_b425fd58-6cbf-429b-b6eb-098318981878" name="us-gaap:Revenues" scale="6" unitref="usd">1,174.0</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ic1a606c172db416288ba0bbd8baa9966_D20220701-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMTEtMy0xLTEtMTU5NTQw_50dee3e7-ab7f-476a-9f1a-44ec81c342c0" name="us-gaap:Revenues" scale="6" unitref="usd">3,662.6</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i9d79583b71134ad5b1affaf7d3c9e867_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMTEtNS0xLTEtMTU5NTQw_b6662909-18d3-492e-a0ef-055e21944738" name="us-gaap:Revenues" scale="6" unitref="usd">2,143.0</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i74d4b85fd2a346fb93493d49de1c2bce_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMTEtNi0xLTEtMTU5NTQw_c983a16c-6278-49dd-b11e-d5a0cb1ee3e9" name="us-gaap:Revenues" scale="6" unitref="usd">1,131.1</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i42ad32bd431444b189dab3e866f14dce_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMTEtNy0xLTEtMTU5NTQw_cf24845e-71e1-48db-a723-30807d75527f" name="us-gaap:Revenues" scale="6" unitref="usd">3,274.1</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oncology:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Verzenio</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i0c515dd1cd2b453686e3e31d8c9a32d3_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMTQtMS0xLTEtMTU5NTQw_e069ea93-cd38-4c38-b992-e533125625d9" name="us-gaap:Revenues" scale="6" unitref="usd">414.8</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="id154bceb5f3a4af7bf7c046f1608e110_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMTQtMi0xLTEtMTU5NTQw_2de77508-96e1-4f18-87f4-307ed27cf4a0" name="us-gaap:Revenues" scale="6" unitref="usd">202.9</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ifb827f745b3b446f900ce979a433b71f_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMTQtMy0xLTEtMTU5NTQw_90b049e2-586b-47ce-9e23-2a66d21a6b97" name="us-gaap:Revenues" scale="6" unitref="usd">617.7</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i1f8a0004521c4a0ab278bcec0c67c5bd_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMTQtNS0xLTEtMTU5NTQw_41af130e-c1ea-4564-8900-daf733b5847d" name="us-gaap:Revenues" scale="6" unitref="usd">199.6</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="iaf75ab0eae484bb4b01f61ae25f750c5_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMTQtNi0xLTEtMTU5NTQw_e87e7d23-008a-4a6f-baf7-d27291162c54" name="us-gaap:Revenues" scale="6" unitref="usd">135.9</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i6b3d0e422c9640ab9313c19640d9fd90_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMTQtNy0xLTEtMTU5NTQw_97860e17-ba67-4bbd-bd88-851e365440b3" name="us-gaap:Revenues" scale="6" unitref="usd">335.5</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Cyramza</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i46e236388c73464e81b03a5d53c0dd53_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMTUtMS0xLTEtMTU5NTQw_a0e70550-a289-48de-9173-910bd3533c20" name="us-gaap:Revenues" scale="6" unitref="usd">87.5</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i5b6d4e4158744aaa95ee5bf00acb80cb_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMTUtMi0xLTEtMTU5NTQw_9a5d3133-6e39-4844-84fa-3543c50ea269" name="us-gaap:Revenues" scale="6" unitref="usd">144.6</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i4c1435377d2042d39e6953c271d4585b_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMTUtMy0xLTEtMTU5NTQw_547eed38-1637-4bb0-96d7-3d6b7b2b83bc" name="us-gaap:Revenues" scale="6" unitref="usd">232.1</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i176af1ca7219458c851326db4f5f0e18_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMTUtNS0xLTEtMTU5NTQw_ef4c93db-fa39-455f-b988-fb25c2b566f7" name="us-gaap:Revenues" scale="6" unitref="usd">84.8</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie4ca284b63654c0bbf5fc3646e324b1b_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMTUtNi0xLTEtMTU5NTQw_c2e46eb6-79f6-4e02-8130-7f4e6ae38029" name="us-gaap:Revenues" scale="6" unitref="usd">168.6</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i48871c7176154dbb971dc8a40b431eca_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMTUtNy0xLTEtMTU5NTQw_35b4bdb8-c6a3-47a5-81ce-b9cccf2f2883" name="us-gaap:Revenues" scale="6" unitref="usd">253.4</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Erbitux</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ifc30105eafd9459d81eaf411eb4da357_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMTctMS0xLTEtMTg5ODM0_cbcb7a5f-830c-41ab-a693-93520437ecbe" name="us-gaap:Revenues" scale="6" unitref="usd">126.3</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i84fe5c0fb05340ce93ab592130765d86_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMTctMi0xLTEtMTg5ODM0_a03d3848-0b20-4d31-8513-39008743b95f" name="us-gaap:Revenues" scale="6" unitref="usd">18.7</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i75db1e7f9d154c588f6bfd88b08dacf2_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMTctMy0xLTEtMTg5ODM0_d5c0c9dd-5cfc-4f6d-9a11-c714c7907dc1" name="us-gaap:Revenues" scale="6" unitref="usd">144.9</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ifb220bd49b9b4fee9a08cf2aba4811ff_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMTctNS0xLTEtMTg5ODM0_4aa752af-408e-483d-97a7-6121f91d106b" name="us-gaap:Revenues" scale="6" unitref="usd">114.0</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="if441e31221c74fb7b06ce4acda75a1ac_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMTctNi0xLTEtMTg5ODM0_6df77aae-22e4-46f8-ac1a-6250a2c21fe2" name="us-gaap:Revenues" scale="6" unitref="usd">20.3</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i74ebe2d40f834c6aaed2f9503f82b5c2_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMTctNy0xLTEtMTg5ODM0_6a36e185-5ee4-4985-a13b-b101f56933ad" name="us-gaap:Revenues" scale="6" unitref="usd">134.3</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Alimta</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i51fae75c655f4c9db22deca064e1d22a_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMTYtMS0xLTEtMTU5NTQw_008998d3-636a-47ac-98d6-abb4776e490a" name="us-gaap:Revenues" scale="6" unitref="usd">64.6</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i814e9ebeca8f4359b602b1c4116691fa_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMTYtMi0xLTEtMTU5NTQw_2f8e2d9e-70d2-4996-99ca-902541697733" name="us-gaap:Revenues" scale="6" unitref="usd">54.8</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i093d47ca61034ea8b9f0303b73074f6e_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMTYtMy0xLTEtMTU5NTQw_f5b1ff49-0ed6-42ff-82f9-9557ec1dad79" name="us-gaap:Revenues" scale="6" unitref="usd">119.4</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i5b8a2c0676cd456a958892b0fdc5f275_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMTYtNS0xLTEtMTU5NTQw_658bca63-6a3a-4b70-9f15-b79f6cd0632c" name="us-gaap:Revenues" scale="6" unitref="usd">297.2</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i01f53de517814e9fae0973ed84a89508_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMTYtNi0xLTEtMTU5NTQw_f9ccac0c-976b-4085-a8a9-a7ed24d35244" name="us-gaap:Revenues" scale="6" unitref="usd">159.8</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i91b98892233a42579bec90b2f1f07fad_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMTYtNy0xLTEtMTU5NTQw_6fff5085-50a8-400c-a933-ec49cc7f7619" name="us-gaap:Revenues" scale="6" unitref="usd">457.0</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Tyvyt</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i578736c37abd4751958301e188d9a111_D20220701-20220930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMTgtMS0xLTEtMTU5NTQw_c2b50857-bdbe-42bf-b4f4-61c3da66822e" name="us-gaap:Revenues" scale="6" unitref="usd">&#8212;</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ic105c32b09d5439ab48f1ea47e388e5c_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMTgtMi0xLTEtMTU5NTQw_7cd0c5a8-1419-44f5-a7b7-bcbb4af3d433" name="us-gaap:Revenues" scale="6" unitref="usd">76.8</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ifc8fc5f6c1924a46b0d88ad7ea894f53_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMTgtMy0xLTEtMTU5NTQw_dffb5a95-e891-48a9-a689-abb5c7e30b8f" name="us-gaap:Revenues" scale="6" unitref="usd">76.8</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i326cec97451b4c0fa64fb496bcc0d262_D20210701-20210930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMTgtNS0xLTEtMTU5NTQw_8fe7e548-688b-46b3-a0c7-af6fa6954001" name="us-gaap:Revenues" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="id6f0f8b1cbb14fe5bc88c77765723cdc_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMTgtNi0xLTEtMTU5NTQw_7d371912-8da9-4688-b513-e8225a93b469" name="us-gaap:Revenues" scale="6" unitref="usd">125.6</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i9da960751fa245d8bf93fa1681ead439_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMTgtNy0xLTEtMTU5NTQw_c37672f7-0a32-4eec-a93a-db53ea961956" name="us-gaap:Revenues" scale="6" unitref="usd">125.6</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other oncology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i4280b008d25146138bb9937941f505ac_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMTktMS0xLTEtMTU5NTQw_771d4ba2-7381-4a38-b5fb-9cd908d128f3" name="us-gaap:Revenues" scale="6" unitref="usd">39.5</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ib83a82fddc51484f973f835759a83951_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMTktMi0xLTEtMTU5NTQw_1a94ecd5-7153-462b-a9c6-0bb2bc805a21" name="us-gaap:Revenues" scale="6" unitref="usd">62.8</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i7add942c6a224625b4aa726843340e48_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMTktMy0xLTEtMTU5NTQw_0f863038-dd11-4964-bd8c-b8fb3ec61ba2" name="us-gaap:Revenues" scale="6" unitref="usd">102.4</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i010a412d535641f895d21d4765b984db_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMTktNS0xLTEtMTU5NTQw_3b3ce568-b14b-404d-a467-e6d8521fd535" name="us-gaap:Revenues" scale="6" unitref="usd">35.3</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i9a1ab61d480a42babad1c189210b4f6f_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMTktNi0xLTEtMTU5NTQw_667f8e4f-545e-4583-8bf6-fdaa6d165c36" name="us-gaap:Revenues" scale="6" unitref="usd">65.1</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i3d24e8995a5a4ced9875b8b9174e8096_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMTktNy0xLTEtMTU5NTQw_9a0a5031-2d6f-4026-a508-b22b91f65eb3" name="us-gaap:Revenues" scale="6" unitref="usd">100.3</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total oncology</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="if7ca1b1b8ebc4b97a61e679591aa9aa4_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMjAtMS0xLTEtMTU5NTQw_baa6c5e9-cc3c-4079-ba64-1bf89df4d6e6" name="us-gaap:Revenues" scale="6" unitref="usd">732.7</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i98dec2ee927948db8ae6249a13fbc06a_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMjAtMi0xLTEtMTU5NTQw_3dc52c54-71ba-4422-a2ef-751c1b81edd1" name="us-gaap:Revenues" scale="6" unitref="usd">560.6</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="idacb7a7257294fe689d448659352e301_D20220701-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMjAtMy0xLTEtMTU5NTQw_544235f5-6797-4de9-a4d2-b6b9a58f1718" name="us-gaap:Revenues" scale="6" unitref="usd">1,293.3</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i573f860cee384e44a092723fc9aaea21_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMjAtNS0xLTEtMTU5NTQw_ca75517a-c1c9-4dfe-9d59-26c6c87a57d1" name="us-gaap:Revenues" scale="6" unitref="usd">730.9</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ic45235af254e414c87819d6a61117897_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMjAtNi0xLTEtMTU5NTQw_9679b0de-f48b-4fb9-b293-c46ba1331ade" name="us-gaap:Revenues" scale="6" unitref="usd">675.3</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i3490b47c9d914a7a80f4c441455b8ead_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMjAtNy0xLTEtMTU5NTQw_589cc164-6ff6-4f93-b74f-60482aaf352e" name="us-gaap:Revenues" scale="6" unitref="usd">1,406.1</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Immunology:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Taltz</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="id3ed2240ab2944e1a3695929ccce3c61_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMjMtMS0xLTEtMTU5NTQw_0830681a-f057-4aee-86f5-6791461a3846" name="us-gaap:Revenues" scale="6" unitref="usd">493.8</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="iec46bce8b1474abc9815b6e1b2d7a169_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMjMtMi0xLTEtMTU5NTQw_e2297c6f-9a44-4e35-ada7-f2e73020a633" name="us-gaap:Revenues" scale="6" unitref="usd">186.1</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i800167f3776142a4bf399d8f51830c78_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMjMtMy0xLTEtMTU5NTQw_137072df-c045-4937-8754-4bd0ad4db73e" name="us-gaap:Revenues" scale="6" unitref="usd">679.9</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ia22b346dd2a54714a0f4ba483559b116_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMjMtNS0xLTEtMTU5NTQw_c32ea69c-4566-46a7-a983-5778aa7bb7b5" name="us-gaap:Revenues" scale="6" unitref="usd">422.2</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i0852df9f516e48b4a9af370971f46a78_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMjMtNi0xLTEtMTU5NTQw_dc0aaf75-cbb0-44ef-ba19-a57f93b60d8d" name="us-gaap:Revenues" scale="6" unitref="usd">170.9</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ia60c521d441f43a2b5801e09809d0abe_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMjMtNy0xLTEtMTU5NTQw_dadaba69-0e03-41d5-ba60-88fed39d1579" name="us-gaap:Revenues" scale="6" unitref="usd">593.1</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Olumiant</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; (3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i16529d5d29744762b0746672c1ef5cbf_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMjQtMS0xLTEtMTU5NTQw_50b999b2-f31a-41f5-8415-e5aca82bc315" name="us-gaap:Revenues" scale="6" unitref="usd">22.9</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i2456bc73ed7d4b8b8bc891900fd86004_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMjQtMi0xLTEtMTU5NTQw_5b4a0366-f77b-4317-8dbb-d09afc7fce7e" name="us-gaap:Revenues" scale="6" unitref="usd">160.0</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i65843c3594444a24be3c2dd715fb25e8_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMjQtMy0xLTEtMTU5NTQw_257580ce-899d-4d9b-ab06-7b681acb7802" name="us-gaap:Revenues" scale="6" unitref="usd">182.9</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="idef6b1951baa49b98d6da883dd4d89b9_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMjQtNS0xLTEtMTU5NTQw_26e2b0c3-c706-449d-86a1-0941b2c6e40c" name="us-gaap:Revenues" scale="6" unitref="usd">194.0</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ia1eb3846894a440d9b3b08cf8304da43_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMjQtNi0xLTEtMTU5NTQw_7f39255d-1753-4e20-8646-5b6010d5bb5b" name="us-gaap:Revenues" scale="6" unitref="usd">212.9</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i342e7e7b465546ffa22256042c6bf573_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMjQtNy0xLTEtMTU5NTQw_64568da7-872d-4490-bbf2-bebf62cdca4f" name="us-gaap:Revenues" scale="6" unitref="usd">406.9</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other immunology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="id0dbce0c2a604a12ab2550f876430b73_D20220701-20220930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMjUtMS0xLTEtMTU5NTQw_e5b3fd3a-aa09-4caf-90d1-51c3a7bd466c" name="us-gaap:Revenues" scale="6" unitref="usd">&#8212;</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i32547c688b2942bb9648bd77d09fed5d_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMjUtMi0xLTEtMTU5NTQw_9fadcc39-0896-4434-bb80-61bc1bd82107" name="us-gaap:Revenues" scale="6" unitref="usd">3.6</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ic666c0215c174e0da07f4d1e09afbca8_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMjUtMy0xLTEtMTU5NTQw_82840e44-5947-4878-bcc6-565b79cab370" name="us-gaap:Revenues" scale="6" unitref="usd">3.6</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i24578a0bb60d41509dae6c91cf840cf4_D20210701-20210930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMjUtNS0xLTEtMTU5NTQw_095cc759-d686-4964-a679-46b98946033d" name="us-gaap:Revenues" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i797465f9dcae46679ecb0c162248cdbf_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMjUtNi0xLTEtMTU5NTQw_be09041e-57b0-43ee-b41b-cb85903b5a21" name="us-gaap:Revenues" scale="6" unitref="usd">4.9</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i01bedd14598d4bef97fe5433a5abe2ec_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMjUtNy0xLTEtMTU5NTQw_f4b7064f-b241-48a0-b064-0e6721d8a44a" name="us-gaap:Revenues" scale="6" unitref="usd">4.9</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total immunology</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i0bca0633651d410a8f37cdc991be5df2_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMjYtMS0xLTEtMTU5NTQw_77d4aa5f-7606-426e-9162-d519fb860bf1" name="us-gaap:Revenues" scale="6" unitref="usd">516.7</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i0952e420996041498b88ed77f880c508_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMjYtMi0xLTEtMTU5NTQw_e9e7b637-6efc-421e-bec8-2dacd3f3521e" name="us-gaap:Revenues" scale="6" unitref="usd">349.7</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i6386f383c2e5484da28e805bf356222b_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMjYtMy0xLTEtMTU5NTQw_1bc8f1fc-9d20-490f-864a-30c2b71145e1" name="us-gaap:Revenues" scale="6" unitref="usd">866.4</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i4d8dd9cfbda345988f0d1cea4fac4546_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMjYtNS0xLTEtMTU5NTQw_b01d6266-b78a-4379-9bc0-fcfe47e68409" name="us-gaap:Revenues" scale="6" unitref="usd">616.2</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="icff9e13bc98e41938e743e7a4e4fd6de_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMjYtNi0xLTEtMTU5NTQw_d4182dd0-43a7-486a-8bc1-c47dc10ad1af" name="us-gaap:Revenues" scale="6" unitref="usd">388.7</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i5adbec8a8b6b48f7a5d1e48f49bf3411_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMjYtNy0xLTEtMTU5NTQw_35717df8-0dcd-4782-b080-1f21092ebd04" name="us-gaap:Revenues" scale="6" unitref="usd">1,004.9</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuroscience:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Emgality</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i358dff328e02486cae97aaae267517fd_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMjktMS0xLTEtMTU5NTQw_8967f1e2-4625-4893-a0c4-2f543d39af2d" name="us-gaap:Revenues" scale="6" unitref="usd">114.0</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i9c4b3d872761408cb58a702f02c9d3dd_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMjktMi0xLTEtMTU5NTQw_befa0c0c-a1dc-40c3-8369-cffc7d5e1ee5" name="us-gaap:Revenues" scale="6" unitref="usd">54.6</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i88720be3d2b447b38eacb349e966b957_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMjktMy0xLTEtMTU5NTQw_8ee494a4-a31d-4595-8d27-08873bef5193" name="us-gaap:Revenues" scale="6" unitref="usd">168.5</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i306f66892e60463a9440dd8625f955f2_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMjktNS0xLTEtMTU5NTQw_c51a5040-112c-4cf6-a2e6-dea3609e2f95" name="us-gaap:Revenues" scale="6" unitref="usd">99.9</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i830b5f4dd99f475f892c9b95d9c74688_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMjktNi0xLTEtMTU5NTQw_a1ce6726-10fb-41ba-aeb2-500152ff68c4" name="us-gaap:Revenues" scale="6" unitref="usd">40.1</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i04f1fa38b33d409c95edc1ca5dddc792_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMjktNy0xLTEtMTU5NTQw_32a8996b-1635-4f14-9bbf-798c243c78d5" name="us-gaap:Revenues" scale="6" unitref="usd">140.0</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Zyprexa</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ib3165ffc22844091b6dfdb6536ee8f81_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMzAtMS0xLTEtMTU5NTQw_560db19e-bd9a-4b62-a91b-9536f09d0e72" name="us-gaap:Revenues" scale="6" unitref="usd">8.0</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i93ab8179e11b4f23a7909ff2a1a2042f_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMzAtMi0xLTEtMTU5NTQw_64ae06ae-b854-405e-ad14-642010136a75" name="us-gaap:Revenues" scale="6" unitref="usd">73.4</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ia17da4c4f6b642d596703193f6afe6b9_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMzAtMy0xLTEtMTU5NTQw_ab5c4348-1e7e-4b8b-93a7-69d8e5158abf" name="us-gaap:Revenues" scale="6" unitref="usd">81.4</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i870e9a03322b437eab5ad616b9b96c9f_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMzAtNS0xLTEtMTU5NTQw_e04efa83-7f5f-434b-9e23-a60e1458723e" name="us-gaap:Revenues" scale="6" unitref="usd">13.0</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i119d9834ae424e7fa424cf206e1fa0fa_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMzAtNi0xLTEtMTU5NTQw_f3dae17b-3259-47bb-ae80-452ce0416c7a" name="us-gaap:Revenues" scale="6" unitref="usd">88.7</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i9028e0822d8749e59ae82cba528438af_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMzAtNy0xLTEtMTU5NTQw_b76c7e98-774b-4dc1-a816-50b4e7a108eb" name="us-gaap:Revenues" scale="6" unitref="usd">101.7</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Cymbalta</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ib6ab25c06067493bbca70a4e7597fdb8_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMzEtMS0xLTEtMTU5NTQw_a7af9985-6940-4b9f-9315-032dd66a34a7" name="us-gaap:Revenues" scale="6" unitref="usd">7.8</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i85be7a9452cb426a90fedddc2f455b01_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMzEtMi0xLTEtMTU5NTQw_ad99c188-31f1-49d4-82c1-fd460b314ca9" name="us-gaap:Revenues" scale="6" unitref="usd">54.9</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i2b6eac789003419ebceebcc13f624925_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMzEtMy0xLTEtMTU5NTQw_40a7a521-b55b-430a-8278-3bf5163ad5c4" name="us-gaap:Revenues" scale="6" unitref="usd">62.7</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ibd3368429e0140009581d9d510f8d8ff_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMzEtNS0xLTEtMTU5NTQw_c2357e65-39cb-435f-862c-4aa87032718d" name="us-gaap:Revenues" scale="6" unitref="usd">7.0</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i734fc13568954b75bd88b7375fbfa00d_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMzEtNi0xLTEtMTU5NTQw_2737e1c9-60a5-438b-98f5-d2c8e956d29f" name="us-gaap:Revenues" scale="6" unitref="usd">125.1</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i53769ba188564f8a86965473de7ac7a2_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMzEtNy0xLTEtMTU5NTQw_3caf55c9-ac07-4833-82f7-b93449a6e5d7" name="us-gaap:Revenues" scale="6" unitref="usd">132.0</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other neuroscience</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ic8c180d54e944d17bbbf0438a4c8f563_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMzMtMS0xLTEtMTU5NTQw_bf6d0e00-4fee-46af-b567-65b296a42b67" name="us-gaap:Revenues" scale="6" unitref="usd">16.0</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i31bc9c1361964102bc7f26ff4a6390ee_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMzMtMi0xLTEtMTU5NTQw_162173ef-fc97-43b3-9c37-e122f2132b45" name="us-gaap:Revenues" scale="6" unitref="usd">44.5</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="icf97b2cc85a442f5bc488f333e264c43_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMzMtMy0xLTEtMTU5NTQw_366c4be6-d347-43d9-ab7f-95b0b50139b9" name="us-gaap:Revenues" scale="6" unitref="usd">60.6</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7434dc344c6b4a99973bac3fef8d4f3a_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMzMtNS0xLTEtMTU5NTQw_59d648e5-e908-4777-ba0d-d290ded228af" name="us-gaap:Revenues" scale="6" unitref="usd">24.7</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i3ed4e34eaaf642748b03cff5ec59a742_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMzMtNi0xLTEtMTU5NTQw_14801ce0-8a85-4c5d-b273-23b59535068c" name="us-gaap:Revenues" scale="6" unitref="usd">51.6</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ifdd2b94511c147b0aa78edfbd1578f35_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMzMtNy0xLTEtMTU5NTQw_98f63d11-caca-45fb-8d9b-9b52390a9f67" name="us-gaap:Revenues" scale="6" unitref="usd">76.5</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total neuroscience</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i75c76b5ae8b04d0694593c6b670f2a70_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMzQtMS0xLTEtMTU5NTQw_089e8a8d-bcbb-4507-95b5-f188b6e4da93" name="us-gaap:Revenues" scale="6" unitref="usd">145.8</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="if373b9f49fe74bdbbcaeb90bdcf2de8e_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMzQtMi0xLTEtMTU5NTQw_aa962b8e-92b2-4d7e-9852-fb025339841d" name="us-gaap:Revenues" scale="6" unitref="usd">227.4</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i1f4a20a3083448aabf8de47a307ae3fc_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMzQtMy0xLTEtMTU5NTQw_8d188003-97ae-455e-9a08-7eeb0bff9748" name="us-gaap:Revenues" scale="6" unitref="usd">373.2</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i9aabeac82be44155a967c8ced0c3a972_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMzQtNS0xLTEtMTU5NTQw_c96669b8-52ce-4837-9b04-7dd519f55dc0" name="us-gaap:Revenues" scale="6" unitref="usd">144.6</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i6d31ef68d52e4c1680dc7d71063a6777_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMzQtNi0xLTEtMTU5NTQw_d4724dbb-e2a0-4f6b-9df7-fef5c124aa39" name="us-gaap:Revenues" scale="6" unitref="usd">305.5</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i6cb7b465f1794abdb49eb28db9903a03_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMzQtNy0xLTEtMTU5NTQw_f4fd061b-510c-41ed-8f74-f2164e8e6c40" name="us-gaap:Revenues" scale="6" unitref="usd">450.2</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">COVID-19 antibodies</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i0fe5df95a127467ea05981672b21cdba_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMzktMS0xLTEtMTg5ODQ0_3ac039e5-b096-4982-9fb4-378136d0ced2" name="us-gaap:Revenues" scale="6" unitref="usd">386.6</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ib4b9aa980cc940d3870c8d9e4046840e_D20220701-20220930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMzktMi0xLTEtMTg5ODQ0_8c158368-7148-4a58-b873-4cd8f2a2f7e2" name="us-gaap:Revenues" scale="6" unitref="usd">&#8212;</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ic89265df487544d48f864b30c7c12762_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMzktMy0xLTEtMTg5ODQ0_71e40ea7-c487-4757-9800-7bafda958193" name="us-gaap:Revenues" scale="6" unitref="usd">386.6</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i136c9d207de14e89bbae2b72e3112e4a_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMzktNS0xLTEtMTg5ODQ0_d5af7875-149b-442c-8710-94ebf0d1fd20" name="us-gaap:Revenues" scale="6" unitref="usd">215.5</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ic05b3db77dcf4e66b1e09c07f79fd579_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMzktNi0xLTEtMTg5ODQ0_e795a3c8-c7f0-4056-9013-7c278317fa67" name="us-gaap:Revenues" scale="6" unitref="usd">1.6</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i05b4b2fd75f8488cafa80162074dca18_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMzktNy0xLTEtMTg5ODQ0_68157132-4443-4e9f-95c1-d21929f2a3b7" name="us-gaap:Revenues" scale="6" unitref="usd">217.1</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Forteo</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i78e14fd2e59849538d2032aed3e9bb0c_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfNDAtMS0xLTEtMTg5ODU2_82afa443-ae00-4d17-9ac7-bd7485cc4e11" name="us-gaap:Revenues" scale="6" unitref="usd">112.7</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ic73ca51c96f5471cb91194277c299762_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfNDAtMi0xLTEtMTg5ODU2_1abef22b-0ded-4d80-93c6-4c7b1c531843" name="us-gaap:Revenues" scale="6" unitref="usd">64.4</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i29d5f03b98014ea7af366d7dbec08cc2_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfNDAtMy0xLTEtMTg5ODU2_c1b32467-a42b-4b3a-9ec5-d312c34430cf" name="us-gaap:Revenues" scale="6" unitref="usd">177.1</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i5b6529d5d56e42959333a8689a171264_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfNDAtNS0xLTEtMTg5ODU2_85c89292-5642-42e1-9658-fceb79e3828a" name="us-gaap:Revenues" scale="6" unitref="usd">109.6</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i99005918fc524bff85805ac964cb5794_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfNDAtNi0xLTEtMTg5ODU2_2a89c97d-2750-4da2-b177-3640dc13e2dc" name="us-gaap:Revenues" scale="6" unitref="usd">91.3</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i6ec8ff4aa32b406db0037636d5d11b91_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfNDAtNy0xLTEtMTg5ODU2_facfc698-fc04-49af-bb00-5b0b2593d797" name="us-gaap:Revenues" scale="6" unitref="usd">200.9</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Cialis</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="id253637b6dc04f4593c5389197fd1ed5_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMzgtMS0xLTEtMTU5NTQw_1720fbd3-7d60-4fbf-865e-5af8fdce5f1f" name="us-gaap:Revenues" scale="6" unitref="usd">8.1</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i9b5c45eac140477aa0acc064ef0011ea_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMzgtMi0xLTEtMTU5NTQw_4b4840d8-4b80-415f-8dd8-32096ab164e0" name="us-gaap:Revenues" scale="6" unitref="usd">107.7</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i57e0cd27dd3c4483afca4b02ab1ab2ea_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMzgtMy0xLTEtMTU5NTQw_76e3f28e-af56-4a81-be9d-ca0f83620ce0" name="us-gaap:Revenues" scale="6" unitref="usd">115.7</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i71526b83a9b84d10a6e1ab1807ab8e18_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMzgtNS0xLTEtMTU5NTQw_f022107b-baf5-4b6b-bb62-e1cabad8fa34" name="us-gaap:Revenues" scale="6" sign="-" unitref="usd">6.5</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i04e727dddbbd447c91777ca002cf2367_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMzgtNi0xLTEtMTU5NTQw_10342b0c-bfbf-4eb4-8b34-30977ee43ff1" name="us-gaap:Revenues" scale="6" unitref="usd">137.4</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i01198f0de24240588ceb005e3647087b_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfMzgtNy0xLTEtMTU5NTQw_e24217b2-5baa-4c6b-9461-08c731010070" name="us-gaap:Revenues" scale="6" unitref="usd">130.9</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="if0fe66e11e054c0a85bb68ff7d7f2857_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfNDEtMS0xLTEtMTU5NTQw_2cdfa985-29ee-4f37-a429-ff25d7c6071c" name="us-gaap:Revenues" scale="6" unitref="usd">30.9</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i347c502b181c4a13a94b72d8e2a383bf_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfNDEtMi0xLTEtMTU5NTQw_c16ee405-5e27-40eb-a8bb-2bb188633c30" name="us-gaap:Revenues" scale="6" unitref="usd">35.7</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ic32c291337714cc290c1dac418f4d40a_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfNDEtMy0xLTEtMTU5NTQw_25dec1dc-a949-44ce-b519-9f6823bdc69b" name="us-gaap:Revenues" scale="6" unitref="usd">66.6</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i4760c4e663814ba4816919d7cf1c133d_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfNDEtNS0xLTEtMTU5NTQw_ae0548ac-6608-4708-af7f-6160ac8b001f" name="us-gaap:Revenues" scale="6" unitref="usd">36.3</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i0b57a14b81924b58a902d121891b42eb_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfNDEtNi0xLTEtMTU5NTQw_fae2249b-e12d-4dc9-8c9b-46d04fe62d9d" name="us-gaap:Revenues" scale="6" unitref="usd">52.4</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ib28a57467090415586ea5d4a46d5a6ff_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfNDEtNy0xLTEtMTU5NTQw_c8286fcc-052e-4195-b64f-26eaeb84d91d" name="us-gaap:Revenues" scale="6" unitref="usd">88.8</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i3bfde2172ab44bdb98ffec5b7744d66c_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfNDItMS0xLTEtMTU5NTQw_c4c276fe-f52c-4bb8-941b-9006a1ba6cf3" name="us-gaap:Revenues" scale="6" unitref="usd">538.3</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i4e976e03f8b7452b97fe7c6fa5a98acb_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfNDItMi0xLTEtMTU5NTQw_ab281325-aa88-4edc-a928-62f9ee2e8ac4" name="us-gaap:Revenues" scale="6" unitref="usd">207.8</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ibb8a914c841d467289183242e217e8c8_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfNDItMy0xLTEtMTU5NTQw_c1372e67-c2c5-4b5d-936e-89d76f7cc1da" name="us-gaap:Revenues" scale="6" unitref="usd">746.0</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i23b21b36e578436fa92bcc41739470c2_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfNDItNS0xLTEtMTU5NTQw_3b02b59e-955c-4e54-8c30-7609a14b04b1" name="us-gaap:Revenues" scale="6" unitref="usd">354.9</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ibe9720e656b242efa27c155f58ea5690_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfNDItNi0xLTEtMTU5NTQw_06ec6791-c558-4e7f-b1c3-4f6e4064dd99" name="us-gaap:Revenues" scale="6" unitref="usd">282.7</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i9af8cc7ddb614c4d8a4d4ce694795736_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfNDItNy0xLTEtMTU5NTQw_bd6b51b4-dfdb-4ef3-80e7-1ee168d043ed" name="us-gaap:Revenues" scale="6" unitref="usd">637.7</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i5ef4c6628ee44bfaba7f2e062c3984ca_D20220701-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfNDMtMS0xLTEtMTU5NTQw_36d2d49b-a03a-402f-8870-b74fd2142958" name="us-gaap:Revenues" scale="6" unitref="usd">4,422.1</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i553eac0570bc41a68be3130cb9383387_D20220701-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfNDMtMi0xLTEtMTU5NTQw_6d3f2eaa-477b-45aa-ad0b-d2e593013d29" name="us-gaap:Revenues" scale="6" unitref="usd">2,519.4</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i19fc0325c48543008ea71e1fdcf11d86_D20220701-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfNDMtMy0xLTEtMTU5NTQw_7a6111b5-5456-4a75-b85e-f449c909d6c9" name="us-gaap:Revenues" scale="6" unitref="usd">6,941.6</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ib7200d1730974b7f929910230bd89187_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfNDMtNS0xLTEtMTU5NTQw_930cff6b-fa4e-4b50-8808-24330c9ad2b7" name="us-gaap:Revenues" scale="6" unitref="usd">3,989.6</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i8bdc66e6dc0c4330955f23ef9a18d769_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfNDMtNi0xLTEtMTU5NTQw_cdcf29b5-0707-4a98-a656-321aa03a343f" name="us-gaap:Revenues" scale="6" unitref="usd">2,783.3</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie4fa4f6b472a4f269297591b44aba572_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOmZhYTNkYzBhZjFhNjQ4NDM5ZGE3NWY1MTZlNTM2YjMyL3RhYmxlcmFuZ2U6ZmFhM2RjMGFmMWE2NDg0MzlkYTc1ZjUxNmU1MzZiMzJfNDMtNy0xLTEtMTU5NTQw_cd4c6a4e-adc6-4b3f-aa23-70ff34b66eb2" name="us-gaap:Revenues" scale="6" unitref="usd">6,772.8</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Numbers may not add due to rounding.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Jardiance revenue includes Glyxambi</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Synjardy</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">and Trijardy</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> XR. </span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Humalog revenue includes insulin lispro. </span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(3) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Olumiant revenue includes sales for baricitinib that were made pursuant to Emergency Use Authorization (EUA) or similar regulatory authorizations.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(4) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">COVID-19 antibodies include sales for bamlanivimab administered alone, for bamlanivimab and etesevimab administered together, and for bebtelovimab and were made pursuant to EUAs or similar regulatory authorizations.</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation continuedat="ib7361aaef70b4b8fa3c69ad4809e4450" id="i8a87bd7f728c4956b4f7b4a382aa7a0a"><ix:continuation continuedat="i112884bde4f449e382ba04acb79a007c" id="ia7ddf8304b894ea5ae7ce70c55fcc02c"><div style="margin-bottom:6pt;margin-top:6pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes revenue by product for the nine months ended September&#160;30, 2022 and 2021:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.577%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outside U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outside U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue&#8212;to unaffiliated customers:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diabetes:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Trulicity</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ie25d63c812ca4ba5bcb202b4ef3da925_D20220101-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfNS0xLTEtMS0xNTk1NDA_78f7c6bc-53e5-42c4-8e6f-369bee45a702" name="us-gaap:Revenues" scale="6" unitref="usd">4,162.4</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i91615b3923a04f6a8fd92d711866d588_D20220101-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfNS0yLTEtMS0xNTk1NDA_f867169a-8cdc-4b4b-ad2e-7ae8ce771bf9" name="us-gaap:Revenues" scale="6" unitref="usd">1,341.1</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i9623881a23db40a3b62885fe7a43e0c9_D20220101-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfNS0zLTEtMS0xNTk1NDA_f9ebcd49-bc95-41e2-a637-fcd13893f83d" name="us-gaap:Revenues" scale="6" unitref="usd">5,503.5</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i46ce2dc33fb14a94972b38a4c73c48ee_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfNS01LTEtMS0xNTk1NDA_d9357e3f-a140-4be6-869d-6725de106ea3" name="us-gaap:Revenues" scale="6" unitref="usd">3,465.7</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i9d256a84bdcc43939ac6114642c9df5a_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfNS02LTEtMS0xNTk1NDA_07603271-9bbc-4458-8ef3-31812afafdc4" name="us-gaap:Revenues" scale="6" unitref="usd">1,122.5</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="idb96fc34e7f1409fb5661213f97e7f9d_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfNS03LTEtMS0xNTk1NDA_3262ba04-7f0f-430f-88bb-cfd59fc91394" name="us-gaap:Revenues" scale="6" unitref="usd">4,588.2</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Humalog</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i29b3721d52314523b933748df1c86126_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfNi0xLTEtMS0xNTk1NDA_4e97100c-6d9e-4b42-a6b4-9281d12c89d2" name="us-gaap:Revenues" scale="6" unitref="usd">855.8</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i50fdff0f3f64436b8220edeb6c5da6b9_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfNi0yLTEtMS0xNTk1NDA_191ce3f9-8adf-44ba-aa10-bafd4e89b835" name="us-gaap:Revenues" scale="6" unitref="usd">656.4</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i2bbcd6ec5faf46bc81ff607368bdd5ab_D20220101-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfNi0zLTEtMS0xNTk1NDA_314f2181-a085-4dce-8fa0-58e41ce454f6" name="us-gaap:Revenues" scale="6" unitref="usd">1,512.3</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i5f2bb68aeed244a48b9a5b9fe2b0b039_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfNi01LTEtMS0xNTk1NDA_9c67c148-0208-444e-89c5-563f8d84e047" name="us-gaap:Revenues" scale="6" unitref="usd">1,009.0</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ib6a78f62d5834a11a82558249ee89a7a_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfNi02LTEtMS0xNTk1NDA_8c93613c-4e26-430f-b8e4-3fd4afd4bca6" name="us-gaap:Revenues" scale="6" unitref="usd">842.3</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i6afc7019eb204b20bc59d3a19fef7f74_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfNi03LTEtMS0xNTk1NDA_8191ab00-1b6f-41f9-a8d6-e7ad1136a125" name="us-gaap:Revenues" scale="6" unitref="usd">1,851.3</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Jardiance</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i1e18d072344643ada09a2e6559995804_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfNy0xLTEtMS0xNTk1NDA_2029b5b6-f677-46d0-8252-8915b807e55f" name="us-gaap:Revenues" scale="6" unitref="usd">831.4</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="idb016f4e6a094b91ac0aee6fd832f15c_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfNy0yLTEtMS0xNTk1NDA_8a27f5df-9a0f-407d-9bfc-a282cdf5a0e1" name="us-gaap:Revenues" scale="6" unitref="usd">622.4</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i1c01691865ed49fc84902886c99bbbdf_D20220101-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfNy0zLTEtMS0xNTk1NDA_cb373d45-18c4-40fb-bb86-e9d14a320f3a" name="us-gaap:Revenues" scale="6" unitref="usd">1,453.7</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ia2d8d981e4314247892b22b49b01d418_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfNy01LTEtMS0xNTk1NDA_8cc9ca82-3ef7-4a0d-8bd5-5a4ea9e955e5" name="us-gaap:Revenues" scale="6" unitref="usd">566.8</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie65c118c7eb54da8b92e056d23b07e85_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfNy02LTEtMS0xNTk1NDA_f26c63fc-a0e4-42b7-8a71-21244b727bb3" name="us-gaap:Revenues" scale="6" unitref="usd">492.1</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i46099dfb95b0484ab5891f186d350f52_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfNy03LTEtMS0xNTk1NDA_70ca7508-c330-4dc2-95ef-5b171312bb25" name="us-gaap:Revenues" scale="6" unitref="usd">1,058.9</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Humulin</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i3ad9a3d1e7704c9f8a4c92e4f18248ef_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfOC0xLTEtMS0xNTk1NDA_00d765a6-e520-48ad-9f0c-a33a20fe91ed" name="us-gaap:Revenues" scale="6" unitref="usd">562.3</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ib4c358f120c14431858d22fd921cdb1a_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfOC0yLTEtMS0xNTk1NDA_7348fdbe-cea7-4e55-bcad-71095de37c50" name="us-gaap:Revenues" scale="6" unitref="usd">223.1</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i97453ba9a92b4601b70738c5fd865a63_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfOC0zLTEtMS0xNTk1NDA_e2811bc0-5b34-4a0f-8df4-2026c523050e" name="us-gaap:Revenues" scale="6" unitref="usd">785.4</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i9a4be59d818242b8a5d6e29a133e78b3_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfOC01LTEtMS0xNTk1NDA_4bf79573-94d0-4f2a-ab2e-c43f60f53746" name="us-gaap:Revenues" scale="6" unitref="usd">633.5</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i74ac58ad376e44179242350ff8091245_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfOC02LTEtMS0xNTk1NDA_76a5202e-4615-4ec4-99c0-14bf221c19c5" name="us-gaap:Revenues" scale="6" unitref="usd">290.3</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i4d442db3854641bb9c50b1533223b1bf_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfOC03LTEtMS0xNTk1NDA_849b745e-00dd-4fb1-80df-ec298c532e4d" name="us-gaap:Revenues" scale="6" unitref="usd">923.8</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Basaglar</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i9b84a7f78d3743f383680162b1a79677_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfOS0xLTEtMS0xNTk1NDA_5adc3df3-376b-4f63-8a1c-18c0eb84801f" name="us-gaap:Revenues" scale="6" unitref="usd">339.9</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="if1fd51de24bf4269a3f10390a0eb16b8_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfOS0yLTEtMS0xNTk1NDA_bc8b7b5b-7aba-4d58-94ed-61b1bd68e367" name="us-gaap:Revenues" scale="6" unitref="usd">218.8</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i1f95ba5af9c24c3eb20dc2c5a3979588_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfOS0zLTEtMS0xNTk1NDA_11a1b9ff-2de8-493b-989f-355beeaf0e2b" name="us-gaap:Revenues" scale="6" unitref="usd">558.7</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i9df6a30c7e76498dbe8e2c10556551c7_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfOS01LTEtMS0xNTk1NDA_a9f3c5fa-5c69-4356-88be-49889c5a8b3f" name="us-gaap:Revenues" scale="6" unitref="usd">423.3</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ifc6cb890a5e04ad3ab5d2c0f4a2935cb_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfOS02LTEtMS0xNTk1NDA_423620b9-1c16-42b8-87a5-b57c86dceb50" name="us-gaap:Revenues" scale="6" unitref="usd">226.8</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="id065d1641c8b4bc19bda4f978edc7f70_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfOS03LTEtMS0xNTk1NDA_ce835c8b-bb9d-4ca6-af69-991834fa4bc4" name="us-gaap:Revenues" scale="6" unitref="usd">650.1</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Mounjaro</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ie9c6e93828454ef795aef5751d0352fd_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMTAtMS0xLTEtMTg5NTU2_b263dd4a-d009-4717-aa7c-765bc613ba3d" name="us-gaap:Revenues" scale="6" unitref="usd">109.9</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i844e2c3c4d3c4a4eb90a291b6edaa117_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMTAtMi0xLTEtMTg5NTU5_ef04d445-3a87-42d9-983f-f71f06ea12cd" name="us-gaap:Revenues" scale="6" unitref="usd">93.3</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i8d0e3b68ad424288aedc96a1c3c5e2d2_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMTAtMy0xLTEtMTg5NTYy_fad2afec-0f97-4a73-9967-bd21e86d2bcc" name="us-gaap:Revenues" scale="6" unitref="usd">203.2</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ibd146a846a384a1cbb7ed3016e2cb317_D20210101-20210930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMTAtNS0xLTEtMTg5NTY1_f1e746f9-8f1c-435d-8ea4-f56ea71f1235" name="us-gaap:Revenues" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="idea0b040a90e4c93ababd4c0d4f02647_D20210101-20210930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMTAtNi0xLTEtMTg5NTcy_0e54ba4a-3ab6-433c-9362-64f9ad86d975" name="us-gaap:Revenues" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie993c12313da41f38573f6bc42f10868_D20210101-20210930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMTAtNy0xLTEtMTg5NTc5_1573663c-598c-4a5a-8426-f3e528222106" name="us-gaap:Revenues" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other diabetes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i1ed26a3d9a8b45559192c48d5bb034d4_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMTAtMS0xLTEtMTU5NTQw_9eebadc7-e2dd-4ff6-9757-a1cbc244549a" name="us-gaap:Revenues" scale="6" unitref="usd">195.6</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i4cfbe889964e44e3a453aa644188647d_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMTAtMi0xLTEtMTU5NTQw_d91c4ecb-f2dd-4775-bcea-dd9f8913deb0" name="us-gaap:Revenues" scale="6" unitref="usd">276.5</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i1414ede1c78a462e95bd1b8346592f8b_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMTAtMy0xLTEtMTU5NTQw_c6c7a97f-a239-41be-9b53-faaa8ff25109" name="us-gaap:Revenues" scale="6" unitref="usd">472.2</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i20194883f2624f82b663260d5199fa21_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMTAtNS0xLTEtMTU5NTQw_d86144ec-142c-4709-be8a-e49ae2a040dc" name="us-gaap:Revenues" scale="6" unitref="usd">185.7</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i820e5b799761449bbbf32e97e1e019fa_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMTAtNi0xLTEtMTU5NTQw_7d9e2052-ecdb-4055-94a9-b2287dc200d6" name="us-gaap:Revenues" scale="6" unitref="usd">302.6</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="iab636b5286134cd7875bd3dfdf73353a_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMTAtNy0xLTEtMTU5NTQw_54996cc7-c9cc-4897-a7be-0c25eb5efb56" name="us-gaap:Revenues" scale="6" unitref="usd">488.3</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total diabetes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i1356cd272fa54029ba0f0c21fab222b4_D20220101-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMTEtMS0xLTEtMTU5NTQw_68778c5e-1a3b-4eda-9cfa-9a7300b6e342" name="us-gaap:Revenues" scale="6" unitref="usd">7,057.3</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i19fb57248d6f41d19ef8485870fa08f3_D20220101-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMTEtMi0xLTEtMTU5NTQw_95358171-7207-4b47-9a61-44cdef026f72" name="us-gaap:Revenues" scale="6" unitref="usd">3,431.6</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i2a4c43c5e76a47ceb09387d84fc5d358_D20220101-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMTEtMy0xLTEtMTU5NTQw_02a093a9-b99a-45ff-a708-0e75cc307561" name="us-gaap:Revenues" scale="6" unitref="usd">10,489.0</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ifc6e032f5a9d4001ba9413713acf7354_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMTEtNS0xLTEtMTU5NTQw_99e215c7-7077-4ecc-9863-46656418e352" name="us-gaap:Revenues" scale="6" unitref="usd">6,284.0</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="iabf6366b8c134597b8ac64603a6cb066_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMTEtNi0xLTEtMTU5NTQw_b772e530-7522-4cb6-9a4b-4a45abd4bdcf" name="us-gaap:Revenues" scale="6" unitref="usd">3,276.6</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i44a3630aeb244ec2ab5204f6c1650459_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMTEtNy0xLTEtMTU5NTQw_83da6114-3ea7-43f6-b461-f6737d4a1efc" name="us-gaap:Revenues" scale="6" unitref="usd">9,560.6</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oncology:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Verzenio</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i630ed70ef3804cddb8e7bd6a2c884284_D20220101-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMTQtMS0xLTEtMTU5NTQw_6d34a77f-8ec5-4c24-bc5c-7b5834e8e748" name="us-gaap:Revenues" scale="6" unitref="usd">1,100.5</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="id50357546429495db587cbaca50bd352_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMTQtMi0xLTEtMTU5NTQw_1c68d4f4-8093-4ec0-9529-9e4e7501be18" name="us-gaap:Revenues" scale="6" unitref="usd">575.1</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i20c536a6925e49838b17da59e54c92aa_D20220101-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMTQtMy0xLTEtMTU5NTQw_9bede702-2b65-435e-878c-e753d652c795" name="us-gaap:Revenues" scale="6" unitref="usd">1,675.6</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="if8fd3622c0c34f5f942c2bcf19a84b1b_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMTQtNS0xLTEtMTU5NTQw_81cfc482-4d67-4f67-9360-6b2ac4f69366" name="us-gaap:Revenues" scale="6" unitref="usd">582.1</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i08e4bcea32b741f3ad619cb7789236d1_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMTQtNi0xLTEtMTU5NTQw_28a4ad81-4c7f-4a41-a9f7-03ea4c729c1b" name="us-gaap:Revenues" scale="6" unitref="usd">363.7</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i6ea3180802c144d4924a8a4b8a919abd_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMTQtNy0xLTEtMTU5NTQw_61a50161-29e5-4a7b-828a-56e401cb2d66" name="us-gaap:Revenues" scale="6" unitref="usd">945.8</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Cyramza</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ia0759c0458d14fac885984f8686a83c3_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMTYtMS0xLTEtMTg5ODcz_09943eef-4d04-42fc-abb8-123256cf513d" name="us-gaap:Revenues" scale="6" unitref="usd">259.3</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i234acbdded404fc5bcf21a6ea711e9ef_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMTYtMi0xLTEtMTg5ODcz_75d5dc1a-40bb-473e-9784-6dd0ce642bee" name="us-gaap:Revenues" scale="6" unitref="usd">434.3</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ib28d65608ad54ff9b7e45a5c0298b338_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMTYtMy0xLTEtMTg5ODcz_228265e0-bba2-4a9e-b79f-8950634447b6" name="us-gaap:Revenues" scale="6" unitref="usd">693.6</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i98867991ccbb44078d309a9dd8539a71_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMTYtNS0xLTEtMTg5ODcz_05dedfbf-9c60-4ae2-ad1e-114c5eabeb0b" name="us-gaap:Revenues" scale="6" unitref="usd">266.3</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ib811fbcdfc1241359475319e63db4106_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMTYtNi0xLTEtMTg5ODcz_c7fd8e86-3aaa-428c-95f3-19abd31c4213" name="us-gaap:Revenues" scale="6" unitref="usd">496.3</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ieb20b9b0be4f46bfb05c7b12f39a6a9e_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMTYtNy0xLTEtMTg5ODcz_6cfd3129-2b99-4295-bf5a-3f9cd635c1ad" name="us-gaap:Revenues" scale="6" unitref="usd">762.5</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Alimta</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i64bc0872b6e94aa7bf69b1268d189134_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMTUtMS0xLTEtMTU5NTQw_9e452868-a984-406b-a2c7-95c8f6d4add8" name="us-gaap:Revenues" scale="6" unitref="usd">490.5</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="id1a6ba9c9b6a42638bdfdbee6e6f2758_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMTUtMi0xLTEtMTU5NTQw_55088cd5-938e-4b10-955f-025453af8e44" name="us-gaap:Revenues" scale="6" unitref="usd">200.5</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i07ddaa6f5dd549048da689638ae982f5_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMTUtMy0xLTEtMTU5NTQw_36e6a5a1-2443-4576-a596-1070445ca1db" name="us-gaap:Revenues" scale="6" unitref="usd">691.1</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i9571c6749464454692162cefb3bb7738_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMTUtNS0xLTEtMTU5NTQw_384bf604-3f03-41f6-a2cd-90ceb022ef9d" name="us-gaap:Revenues" scale="6" unitref="usd">911.9</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i546701dbe3cb400c84bc62c598271f8b_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMTUtNi0xLTEtMTU5NTQw_1a674613-abf5-4c24-97eb-54e01023d3d8" name="us-gaap:Revenues" scale="6" unitref="usd">714.7</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i70cb0ea9b68f4680b98801d50a608b14_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMTUtNy0xLTEtMTU5NTQw_dcc8dcea-ec27-4cf4-b5df-e8e4596da607" name="us-gaap:Revenues" scale="6" unitref="usd">1,626.6</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Erbitux</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i40507b3da3804796ace099350f243c27_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMTctMS0xLTEtMTU5NTQw_4655b855-be03-40a9-bfb6-55802404e5a4" name="us-gaap:Revenues" scale="6" unitref="usd">361.0</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i680ed22913654e2ead217f9b5989504b_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMTctMi0xLTEtMTU5NTQw_fad0f39a-54f4-4c56-85be-3614512d2b04" name="us-gaap:Revenues" scale="6" unitref="usd">47.4</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i0088a078fdd54003819037635cb52f70_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMTctMy0xLTEtMTU5NTQw_cb8ab5bf-cd75-4e83-8ee2-88f9656ade25" name="us-gaap:Revenues" scale="6" unitref="usd">408.3</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i27e99c349c3a48dcb14b9a15ed3dafe5_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMTctNS0xLTEtMTU5NTQw_746df41d-a5d6-479b-994c-ef88cb2a48bc" name="us-gaap:Revenues" scale="6" unitref="usd">357.7</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="if0246564d9bc4f02a5441b1f2566bf51_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMTctNi0xLTEtMTU5NTQw_12cf1918-9117-400f-b35f-2884cd95979d" name="us-gaap:Revenues" scale="6" unitref="usd">45.9</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ic3c22691b22448eca997f30d1f1366e2_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMTctNy0xLTEtMTU5NTQw_64961947-4df9-467d-a715-be43889fc82d" name="us-gaap:Revenues" scale="6" unitref="usd">403.7</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Tyvyt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i0302245b5cc5492d85c394bdbd9a59c3_D20220101-20220930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMTgtMS0xLTEtMTU5NTQw_cc4c44ca-2a22-4d11-86ba-464533ca76af" name="us-gaap:Revenues" scale="6" unitref="usd">&#8212;</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="iab104518f25b49a4b922a68ba94e910b_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMTgtMi0xLTEtMTU5NTQw_af0994c6-c648-4b7d-82ee-8f1972e444a4" name="us-gaap:Revenues" scale="6" unitref="usd">235.8</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i6633f1ca883b4a32962bcd825ba66bfc_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMTgtMy0xLTEtMTU5NTQw_e0a86df6-6300-4357-90bd-48dc6a115ee0" name="us-gaap:Revenues" scale="6" unitref="usd">235.8</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i6761a6ec70464bd2bba2e8b31d7dfb55_D20210101-20210930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMTgtNS0xLTEtMTU5NTQw_b4cabb1f-f6f9-47aa-8420-70ce2b8f5a94" name="us-gaap:Revenues" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i68cac27afeeb4c6ca2de0e2af5aeecd2_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMTgtNi0xLTEtMTU5NTQw_ae4c7127-fc5d-421f-beaf-c68b55cab49d" name="us-gaap:Revenues" scale="6" unitref="usd">340.2</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i3a42a2407e7046519687e4401e714180_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMTgtNy0xLTEtMTU5NTQw_035251c1-2596-483b-bfe5-5ec2455ef786" name="us-gaap:Revenues" scale="6" unitref="usd">340.2</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other oncology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ib89a61de2c8542719d727ea9b2e4d288_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMTktMS0xLTEtMTU5NTQw_d1954928-0d68-436a-b652-b8f4b43c336d" name="us-gaap:Revenues" scale="6" unitref="usd">124.1</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ie1753f6d5c4044468226ef9a5f59457c_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMTktMi0xLTEtMTU5NTQw_d5afd4d1-6da6-496e-8e0f-2ddf9931b1ef" name="us-gaap:Revenues" scale="6" unitref="usd">186.5</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="iffc444b9d88245d5a3bdb35b82ef0d55_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMTktMy0xLTEtMTU5NTQw_bdfc72d6-c0a0-4d00-9cfd-5a5c91d2c5a4" name="us-gaap:Revenues" scale="6" unitref="usd">310.6</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i85c317c4af504382b28dfedc3facb2dc_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMTktNS0xLTEtMTU5NTQw_27f30563-5d83-492f-9890-653dad2fdebf" name="us-gaap:Revenues" scale="6" unitref="usd">83.7</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i6290305d31574c06901b06e6eacfd414_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMTktNi0xLTEtMTU5NTQw_430358fb-1e2e-40f3-919d-b3d16bf185e6" name="us-gaap:Revenues" scale="6" unitref="usd">169.9</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7bf748b95e7a45cf9e722167434f1385_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMTktNy0xLTEtMTU5NTQw_47730d60-9fe8-4567-ba6c-421b2883efd5" name="us-gaap:Revenues" scale="6" unitref="usd">253.6</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total oncology</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i240fc921c5ef4622986756418d0b3d39_D20220101-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMjAtMS0xLTEtMTU5NTQw_b76b1790-9c2d-4393-a4c4-1dd489a1d3f0" name="us-gaap:Revenues" scale="6" unitref="usd">2,335.4</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i5db5d222d3da4495a3cd1481fae9b1eb_D20220101-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMjAtMi0xLTEtMTU5NTQw_d98bb26f-8708-4478-859d-fc50d47e4d1e" name="us-gaap:Revenues" scale="6" unitref="usd">1,679.6</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="id3038a6b1fd04b43a1855095f482ffd4_D20220101-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMjAtMy0xLTEtMTU5NTQw_b9a08008-cef8-44af-985f-21c664d06f00" name="us-gaap:Revenues" scale="6" unitref="usd">4,015.0</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="idf34cf4a2aae43eda96963b778a49168_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMjAtNS0xLTEtMTU5NTQw_ed797912-125b-4f4a-aa8e-f857787ec7f2" name="us-gaap:Revenues" scale="6" unitref="usd">2,201.7</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ib71c38ea0818475aa548176344240c72_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMjAtNi0xLTEtMTU5NTQw_4654c914-0650-4861-b47f-422d9e58cada" name="us-gaap:Revenues" scale="6" unitref="usd">2,130.7</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7cc9d1bb283d475d915f7fcb4f945c8c_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMjAtNy0xLTEtMTU5NTQw_dc4cf420-6e48-42d4-911d-2ecaca404342" name="us-gaap:Revenues" scale="6" unitref="usd">4,332.4</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Immunology:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Taltz</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i08907695f17c4fe487c0f59792752c89_D20220101-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMjMtMS0xLTEtMTU5NTQw_7170280b-4102-49f8-8f6c-27a5d09a5424" name="us-gaap:Revenues" scale="6" unitref="usd">1,212.6</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i4d2d7d0cc9e04232b6d62adfc3777b93_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMjMtMi0xLTEtMTU5NTQw_037c63eb-a53f-48a3-93e6-05c59f8fa181" name="us-gaap:Revenues" scale="6" unitref="usd">561.6</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i7453a607ad674e25bbab08ef19e88d3c_D20220101-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMjMtMy0xLTEtMTU5NTQw_90de6c5f-36a3-491b-bf87-80b0910ab151" name="us-gaap:Revenues" scale="6" unitref="usd">1,774.2</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="iccd3059fecb04f1d94d0044c6e3c7e32_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMjMtNS0xLTEtMTU5NTQw_4815ccb4-fc7a-4228-8bbe-81a4cdfb4d0f" name="us-gaap:Revenues" scale="6" unitref="usd">1,071.6</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i3036c3ea47bd4c89bafa4bdba1320abf_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMjMtNi0xLTEtMTU5NTQw_3589a551-23f3-4fb5-a75e-ce83e5303093" name="us-gaap:Revenues" scale="6" unitref="usd">493.8</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ifea4d8eb21b94b0ca8248b42f02b49e9_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMjMtNy0xLTEtMTU5NTQw_3af34f47-3d64-411d-aa4b-fd0846638dc8" name="us-gaap:Revenues" scale="6" unitref="usd">1,565.4</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Olumiant</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ia4036604f9c945e1a19be8b3aa38e334_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMjQtMS0xLTEtMTU5NTQw_f2338a2d-334b-488e-8454-5c8fa3aabc6d" name="us-gaap:Revenues" scale="6" unitref="usd">104.6</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i381560b71db64644aa7adbc056fac279_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMjQtMi0xLTEtMTU5NTQw_3b095cd8-e776-41b7-83a4-56c231624b5c" name="us-gaap:Revenues" scale="6" unitref="usd">520.1</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i5da2c0b8af014f4085d9e2a62f64ccc7_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMjQtMy0xLTEtMTU5NTQw_0df76049-ccad-4122-b1a1-eae0338220ed" name="us-gaap:Revenues" scale="6" unitref="usd">624.7</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i9a1215ba2eae4c7da8010b728800b4d3_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMjQtNS0xLTEtMTU5NTQw_a3ded4d3-5609-4fa3-a38a-aa000fef4537" name="us-gaap:Revenues" scale="6" unitref="usd">236.5</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ife8cad1b8c0f45d89f7c79beb6a9506c_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMjQtNi0xLTEtMTU5NTQw_8a7fef6a-7192-4e4f-bbde-8f108239dd41" name="us-gaap:Revenues" scale="6" unitref="usd">572.6</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i681b00cc06e740d5afd240016ce29efc_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMjQtNy0xLTEtMTU5NTQw_0e645580-44b6-4123-bb51-2c0d05b45c34" name="us-gaap:Revenues" scale="6" unitref="usd">809.1</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other immunology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i8cdc5308202645dfa9f06b53e46a162b_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMjUtMS0xLTEtMTU5NTQw_84eff3e8-f7a9-45e5-b5a4-7e930c0354d6" name="us-gaap:Revenues" scale="6" unitref="usd">0.1</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i6010298ee7bc433e8bebac5a5efc972e_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMjUtMi0xLTEtMTU5NTQw_dbff1416-bdfa-4649-9dde-32101d8f32d3" name="us-gaap:Revenues" scale="6" unitref="usd">12.1</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i659d2c39bfc34df8bd9f7d944a3822a2_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMjUtMy0xLTEtMTU5NTQw_a3bf93f1-ec60-48a2-88a2-911f67889c4c" name="us-gaap:Revenues" scale="6" unitref="usd">12.1</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i61df0f1a279148aa9e8254f5980c32dc_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMjUtNS0xLTEtMTU5NTQw_a2d5afe6-fb45-42a9-a57b-121984acfbf8" name="us-gaap:Revenues" scale="6" unitref="usd">15.2</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i1e4c4171e5c3493aa1885a72fe4cfa14_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMjUtNi0xLTEtMTU5NTQw_e82df984-0ab3-4cda-932f-df2805c2afaf" name="us-gaap:Revenues" scale="6" unitref="usd">14.5</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ic9a4f1d7373649528e8dfb81328134a4_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMjUtNy0xLTEtMTU5NTQw_bac4c98a-62f5-44d8-b79e-864d331ebbec" name="us-gaap:Revenues" scale="6" unitref="usd">29.7</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total immunology</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ibb0659e3898241ecbd83bdbf9dc59c78_D20220101-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMjYtMS0xLTEtMTU5NTQw_322295e6-f0a1-4117-bf6c-23b22e8051fa" name="us-gaap:Revenues" scale="6" unitref="usd">1,317.3</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i4e251958291a42a3a1c5447458b86d15_D20220101-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMjYtMi0xLTEtMTU5NTQw_3b945b74-f88c-455c-b295-8cce5ce019f8" name="us-gaap:Revenues" scale="6" unitref="usd">1,093.8</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i8aaae8dc85e144a6a4bf886fd061d950_D20220101-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMjYtMy0xLTEtMTU5NTQw_2a1b4de2-78f1-4358-94f5-0e85ec10895e" name="us-gaap:Revenues" scale="6" unitref="usd">2,411.0</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i2d035bb38a454213828a14551e6edea5_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMjYtNS0xLTEtMTU5NTQw_bf15046f-bd16-41b8-9a5f-3d03b05e718c" name="us-gaap:Revenues" scale="6" unitref="usd">1,323.3</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i71c9047535fe473ba6d96eba16066ad6_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMjYtNi0xLTEtMTU5NTQw_ddb39170-32cc-4211-b1c9-271ee3933363" name="us-gaap:Revenues" scale="6" unitref="usd">1,080.9</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i4cef6079bf0146839ee9f000bdcfe3c4_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMjYtNy0xLTEtMTU5NTQw_d5844e8d-7abe-44f0-b189-b56d4ef1cc00" name="us-gaap:Revenues" scale="6" unitref="usd">2,404.2</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuroscience:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Emgality</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="iaf50cba6df584b358ccfd1c552ac603a_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMjktMS0xLTEtMTU5NTQw_308f3405-b807-43c5-b079-9b53b9ce1c94" name="us-gaap:Revenues" scale="6" unitref="usd">330.8</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ife6ede2d6f41458f8f350cd5f6ddeb17_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMjktMi0xLTEtMTU5NTQw_12a2d764-0b04-49ab-b36a-d06ff1fe8340" name="us-gaap:Revenues" scale="6" unitref="usd">144.4</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i0b7c20f1ff97494783d6f4579ff8f7f8_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMjktMy0xLTEtMTU5NTQw_66b2cf61-0883-49b8-8cc3-19c42c885acf" name="us-gaap:Revenues" scale="6" unitref="usd">475.2</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i2892d650df3349fe9ae882f6ae942d58_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMjktNS0xLTEtMTU5NTQw_f2fa058b-7488-4f61-a64a-f8fa583457e5" name="us-gaap:Revenues" scale="6" unitref="usd">313.5</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ibc4bdc96c6434cc8b53a24c987e9c41e_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMjktNi0xLTEtMTU5NTQw_3454f956-24d2-48a7-8a2d-b04c804ac919" name="us-gaap:Revenues" scale="6" unitref="usd">102.2</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i5d73674530f248b5a702b835849253ef_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMjktNy0xLTEtMTU5NTQw_8765ed08-e070-4308-9f0f-367204ab3919" name="us-gaap:Revenues" scale="6" unitref="usd">415.7</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Zyprexa</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ibd5454cbe2de4d0ea429015722b20f15_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMzAtMS0xLTEtMTU5NTQw_a45535e3-b672-4bc1-8551-d783e45a7da8" name="us-gaap:Revenues" scale="6" unitref="usd">26.2</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="id7ad299a8b764bb9813cbf2dcae42919_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMzAtMi0xLTEtMTU5NTQw_98b61161-64fb-4843-a541-2c35f32b06a7" name="us-gaap:Revenues" scale="6" unitref="usd">235.5</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ic3a68db7fa3b428995899c0bf854ba94_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMzAtMy0xLTEtMTU5NTQw_27530aab-c6b1-4264-90b9-872e0b87c681" name="us-gaap:Revenues" scale="6" unitref="usd">261.7</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i006ca6ec8c3c4717aef2b19d419c92a3_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMzAtNS0xLTEtMTU5NTQw_cf9ab302-ff9b-4004-b925-3de48c55b160" name="us-gaap:Revenues" scale="6" unitref="usd">28.3</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ib90b244e7d0040c68677396984559ec8_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMzAtNi0xLTEtMTU5NTQw_7d00e1e3-02ca-4f0e-930f-9f409f4aa72a" name="us-gaap:Revenues" scale="6" unitref="usd">264.5</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="iedfe879bea3a496bb3766920c821c198_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMzAtNy0xLTEtMTU5NTQw_8323e1b4-bdca-4a0b-a930-4fc4f2df5d63" name="us-gaap:Revenues" scale="6" unitref="usd">292.8</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Cymbalta</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i3f91e524972e42a98fc9b5abba31e458_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMzEtMS0xLTEtMTU5NTQw_eafd4191-eaf5-4990-bdbb-aaf97378e6f1" name="us-gaap:Revenues" scale="6" unitref="usd">25.0</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ic3c6fe2019a042c4909c317b26cdf477_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMzEtMi0xLTEtMTU5NTQw_021cd889-11c2-4ce1-9d12-d5f5b217448c" name="us-gaap:Revenues" scale="6" unitref="usd">194.3</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="iee5d9669f4b344499cebdffb37f32030_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMzEtMy0xLTEtMTU5NTQw_1b415956-8aa6-4f0a-9859-2a5f0d137fec" name="us-gaap:Revenues" scale="6" unitref="usd">219.3</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i3f307f23d1de4f80bbe2e59ea610ff7f_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMzEtNS0xLTEtMTU5NTQw_26a269cb-9d2c-41ad-865f-dc1e3fdcb92a" name="us-gaap:Revenues" scale="6" unitref="usd">30.3</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i526c0b4d4b3140cfaf92e5209854bd78_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMzEtNi0xLTEtMTU5NTQw_f184166e-77fa-41cc-a27f-2f86abde8c08" name="us-gaap:Revenues" scale="6" unitref="usd">454.0</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i733173c6b1a342488769f27288f96647_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMzEtNy0xLTEtMTU5NTQw_625e4818-16b5-44e8-bf09-d39441263f9e" name="us-gaap:Revenues" scale="6" unitref="usd">484.3</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other neuroscience</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i00d29df7fc444a888bd8f1ac7c7fcd63_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMzMtMS0xLTEtMTU5NTQw_c2416596-e2c0-495e-8182-f65f0142c472" name="us-gaap:Revenues" scale="6" unitref="usd">62.0</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="id5a61b3abda849d981158a33cc123750_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMzMtMi0xLTEtMTU5NTQw_d030dd11-a637-4d5a-99f0-d394fce76db8" name="us-gaap:Revenues" scale="6" unitref="usd">142.7</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i4894a69792984d28b5bd70bdcb925593_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMzMtMy0xLTEtMTU5NTQw_cc24c286-506d-4492-ab7d-1327d7c2bb52" name="us-gaap:Revenues" scale="6" unitref="usd">204.7</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i2af7293d556c4ac189783fd3d7bfa089_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMzMtNS0xLTEtMTU5NTQw_05c7f402-9405-4ada-9f53-5e46a10da191" name="us-gaap:Revenues" scale="6" unitref="usd">81.0</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="id7dd70175fc2484e9291653ca9b5bcd0_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMzMtNi0xLTEtMTU5NTQw_1ff1c493-5cbe-4f08-b556-4b3804047aac" name="us-gaap:Revenues" scale="6" unitref="usd">154.0</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="iaffd646b91554c9fbd55b7373a9ab9f2_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMzMtNy0xLTEtMTU5NTQw_899bd158-7165-49f4-82b2-7b6596cb6875" name="us-gaap:Revenues" scale="6" unitref="usd">235.0</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total neuroscience</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i177e8ff27d1b444d8032f9fd6e71b86e_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMzQtMS0xLTEtMTU5NTQw_be398c11-6894-431e-9e28-0ee67b4475fa" name="us-gaap:Revenues" scale="6" unitref="usd">444.0</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i20063c304d1142018b211b53b3a1c50b_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMzQtMi0xLTEtMTU5NTQw_8e7429f4-d1a6-47a4-b6a1-00587456c0e2" name="us-gaap:Revenues" scale="6" unitref="usd">716.9</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i7a5789bb5ddb493385ae07bb301aa500_D20220101-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMzQtMy0xLTEtMTU5NTQw_f91f288f-acb2-4b3e-85f1-5a1d73cb38d7" name="us-gaap:Revenues" scale="6" unitref="usd">1,160.9</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i8c8cfb5bc4ac42dba8e3851f39bd2683_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMzQtNS0xLTEtMTU5NTQw_32d83a4e-1114-4e6a-8108-d5c53edfb38a" name="us-gaap:Revenues" scale="6" unitref="usd">453.1</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ib59bf69a9b284970b3b6642f7e4b795c_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMzQtNi0xLTEtMTU5NTQw_431ac662-ce23-4ac6-ba0d-9f78b9786908" name="us-gaap:Revenues" scale="6" unitref="usd">974.7</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i84bebc50684e4e1b90500bbb83bb79a6_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMzQtNy0xLTEtMTU5NTQw_cbd4c88d-c298-4d52-a99d-52477d083eea" name="us-gaap:Revenues" scale="6" unitref="usd">1,427.8</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">COVID-19 antibodies</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i0e5b50746e074ddabe26161b8cf97195_D20220101-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMzctMS0xLTEtMTU5NTQw_5aa3a9b2-3e1c-4f33-99f7-7a72796a434b" name="us-gaap:Revenues" scale="6" unitref="usd">1,970.9</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i2ce72c9f883a452ca19b57204999df16_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMzctMi0xLTEtMTU5NTQw_6e16a7c5-f921-4f65-a876-31902fff3d34" name="us-gaap:Revenues" scale="6" unitref="usd">14.7</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ie674d270134f4cffaff8f7a15471b73e_D20220101-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMzctMy0xLTEtMTU5NTQw_7a9a30a8-9c8c-485a-bfb7-42874b8658e5" name="us-gaap:Revenues" scale="6" unitref="usd">1,985.5</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i62f7a17973be46d9bf4530c993775bef_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMzctNS0xLTEtMTU5NTQw_2d5a706e-a578-469f-a69f-6219045e347c" name="us-gaap:Revenues" scale="6" unitref="usd">949.5</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ifb238d01fbaa4761a5fe7a7c91587c74_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMzctNi0xLTEtMTU5NTQw_0a7b29ef-0cbe-4090-936f-d321c82d74ed" name="us-gaap:Revenues" scale="6" unitref="usd">226.7</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ic06f11244a5a4b88822809b3b3941ffe_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMzctNy0xLTEtMTU5NTQw_d3fac61e-40f3-4c74-868b-7e1273c87a02" name="us-gaap:Revenues" scale="6" unitref="usd">1,176.2</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Cialis</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ifa18b54c7e0f4330b37b5256dc5dffac_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMzgtMS0xLTEtMTU5NTQw_f6758b03-d34a-4919-92eb-f2ca9590795a" name="us-gaap:Revenues" scale="6" unitref="usd">25.8</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i8a49509981cc41bbafe688a08ea538c6_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMzgtMi0xLTEtMTU5NTQw_86893191-cf05-42b1-8797-7d9848b02abc" name="us-gaap:Revenues" scale="6" unitref="usd">454.7</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="iac7de63087cb4fa28c15d4fe01f12460_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMzgtMy0xLTEtMTU5NTQw_dd613df6-183f-410e-add4-309494740e73" name="us-gaap:Revenues" scale="6" unitref="usd">480.4</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i80c0d99bb34b42e1adce6dce3134630a_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMzgtNS0xLTEtMTU5NTQw_1a856c7c-f1aa-4213-b67c-03d95d46c5da" name="us-gaap:Revenues" scale="6" sign="-" unitref="usd">3.1</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i6dd390f6ff6a43b49662e266d7334459_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMzgtNi0xLTEtMTU5NTQw_4aed1679-c9cf-4d83-a8dc-cafbbdd71721" name="us-gaap:Revenues" scale="6" unitref="usd">541.8</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i51c31c17a15244248305698502760153_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMzgtNy0xLTEtMTU5NTQw_c4884def-b052-4a85-af44-e0510efa7ce7" name="us-gaap:Revenues" scale="6" unitref="usd">538.7</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Forteo</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i3c39dd39688f4abb8ddb719a2260f6bf_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMzktMS0xLTEtMTU5NTQw_b9ad8ddb-a960-4578-b59d-fe3855a2aad9" name="us-gaap:Revenues" scale="6" unitref="usd">261.4</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i56ac4d65faa946aaaebabc3dc7ca99f9_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMzktMi0xLTEtMTU5NTQw_6226f064-40a0-4192-aa5a-ad55e7c70e77" name="us-gaap:Revenues" scale="6" unitref="usd">191.7</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i185dafd0ab80405eb3f78281a2098c9f_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMzktMy0xLTEtMTU5NTQw_fcf3196b-a9ea-468a-b614-74f71b8aeef3" name="us-gaap:Revenues" scale="6" unitref="usd">453.0</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ice1d37ac1886488088492ea4c957a118_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMzktNS0xLTEtMTU5NTQw_52a5a948-bac9-4bd4-b974-fe6b7f9d24e8" name="us-gaap:Revenues" scale="6" unitref="usd">330.1</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i33b45d6e796b4bab93b3906f52ced571_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMzktNi0xLTEtMTU5NTQw_5a4de6ff-7d0f-4a84-8e47-ddb5998f90c4" name="us-gaap:Revenues" scale="6" unitref="usd">287.7</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i606443bf75d84de3b93c88a5d2c2a9c5_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfMzktNy0xLTEtMTU5NTQw_f719b0af-37e2-4069-88db-a82c09493c0d" name="us-gaap:Revenues" scale="6" unitref="usd">617.8</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i62be4d98bd454dbea6bd3764ddcdacb4_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfNDAtMS0xLTEtMTU5NTQw_6ba9d7e5-aa81-4bbf-a522-9702171e5628" name="us-gaap:Revenues" scale="6" unitref="usd">119.4</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i774d30363ab447e4b7b6985e99b6de0d_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfNDAtMi0xLTEtMTU5NTQw_c9d2ddfc-a807-4a7f-abd7-1682156006c5" name="us-gaap:Revenues" scale="6" unitref="usd">125.1</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i238722e1d54440828f51f9f11854afaf_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfNDAtMy0xLTEtMTU5NTQw_1bf029e8-7051-40f5-bcb3-c8fd0c16f192" name="us-gaap:Revenues" scale="6" unitref="usd">244.8</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ib4554ea5474043e5b51ccd4cca5610ae_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfNDAtNS0xLTEtMTU5NTQw_b0efffcb-c735-4c5a-916f-72c626bc80a3" name="us-gaap:Revenues" scale="6" unitref="usd">96.5</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i1a25265d56d04bc481727001f1d55ecc_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfNDAtNi0xLTEtMTU5NTQw_c742b6f4-9f5d-487c-989b-9afb04d35af6" name="us-gaap:Revenues" scale="6" unitref="usd">164.3</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i1fc264d1cb9b42cd927c0bbd387866cc_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfNDAtNy0xLTEtMTU5NTQw_65a7826e-3d20-4a60-bf44-61163cafa545" name="us-gaap:Revenues" scale="6" unitref="usd">260.8</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i13e5988f996e48299f0ddef7dd648213_D20220101-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfNDEtMS0xLTEtMTU5NTQw_dfc87ea7-b2cf-4b6c-b3af-cd7054a6ca8f" name="us-gaap:Revenues" scale="6" unitref="usd">2,377.5</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i3b007283f3094ae08f3a1b5eca4a7fb8_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfNDEtMi0xLTEtMTU5NTQw_935de9a4-b15d-4677-87ce-59467bff3f19" name="us-gaap:Revenues" scale="6" unitref="usd">786.2</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i5b6298a19c0a4c5da470fa7e5e3e967a_D20220101-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfNDEtMy0xLTEtMTU5NTQw_b246ea30-eda0-4771-b21d-dc81c5ef75a8" name="us-gaap:Revenues" scale="6" unitref="usd">3,163.7</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="idcc7138275c74437be6ca40f1474b509_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfNDEtNS0xLTEtMTU5NTQw_ce57a28b-7964-4566-b132-c2a5f727a8f7" name="us-gaap:Revenues" scale="6" unitref="usd">1,373.0</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7efeaf621a9e448fa08571db01806cd3_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfNDEtNi0xLTEtMTU5NTQw_ac883ad5-414a-439b-939f-eceb98fb8966" name="us-gaap:Revenues" scale="6" unitref="usd">1,220.5</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7fe3dcab54b44eaf90f9f242c2fe0f52_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfNDEtNy0xLTEtMTU5NTQw_ba66f90c-6765-47fc-bfdb-9dca322733c0" name="us-gaap:Revenues" scale="6" unitref="usd">2,593.5</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i60c5eb8ff51d4d9fa0a74c53c73aa0dd_D20220101-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfNDItMS0xLTEtMTU5NTQw_f7b95b53-67a9-4e1e-9d54-11edea30b950" name="us-gaap:Revenues" scale="6" unitref="usd">13,531.5</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="if326645430854a2d9ac96495205c029f_D20220101-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfNDItMi0xLTEtMTU5NTQw_d9e090eb-f8ef-4af5-9ea1-fe546ef35914" name="us-gaap:Revenues" scale="6" unitref="usd">7,708.1</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfNDItMy0xLTEtMTU5NTQw_5c289ad6-b9d0-4de9-a767-912454043fd8" name="us-gaap:Revenues" scale="6" unitref="usd">21,239.6</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i2783a40327b64633b6abee19f7b4ca30_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfNDItNS0xLTEtMTU5NTQw_b734da01-1a15-4bfd-b067-7404be20971b" name="us-gaap:Revenues" scale="6" unitref="usd">11,635.1</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i9ff1711a07ba45ffadc911d350d44f94_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfNDItNi0xLTEtMTU5NTQw_a4c93317-7d6c-410a-872b-399af12dee02" name="us-gaap:Revenues" scale="6" unitref="usd">8,683.4</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjI4NTk2ODI3YjI2ODQzMjI4YTI1ZGMxMzM0NzkzN2I4L3RhYmxlcmFuZ2U6Mjg1OTY4MjdiMjY4NDMyMjhhMjVkYzEzMzQ3OTM3YjhfNDItNy0xLTEtMTU5NTQw_7af87305-39ea-4021-beb7-4f04fe13d67e" name="us-gaap:Revenues" scale="6" unitref="usd">20,318.5</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Numbers may not add due to rounding.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Humalog revenue includes insulin lispro.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Jardiance revenue includes Glyxambi,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Synjardy,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">and Trijardy XR.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(3) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Olumiant revenue includes sales for baricitinib that were made pursuant to EUA or similar regulatory authorizations.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(4) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">COVID-19 antibodies include sales for bamlanivimab administered alone, for bamlanivimab and etesevimab administered together, and for bebtelovimab and were made pursuant to EUAs or similar regulatory authorizations.</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ib7361aaef70b4b8fa3c69ad4809e4450"><ix:continuation id="i112884bde4f449e382ba04acb79a007c"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes revenue by geographical area:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.206%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue&#8212;to unaffiliated customers</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i5ef4c6628ee44bfaba7f2e062c3984ca_D20220701-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjE3ZWUzZDMzZjVjNDRkMWU4ZjgxYjZkOGYxZDRkODdiL3RhYmxlcmFuZ2U6MTdlZTNkMzNmNWM0NGQxZThmODFiNmQ4ZjFkNGQ4N2JfMy0xLTEtMS0xNTk1NDA_e494795c-195e-4e17-acc0-c4d87fd013a0" name="us-gaap:Revenues" scale="6" unitref="usd">4,422.1</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ib7200d1730974b7f929910230bd89187_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjE3ZWUzZDMzZjVjNDRkMWU4ZjgxYjZkOGYxZDRkODdiL3RhYmxlcmFuZ2U6MTdlZTNkMzNmNWM0NGQxZThmODFiNmQ4ZjFkNGQ4N2JfMy0zLTEtMS0xNTk1NDA_c1810556-5ea1-4f39-b1b4-9505f760d904" name="us-gaap:Revenues" scale="6" unitref="usd">3,989.6</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i60c5eb8ff51d4d9fa0a74c53c73aa0dd_D20220101-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjE3ZWUzZDMzZjVjNDRkMWU4ZjgxYjZkOGYxZDRkODdiL3RhYmxlcmFuZ2U6MTdlZTNkMzNmNWM0NGQxZThmODFiNmQ4ZjFkNGQ4N2JfMy01LTEtMS0xNTk1NDA_8ed50024-bfcb-4b87-904c-5493d51273b3" name="us-gaap:Revenues" scale="6" unitref="usd">13,531.5</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i2783a40327b64633b6abee19f7b4ca30_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjE3ZWUzZDMzZjVjNDRkMWU4ZjgxYjZkOGYxZDRkODdiL3RhYmxlcmFuZ2U6MTdlZTNkMzNmNWM0NGQxZThmODFiNmQ4ZjFkNGQ4N2JfMy03LTEtMS0xNTk1NDA_37b2118d-2c3f-47df-bac7-c96fca7f5488" name="us-gaap:Revenues" scale="6" unitref="usd">11,635.1</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i812f3d20a1af4d92924e0bbe1371c71e_D20220701-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjE3ZWUzZDMzZjVjNDRkMWU4ZjgxYjZkOGYxZDRkODdiL3RhYmxlcmFuZ2U6MTdlZTNkMzNmNWM0NGQxZThmODFiNmQ4ZjFkNGQ4N2JfNC0xLTEtMS0xNTk1NDA_b35a54cb-bbc5-4a76-9c86-7b2a5f8b3a0a" name="us-gaap:Revenues" scale="6" unitref="usd">1,056.4</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i973b61d370734fa5bcf42303b4a667df_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjE3ZWUzZDMzZjVjNDRkMWU4ZjgxYjZkOGYxZDRkODdiL3RhYmxlcmFuZ2U6MTdlZTNkMzNmNWM0NGQxZThmODFiNmQ4ZjFkNGQ4N2JfNC0zLTEtMS0xNTk1NDA_04403aaa-5c93-4628-a577-8849b48afedf" name="us-gaap:Revenues" scale="6" unitref="usd">1,098.6</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i4cf771cc163e44ed8acdd62a65cc8b4c_D20220101-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjE3ZWUzZDMzZjVjNDRkMWU4ZjgxYjZkOGYxZDRkODdiL3RhYmxlcmFuZ2U6MTdlZTNkMzNmNWM0NGQxZThmODFiNmQ4ZjFkNGQ4N2JfNC01LTEtMS0xNTk1NDA_b1a7b8e1-f2d1-453c-a420-adcba0497d55" name="us-gaap:Revenues" scale="6" unitref="usd">3,224.8</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="id0ffca9720f342dbbe64a17e04c55d84_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjE3ZWUzZDMzZjVjNDRkMWU4ZjgxYjZkOGYxZDRkODdiL3RhYmxlcmFuZ2U6MTdlZTNkMzNmNWM0NGQxZThmODFiNmQ4ZjFkNGQ4N2JfNC03LTEtMS0xNTk1NDA_1b417717-307e-4f96-9ed7-20094b2b2832" name="us-gaap:Revenues" scale="6" unitref="usd">3,629.6</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ib92bd7160fd94961b7bba02ffbd18490_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjE3ZWUzZDMzZjVjNDRkMWU4ZjgxYjZkOGYxZDRkODdiL3RhYmxlcmFuZ2U6MTdlZTNkMzNmNWM0NGQxZThmODFiNmQ4ZjFkNGQ4N2JfNS0xLTEtMS0xNTk1NDA_2c9f2b01-887f-4033-a1da-91eb83104354" name="us-gaap:Revenues" scale="6" unitref="usd">487.7</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i25019079a8464a91a3cf96012fcc0d52_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjE3ZWUzZDMzZjVjNDRkMWU4ZjgxYjZkOGYxZDRkODdiL3RhYmxlcmFuZ2U6MTdlZTNkMzNmNWM0NGQxZThmODFiNmQ4ZjFkNGQ4N2JfNS0zLTEtMS0xNTk1NDA_52023aa9-af64-4fa6-bb1e-90562938225e" name="us-gaap:Revenues" scale="6" unitref="usd">595.0</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ib37e987842e2478dab07f58a5f789a49_D20220101-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjE3ZWUzZDMzZjVjNDRkMWU4ZjgxYjZkOGYxZDRkODdiL3RhYmxlcmFuZ2U6MTdlZTNkMzNmNWM0NGQxZThmODFiNmQ4ZjFkNGQ4N2JfNS01LTEtMS0xNTk1NDA_c5edc270-7a0d-4379-8d2e-7b30cb33a916" name="us-gaap:Revenues" scale="6" unitref="usd">1,352.3</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="if9ff4ce3b7704faaa359e30df99f2b54_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjE3ZWUzZDMzZjVjNDRkMWU4ZjgxYjZkOGYxZDRkODdiL3RhYmxlcmFuZ2U6MTdlZTNkMzNmNWM0NGQxZThmODFiNmQ4ZjFkNGQ4N2JfNS03LTEtMS0xNTk1NDA_648df1d2-ec98-483e-9066-e540213dc338" name="us-gaap:Revenues" scale="6" unitref="usd">1,832.2</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ic678bb62bdef4faea88b4e3dfd6a7971_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjE3ZWUzZDMzZjVjNDRkMWU4ZjgxYjZkOGYxZDRkODdiL3RhYmxlcmFuZ2U6MTdlZTNkMzNmNWM0NGQxZThmODFiNmQ4ZjFkNGQ4N2JfNi0xLTEtMS0xNTk1NDA_481185cb-e19d-4fe4-9b55-f335452f974b" name="us-gaap:Revenues" scale="6" unitref="usd">343.4</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ib648672815904a56b3a3874c085884b6_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjE3ZWUzZDMzZjVjNDRkMWU4ZjgxYjZkOGYxZDRkODdiL3RhYmxlcmFuZ2U6MTdlZTNkMzNmNWM0NGQxZThmODFiNmQ4ZjFkNGQ4N2JfNi0zLTEtMS0xNTk1NDA_c0605c90-d2c2-493f-ac20-eb22c98cfa57" name="us-gaap:Revenues" scale="6" unitref="usd">400.3</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="id085508ee8c24a36a655eea7d3096500_D20220101-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjE3ZWUzZDMzZjVjNDRkMWU4ZjgxYjZkOGYxZDRkODdiL3RhYmxlcmFuZ2U6MTdlZTNkMzNmNWM0NGQxZThmODFiNmQ4ZjFkNGQ4N2JfNi01LTEtMS0xNTk1NDA_c7458d53-fe69-44d1-8ba0-43882a9d94df" name="us-gaap:Revenues" scale="6" unitref="usd">1,102.0</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i4b2b1ef297534a4a801da2637a1d37e4_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjE3ZWUzZDMzZjVjNDRkMWU4ZjgxYjZkOGYxZDRkODdiL3RhYmxlcmFuZ2U6MTdlZTNkMzNmNWM0NGQxZThmODFiNmQ4ZjFkNGQ4N2JfNi03LTEtMS0xNTk1NDA_f8ffdb9e-a949-4c29-b9af-516ea72b450d" name="us-gaap:Revenues" scale="6" unitref="usd">1,285.0</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other foreign countries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ib2c80ff08a384ec7a8c6dd07798b9efd_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjE3ZWUzZDMzZjVjNDRkMWU4ZjgxYjZkOGYxZDRkODdiL3RhYmxlcmFuZ2U6MTdlZTNkMzNmNWM0NGQxZThmODFiNmQ4ZjFkNGQ4N2JfNy0xLTEtMS0xNTk1NDA_5e100b96-21c6-4c0d-a597-de4acdab4d52" name="us-gaap:Revenues" scale="6" unitref="usd">632.0</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i59dcfcfb04c94ad588f473c50147a921_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjE3ZWUzZDMzZjVjNDRkMWU4ZjgxYjZkOGYxZDRkODdiL3RhYmxlcmFuZ2U6MTdlZTNkMzNmNWM0NGQxZThmODFiNmQ4ZjFkNGQ4N2JfNy0zLTEtMS0xNTk1NDA_a945ddd6-e144-4647-b9ec-0127f970c063" name="us-gaap:Revenues" scale="6" unitref="usd">689.4</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i20e09a0b7eb34ffbbc4057f306b92c3d_D20220101-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjE3ZWUzZDMzZjVjNDRkMWU4ZjgxYjZkOGYxZDRkODdiL3RhYmxlcmFuZ2U6MTdlZTNkMzNmNWM0NGQxZThmODFiNmQ4ZjFkNGQ4N2JfNy01LTEtMS0xNTk1NDA_e2d90996-5bac-4bb9-9b36-f894c73a19c7" name="us-gaap:Revenues" scale="6" unitref="usd">2,029.1</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i3c8b51c823f54bb1a2efb0592f5476a3_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjE3ZWUzZDMzZjVjNDRkMWU4ZjgxYjZkOGYxZDRkODdiL3RhYmxlcmFuZ2U6MTdlZTNkMzNmNWM0NGQxZThmODFiNmQ4ZjFkNGQ4N2JfNy03LTEtMS0xNTk1NDA_6e30a109-699d-47f3-9c3d-9590872718f6" name="us-gaap:Revenues" scale="6" unitref="usd">1,936.7</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i19fc0325c48543008ea71e1fdcf11d86_D20220701-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjE3ZWUzZDMzZjVjNDRkMWU4ZjgxYjZkOGYxZDRkODdiL3RhYmxlcmFuZ2U6MTdlZTNkMzNmNWM0NGQxZThmODFiNmQ4ZjFkNGQ4N2JfOC0xLTEtMS0xNTk1NDA_f8f0b6e6-9cba-4307-b2be-39893593c9fb" name="us-gaap:Revenues" scale="6" unitref="usd">6,941.6</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie4fa4f6b472a4f269297591b44aba572_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjE3ZWUzZDMzZjVjNDRkMWU4ZjgxYjZkOGYxZDRkODdiL3RhYmxlcmFuZ2U6MTdlZTNkMzNmNWM0NGQxZThmODFiNmQ4ZjFkNGQ4N2JfOC0zLTEtMS0xNTk1NDA_326ddb93-9840-4cb9-b7ef-3ca94ed85232" name="us-gaap:Revenues" scale="6" unitref="usd">6,772.8</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjE3ZWUzZDMzZjVjNDRkMWU4ZjgxYjZkOGYxZDRkODdiL3RhYmxlcmFuZ2U6MTdlZTNkMzNmNWM0NGQxZThmODFiNmQ4ZjFkNGQ4N2JfOC01LTEtMS0xNTk1NDA_bf893bbf-e7c6-4f13-917f-b0ac4b0ab7f0" name="us-gaap:Revenues" scale="6" unitref="usd">21,239.6</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180My9mcmFnOjMwYTQ3MzM1MjIxYzQwOGI4ODIxYjA1ZmZlNDJjMzU3L3RhYmxlOjE3ZWUzZDMzZjVjNDRkMWU4ZjgxYjZkOGYxZDRkODdiL3RhYmxlcmFuZ2U6MTdlZTNkMzNmNWM0NGQxZThmODFiNmQ4ZjFkNGQ4N2JfOC03LTEtMS0xNTk1NDA_a2778e51-db16-45da-907f-c4e990974baf" name="us-gaap:Revenues" scale="6" unitref="usd">20,318.5</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Numbers may not add due to rounding.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Revenue is attributed to the countries based on the location of the customer.</span></div></ix:continuation></ix:continuation><div style="margin-top:6pt"><span><br/></span></div><div id="i5fed483d9c7e4f3cbba3a62c53226cd7_49"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note&#160;3:&#160;<ix:nonnumeric contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" continuedat="ic4a6a0b7b6854ae39bc00c0e3afbf068" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180OS9mcmFnOmVkZDg1Zjg2YWYyNjQ0MGU5ZWZhMDdiM2U3YmE5ODY0L3RleHRyZWdpb246ZWRkODVmODZhZjI2NDQwZTllZmEwN2IzZTdiYTk4NjRfNTM4OA_9c9d5dc2-2183-457b-ba18-d6a3c679b6a2" name="us-gaap:AssetAcquisitionTextBlock"><ix:nonnumeric contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" continuedat="i332885803b5f46c8bd7bc737b6c88549" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180OS9mcmFnOmVkZDg1Zjg2YWYyNjQ0MGU5ZWZhMDdiM2U3YmE5ODY0L3RleHRyZWdpb246ZWRkODVmODZhZjI2NDQwZTllZmEwN2IzZTdiYTk4NjRfNTM4OA_b088c754-96b4-4a83-8614-5eba5465b419" name="us-gaap:BusinessCombinationDisclosureTextBlock">Acquisitions</ix:nonnumeric></ix:nonnumeric></span></div><ix:continuation continuedat="i79ca4b26995a420b9671af6ce640942b" id="ic4a6a0b7b6854ae39bc00c0e3afbf068"><ix:continuation continuedat="ida4a1d9320294c6c802da257ee40cd25" id="i332885803b5f46c8bd7bc737b6c88549"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We engage in various forms of business development activities to enhance our product pipeline, including acquisitions, collaborations, investments, and licensing arrangements. In connection with these arrangements, our partners may be entitled to future royalties and/or commercial milestones based on sales should products be approved for commercialization and/or milestones based on the successful progress of compounds through the development process.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, we completed the acquisition of Prevail Therapeutics Inc. (Prevail). This transaction, as further discussed below in Acquisition of a Business, was accounted for as a business combination under the acquisition method of accounting. <ix:nonnumeric contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" continuedat="i85d462e013914613971ca6381af3c5a7" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180OS9mcmFnOmVkZDg1Zjg2YWYyNjQ0MGU5ZWZhMDdiM2U3YmE5ODY0L3RleHRyZWdpb246ZWRkODVmODZhZjI2NDQwZTllZmEwN2IzZTdiYTk4NjRfNTM4Mg_566b54f7-348e-45d8-adfd-16d9cd26da4c" name="us-gaap:BusinessCombinationsPolicy">Under this method, the assets acquired and liabilities assumed were recorded at their respective fair values as of the acquisition date in our consolidated condensed financial statements. The determination of estimated fair value required management to make significant estimates and assumptions. The excess of the purchase price over the fair value of the acquired net assets, where applicable, has been recorded as goodwill. The results of operations of this acquisition is included in our consolidated condensed financial statements from the date of acquisition.</ix:nonnumeric></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also acquired assets in development which are further discussed below in Asset Acquisitions. <ix:continuation id="i85d462e013914613971ca6381af3c5a7">Upon each acquisition, the cost allocated to acquired IPR&amp;D is immediately expensed if the compound has no alternative future use. Milestone payment obligations incurred prior to regulatory approval of the compound are expensed when the event triggering an obligation to pay the milestone occurs.</ix:continuation> We recognized acquired IPR&amp;D and development milestone charges of $<ix:nonfraction contextref="i19fc0325c48543008ea71e1fdcf11d86_D20220701-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180OS9mcmFnOmVkZDg1Zjg2YWYyNjQ0MGU5ZWZhMDdiM2U3YmE5ODY0L3RleHRyZWdpb246ZWRkODVmODZhZjI2NDQwZTllZmEwN2IzZTdiYTk4NjRfMTc1NQ_8b459b38-3dde-4b01-86a3-b90670ef8e72" name="lly:AcquiredInProcessResearchAndDevelopmentAndDevelopmentMilestones" scale="6" unitref="usd">62.4</ix:nonfraction> million and $<ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180OS9mcmFnOmVkZDg1Zjg2YWYyNjQ0MGU5ZWZhMDdiM2U3YmE5ODY0L3RleHRyZWdpb246ZWRkODVmODZhZjI2NDQwZTllZmEwN2IzZTdiYTk4NjRfMTc2Mg_814d2bcb-fad1-4171-8df7-5bf614293fde" name="lly:AcquiredInProcessResearchAndDevelopmentAndDevelopmentMilestones" scale="6" unitref="usd">668.4</ix:nonfraction> million for the three and nine months ended September&#160;30, 2022, respectively, and $<ix:nonfraction contextref="ie4fa4f6b472a4f269297591b44aba572_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180OS9mcmFnOmVkZDg1Zjg2YWYyNjQ0MGU5ZWZhMDdiM2U3YmE5ODY0L3RleHRyZWdpb246ZWRkODVmODZhZjI2NDQwZTllZmEwN2IzZTdiYTk4NjRfMTgxMQ_930acb16-c7a4-46f2-b4ec-0c4ce1d82bd4" name="lly:AcquiredInProcessResearchAndDevelopmentAndDevelopmentMilestones" scale="6" unitref="usd">177.6</ix:nonfraction> million and $<ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180OS9mcmFnOmVkZDg1Zjg2YWYyNjQ0MGU5ZWZhMDdiM2U3YmE5ODY0L3RleHRyZWdpb246ZWRkODVmODZhZjI2NDQwZTllZmEwN2IzZTdiYTk4NjRfMTgxOA_08faa181-0763-4f6c-9031-a7e1539d6611" name="lly:AcquiredInProcessResearchAndDevelopmentAndDevelopmentMilestones" scale="6" unitref="usd">532.4</ix:nonfraction> million for the three and nine months ended September&#160;30, 2021, respectively. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisition of a Business</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Prevail Acquisition</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Overview of Transaction</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, we acquired all shares of Prevail for a purchase price that included $<ix:nonfraction contextref="id1a51594b8b04df48cf5b7eff20f7e6d_I20210131" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180OS9mcmFnOmVkZDg1Zjg2YWYyNjQ0MGU5ZWZhMDdiM2U3YmE5ODY0L3RleHRyZWdpb246ZWRkODVmODZhZjI2NDQwZTllZmEwN2IzZTdiYTk4NjRfMjAyMA_6f244deb-9d0b-474c-99fb-f51b8fffa448" name="us-gaap:BusinessAcquisitionSharePrice" scale="0" unitref="usdPerShare">22.50</ix:nonfraction> per share in cash (or an aggregate of $<ix:nonfraction contextref="i28f89248cda04bd08a5c9d722de7c1db_D20210101-20210131" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180OS9mcmFnOmVkZDg1Zjg2YWYyNjQ0MGU5ZWZhMDdiM2U3YmE5ODY0L3RleHRyZWdpb246ZWRkODVmODZhZjI2NDQwZTllZmEwN2IzZTdiYTk4NjRfMjA2MQ_645d971d-3cd1-4fdc-87fb-8e286f6e284c" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" unitref="usd">747.4</ix:nonfraction>&#160;million, net of cash acquired) plus <ix:nonfraction contextref="i28f89248cda04bd08a5c9d722de7c1db_D20210101-20210131" decimals="INF" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180OS9mcmFnOmVkZDg1Zjg2YWYyNjQ0MGU5ZWZhMDdiM2U3YmE5ODY0L3RleHRyZWdpb246ZWRkODVmODZhZjI2NDQwZTllZmEwN2IzZTdiYTk4NjRfMjA5Mg_aa7d0c8c-64b4-4d7e-82ae-bd200b947af6" name="lly:BusinessCombinationConsiderationTransferredNumberOfContingentValueRights" scale="0" unitref="right">one</ix:nonfraction> non-tradable contingent value right (CVR) per share. The CVR entitles Prevail stockholders up to an additional $<ix:nonfraction contextref="id1a51594b8b04df48cf5b7eff20f7e6d_I20210131" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180OS9mcmFnOmVkZDg1Zjg2YWYyNjQ0MGU5ZWZhMDdiM2U3YmE5ODY0L3RleHRyZWdpb246ZWRkODVmODZhZjI2NDQwZTllZmEwN2IzZTdiYTk4NjRfMjIwNg_f4c96899-c61c-4e25-9cbc-4d4b5a039966" name="lly:BusinessAcquisitionContingentValueRightAdditionalPricePerShare" scale="0" unitref="usdPerShare">4.00</ix:nonfraction> per share in cash (or an aggregate of approximately $<ix:nonfraction contextref="id1a51594b8b04df48cf5b7eff20f7e6d_I20210131" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180OS9mcmFnOmVkZDg1Zjg2YWYyNjQ0MGU5ZWZhMDdiM2U3YmE5ODY0L3RleHRyZWdpb246ZWRkODVmODZhZjI2NDQwZTllZmEwN2IzZTdiYTk4NjRfMjI2MQ_933609d8-ce89-48bc-a35b-0ffd528363ad" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" scale="6" unitref="usd">160</ix:nonfraction>&#160;million) payable, subject to certain terms and conditions, upon the first regulatory approval of a Prevail product in one of the following countries: U.S., Japan, United Kingdom, Germany, France, Italy, or Spain. To achieve the full value of the CVR, such regulatory approval must occur by December 31, 2024. If such regulatory approval occurs after December 31, 2024, the value of the CVR will be reduced by approximately <ix:nonfraction contextref="id1a51594b8b04df48cf5b7eff20f7e6d_I20210131" decimals="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180OS9mcmFnOmVkZDg1Zjg2YWYyNjQ0MGU5ZWZhMDdiM2U3YmE5ODY0L3RleHRyZWdpb246ZWRkODVmODZhZjI2NDQwZTllZmEwN2IzZTdiYTk4NjRfMjY3OA_690a7673-9b2f-4993-87ad-3dbbf8c0e150" name="lly:BusinessAcquisitionContingentValueRightRegulatoryApprovalDelayMonthlyReduction" scale="-2" unitref="usdPerShare">8.3</ix:nonfraction> cents per month until December 1, 2028, at which point the CVR will expire without payment.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the agreement, we acquired potentially disease-modifying AAV9-based gene therapies for patients with neurodegenerative diseases. The acquisition established a new modality for drug discovery and development, extending our research efforts through the creation of a gene therapy program that is being anchored by Prevail's portfolio of assets. The lead gene therapies in clinical development that we acquired were PR001 for patients with Parkinson's disease with GBA1 mutations and neuronopathic Gaucher disease and PR006 for patients with frontotemporal dementia with GRN mutations. Both PR001 and PR006 were granted Fast Track designation from the U.S. Food and Drug Administration (FDA). </span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation continuedat="if80b203fcde347c0938caeef136b6e9a" id="i79ca4b26995a420b9671af6ce640942b"><ix:continuation continuedat="iee6f84e6979e404791cade9f5002e52c" id="ida4a1d9320294c6c802da257ee40cd25"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets Acquired and Liabilities Assumed</span></div><ix:nonnumeric contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" continuedat="iae3d512978a044fabebff17c3aa0bb87" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180OS9mcmFnOmVkZDg1Zjg2YWYyNjQ0MGU5ZWZhMDdiM2U3YmE5ODY0L3RleHRyZWdpb246ZWRkODVmODZhZjI2NDQwZTllZmEwN2IzZTdiYTk4NjRfNTM4Mw_44d6e0ee-dbf4-4a3a-b21c-845be5d49516" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the amounts recognized for assets acquired and liabilities assumed as of the acquisition date:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.784%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair Value at January 22, 2021</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie6db4c7ca7af4463afc62347bd8b3a94_I20210122" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180OS9mcmFnOmVkZDg1Zjg2YWYyNjQ0MGU5ZWZhMDdiM2U3YmE5ODY0L3RhYmxlOjNlMDE0MGU5YTIxMjQ0NWJiMzljMWI4MWY2ZWIxMGY4L3RhYmxlcmFuZ2U6M2UwMTQwZTlhMjEyNDQ1YmIzOWMxYjgxZjZlYjEwZjhfMS0xLTEtMS0xNTk1NDA_58807b48-29be-4d10-a0b2-17298c13efaa" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" scale="6" unitref="usd">90.5</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired IPR&amp;D</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie6db4c7ca7af4463afc62347bd8b3a94_I20210122" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180OS9mcmFnOmVkZDg1Zjg2YWYyNjQ0MGU5ZWZhMDdiM2U3YmE5ODY0L3RhYmxlOjNlMDE0MGU5YTIxMjQ0NWJiMzljMWI4MWY2ZWIxMGY4L3RhYmxlcmFuZ2U6M2UwMTQwZTlhMjEyNDQ1YmIzOWMxYjgxZjZlYjEwZjhfMi0xLTEtMS0xNTk1NDA_db4146de-1491-4d4a-bf18-705b2b325b85" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" unitref="usd">824.0</ix:nonfraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie6db4c7ca7af4463afc62347bd8b3a94_I20210122" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180OS9mcmFnOmVkZDg1Zjg2YWYyNjQ0MGU5ZWZhMDdiM2U3YmE5ODY0L3RhYmxlOjNlMDE0MGU5YTIxMjQ0NWJiMzljMWI4MWY2ZWIxMGY4L3RhYmxlcmFuZ2U6M2UwMTQwZTlhMjEyNDQ1YmIzOWMxYjgxZjZlYjEwZjhfMy0xLTEtMS0xNTk1NDA_7518ab8b-58df-47b7-b570-af626e5a5e5d" name="us-gaap:Goodwill" scale="6" unitref="usd">126.8</ix:nonfraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="ie6db4c7ca7af4463afc62347bd8b3a94_I20210122" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180OS9mcmFnOmVkZDg1Zjg2YWYyNjQ0MGU5ZWZhMDdiM2U3YmE5ODY0L3RhYmxlOjNlMDE0MGU5YTIxMjQ0NWJiMzljMWI4MWY2ZWIxMGY4L3RhYmxlcmFuZ2U6M2UwMTQwZTlhMjEyNDQ1YmIzOWMxYjgxZjZlYjEwZjhfNC0xLTEtMS0xNTk1NDA_771f6ac2-5610-47c2-b998-3169ded53077" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="6" unitref="usd">106.0</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets and liabilities, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="ie6db4c7ca7af4463afc62347bd8b3a94_I20210122" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180OS9mcmFnOmVkZDg1Zjg2YWYyNjQ0MGU5ZWZhMDdiM2U3YmE5ODY0L3RhYmxlOjNlMDE0MGU5YTIxMjQ0NWJiMzljMWI4MWY2ZWIxMGY4L3RhYmxlcmFuZ2U6M2UwMTQwZTlhMjEyNDQ1YmIzOWMxYjgxZjZlYjEwZjhfNS0xLTEtMS0xNTk1NDA_a0484e4d-414f-48da-8763-6a56fbd2d0df" name="lly:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssetsLiabilitiesNet" scale="6" sign="-" unitref="usd">31.5</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition date fair value of consideration transferred </span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie6db4c7ca7af4463afc62347bd8b3a94_I20210122" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180OS9mcmFnOmVkZDg1Zjg2YWYyNjQ0MGU5ZWZhMDdiM2U3YmE5ODY0L3RhYmxlOjNlMDE0MGU5YTIxMjQ0NWJiMzljMWI4MWY2ZWIxMGY4L3RhYmxlcmFuZ2U6M2UwMTQwZTlhMjEyNDQ1YmIzOWMxYjgxZjZlYjEwZjhfNi0xLTEtMS0xNTk1NDA_0cc12a80-9b70-4f37-bd64-ec50299eb884" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="6" unitref="usd">903.8</ix:nonfraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i10a5ee4bd0c64813b300c5389565a056_D20210122-20210122" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180OS9mcmFnOmVkZDg1Zjg2YWYyNjQ0MGU5ZWZhMDdiM2U3YmE5ODY0L3RhYmxlOjNlMDE0MGU5YTIxMjQ0NWJiMzljMWI4MWY2ZWIxMGY4L3RhYmxlcmFuZ2U6M2UwMTQwZTlhMjEyNDQ1YmIzOWMxYjgxZjZlYjEwZjhfOC0xLTEtMS0xNTk1NDA_1a79c54a-800b-454d-8e0f-bb3d3d9cf90e" name="us-gaap:CashAcquiredFromAcquisition" scale="6" unitref="usd">90.5</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of CVR liability</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="ie6db4c7ca7af4463afc62347bd8b3a94_I20210122" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180OS9mcmFnOmVkZDg1Zjg2YWYyNjQ0MGU5ZWZhMDdiM2U3YmE5ODY0L3RhYmxlOjNlMDE0MGU5YTIxMjQ0NWJiMzljMWI4MWY2ZWIxMGY4L3RhYmxlcmFuZ2U6M2UwMTQwZTlhMjEyNDQ1YmIzOWMxYjgxZjZlYjEwZjhfOS0xLTEtMS0xNTk1NDA_cca5af70-b6b3-41a5-a994-fb0e3d134546" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" scale="6" unitref="usd">65.9</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid, net of cash acquired</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i28f89248cda04bd08a5c9d722de7c1db_D20210101-20210131" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180OS9mcmFnOmVkZDg1Zjg2YWYyNjQ0MGU5ZWZhMDdiM2U3YmE5ODY0L3RhYmxlOjNlMDE0MGU5YTIxMjQ0NWJiMzljMWI4MWY2ZWIxMGY4L3RhYmxlcmFuZ2U6M2UwMTQwZTlhMjEyNDQ1YmIzOWMxYjgxZjZlYjEwZjhfMTAtMS0xLTEtMTU5NTQw_645d971d-3cd1-4fdc-87fb-8e286f6e284c" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" unitref="usd">747.4</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Acquired IPR&amp;D intangibles primarily relate to PR001. In the third quarter of 2022, we impaired the intangible asset related to PR001. See Note 5 for additional information.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The goodwill recognized from this acquisition is not deductible for tax purposes. </span></div></ix:nonnumeric><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"><ix:continuation continuedat="i2bebdf1948ef426997642cf00c12249f" id="iae3d512978a044fabebff17c3aa0bb87">(3) </ix:continuation></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="i2bebdf1948ef426997642cf00c12249f">See Note 6 for a discussion on the estimation of the CVR liability.</ix:continuation> </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are unable to provide the results of operations for the three and nine months ended September&#160;30, 2022 and 2021 attributable to Prevail as those operations were substantially integrated into our legacy business.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pro forma information has not been included as this acquisition did not have a material impact on our consolidated condensed statements of operations for the three and nine months ended September&#160;30, 2021.</span></div><div style="margin-top:6pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Asset Acquisitions</span></div><ix:nonnumeric contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" continuedat="ic690359283f84e42bd0f9322b4d832c5" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180OS9mcmFnOmVkZDg1Zjg2YWYyNjQ0MGU5ZWZhMDdiM2U3YmE5ODY0L3RleHRyZWdpb246ZWRkODVmODZhZjI2NDQwZTllZmEwN2IzZTdiYTk4NjRfNTM5NA_05d2cd9a-ce90-45b6-8093-3723db29a26e" name="us-gaap:ScheduleOfResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationTextBlock"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our significant asset acquisitions during the nine months ended September&#160;30, 2022 and 2021:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.531%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.104%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.916%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Counterparty</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Compound(s), Therapy or Asset</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Acquisition Month</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Phase of Development</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Acquired IPR&amp;D Expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BioMarin Pharmaceutical Inc.</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Priority Review Voucher</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Not applicable</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i3b190c0fcac94cb9b4d37191d35b87bb_D20220201-20220228" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180OS9mcmFnOmVkZDg1Zjg2YWYyNjQ0MGU5ZWZhMDdiM2U3YmE5ODY0L3RhYmxlOmQzYjJkZDUwNzFlNzRiZTZhZWJmMGJhNWFlYjQ1YWQ0L3RhYmxlcmFuZ2U6ZDNiMmRkNTA3MWU3NGJlNmFlYmYwYmE1YWViNDVhZDRfMS02LTEtMS0xNTk1NDA_863e82e8-4b04-40e1-bf47-c8f31648e415" name="lly:PaymentsForAssetAcquisitions" scale="6" unitref="usd">110.0</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rigel Pharmaceuticals, Inc.</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">R552, a receptor-interacting serine/threonine-protein kinase 1 (RIPK1) inhibitor, for the potential treatment of autoimmune and inflammatory diseases</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phase I</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ifa2b520f9b26403ca1dfc59f5150bb2a_D20210301-20210331" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180OS9mcmFnOmVkZDg1Zjg2YWYyNjQ0MGU5ZWZhMDdiM2U3YmE5ODY0L3RhYmxlOmQzYjJkZDUwNzFlNzRiZTZhZWJmMGJhNWFlYjQ1YWQ0L3RhYmxlcmFuZ2U6ZDNiMmRkNTA3MWU3NGJlNmFlYmYwYmE1YWViNDVhZDRfMy02LTEtMS0xNTk1NDA_ae271ce7-8708-4774-a62a-edc05567b11c" name="lly:PaymentsForAssetAcquisitions" scale="6" unitref="usd">125.0</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Precision Biosciences, Inc. </span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Potential in vivo therapies for genetic disorders</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-clinical</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i2a70d59a929b499ca4d9201b21544293_D20210101-20210131" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180OS9mcmFnOmVkZDg1Zjg2YWYyNjQ0MGU5ZWZhMDdiM2U3YmE5ODY0L3RhYmxlOmQzYjJkZDUwNzFlNzRiZTZhZWJmMGJhNWFlYjQ1YWQ0L3RhYmxlcmFuZ2U6ZDNiMmRkNTA3MWU3NGJlNmFlYmYwYmE1YWViNDVhZDRfNC02LTEtMS0xNTk1NDA_9765f2d6-d196-430b-9962-1014523454dd" name="lly:PaymentsForAssetAcquisitions" scale="6" unitref="usd">107.8</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonnumeric><div style="padding-left:9pt;text-indent:-9pt"><ix:continuation continuedat="i4d31b2f1b0134117bf6f5ffdac4e7b0e" id="ic690359283f84e42bd0f9322b4d832c5"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></ix:continuation><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="i4d31b2f1b0134117bf6f5ffdac4e7b0e">The phase of development presented is as of the date of the arrangement and represents the phase of development of the most advanced asset acquired, where applicable.</ix:continuation> </span></div><div style="padding-left:9pt;text-indent:-9pt"><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with our acquisition of Petra Pharma Corporation (Petra), we were required to make milestone payments to Petra shareholders contingent upon the occurrence of certain future events linked to the success of the mutant-selective PI3K</span><span style="color:#000000;font-family:'Book Antiqua',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#945;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> inhibitor. In the second quarter of 2022, we entered into agreements with substantially all Petra shareholders to acquire their rights to receive any future milestone payments in exchange for a one-time payment. As a result of these agreements, we recognized a charge of $<ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180OS9mcmFnOmVkZDg1Zjg2YWYyNjQ0MGU5ZWZhMDdiM2U3YmE5ODY0L3RleHRyZWdpb246ZWRkODVmODZhZjI2NDQwZTllZmEwN2IzZTdiYTk4NjRfNTA2NA_becd547d-bff8-40b6-8fcd-5b41bf6b3d7b" name="lly:PaymentsForAssetAcquisitions" scale="6" unitref="usd">333.8</ix:nonfraction>&#160;million as a development milestone during the nine months ended September&#160;30, 2022. Any remaining contingent milestones payments linked to the success of the mutant-selective PI3K&#945; are not expected to be material. We recognized no other significant development milestones during the three and nine months ended September&#160;30, 2022 and 2021.</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:continuation continuedat="i6bfdb0d50a4342a1bf004caaee3991cd" id="if80b203fcde347c0938caeef136b6e9a"><ix:continuation continuedat="i5392492144ef471382a6490f6b4ea5c0" id="iee6f84e6979e404791cade9f5002e52c">Subsequent Event - Akouos, Inc. (Akouos) Acquisition</ix:continuation></ix:continuation></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i6bfdb0d50a4342a1bf004caaee3991cd"><ix:continuation id="i5392492144ef471382a6490f6b4ea5c0">On October 17, 2022, we entered into a definitive agreement to acquire Akouos. Pursuant to the terms of the agreement, we have commenced a tender offer to acquire all outstanding shares of Akouos for a purchase price of $<ix:nonfraction contextref="ieacc700b698842408fe2f8c736054aa3_I20221231" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180OS9mcmFnOmVkZDg1Zjg2YWYyNjQ0MGU5ZWZhMDdiM2U3YmE5ODY0L3RleHRyZWdpb246ZWRkODVmODZhZjI2NDQwZTllZmEwN2IzZTdiYTk4NjRfMzI5ODUzNDg5NTU2MA_dea851e6-3eb9-4e84-ab22-60afe15d8fd4" name="us-gaap:BusinessAcquisitionSharePrice" scale="0" unitref="usdPerShare">12.50</ix:nonfraction> per share in cash (an aggregate of approximately $<ix:nonfraction contextref="i7d940f045f1243808212f82e48b91487_D20221001-20221231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180OS9mcmFnOmVkZDg1Zjg2YWYyNjQ0MGU5ZWZhMDdiM2U3YmE5ODY0L3RleHRyZWdpb246ZWRkODVmODZhZjI2NDQwZTllZmEwN2IzZTdiYTk4NjRfMzI5ODUzNDg5NTU2OA_48817f80-3aff-4262-bb7f-9452924fa23c" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" unitref="usd">487</ix:nonfraction>&#160;million), payable at closing, plus <ix:nonfraction contextref="i7d940f045f1243808212f82e48b91487_D20221001-20221231" decimals="INF" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180OS9mcmFnOmVkZDg1Zjg2YWYyNjQ0MGU5ZWZhMDdiM2U3YmE5ODY0L3RleHRyZWdpb246ZWRkODVmODZhZjI2NDQwZTllZmEwN2IzZTdiYTk4NjRfMzI5ODUzNDg5NTYwMg_a6298565-022d-4050-befe-0451b3175c02" name="lly:BusinessCombinationConsiderationTransferredNumberOfContingentValueRights" scale="0" unitref="right">one</ix:nonfraction> non-tradable CVR per share that will entitle the holder to receive up to an additional $<ix:nonfraction contextref="ieacc700b698842408fe2f8c736054aa3_I20221231" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180OS9mcmFnOmVkZDg1Zjg2YWYyNjQ0MGU5ZWZhMDdiM2U3YmE5ODY0L3RleHRyZWdpb246ZWRkODVmODZhZjI2NDQwZTllZmEwN2IzZTdiYTk4NjRfMzI5ODUzNDg5NTU4Mg_7f4c5933-1d83-45f0-bc0a-3a778944d759" name="lly:BusinessAcquisitionContingentValueRightAdditionalPricePerShare" scale="0" unitref="usdPerShare">3.00</ix:nonfraction> per CVR in cash (an aggregate of up to approximately $<ix:nonfraction contextref="ieacc700b698842408fe2f8c736054aa3_I20221231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN180OS9mcmFnOmVkZDg1Zjg2YWYyNjQ0MGU5ZWZhMDdiM2U3YmE5ODY0L3RleHRyZWdpb246ZWRkODVmODZhZjI2NDQwZTllZmEwN2IzZTdiYTk4NjRfMzI5ODUzNDg5NTU4OQ_428d1249-58fb-4a3b-8759-3f6d0b0315b5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" scale="6" unitref="usd">123</ix:nonfraction>&#160;million) upon the achievement of certain specified milestones. The acquisition will expand our gene therapy portfolio to include potential treatments for hearing loss and other inner ear conditions. The acquisition is not subject to any financing condition and is expected to close in the fourth quarter of 2022, subject to customary closing conditions, including receipt of required antitrust clearance and the tender of a majority of the outstanding shares of Akouos's common stock.</ix:continuation></ix:continuation> </span></div><div style="margin-top:6pt"><span><br/></span></div><div id="i5fed483d9c7e4f3cbba3a62c53226cd7_52"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 4: <ix:nonnumeric contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" continuedat="i42589800df9b409f80be60e460bea592" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN181Mi9mcmFnOmIxNmQ0YjlkMmM5MzQ4ODZiZjM3YTgxYThjM2FiODM0L3RleHRyZWdpb246YjE2ZDRiOWQyYzkzNDg4NmJmMzdhODFhOGMzYWI4MzRfMTA3NTc_2f88cd9c-8e4f-4d20-88b6-307bd28c5de8" name="us-gaap:CollaborativeArrangementDisclosureTextBlock">Collaborations and Other Arrangements</ix:nonnumeric></span></div><ix:continuation continuedat="i37308c9518cf4ab5bd2f67e52edd2bbd" id="i42589800df9b409f80be60e460bea592"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We often enter into collaborative and other similar arrangements to develop and commercialize drug candidates. Collaborative activities may include research and development, marketing and selling (including promotional activities and physician detailing), manufacturing, and distribution. These arrangements often require milestone as well as royalty or profit-share payments, contingent upon the occurrence of certain future events linked to the success of the asset in development, as well as expense reimbursements from or payments to the collaboration partner. See Note 2 for amounts of collaboration and other revenue recognized from these types of arrangements. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating expenses for costs incurred pursuant to these arrangements are reported in their respective expense line item, net of any payments due to or reimbursements due from our collaboration partners, with such reimbursements being recognized at the time the party becomes obligated to pay. Each collaboration is unique in nature, and our more significant arrangements are discussed below. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Boehringer Ingelheim Diabetes Collaboration</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and Boehringer Ingelheim have a global agreement to jointly develop and commercialize a portfolio of diabetes compounds. Currently included in the collaboration are Boehringer Ingelheim's oral diabetes products: Jardiance, Glyxambi, Synjardy, Trijardy XR, Trajenta, and Jentadueto</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as well as our basal insulin, Basaglar. Glyxambi, Synjardy, and Trijardy XR are included in the Jardiance product family. Jentadueto is included in the Trajenta product family. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the regulatory approvals of Jardiance, Trajenta, and Basaglar in the U.S., Europe, and Japan, milestone payments made for Jardiance and Trajenta were capitalized as intangible assets and are being amortized to cost of sales, and milestone payments received for Basaglar were recorded as contract liabilities and are being amortized to collaboration and other revenue. The milestones pertaining to Jardiance and Trajenta are being amortized through their respective term under the collaboration, which, depending on country or region, is determined based on the latest to occur of (a) a defined number of years following launch date, (b) the expiration of the compound patent, or (c) the expiration of marketing authorization exclusivity. The milestones pertaining to Basaglar are being amortized through 2029. <ix:nonnumeric contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" continuedat="i1768c6828f5b4a75bb4f355d4c46cc3a" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN181Mi9mcmFnOmIxNmQ0YjlkMmM5MzQ4ODZiZjM3YTgxYThjM2FiODM0L3RleHRyZWdpb246YjE2ZDRiOWQyYzkzNDg4NmJmMzdhODFhOGMzYWI4MzRfMTA3NDk_78f77876-c203-4d20-9203-7cacc98da862" name="us-gaap:ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock">The table below summarizes the net milestones capitalized with respect to the Jardiance and Trajenta families of products and the net milestones deferred with respect to Basaglar as of September&#160;30, 2022 and December&#160;31, 2021: </ix:nonnumeric></span></div><ix:continuation continuedat="i7885d94a1add4d3e9f555862d2649742" id="i1768c6828f5b4a75bb4f355d4c46cc3a"><div style="margin-top:6pt;padding-left:9pt;text-indent:-9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.812%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.445%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Milestones Capitalized (Deferred)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1) </span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jardiance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="if142129c01ca4ea0b352f378c8bc9899_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN181Mi9mcmFnOmIxNmQ0YjlkMmM5MzQ4ODZiZjM3YTgxYThjM2FiODM0L3RhYmxlOjA3MjlmMmMyMWEyNDQ2MGQ5NzIwYTI0ZDgwMzVhYmYxL3RhYmxlcmFuZ2U6MDcyOWYyYzIxYTI0NDYwZDk3MjBhMjRkODAzNWFiZjFfMi0xLTEtMS0xNTk1NDA_7c5f2ab0-39c4-4a24-a141-bc0fc8e243f1" name="lly:CollaborativeArrangementRightsAndObligationsRightsObligations" scale="6" unitref="usd">121.2</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i744124019ee24c83852d6d07406b514c_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN181Mi9mcmFnOmIxNmQ0YjlkMmM5MzQ4ODZiZjM3YTgxYThjM2FiODM0L3RhYmxlOjA3MjlmMmMyMWEyNDQ2MGQ5NzIwYTI0ZDgwMzVhYmYxL3RhYmxlcmFuZ2U6MDcyOWYyYzIxYTI0NDYwZDk3MjBhMjRkODAzNWFiZjFfMi0yLTEtMS0xNTk1NDA_cfdca453-350a-48f7-982a-fcfe59c2edf4" name="lly:CollaborativeArrangementRightsAndObligationsRightsObligations" scale="6" unitref="usd">136.1</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trajenta</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i8a19b281bf8a4f059256a5bba91d053c_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN181Mi9mcmFnOmIxNmQ0YjlkMmM5MzQ4ODZiZjM3YTgxYThjM2FiODM0L3RhYmxlOjA3MjlmMmMyMWEyNDQ2MGQ5NzIwYTI0ZDgwMzVhYmYxL3RhYmxlcmFuZ2U6MDcyOWYyYzIxYTI0NDYwZDk3MjBhMjRkODAzNWFiZjFfMy0xLTEtMS0xNTk1NDA_08154d56-bd1b-45a6-a7bf-04bae21e3727" name="lly:CollaborativeArrangementRightsAndObligationsRightsObligations" scale="6" unitref="usd">69.6</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ic00807c6a67343bd9b77d66d8f53542e_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN181Mi9mcmFnOmIxNmQ0YjlkMmM5MzQ4ODZiZjM3YTgxYThjM2FiODM0L3RhYmxlOjA3MjlmMmMyMWEyNDQ2MGQ5NzIwYTI0ZDgwMzVhYmYxL3RhYmxlcmFuZ2U6MDcyOWYyYzIxYTI0NDYwZDk3MjBhMjRkODAzNWFiZjFfMy0yLTEtMS0xNTk1NDA_79a754c3-684f-4b05-a429-21d6d2e535ed" name="lly:CollaborativeArrangementRightsAndObligationsRightsObligations" scale="6" unitref="usd">88.5</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basaglar</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="ie2eb6b846c0e477a94f57d35ebf60943_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN181Mi9mcmFnOmIxNmQ0YjlkMmM5MzQ4ODZiZjM3YTgxYThjM2FiODM0L3RhYmxlOjA3MjlmMmMyMWEyNDQ2MGQ5NzIwYTI0ZDgwMzVhYmYxL3RhYmxlcmFuZ2U6MDcyOWYyYzIxYTI0NDYwZDk3MjBhMjRkODAzNWFiZjFfNC0xLTEtMS0xNTk1NDA_cf91d070-eef0-44fa-a9b7-0169329da805" name="lly:CollaborativeArrangementRightsAndObligationsRightsObligations" scale="6" sign="-" unitref="usd">135.3</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="ib6657690bf5241ba82f0d73292ac9ea7_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN181Mi9mcmFnOmIxNmQ0YjlkMmM5MzQ4ODZiZjM3YTgxYThjM2FiODM0L3RhYmxlOjA3MjlmMmMyMWEyNDQ2MGQ5NzIwYTI0ZDgwMzVhYmYxL3RhYmxlcmFuZ2U6MDcyOWYyYzIxYTI0NDYwZDk3MjBhMjRkODAzNWFiZjFfNC0yLTEtMS0xNTk1NDA_447b4005-69d8-40b2-94f4-db759d560cf3" name="lly:CollaborativeArrangementRightsAndObligationsRightsObligations" scale="6" sign="-" unitref="usd">149.3</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">This represents the amounts that have been capitalized (deferred) from the start of this collaboration through the end of the reporting period, net of amount amortized. </span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation continuedat="i1607506c39164692869697afa4f7ea2d" id="i37308c9518cf4ab5bd2f67e52edd2bbd"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the Jardiance product family, we and Boehringer Ingelheim share equally the ongoing development and commercialization costs in the most significant markets, and we record our portion of the development and commercialization costs as research and development expense and marketing, selling, and administrative expense, respectively. We receive a royalty on net sales of Boehringer Ingelheim's products in the most significant markets and recognize the royalty as collaboration and other revenue. Boehringer Ingelheim is entitled to potential performance payments depending on the net sales of the Jardiance product family; therefore, our reported revenue for Jardiance may be reduced by any potential performance payments we make related to this product family. The royalty received by us related to the Jardiance product family may also be increased or decreased depending on whether net sales for this product family exceed or fall below certain thresholds. We pay to Boehringer Ingelheim a royalty on net sales for Basaglar in the U.S. We record our sales of Basaglar to third parties as net product revenue with the royalty payments made to Boehringer Ingelheim recorded as cost of sales.</span></div><ix:continuation continuedat="if04031cc01bd4a95ac0b4852d726204a" id="i7885d94a1add4d3e9f555862d2649742"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our collaboration and other revenue recognized with respect to the Jardiance and Trajenta families of products and net product revenue recognized with respect to Basaglar:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.206%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jardiance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="idfba5b60fbbe4370bad16f003f72e3c1_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN181Mi9mcmFnOmIxNmQ0YjlkMmM5MzQ4ODZiZjM3YTgxYThjM2FiODM0L3RhYmxlOmRjNWFmNjFjMDJjNTQ2NDFhYjdkNjc3ODI1N2E5YzA0L3RhYmxlcmFuZ2U6ZGM1YWY2MWMwMmM1NDY0MWFiN2Q2Nzc4MjU3YTljMDRfMi0xLTEtMS0xNTk1NDA_4b4062e7-4dbf-476d-b7d9-c49ae88fb823" name="us-gaap:Revenues" scale="6" unitref="usd">573.3</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ia28641f7c767406eacaa8089e13a2e77_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN181Mi9mcmFnOmIxNmQ0YjlkMmM5MzQ4ODZiZjM3YTgxYThjM2FiODM0L3RhYmxlOmRjNWFmNjFjMDJjNTQ2NDFhYjdkNjc3ODI1N2E5YzA0L3RhYmxlcmFuZ2U6ZGM1YWY2MWMwMmM1NDY0MWFiN2Q2Nzc4MjU3YTljMDRfMi0zLTEtMS0xNTk1NDA_a6146567-ce3d-4baa-8cc0-7c8b22aba394" name="us-gaap:Revenues" scale="6" unitref="usd">390.4</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i1c01691865ed49fc84902886c99bbbdf_D20220101-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN181Mi9mcmFnOmIxNmQ0YjlkMmM5MzQ4ODZiZjM3YTgxYThjM2FiODM0L3RhYmxlOmRjNWFmNjFjMDJjNTQ2NDFhYjdkNjc3ODI1N2E5YzA0L3RhYmxlcmFuZ2U6ZGM1YWY2MWMwMmM1NDY0MWFiN2Q2Nzc4MjU3YTljMDRfMi01LTEtMS0xNTk1NDA_cb373d45-18c4-40fb-bb86-e9d14a320f3a" name="us-gaap:Revenues" scale="6" unitref="usd">1,453.7</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i46099dfb95b0484ab5891f186d350f52_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN181Mi9mcmFnOmIxNmQ0YjlkMmM5MzQ4ODZiZjM3YTgxYThjM2FiODM0L3RhYmxlOmRjNWFmNjFjMDJjNTQ2NDFhYjdkNjc3ODI1N2E5YzA0L3RhYmxlcmFuZ2U6ZGM1YWY2MWMwMmM1NDY0MWFiN2Q2Nzc4MjU3YTljMDRfMi03LTEtMS0xNTk1NDA_70ca7508-c330-4dc2-95ef-5b171312bb25" name="us-gaap:Revenues" scale="6" unitref="usd">1,058.9</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basaglar</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="id6f3b41d10de4dfb99b809554e15f4ca_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN181Mi9mcmFnOmIxNmQ0YjlkMmM5MzQ4ODZiZjM3YTgxYThjM2FiODM0L3RhYmxlOmRjNWFmNjFjMDJjNTQ2NDFhYjdkNjc3ODI1N2E5YzA0L3RhYmxlcmFuZ2U6ZGM1YWY2MWMwMmM1NDY0MWFiN2Q2Nzc4MjU3YTljMDRfMy0xLTEtMS0xNTk1NDA_f5a63c3a-96cf-4c8e-978e-398f3ff81c82" name="us-gaap:Revenues" scale="6" unitref="usd">193.0</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ieef95d1c0c4643f8a5a104c9301c56f6_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN181Mi9mcmFnOmIxNmQ0YjlkMmM5MzQ4ODZiZjM3YTgxYThjM2FiODM0L3RhYmxlOmRjNWFmNjFjMDJjNTQ2NDFhYjdkNjc3ODI1N2E5YzA0L3RhYmxlcmFuZ2U6ZGM1YWY2MWMwMmM1NDY0MWFiN2Q2Nzc4MjU3YTljMDRfMy0zLTEtMS0xNTk1NDA_f749cbc3-4bf9-40a9-9045-7be859795e51" name="us-gaap:Revenues" scale="6" unitref="usd">192.8</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i1f95ba5af9c24c3eb20dc2c5a3979588_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN181Mi9mcmFnOmIxNmQ0YjlkMmM5MzQ4ODZiZjM3YTgxYThjM2FiODM0L3RhYmxlOmRjNWFmNjFjMDJjNTQ2NDFhYjdkNjc3ODI1N2E5YzA0L3RhYmxlcmFuZ2U6ZGM1YWY2MWMwMmM1NDY0MWFiN2Q2Nzc4MjU3YTljMDRfMy01LTEtMS0xNTk1NDA_11a1b9ff-2de8-493b-989f-355beeaf0e2b" name="us-gaap:Revenues" scale="6" unitref="usd">558.7</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="id065d1641c8b4bc19bda4f978edc7f70_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN181Mi9mcmFnOmIxNmQ0YjlkMmM5MzQ4ODZiZjM3YTgxYThjM2FiODM0L3RhYmxlOmRjNWFmNjFjMDJjNTQ2NDFhYjdkNjc3ODI1N2E5YzA0L3RhYmxlcmFuZ2U6ZGM1YWY2MWMwMmM1NDY0MWFiN2Q2Nzc4MjU3YTljMDRfMy03LTEtMS0xNTk1NDA_ce835c8b-bb9d-4ca6-af69-991834fa4bc4" name="us-gaap:Revenues" scale="6" unitref="usd">650.1</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trajenta</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i91e1bea218144eab958a68c72b25b13d_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN181Mi9mcmFnOmIxNmQ0YjlkMmM5MzQ4ODZiZjM3YTgxYThjM2FiODM0L3RhYmxlOmRjNWFmNjFjMDJjNTQ2NDFhYjdkNjc3ODI1N2E5YzA0L3RhYmxlcmFuZ2U6ZGM1YWY2MWMwMmM1NDY0MWFiN2Q2Nzc4MjU3YTljMDRfNC0xLTEtMS0xNTk1NDA_e1ddd021-8863-4d52-87c7-21043d1d2d01" name="us-gaap:Revenues" scale="6" unitref="usd">103.8</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i9fe7212a81994bafa9e83b419cfb489f_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN181Mi9mcmFnOmIxNmQ0YjlkMmM5MzQ4ODZiZjM3YTgxYThjM2FiODM0L3RhYmxlOmRjNWFmNjFjMDJjNTQ2NDFhYjdkNjc3ODI1N2E5YzA0L3RhYmxlcmFuZ2U6ZGM1YWY2MWMwMmM1NDY0MWFiN2Q2Nzc4MjU3YTljMDRfNC0zLTEtMS0xNTk1NDA_38c0a24d-a730-4496-b8f8-5919446b8f00" name="us-gaap:Revenues" scale="6" unitref="usd">96.1</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i4cbfd23e4f9c474bac8535d65c4695e8_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN181Mi9mcmFnOmIxNmQ0YjlkMmM5MzQ4ODZiZjM3YTgxYThjM2FiODM0L3RhYmxlOmRjNWFmNjFjMDJjNTQ2NDFhYjdkNjc3ODI1N2E5YzA0L3RhYmxlcmFuZ2U6ZGM1YWY2MWMwMmM1NDY0MWFiN2Q2Nzc4MjU3YTljMDRfNC01LTEtMS0xNTk1NDA_63f9b6e9-36d6-40c9-bd8d-27168e12376d" name="us-gaap:Revenues" scale="6" unitref="usd">293.0</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i57c459014f2c4c2797423bd9e7eff879_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN181Mi9mcmFnOmIxNmQ0YjlkMmM5MzQ4ODZiZjM3YTgxYThjM2FiODM0L3RhYmxlOmRjNWFmNjFjMDJjNTQ2NDFhYjdkNjc3ODI1N2E5YzA0L3RhYmxlcmFuZ2U6ZGM1YWY2MWMwMmM1NDY0MWFiN2Q2Nzc4MjU3YTljMDRfNC03LTEtMS0xNTk1NDA_67e2a83d-773e-46af-90d5-440415a399aa" name="us-gaap:Revenues" scale="6" unitref="usd">279.9</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div></ix:continuation><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Olumiant</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a worldwide license and collaboration agreement with Incyte Corporation (Incyte), which provides us the development and commercialization rights to baricitinib, branded and trademarked as Olumiant, and certain follow-on compounds, for the treatment of inflammatory and autoimmune diseases and COVID-19. Incyte has the right to receive tiered, double digit royalty payments on worldwide net sales with rates ranging up to <ix:nonfraction contextref="idfc0a5f22fb44537835f6510caaa9fa5_D20220101-20220930" decimals="2" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN181Mi9mcmFnOmIxNmQ0YjlkMmM5MzQ4ODZiZjM3YTgxYThjM2FiODM0L3RleHRyZWdpb246YjE2ZDRiOWQyYzkzNDg4NmJmMzdhODFhOGMzYWI4MzRfNDY4NQ_52dc7c2d-ce3b-484e-8820-da8deb37ac53" name="lly:CollaborativeArrangementRightsAndObligationsPercent" scale="-2" unitref="number">20</ix:nonfraction> percent. Incyte has the right to receive an additional royalty ranging up to the low teens on worldwide net sales for the treatment of COVID-19 that exceed a specified aggregate worldwide net sales threshold. The agreement calls for payments by us to Incyte associated with certain development, success-based regulatory, and sales-based milestones. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the regulatory approvals of Olumiant in the U.S., Europe, and Japan, as well as achievement of a sales-based milestone, milestone payments of $<ix:nonfraction contextref="i46a25e2e10224815a8f7d26777b2eb48_I20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN181Mi9mcmFnOmIxNmQ0YjlkMmM5MzQ4ODZiZjM3YTgxYThjM2FiODM0L3RleHRyZWdpb246YjE2ZDRiOWQyYzkzNDg4NmJmMzdhODFhOGMzYWI4MzRfNTE5MQ_fa58c009-cddb-453c-b9ad-ccec3892dbd5" name="lly:CollaborativeArrangementRightsAndObligationsRightsObligations" scale="6" unitref="usd">330.0</ix:nonfraction> million and $<ix:nonfraction contextref="i445e64ca4f7041e49970bead926a789e_I20211231" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN181Mi9mcmFnOmIxNmQ0YjlkMmM5MzQ4ODZiZjM3YTgxYThjM2FiODM0L3RleHRyZWdpb246YjE2ZDRiOWQyYzkzNDg4NmJmMzdhODFhOGMzYWI4MzRfNTE5OA_d0840c62-9cc7-4622-b373-a0656d5f6900" name="lly:CollaborativeArrangementRightsAndObligationsRightsObligations" scale="6" unitref="usd">260.0</ix:nonfraction> million were capitalized as intangible assets as of September&#160;30, 2022 and December&#160;31, 2021, respectively, and are being amortized to cost of sales through the term of the collaboration. This represents the cumulative amounts that have been capitalized from the start of this collaboration through the end of each reporting period.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, Incyte is eligible to receive up to $<ix:nonfraction contextref="i97f0fe2e404740069df426fbe933ed1d_I20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN181Mi9mcmFnOmIxNmQ0YjlkMmM5MzQ4ODZiZjM3YTgxYThjM2FiODM0L3RleHRyZWdpb246YjE2ZDRiOWQyYzkzNDg4NmJmMzdhODFhOGMzYWI4MzRfNTU0MQ_dd7e39fd-0976-4f85-9a1c-db6ffbeaaf75" name="lly:CollaborativeArrangementRightsAndObligationsRightsObligations" scale="6" unitref="usd">100.0</ix:nonfraction>&#160;million of additional payments from us in potential sales-based milestones.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record our sales of Olumiant, including sales of baricitinib that were made pursuant to EUA or similar regulatory authorizations, to third parties as net product revenue with the royalty payments made to Incyte recorded as cost of sales. <ix:continuation continuedat="ib45ada16e894467ba256f4720108241b" id="if04031cc01bd4a95ac0b4852d726204a">The following table summarizes our net product revenue recognized with respect to Olumiant:</ix:continuation></span></div><div style="margin-top:6pt;text-align:center"><ix:continuation continuedat="i29d0279936634dd4a8516c55644e400d" id="ib45ada16e894467ba256f4720108241b"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.206%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Olumiant</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i65843c3594444a24be3c2dd715fb25e8_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN181Mi9mcmFnOmIxNmQ0YjlkMmM5MzQ4ODZiZjM3YTgxYThjM2FiODM0L3RhYmxlOmJhZTliNGI0MzhjZjRjY2Y5MDE2NTI3M2YyOTlkNmUzL3RhYmxlcmFuZ2U6YmFlOWI0YjQzOGNmNGNjZjkwMTY1MjczZjI5OWQ2ZTNfMi0xLTEtMS0xNTk1NDA_257580ce-899d-4d9b-ab06-7b681acb7802" name="us-gaap:Revenues" scale="6" unitref="usd">182.9</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i342e7e7b465546ffa22256042c6bf573_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN181Mi9mcmFnOmIxNmQ0YjlkMmM5MzQ4ODZiZjM3YTgxYThjM2FiODM0L3RhYmxlOmJhZTliNGI0MzhjZjRjY2Y5MDE2NTI3M2YyOTlkNmUzL3RhYmxlcmFuZ2U6YmFlOWI0YjQzOGNmNGNjZjkwMTY1MjczZjI5OWQ2ZTNfMi0zLTEtMS0xNTk1NDA_64568da7-872d-4490-bbf2-bebf62cdca4f" name="us-gaap:Revenues" scale="6" unitref="usd">406.9</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i5da2c0b8af014f4085d9e2a62f64ccc7_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN181Mi9mcmFnOmIxNmQ0YjlkMmM5MzQ4ODZiZjM3YTgxYThjM2FiODM0L3RhYmxlOmJhZTliNGI0MzhjZjRjY2Y5MDE2NTI3M2YyOTlkNmUzL3RhYmxlcmFuZ2U6YmFlOWI0YjQzOGNmNGNjZjkwMTY1MjczZjI5OWQ2ZTNfMi01LTEtMS0xNTk1NDA_0df76049-ccad-4122-b1a1-eae0338220ed" name="us-gaap:Revenues" scale="6" unitref="usd">624.7</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i681b00cc06e740d5afd240016ce29efc_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN181Mi9mcmFnOmIxNmQ0YjlkMmM5MzQ4ODZiZjM3YTgxYThjM2FiODM0L3RhYmxlOmJhZTliNGI0MzhjZjRjY2Y5MDE2NTI3M2YyOTlkNmUzL3RhYmxlcmFuZ2U6YmFlOWI0YjQzOGNmNGNjZjkwMTY1MjczZjI5OWQ2ZTNfMi03LTEtMS0xNTk1NDA_0e645580-44b6-4123-bb51-2c0d05b45c34" name="us-gaap:Revenues" scale="6" unitref="usd">809.1</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation continuedat="ibad8abd71c984a5394a588f0ecc207a1" id="i1607506c39164692869697afa4f7ea2d"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COVID-19 Antibodies</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a worldwide license and collaboration agreement with AbCellera Biologics Inc. (AbCellera) to co-develop therapeutic antibodies for the potential prevention and treatment of COVID-19, including bamlanivimab and bebtelovimab, for which we hold development and commercialization rights. AbCellera has the right to receive tiered royalty payments on worldwide net sales of bamlanivimab and bebtelovimab with percentages ranging in the mid-teens to mid-twenties. Royalty payments made to AbCellera are recorded as cost of sales.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a license and collaboration agreement with Shanghai Junshi Biosciences Co., Ltd. (Junshi Biosciences) to co-develop therapeutic antibodies for the potential prevention and treatment of COVID-19, including etesevimab, for which we hold development and commercialization rights outside of mainland China and the Special Administrative Regions of Hong Kong and Macau, and for which Junshi Biosciences currently maintains all rights in mainland China and the Special Administrative Regions of Hong Kong and Macau. Junshi Biosciences has the right to receive royalty payments in the mid-teens on our net sales of etesevimab. Junshi Biosciences received certain development, success-based regulatory and sales-based milestones. Capitalized regulatory and sales-based milestones were fully amortized to cost of sales as of September&#160;30, 2022. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to EUAs or similar regulatory authorizations, we recognized net product revenue associated with our sales of our COVID-19 antibodies of $<ix:nonfraction contextref="ic89265df487544d48f864b30c7c12762_D20220701-20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN181Mi9mcmFnOmIxNmQ0YjlkMmM5MzQ4ODZiZjM3YTgxYThjM2FiODM0L3RleHRyZWdpb246YjE2ZDRiOWQyYzkzNDg4NmJmMzdhODFhOGMzYWI4MzRfNzE0NjgyNTU5MjY4OQ_84c24c47-9b52-4830-9028-647017123355" name="us-gaap:Revenues" scale="6" unitref="usd">386.6</ix:nonfraction> million and $<ix:nonfraction contextref="ie674d270134f4cffaff8f7a15471b73e_D20220101-20220930" decimals="-7" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN181Mi9mcmFnOmIxNmQ0YjlkMmM5MzQ4ODZiZjM3YTgxYThjM2FiODM0L3RleHRyZWdpb246YjE2ZDRiOWQyYzkzNDg4NmJmMzdhODFhOGMzYWI4MzRfNzE0NjgyNTU5MjcwMg_2b20ced1-1fef-4ea4-92ae-675404e43394" name="us-gaap:Revenues" scale="9" unitref="usd">1.99</ix:nonfraction> billion for the three and nine months ended September&#160;30, 2022, respectively, and $<ix:nonfraction contextref="i05b4b2fd75f8488cafa80162074dca18_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN181Mi9mcmFnOmIxNmQ0YjlkMmM5MzQ4ODZiZjM3YTgxYThjM2FiODM0L3RleHRyZWdpb246YjE2ZDRiOWQyYzkzNDg4NmJmMzdhODFhOGMzYWI4MzRfNzUyOQ_68157132-4443-4e9f-95c1-d21929f2a3b7" name="us-gaap:Revenues" scale="6" unitref="usd">217.1</ix:nonfraction>&#160;million and $<ix:nonfraction contextref="ic06f11244a5a4b88822809b3b3941ffe_D20210101-20210930" decimals="-7" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN181Mi9mcmFnOmIxNmQ0YjlkMmM5MzQ4ODZiZjM3YTgxYThjM2FiODM0L3RleHRyZWdpb246YjE2ZDRiOWQyYzkzNDg4NmJmMzdhODFhOGMzYWI4MzRfNTQ5NzU1ODI2MDE4_ce62e567-a21b-4e98-8737-7351a6a6f471" name="us-gaap:Revenues" scale="9" unitref="usd">1.18</ix:nonfraction> billion for the three and nine months ended September&#160;30, 2021, respectively. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sintilimab Injection</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a collaboration agreement with Innovent Biologics, Inc. (Innovent) to jointly develop and commercialize sintilimab injection in China, where it is branded and trademarked as Tyvyt. In connection with regulatory approvals for Tyvyt in China, milestone payments of $<ix:nonfraction contextref="ia361008dd9de45979f0de7611a5df845_I20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN181Mi9mcmFnOmIxNmQ0YjlkMmM5MzQ4ODZiZjM3YTgxYThjM2FiODM0L3RleHRyZWdpb246YjE2ZDRiOWQyYzkzNDg4NmJmMzdhODFhOGMzYWI4MzRfODI2Ng_4cea3fff-5730-4da4-817c-c951866d375d" name="lly:CollaborativeArrangementRightsAndObligationsRightsObligations" scale="6" unitref="usd">120.0</ix:nonfraction>&#160;million and $<ix:nonfraction contextref="i9f82e7316ae6411ea23d0347aa8ad8db_I20211231" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN181Mi9mcmFnOmIxNmQ0YjlkMmM5MzQ4ODZiZjM3YTgxYThjM2FiODM0L3RleHRyZWdpb246YjE2ZDRiOWQyYzkzNDg4NmJmMzdhODFhOGMzYWI4MzRfODI3Mw_7a723e72-ba2a-4889-8d0d-4b4545b3cbdf" name="lly:CollaborativeArrangementRightsAndObligationsRightsObligations" scale="6" unitref="usd">40.0</ix:nonfraction>&#160;million were capitalized as intangible assets as of September&#160;30, 2022 and December&#160;31, 2021, respectively, and are being amortized to cost of sales through the term of the collaboration. This represents the cumulative amounts that have been capitalized from the start of this collaboration through the end of each reporting period. As of September&#160;30, 2022, Innovent is eligible to receive up to $<ix:nonfraction contextref="i8e3c0bf77cd749d8b6fec828c354954b_I20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN181Mi9mcmFnOmIxNmQ0YjlkMmM5MzQ4ODZiZjM3YTgxYThjM2FiODM0L3RleHRyZWdpb246YjE2ZDRiOWQyYzkzNDg4NmJmMzdhODFhOGMzYWI4MzRfODY2NA_897e055d-5e0a-4dcc-a5a8-c57f56ac373d" name="lly:CollaborativeArrangementRightsAndObligationsRightsObligations" scale="6" unitref="usd">115.0</ix:nonfraction>&#160;million in success-based regulatory and sales-based milestones.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record our sales of Tyvyt to third parties as net product revenue, with payments made to Innovent for its portion of the gross margin reported as cost of sales. We report as collaboration and other revenue our portion of the gross margin for Tyvyt sales made by Innovent to third parties. <ix:continuation continuedat="i6347470199ed462697a9c005688aec57" id="i29d0279936634dd4a8516c55644e400d">The following table summarizes our revenue recognized in China with respect to Tyvyt:</ix:continuation></span></div><div style="margin-top:6pt;text-align:center"><ix:continuation id="i6347470199ed462697a9c005688aec57"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.206%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tyvyt</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ifc8fc5f6c1924a46b0d88ad7ea894f53_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN181Mi9mcmFnOmIxNmQ0YjlkMmM5MzQ4ODZiZjM3YTgxYThjM2FiODM0L3RhYmxlOjhjZDYxOTA4MTdlMjQ4NmM4ZDkyNzRhNWFjMzE5MzY0L3RhYmxlcmFuZ2U6OGNkNjE5MDgxN2UyNDg2YzhkOTI3NGE1YWMzMTkzNjRfMi0xLTEtMS0xNTk1NDA_dffb5a95-e891-48a9-a689-abb5c7e30b8f" name="us-gaap:Revenues" scale="6" unitref="usd">76.8</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i9da960751fa245d8bf93fa1681ead439_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN181Mi9mcmFnOmIxNmQ0YjlkMmM5MzQ4ODZiZjM3YTgxYThjM2FiODM0L3RhYmxlOjhjZDYxOTA4MTdlMjQ4NmM4ZDkyNzRhNWFjMzE5MzY0L3RhYmxlcmFuZ2U6OGNkNjE5MDgxN2UyNDg2YzhkOTI3NGE1YWMzMTkzNjRfMi0zLTEtMS0xNTk1NDA_c37672f7-0a32-4eec-a93a-db53ea961956" name="us-gaap:Revenues" scale="6" unitref="usd">125.6</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i6633f1ca883b4a32962bcd825ba66bfc_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN181Mi9mcmFnOmIxNmQ0YjlkMmM5MzQ4ODZiZjM3YTgxYThjM2FiODM0L3RhYmxlOjhjZDYxOTA4MTdlMjQ4NmM4ZDkyNzRhNWFjMzE5MzY0L3RhYmxlcmFuZ2U6OGNkNjE5MDgxN2UyNDg2YzhkOTI3NGE1YWMzMTkzNjRfMi01LTEtMS0xNTk1NDA_e0a86df6-6300-4357-90bd-48dc6a115ee0" name="us-gaap:Revenues" scale="6" unitref="usd">235.8</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i3a42a2407e7046519687e4401e714180_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN181Mi9mcmFnOmIxNmQ0YjlkMmM5MzQ4ODZiZjM3YTgxYThjM2FiODM0L3RhYmxlOjhjZDYxOTA4MTdlMjQ4NmM4ZDkyNzRhNWFjMzE5MzY0L3RhYmxlcmFuZ2U6OGNkNjE5MDgxN2UyNDg2YzhkOTI3NGE1YWMzMTkzNjRfMi03LTEtMS0xNTk1NDA_035251c1-2596-483b-bfe5-5ec2455ef786" name="us-gaap:Revenues" scale="6" unitref="usd">340.2</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, we obtained an exclusive license for sintilimab injection from Innovent for geographies outside of China, which was subsequently terminated and rights have reverted to Innovent in October 2022.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lebrikizumab</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a worldwide license agreement with F. Hoffmann-La Roche Ltd and Genentech, Inc. (collectively, Roche), which provides us the worldwide development and commercialization rights to lebrikizumab. Roche has the right to receive tiered royalty payments on future worldwide net sales ranging in percentages from high single digits to high teens if the product is successfully commercialized. As of September&#160;30, 2022, Roche is eligible to receive up to $<ix:nonfraction contextref="ic7d2b40b9fc943b9bfb247bb3c25f43f_I20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN181Mi9mcmFnOmIxNmQ0YjlkMmM5MzQ4ODZiZjM3YTgxYThjM2FiODM0L3RleHRyZWdpb246YjE2ZDRiOWQyYzkzNDg4NmJmMzdhODFhOGMzYWI4MzRfOTY3OQ_1dd06fe1-611c-4c8a-9fc1-0304b156891f" name="lly:CollaborativeArrangementRightsAndObligationsRightsObligations" scale="6" unitref="usd">180.0</ix:nonfraction>&#160;million of payments from us contingent upon the achievement of success-based regulatory milestones and up to $<ix:nonfraction contextref="id7f02cde7e1c419684772d2d99dda277_I20220930" decimals="-7" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN181Mi9mcmFnOmIxNmQ0YjlkMmM5MzQ4ODZiZjM3YTgxYThjM2FiODM0L3RleHRyZWdpb246YjE2ZDRiOWQyYzkzNDg4NmJmMzdhODFhOGMzYWI4MzRfOTc4Mw_5b09a2e2-6a19-45bb-8c28-a89c6a5ad3d2" name="lly:CollaborativeArrangementRightsAndObligationsRightsObligations" scale="9" unitref="usd">1.03</ix:nonfraction> billion in a series of sales-based milestones, contingent upon the commercial success of lebrikizumab.</span></div></ix:continuation><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ibad8abd71c984a5394a588f0ecc207a1">We have a license agreement with Almirall, S.A. (Almirall), under which Almirall licensed the rights to develop and commercialize lebrikizumab for the treatment or prevention of dermatology indications, including, but not limited to, atopic dermatitis in Europe. We have the right to receive tiered royalty payments on future net sales in Europe ranging in percentages from low double digits to low twenties if the product is successfully commercialized. As of September&#160;30, 2022, we are eligible to receive additional payments of $<ix:nonfraction contextref="i9e48d839c4b14a2e953d735b3bb79f88_I20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN181Mi9mcmFnOmIxNmQ0YjlkMmM5MzQ4ODZiZjM3YTgxYThjM2FiODM0L3RleHRyZWdpb246YjE2ZDRiOWQyYzkzNDg4NmJmMzdhODFhOGMzYWI4MzRfMTAzOTY_abe0622e-8118-47c2-ae5e-fba10e22f7af" name="lly:CollaborativeArrangementRightsAndObligationsRightsObligations" scale="6" unitref="usd">85.0</ix:nonfraction>&#160;million from Almirall contingent upon the achievement of success-based regulatory milestones and up to $<ix:nonfraction contextref="id39a445d06074ecaa26735263645cb4e_I20220930" decimals="-7" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN181Mi9mcmFnOmIxNmQ0YjlkMmM5MzQ4ODZiZjM3YTgxYThjM2FiODM0L3RleHRyZWdpb246YjE2ZDRiOWQyYzkzNDg4NmJmMzdhODFhOGMzYWI4MzRfMTA0OTQ_8f138dcc-b845-4cf3-b29f-ec17c2281664" name="lly:CollaborativeArrangementRightsAndObligationsRightsObligations" scale="9" unitref="usd">1.25</ix:nonfraction>&#160;billion in a series of sales-based milestones, contingent upon the commercial success of lebrikizumab. There were <ix:nonfraction contextref="iae28a429ac4b40e2a498a65c7eaaedc6_I20220930" decimals="INF" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN181Mi9mcmFnOmIxNmQ0YjlkMmM5MzQ4ODZiZjM3YTgxYThjM2FiODM0L3RleHRyZWdpb246YjE2ZDRiOWQyYzkzNDg4NmJmMzdhODFhOGMzYWI4MzRfMzI5ODUzNDg5NTkzNQ_ef166288-ac09-4915-b8a3-ff370612e89e" name="us-gaap:ContractWithCustomerLiability" scale="0" unitref="usd">no</ix:nonfraction> remaining contract liabilities as of September&#160;30, 2022. As of December&#160;31, 2021, contract liabilities were not material. During the three and nine months ended September&#160;30, 2022 and 2021, collaboration and other revenue recognized was not material.</ix:continuation> </span></div><div style="margin-top:6pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><div id="i5fed483d9c7e4f3cbba3a62c53226cd7_58"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 5: <ix:nonnumeric contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" continuedat="icd765b037a83457d970e625a5f8d3f75" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN181OC9mcmFnOjdhMjU0OTU2YzMzNTQ1Y2Y4M2YzNGQyMTZiNzAwM2IyL3RleHRyZWdpb246N2EyNTQ5NTZjMzM1NDVjZjgzZjM0ZDIxNmI3MDAzYjJfMTQ1OQ_36fb74c1-3feb-4aa2-a9d1-776a73faf563" name="us-gaap:RestructuringImpairmentAndOtherActivitiesDisclosureTextBlock">Asset Impairment, Restructuring, and Other Special Charges</ix:nonnumeric></span></div><ix:continuation id="icd765b037a83457d970e625a5f8d3f75"><ix:nonnumeric contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN181OC9mcmFnOjdhMjU0OTU2YzMzNTQ1Y2Y4M2YzNGQyMTZiNzAwM2IyL3RleHRyZWdpb246N2EyNTQ5NTZjMzM1NDVjZjgzZjM0ZDIxNmI3MDAzYjJfMTQ2Mw_30eb621b-b403-49a9-b4f2-cf6793535fbf" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the charges included in asset impairment, restructuring, and other special charges in our consolidated condensed statements of operations are described below. </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.206%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i19fc0325c48543008ea71e1fdcf11d86_D20220701-20220930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN181OC9mcmFnOjdhMjU0OTU2YzMzNTQ1Y2Y4M2YzNGQyMTZiNzAwM2IyL3RhYmxlOjMzZWJjYzY5ZmUzMzQ5Njc4OTEwNTYwMGIxODAxOTNhL3RhYmxlcmFuZ2U6MzNlYmNjNjlmZTMzNDk2Nzg5MTA1NjAwYjE4MDE5M2FfMi0xLTEtMS0xNTk1NDA_380697ba-892c-49de-98d4-b56752660ac8" name="us-gaap:SeveranceCosts1" scale="6" unitref="usd">&#8212;</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie4fa4f6b472a4f269297591b44aba572_D20210701-20210930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN181OC9mcmFnOjdhMjU0OTU2YzMzNTQ1Y2Y4M2YzNGQyMTZiNzAwM2IyL3RhYmxlOjMzZWJjYzY5ZmUzMzQ5Njc4OTEwNTYwMGIxODAxOTNhL3RhYmxlcmFuZ2U6MzNlYmNjNjlmZTMzNDk2Nzg5MTA1NjAwYjE4MDE5M2FfMi0zLTEtMS0xNTk1NDA_2782df8a-3172-459a-a984-388835739f8e" name="us-gaap:SeveranceCosts1" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN181OC9mcmFnOjdhMjU0OTU2YzMzNTQ1Y2Y4M2YzNGQyMTZiNzAwM2IyL3RhYmxlOjMzZWJjYzY5ZmUzMzQ5Njc4OTEwNTYwMGIxODAxOTNhL3RhYmxlcmFuZ2U6MzNlYmNjNjlmZTMzNDk2Nzg5MTA1NjAwYjE4MDE5M2FfMi01LTEtMS0xNTk1NDA_4961dac5-007a-46db-9323-8f4e563cee79" name="us-gaap:SeveranceCosts1" scale="6" unitref="usd">&#8212;</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN181OC9mcmFnOjdhMjU0OTU2YzMzNTQ1Y2Y4M2YzNGQyMTZiNzAwM2IyL3RhYmxlOjMzZWJjYzY5ZmUzMzQ5Njc4OTEwNTYwMGIxODAxOTNhL3RhYmxlcmFuZ2U6MzNlYmNjNjlmZTMzNDk2Nzg5MTA1NjAwYjE4MDE5M2FfMi03LTEtMS0xNTk1NDA_d03c8e32-2bdd-4e53-a743-aa601fb53597" name="us-gaap:SeveranceCosts1" scale="6" unitref="usd">11.5</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairment and other special charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i19fc0325c48543008ea71e1fdcf11d86_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN181OC9mcmFnOjdhMjU0OTU2YzMzNTQ1Y2Y4M2YzNGQyMTZiNzAwM2IyL3RhYmxlOjMzZWJjYzY5ZmUzMzQ5Njc4OTEwNTYwMGIxODAxOTNhL3RhYmxlcmFuZ2U6MzNlYmNjNjlmZTMzNDk2Nzg5MTA1NjAwYjE4MDE5M2FfMy0xLTEtMS0xNTk1NDA_c701641e-aa73-4776-9ea8-73bd44204eeb" name="lly:AssetImpairmentChargesRecoveriesAndOtherSpecialCharges" scale="6" unitref="usd">206.5</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie4fa4f6b472a4f269297591b44aba572_D20210701-20210930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN181OC9mcmFnOjdhMjU0OTU2YzMzNTQ1Y2Y4M2YzNGQyMTZiNzAwM2IyL3RhYmxlOjMzZWJjYzY5ZmUzMzQ5Njc4OTEwNTYwMGIxODAxOTNhL3RhYmxlcmFuZ2U6MzNlYmNjNjlmZTMzNDk2Nzg5MTA1NjAwYjE4MDE5M2FfMy0zLTEtMS0xNTk1NDA_38836c07-2dc0-4a68-96b1-789c0ddce6d4" name="lly:AssetImpairmentChargesRecoveriesAndOtherSpecialCharges" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN181OC9mcmFnOjdhMjU0OTU2YzMzNTQ1Y2Y4M2YzNGQyMTZiNzAwM2IyL3RhYmxlOjMzZWJjYzY5ZmUzMzQ5Njc4OTEwNTYwMGIxODAxOTNhL3RhYmxlcmFuZ2U6MzNlYmNjNjlmZTMzNDk2Nzg5MTA1NjAwYjE4MDE5M2FfMy01LTEtMS0xNTk1NDA_4a7fc6a4-00eb-48e0-9be6-7541e73b4e57" name="lly:AssetImpairmentChargesRecoveriesAndOtherSpecialCharges" scale="6" unitref="usd">206.5</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN181OC9mcmFnOjdhMjU0OTU2YzMzNTQ1Y2Y4M2YzNGQyMTZiNzAwM2IyL3RhYmxlOjMzZWJjYzY5ZmUzMzQ5Njc4OTEwNTYwMGIxODAxOTNhL3RhYmxlcmFuZ2U6MzNlYmNjNjlmZTMzNDk2Nzg5MTA1NjAwYjE4MDE5M2FfMy03LTEtMS0xNTk1NDA_22f520ff-4c8a-4171-8bec-3ed929512e3f" name="lly:AssetImpairmentChargesRecoveriesAndOtherSpecialCharges" scale="6" unitref="usd">200.1</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total asset impairment, restructuring, and other special charges</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i19fc0325c48543008ea71e1fdcf11d86_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN181OC9mcmFnOjdhMjU0OTU2YzMzNTQ1Y2Y4M2YzNGQyMTZiNzAwM2IyL3RhYmxlOjMzZWJjYzY5ZmUzMzQ5Njc4OTEwNTYwMGIxODAxOTNhL3RhYmxlcmFuZ2U6MzNlYmNjNjlmZTMzNDk2Nzg5MTA1NjAwYjE4MDE5M2FfNC0xLTEtMS0xNTk1NDA_871cfb58-2491-43dc-b184-34f9c6cf822b" name="us-gaap:RestructuringSettlementAndImpairmentProvisions" scale="6" unitref="usd">206.5</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie4fa4f6b472a4f269297591b44aba572_D20210701-20210930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN181OC9mcmFnOjdhMjU0OTU2YzMzNTQ1Y2Y4M2YzNGQyMTZiNzAwM2IyL3RhYmxlOjMzZWJjYzY5ZmUzMzQ5Njc4OTEwNTYwMGIxODAxOTNhL3RhYmxlcmFuZ2U6MzNlYmNjNjlmZTMzNDk2Nzg5MTA1NjAwYjE4MDE5M2FfNC0zLTEtMS0xNTk1NDA_440c64be-a839-43d8-afea-b5abbee97a08" name="us-gaap:RestructuringSettlementAndImpairmentProvisions" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN181OC9mcmFnOjdhMjU0OTU2YzMzNTQ1Y2Y4M2YzNGQyMTZiNzAwM2IyL3RhYmxlOjMzZWJjYzY5ZmUzMzQ5Njc4OTEwNTYwMGIxODAxOTNhL3RhYmxlcmFuZ2U6MzNlYmNjNjlmZTMzNDk2Nzg5MTA1NjAwYjE4MDE5M2FfNC01LTEtMS0xNTk1NDA_3d999b88-4ddd-4fb1-bbaa-a10090f42bea" name="us-gaap:RestructuringSettlementAndImpairmentProvisions" scale="6" unitref="usd">206.5</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN181OC9mcmFnOjdhMjU0OTU2YzMzNTQ1Y2Y4M2YzNGQyMTZiNzAwM2IyL3RhYmxlOjMzZWJjYzY5ZmUzMzQ5Njc4OTEwNTYwMGIxODAxOTNhL3RhYmxlcmFuZ2U6MzNlYmNjNjlmZTMzNDk2Nzg5MTA1NjAwYjE4MDE5M2FfNC03LTEtMS0xNTk1NDA_6408657e-186f-4757-bc29-234f3692c156" name="us-gaap:RestructuringSettlementAndImpairmentProvisions" scale="6" unitref="usd">211.6</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonnumeric><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Asset impairment, restructuring, and other special charges recognized during the three and nine months ended September 30, 2022 were primarily related to an intangible asset impairment for GBA1 Gene Therapy (PR001), acquired in the Prevail acquisition, as a result of changes in key assumptions used in the valuation due to delays in estimated launch timing.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Asset impairment, restructuring, and other special charges recognized during the nine months ended September&#160;30, 2021 were primarily related to an intangible asset impairment of $<ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN181OC9mcmFnOjdhMjU0OTU2YzMzNTQ1Y2Y4M2YzNGQyMTZiNzAwM2IyL3RleHRyZWdpb246N2EyNTQ5NTZjMzM1NDVjZjgzZjM0ZDIxNmI3MDAzYjJfNTUy_a6a138de-a385-482a-9695-61f4d5e3e137" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" scale="6" unitref="usd">108.1</ix:nonfraction>&#160;million resulting from the sale of the rights to Qbrexza</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as well as acquisition and integration costs associated with the acquisition of Prevail. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognized a net inventory impairment charge related to our COVID-19 antibodies of $<ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN181OC9mcmFnOjdhMjU0OTU2YzMzNTQ1Y2Y4M2YzNGQyMTZiNzAwM2IyL3RleHRyZWdpb246N2EyNTQ5NTZjMzM1NDVjZjgzZjM0ZDIxNmI3MDAzYjJfMzI5ODUzNDg5MTA1NQ_588cbba9-1f4c-4fa0-bc05-1cf0e9111c12" name="us-gaap:InventoryWriteDown" scale="6" unitref="usd">435.1</ix:nonfraction>&#160;million during the nine months ended September&#160;30, 2021 in cost of sales in our consolidated condensed statements of operations. As part of our response to the COVID-19 pandemic, and at the request of the U.S. and international governments, we invested in large-scale manufacturing of COVID-19 antibodies at risk, in order to ensure rapid access to patients around the world. As the COVID-19 pandemic evolved during 2021, we incurred a net inventory impairment charge primarily due to the combination of changes to demand from U.S. and international governments, including changes to our agreement with the U.S. government, and near-term expiry dates of COVID-19 antibodies.</span></div></ix:continuation><div style="margin-top:6pt"><span><br/></span></div><div id="i5fed483d9c7e4f3cbba3a62c53226cd7_61"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 6: <ix:nonnumeric contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" continuedat="i22eac50db1234c699d1d6d1c48247d51" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RleHRyZWdpb246OGRmOTEwZDdhYjFhNDFmMThlODU5ZTE4OTQxY2E4MDhfMTUxNjc_c5b9d29e-47f2-4819-a809-42a93bda0875" name="us-gaap:FairValueDisclosuresTextBlock">Financial Instruments</ix:nonnumeric></span></div><ix:continuation continuedat="i272d0faec1534fd68944863c239a84ec" id="i22eac50db1234c699d1d6d1c48247d51"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject us to credit risk consist principally of trade receivables and interest-bearing investments. Wholesale distributors of life science products account for a substantial portion of our trade receivables; collateral is generally not required. We seek to mitigate the risk associated with this concentration through our ongoing credit-review procedures and insurance. A large portion of our cash is held by a few major financial institutions. We monitor our exposures with these institutions and do not expect any of these institutions to fail to meet their obligations. In accordance with documented corporate risk-management policies, we monitor the amount of credit exposure to any one financial institution or corporate issuer. We are exposed to credit-related losses in the event of nonperformance by counterparties to risk-management instruments but do not expect any counterparties to fail to meet their obligations given their investment grade credit ratings.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider all highly liquid investments with a maturity of three months or less from the date of purchase to be cash equivalents. The cost of these investments approximates fair value.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our equity investments are accounted for using three different methods depending on the type of equity investment:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Investments in companies over which we have significant influence but not a controlling interest are accounted for using the equity method, with our share of earnings or losses reported in other-net, (income) expense. </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">For equity investments that do not have readily determinable fair values, we measure these investments at cost, less any impairment, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment of the same issuer. Any change in recorded value is recorded in other-net, (income) expense. </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our public equity investments are measured and carried at fair value. Any change in fair value is recognized in other-net, (income) expense. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We review equity investments other than public equity investments for indications of impairment and observable price changes on a regular basis.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation continuedat="i3620a190ca6c48c9bbbe0ac45245a2a4" id="i272d0faec1534fd68944863c239a84ec"><ix:nonnumeric contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" continuedat="i37426f726b8c48eba19a89cf7a4aa0b4" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RleHRyZWdpb246OGRmOTEwZDdhYjFhNDFmMThlODU5ZTE4OTQxY2E4MDhfMTUxNzM_083e67c0-6517-4e27-bc90-3f30344102df" name="us-gaap:DerivativesPolicyTextBlock"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our derivative activities are initiated within the guidelines of documented corporate risk-management policies and are intended to offset losses and gains on the assets, liabilities, and transactions being hedged. Management reviews the correlation and effectiveness of our derivatives on a quarterly basis.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For derivative instruments that are designated and qualify as fair value hedges, the derivative instrument is marked to market, with gains and losses recognized currently in income to offset the respective losses and gains recognized on the underlying exposure. For derivative instruments that are designated and qualify as cash flow hedges, gains and losses are reported as a component of accumulated other comprehensive loss and reclassified into earnings in the same period the hedged transaction affects earnings. For derivative and non-derivative instruments that are designated and qualify as net investment hedges, the foreign currency translation gains or losses due to spot rate fluctuations are reported as a component of accumulated other comprehensive loss. Derivative contracts that are not designated as hedging instruments are recorded at fair value with the gain or loss recognized in earnings during the period of change.</span></div></ix:nonnumeric><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i37426f726b8c48eba19a89cf7a4aa0b4">We may enter into foreign currency forward or option contracts to reduce the effect of fluctuating currency exchange rates (principally the euro, British pound, Chinese yuan, and Japanese yen). Foreign currency derivatives used for hedging are put in place using the same or like currencies and duration as the underlying exposures. Forward and option contracts are principally used to manage exposures arising from subsidiary trade and loan payables and receivables denominated in foreign currencies. These contracts are recorded at fair value with the gain or loss recognized in other&#8211;net, (income) expense. We may enter into foreign currency forward and option contracts and currency swaps as fair value hedges of firm commitments. Forward contracts generally have maturities not exceeding 12 months.</ix:continuation> At September&#160;30, 2022, we had outstanding foreign currency forward commitments to purchase <ix:nonfraction contextref="id7a3c615db604cd2baec39887078a8e2_I20220930" decimals="-7" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RleHRyZWdpb246OGRmOTEwZDdhYjFhNDFmMThlODU5ZTE4OTQxY2E4MDhfNDQyOQ_a74c6b7d-e01b-4fff-899d-93fdfa5fcc31" name="us-gaap:DerivativeLiabilityNotionalAmount" scale="9" unitref="usd">1.69</ix:nonfraction> billion U.S. dollars and sell <ix:nonfraction contextref="id7a3c615db604cd2baec39887078a8e2_I20220930" decimals="-7" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RleHRyZWdpb246OGRmOTEwZDdhYjFhNDFmMThlODU5ZTE4OTQxY2E4MDhfNDQ1NA_10b3bc07-0b02-4799-8b4e-6c7ea350c6d4" name="us-gaap:DerivativeAssetNotionalAmount" scale="9" unitref="eur">1.71</ix:nonfraction> billion euro; commitments to purchase <ix:nonfraction contextref="icbc49bb61efe4f65ba8c0e7f0093e86a_I20220930" decimals="-7" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RleHRyZWdpb246OGRmOTEwZDdhYjFhNDFmMThlODU5ZTE4OTQxY2E4MDhfNDQ4Nw_cc0d41a1-e5b0-4b89-8ece-06b439ee1596" name="us-gaap:DerivativeLiabilityNotionalAmount" scale="9" unitref="eur">2.24</ix:nonfraction> billion euro and sell <ix:nonfraction contextref="icbc49bb61efe4f65ba8c0e7f0093e86a_I20220930" decimals="-7" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RleHRyZWdpb246OGRmOTEwZDdhYjFhNDFmMThlODU5ZTE4OTQxY2E4MDhfNDUwNA_bf5baa84-61a7-4aa3-943a-cdb2b32ef617" name="us-gaap:DerivativeAssetNotionalAmount" scale="9" unitref="usd">2.24</ix:nonfraction>&#160;billion U.S. dollars; commitments to purchase <ix:nonfraction contextref="i77c728fb616a42cc8c6b40e0bbdd95d4_I20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RleHRyZWdpb246OGRmOTEwZDdhYjFhNDFmMThlODU5ZTE4OTQxY2E4MDhfNDU0NQ_0c46b301-a1d9-4ac4-9236-2758227b2a36" name="us-gaap:DerivativeLiabilityNotionalAmount" scale="6" unitref="usd">239.5</ix:nonfraction> million U.S. dollars and sell <ix:nonfraction contextref="i77c728fb616a42cc8c6b40e0bbdd95d4_I20220930" decimals="-7" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RleHRyZWdpb246OGRmOTEwZDdhYjFhNDFmMThlODU5ZTE4OTQxY2E4MDhfNDU3MA_2954e008-0049-4aed-a058-ca48833de239" name="us-gaap:DerivativeAssetNotionalAmount" scale="9" unitref="cny">1.63</ix:nonfraction> billion Chinese yuan; commitments to purchase <ix:nonfraction contextref="i80a649fe7dd9480994358ed2532d905d_I20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RleHRyZWdpb246OGRmOTEwZDdhYjFhNDFmMThlODU5ZTE4OTQxY2E4MDhfNDYxMQ_b5308860-f970-4a43-a307-7417551accf7" name="us-gaap:DerivativeLiabilityNotionalAmount" scale="6" unitref="usd">82.1</ix:nonfraction>&#160;million U.S. dollars and sell <ix:nonfraction contextref="i80a649fe7dd9480994358ed2532d905d_I20220930" decimals="-7" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RleHRyZWdpb246OGRmOTEwZDdhYjFhNDFmMThlODU5ZTE4OTQxY2E4MDhfNDYzNg_78be03b4-0d03-4ba4-9113-d2d8ea320b6c" name="us-gaap:DerivativeAssetNotionalAmount" scale="9" unitref="jpy">11.86</ix:nonfraction> billion Japanese yen; and commitments to purchase <ix:nonfraction contextref="i04bcb23b9ae84c9c9a64aca2a3cc4a34_I20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RleHRyZWdpb246OGRmOTEwZDdhYjFhNDFmMThlODU5ZTE4OTQxY2E4MDhfNDY4MQ_0ba8459b-6759-4c70-a770-bcdcd8d741e8" name="us-gaap:DerivativeLiabilityNotionalAmount" scale="6" unitref="gbp">182.1</ix:nonfraction> million British pounds and sell <ix:nonfraction contextref="i04bcb23b9ae84c9c9a64aca2a3cc4a34_I20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RleHRyZWdpb246OGRmOTEwZDdhYjFhNDFmMThlODU5ZTE4OTQxY2E4MDhfNDcwOA_cc4644b0-58d3-42a5-8ae5-aae578f05aff" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" unitref="usd">206.9</ix:nonfraction>&#160;million U.S. dollars, which all have settlement dates within <ix:nonnumeric contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RleHRyZWdpb246OGRmOTEwZDdhYjFhNDFmMThlODU5ZTE4OTQxY2E4MDhfNDc2NA_a682fe0f-96b5-453c-9736-9aab3a483f2d" name="us-gaap:MaximumRemainingMaturityOfForeignCurrencyDerivatives1">180</ix:nonnumeric> days.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign currency exchange risk is also managed through the use of foreign currency debt, cross-currency interest rate swaps, and foreign currency forward contracts. Our foreign currency-denominated notes had carrying amounts of $<ix:nonfraction contextref="ifd62109e29474416b9bd4cb46c68e40f_I20220930" decimals="-7" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RleHRyZWdpb246OGRmOTEwZDdhYjFhNDFmMThlODU5ZTE4OTQxY2E4MDhfNDk5Ng_1f3244f1-a7d5-4d3a-aae9-770af8f74064" name="us-gaap:LongTermDebt" scale="9" unitref="usd">6.23</ix:nonfraction> billion and $<ix:nonfraction contextref="i9e675ec6e62d42a9bc9b9a5e61226095_I20211231" decimals="-7" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RleHRyZWdpb246OGRmOTEwZDdhYjFhNDFmMThlODU5ZTE4OTQxY2E4MDhfNTAwMw_b5fb8667-238a-4aba-bc32-b45eabce2aa6" name="us-gaap:LongTermDebt" scale="9" unitref="usd">7.90</ix:nonfraction>&#160;billion as of September&#160;30, 2022 and December&#160;31, 2021, respectively, of which $<ix:nonfraction contextref="i08ccb35f6ad24d7793c9c91b74ca2ea1_I20220930" decimals="-7" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RleHRyZWdpb246OGRmOTEwZDdhYjFhNDFmMThlODU5ZTE4OTQxY2E4MDhfNTA0Ng_b8b0af48-04d0-4d19-90be-7b2c8e0c91c9" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeNetOfTax" scale="9" unitref="usd">4.94</ix:nonfraction>&#160;billion and $<ix:nonfraction contextref="i0973ba0c1d894ceaa494709a13f814fb_I20211231" decimals="-7" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RleHRyZWdpb246OGRmOTEwZDdhYjFhNDFmMThlODU5ZTE4OTQxY2E4MDhfNTA1Mw_02423f90-bbe6-4b31-b670-0b1665f70c3a" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeNetOfTax" scale="9" unitref="usd">5.79</ix:nonfraction> billion have been designated as, and are effective as, economic hedges of net investments in certain of our foreign operations as of September&#160;30, 2022 and December&#160;31, 2021, respectively. At September&#160;30, 2022, we had outstanding cross-currency swaps with notional amounts of $<ix:nonfraction contextref="i5b6a7a49e6b543c7a9c9f34217259d0f_I20220930" decimals="-7" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RleHRyZWdpb246OGRmOTEwZDdhYjFhNDFmMThlODU5ZTE4OTQxY2E4MDhfNTI3OA_343b1e68-7452-4b3a-844c-c8ec49513718" name="us-gaap:DerivativeNotionalAmount" scale="9" unitref="usd">1.56</ix:nonfraction> billion swapping U.S. dollars to euro and $<ix:nonfraction contextref="i5f4cbed09a8d4efbba96a84a21c4f229_I20220930" decimals="-7" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RleHRyZWdpb246OGRmOTEwZDdhYjFhNDFmMThlODU5ZTE4OTQxY2E4MDhfNTMxNQ_cfa93c94-d8df-479c-aa9c-0481091d5af0" name="us-gaap:DerivativeNotionalAmount" scale="9" unitref="usd">1.00</ix:nonfraction>&#160;billion swapping Swiss francs to U.S. dollars which have settlement dates ranging through 2028. Our cross-currency interest rate swaps, for which a majority convert a portion of our U.S. dollar-denominated fixed-rate debt to foreign-denominated fixed-rate debt, have also been designated as, and are effective as, economic hedges of net investments. At September&#160;30, 2022, we had outstanding foreign currency forward contracts to sell <ix:nonfraction contextref="i223b03ef72744bd2b0b10b131126e63e_I20220930" decimals="-7" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RleHRyZWdpb246OGRmOTEwZDdhYjFhNDFmMThlODU5ZTE4OTQxY2E4MDhfNTcyOQ_fa195d7c-17a4-46ce-badc-403e77c1c4af" name="us-gaap:DerivativeAssetNotionalAmount" scale="9" unitref="eur">1.34</ix:nonfraction> billion euro with settlement dates ranging through 2023, which have been designated as, and are effective as, economic hedges of net investments.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, our operations are exposed to fluctuations in interest rates which can vary the costs of financing, investing, and operating. We seek to address a portion of these risks through a controlled program of risk management that includes the use of derivative financial instruments. The objective of controlling these risks is to limit the impact of fluctuations in interest rates on earnings. Our primary interest-rate risk exposure results from changes in short-term U.S. dollar interest rates. In an effort to manage interest-rate exposures, we strive to achieve an acceptable balance between fixed- and floating-rate debt and investment positions and may enter into interest rate swaps or collars to help maintain that balance.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest rate swaps or collars that convert our fixed-rate debt to a floating rate are designated as fair value hedges of the underlying instruments. Interest rate swaps or collars that convert floating-rate debt to a fixed rate are designated as cash flow hedges. Interest expense on the debt is adjusted to include the payments made or received under the swap agreements. Cash proceeds from or payments to counterparties resulting from the termination of interest rate swaps are classified as operating activities in our consolidated condensed statements of cash flows. At September&#160;30, 2022, substantially all of our total long-term debt is at a fixed rate. We have converted approximately <ix:nonfraction contextref="i08ccb35f6ad24d7793c9c91b74ca2ea1_I20220930" decimals="2" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RleHRyZWdpb246OGRmOTEwZDdhYjFhNDFmMThlODU5ZTE4OTQxY2E4MDhfNzMxNQ_c27361a5-c64b-408f-acaa-b2836a5cc3c5" name="lly:DescriptionOfDerivativeActivityVolumePercent" scale="-2" unitref="number">10</ix:nonfraction> percent of our long-term fixed-rate notes to floating rates through the use of interest rate swaps.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation continuedat="ie2d1b96979184c80ab5eb2a40bb0da95" id="i3620a190ca6c48c9bbbe0ac45245a2a4"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also may enter into forward-starting interest rate swaps, which we designate as cash flow hedges, as part of any anticipated future debt issuances in order to reduce the risk of cash flow volatility from future changes in interest rates. The change in fair value of these instruments is recorded as part of other comprehensive income (loss) and, upon completion of a debt issuance and termination of the swap, is amortized to interest expense over the life of the underlying debt. As of September&#160;30, 2022, the total notional amounts of forward-starting interest rate contracts in designated cash flow hedging instruments were $<ix:nonfraction contextref="iea65a7fd63824506a3ca41c5d51257a3_I20220930" decimals="-7" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RleHRyZWdpb246OGRmOTEwZDdhYjFhNDFmMThlODU5ZTE4OTQxY2E4MDhfODAxNw_0f465d2c-ee23-41d4-b53d-487c29e7e8fc" name="us-gaap:DerivativeNotionalAmount" scale="9" unitref="usd">1.75</ix:nonfraction> billion, which have settlement dates ranging between 2023 and 2025.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective September 15, 2022, we increased our <ix:nonnumeric contextref="i788cd34fd44840639efca67d73c371ff_D20220915-20220915" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RleHRyZWdpb246OGRmOTEwZDdhYjFhNDFmMThlODU5ZTE4OTQxY2E4MDhfMzI5ODUzNDkwMzAxNw_ce7d2d87-4026-482f-97b8-93cb1c592998" name="us-gaap:DebtInstrumentTerm">364-day</ix:nonnumeric> credit facility from $<ix:nonfraction contextref="i5d53c58f4c7d459489a11fd8bfd27153_I20220914" decimals="-7" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RleHRyZWdpb246OGRmOTEwZDdhYjFhNDFmMThlODU5ZTE4OTQxY2E4MDhfMzI5ODUzNDkwMjk1NQ_03c38822-6492-4c38-93c1-a50755127fa1" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="9" unitref="usd">2.00</ix:nonfraction>&#160;billion to $<ix:nonfraction contextref="i2c071467da4c408bbfd8f27f707626e7_I20220915" decimals="-7" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RleHRyZWdpb246OGRmOTEwZDdhYjFhNDFmMThlODU5ZTE4OTQxY2E4MDhfMzI5ODUzNDkwMjk3MA_59e876b1-ba17-4119-aa39-c2d44605e198" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="9" unitref="usd">4.00</ix:nonfraction>&#160;billion, which will expire in September 2023, and is available to support our commercial paper program. We have not drawn against the $<ix:nonfraction contextref="i2c071467da4c408bbfd8f27f707626e7_I20220915" decimals="-7" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RleHRyZWdpb246OGRmOTEwZDdhYjFhNDFmMThlODU5ZTE4OTQxY2E4MDhfMzI5ODUzNDkwMjk4NQ_3b24ed1c-d1d4-4ebd-a28a-94b6d7e89ddc" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="9" unitref="usd">4.00</ix:nonfraction>&#160;billion <ix:nonnumeric contextref="i788cd34fd44840639efca67d73c371ff_D20220915-20220915" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RleHRyZWdpb246OGRmOTEwZDdhYjFhNDFmMThlODU5ZTE4OTQxY2E4MDhfMzI5ODUzNDkwMzAxOA_694da09d-cb8c-4113-9beb-2dffa4b64e6f" name="us-gaap:DebtInstrumentTerm">364-day</ix:nonnumeric> credit facility as of September 30, 2022.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2021, we issued euro-denominated notes consisting of &#8364;<ix:nonfraction contextref="i17173f194d1742f38780c496d01c1177_I20210930" decimals="INF" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RleHRyZWdpb246OGRmOTEwZDdhYjFhNDFmMThlODU5ZTE4OTQxY2E4MDhfMzI5ODUzNDkwMTE5OA_fabf239f-6312-44b9-9ce8-43bbc6b59362" name="us-gaap:DebtInstrumentFaceAmount" scale="6" unitref="eur">600.0</ix:nonfraction>&#160;million of <ix:nonfraction contextref="i17173f194d1742f38780c496d01c1177_I20210930" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RleHRyZWdpb246OGRmOTEwZDdhYjFhNDFmMThlODU5ZTE4OTQxY2E4MDhfMzI5ODUzNDkwMTIxNA_a89528c5-914f-4899-b7f3-320697f05b06" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="0" unitref="number">0.50</ix:nonfraction> percent fixed-rate notes due in September 2033, with interest to be paid annually. The net proceeds from the offering have been, and will continue to be, used to fund, in whole or in part, eligible projects designed to advance one or more of our environmental, social, and governance objectives.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2021, we issued euro-denominated notes consisting of &#8364;<ix:nonfraction contextref="iff7c9802a16c4e94a8b83d2c06fbfd30_I20210930" decimals="INF" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RleHRyZWdpb246OGRmOTEwZDdhYjFhNDFmMThlODU5ZTE4OTQxY2E4MDhfMzI5ODUzNDkwMDU5Mg_e09fb3a2-d8d3-496f-ae95-6f9d425edad8" name="us-gaap:DebtInstrumentFaceAmount" scale="6" unitref="eur">500.0</ix:nonfraction>&#160;million of <ix:nonfraction contextref="iff7c9802a16c4e94a8b83d2c06fbfd30_I20210930" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RleHRyZWdpb246OGRmOTEwZDdhYjFhNDFmMThlODU5ZTE4OTQxY2E4MDhfMzI5ODUzNDkwMDYwOA_ffb64c0c-3315-4943-b496-0acaf2271454" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="0" unitref="number">1.125</ix:nonfraction> percent fixed-rate notes due in September 2051 and &#8364;<ix:nonfraction contextref="i11a8fe2e658c49ab879c662bd320fc8e_I20210930" decimals="INF" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RleHRyZWdpb246OGRmOTEwZDdhYjFhNDFmMThlODU5ZTE4OTQxY2E4MDhfMzI5ODUzNDkwMDYxNQ_8c2421ec-6805-49f0-abfc-907a2d70ae19" name="us-gaap:DebtInstrumentFaceAmount" scale="6" unitref="eur">700.0</ix:nonfraction>&#160;million of <ix:nonfraction contextref="i11a8fe2e658c49ab879c662bd320fc8e_I20210930" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RleHRyZWdpb246OGRmOTEwZDdhYjFhNDFmMThlODU5ZTE4OTQxY2E4MDhfMzI5ODUzNDkwMDYzMQ_95d377da-b023-432b-a5c5-3cd13eafd92a" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="0" unitref="number">1.375</ix:nonfraction> percent fixed-rate notes due in September 2061, with interest to be paid annually, and British pound-denominated notes consisting of &#163;<ix:nonfraction contextref="iea81ed26b993414992722e426a530c04_I20210930" decimals="INF" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RleHRyZWdpb246OGRmOTEwZDdhYjFhNDFmMThlODU5ZTE4OTQxY2E4MDhfMzI5ODUzNDkwMDYzOA_ecaafde3-786f-4832-a0d2-e47e6084fa99" name="us-gaap:DebtInstrumentFaceAmount" scale="6" unitref="gbp">250.0</ix:nonfraction>&#160;million of <ix:nonfraction contextref="iea81ed26b993414992722e426a530c04_I20210930" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RleHRyZWdpb246OGRmOTEwZDdhYjFhNDFmMThlODU5ZTE4OTQxY2E4MDhfMzI5ODUzNDkwMDY1NA_9bac2bf5-3734-43f3-8c9c-c37e9ed447a6" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="0" unitref="number">1.625</ix:nonfraction> percent fixed-rate notes due in September 2043, with interest to be paid annually. We paid $<ix:nonfraction contextref="icdfd3853e3eb4a398286b232426b38b1_D20210901-20210930" decimals="-7" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RleHRyZWdpb246OGRmOTEwZDdhYjFhNDFmMThlODU5ZTE4OTQxY2E4MDhfMzI5ODUzNDkwMDY2MQ_01f5fe97-07e9-40cd-a008-d0e4dd747414" name="us-gaap:PaymentsOfDebtExtinguishmentCosts" scale="9" unitref="usd">1.91</ix:nonfraction>&#160;billion of the net cash proceeds from the offering to purchase and redeem certain higher interest rate U.S. dollar-denominated notes with an aggregate principal amount of $<ix:nonfraction contextref="icdfd3853e3eb4a398286b232426b38b1_D20210901-20210930" decimals="-7" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RleHRyZWdpb246OGRmOTEwZDdhYjFhNDFmMThlODU5ZTE4OTQxY2E4MDhfMzI5ODUzNDkwMDY3Ng_77656b80-9cdf-43ef-8295-52415607ddc0" name="us-gaap:ExtinguishmentOfDebtAmount" scale="9" unitref="usd">1.50</ix:nonfraction>&#160;billion, resulting in a debt extinguishment loss of $<ix:nonfraction contextref="icdfd3853e3eb4a398286b232426b38b1_D20210901-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RleHRyZWdpb246OGRmOTEwZDdhYjFhNDFmMThlODU5ZTE4OTQxY2E4MDhfMzI5ODUzNDkwMDY5MQ_3f663fd6-62a2-4a6d-8eaa-a65c832b3eb8" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" sign="-" unitref="usd">405.2</ix:nonfraction>&#160;million. This loss was included in other net, (income) expense in our consolidated condensed statement of operations during the three and nine months ended September 30, 2021. The $<ix:nonfraction contextref="icdfd3853e3eb4a398286b232426b38b1_D20210901-20210930" decimals="-7" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RleHRyZWdpb246OGRmOTEwZDdhYjFhNDFmMThlODU5ZTE4OTQxY2E4MDhfMzI5ODUzNDkwMDcwNw_a500e631-12ca-44b6-af36-97afec4dfb37" name="us-gaap:ExtinguishmentOfDebtAmount" scale="9" unitref="usd">1.50</ix:nonfraction>&#160;billion principal amount of higher interest rate U.S. dollar-denominated notes that were redeemed primarily included $<ix:nonfraction contextref="i96587d4174a14444becf7821313b1347_D20210901-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RleHRyZWdpb246OGRmOTEwZDdhYjFhNDFmMThlODU5ZTE4OTQxY2E4MDhfMzI5ODUzNDkwMDcyMg_702426dc-cd70-47c9-9146-873f2a3501c3" name="us-gaap:ExtinguishmentOfDebtAmount" scale="6" unitref="usd">541.8</ix:nonfraction>&#160;million of <ix:nonfraction contextref="i750c23289e514e58bf58ede4855592f4_I20210930" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RleHRyZWdpb246OGRmOTEwZDdhYjFhNDFmMThlODU5ZTE4OTQxY2E4MDhfMzI5ODUzNDkwMDczOA_047fb137-f65c-4028-8748-262cfe831471" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="0" unitref="number">3.95</ix:nonfraction> percent notes due 2049, $<ix:nonfraction contextref="ice18fb651f95409d813656a157f34daf_D20210901-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RleHRyZWdpb246OGRmOTEwZDdhYjFhNDFmMThlODU5ZTE4OTQxY2E4MDhfMzI5ODUzNDkwMDc0NA_bca6857f-0b81-4779-8dd1-291d63c94b48" name="us-gaap:ExtinguishmentOfDebtAmount" scale="6" unitref="usd">408.7</ix:nonfraction>&#160;million of <ix:nonfraction contextref="i50894bb5721f4dd58072e6ce75ebf15d_I20210930" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RleHRyZWdpb246OGRmOTEwZDdhYjFhNDFmMThlODU5ZTE4OTQxY2E4MDhfMzI5ODUzNDkwMDc2MA_62d97da8-c395-40b2-b7a6-f90739a6cb1a" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="0" unitref="number">4.15</ix:nonfraction> percent notes due 2059, and $<ix:nonfraction contextref="ice022568bdf042618c2c002393cc3c5d_D20210901-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RleHRyZWdpb246OGRmOTEwZDdhYjFhNDFmMThlODU5ZTE4OTQxY2E4MDhfMzI5ODUzNDkwMDc2Ng_6feda03f-fc2e-4783-822a-9b435148eb37" name="us-gaap:ExtinguishmentOfDebtAmount" scale="6" unitref="usd">219.4</ix:nonfraction>&#160;million of <ix:nonfraction contextref="iccc6f8c08fc6454c849c681a4dbe3d01_I20210930" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RleHRyZWdpb246OGRmOTEwZDdhYjFhNDFmMThlODU5ZTE4OTQxY2E4MDhfMzI5ODUzNDkwMDc4Mg_46ae064e-e5b3-4fa2-b782-46ae301f6c8b" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="0" unitref="number">3.375</ix:nonfraction> percent notes due 2029. We used the remaining net proceeds from the offering to prefund certain 2022 debt maturities and for general corporate purposes.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Effect of Risk-Management Instruments on the Consolidated Condensed Statements of Operations</span></div><ix:nonnumeric contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RleHRyZWdpb246OGRmOTEwZDdhYjFhNDFmMThlODU5ZTE4OTQxY2E4MDhfMTUxMDk_30459d61-6677-4ad8-8dba-ecb15fc493c8" name="us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following effects of risk-management instruments were recognized in other&#8211;net, (income) expense:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.160%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value hedges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect from hedged fixed-rate debt</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="i65012aa62d474ff8af6d08eeb55d206a_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOmY2M2E4OTNjOGY5MzQ0M2ViOTA2ZDYwZWNjMWRhMzJiL3RhYmxlcmFuZ2U6ZjYzYTg5M2M4ZjkzNDQzZWI5MDZkNjBlY2MxZGEzMmJfMy0xLTEtMS0xNTk1NDA_f7e28d6f-0f64-4fb1-9f5d-f00ca3de4b58" name="us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" scale="6" unitref="usd">62.9</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="ib627ecf64a434a6b8135da0ac7a5fdf7_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOmY2M2E4OTNjOGY5MzQ0M2ViOTA2ZDYwZWNjMWRhMzJiL3RhYmxlcmFuZ2U6ZjYzYTg5M2M4ZjkzNDQzZWI5MDZkNjBlY2MxZGEzMmJfMy0zLTEtMS0xNTk1NDA_40c651de-326e-477f-8354-547f965a0334" name="us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" scale="6" unitref="usd">10.1</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="i1d213f8c24344d22ada6f016432acea5_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOmY2M2E4OTNjOGY5MzQ0M2ViOTA2ZDYwZWNjMWRhMzJiL3RhYmxlcmFuZ2U6ZjYzYTg5M2M4ZjkzNDQzZWI5MDZkNjBlY2MxZGEzMmJfMy01LTEtMS0xNTk1NDA_496be9f4-9bd5-4012-8cc5-bdb0502bfaa3" name="us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" scale="6" unitref="usd">215.7</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i41a4fdad9bd748be972c155f2f3acedf_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOmY2M2E4OTNjOGY5MzQ0M2ViOTA2ZDYwZWNjMWRhMzJiL3RhYmxlcmFuZ2U6ZjYzYTg5M2M4ZjkzNDQzZWI5MDZkNjBlY2MxZGEzMmJfMy03LTEtMS0xNTk1NDA_eb181ae3-ffba-4a20-a5f7-3c49c81ac772" name="us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" scale="6" unitref="usd">60.5</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect from interest rate contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ic55d4cfd09d8486a8b6e1be77dcc5426_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOmY2M2E4OTNjOGY5MzQ0M2ViOTA2ZDYwZWNjMWRhMzJiL3RhYmxlcmFuZ2U6ZjYzYTg5M2M4ZjkzNDQzZWI5MDZkNjBlY2MxZGEzMmJfNC0xLTEtMS0xNTk1NDA_07fc5259-89e6-4bc6-b021-d086c6e94a2a" name="us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" scale="6" sign="-" unitref="usd">62.9</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i519d9df9a61b4cbf87c342e3496785cc_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOmY2M2E4OTNjOGY5MzQ0M2ViOTA2ZDYwZWNjMWRhMzJiL3RhYmxlcmFuZ2U6ZjYzYTg5M2M4ZjkzNDQzZWI5MDZkNjBlY2MxZGEzMmJfNC0zLTEtMS0xNTk1NDA_751aaf20-0bb2-464e-ae8c-c294a7f06e88" name="us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" scale="6" sign="-" unitref="usd">10.1</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i7bcae384fb484b6aa3e84e7d484b69e9_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOmY2M2E4OTNjOGY5MzQ0M2ViOTA2ZDYwZWNjMWRhMzJiL3RhYmxlcmFuZ2U6ZjYzYTg5M2M4ZjkzNDQzZWI5MDZkNjBlY2MxZGEzMmJfNC01LTEtMS0xNTk1NDA_5aeac55d-65ff-4c3d-873b-be05ab82e2dd" name="us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" scale="6" sign="-" unitref="usd">215.7</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i4cc8664469d846a2b0472f04c7e39442_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOmY2M2E4OTNjOGY5MzQ0M2ViOTA2ZDYwZWNjMWRhMzJiL3RhYmxlcmFuZ2U6ZjYzYTg5M2M4ZjkzNDQzZWI5MDZkNjBlY2MxZGEzMmJfNC03LTEtMS0xNTk1NDA_a703e13a-35d7-422d-8d7b-a0ddbe49efc4" name="us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" scale="6" sign="-" unitref="usd">60.5</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective portion of losses on interest rate contracts reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ic55d4cfd09d8486a8b6e1be77dcc5426_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOmY2M2E4OTNjOGY5MzQ0M2ViOTA2ZDYwZWNjMWRhMzJiL3RhYmxlcmFuZ2U6ZjYzYTg5M2M4ZjkzNDQzZWI5MDZkNjBlY2MxZGEzMmJfNi0xLTEtMS0xNTk1NDA_deec1bc1-e224-4ddc-b5b8-535d47d558c9" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" unitref="usd">4.1</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i519d9df9a61b4cbf87c342e3496785cc_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOmY2M2E4OTNjOGY5MzQ0M2ViOTA2ZDYwZWNjMWRhMzJiL3RhYmxlcmFuZ2U6ZjYzYTg5M2M4ZjkzNDQzZWI5MDZkNjBlY2MxZGEzMmJfNi0zLTEtMS0xNTk1NDA_27a2de22-f375-4abb-8d67-1a70d53868dc" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" unitref="usd">4.2</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i7bcae384fb484b6aa3e84e7d484b69e9_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOmY2M2E4OTNjOGY5MzQ0M2ViOTA2ZDYwZWNjMWRhMzJiL3RhYmxlcmFuZ2U6ZjYzYTg5M2M4ZjkzNDQzZWI5MDZkNjBlY2MxZGEzMmJfNi01LTEtMS0xNTk1NDA_2081da8d-0d6d-4f45-aaea-f2c570fcbaaf" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" unitref="usd">12.3</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i4cc8664469d846a2b0472f04c7e39442_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOmY2M2E4OTNjOGY5MzQ0M2ViOTA2ZDYwZWNjMWRhMzJiL3RhYmxlcmFuZ2U6ZjYzYTg5M2M4ZjkzNDQzZWI5MDZkNjBlY2MxZGEzMmJfNi03LTEtMS0xNTk1NDA_2c1682bd-562f-46aa-8fc3-768ec6328ace" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" unitref="usd">12.5</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency interest rate swaps</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ic1eb1816cd7241e7af47383c68f534c0_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOmY2M2E4OTNjOGY5MzQ0M2ViOTA2ZDYwZWNjMWRhMzJiL3RhYmxlcmFuZ2U6ZjYzYTg5M2M4ZjkzNDQzZWI5MDZkNjBlY2MxZGEzMmJfNy0xLTEtMS0xNTk1NDA_9d72c7a5-5f9e-4df6-ae38-aece61fa2fcb" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" unitref="usd">33.1</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="if7cd0109836d43de86e2c830d47c9aec_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOmY2M2E4OTNjOGY5MzQ0M2ViOTA2ZDYwZWNjMWRhMzJiL3RhYmxlcmFuZ2U6ZjYzYTg5M2M4ZjkzNDQzZWI5MDZkNjBlY2MxZGEzMmJfNy0zLTEtMS0xNTk1NDA_7859894c-8a1c-41e6-88d3-68b247684a74" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" unitref="usd">10.0</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i5f64e83e66774562be40774b52732fd5_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOmY2M2E4OTNjOGY5MzQ0M2ViOTA2ZDYwZWNjMWRhMzJiL3RhYmxlcmFuZ2U6ZjYzYTg5M2M4ZjkzNDQzZWI5MDZkNjBlY2MxZGEzMmJfNy01LTEtMS0xNTk1NDA_9952a76f-c00c-4375-9adf-f73464f36a14" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" unitref="usd">75.0</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i9ed2f279ccc74f238d18ee7977fea9e0_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOmY2M2E4OTNjOGY5MzQ0M2ViOTA2ZDYwZWNjMWRhMzJiL3RhYmxlcmFuZ2U6ZjYzYTg5M2M4ZjkzNDQzZWI5MDZkNjBlY2MxZGEzMmJfNy03LTEtMS0xNTk1NDA_75f0bbca-be3b-4cfb-bcc0-55d6d52f0f01" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" unitref="usd">58.1</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (gains) losses on foreign currency exchange contracts not designated as hedging instruments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="iaaffba52583d4dd09213c45974bda81f_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOmY2M2E4OTNjOGY5MzQ0M2ViOTA2ZDYwZWNjMWRhMzJiL3RhYmxlcmFuZ2U6ZjYzYTg5M2M4ZjkzNDQzZWI5MDZkNjBlY2MxZGEzMmJfOC0xLTEtMS0xNTk1NDA_45ad136c-ec3b-4b58-9265-6dcfcbf87432" name="us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" scale="6" sign="-" unitref="usd">129.6</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="idb22c9f9ae5f42d5b5d0691a5daa1547_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOmY2M2E4OTNjOGY5MzQ0M2ViOTA2ZDYwZWNjMWRhMzJiL3RhYmxlcmFuZ2U6ZjYzYTg5M2M4ZjkzNDQzZWI5MDZkNjBlY2MxZGEzMmJfOC0zLTEtMS0xNTk1NDA_feea260b-9edd-4420-8f6a-004a68ebd262" name="us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" scale="6" sign="-" unitref="usd">50.8</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i00fa96d219234882925d8b07dc0e9a2f_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOmY2M2E4OTNjOGY5MzQ0M2ViOTA2ZDYwZWNjMWRhMzJiL3RhYmxlcmFuZ2U6ZjYzYTg5M2M4ZjkzNDQzZWI5MDZkNjBlY2MxZGEzMmJfOC01LTEtMS0xNTk1NDA_edd95548-5100-4323-a726-ef27ed518838" name="us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" scale="6" sign="-" unitref="usd">280.7</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i5a4ce07ee9fd474a956ccb68a6af4713_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOmY2M2E4OTNjOGY5MzQ0M2ViOTA2ZDYwZWNjMWRhMzJiL3RhYmxlcmFuZ2U6ZjYzYTg5M2M4ZjkzNDQzZWI5MDZkNjBlY2MxZGEzMmJfOC03LTEtMS0xNTk1NDA_899dca17-35aa-4d2f-8658-642ad5f08d4f" name="us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" scale="6" sign="-" unitref="usd">110.6</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i19fc0325c48543008ea71e1fdcf11d86_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOmY2M2E4OTNjOGY5MzQ0M2ViOTA2ZDYwZWNjMWRhMzJiL3RhYmxlcmFuZ2U6ZjYzYTg5M2M4ZjkzNDQzZWI5MDZkNjBlY2MxZGEzMmJfOS0xLTEtMS0xNTk1NDA_26ee518e-1941-4c09-b6a5-0c2fe576c581" name="lly:DerivativeInstrumentsGainLossRecognized" scale="6" sign="-" unitref="usd">166.8</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie4fa4f6b472a4f269297591b44aba572_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOmY2M2E4OTNjOGY5MzQ0M2ViOTA2ZDYwZWNjMWRhMzJiL3RhYmxlcmFuZ2U6ZjYzYTg5M2M4ZjkzNDQzZWI5MDZkNjBlY2MxZGEzMmJfOS0zLTEtMS0xNTk1NDA_739481e3-e83a-4ca5-abd9-415495b69ef0" name="lly:DerivativeInstrumentsGainLossRecognized" scale="6" sign="-" unitref="usd">65.0</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOmY2M2E4OTNjOGY5MzQ0M2ViOTA2ZDYwZWNjMWRhMzJiL3RhYmxlcmFuZ2U6ZjYzYTg5M2M4ZjkzNDQzZWI5MDZkNjBlY2MxZGEzMmJfOS01LTEtMS0xNTk1NDA_031e8542-3748-4884-b7af-152aaaf951fe" name="lly:DerivativeInstrumentsGainLossRecognized" scale="6" sign="-" unitref="usd">368.0</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOmY2M2E4OTNjOGY5MzQ0M2ViOTA2ZDYwZWNjMWRhMzJiL3RhYmxlcmFuZ2U6ZjYzYTg5M2M4ZjkzNDQzZWI5MDZkNjBlY2MxZGEzMmJfOS03LTEtMS0xNTk1NDA_97ebec2e-25a4-4154-8eee-716bbe3cb9b0" name="lly:DerivativeInstrumentsGainLossRecognized" scale="6" sign="-" unitref="usd">181.2</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonnumeric><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and nine months ended September&#160;30, 2022 and 2021, the amortization of losses related to the portion of our risk management hedging instruments, fair value hedges, and cash flow hedges that was excluded from the assessment of effectiveness was not material.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation continuedat="i51161b7126f64961b8d320046e8e9f6c" id="ie2d1b96979184c80ab5eb2a40bb0da95"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Effect of Risk-Management Instruments on Other Comprehensive Income (Loss)</span></div><ix:nonnumeric contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RleHRyZWdpb246OGRmOTEwZDdhYjFhNDFmMThlODU5ZTE4OTQxY2E4MDhfMTUxNjk_af7c9e84-70f2-4f2d-b46f-c00a40254ce4" name="us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"><ix:nonnumeric contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RleHRyZWdpb246OGRmOTEwZDdhYjFhNDFmMThlODU5ZTE4OTQxY2E4MDhfMTUxODk_228ac172-3acf-4d55-9fbf-db92983ef792" name="us-gaap:ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective portion of risk-management instruments that was recognized in other comprehensive income (loss) is as follows:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.206%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency-denominated notes</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i0803c43adcc2406c8d72a961bdbdb03a_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOmQ4YWMyOTIzMWExMjRmZTRhMzI5NWJhOGNmMTgzZGQ5L3RhYmxlcmFuZ2U6ZDhhYzI5MjMxYTEyNGZlNGEzMjk1YmE4Y2YxODNkZDlfMy0xLTEtMS0xNTk1NDA_8ada233f-b314-42ff-a8c1-c7626a18e18d" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" unitref="usd">435.1</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ifa347bfa67994dfbad7418e0ab44ad66_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOmQ4YWMyOTIzMWExMjRmZTRhMzI5NWJhOGNmMTgzZGQ5L3RhYmxlcmFuZ2U6ZDhhYzI5MjMxYTEyNGZlNGEzMjk1YmE4Y2YxODNkZDlfMy0zLTEtMS0xNTk1NDA_dd5e03a5-f1b0-4c63-b06d-296d73176244" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" unitref="usd">119.0</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i9300bb3fb0c149928c10ce50be156517_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOmQ4YWMyOTIzMWExMjRmZTRhMzI5NWJhOGNmMTgzZGQ5L3RhYmxlcmFuZ2U6ZDhhYzI5MjMxYTEyNGZlNGEzMjk1YmE4Y2YxODNkZDlfMy01LTEtMS0xNTk1NDA_ea03d8bc-cc9d-43bc-bdbb-278a93295c5d" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" unitref="usd">822.8</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i65cd935c26b44824a9d84d0554032fa4_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOmQ4YWMyOTIzMWExMjRmZTRhMzI5NWJhOGNmMTgzZGQ5L3RhYmxlcmFuZ2U6ZDhhYzI5MjMxYTEyNGZlNGEzMjk1YmE4Y2YxODNkZDlfMy03LTEtMS0xNTk1NDA_e0b9d6aa-0e2a-4fa9-bfb0-d102ea25b064" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" unitref="usd">268.8</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency interest rate swaps</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ie32852c9ac004e18a40bd3c886375fa2_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOmQ4YWMyOTIzMWExMjRmZTRhMzI5NWJhOGNmMTgzZGQ5L3RhYmxlcmFuZ2U6ZDhhYzI5MjMxYTEyNGZlNGEzMjk1YmE4Y2YxODNkZDlfNC0xLTEtMS0xNTk1NDA_c41fbcd4-8d83-4050-9bea-1f227220f00a" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" unitref="usd">92.1</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie539446ea66443f18894fe65b477f3f2_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOmQ4YWMyOTIzMWExMjRmZTRhMzI5NWJhOGNmMTgzZGQ5L3RhYmxlcmFuZ2U6ZDhhYzI5MjMxYTEyNGZlNGEzMjk1YmE4Y2YxODNkZDlfNC0zLTEtMS0xNTk1NDA_048d8537-f679-4fa0-85af-c34f3f2b9be8" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" unitref="usd">66.7</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ieb0755f46c634be3a274f37154dcd835_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOmQ4YWMyOTIzMWExMjRmZTRhMzI5NWJhOGNmMTgzZGQ5L3RhYmxlcmFuZ2U6ZDhhYzI5MjMxYTEyNGZlNGEzMjk1YmE4Y2YxODNkZDlfNC01LTEtMS0xNTk1NDA_dfdd2151-8699-4f50-a371-65c0f73a14b3" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" unitref="usd">171.4</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ib38ae8d2eee24da7b665b5ba4af2fc25_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOmQ4YWMyOTIzMWExMjRmZTRhMzI5NWJhOGNmMTgzZGQ5L3RhYmxlcmFuZ2U6ZDhhYzI5MjMxYTEyNGZlNGEzMjk1YmE4Y2YxODNkZDlfNC03LTEtMS0xNTk1NDA_efb63077-67bf-4515-a6db-2f7fd81f422b" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" unitref="usd">170.8</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="iee72a06ebc24478d804a01c9c07503e0_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOmQ4YWMyOTIzMWExMjRmZTRhMzI5NWJhOGNmMTgzZGQ5L3RhYmxlcmFuZ2U6ZDhhYzI5MjMxYTEyNGZlNGEzMjk1YmE4Y2YxODNkZDlfNS0xLTEtMS0xNTk1NDA_0907f90c-cb5f-400a-ba6b-147a64dbdf37" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" unitref="usd">107.8</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i847e2e726f374b8997cd2f409d0da50e_D20210701-20210930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOmQ4YWMyOTIzMWExMjRmZTRhMzI5NWJhOGNmMTgzZGQ5L3RhYmxlcmFuZ2U6ZDhhYzI5MjMxYTEyNGZlNGEzMjk1YmE4Y2YxODNkZDlfNS0zLTEtMS0xNTk1NDA_29d30dc8-c02f-451c-a952-9092e948fc6f" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i04964a8dc75f42aeb12d4f04a8c4b0eb_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOmQ4YWMyOTIzMWExMjRmZTRhMzI5NWJhOGNmMTgzZGQ5L3RhYmxlcmFuZ2U6ZDhhYzI5MjMxYTEyNGZlNGEzMjk1YmE4Y2YxODNkZDlfNS01LTEtMS0xNTk1NDA_a5a07281-e177-4764-b709-6a94347197e5" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" unitref="usd">121.4</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i735c7ed5628e404298cd5de9565781a5_D20210101-20210930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOmQ4YWMyOTIzMWExMjRmZTRhMzI5NWJhOGNmMTgzZGQ5L3RhYmxlcmFuZ2U6ZDhhYzI5MjMxYTEyNGZlNGEzMjk1YmE4Y2YxODNkZDlfNS03LTEtMS0xNTk1NDA_1783236e-7f89-4fb1-80e3-5d415876b230" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward-starting interest rate swaps</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i874a4fa6b8034fb7b972ede3e49e5375_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOmQ4YWMyOTIzMWExMjRmZTRhMzI5NWJhOGNmMTgzZGQ5L3RhYmxlcmFuZ2U6ZDhhYzI5MjMxYTEyNGZlNGEzMjk1YmE4Y2YxODNkZDlfNy0xLTEtMS0xNTk1NDA_8ef7bfed-ecbe-45f5-a075-60517430e066" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" unitref="usd">57.5</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="icc403fcb68ad44ae8c3d0f5675e78f2a_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOmQ4YWMyOTIzMWExMjRmZTRhMzI5NWJhOGNmMTgzZGQ5L3RhYmxlcmFuZ2U6ZDhhYzI5MjMxYTEyNGZlNGEzMjk1YmE4Y2YxODNkZDlfNy0zLTEtMS0xNTk1NDA_5bfb10b8-46fd-4378-a2fd-6705949223e7" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" unitref="usd">19.4</ix:nonfraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ic9cf169896e649948e7319fca615da6c_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOmQ4YWMyOTIzMWExMjRmZTRhMzI5NWJhOGNmMTgzZGQ5L3RhYmxlcmFuZ2U6ZDhhYzI5MjMxYTEyNGZlNGEzMjk1YmE4Y2YxODNkZDlfNy01LTEtMS0xNTk1NDA_50bdee4f-f2a3-415b-86e0-46b280e4ec5b" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" unitref="usd">337.7</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i792ad77b79a7422690de67f74dc5988f_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOmQ4YWMyOTIzMWExMjRmZTRhMzI5NWJhOGNmMTgzZGQ5L3RhYmxlcmFuZ2U6ZDhhYzI5MjMxYTEyNGZlNGEzMjk1YmE4Y2YxODNkZDlfNy03LTEtMS0xNTk1NDA_ed88540e-2eda-47af-a347-b3432e3c2e17" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" unitref="usd">149.3</ix:nonfraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency interest rate swaps</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ie32852c9ac004e18a40bd3c886375fa2_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOmQ4YWMyOTIzMWExMjRmZTRhMzI5NWJhOGNmMTgzZGQ5L3RhYmxlcmFuZ2U6ZDhhYzI5MjMxYTEyNGZlNGEzMjk1YmE4Y2YxODNkZDlfOC0xLTEtMS0xNTk1NDA_881e6419-f1ab-45f1-8519-d30cc48be0d2" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" unitref="usd">19.9</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie539446ea66443f18894fe65b477f3f2_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOmQ4YWMyOTIzMWExMjRmZTRhMzI5NWJhOGNmMTgzZGQ5L3RhYmxlcmFuZ2U6ZDhhYzI5MjMxYTEyNGZlNGEzMjk1YmE4Y2YxODNkZDlfOC0zLTEtMS0xNTk1NDA_068058f8-7d3d-4ccc-a2aa-1bd84a03fe93" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" unitref="usd">3.1</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ieb0755f46c634be3a274f37154dcd835_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOmQ4YWMyOTIzMWExMjRmZTRhMzI5NWJhOGNmMTgzZGQ5L3RhYmxlcmFuZ2U6ZDhhYzI5MjMxYTEyNGZlNGEzMjk1YmE4Y2YxODNkZDlfOC01LTEtMS0xNTk1NDA_556f17c3-68c7-4d1c-ab01-9229419f0ea1" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" unitref="usd">38.4</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ib38ae8d2eee24da7b665b5ba4af2fc25_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOmQ4YWMyOTIzMWExMjRmZTRhMzI5NWJhOGNmMTgzZGQ5L3RhYmxlcmFuZ2U6ZDhhYzI5MjMxYTEyNGZlNGEzMjk1YmE4Y2YxODNkZDlfOC03LTEtMS0xNTk1NDA_6d80bf62-6bb6-4a2a-aa78-bffb042c7d8a" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" unitref="usd">22.5</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonnumeric></ix:nonnumeric><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the next 12&#160;months, we expect to reclassify $<ix:nonfraction contextref="i08ccb35f6ad24d7793c9c91b74ca2ea1_I20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RleHRyZWdpb246OGRmOTEwZDdhYjFhNDFmMThlODU5ZTE4OTQxY2E4MDhfODc3MQ_cc02ee53-2444-4fa4-9307-1ae16614df16" name="us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" scale="6" sign="-" unitref="usd">16.7</ix:nonfraction>&#160;million of pretax net losses on cash flow hedges from accumulated other comprehensive loss to other&#8211;net, (income) expense. During the three and nine months ended September&#160;30, 2022 and 2021, the amounts excluded from the assessment of hedge effectiveness recognized in other comprehensive income (loss) were not material.</span></div></ix:continuation><div style="margin-top:9pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation continuedat="i81a1014c662b4c0a83dff086461700ef" id="i51161b7126f64961b8d320046e8e9f6c"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value of Financial Instruments</span></div><ix:nonnumeric contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RleHRyZWdpb246OGRmOTEwZDdhYjFhNDFmMThlODU5ZTE4OTQxY2E4MDhfMTUxMTg_8c519f20-07b4-4979-970c-a1817df9b732" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize certain fair value information at September&#160;30, 2022 and December&#160;31, 2021 for assets and liabilities measured at fair value on a recurring basis, as well as the carrying amount and amortized cost of certain other investments:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:34.624%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.466%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.714%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements Using</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted Prices in Active Markets for Identical Assets<br/>(Level 1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other<br/>Observable Inputs<br/>(Level 2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs<br/>(Level 3)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ia25fb80ee7f14608ad1bc42cf7dc3d85_I20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMy0xLTEtMS0xNTk1NDA_170efdd2-271a-472e-a1fd-0e5db5f1eb2c" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" unitref="usd">1,246.8</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ieb1b4d0ca2904d3699b0c20378d2d4de_I20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMy0zLTEtMS0xNTk1NDA_cf4ac1dc-54d9-438d-a3a9-d509b2db1389" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" unitref="usd">1,246.8</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i909f721d549b4d17b64fd5ef7a64ed65_I20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMy01LTEtMS0xNTk1NDA_76e28b35-7962-4a4d-81bb-c2a7e1b86e75" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" unitref="usd">1,239.2</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ida76f129eae2411aac66cefe0c47c6fc_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMy03LTEtMS0xNTk1NDA_74cf33c2-091c-4dc6-af1d-50073c278e6b" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" unitref="usd">7.6</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ic34ce18d9ac34702bf22cdc268d8fddc_I20220930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMy05LTEtMS0xNTk1NDA_5234a2e4-073c-49a9-929c-c76431a66b80" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" unitref="usd">&#8212;</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ice641419095d40b58b1ec413657e5350_I20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMy0xMS0xLTEtMTU5NTQw_4f6ca784-8d50-441e-97f9-624c2e4bddac" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" unitref="usd">1,246.8</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Short-term investments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ifab6a7669381463baa4bcac0c28cb1ec_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfNi0xLTEtMS0xNTk1NDA_30c10619-e70d-4924-8576-408b3384afd1" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" unitref="usd">43.0</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ic8f3a57231c145049540a666d70b036f_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfNi0zLTEtMS0xNTk1NDA_6c7e25e5-e196-4019-9910-9a46acd1fe9a" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" unitref="usd">43.5</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i0bdbf4b6981d423b84e97332dcaf6c1a_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfNi01LTEtMS0xNTk1NDA_e95852ef-2150-4460-96d5-df7dd02cd1c9" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" unitref="usd">43.0</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="if1140c058291487fa611ebff0a87770b_I20220930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfNi03LTEtMS0xNTk1NDA_7a8defb7-caba-4e2f-af41-4fca2c8d2dfa" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i78d99dff74e3423da8f09146d5ccfac9_I20220930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfNi05LTEtMS0xNTk1NDA_b048abc3-724b-4299-99f4-0e5db8b9110b" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i047635964deb4302a146b6e33a2497a8_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfNi0xMS0xLTEtMTU5NTQw_530f232d-70f6-446d-8429-0270e04c02dc" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" unitref="usd">43.0</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i2743696771f346c8b079973d11a7071f_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfNy0xLTEtMS0xNTk1NDA_052d25d3-5810-4ec2-b834-e709b357e3de" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" unitref="usd">51.7</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i33275a4d21e64200a487dc63563ca001_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfNy0zLTEtMS0xNTk1NDA_3e135d91-f69e-4dad-a13e-e2b15b3c3399" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" unitref="usd">51.8</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i0a4a874cc47f46a2a264722d13461f46_I20220930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfNy01LTEtMS0xNTk1NDA_754dc1ae-d820-4afd-8d9b-97429fd3224b" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i5b78e10d989e462c8d6d0340d904cc92_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfNy03LTEtMS0xNTk1NDA_33403580-2a0c-43fe-b168-fc6e2fbfad72" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" unitref="usd">51.7</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ic182ac3c1369411e8483ee598bedbe15_I20220930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfNy05LTEtMS0xNTk1NDA_25e41940-af39-4cb4-aee3-3a2090439889" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ie5db88938a794a79995152d200739e71_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfNy0xMS0xLTEtMTU5NTQw_bfb58401-b833-4ebe-9ed9-5cc87c5afa3d" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" unitref="usd">51.7</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="if975bb8107f649de87a30d9d0518813d_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfOS0xLTEtMS0xNTk1NDA_f5dc5b67-6257-423e-b9bb-a359f20d9c1c" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" unitref="usd">3.0</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i035b6f8bf7fd4eb2ade6d5c56da79b71_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfOS0zLTEtMS0xNTk1NDA_62c20e37-31ec-4725-b18a-1bac93ee5e7a" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" unitref="usd">3.0</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i313d32c12b5e46a3b70bb355b88d33ae_I20220930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfOS01LTEtMS0xNTk1NDA_d681c21b-5ac0-434f-9eb6-c46ce72a7632" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ia62987f3e7a14b4cba45477046b24356_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfOS03LTEtMS0xNTk1NDA_c5c302ef-e225-4bd5-84cf-2b29c818f545" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" unitref="usd">3.0</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i81cc2677a958476298d6e691a227d2ef_I20220930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfOS05LTEtMS0xNTk1NDA_13665a64-fc20-4dc7-a36a-7b63f395c683" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ibafa8194f14245d092cf8e3fef7acc20_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfOS0xMS0xLTEtMTU5NTQw_90b91c05-9116-449d-ad0e-8b815dffc699" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" unitref="usd">3.0</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="if5c5c6181311407dbfeb6b2bc5dabd45_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMTAtMS0xLTEtMTU5NTQw_655c3b21-9340-4c2d-94f0-a83cfc66d1f7" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" unitref="usd">27.0</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i4cd5419a2b1e4f1dae5ad80e024ffbd8_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMTAtMy0xLTEtMTU5NTQw_5362c58b-b06e-4e49-958a-e7cb4b853572" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" unitref="usd">27.0</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ifa5439e6f71a449badc6db614afe1fc0_I20220930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMTAtNS0xLTEtMTU5NTQw_6f85d79f-bca6-44c5-82d2-4cfd7bf4fd08" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ia7e1bfc7167249e09fd9253c7056e6a4_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMTAtNy0xLTEtMTU5NTQw_83a8514f-05a2-4242-893b-05fb9e3b34db" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" unitref="usd">14.8</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i184415738c194fc89b0a1a3ae91e05f6_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMTAtOS0xLTEtMTU5NTQw_03eee07c-6243-4f36-9b5b-1e290e847a13" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" unitref="usd">12.2</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i99cd69cddcd1432eb41f86a6c107e126_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMTAtMTEtMS0xLTE1OTU0MA_1c009b28-7a56-4655-aa0d-9dc0a09be431" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" unitref="usd">27.0</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Short-term investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ia25fb80ee7f14608ad1bc42cf7dc3d85_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMTItMS0xLTEtMTU5NTQw_8c9fa782-80ad-44f5-b3dc-09784bd399a7" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" unitref="usd">124.7</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncurrent investments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ifab6a7669381463baa4bcac0c28cb1ec_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMTUtMS0xLTEtMTU5NTQw_4f823aca-1097-4ad5-97ae-fdff8e8fc161" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="6" unitref="usd">131.4</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ic8f3a57231c145049540a666d70b036f_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMTUtMy0xLTEtMTU5NTQw_77e928af-9068-4fa5-8b1a-69b9a853ce55" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="6" unitref="usd">148.3</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i0bdbf4b6981d423b84e97332dcaf6c1a_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMTUtNS0xLTEtMTU5NTQw_ddfa3ae4-10f1-44bf-85c9-d383008ad0aa" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="6" unitref="usd">131.4</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="if1140c058291487fa611ebff0a87770b_I20220930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMTUtNy0xLTEtMTU5NTQw_e7483636-af60-4210-9bda-9fe45a5d47c4" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i78d99dff74e3423da8f09146d5ccfac9_I20220930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMTUtOS0xLTEtMTU5NTQw_a2e639ef-7940-42d6-9901-835994db0016" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i047635964deb4302a146b6e33a2497a8_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMTUtMTEtMS0xLTE1OTU0MA_eeedb3d3-15cc-415f-8f04-751577dad833" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="6" unitref="usd">131.4</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i2743696771f346c8b079973d11a7071f_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMTctMS0xLTEtMTU5NTQw_3e4935bf-3fff-429c-80f9-04ca0d240a88" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="6" unitref="usd">206.4</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i33275a4d21e64200a487dc63563ca001_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMTctMy0xLTEtMTU5NTQw_3a8e0db3-9cd8-45a7-97f2-cfea141b3f9e" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="6" unitref="usd">232.5</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i0a4a874cc47f46a2a264722d13461f46_I20220930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMTctNS0xLTEtMTU5NTQw_a0e12a97-0adb-48af-9231-76f57b931744" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i5b78e10d989e462c8d6d0340d904cc92_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMTctNy0xLTEtMTU5NTQw_e4b6dce1-f351-4c15-ad3d-9ca8bda89b82" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="6" unitref="usd">206.4</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ic182ac3c1369411e8483ee598bedbe15_I20220930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMTctOS0xLTEtMTU5NTQw_237d224d-90b4-4756-bce8-3a42084e7e1e" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ie5db88938a794a79995152d200739e71_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMTctMTEtMS0xLTE1OTU0MA_f3105b3b-383d-4e1c-a067-e9dd9ece33e7" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="6" unitref="usd">206.4</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i9351338d7d4b429093117dd87f8b02de_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMTgtMS0xLTEtMTU5NTQw_b6810022-f21d-46cd-b78a-e1c90023a85a" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="6" unitref="usd">143.1</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i98487cf76fa84cba948c2fa763c08c17_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMTgtMy0xLTEtMTU5NTQw_e1b71066-7247-4bd3-9785-ff5d464a2cbd" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="6" unitref="usd">156.1</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i921241c16da34890a377c6cc0f05bf9a_I20220930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMTgtNS0xLTEtMTU5NTQw_91f8ac2a-d7ef-4aec-b737-64ecf554b6c7" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ib8c508d73f5d490c991f152f357c2edc_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMTgtNy0xLTEtMTU5NTQw_bcbd68c1-7006-4713-948c-68c05b6c9c11" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="6" unitref="usd">143.1</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i4fcf6ea2160140fcb9374937bebdf459_I20220930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMTgtOS0xLTEtMTU5NTQw_df7a88ff-de03-4b12-95d6-30eb7d45e8be" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i5892dce618474c3397f2f21748d154da_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMTgtMTEtMS0xLTE1OTU0MA_63dc4ef0-f59a-4ac3-af4a-4efcfbefee01" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="6" unitref="usd">143.1</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="if975bb8107f649de87a30d9d0518813d_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMTktMS0xLTEtMTU5NTQw_00bb232e-3f9e-492d-8852-39fa209c29ec" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="6" unitref="usd">43.6</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i035b6f8bf7fd4eb2ade6d5c56da79b71_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMTktMy0xLTEtMTU5NTQw_78f53150-12e4-4128-8201-ce9f46292ed8" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="6" unitref="usd">45.5</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i313d32c12b5e46a3b70bb355b88d33ae_I20220930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMTktNS0xLTEtMTU5NTQw_90ad37c5-85a5-49b7-b7a9-2516c044a82f" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ia62987f3e7a14b4cba45477046b24356_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMTktNy0xLTEtMTU5NTQw_337140b6-4036-4440-91a4-520f6c52cc7d" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="6" unitref="usd">43.6</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i81cc2677a958476298d6e691a227d2ef_I20220930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMTktOS0xLTEtMTU5NTQw_9f352256-cbf6-494b-bf6b-42fb4eadfdf7" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ibafa8194f14245d092cf8e3fef7acc20_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMTktMTEtMS0xLTE1OTU0MA_06039997-5311-44ab-9897-d7774104aca5" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="6" unitref="usd">43.6</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i839d1d25f31e4a1e8f8686d85cd27d6f_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMjAtMS0xLTEtMTU5NTQw_a978486d-6469-4731-a897-bc81703c9538" name="us-gaap:EquitySecuritiesFvNi" scale="6" unitref="usd">152.5</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i66f937e8eb9d439fb99fc1eaf5bb8229_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMjAtMy0xLTEtMTU5NTQw_c61d361a-f168-4771-a0a5-63f9d93e8afb" name="us-gaap:EquitySecuritiesFvNi" scale="6" unitref="usd">96.3</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i8d540d6e9952406eae86fcb404c8aa3f_I20220930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMjAtNS0xLTEtMTU5NTQw_59f6c1fa-eaae-421c-baac-26a07a8a8df9" name="us-gaap:EquitySecuritiesFvNi" scale="6" unitref="usd">&#8212;</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="iac853f32fb164d5dbb16b853b6478ad8_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMjAtNy0xLTEtMTU5NTQw_66d96170-cb32-4695-aafa-ea428c262282" name="us-gaap:EquitySecuritiesFvNi" scale="6" unitref="usd">39.5</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i4d0248c83e9f42aebdedbe45913091c1_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMjAtOS0xLTEtMTU5NTQw_08491453-b555-48d9-9d2c-f5bfe431e8bd" name="us-gaap:EquitySecuritiesFvNi" scale="6" unitref="usd">113.0</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i1f00b6f0d7a346a0bbf8ca789b9b4986_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMjAtMTEtMS0xLTE1OTU0MA_ae0e8a05-1354-4c22-ba19-f8244b2dddef" name="us-gaap:EquitySecuritiesFvNi" scale="6" unitref="usd">152.5</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Marketable equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="id469158a1a2340c0b51dedb185916c2c_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMjEtMS0xLTEtMTU5NTQw_deeb4aa8-eeb0-414b-a3a0-d86e3e1c4b05" name="us-gaap:EquitySecuritiesFvNi" scale="6" unitref="usd">549.1</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i2330a365ee524585810c28f7dc20e39e_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMjEtMy0xLTEtMTU5NTQw_f4fa3e8b-597c-4675-a1ee-fa981aa22eba" name="us-gaap:EquitySecuritiesFvNi" scale="6" unitref="usd">416.1</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="idb940b9eace84fd38c98429f0f9808ce_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMjEtNS0xLTEtMTU5NTQw_ca7f6c7a-476d-4396-a753-7d810ecda772" name="us-gaap:EquitySecuritiesFvNi" scale="6" unitref="usd">549.1</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ib28917d514b84c3397d29e8e54a589da_I20220930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMjEtNy0xLTEtMTU5NTQw_b6f663a8-89fa-495e-ac7a-60c38a461325" name="us-gaap:EquitySecuritiesFvNi" scale="6" unitref="usd">&#8212;</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ia4c3874a92684287bd36704e5ff16e8a_I20220930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMjEtOS0xLTEtMTU5NTQw_cc1ddcd6-f30f-499d-a748-69e8cc826391" name="us-gaap:EquitySecuritiesFvNi" scale="6" unitref="usd">&#8212;</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i700bccbf1683474084361d2cee367dc8_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMjEtMTEtMS0xLTE1OTU0MA_b827dbfd-5d6f-4daf-8ebb-691b6612c340" name="us-gaap:EquitySecuritiesFvNi" scale="6" unitref="usd">549.1</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity investments without readily determinable fair values</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ia25fb80ee7f14608ad1bc42cf7dc3d85_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMjItMS0xLTEtMTU5NTQw_43cf3cab-66bc-410a-815d-0db050aa205b" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" unitref="usd">583.7</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity method investments</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ib7532b4a86304eaf897b92f1ef90f733_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMjMtMS0xLTEtMTU5NTQw_0e8d0aab-2aca-45db-b861-610cbb6dfc1a" name="us-gaap:OtherLongTermInvestments" scale="6" unitref="usd">764.8</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncurrent investments</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ia25fb80ee7f14608ad1bc42cf7dc3d85_I20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMjQtMS0xLTEtMTU5NTQw_ceea8f95-4c9c-473c-9381-a572a8716b92" name="us-gaap:LongTermInvestments" scale="6" unitref="usd">2,574.6</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ic3b630730b424a6d8b697cf0362c83d2_I20211231" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMjctMS0xLTEtMTU5NTQw_7b66aac1-5e07-4766-b62d-f2d335009b63" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" unitref="usd">2,379.5</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i0d06252e717445c989a037b2b13d0128_I20211231" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMjctMy0xLTEtMTU5NTQw_0dbc3d35-107a-4fb6-a6db-8ab9a1fbf94e" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" unitref="usd">2,379.5</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i6802f141d8af4b8aa65c6abe305eeed2_I20211231" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMjctNS0xLTEtMTU5NTQw_2467fa7e-f467-41ab-bd5c-7b6ee9e5b6cc" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" unitref="usd">2,361.0</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i124320eb89ce4dfa87c2f2083ad1e10b_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMjctNy0xLTEtMTU5NTQw_e9ca3d15-ce0a-4578-b6af-74402e255acc" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" unitref="usd">18.5</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i2f37875c8bb94fed916b3375076f0703_I20211231" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMjctOS0xLTEtMTU5NTQw_1f815554-d81c-4187-91a3-b86b238069f3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i52e3293fb124489e844061750e511c35_I20211231" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMjctMTEtMS0xLTE1OTU0MA_e256ec1c-7bcc-436f-88d0-73c5fb6c3cb4" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" unitref="usd">2,379.5</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Short-term investments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i70cd211932aa44d4b6f18e4a94acaa15_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMzAtMS0xLTEtMTU5NTQw_c0da060b-b885-453b-ae08-f6ba6607790c" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" unitref="usd">25.7</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i47952f5ad6b1477c8890a2ebe950ab13_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMzAtMy0xLTEtMTU5NTQw_1100363e-6803-4544-976c-fb8ae6ea81cf" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" unitref="usd">25.6</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="iddfe43e26a024cd3b793575cebd70372_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMzAtNS0xLTEtMTU5NTQw_421764a3-8a3b-46f1-ace1-ae0f5ccc3cc5" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" unitref="usd">25.7</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ic82b5cca8a0748c4ad44ff28aa5c8c63_I20211231" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMzAtNy0xLTEtMTU5NTQw_18bb5c48-352d-4382-961b-64103c434c69" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i19bcbbad1685404f997100cdd7ba2b51_I20211231" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMzAtOS0xLTEtMTU5NTQw_a9166f0a-1aeb-4cec-8635-8f0dbc18e355" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ibb1ad2dc0cab41488bb60c7f417df54c_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMzAtMTEtMS0xLTE1OTU0MA_4889383f-c53b-4aaf-a727-f8c740d6bd93" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" unitref="usd">25.7</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ifb25438d52ac455ba62e9095554c8121_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMzEtMS0xLTEtMTU5NTQw_2cad25b6-ee2b-4be4-922b-ca87f6302be4" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" unitref="usd">43.7</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="iabe3e352015e443c90f93e7aee3a5340_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMzEtMy0xLTEtMTU5NTQw_52209efd-b5d5-488f-a728-e16b4a341a5a" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" unitref="usd">43.7</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i4d09607d938a418caf31b9504379627d_I20211231" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMzEtNS0xLTEtMTU5NTQw_2044d514-8d2a-42b4-aaee-83dbbf2bc194" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i70c1a238fafa4e82bb91738050707531_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMzEtNy0xLTEtMTU5NTQw_48e6f4de-f6d0-48c7-8bf8-d65fb435960c" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" unitref="usd">43.7</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i94da7f9a237b4f5d92545750475e0865_I20211231" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMzEtOS0xLTEtMTU5NTQw_0387427d-5688-4a9f-8513-3db44bf13f13" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="iace537990e0345b984d5d9b511dbd56b_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMzEtMTEtMS0xLTE1OTU0MA_ddb7535a-79ad-41a1-8028-5238d3eaa7e2" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" unitref="usd">43.7</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i122e96dd9f3645a1845a400915d238b3_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMzItMS0xLTEtMTU5NTQw_4a9755d6-1970-4c49-a26b-2f96abe30c17" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" unitref="usd">0.2</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i2193cdcf640b46f79e5eb9ee0bdb3eb2_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMzItMy0xLTEtMTU5NTQw_968a280b-6dfe-49ea-8996-8171f0ba60d2" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" unitref="usd">0.2</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="idb15d5720b2447969c89619f23a52bcd_I20211231" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMzItNS0xLTEtMTU5NTQw_4bb90297-c356-45c8-9a40-66fc5dc9e3d9" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i83fbafd3b87749b69732c68f1032fe86_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMzItNy0xLTEtMTU5NTQw_9431e545-5966-4707-9c0c-c892fa07d563" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" unitref="usd">0.2</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="if5e4829c2687480ba72b8c79c38602c5_I20211231" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMzItOS0xLTEtMTU5NTQw_53f4bbc9-a0f8-43b3-80ef-1c4747e2322f" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i5e0c7dd136f94803b44868029c626465_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMzItMTEtMS0xLTE1OTU0MA_21f0e55a-d8a9-4231-8d6b-71693a9361d2" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" unitref="usd">0.2</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i77a8bad9e7b643b3be999c26e7f341f3_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMzMtMS0xLTEtMTU5NTQw_6ef467e6-6bec-4457-9999-ed448e96fa78" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" unitref="usd">6.2</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i3729e6381590490cad36d5c52a3a9a30_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMzMtMy0xLTEtMTU5NTQw_bc0c326f-5d34-4b0e-8f3b-530d7b55417d" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" unitref="usd">6.2</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i65d4f921c43e46389cd396c859835baa_I20211231" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMzMtNS0xLTEtMTU5NTQw_fe9752cc-d4f5-4125-9759-093427290636" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ifea7137c64a940b98bfaf9336e0de8ed_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMzMtNy0xLTEtMTU5NTQw_0cd4dba2-48f3-4ac3-a17e-a844b4aa9585" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" unitref="usd">6.2</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ibb1fc1f870e44eb8b489ae050e35d2ec_I20211231" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMzMtOS0xLTEtMTU5NTQw_b34f0e66-9494-4c18-8c85-c649a7749463" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i5843990a9b9642e089425093f642f011_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMzMtMTEtMS0xLTE1OTU0MA_19f2a45a-3903-414b-bc1f-f9b46120e90b" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" unitref="usd">6.2</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i3d4a6fcb14b84769a71beaa7fadd7543_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMzQtMS0xLTEtMTU5NTQw_bbd695a7-43e1-47aa-8426-a73e14e4140d" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" unitref="usd">14.3</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ib55c35900e8f4879bbab1c3db2b414e6_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMzQtMy0xLTEtMTU5NTQw_4f332b60-d353-403c-b638-2d42cbcc726e" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" unitref="usd">14.3</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i514a63925c814a928a17a95e4d93d7cb_I20211231" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMzQtNS0xLTEtMTU5NTQw_6e73d3d1-890b-4ece-ba14-28fa22ac6d35" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i4e737ad3e2234f028bf65d35bf37f064_I20211231" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMzQtNy0xLTEtMTU5NTQw_df349d80-9897-4b76-b9cc-7c5cfc836467" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie8e9125bc9f34767a3e05b3c767b3498_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMzQtOS0xLTEtMTU5NTQw_9cd8843e-e6f3-44ae-acc0-4c612e6dc78b" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" unitref="usd">14.3</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ib0e7cf4206ef42778711f85fddbfe12c_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMzQtMTEtMS0xLTE1OTU0MA_84661a8f-36b9-416e-8bf4-17b53ea56a91" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" unitref="usd">14.3</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Short-term investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ic3b630730b424a6d8b697cf0362c83d2_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMzYtMS0xLTEtMTU5NTQw_a1311ae5-10fe-420c-a7e9-178fa9e5e494" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" unitref="usd">90.1</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncurrent investments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i70cd211932aa44d4b6f18e4a94acaa15_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMzktMS0xLTEtMTU5NTQw_15d66309-3d4f-4f49-abc4-eb1330c14607" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="6" unitref="usd">137.0</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i47952f5ad6b1477c8890a2ebe950ab13_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMzktMy0xLTEtMTU5NTQw_fe7d663f-4f6a-4d1f-9e54-34ed4130ae72" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="6" unitref="usd">136.8</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="iddfe43e26a024cd3b793575cebd70372_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMzktNS0xLTEtMTU5NTQw_69e75e5e-d4bb-4e0a-9c94-b5f82f911162" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="6" unitref="usd">137.0</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ic82b5cca8a0748c4ad44ff28aa5c8c63_I20211231" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMzktNy0xLTEtMTU5NTQw_ddcd1559-d70f-4d48-9409-d74db71cf56b" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i19bcbbad1685404f997100cdd7ba2b51_I20211231" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMzktOS0xLTEtMTU5NTQw_6e712349-8bf7-4309-896e-f5650e62a9e7" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ibb1ad2dc0cab41488bb60c7f417df54c_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfMzktMTEtMS0xLTE1OTU0MA_b55c9a85-870a-4bd9-a2f2-0efd372b7297" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="6" unitref="usd">137.0</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ifb25438d52ac455ba62e9095554c8121_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfNDAtMS0xLTEtMTU5NTQw_9de13d7e-0e0f-4a2f-af06-a6c84ccb4588" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="6" unitref="usd">235.3</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="iabe3e352015e443c90f93e7aee3a5340_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfNDAtMy0xLTEtMTU5NTQw_319ad318-d462-40de-b52f-9714e3100bd4" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="6" unitref="usd">232.7</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i4d09607d938a418caf31b9504379627d_I20211231" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfNDAtNS0xLTEtMTU5NTQw_ed893770-c64a-4eff-aa20-8542c474a054" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i70c1a238fafa4e82bb91738050707531_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfNDAtNy0xLTEtMTU5NTQw_0057f2b7-d6d0-4974-9749-e94009453be8" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="6" unitref="usd">235.3</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i94da7f9a237b4f5d92545750475e0865_I20211231" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfNDAtOS0xLTEtMTU5NTQw_71e41d7a-b672-4263-a7a5-994a9e9f7f4c" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="iace537990e0345b984d5d9b511dbd56b_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfNDAtMTEtMS0xLTE1OTU0MA_8b3486fb-70b4-4456-8250-34073e4aa89b" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="6" unitref="usd">235.3</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i122e96dd9f3645a1845a400915d238b3_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfNDEtMS0xLTEtMTU5NTQw_53fe74f9-f8d7-42b4-9afb-6fb9f7bbc2b6" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="6" unitref="usd">109.8</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i2193cdcf640b46f79e5eb9ee0bdb3eb2_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfNDEtMy0xLTEtMTU5NTQw_3aa812ff-adfc-4eb1-9951-66c05d711224" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="6" unitref="usd">108.1</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="idb15d5720b2447969c89619f23a52bcd_I20211231" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfNDEtNS0xLTEtMTU5NTQw_c5014f5c-26e0-4957-a321-8c117536ad26" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i83fbafd3b87749b69732c68f1032fe86_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfNDEtNy0xLTEtMTU5NTQw_2a512c98-0933-4e70-80a6-666b5f66bce2" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="6" unitref="usd">109.8</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="if5e4829c2687480ba72b8c79c38602c5_I20211231" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfNDEtOS0xLTEtMTU5NTQw_2cf65041-9992-4987-906b-efa0d10d7c05" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i5e0c7dd136f94803b44868029c626465_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfNDEtMTEtMS0xLTE1OTU0MA_7ddec577-50c1-42e6-9764-7cb61a987502" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="6" unitref="usd">109.8</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i77a8bad9e7b643b3be999c26e7f341f3_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfNDItMS0xLTEtMTU5NTQw_c6ec8f93-6aec-4720-a531-22fb6fb38030" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="6" unitref="usd">23.1</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i3729e6381590490cad36d5c52a3a9a30_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfNDItMy0xLTEtMTU5NTQw_408b5c13-68ae-451f-b783-5f190843a3c5" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="6" unitref="usd">23.1</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i65d4f921c43e46389cd396c859835baa_I20211231" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfNDItNS0xLTEtMTU5NTQw_12486ee3-0f84-4d73-a39f-011c522d1c62" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ifea7137c64a940b98bfaf9336e0de8ed_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfNDItNy0xLTEtMTU5NTQw_d0c68b71-0a25-498b-87c8-d5d82386e23b" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="6" unitref="usd">23.1</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ibb1fc1f870e44eb8b489ae050e35d2ec_I20211231" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfNDItOS0xLTEtMTU5NTQw_d4c91593-5ee7-40c7-bd37-549f7fd6aede" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i5843990a9b9642e089425093f642f011_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfNDItMTEtMS0xLTE1OTU0MA_f43e31f5-5d4f-4601-90a5-6f245ac2b14a" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="6" unitref="usd">23.1</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i37d081dc80d549d0b7cf06f3dd0f097c_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfNDMtMS0xLTEtMTU5NTQw_c27e376e-c098-4bbf-a860-8d10b104fc45" name="us-gaap:EquitySecuritiesFvNi" scale="6" unitref="usd">108.1</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="iebaf7a78928c429596dc216106cd2f95_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfNDMtMy0xLTEtMTU5NTQw_6fc87c01-6efe-4949-9de4-b7ba6e85c61e" name="us-gaap:EquitySecuritiesFvNi" scale="6" unitref="usd">22.2</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i4a82bacb2ac843e1b6f6f2fe0be9b508_I20211231" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfNDMtNS0xLTEtMTU5NTQw_64426407-62cc-4ce5-8bd8-2e1bd520a816" name="us-gaap:EquitySecuritiesFvNi" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="iddd8d40ea4024e44853ebae245c8ff89_I20211231" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfNDMtNy0xLTEtMTU5NTQw_461d6cc0-c4a8-4f21-ac5a-aab383791e52" name="us-gaap:EquitySecuritiesFvNi" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="iee09e9df8cb24a98b446ff1b40b49036_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfNDMtOS0xLTEtMTU5NTQw_1a1d9ffa-324d-46aa-98e7-b103c32ed0cb" name="us-gaap:EquitySecuritiesFvNi" scale="6" unitref="usd">108.1</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i76efc9c2d361426a8fabf8f468eae443_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfNDMtMTEtMS0xLTE1OTU0MA_51023642-42a9-4daf-828d-c13b9640b9ef" name="us-gaap:EquitySecuritiesFvNi" scale="6" unitref="usd">108.1</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Marketable equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i900be75d24cb4d0e8aaf431324f245f7_I20211231" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfNDQtMS0xLTEtMTU5NTQw_d6163976-f1e6-46e1-a57a-c5a5384560b5" name="us-gaap:EquitySecuritiesFvNi" scale="6" unitref="usd">1,279.7</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ic0829e7b5687473690dec2d117e19409_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfNDQtMy0xLTEtMTU5NTQw_37ed1f2b-2553-434a-9a38-94cf9064822d" name="us-gaap:EquitySecuritiesFvNi" scale="6" unitref="usd">487.0</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="icdba688916644cc684b154cd319074ad_I20211231" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfNDQtNS0xLTEtMTU5NTQw_66d6b23e-834a-4a90-bc92-826cf0c93afa" name="us-gaap:EquitySecuritiesFvNi" scale="6" unitref="usd">1,279.7</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i74870f5304a445feafaa0e95c37df511_I20211231" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfNDQtNy0xLTEtMTU5NTQw_fc360f18-9e6a-4ac0-bce3-2d65f108c76e" name="us-gaap:EquitySecuritiesFvNi" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="iec666b23a81840999cae844ee05abaf5_I20211231" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfNDQtOS0xLTEtMTU5NTQw_c07932cc-717a-49c5-be6c-d06aa60b62ac" name="us-gaap:EquitySecuritiesFvNi" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i4dddf28fc04840efa98b6944bdadf64c_I20211231" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfNDQtMTEtMS0xLTE1OTU0MA_ff317ec6-c800-44f2-8a1d-ae36d8af4ce2" name="us-gaap:EquitySecuritiesFvNi" scale="6" unitref="usd">1,279.7</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity investments without readily determinable fair values</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ic3b630730b424a6d8b697cf0362c83d2_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfNDUtMS0xLTEtMTU5NTQw_6a77511b-20ea-4d06-9057-064a5f628f72" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" unitref="usd">548.1</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity method investments</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i89e7fea8ea92492693f830dd7afa0d55_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfNDYtMS0xLTEtMTU5NTQw_5d9bcb86-8e21-4517-8e47-2fa2d674c981" name="us-gaap:OtherLongTermInvestments" scale="6" unitref="usd">771.5</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncurrent investments</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ic3b630730b424a6d8b697cf0362c83d2_I20211231" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjMyYWY3NWMxMWNhYTQ0ZmNiYzA4OGRkMzI3YzYzY2NmL3RhYmxlcmFuZ2U6MzJhZjc1YzExY2FhNDRmY2JjMDg4ZGQzMjdjNjNjY2ZfNDctMS0xLTEtMTU5NTQw_2102108b-a17f-4cba-ba25-7847b199c60c" name="us-gaap:LongTermInvestments" scale="6" unitref="usd">3,212.6</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">For available-for-sale debt securities, amounts disclosed represent the securities' amortized cost.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Fair value disclosures are not applicable for equity method investments and investments accounted for under the measurement alternative for equity investments.</span></div></ix:nonnumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:11pt"><ix:continuation continuedat="if70a84d3b8e9487ea97fe69a98293411" id="i81a1014c662b4c0a83dff086461700ef"><ix:nonnumeric contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RleHRyZWdpb246OGRmOTEwZDdhYjFhNDFmMThlODU5ZTE4OTQxY2E4MDhfMTUxNjQ_9cf34e74-a993-46a9-8fb7-348a8e1f7585" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:38.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.320%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.320%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.320%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.320%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.322%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements Using</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted Prices in Active Markets for Identical Assets<br/>(Level 1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Other Observable Inputs<br/>(Level 2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs<br/>(Level 3)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Short-term commercial paper borrowings</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="ia25fb80ee7f14608ad1bc42cf7dc3d85_I20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjcyZmFiYWVlZWVhODRmZTdiN2E3NjI2ZTAwNzM2ODg2L3RhYmxlcmFuZ2U6NzJmYWJhZWVlZWE4NGZlN2I3YTc2MjZlMDA3MzY4ODZfMy0xLTEtMS0xNTk1NDA_7420c4f6-cf56-4f12-bad4-5a53445716fd" name="us-gaap:CommercialPaper" scale="6" unitref="usd">1,741.3</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i909f721d549b4d17b64fd5ef7a64ed65_I20220930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjcyZmFiYWVlZWVhODRmZTdiN2E3NjI2ZTAwNzM2ODg2L3RhYmxlcmFuZ2U6NzJmYWJhZWVlZWE4NGZlN2I3YTc2MjZlMDA3MzY4ODZfMy0zLTEtMS0xNTk1NDA_48d1e888-4a78-41b2-8575-3184a47b5b45" name="us-gaap:CommercialPaper" scale="6" unitref="usd">&#8212;</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="ida76f129eae2411aac66cefe0c47c6fc_I20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjcyZmFiYWVlZWVhODRmZTdiN2E3NjI2ZTAwNzM2ODg2L3RhYmxlcmFuZ2U6NzJmYWJhZWVlZWE4NGZlN2I3YTc2MjZlMDA3MzY4ODZfMy01LTEtMS0xNTk1NDA_b88c5560-aa75-4b1f-8c2a-232eab6d23f7" name="us-gaap:CommercialPaper" scale="6" unitref="usd">1,738.0</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ic34ce18d9ac34702bf22cdc268d8fddc_I20220930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjcyZmFiYWVlZWVhODRmZTdiN2E3NjI2ZTAwNzM2ODg2L3RhYmxlcmFuZ2U6NzJmYWJhZWVlZWE4NGZlN2I3YTc2MjZlMDA3MzY4ODZfMy03LTEtMS0xNTk1NDA_7a4cc1b6-b1c6-495a-ae98-04e8ae4f9fae" name="us-gaap:CommercialPaper" scale="6" unitref="usd">&#8212;</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="ice641419095d40b58b1ec413657e5350_I20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjcyZmFiYWVlZWVhODRmZTdiN2E3NjI2ZTAwNzM2ODg2L3RhYmxlcmFuZ2U6NzJmYWJhZWVlZWE4NGZlN2I3YTc2MjZlMDA3MzY4ODZfMy05LTEtMS0xNTk1NDA_2c2af7bf-92d5-4a21-9fa7-7fb4c3947d94" name="us-gaap:CommercialPaper" scale="6" unitref="usd">1,738.0</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ic3b630730b424a6d8b697cf0362c83d2_I20211231" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjcyZmFiYWVlZWVhODRmZTdiN2E3NjI2ZTAwNzM2ODg2L3RhYmxlcmFuZ2U6NzJmYWJhZWVlZWE4NGZlN2I3YTc2MjZlMDA3MzY4ODZfNC0xLTEtMS0xNTk1NDA_025c32dc-423b-4e5f-955e-380391d3d409" name="us-gaap:CommercialPaper" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i6802f141d8af4b8aa65c6abe305eeed2_I20211231" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjcyZmFiYWVlZWVhODRmZTdiN2E3NjI2ZTAwNzM2ODg2L3RhYmxlcmFuZ2U6NzJmYWJhZWVlZWE4NGZlN2I3YTc2MjZlMDA3MzY4ODZfNC0zLTEtMS0xNTk1NDA_3a4f749f-fc88-45b4-b3e9-24998a15bb87" name="us-gaap:CommercialPaper" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i124320eb89ce4dfa87c2f2083ad1e10b_I20211231" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjcyZmFiYWVlZWVhODRmZTdiN2E3NjI2ZTAwNzM2ODg2L3RhYmxlcmFuZ2U6NzJmYWJhZWVlZWE4NGZlN2I3YTc2MjZlMDA3MzY4ODZfNC01LTEtMS0xNTk1NDA_546cb3b4-8d82-4d9b-83fb-b37859df70e9" name="us-gaap:CommercialPaper" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i2f37875c8bb94fed916b3375076f0703_I20211231" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjcyZmFiYWVlZWVhODRmZTdiN2E3NjI2ZTAwNzM2ODg2L3RhYmxlcmFuZ2U6NzJmYWJhZWVlZWE4NGZlN2I3YTc2MjZlMDA3MzY4ODZfNC03LTEtMS0xNTk1NDA_8ee8caf3-bdf4-4424-b31b-421b1224d2d9" name="us-gaap:CommercialPaper" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i52e3293fb124489e844061750e511c35_I20211231" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjcyZmFiYWVlZWVhODRmZTdiN2E3NjI2ZTAwNzM2ODg2L3RhYmxlcmFuZ2U6NzJmYWJhZWVlZWE4NGZlN2I3YTc2MjZlMDA3MzY4ODZfNC05LTEtMS0xNTk1NDA_7df4475d-7590-4e02-b1e6-271976608ede" name="us-gaap:CommercialPaper" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-term debt, including current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="ia25fb80ee7f14608ad1bc42cf7dc3d85_I20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjcyZmFiYWVlZWVhODRmZTdiN2E3NjI2ZTAwNzM2ODg2L3RhYmxlcmFuZ2U6NzJmYWJhZWVlZWE4NGZlN2I3YTc2MjZlMDA3MzY4ODZfNi0xLTEtMS0xNTk1NDA_d62b2cfe-dc1a-4374-bd46-a55cfcc379f3" name="us-gaap:LongTermDebt" scale="6" unitref="usd">14,147.1</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i909f721d549b4d17b64fd5ef7a64ed65_I20220930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjcyZmFiYWVlZWVhODRmZTdiN2E3NjI2ZTAwNzM2ODg2L3RhYmxlcmFuZ2U6NzJmYWJhZWVlZWE4NGZlN2I3YTc2MjZlMDA3MzY4ODZfNi0zLTEtMS0xNTk1NDA_10d5c607-7b6c-4243-b863-c2dcaae216b6" name="us-gaap:LongTermDebt" scale="6" unitref="usd">&#8212;</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="ida76f129eae2411aac66cefe0c47c6fc_I20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjcyZmFiYWVlZWVhODRmZTdiN2E3NjI2ZTAwNzM2ODg2L3RhYmxlcmFuZ2U6NzJmYWJhZWVlZWE4NGZlN2I3YTc2MjZlMDA3MzY4ODZfNi01LTEtMS0xNTk1NDA_70b5fdf3-9fc1-4290-bd75-44b912f10b37" name="us-gaap:LongTermDebt" scale="6" unitref="usd">11,848.6</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ic34ce18d9ac34702bf22cdc268d8fddc_I20220930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjcyZmFiYWVlZWVhODRmZTdiN2E3NjI2ZTAwNzM2ODg2L3RhYmxlcmFuZ2U6NzJmYWJhZWVlZWE4NGZlN2I3YTc2MjZlMDA3MzY4ODZfNi03LTEtMS0xNTk1NDA_ff95524b-e84f-4008-97ef-2a9e3c150d63" name="us-gaap:LongTermDebt" scale="6" unitref="usd">&#8212;</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="ice641419095d40b58b1ec413657e5350_I20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjcyZmFiYWVlZWVhODRmZTdiN2E3NjI2ZTAwNzM2ODg2L3RhYmxlcmFuZ2U6NzJmYWJhZWVlZWE4NGZlN2I3YTc2MjZlMDA3MzY4ODZfNi05LTEtMS0xNTk1NDA_34707b5d-0cc8-4966-b228-a657e42af3b8" name="us-gaap:LongTermDebt" scale="6" unitref="usd">11,848.6</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="ic3b630730b424a6d8b697cf0362c83d2_I20211231" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjcyZmFiYWVlZWVhODRmZTdiN2E3NjI2ZTAwNzM2ODg2L3RhYmxlcmFuZ2U6NzJmYWJhZWVlZWE4NGZlN2I3YTc2MjZlMDA3MzY4ODZfNy0xLTEtMS0xNTk1NDA_2b9e2e9d-7c11-4a8a-ac3a-18ac3d4dac90" name="us-gaap:LongTermDebt" scale="6" unitref="usd">16,884.7</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i6802f141d8af4b8aa65c6abe305eeed2_I20211231" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjcyZmFiYWVlZWVhODRmZTdiN2E3NjI2ZTAwNzM2ODg2L3RhYmxlcmFuZ2U6NzJmYWJhZWVlZWE4NGZlN2I3YTc2MjZlMDA3MzY4ODZfNy0zLTEtMS0xNTk1NDA_09d7cbb5-d425-407d-abd5-daf856309fb4" name="us-gaap:LongTermDebt" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i124320eb89ce4dfa87c2f2083ad1e10b_I20211231" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjcyZmFiYWVlZWVhODRmZTdiN2E3NjI2ZTAwNzM2ODg2L3RhYmxlcmFuZ2U6NzJmYWJhZWVlZWE4NGZlN2I3YTc2MjZlMDA3MzY4ODZfNy01LTEtMS0xNTk1NDA_c8f22544-7716-4e98-a73e-0b08ced8dc96" name="us-gaap:LongTermDebt" scale="6" unitref="usd">18,157.7</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i2f37875c8bb94fed916b3375076f0703_I20211231" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjcyZmFiYWVlZWVhODRmZTdiN2E3NjI2ZTAwNzM2ODg2L3RhYmxlcmFuZ2U6NzJmYWJhZWVlZWE4NGZlN2I3YTc2MjZlMDA3MzY4ODZfNy03LTEtMS0xNTk1NDA_434d68d6-5d65-4d5e-bff7-3638f8705a88" name="us-gaap:LongTermDebt" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i52e3293fb124489e844061750e511c35_I20211231" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjcyZmFiYWVlZWVhODRmZTdiN2E3NjI2ZTAwNzM2ODg2L3RhYmxlcmFuZ2U6NzJmYWJhZWVlZWE4NGZlN2I3YTc2MjZlMDA3MzY4ODZfNy05LTEtMS0xNTk1NDA_a78bfa23-a816-4245-b199-c78a9bd93809" name="us-gaap:LongTermDebt" scale="6" unitref="usd">18,157.7</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonnumeric></ix:continuation></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt"><span><br/></span></div><div><ix:continuation continuedat="i69c07437f434411caf87c5d63a2351cb" id="if70a84d3b8e9487ea97fe69a98293411"><ix:nonnumeric contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RleHRyZWdpb246OGRmOTEwZDdhYjFhNDFmMThlODU5ZTE4OTQxY2E4MDhfMTUxMjU_1236d36a-e08a-4940-96ed-a206440b1a5f" name="us-gaap:FairValueByBalanceSheetGroupingTextBlock"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:37.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.517%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.517%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.517%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.517%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.522%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements Using</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted Prices in Active Markets for Identical Assets<br/>(Level 1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Other Observable Inputs<br/>(Level 2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs<br/>(Level 3)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-management instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate contracts designated as fair value hedges:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other noncurrent liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="i49af86cdb4774f6da136e21a258b9f38_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfOC0xLTEtMS0xNTk1NDA_458a107c-8eea-400b-a657-4a0ff904219c" name="us-gaap:DerivativeLiabilitiesNoncurrent" scale="6" unitref="usd">140.2</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i9b96398a66a144a9aa05b43dea309d1a_I20220930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfOC0zLTEtMS0xNTk1NDA_3c2c8659-be59-40fa-b529-3cc9c6818c50" name="us-gaap:DerivativeLiabilitiesNoncurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="i9eb05f2daf0940029ed9c6f6079b072c_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfOC01LTEtMS0xNTk1NDA_bd5d7c80-fb2a-4011-b95d-1b181930c010" name="us-gaap:DerivativeLiabilitiesNoncurrent" scale="6" unitref="usd">140.2</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i0cbd0bb84e934e18aa8a68f2ed4e3278_I20220930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfOC03LTEtMS0xNTk1NDA_8c46a2ad-b135-4b31-bfa5-f2f58be6dc64" name="us-gaap:DerivativeLiabilitiesNoncurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="i5e03886140d04a0f90b726a0b8cb04a2_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfOC05LTEtMS0xNTk1NDA_8bd8e3b3-e776-4f74-9f05-dc9e9f141d1c" name="us-gaap:DerivativeLiabilitiesNoncurrent" scale="6" unitref="usd">140.2</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate contracts designated as cash flow hedges:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other noncurrent assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ie1da8e0f672e4bc390cd335a91d4cf83_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfMTItMS0xLTEtMTU5NTQw_dd57b20d-a74f-471c-99f6-8a7149749b93" name="us-gaap:DerivativeAssetsNoncurrent" scale="6" unitref="usd">355.2</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i7cba691ea8004d118d604043b64cd431_I20220930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfMTItMy0xLTEtMTU5NTQw_58e7a805-65fb-4e70-b417-727798ba8336" name="us-gaap:DerivativeAssetsNoncurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="id1657a9a2856448687ac9aaada343dd5_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfMTItNS0xLTEtMTU5NTQw_57ceef84-3fe3-46de-ad91-c9b62812e074" name="us-gaap:DerivativeAssetsNoncurrent" scale="6" unitref="usd">355.2</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i020782910cc740779ffa9060458113ba_I20220930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfMTItNy0xLTEtMTU5NTQw_242c5ee9-a6c5-47ae-bc3a-fb17e62ed2a9" name="us-gaap:DerivativeAssetsNoncurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i8f69ca689c7e4d23aa1cab488bb7ed65_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfMTItOS0xLTEtMTU5NTQw_cab06653-49d3-4d64-a9d9-83ce5314f2a3" name="us-gaap:DerivativeAssetsNoncurrent" scale="6" unitref="usd">355.2</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency interest rate contracts designated as net investment hedges:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i1300d5f8c7d44be79cb93f333746c580_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfMTUtMS0xLTEtMTU5NTQw_22e1f2f2-1e6c-42b2-ba3a-17acb986d6ad" name="us-gaap:DerivativeAssetsCurrent" scale="6" unitref="usd">81.6</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="iaca361ecbf3749b7a324afc87754e17e_I20220930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfMTUtMy0xLTEtMTU5NTQw_490ee643-f78c-48e4-9a9f-e0a1cbc14e98" name="us-gaap:DerivativeAssetsCurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i5ac9d317ae404d2ebdc37459bd98e0c0_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfMTUtNS0xLTEtMTU5NTQw_78af148b-8a72-4cc9-8391-b3bbc42f15e9" name="us-gaap:DerivativeAssetsCurrent" scale="6" unitref="usd">81.6</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ib6a56ab1b3ed4c26b10443b11b7c0c23_I20220930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfMTUtNy0xLTEtMTU5NTQw_b54fa0cf-6abb-4ef0-a3db-ff471554b1bc" name="us-gaap:DerivativeAssetsCurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="id7268bc376574172920167043f112985_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfMTUtOS0xLTEtMTU5NTQw_453b9670-6638-4ae0-9088-6b1158b6a484" name="us-gaap:DerivativeAssetsCurrent" scale="6" unitref="usd">81.6</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other noncurrent assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i1300d5f8c7d44be79cb93f333746c580_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfMTYtMS0xLTEtMTU5NTQw_ebdf50ae-a827-4b98-b760-613c9438eaa8" name="us-gaap:DerivativeAssetsNoncurrent" scale="6" unitref="usd">116.9</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="iaca361ecbf3749b7a324afc87754e17e_I20220930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfMTYtMy0xLTEtMTU5NTQw_9e27aa07-70a0-44fb-a605-0e79a35b8fee" name="us-gaap:DerivativeAssetsNoncurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i5ac9d317ae404d2ebdc37459bd98e0c0_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfMTYtNS0xLTEtMTU5NTQw_d79fea84-482e-413c-ba99-842ed843cfd9" name="us-gaap:DerivativeAssetsNoncurrent" scale="6" unitref="usd">116.9</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ib6a56ab1b3ed4c26b10443b11b7c0c23_I20220930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfMTYtNy0xLTEtMTU5NTQw_19332f46-9c44-491f-a98d-0aa5ba060b83" name="us-gaap:DerivativeAssetsNoncurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="id7268bc376574172920167043f112985_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfMTYtOS0xLTEtMTU5NTQw_7e20ae77-589b-47c0-89e9-fa96c848500c" name="us-gaap:DerivativeAssetsNoncurrent" scale="6" unitref="usd">116.9</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency interest rate contracts designated as cash flow hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other noncurrent assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="id872aa3055934897a2abffb3543add56_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfMjAtMS0xLTEtMTU5NTQw_322b03c2-a902-4e01-8414-dc789221f7b3" name="us-gaap:DerivativeAssetsNoncurrent" scale="6" unitref="usd">8.3</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="idfd9f0975707442aa9a203b7a16441c5_I20220930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfMjAtMy0xLTEtMTU5NTQw_1d3e6a0d-572b-4c76-9a66-2ed3d74705df" name="us-gaap:DerivativeAssetsNoncurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ib2eb41ed3d014ed4b273125814f78a0d_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfMjAtNS0xLTEtMTU5NTQw_aef1fa34-da10-42bb-ab0c-3951d152889e" name="us-gaap:DerivativeAssetsNoncurrent" scale="6" unitref="usd">8.3</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i79464644e1f741088bd241cb52754676_I20220930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfMjAtNy0xLTEtMTU5NTQw_93bc179c-7728-47a6-b89c-a9105457fb44" name="us-gaap:DerivativeAssetsNoncurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i35a8009df6dc423f85c1ef726d565a66_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfMjAtOS0xLTEtMTU5NTQw_42a55421-ee80-4a33-b659-64ba86119db7" name="us-gaap:DerivativeAssetsNoncurrent" scale="6" unitref="usd">8.3</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other noncurrent liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="id872aa3055934897a2abffb3543add56_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfMjEtMS0xLTEtMTU5NTQw_c363b830-0837-4e83-a387-ed9a16b84915" name="us-gaap:DerivativeLiabilitiesNoncurrent" scale="6" unitref="usd">12.9</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="idfd9f0975707442aa9a203b7a16441c5_I20220930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfMjEtMy0xLTEtMTU5NTQw_aa85cf5a-507e-4e24-9be3-f79ad22f66fa" name="us-gaap:DerivativeLiabilitiesNoncurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="ib2eb41ed3d014ed4b273125814f78a0d_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfMjEtNS0xLTEtMTU5NTQw_e51dd8d9-ef2c-4045-8cf7-ff180aaef8fa" name="us-gaap:DerivativeLiabilitiesNoncurrent" scale="6" unitref="usd">12.9</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i79464644e1f741088bd241cb52754676_I20220930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfMjEtNy0xLTEtMTU5NTQw_27ebc35b-1998-4036-afd2-bd6b12d89ea4" name="us-gaap:DerivativeLiabilitiesNoncurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="i35a8009df6dc423f85c1ef726d565a66_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfMjEtOS0xLTEtMTU5NTQw_b51103a3-95d7-424a-9274-1804e5eecfb1" name="us-gaap:DerivativeLiabilitiesNoncurrent" scale="6" unitref="usd">12.9</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange contracts designated as net investment hedges:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ib616e3ba735b4f66ace91c9075e315e3_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfMjMtMS0xLTEtMTU5NTQw_3c67fe3d-379c-49cb-b9fe-2c92be70cbee" name="us-gaap:DerivativeAssetsCurrent" scale="6" unitref="usd">108.2</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7d14a5f5fcc44e8b974f3d717097b500_I20220930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfMjMtMy0xLTEtMTU5NTQw_29cd5751-904d-4024-8d1e-20e27e2c3403" name="us-gaap:DerivativeAssetsCurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i7cf0b43a5a854904951946bba3c063dd_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfMjMtNS0xLTEtMTU5NTQw_419d7262-2984-4541-a997-45292104b17e" name="us-gaap:DerivativeAssetsCurrent" scale="6" unitref="usd">108.2</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie06f4bbec8ae497db6f7f77940abcf72_I20220930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfMjMtNy0xLTEtMTU5NTQw_f03efa66-b48c-4f00-a2cf-3eae3b20eee9" name="us-gaap:DerivativeAssetsCurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="idd5c8623b0274f569a6e9cb890fe814d_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfMjMtOS0xLTEtMTU5NTQw_36bbdbae-cf70-4c04-898a-e2f63ee18621" name="us-gaap:DerivativeAssetsCurrent" scale="6" unitref="usd">108.2</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="ib616e3ba735b4f66ace91c9075e315e3_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfMjQtMS0xLTEtMTkzNDEz_076b24bf-65b5-41f5-a7c4-a3e96ec78f00" name="us-gaap:DerivativeLiabilitiesCurrent" scale="6" unitref="usd">2.9</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7d14a5f5fcc44e8b974f3d717097b500_I20220930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfMjQtMy0xLTEtMTkzNDI3_c51231dc-48c5-4320-957a-8698b6877907" name="us-gaap:DerivativeLiabilitiesCurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="i7cf0b43a5a854904951946bba3c063dd_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfMjQtNS0xLTEtMTkzNDQw_a0e929d0-4d82-4022-bdbe-6c8c242d63f8" name="us-gaap:DerivativeLiabilitiesCurrent" scale="6" unitref="usd">2.9</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie06f4bbec8ae497db6f7f77940abcf72_I20220930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfMjQtNy0xLTEtMTkzNDUx_acc3f89d-a9d6-45a2-99ab-1a658503186d" name="us-gaap:DerivativeLiabilitiesCurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="idd5c8623b0274f569a6e9cb890fe814d_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfMjQtOS0xLTEtMTkzNDU5_910d3f44-e0c1-437c-a1cc-a3d03f00f7e6" name="us-gaap:DerivativeLiabilitiesCurrent" scale="6" unitref="usd">2.9</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange contracts not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="id0faa86378a146a48b2256a18f02b7d5_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfMjUtMS0xLTEtMTU5NTQw_c1ce4a22-4048-4e66-958a-e5fcb6eb2431" name="us-gaap:DerivativeAssetsCurrent" scale="6" unitref="usd">48.1</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="iec96867cd1734fb382b9a966a90c804e_I20220930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfMjUtMy0xLTEtMTU5NTQw_70306229-3d77-49c6-9e24-823876c48528" name="us-gaap:DerivativeAssetsCurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i8d0b53a09fec472eab66541ef6214321_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfMjUtNS0xLTEtMTU5NTQw_2f215724-f9de-4e5d-86e0-08bb6dc6c70d" name="us-gaap:DerivativeAssetsCurrent" scale="6" unitref="usd">48.1</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i1354c03ac64d49b996ad815decc0f6d7_I20220930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfMjUtNy0xLTEtMTU5NTQw_bab00712-5d23-4f4e-8bd1-afb3c3cbf3bd" name="us-gaap:DerivativeAssetsCurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ibc6aec644ba74dffa95a469f4848e6bc_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfMjUtOS0xLTEtMTU5NTQw_c6862c6f-4407-4d85-8438-9d3223841264" name="us-gaap:DerivativeAssetsCurrent" scale="6" unitref="usd">48.1</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="id0faa86378a146a48b2256a18f02b7d5_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfMjYtMS0xLTEtMTU5NTQw_7d2604a2-9b3d-40e6-9bd2-64e0a2c09aa7" name="us-gaap:DerivativeLiabilitiesCurrent" scale="6" unitref="usd">93.5</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="iec96867cd1734fb382b9a966a90c804e_I20220930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfMjYtMy0xLTEtMTU5NTQw_9fc9ed45-d004-4eb3-ba6a-1775e77d8531" name="us-gaap:DerivativeLiabilitiesCurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="i8d0b53a09fec472eab66541ef6214321_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfMjYtNS0xLTEtMTU5NTQw_053940e5-47ac-4261-adcf-247d072cfff1" name="us-gaap:DerivativeLiabilitiesCurrent" scale="6" unitref="usd">93.5</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i1354c03ac64d49b996ad815decc0f6d7_I20220930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfMjYtNy0xLTEtMTU5NTQw_4fcf2bac-7145-46c9-8760-e4e4a03c9587" name="us-gaap:DerivativeLiabilitiesCurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="ibc6aec644ba74dffa95a469f4848e6bc_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfMjYtOS0xLTEtMTU5NTQw_3c8b48a8-9362-44d5-a394-3910de794eec" name="us-gaap:DerivativeLiabilitiesCurrent" scale="6" unitref="usd">93.5</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent consideration liability:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other noncurrent liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="ia25fb80ee7f14608ad1bc42cf7dc3d85_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfMzEtMS0xLTEtMTU5NTQw_a454c479-b41d-4f7e-a863-9b67a1e1b97c" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" unitref="usd">42.1</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i909f721d549b4d17b64fd5ef7a64ed65_I20220930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfMzEtMy0xLTEtMTU5NTQw_dab904da-6fb0-4d2b-8e46-5ff134a993ba" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" unitref="usd">&#8212;</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ida76f129eae2411aac66cefe0c47c6fc_I20220930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfMzEtNS0xLTEtMTU5NTQw_cbae7742-04e8-4363-a60a-a6758557c5e4" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" unitref="usd">&#8212;</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="ic34ce18d9ac34702bf22cdc268d8fddc_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfMzEtNy0xLTEtMTU5NTQw_b841238f-51cb-4aac-8384-aeff066ddc2b" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" unitref="usd">42.1</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="ice641419095d40b58b1ec413657e5350_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfMzEtOS0xLTEtMTU5NTQw_337496d2-9905-448b-821d-30774d7d1d91" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" unitref="usd">42.1</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-management instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate contracts designated as fair value hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other receivables</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i3a65232f1fca4f95abbb3167ab435068_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfMzYtMS0xLTEtMTU5NTQw_195b3f84-4bed-410a-8639-e544a1b13819" name="us-gaap:DerivativeAssetsCurrent" scale="6" unitref="usd">4.8</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i40ccf9cc0ff7401eab9722772af73854_I20211231" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfMzYtMy0xLTEtMTU5NTQw_b0805d62-c47a-43df-b8fb-b2f222781eb1" name="us-gaap:DerivativeAssetsCurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i4aa9bedfa4ea4600ab40f4f731255ce9_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfMzYtNS0xLTEtMTU5NTQw_40c5ea8c-6acb-4401-a7ed-8908804f41c9" name="us-gaap:DerivativeAssetsCurrent" scale="6" unitref="usd">4.8</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i6a47a49c720948c3b475ad8f3cf1ff16_I20211231" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfMzYtNy0xLTEtMTU5NTQw_6feccb88-17e0-4e30-a902-73b0f20dc399" name="us-gaap:DerivativeAssetsCurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i024a1912186c40c1a4e62a542f42350c_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfMzYtOS0xLTEtMTU5NTQw_f9da8fe1-542a-44e3-86f8-c4cc8bfbf9d2" name="us-gaap:DerivativeAssetsCurrent" scale="6" unitref="usd">4.8</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other noncurrent assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i3a65232f1fca4f95abbb3167ab435068_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfMzctMS0xLTEtMTU5NTQw_702c5be3-298d-4de9-a7b6-efe750261277" name="us-gaap:DerivativeAssetsNoncurrent" scale="6" unitref="usd">78.3</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i40ccf9cc0ff7401eab9722772af73854_I20211231" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfMzctMy0xLTEtMTU5NTQw_0bd23237-d998-4adc-9bb2-7f8b45437b17" name="us-gaap:DerivativeAssetsNoncurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i4aa9bedfa4ea4600ab40f4f731255ce9_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfMzctNS0xLTEtMTU5NTQw_beb31b67-0a26-4dea-b222-cf250671cfa7" name="us-gaap:DerivativeAssetsNoncurrent" scale="6" unitref="usd">78.3</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i6a47a49c720948c3b475ad8f3cf1ff16_I20211231" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfMzctNy0xLTEtMTU5NTQw_a20c48d6-e999-4249-b5e1-5de5ddab3c9f" name="us-gaap:DerivativeAssetsNoncurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i024a1912186c40c1a4e62a542f42350c_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfMzctOS0xLTEtMTU5NTQw_475a7dd8-a682-425c-b578-4ac9f9ee364c" name="us-gaap:DerivativeAssetsNoncurrent" scale="6" unitref="usd">78.3</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other noncurrent liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i3a65232f1fca4f95abbb3167ab435068_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfMzktMS0xLTEtMTU5NTQw_2345edfb-29e7-40cc-8c45-9a5fb16e7a96" name="us-gaap:DerivativeLiabilitiesNoncurrent" scale="6" unitref="usd">7.6</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i40ccf9cc0ff7401eab9722772af73854_I20211231" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfMzktMy0xLTEtMTU5NTQw_54c0ae5d-4ebd-4cdd-8771-a21ecd0debba" name="us-gaap:DerivativeLiabilitiesNoncurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i4aa9bedfa4ea4600ab40f4f731255ce9_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfMzktNS0xLTEtMTU5NTQw_00c322f4-1993-4e4c-adab-b5171fe83939" name="us-gaap:DerivativeLiabilitiesNoncurrent" scale="6" unitref="usd">7.6</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i6a47a49c720948c3b475ad8f3cf1ff16_I20211231" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfMzktNy0xLTEtMTU5NTQw_308c6d03-3d42-43f0-91c8-464a1e037031" name="us-gaap:DerivativeLiabilitiesNoncurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i024a1912186c40c1a4e62a542f42350c_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfMzktOS0xLTEtMTU5NTQw_d7a73612-0090-44cb-8650-8b6301153b76" name="us-gaap:DerivativeLiabilitiesNoncurrent" scale="6" unitref="usd">7.6</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate contracts designated as cash flow hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other noncurrent assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i318612662ee348ca8f4c50e967285c42_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfNDEtMS0xLTEtMTU5NTQw_917b7e63-9c66-4cbe-a2ba-0a05b33173fb" name="us-gaap:DerivativeAssetsNoncurrent" scale="6" unitref="usd">49.2</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i6b3448a25ab94a89aef263d03a2bd29a_I20211231" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfNDEtMy0xLTEtMTU5NTQw_00327ed6-0618-4511-8450-fd99d0855b47" name="us-gaap:DerivativeAssetsNoncurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i841d22572a894c128f4304c5a9d761b0_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfNDEtNS0xLTEtMTU5NTQw_81eb4109-b8d2-478a-883d-dbb63601a4d6" name="us-gaap:DerivativeAssetsNoncurrent" scale="6" unitref="usd">49.2</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie51a0fafa7104530b58bfc8df0b750d4_I20211231" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfNDEtNy0xLTEtMTU5NTQw_8f4b0654-943a-4599-ad40-84f822e9c1d8" name="us-gaap:DerivativeAssetsNoncurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i0999361082eb4d43bc2fc7f00ef0bae3_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfNDEtOS0xLTEtMTU5NTQw_60039a2b-bdf9-42d9-995b-44b0b7308935" name="us-gaap:DerivativeAssetsNoncurrent" scale="6" unitref="usd">49.2</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other noncurrent liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i318612662ee348ca8f4c50e967285c42_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfNDItMS0xLTEtMTU5NTQw_d47a46f8-49dd-4078-902d-2f9779a4bbd0" name="us-gaap:DerivativeLiabilitiesNoncurrent" scale="6" unitref="usd">31.7</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i6b3448a25ab94a89aef263d03a2bd29a_I20211231" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfNDItMy0xLTEtMTU5NTQw_f5fbe6a4-1584-43f3-a48d-eefc3dcef4c8" name="us-gaap:DerivativeLiabilitiesNoncurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i841d22572a894c128f4304c5a9d761b0_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfNDItNS0xLTEtMTU5NTQw_176a13ce-2a0d-4a95-8a2b-4a423e4e2f10" name="us-gaap:DerivativeLiabilitiesNoncurrent" scale="6" unitref="usd">31.7</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie51a0fafa7104530b58bfc8df0b750d4_I20211231" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfNDItNy0xLTEtMTU5NTQw_219e1619-a0f5-44aa-acef-6d9e990e3d47" name="us-gaap:DerivativeLiabilitiesNoncurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i0999361082eb4d43bc2fc7f00ef0bae3_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfNDItOS0xLTEtMTU5NTQw_a95a4bc5-66ef-488a-97fb-25f60cf77f9b" name="us-gaap:DerivativeLiabilitiesNoncurrent" scale="6" unitref="usd">31.7</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency interest rate contracts designated as net investment hedges:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other noncurrent assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i8a94f32b7cb642279222210de17f03ed_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfNDUtMS0xLTEtMTU5NTQw_02897dc0-1425-4404-bbb3-106c18765a50" name="us-gaap:DerivativeAssetsNoncurrent" scale="6" unitref="usd">31.3</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="iab252218731740b9a75cb6728b7b9503_I20211231" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfNDUtMy0xLTEtMTU5NTQw_408933ea-01e8-48d6-9296-f809cb500bdd" name="us-gaap:DerivativeAssetsNoncurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i5a6a92fb8f674015b49e7f493a12c723_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfNDUtNS0xLTEtMTU5NTQw_29d4b28f-a95b-48d2-8f91-b467d51af740" name="us-gaap:DerivativeAssetsNoncurrent" scale="6" unitref="usd">31.3</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="iee54e09047ba4b21a41fa3c8cc49cec2_I20211231" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfNDUtNy0xLTEtMTU5NTQw_73b2b14e-1ac8-43f2-a758-1317b01eee79" name="us-gaap:DerivativeAssetsNoncurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="icf2c03c7d41e4db1941ec3f47533b5ac_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfNDUtOS0xLTEtMTU5NTQw_51cff681-efa0-470a-841d-615888177fcb" name="us-gaap:DerivativeAssetsNoncurrent" scale="6" unitref="usd">31.3</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i8a94f32b7cb642279222210de17f03ed_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfNDYtMS0xLTEtMTU5NTQw_aaf65246-76f2-4489-9052-46905345cf8e" name="us-gaap:DerivativeLiabilitiesCurrent" scale="6" unitref="usd">1.2</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="iab252218731740b9a75cb6728b7b9503_I20211231" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfNDYtMy0xLTEtMTU5NTQw_a0278670-f225-4e35-b8e0-6cc186705f5a" name="us-gaap:DerivativeLiabilitiesCurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i5a6a92fb8f674015b49e7f493a12c723_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfNDYtNS0xLTEtMTU5NTQw_9742dacc-dcc1-42bd-a5f3-b15ebffd65e3" name="us-gaap:DerivativeLiabilitiesCurrent" scale="6" unitref="usd">1.2</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="iee54e09047ba4b21a41fa3c8cc49cec2_I20211231" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfNDYtNy0xLTEtMTU5NTQw_659aac83-3f23-4f40-b405-18d21242290e" name="us-gaap:DerivativeLiabilitiesCurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="icf2c03c7d41e4db1941ec3f47533b5ac_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfNDYtOS0xLTEtMTU5NTQw_83417eee-68cb-496e-b74d-5f873ab1e22a" name="us-gaap:DerivativeLiabilitiesCurrent" scale="6" unitref="usd">1.2</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency interest rate contracts designated as cash flow hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other noncurrent assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i09f8de57c8924dc5916922a278ad4eb1_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfNDktMS0xLTEtMTU5NTQw_9b37ebf6-5a55-4a58-954c-cb957e1d7001" name="us-gaap:DerivativeAssetsNoncurrent" scale="6" unitref="usd">33.2</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i1339ff825ab84e1292a5f32205bb84fb_I20211231" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfNDktMy0xLTEtMTU5NTQw_a1425879-238d-4785-b0e5-50b10586d791" name="us-gaap:DerivativeAssetsNoncurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="iddd7166aae2b440ab53a23a0b63e2aa9_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfNDktNS0xLTEtMTU5NTQw_92564f90-5f65-47e3-b196-c0c5d5911a29" name="us-gaap:DerivativeAssetsNoncurrent" scale="6" unitref="usd">33.2</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ic06c23f16f4443f78411fcbe2a43f013_I20211231" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfNDktNy0xLTEtMTU5NTQw_f548e4cc-715c-4114-a162-3be09cf3f950" name="us-gaap:DerivativeAssetsNoncurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ia6485e6d1b024de18d35df5658693713_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfNDktOS0xLTEtMTU5NTQw_813e35ca-491b-4823-b2f7-d887a95854b1" name="us-gaap:DerivativeAssetsNoncurrent" scale="6" unitref="usd">33.2</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other noncurrent liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i09f8de57c8924dc5916922a278ad4eb1_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfNTAtMS0xLTEtMTU5NTQw_e9d349c3-961b-4583-a904-0f5e3c7e0023" name="us-gaap:DerivativeLiabilitiesNoncurrent" scale="6" unitref="usd">1.3</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i1339ff825ab84e1292a5f32205bb84fb_I20211231" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfNTAtMy0xLTEtMTU5NTQw_c8c7c961-faa8-4d2a-b814-a2461de9becb" name="us-gaap:DerivativeLiabilitiesNoncurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="iddd7166aae2b440ab53a23a0b63e2aa9_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfNTAtNS0xLTEtMTU5NTQw_1b99872b-28ce-47dd-ac6c-b82b08275635" name="us-gaap:DerivativeLiabilitiesNoncurrent" scale="6" unitref="usd">1.3</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ic06c23f16f4443f78411fcbe2a43f013_I20211231" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfNTAtNy0xLTEtMTU5NTQw_858eca8f-8a4d-4a7a-9b91-c65637099667" name="us-gaap:DerivativeLiabilitiesNoncurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="ia6485e6d1b024de18d35df5658693713_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfNTAtOS0xLTEtMTU5NTQw_e74e45b5-f654-460b-a5e0-91c4df806c49" name="us-gaap:DerivativeLiabilitiesNoncurrent" scale="6" unitref="usd">1.3</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange contracts not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i9674dda0210248f68699af728a2b7366_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfNTItMS0xLTEtMTU5NTQw_a9b0cb44-1e16-4364-b2aa-dc206796df41" name="us-gaap:DerivativeAssetsCurrent" scale="6" unitref="usd">9.9</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i05396d0962d648b89a38691fab6227da_I20211231" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfNTItMy0xLTEtMTU5NTQw_42e63e7d-0796-40fe-9a02-7f231569f3d9" name="us-gaap:DerivativeAssetsCurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i637a8ab6a8a7402880d7c301d82ac216_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfNTItNS0xLTEtMTU5NTQw_493600d2-6bfe-4c94-8df7-31aaa9debfad" name="us-gaap:DerivativeAssetsCurrent" scale="6" unitref="usd">9.9</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i47903bc5967647c3ad861c42d533efb5_I20211231" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfNTItNy0xLTEtMTU5NTQw_97d07676-b86b-4f5b-8ca1-36c00b747282" name="us-gaap:DerivativeAssetsCurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i22af614be29843faa74794b4926362d9_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfNTItOS0xLTEtMTU5NTQw_d83d8859-efbb-4768-9e5f-373d7c668e82" name="us-gaap:DerivativeAssetsCurrent" scale="6" unitref="usd">9.9</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i9674dda0210248f68699af728a2b7366_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfNTMtMS0xLTEtMTU5NTQw_f313140b-25f3-47d2-9903-34254c7891fe" name="us-gaap:DerivativeLiabilitiesCurrent" scale="6" unitref="usd">35.3</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i05396d0962d648b89a38691fab6227da_I20211231" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfNTMtMy0xLTEtMTU5NTQw_678f0086-bb4a-4545-83af-07b09c223ad8" name="us-gaap:DerivativeLiabilitiesCurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i637a8ab6a8a7402880d7c301d82ac216_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfNTMtNS0xLTEtMTU5NTQw_ac2d072f-8ad2-4e4d-9bea-65d9a6fd2b2f" name="us-gaap:DerivativeLiabilitiesCurrent" scale="6" unitref="usd">35.3</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i47903bc5967647c3ad861c42d533efb5_I20211231" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfNTMtNy0xLTEtMTU5NTQw_a1828f81-f9b2-4ffd-90a9-7b0c4e2e3ac1" name="us-gaap:DerivativeLiabilitiesCurrent" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i22af614be29843faa74794b4926362d9_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfNTMtOS0xLTEtMTU5NTQw_cd7b2b48-874a-4b7b-9b88-eea51378640a" name="us-gaap:DerivativeLiabilitiesCurrent" scale="6" unitref="usd">35.3</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent consideration liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other noncurrent liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="ic3b630730b424a6d8b697cf0362c83d2_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfNTYtMS0xLTEtMTU5NTQw_90fecfdc-c5d0-4fb1-af0a-e713a3f4d323" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" unitref="usd">70.5</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i6802f141d8af4b8aa65c6abe305eeed2_I20211231" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfNTYtMy0xLTEtMTU5NTQw_7b158f4d-f4b4-4984-9a2c-6daf3b115547" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i124320eb89ce4dfa87c2f2083ad1e10b_I20211231" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfNTYtNS0xLTEtMTU5NTQw_e4a927e1-ca5b-4995-a608-b10f14caf1ff" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i2f37875c8bb94fed916b3375076f0703_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfNTYtNy0xLTEtMTU5NTQw_28112ff9-cc87-4a90-92cd-2a6cd75442e2" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" unitref="usd">70.5</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i52e3293fb124489e844061750e511c35_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjk0YTA5MzRkZmM4ZTQ3ZmY4YTdmNjllZTFmYTM4YmYwL3RhYmxlcmFuZ2U6OTRhMDkzNGRmYzhlNDdmZjhhN2Y2OWVlMWZhMzhiZjBfNTYtOS0xLTEtMTU5NTQw_e816fe41-013d-4fa3-8f42-ee1697c3d840" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" unitref="usd">70.5</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonnumeric></ix:continuation></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation continuedat="i0580b0c8eb2543f7a8cb29921b6585ba" id="i69c07437f434411caf87c5d63a2351cb"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk-management instruments above are disclosed on a gross basis. There are various rights of setoff associated with certain of the risk-management instruments above that are subject to enforceable master netting arrangements or similar agreements. Although various rights of setoff and master netting arrangements or similar agreements may exist with the individual counterparties to the risk-management instruments above, individually, these financial rights are not material.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine our Level 1 and Level 2 fair value measurements based on a market approach using quoted market values, significant other observable inputs for identical or comparable assets or liabilities, or discounted cash flow analyses. Level 3 fair value measurements for other investment securities are determined using unobservable inputs, including the investments' cost adjusted for impairments and price changes from orderly transactions. Fair values are not readily available for certain equity investments measured under the measurement alternative. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, we had approximately $<ix:nonfraction contextref="i08ccb35f6ad24d7793c9c91b74ca2ea1_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RleHRyZWdpb246OGRmOTEwZDdhYjFhNDFmMThlODU5ZTE4OTQxY2E4MDhfMTA2Njc_4d1d6cb8-c65c-4dac-bd5f-f1074917dfbb" name="us-gaap:FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareUnfundedCommittments" scale="6" unitref="usd">854</ix:nonfraction> million of unfunded commitments to invest in venture capital funds, which we anticipate will be paid over a period of up to <ix:nonnumeric contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RleHRyZWdpb246OGRmOTEwZDdhYjFhNDFmMThlODU5ZTE4OTQxY2E4MDhfMTA3ODY_c0b48292-becb-48a7-bdeb-620ef39ad735" name="lly:FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareUnfundedCommitmentsPaymentPeriod">10</ix:nonnumeric> years. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contingent consideration liability relates to our liability arising in connection with the CVR issued as a result of the Prevail acquisition. The fair value of the CVR liability was estimated using a discounted cash flow analysis and Level 3 inputs, including projections representative of a market participant's view of the expected cash payment associated with the first potential regulatory approval of a Prevail compound in the applicable countries based on probabilities of technical success, timing of the potential approval events for the compounds, and an estimated discount rate. See Note 3 for additional information related to the CVR arrangement. </span></div><ix:nonnumeric contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RleHRyZWdpb246OGRmOTEwZDdhYjFhNDFmMThlODU5ZTE4OTQxY2E4MDhfMTUxMDc_8195e1d3-627d-4380-a914-1bab3363b2db" name="us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the contractual maturities of our investments in debt securities measured at fair value as of September&#160;30, 2022:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:40.162%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.060%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.060%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.060%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.060%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.062%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturities by Period</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less&#160;Than<br/>1 Year</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1-5<br/>Years</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">6-10<br/>Years</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">More&#160;Than<br/>10 Years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of debt securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i08ccb35f6ad24d7793c9c91b74ca2ea1_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOmIyMDQ2NGYwYTg3NDRmNTE4NmY0ZTY4MmIwNmZiZWJlL3RhYmxlcmFuZ2U6YjIwNDY0ZjBhODc0NGY1MTg2ZjRlNjgyYjA2ZmJlYmVfMi0xLTEtMS0xNTk1NDA_b9dc3d8b-4db6-4ba5-b0d4-8b5002df5e24" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">622.2</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i08ccb35f6ad24d7793c9c91b74ca2ea1_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOmIyMDQ2NGYwYTg3NDRmNTE4NmY0ZTY4MmIwNmZiZWJlL3RhYmxlcmFuZ2U6YjIwNDY0ZjBhODc0NGY1MTg2ZjRlNjgyYjA2ZmJlYmVfMi0zLTEtMS0xNTk1NDA_872c587f-8a3e-4ab4-9cfb-2a4740153aa4" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" scale="6" unitref="usd">97.7</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i08ccb35f6ad24d7793c9c91b74ca2ea1_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOmIyMDQ2NGYwYTg3NDRmNTE4NmY0ZTY4MmIwNmZiZWJlL3RhYmxlcmFuZ2U6YjIwNDY0ZjBhODc0NGY1MTg2ZjRlNjgyYjA2ZmJlYmVfMi01LTEtMS0xNTk1NDA_eae1fcb3-6f93-441e-8c6e-773ba30e70a7" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" scale="6" unitref="usd">197.8</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i08ccb35f6ad24d7793c9c91b74ca2ea1_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOmIyMDQ2NGYwYTg3NDRmNTE4NmY0ZTY4MmIwNmZiZWJlL3RhYmxlcmFuZ2U6YjIwNDY0ZjBhODc0NGY1MTg2ZjRlNjgyYjA2ZmJlYmVfMi03LTEtMS0xNTk1NDA_a8569ec8-bc0a-4b58-8d66-da4429ca1a33" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" scale="6" unitref="usd">121.0</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i08ccb35f6ad24d7793c9c91b74ca2ea1_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOmIyMDQ2NGYwYTg3NDRmNTE4NmY0ZTY4MmIwNmZiZWJlL3RhYmxlcmFuZ2U6YjIwNDY0ZjBhODc0NGY1MTg2ZjRlNjgyYjA2ZmJlYmVfMi05LTEtMS0xNTk1NDA_4a30bdbb-dee8-4fb4-a28c-7adb4d192156" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" scale="6" unitref="usd">205.7</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div></ix:nonnumeric><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net gains (losses) recognized in our consolidated condensed statements of operations for equity securities were $(<ix:nonfraction contextref="i19fc0325c48543008ea71e1fdcf11d86_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RleHRyZWdpb246OGRmOTEwZDdhYjFhNDFmMThlODU5ZTE4OTQxY2E4MDhfMTE2OTQ_8f0a0b99-1ff4-4ac8-8531-70c7ebd1dd6f" name="us-gaap:EquitySecuritiesFvNiGainLoss" scale="6" sign="-" unitref="usd">123.3</ix:nonfraction>)&#160;million and $(<ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RleHRyZWdpb246OGRmOTEwZDdhYjFhNDFmMThlODU5ZTE4OTQxY2E4MDhfMTE3MDE_eb576f1c-f504-4904-89ff-727ba1432122" name="us-gaap:EquitySecuritiesFvNiGainLoss" scale="6" sign="-" unitref="usd">667.6</ix:nonfraction>)&#160;million for the three and nine months ended September&#160;30, 2022, respectively, and $(<ix:nonfraction contextref="ie4fa4f6b472a4f269297591b44aba572_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RleHRyZWdpb246OGRmOTEwZDdhYjFhNDFmMThlODU5ZTE4OTQxY2E4MDhfMTE3NTA_2bb44b70-0646-4de6-8b8f-88101b95cec8" name="us-gaap:EquitySecuritiesFvNiGainLoss" scale="6" sign="-" unitref="usd">246.8</ix:nonfraction>)&#160;million and $<ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RleHRyZWdpb246OGRmOTEwZDdhYjFhNDFmMThlODU5ZTE4OTQxY2E4MDhfMTE3NTc_4a4d3e33-c128-44a6-ab68-0d7e5da2a7aa" name="us-gaap:EquitySecuritiesFvNiGainLoss" scale="6" unitref="usd">270.1</ix:nonfraction>&#160;million for the three and nine months ended September&#160;30, 2021, respectively. The net gains (losses) recognized for the three and nine months ended September&#160;30, 2022 and 2021 on equity securities sold during the respective periods were not material.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We adjust our equity investments without readily determinable fair values based upon changes in the equity instruments' values resulting from observable price changes in orderly transactions for an identical or similar investment of the same issuer. Downward adjustments resulting from an impairment are recorded based upon impairment considerations, including the financial condition and near term prospects of the issuer, general market conditions, and industry specific factors. Adjustments recorded for the three and nine months ended September&#160;30, 2022 and 2021 were not material.</span></div><ix:nonnumeric contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RleHRyZWdpb246OGRmOTEwZDdhYjFhNDFmMThlODU5ZTE4OTQxY2E4MDhfMTUxNzg_54b52b0d-743c-45a2-b58d-52f1f154cd39" name="us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the amount of unrealized gains and losses in accumulated other comprehensive loss and the fair value of available-for-sale securities in an unrealized gain or loss position follows:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:66.249%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.859%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.860%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gross gains</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i08ccb35f6ad24d7793c9c91b74ca2ea1_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjA4MmY3YTI1MmU1ZjRlYjRhNTZkZDU5M2YxMzEyMGZjL3RhYmxlcmFuZ2U6MDgyZjdhMjUyZTVmNGViNGE1NmRkNTkzZjEzMTIwZmNfMS0xLTEtMS0xNTk1NDA_78bb3a83-371d-4dda-8a45-2f0d8b9b1022" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" unitref="usd">0.1</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i0973ba0c1d894ceaa494709a13f814fb_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjA4MmY3YTI1MmU1ZjRlYjRhNTZkZDU5M2YxMzEyMGZjL3RhYmxlcmFuZ2U6MDgyZjdhMjUyZTVmNGViNGE1NmRkNTkzZjEzMTIwZmNfMS0zLTEtMS0xNTk1NDA_d7865bfd-e2ba-4d45-8973-8bd1df337ff6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" unitref="usd">9.7</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gross losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i08ccb35f6ad24d7793c9c91b74ca2ea1_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjA4MmY3YTI1MmU1ZjRlYjRhNTZkZDU5M2YxMzEyMGZjL3RhYmxlcmFuZ2U6MDgyZjdhMjUyZTVmNGViNGE1NmRkNTkzZjEzMTIwZmNfMi0xLTEtMS0xNTk1NDA_7716b38b-927f-4600-b2e9-a5de79a6c7b5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" unitref="usd">51.6</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i0973ba0c1d894ceaa494709a13f814fb_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjA4MmY3YTI1MmU1ZjRlYjRhNTZkZDU5M2YxMzEyMGZjL3RhYmxlcmFuZ2U6MDgyZjdhMjUyZTVmNGViNGE1NmRkNTkzZjEzMTIwZmNfMi0zLTEtMS0xNTk1NDA_d13aca1f-0646-4b11-b367-d224022e1dd5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" unitref="usd">5.2</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of securities in an unrealized gain position</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i08ccb35f6ad24d7793c9c91b74ca2ea1_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjA4MmY3YTI1MmU1ZjRlYjRhNTZkZDU5M2YxMzEyMGZjL3RhYmxlcmFuZ2U6MDgyZjdhMjUyZTVmNGViNGE1NmRkNTkzZjEzMTIwZmNfMy0xLTEtMS0xNTk1NDA_e6afa47d-02f3-4ee3-bc7a-a1799604434c" name="lly:DebtSecuritiesAvailableforsaleUnrealizedGainPosition" scale="6" unitref="usd">13.8</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i0973ba0c1d894ceaa494709a13f814fb_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjA4MmY3YTI1MmU1ZjRlYjRhNTZkZDU5M2YxMzEyMGZjL3RhYmxlcmFuZ2U6MDgyZjdhMjUyZTVmNGViNGE1NmRkNTkzZjEzMTIwZmNfMy0zLTEtMS0xNTk1NDA_fe856a80-2c92-451b-9066-c79017d564cf" name="lly:DebtSecuritiesAvailableforsaleUnrealizedGainPosition" scale="6" unitref="usd">250.7</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of securities in an unrealized loss position</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i08ccb35f6ad24d7793c9c91b74ca2ea1_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjA4MmY3YTI1MmU1ZjRlYjRhNTZkZDU5M2YxMzEyMGZjL3RhYmxlcmFuZ2U6MDgyZjdhMjUyZTVmNGViNGE1NmRkNTkzZjEzMTIwZmNfNC0xLTEtMS0xNTk1NDA_78b75982-8cd5-47bd-b2cb-c38c52f28428" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" unitref="usd">578.8</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i0973ba0c1d894ceaa494709a13f814fb_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjA4MmY3YTI1MmU1ZjRlYjRhNTZkZDU5M2YxMzEyMGZjL3RhYmxlcmFuZ2U6MDgyZjdhMjUyZTVmNGViNGE1NmRkNTkzZjEzMTIwZmNfNC0zLTEtMS0xNTk1NDA_005f2639-e344-435c-9630-378f3b52c417" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" unitref="usd">290.2</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div></ix:nonnumeric><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We periodically assess our investment in available-for-sale securities for impairment losses and credit losses. The amount of credit losses are determined by comparing the difference between the present value of future cash flows expected to be collected on these securities and the amortized cost. Factors considered in assessing credit losses include the position in the capital structure, vintage and amount of collateral, delinquency rates, current credit support, and geographic concentration. Impairment and credit losses related to available-for-sale securities were not material for the three and nine months ended September&#160;30, 2022 and 2021.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i0580b0c8eb2543f7a8cb29921b6585ba"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, the available-for-sale securities in an unrealized loss position include primarily fixed-rate debt securities of varying maturities, which are sensitive to changes in the yield curve and other market conditions. Approximately <ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="2" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RleHRyZWdpb246OGRmOTEwZDdhYjFhNDFmMThlODU5ZTE4OTQxY2E4MDhfMTM1NTc_c2127107-d222-4181-bc82-39af6a9b7cb6" name="lly:DebtSecuritiesAvailableForSaleUnrealizedLossPositionQualitativeDisclosureOtherPercentageOfNonperformingAssets" scale="-2" unitref="number">95</ix:nonfraction> percent&#160;of the fixed-rate debt securities in a loss position are investment-grade debt securities. As of September&#160;30, 2022, we do not intend to sell, and it is not more likely than not that we will be required to sell, the securities in a loss position before the market values recover or the underlying cash flows have been received, and there is no indication of a material default on interest or principal payments for our debt securities.</span></div><ix:nonnumeric contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RleHRyZWdpb246OGRmOTEwZDdhYjFhNDFmMThlODU5ZTE4OTQxY2E4MDhfMTUxMjk_d53f54cd-0846-4d0c-a453-e9182f065ed0" name="us-gaap:GainLossOnInvestmentsTextBlock"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Activity related to our available-for-sale securities was as follows:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.206%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i19fc0325c48543008ea71e1fdcf11d86_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjYxNGZlZGYwZjc2ZTQwOTc5ZDgwOTc0YmM0ODc3Y2U5L3RhYmxlcmFuZ2U6NjE0ZmVkZjBmNzZlNDA5NzlkODA5NzRiYzQ4NzdjZTlfMi0xLTEtMS0xNTk1NDA_bfcbc4cc-9a0d-4242-bd13-db7902cd263e" name="lly:ProceedsfromSaleofEquityandAvailableforSaleSecurities" scale="6" unitref="usd">50.5</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie4fa4f6b472a4f269297591b44aba572_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjYxNGZlZGYwZjc2ZTQwOTc5ZDgwOTc0YmM0ODc3Y2U5L3RhYmxlcmFuZ2U6NjE0ZmVkZjBmNzZlNDA5NzlkODA5NzRiYzQ4NzdjZTlfMi0zLTEtMS0xNTk1NDA_c69e90ca-bacd-40f8-a7fb-3b246b8d301d" name="lly:ProceedsfromSaleofEquityandAvailableforSaleSecurities" scale="6" unitref="usd">49.6</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjYxNGZlZGYwZjc2ZTQwOTc5ZDgwOTc0YmM0ODc3Y2U5L3RhYmxlcmFuZ2U6NjE0ZmVkZjBmNzZlNDA5NzlkODA5NzRiYzQ4NzdjZTlfMi01LTEtMS0xNTk1NDA_67ddab9b-d464-4e7e-a19f-c86f401e63e0" name="lly:ProceedsfromSaleofEquityandAvailableforSaleSecurities" scale="6" unitref="usd">115.6</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjYxNGZlZGYwZjc2ZTQwOTc5ZDgwOTc0YmM0ODc3Y2U5L3RhYmxlcmFuZ2U6NjE0ZmVkZjBmNzZlNDA5NzlkODA5NzRiYzQ4NzdjZTlfMi03LTEtMS0xNTk1NDA_70857a31-7d04-4515-8db0-c0d9de976179" name="lly:ProceedsfromSaleofEquityandAvailableforSaleSecurities" scale="6" unitref="usd">137.3</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized gross gains on sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i19fc0325c48543008ea71e1fdcf11d86_D20220701-20220930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjYxNGZlZGYwZjc2ZTQwOTc5ZDgwOTc0YmM0ODc3Y2U5L3RhYmxlcmFuZ2U6NjE0ZmVkZjBmNzZlNDA5NzlkODA5NzRiYzQ4NzdjZTlfMy0xLTEtMS0xNTk1NDA_0ee4a37b-1b18-4c7f-a4ff-f5a2ca628f81" name="lly:AvailableforSaleSecuritiesandEquitySecuritiesFVNIRealizedGain" scale="6" unitref="usd">&#8212;</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie4fa4f6b472a4f269297591b44aba572_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjYxNGZlZGYwZjc2ZTQwOTc5ZDgwOTc0YmM0ODc3Y2U5L3RhYmxlcmFuZ2U6NjE0ZmVkZjBmNzZlNDA5NzlkODA5NzRiYzQ4NzdjZTlfMy0zLTEtMS0xNTk1NDA_181e2eff-aa2a-40ae-9cd0-87365340e6df" name="lly:AvailableforSaleSecuritiesandEquitySecuritiesFVNIRealizedGain" scale="6" unitref="usd">0.4</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjYxNGZlZGYwZjc2ZTQwOTc5ZDgwOTc0YmM0ODc3Y2U5L3RhYmxlcmFuZ2U6NjE0ZmVkZjBmNzZlNDA5NzlkODA5NzRiYzQ4NzdjZTlfMy01LTEtMS0xNTk1NDA_a4084db9-d5b2-40ab-a7e6-27ba3c7017db" name="lly:AvailableforSaleSecuritiesandEquitySecuritiesFVNIRealizedGain" scale="6" unitref="usd">0.2</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjYxNGZlZGYwZjc2ZTQwOTc5ZDgwOTc0YmM0ODc3Y2U5L3RhYmxlcmFuZ2U6NjE0ZmVkZjBmNzZlNDA5NzlkODA5NzRiYzQ4NzdjZTlfMy03LTEtMS0xNTk1NDA_2e4bb8bb-6619-4ce0-986e-3d8258673716" name="lly:AvailableforSaleSecuritiesandEquitySecuritiesFVNIRealizedGain" scale="6" unitref="usd">2.2</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized gross losses on sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i19fc0325c48543008ea71e1fdcf11d86_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjYxNGZlZGYwZjc2ZTQwOTc5ZDgwOTc0YmM0ODc3Y2U5L3RhYmxlcmFuZ2U6NjE0ZmVkZjBmNzZlNDA5NzlkODA5NzRiYzQ4NzdjZTlfNC0xLTEtMS0xNTk1NDA_493453ef-6c00-4a69-afe7-7803c4f4272e" name="lly:AvailableforsaleSecuritiesandEquitySecuritiesFVNIRealizedLoss" scale="6" unitref="usd">7.5</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie4fa4f6b472a4f269297591b44aba572_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjYxNGZlZGYwZjc2ZTQwOTc5ZDgwOTc0YmM0ODc3Y2U5L3RhYmxlcmFuZ2U6NjE0ZmVkZjBmNzZlNDA5NzlkODA5NzRiYzQ4NzdjZTlfNC0zLTEtMS0xNTk1NDA_e34a78d3-71a4-45e4-910d-7771596bf60c" name="lly:AvailableforsaleSecuritiesandEquitySecuritiesFVNIRealizedLoss" scale="6" unitref="usd">0.3</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjYxNGZlZGYwZjc2ZTQwOTc5ZDgwOTc0YmM0ODc3Y2U5L3RhYmxlcmFuZ2U6NjE0ZmVkZjBmNzZlNDA5NzlkODA5NzRiYzQ4NzdjZTlfNC01LTEtMS0xNTk1NDA_3da89a97-911b-4877-9510-38345ea87350" name="lly:AvailableforsaleSecuritiesandEquitySecuritiesFVNIRealizedLoss" scale="6" unitref="usd">9.0</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RhYmxlOjYxNGZlZGYwZjc2ZTQwOTc5ZDgwOTc0YmM0ODc3Y2U5L3RhYmxlcmFuZ2U6NjE0ZmVkZjBmNzZlNDA5NzlkODA5NzRiYzQ4NzdjZTlfNC03LTEtMS0xNTk1NDA_ad957c67-3630-48eb-9e9c-e01c0c32a3df" name="lly:AvailableforsaleSecuritiesandEquitySecuritiesFVNIRealizedLoss" scale="6" unitref="usd">1.1</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonnumeric><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Realized gains and losses on sales of available-for-sale investments are computed based upon specific identification of the initial cost adjusted for any other-than-temporary declines in fair value that were recorded in earnings.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounts Receivable Factoring Arrangements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into accounts receivable factoring agreements with financial institutions to sell certain of our non-U.S. accounts receivable. These transactions are accounted for as sales and result in a reduction in accounts receivable because the agreements transfer effective control over, and risk related to, the receivables to the buyers. Our factoring agreements do not allow for recourse in the event of uncollectibility, and we do not retain any interest in the underlying accounts receivable once sold. We derecognized $<ix:nonfraction contextref="i08ccb35f6ad24d7793c9c91b74ca2ea1_I20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RleHRyZWdpb246OGRmOTEwZDdhYjFhNDFmMThlODU5ZTE4OTQxY2E4MDhfMTQ4NTU_d461a7a3-cf80-45a2-b935-0ca765dd766f" name="us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" scale="6" unitref="usd">356.8</ix:nonfraction> million and $<ix:nonfraction contextref="i0973ba0c1d894ceaa494709a13f814fb_I20211231" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182MS9mcmFnOjhkZjkxMGQ3YWIxYTQxZjE4ZTg1OWUxODk0MWNhODA4L3RleHRyZWdpb246OGRmOTEwZDdhYjFhNDFmMThlODU5ZTE4OTQxY2E4MDhfMTQ4NjI_3c509b7e-cf02-4800-bc5e-abc722a8c242" name="us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" scale="6" unitref="usd">550.5</ix:nonfraction> million&#160;of accounts receivable as of September&#160;30, 2022 and December&#160;31, 2021, respectively, under these factoring arrangements. The costs of factoring such accounts receivable on our consolidated condensed results of operations for the three and nine months ended September&#160;30, 2022 and 2021&#160;were&#160;not material.</span></div></ix:continuation><div style="margin-top:6pt"><span><br/></span></div><div id="i5fed483d9c7e4f3cbba3a62c53226cd7_64"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 7: <ix:nonnumeric contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" continuedat="i8b9605b0eade4b6c9df79e0034f776f4" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182NC9mcmFnOmMzYjIwOWNjM2ExMjQ2OWE4NmQ5NTdhYTRkZGUyMmE4L3RleHRyZWdpb246YzNiMjA5Y2MzYTEyNDY5YTg2ZDk1N2FhNGRkZTIyYThfMTMwMw_4da865fa-c18e-49b7-bd05-bde2e642708c" name="us-gaap:IncomeTaxDisclosureTextBlock">Income Taxes </ix:nonnumeric></span></div><ix:continuation continuedat="i41f95466915c4c0986c5f382c4331b2e" id="i8b9605b0eade4b6c9df79e0034f776f4"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rates were <ix:nonfraction contextref="i19fc0325c48543008ea71e1fdcf11d86_D20220701-20220930" decimals="3" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182NC9mcmFnOmMzYjIwOWNjM2ExMjQ2OWE4NmQ5NTdhYTRkZGUyMmE4L3RleHRyZWdpb246YzNiMjA5Y2MzYTEyNDY5YTg2ZDk1N2FhNGRkZTIyYThfNTY_09741c81-4db5-421b-913c-1f9342c8166f" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" unitref="number">7.3</ix:nonfraction> percent and <ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="3" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182NC9mcmFnOmMzYjIwOWNjM2ExMjQ2OWE4NmQ5NTdhYTRkZGUyMmE4L3RleHRyZWdpb246YzNiMjA5Y2MzYTEyNDY5YTg2ZDk1N2FhNGRkZTIyYThfNjM_204ae19b-fe42-4b04-a332-f083899a2403" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" unitref="number">8.6</ix:nonfraction> percent for the three and nine months ended September&#160;30, 2022, respectively, reflecting the favorable tax impact of the implementation of a provision in the Tax Cuts and Jobs Act (2017 Tax Act) that requires capitalization and amortization of research and development expenses for tax purposes starting in 2022, net investment losses on equity securities, and an intangible asset impairment charge. We expect our effective tax rate to be approximately <ix:nonfraction contextref="i62df949acd3f4b47ae7d10432a08e2ab_D20220101-20221231" decimals="2" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182NC9mcmFnOmMzYjIwOWNjM2ExMjQ2OWE4NmQ5NTdhYTRkZGUyMmE4L3RleHRyZWdpb246YzNiMjA5Y2MzYTEyNDY5YTg2ZDk1N2FhNGRkZTIyYThfNTQy_18580e2a-b740-4700-b29a-a2bb08e7e56a" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" unitref="number">13</ix:nonfraction> percent to <ix:nonfraction contextref="i67750cd7b626486fa748e5b71374a667_D20220101-20221231" decimals="2" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182NC9mcmFnOmMzYjIwOWNjM2ExMjQ2OWE4NmQ5NTdhYTRkZGUyMmE4L3RleHRyZWdpb246YzNiMjA5Y2MzYTEyNDY5YTg2ZDk1N2FhNGRkZTIyYThfNTQ4_7ceba8cc-230d-4a04-8485-1d1cf712d502" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" unitref="number">14</ix:nonfraction> percent for 2022 if the capitalization and amortization of research and development expenses provision of the 2017 Tax Act is deferred or repealed by the U.S. Congress effective for 2022.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rate was <ix:nonfraction contextref="ie4fa4f6b472a4f269297591b44aba572_D20210701-20210930" decimals="3" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182NC9mcmFnOmMzYjIwOWNjM2ExMjQ2OWE4NmQ5NTdhYTRkZGUyMmE4L3RleHRyZWdpb246YzNiMjA5Y2MzYTEyNDY5YTg2ZDk1N2FhNGRkZTIyYThfNzYw_58733c71-1992-4699-afb8-e653abf947a3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" unitref="number">10.9</ix:nonfraction> percent for the three months ended September&#160;30, 2021, reflecting the favorable tax impact of a debt extinguishment loss and of net investment losses on equity securities, partially offset by a net discrete tax detriment. The effective tax rate was <ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="3" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182NC9mcmFnOmMzYjIwOWNjM2ExMjQ2OWE4NmQ5NTdhYTRkZGUyMmE4L3RleHRyZWdpb246YzNiMjA5Y2MzYTEyNDY5YTg2ZDk1N2FhNGRkZTIyYThfMjc0ODc3OTA3Mjc5NA_64cf953c-f539-4d84-a573-a47b34d0e185" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" unitref="number">10.7</ix:nonfraction> percent for the nine months ended September&#160;30, 2021, reflecting the favorable tax impact of a net discrete tax benefit, a debt extinguishment loss, and a net inventory impairment charge related to our COVID-19 antibodies. </span></div></ix:continuation><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i41f95466915c4c0986c5f382c4331b2e">The U.S. examination of tax years 2016-2018 began in the fourth quarter of 2019 and remains ongoing. The resolution of this audit period will likely extend beyond the next 12 months.</ix:continuation> </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><div id="i5fed483d9c7e4f3cbba3a62c53226cd7_67"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 8: <ix:nonnumeric contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" continuedat="i0bcd190fbaea4ce79aa8bbcf90cd3509" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182Ny9mcmFnOjc2ODNiYjQ2MzFiMTQ0MTJiMDk2YzNkYmNmOTZiMTFlL3RleHRyZWdpb246NzY4M2JiNDYzMWIxNDQxMmIwOTZjM2RiY2Y5NmIxMWVfMTM3_1c8712a1-f795-4abf-992b-0ac5987fbd6a" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock">Retirement Benefits</ix:nonnumeric></span></div><ix:continuation id="i0bcd190fbaea4ce79aa8bbcf90cd3509"><ix:nonnumeric contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182Ny9mcmFnOjc2ODNiYjQ2MzFiMTQ0MTJiMDk2YzNkYmNmOTZiMTFlL3RleHRyZWdpb246NzY4M2JiNDYzMWIxNDQxMmIwOTZjM2RiY2Y5NmIxMWVfMTQw_8042c4cc-a70c-4f01-8248-31be639cb51f" name="us-gaap:ScheduleOfNetBenefitCostsTableTextBlock"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net pension and retiree health benefit (income) cost included the following components:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.206%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Defined Benefit Pension Plans</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Components of net periodic benefit cost:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ifea67e1feada4a8c8d0bf25c34910e9a_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182Ny9mcmFnOjc2ODNiYjQ2MzFiMTQ0MTJiMDk2YzNkYmNmOTZiMTFlL3RhYmxlOjdhMGMwNmMxMTE0NTRlZmU4ZTc3YWM0MDhmYTQ1NTdmL3RhYmxlcmFuZ2U6N2EwYzA2YzExMTQ1NGVmZThlNzdhYzQwOGZhNDU1N2ZfNC0xLTEtMS0xNTk1NDA_2d091511-32e1-48de-899c-0d41867dc013" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" unitref="usd">87.1</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i19f7d57c42aa4dde893b82e5f134cfc1_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182Ny9mcmFnOjc2ODNiYjQ2MzFiMTQ0MTJiMDk2YzNkYmNmOTZiMTFlL3RhYmxlOjdhMGMwNmMxMTE0NTRlZmU4ZTc3YWM0MDhmYTQ1NTdmL3RhYmxlcmFuZ2U6N2EwYzA2YzExMTQ1NGVmZThlNzdhYzQwOGZhNDU1N2ZfNC0zLTEtMS0xNTk1NDA_b0d3754d-b275-4904-bd17-baa279f27785" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" unitref="usd">92.5</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i0116b5022f7f41b494fd355fe823d76e_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182Ny9mcmFnOjc2ODNiYjQ2MzFiMTQ0MTJiMDk2YzNkYmNmOTZiMTFlL3RhYmxlOjdhMGMwNmMxMTE0NTRlZmU4ZTc3YWM0MDhmYTQ1NTdmL3RhYmxlcmFuZ2U6N2EwYzA2YzExMTQ1NGVmZThlNzdhYzQwOGZhNDU1N2ZfNC01LTEtMS0xNTk1NDA_1270c886-5b81-46b4-86d3-c161d36f5f4c" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" unitref="usd">264.4</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i8a97c43966fd4f6aaf5f8dfb7bba4701_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182Ny9mcmFnOjc2ODNiYjQ2MzFiMTQ0MTJiMDk2YzNkYmNmOTZiMTFlL3RhYmxlOjdhMGMwNmMxMTE0NTRlZmU4ZTc3YWM0MDhmYTQ1NTdmL3RhYmxlcmFuZ2U6N2EwYzA2YzExMTQ1NGVmZThlNzdhYzQwOGZhNDU1N2ZfNC03LTEtMS0xNTk1NDA_a289693d-c14d-45c1-8b22-d2b3288482fc" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" unitref="usd">277.8</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ifea67e1feada4a8c8d0bf25c34910e9a_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182Ny9mcmFnOjc2ODNiYjQ2MzFiMTQ0MTJiMDk2YzNkYmNmOTZiMTFlL3RhYmxlOjdhMGMwNmMxMTE0NTRlZmU4ZTc3YWM0MDhmYTQ1NTdmL3RhYmxlcmFuZ2U6N2EwYzA2YzExMTQ1NGVmZThlNzdhYzQwOGZhNDU1N2ZfNS0xLTEtMS0xNTk1NDA_6af69744-5fdd-44a5-b4e7-996cae1b298a" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" unitref="usd">98.9</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i19f7d57c42aa4dde893b82e5f134cfc1_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182Ny9mcmFnOjc2ODNiYjQ2MzFiMTQ0MTJiMDk2YzNkYmNmOTZiMTFlL3RhYmxlOjdhMGMwNmMxMTE0NTRlZmU4ZTc3YWM0MDhmYTQ1NTdmL3RhYmxlcmFuZ2U6N2EwYzA2YzExMTQ1NGVmZThlNzdhYzQwOGZhNDU1N2ZfNS0zLTEtMS0xNTk1NDA_f003af34-46e5-48f2-a7ce-bb728393949f" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" unitref="usd">84.5</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i0116b5022f7f41b494fd355fe823d76e_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182Ny9mcmFnOjc2ODNiYjQ2MzFiMTQ0MTJiMDk2YzNkYmNmOTZiMTFlL3RhYmxlOjdhMGMwNmMxMTE0NTRlZmU4ZTc3YWM0MDhmYTQ1NTdmL3RhYmxlcmFuZ2U6N2EwYzA2YzExMTQ1NGVmZThlNzdhYzQwOGZhNDU1N2ZfNS01LTEtMS0xNTk1NDA_d0899d1f-4d82-4800-bb9c-d31a07cd8edf" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" unitref="usd">299.0</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i8a97c43966fd4f6aaf5f8dfb7bba4701_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182Ny9mcmFnOjc2ODNiYjQ2MzFiMTQ0MTJiMDk2YzNkYmNmOTZiMTFlL3RhYmxlOjdhMGMwNmMxMTE0NTRlZmU4ZTc3YWM0MDhmYTQ1NTdmL3RhYmxlcmFuZ2U6N2EwYzA2YzExMTQ1NGVmZThlNzdhYzQwOGZhNDU1N2ZfNS03LTEtMS0xNTk1NDA_630c584b-2cc1-4279-9c6b-c4c253956a06" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" unitref="usd">253.6</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="ifea67e1feada4a8c8d0bf25c34910e9a_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182Ny9mcmFnOjc2ODNiYjQ2MzFiMTQ0MTJiMDk2YzNkYmNmOTZiMTFlL3RhYmxlOjdhMGMwNmMxMTE0NTRlZmU4ZTc3YWM0MDhmYTQ1NTdmL3RhYmxlcmFuZ2U6N2EwYzA2YzExMTQ1NGVmZThlNzdhYzQwOGZhNDU1N2ZfNi0xLTEtMS0xNTk1NDA_6ba39726-929b-48f2-9c83-872d1bc37987" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" unitref="usd">235.1</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i19f7d57c42aa4dde893b82e5f134cfc1_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182Ny9mcmFnOjc2ODNiYjQ2MzFiMTQ0MTJiMDk2YzNkYmNmOTZiMTFlL3RhYmxlOjdhMGMwNmMxMTE0NTRlZmU4ZTc3YWM0MDhmYTQ1NTdmL3RhYmxlcmFuZ2U6N2EwYzA2YzExMTQ1NGVmZThlNzdhYzQwOGZhNDU1N2ZfNi0zLTEtMS0xNTk1NDA_1a9cf00b-7436-4fe4-bada-6e60d20b8ff0" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" unitref="usd">237.5</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="i0116b5022f7f41b494fd355fe823d76e_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182Ny9mcmFnOjc2ODNiYjQ2MzFiMTQ0MTJiMDk2YzNkYmNmOTZiMTFlL3RhYmxlOjdhMGMwNmMxMTE0NTRlZmU4ZTc3YWM0MDhmYTQ1NTdmL3RhYmxlcmFuZ2U6N2EwYzA2YzExMTQ1NGVmZThlNzdhYzQwOGZhNDU1N2ZfNi01LTEtMS0xNTk1NDA_bdd9f46a-7357-4dda-97cc-014f240b8071" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" unitref="usd">711.6</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i8a97c43966fd4f6aaf5f8dfb7bba4701_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182Ny9mcmFnOjc2ODNiYjQ2MzFiMTQ0MTJiMDk2YzNkYmNmOTZiMTFlL3RhYmxlOjdhMGMwNmMxMTE0NTRlZmU4ZTc3YWM0MDhmYTQ1NTdmL3RhYmxlcmFuZ2U6N2EwYzA2YzExMTQ1NGVmZThlNzdhYzQwOGZhNDU1N2ZfNi03LTEtMS0xNTk1NDA_6ceeae2f-86ec-45f7-94ed-12dd3f26fd8e" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" unitref="usd">712.7</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ifea67e1feada4a8c8d0bf25c34910e9a_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182Ny9mcmFnOjc2ODNiYjQ2MzFiMTQ0MTJiMDk2YzNkYmNmOTZiMTFlL3RhYmxlOjdhMGMwNmMxMTE0NTRlZmU4ZTc3YWM0MDhmYTQ1NTdmL3RhYmxlcmFuZ2U6N2EwYzA2YzExMTQ1NGVmZThlNzdhYzQwOGZhNDU1N2ZfNy0xLTEtMS0xNTk1NDA_79f7701a-4e75-4ad6-841e-3c300f94aad8" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" unitref="usd">0.6</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i19f7d57c42aa4dde893b82e5f134cfc1_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182Ny9mcmFnOjc2ODNiYjQ2MzFiMTQ0MTJiMDk2YzNkYmNmOTZiMTFlL3RhYmxlOjdhMGMwNmMxMTE0NTRlZmU4ZTc3YWM0MDhmYTQ1NTdmL3RhYmxlcmFuZ2U6N2EwYzA2YzExMTQ1NGVmZThlNzdhYzQwOGZhNDU1N2ZfNy0zLTEtMS0xNTk1NDA_4d01de6d-f33d-4125-b650-2465d8233962" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" unitref="usd">1.0</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i0116b5022f7f41b494fd355fe823d76e_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182Ny9mcmFnOjc2ODNiYjQ2MzFiMTQ0MTJiMDk2YzNkYmNmOTZiMTFlL3RhYmxlOjdhMGMwNmMxMTE0NTRlZmU4ZTc3YWM0MDhmYTQ1NTdmL3RhYmxlcmFuZ2U6N2EwYzA2YzExMTQ1NGVmZThlNzdhYzQwOGZhNDU1N2ZfNy01LTEtMS0xNTk1NDA_bbcd8f96-9617-4756-a8ca-93860fd077ac" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" unitref="usd">1.9</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i8a97c43966fd4f6aaf5f8dfb7bba4701_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182Ny9mcmFnOjc2ODNiYjQ2MzFiMTQ0MTJiMDk2YzNkYmNmOTZiMTFlL3RhYmxlOjdhMGMwNmMxMTE0NTRlZmU4ZTc3YWM0MDhmYTQ1NTdmL3RhYmxlcmFuZ2U6N2EwYzA2YzExMTQ1NGVmZThlNzdhYzQwOGZhNDU1N2ZfNy03LTEtMS0xNTk1NDA_d09315bc-a246-4761-8dcf-d026058a8514" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" unitref="usd">3.2</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized actuarial loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ifea67e1feada4a8c8d0bf25c34910e9a_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182Ny9mcmFnOjc2ODNiYjQ2MzFiMTQ0MTJiMDk2YzNkYmNmOTZiMTFlL3RhYmxlOjdhMGMwNmMxMTE0NTRlZmU4ZTc3YWM0MDhmYTQ1NTdmL3RhYmxlcmFuZ2U6N2EwYzA2YzExMTQ1NGVmZThlNzdhYzQwOGZhNDU1N2ZfOC0xLTEtMS0xNTk1NDA_b56420f5-b92a-4a74-a84f-db8f87c32552" name="us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit" scale="6" sign="-" unitref="usd">85.3</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i19f7d57c42aa4dde893b82e5f134cfc1_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182Ny9mcmFnOjc2ODNiYjQ2MzFiMTQ0MTJiMDk2YzNkYmNmOTZiMTFlL3RhYmxlOjdhMGMwNmMxMTE0NTRlZmU4ZTc3YWM0MDhmYTQ1NTdmL3RhYmxlcmFuZ2U6N2EwYzA2YzExMTQ1NGVmZThlNzdhYzQwOGZhNDU1N2ZfOC0zLTEtMS0xNTk1NDA_67aa935d-0b6b-4e66-9ab9-4385e1182ba1" name="us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit" scale="6" sign="-" unitref="usd">121.9</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i0116b5022f7f41b494fd355fe823d76e_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182Ny9mcmFnOjc2ODNiYjQ2MzFiMTQ0MTJiMDk2YzNkYmNmOTZiMTFlL3RhYmxlOjdhMGMwNmMxMTE0NTRlZmU4ZTc3YWM0MDhmYTQ1NTdmL3RhYmxlcmFuZ2U6N2EwYzA2YzExMTQ1NGVmZThlNzdhYzQwOGZhNDU1N2ZfOC01LTEtMS0xNTk1NDA_17d0dd71-107c-44a9-a8ee-8324ff5a143f" name="us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit" scale="6" sign="-" unitref="usd">256.8</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i8a97c43966fd4f6aaf5f8dfb7bba4701_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182Ny9mcmFnOjc2ODNiYjQ2MzFiMTQ0MTJiMDk2YzNkYmNmOTZiMTFlL3RhYmxlOjdhMGMwNmMxMTE0NTRlZmU4ZTc3YWM0MDhmYTQ1NTdmL3RhYmxlcmFuZ2U6N2EwYzA2YzExMTQ1NGVmZThlNzdhYzQwOGZhNDU1N2ZfOC03LTEtMS0xNTk1NDA_89bf223b-a162-4be6-9096-7103e7c89cda" name="us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit" scale="6" sign="-" unitref="usd">366.3</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit cost</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ifea67e1feada4a8c8d0bf25c34910e9a_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182Ny9mcmFnOjc2ODNiYjQ2MzFiMTQ0MTJiMDk2YzNkYmNmOTZiMTFlL3RhYmxlOjdhMGMwNmMxMTE0NTRlZmU4ZTc3YWM0MDhmYTQ1NTdmL3RhYmxlcmFuZ2U6N2EwYzA2YzExMTQ1NGVmZThlNzdhYzQwOGZhNDU1N2ZfMTAtMS0xLTEtMTU5NTQw_d222aaa8-4de2-464e-ad36-89f18ffdc09e" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" unitref="usd">36.8</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i19f7d57c42aa4dde893b82e5f134cfc1_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182Ny9mcmFnOjc2ODNiYjQ2MzFiMTQ0MTJiMDk2YzNkYmNmOTZiMTFlL3RhYmxlOjdhMGMwNmMxMTE0NTRlZmU4ZTc3YWM0MDhmYTQ1NTdmL3RhYmxlcmFuZ2U6N2EwYzA2YzExMTQ1NGVmZThlNzdhYzQwOGZhNDU1N2ZfMTAtMy0xLTEtMTU5NTQw_2c71567a-37d1-44d3-a00b-549332be76a7" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" unitref="usd">62.4</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i0116b5022f7f41b494fd355fe823d76e_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182Ny9mcmFnOjc2ODNiYjQ2MzFiMTQ0MTJiMDk2YzNkYmNmOTZiMTFlL3RhYmxlOjdhMGMwNmMxMTE0NTRlZmU4ZTc3YWM0MDhmYTQ1NTdmL3RhYmxlcmFuZ2U6N2EwYzA2YzExMTQ1NGVmZThlNzdhYzQwOGZhNDU1N2ZfMTAtNS0xLTEtMTU5NTQw_b0b9ea53-a34e-4cc9-a7a2-e52a6e61d7cf" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" unitref="usd">110.5</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i8a97c43966fd4f6aaf5f8dfb7bba4701_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182Ny9mcmFnOjc2ODNiYjQ2MzFiMTQ0MTJiMDk2YzNkYmNmOTZiMTFlL3RhYmxlOjdhMGMwNmMxMTE0NTRlZmU4ZTc3YWM0MDhmYTQ1NTdmL3RhYmxlcmFuZ2U6N2EwYzA2YzExMTQ1NGVmZThlNzdhYzQwOGZhNDU1N2ZfMTAtNy0xLTEtMTU5NTQw_c3a020f8-bc63-4fc4-ab1e-08f0c7f02b32" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" unitref="usd">188.2</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.206%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retiree Health Benefit Plans</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Components of net periodic benefit income:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i238afcd7e9494cbb9f4c68c1cf1dcc2d_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182Ny9mcmFnOjc2ODNiYjQ2MzFiMTQ0MTJiMDk2YzNkYmNmOTZiMTFlL3RhYmxlOjBhZjE5OWIyY2U1YTQ5ODA4ZTVlYThlMDdjNmE2YmZkL3RhYmxlcmFuZ2U6MGFmMTk5YjJjZTVhNDk4MDhlNWVhOGUwN2M2YTZiZmRfNC0xLTEtMS0xNTk1NDA_7b659c1c-bbe9-425c-8caa-6edcc81ad9f8" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" unitref="usd">11.7</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i6b0c929331c241cb98c2a4d85625e2e7_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182Ny9mcmFnOjc2ODNiYjQ2MzFiMTQ0MTJiMDk2YzNkYmNmOTZiMTFlL3RhYmxlOjBhZjE5OWIyY2U1YTQ5ODA4ZTVlYThlMDdjNmE2YmZkL3RhYmxlcmFuZ2U6MGFmMTk5YjJjZTVhNDk4MDhlNWVhOGUwN2M2YTZiZmRfNC0zLTEtMS0xNTk1NDA_1ee08aff-fd66-4527-b92f-171c895057f3" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" unitref="usd">12.4</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i60435d86ecc44d56b9b471e301119ba4_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182Ny9mcmFnOjc2ODNiYjQ2MzFiMTQ0MTJiMDk2YzNkYmNmOTZiMTFlL3RhYmxlOjBhZjE5OWIyY2U1YTQ5ODA4ZTVlYThlMDdjNmE2YmZkL3RhYmxlcmFuZ2U6MGFmMTk5YjJjZTVhNDk4MDhlNWVhOGUwN2M2YTZiZmRfNC01LTEtMS0xNTk1NDA_03baa210-7659-4b21-a32c-9fcb2dc8e7a1" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" unitref="usd">35.0</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i146fcce3fad6486aa91cf7ba94fd98c8_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182Ny9mcmFnOjc2ODNiYjQ2MzFiMTQ0MTJiMDk2YzNkYmNmOTZiMTFlL3RhYmxlOjBhZjE5OWIyY2U1YTQ5ODA4ZTVlYThlMDdjNmE2YmZkL3RhYmxlcmFuZ2U6MGFmMTk5YjJjZTVhNDk4MDhlNWVhOGUwN2M2YTZiZmRfNC03LTEtMS0xNTk1NDA_dfaa4e37-9742-4f4d-86fb-f3f3b338ce5a" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" unitref="usd">37.0</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i238afcd7e9494cbb9f4c68c1cf1dcc2d_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182Ny9mcmFnOjc2ODNiYjQ2MzFiMTQ0MTJiMDk2YzNkYmNmOTZiMTFlL3RhYmxlOjBhZjE5OWIyY2U1YTQ5ODA4ZTVlYThlMDdjNmE2YmZkL3RhYmxlcmFuZ2U6MGFmMTk5YjJjZTVhNDk4MDhlNWVhOGUwN2M2YTZiZmRfNS0xLTEtMS0xNTk1NDA_5e9dce56-a7a7-454f-8c5c-fe9a11d638ed" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" unitref="usd">9.4</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i6b0c929331c241cb98c2a4d85625e2e7_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182Ny9mcmFnOjc2ODNiYjQ2MzFiMTQ0MTJiMDk2YzNkYmNmOTZiMTFlL3RhYmxlOjBhZjE5OWIyY2U1YTQ5ODA4ZTVlYThlMDdjNmE2YmZkL3RhYmxlcmFuZ2U6MGFmMTk5YjJjZTVhNDk4MDhlNWVhOGUwN2M2YTZiZmRfNS0zLTEtMS0xNTk1NDA_4c0b4229-63c5-4de5-9668-6973b9de3436" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" unitref="usd">8.1</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i60435d86ecc44d56b9b471e301119ba4_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182Ny9mcmFnOjc2ODNiYjQ2MzFiMTQ0MTJiMDk2YzNkYmNmOTZiMTFlL3RhYmxlOjBhZjE5OWIyY2U1YTQ5ODA4ZTVlYThlMDdjNmE2YmZkL3RhYmxlcmFuZ2U6MGFmMTk5YjJjZTVhNDk4MDhlNWVhOGUwN2M2YTZiZmRfNS01LTEtMS0xNTk1NDA_79221b18-8d5e-4e89-8c41-c71302047af2" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" unitref="usd">28.4</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i146fcce3fad6486aa91cf7ba94fd98c8_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182Ny9mcmFnOjc2ODNiYjQ2MzFiMTQ0MTJiMDk2YzNkYmNmOTZiMTFlL3RhYmxlOjBhZjE5OWIyY2U1YTQ5ODA4ZTVlYThlMDdjNmE2YmZkL3RhYmxlcmFuZ2U6MGFmMTk5YjJjZTVhNDk4MDhlNWVhOGUwN2M2YTZiZmRfNS03LTEtMS0xNTk1NDA_190cdb00-ffd0-4447-9151-e314e71cbf4a" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" unitref="usd">24.4</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="i238afcd7e9494cbb9f4c68c1cf1dcc2d_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182Ny9mcmFnOjc2ODNiYjQ2MzFiMTQ0MTJiMDk2YzNkYmNmOTZiMTFlL3RhYmxlOjBhZjE5OWIyY2U1YTQ5ODA4ZTVlYThlMDdjNmE2YmZkL3RhYmxlcmFuZ2U6MGFmMTk5YjJjZTVhNDk4MDhlNWVhOGUwN2M2YTZiZmRfNi0xLTEtMS0xNTk1NDA_5e20d3b0-e504-4cd8-bbba-6febad47b954" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" unitref="usd">38.0</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i6b0c929331c241cb98c2a4d85625e2e7_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182Ny9mcmFnOjc2ODNiYjQ2MzFiMTQ0MTJiMDk2YzNkYmNmOTZiMTFlL3RhYmxlOjBhZjE5OWIyY2U1YTQ5ODA4ZTVlYThlMDdjNmE2YmZkL3RhYmxlcmFuZ2U6MGFmMTk5YjJjZTVhNDk4MDhlNWVhOGUwN2M2YTZiZmRfNi0zLTEtMS0xNTk1NDA_33531405-5355-4e13-ab49-59dfffcffecd" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" unitref="usd">36.5</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="i60435d86ecc44d56b9b471e301119ba4_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182Ny9mcmFnOjc2ODNiYjQ2MzFiMTQ0MTJiMDk2YzNkYmNmOTZiMTFlL3RhYmxlOjBhZjE5OWIyY2U1YTQ5ODA4ZTVlYThlMDdjNmE2YmZkL3RhYmxlcmFuZ2U6MGFmMTk5YjJjZTVhNDk4MDhlNWVhOGUwN2M2YTZiZmRfNi01LTEtMS0xNTk1NDA_bbe145c7-cff3-4935-881c-0d39f4e98c80" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" unitref="usd">114.1</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i146fcce3fad6486aa91cf7ba94fd98c8_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182Ny9mcmFnOjc2ODNiYjQ2MzFiMTQ0MTJiMDk2YzNkYmNmOTZiMTFlL3RhYmxlOjBhZjE5OWIyY2U1YTQ5ODA4ZTVlYThlMDdjNmE2YmZkL3RhYmxlcmFuZ2U6MGFmMTk5YjJjZTVhNDk4MDhlNWVhOGUwN2M2YTZiZmRfNi03LTEtMS0xNTk1NDA_3aa119d3-74c2-4a5e-889e-4a61b2d3523c" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" unitref="usd">109.6</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="i238afcd7e9494cbb9f4c68c1cf1dcc2d_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182Ny9mcmFnOjc2ODNiYjQ2MzFiMTQ0MTJiMDk2YzNkYmNmOTZiMTFlL3RhYmxlOjBhZjE5OWIyY2U1YTQ5ODA4ZTVlYThlMDdjNmE2YmZkL3RhYmxlcmFuZ2U6MGFmMTk5YjJjZTVhNDk4MDhlNWVhOGUwN2M2YTZiZmRfNy0xLTEtMS0xNTk1NDA_b0039838-d99b-4511-b9ee-7d15005dd77d" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" sign="-" unitref="usd">13.7</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i6b0c929331c241cb98c2a4d85625e2e7_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182Ny9mcmFnOjc2ODNiYjQ2MzFiMTQ0MTJiMDk2YzNkYmNmOTZiMTFlL3RhYmxlOjBhZjE5OWIyY2U1YTQ5ODA4ZTVlYThlMDdjNmE2YmZkL3RhYmxlcmFuZ2U6MGFmMTk5YjJjZTVhNDk4MDhlNWVhOGUwN2M2YTZiZmRfNy0zLTEtMS0xNTk1NDA_fced5d52-4240-4409-ac21-c381b98ddb20" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" sign="-" unitref="usd">14.9</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="i60435d86ecc44d56b9b471e301119ba4_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182Ny9mcmFnOjc2ODNiYjQ2MzFiMTQ0MTJiMDk2YzNkYmNmOTZiMTFlL3RhYmxlOjBhZjE5OWIyY2U1YTQ5ODA4ZTVlYThlMDdjNmE2YmZkL3RhYmxlcmFuZ2U6MGFmMTk5YjJjZTVhNDk4MDhlNWVhOGUwN2M2YTZiZmRfNy01LTEtMS0xNTk1NDA_42a2821c-2674-4e97-9067-c041f2b8238d" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" sign="-" unitref="usd">41.1</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i146fcce3fad6486aa91cf7ba94fd98c8_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182Ny9mcmFnOjc2ODNiYjQ2MzFiMTQ0MTJiMDk2YzNkYmNmOTZiMTFlL3RhYmxlOjBhZjE5OWIyY2U1YTQ5ODA4ZTVlYThlMDdjNmE2YmZkL3RhYmxlcmFuZ2U6MGFmMTk5YjJjZTVhNDk4MDhlNWVhOGUwN2M2YTZiZmRfNy03LTEtMS0xNTk1NDA_9c76e13a-df82-4ce2-ae22-c31d846b7b08" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" sign="-" unitref="usd">44.7</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized actuarial loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i238afcd7e9494cbb9f4c68c1cf1dcc2d_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182Ny9mcmFnOjc2ODNiYjQ2MzFiMTQ0MTJiMDk2YzNkYmNmOTZiMTFlL3RhYmxlOjBhZjE5OWIyY2U1YTQ5ODA4ZTVlYThlMDdjNmE2YmZkL3RhYmxlcmFuZ2U6MGFmMTk5YjJjZTVhNDk4MDhlNWVhOGUwN2M2YTZiZmRfOC0xLTEtMS0xNTk1NDA_e0784215-c079-4775-a5b2-742e92fbc4cc" name="us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit" scale="6" sign="-" unitref="usd">0.2</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i6b0c929331c241cb98c2a4d85625e2e7_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182Ny9mcmFnOjc2ODNiYjQ2MzFiMTQ0MTJiMDk2YzNkYmNmOTZiMTFlL3RhYmxlOjBhZjE5OWIyY2U1YTQ5ODA4ZTVlYThlMDdjNmE2YmZkL3RhYmxlcmFuZ2U6MGFmMTk5YjJjZTVhNDk4MDhlNWVhOGUwN2M2YTZiZmRfOC0zLTEtMS0xNTk1NDA_47d99cdf-0375-4cba-b0aa-05328f552da9" name="us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit" scale="6" sign="-" unitref="usd">0.8</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i60435d86ecc44d56b9b471e301119ba4_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182Ny9mcmFnOjc2ODNiYjQ2MzFiMTQ0MTJiMDk2YzNkYmNmOTZiMTFlL3RhYmxlOjBhZjE5OWIyY2U1YTQ5ODA4ZTVlYThlMDdjNmE2YmZkL3RhYmxlcmFuZ2U6MGFmMTk5YjJjZTVhNDk4MDhlNWVhOGUwN2M2YTZiZmRfOC01LTEtMS0xNTk1NDA_21e03264-275f-49f8-96ef-ab83786c7f3e" name="us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit" scale="6" sign="-" unitref="usd">0.7</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i146fcce3fad6486aa91cf7ba94fd98c8_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182Ny9mcmFnOjc2ODNiYjQ2MzFiMTQ0MTJiMDk2YzNkYmNmOTZiMTFlL3RhYmxlOjBhZjE5OWIyY2U1YTQ5ODA4ZTVlYThlMDdjNmE2YmZkL3RhYmxlcmFuZ2U6MGFmMTk5YjJjZTVhNDk4MDhlNWVhOGUwN2M2YTZiZmRfOC03LTEtMS0xNTk1NDA_07011895-c6b7-4421-b55c-bceab32fdfa8" name="us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit" scale="6" sign="-" unitref="usd">2.4</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit income</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="i238afcd7e9494cbb9f4c68c1cf1dcc2d_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182Ny9mcmFnOjc2ODNiYjQ2MzFiMTQ0MTJiMDk2YzNkYmNmOTZiMTFlL3RhYmxlOjBhZjE5OWIyY2U1YTQ5ODA4ZTVlYThlMDdjNmE2YmZkL3RhYmxlcmFuZ2U6MGFmMTk5YjJjZTVhNDk4MDhlNWVhOGUwN2M2YTZiZmRfMTAtMS0xLTEtMTU5NTQw_7842c229-76a1-41f9-91c7-5bc773be8c6d" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" sign="-" unitref="usd">30.4</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i6b0c929331c241cb98c2a4d85625e2e7_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182Ny9mcmFnOjc2ODNiYjQ2MzFiMTQ0MTJiMDk2YzNkYmNmOTZiMTFlL3RhYmxlOjBhZjE5OWIyY2U1YTQ5ODA4ZTVlYThlMDdjNmE2YmZkL3RhYmxlcmFuZ2U6MGFmMTk5YjJjZTVhNDk4MDhlNWVhOGUwN2M2YTZiZmRfMTAtMy0xLTEtMTU5NTQw_6119dc87-bc16-4d11-a6f8-22537b1fe836" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" sign="-" unitref="usd">30.1</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="i60435d86ecc44d56b9b471e301119ba4_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182Ny9mcmFnOjc2ODNiYjQ2MzFiMTQ0MTJiMDk2YzNkYmNmOTZiMTFlL3RhYmxlOjBhZjE5OWIyY2U1YTQ5ODA4ZTVlYThlMDdjNmE2YmZkL3RhYmxlcmFuZ2U6MGFmMTk5YjJjZTVhNDk4MDhlNWVhOGUwN2M2YTZiZmRfMTAtNS0xLTEtMTU5NTQw_639edd6f-88e4-4b6c-bab9-5a0e961e527c" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" sign="-" unitref="usd">91.1</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i146fcce3fad6486aa91cf7ba94fd98c8_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN182Ny9mcmFnOjc2ODNiYjQ2MzFiMTQ0MTJiMDk2YzNkYmNmOTZiMTFlL3RhYmxlOjBhZjE5OWIyY2U1YTQ5ODA4ZTVlYThlMDdjNmE2YmZkL3RhYmxlcmFuZ2U6MGFmMTk5YjJjZTVhNDk4MDhlNWVhOGUwN2M2YTZiZmRfMTAtNy0xLTEtMTU5NTQw_172a5a38-69a0-4b77-a7f5-9ff66dded603" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" sign="-" unitref="usd">90.5</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div></ix:nonnumeric></ix:continuation><div style="margin-top:6pt"><span><br/></span></div><div id="i5fed483d9c7e4f3cbba3a62c53226cd7_70"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 9: <ix:nonnumeric contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" continuedat="i52889ec5ff384d31a9395d774eb8548f" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183MC9mcmFnOjNjOWJjNzRiOGMyODRlZTQ4NThjMTM0MDBiMTE4Zjk1L3RleHRyZWdpb246M2M5YmM3NGI4YzI4NGVlNDg1OGMxMzQwMGIxMThmOTVfMjU1Mjg_816570e0-3745-4ff8-b916-414dbcfea259" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock">Contingencies</ix:nonnumeric></span></div><ix:continuation continuedat="ic6d9a033f0be4f6ba6989be13d6d66ad" id="i52889ec5ff384d31a9395d774eb8548f"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are involved in various lawsuits, claims, government investigations and other legal proceedings that arise in the ordinary course of business. These claims or proceedings can involve various types of parties, including governments, competitors, customers, suppliers, service providers, licensees, employees, or shareholders, among others. These matters may involve patent infringement, antitrust, securities, pricing, sales and marketing practices, environmental, commercial, contractual rights, licensing obligations, health and safety matters, consumer fraud, employment matters, product liability and insurance coverage, among others. The resolution of these matters often develops over a long period of time and expectations can change as a result of new findings, rulings, appeals or settlement arrangements. Legal proceedings that are significant or that we believe could become significant or material are described below. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe the legal proceedings in which we are named as defendants are without merit and we are defending against them vigorously. It is not possible to determine the final outcome of these matters, and we cannot reasonably estimate the maximum potential exposure or the range of possible loss in excess of amounts accrued for any of these matters; however, we believe that the resolution of all such matters will not have a material adverse effect on our consolidated financial position or liquidity, but could possibly be material to our consolidated results of operations in any one accounting period.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonnumeric contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" continuedat="i114efd4796cb4b0892c0d74f5d87e89e" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183MC9mcmFnOjNjOWJjNzRiOGMyODRlZTQ4NThjMTM0MDBiMTE4Zjk1L3RleHRyZWdpb246M2M5YmM3NGI4YzI4NGVlNDg1OGMxMzQwMGIxMThmOTVfMjU1Mjc_94d35f0a-1f1c-40a2-a374-cb9a1db87e4c" name="us-gaap:CommitmentsAndContingenciesPolicyTextBlock">Litigation accruals, environmental liabilities, and the related estimated insurance recoverables are reflected on a gross basis as liabilities and assets, respectively, on our consolidated condensed balance sheets. With respect to the product liability claims currently asserted against us, we have accrued for our estimated exposures to the extent they are both probable and reasonably estimable based on the information available to us. We accrue for certain product liability claims incurred but not filed to the extent we can formulate a reasonable estimate of their costs. We estimate these expenses based primarily on historical claims experience and data regarding product usage. Legal defense costs expected to be incurred in connection with significant product liability loss contingencies are accrued when both probable and reasonably estimable.</ix:nonnumeric></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i114efd4796cb4b0892c0d74f5d87e89e">Because of the nature of pharmaceutical products, it is possible that we could become subject to large numbers of additional product liability and related claims in the future. Due to a very restrictive market for litigation liability insurance, we are self-insured for litigation liability losses for all our currently and previously marketed products.</ix:continuation> </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation continuedat="i21ea1be77e034af49bfdae98dea849af" id="ic6d9a033f0be4f6ba6989be13d6d66ad"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Patent Litigation</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Alimta European Patent Litigation</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In Europe, Alimta (pemetrexed) was protected by a patent through June 2021. A number of legal proceedings that were initiated prior to patent expiration are ongoing. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Emgality Patent Litigation</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a named defendant in litigation filed by Teva Pharmaceuticals International GMBH and Teva Pharmaceuticals USA, Inc. (collectively, Teva) in the U.S. District Court for the District of Massachusetts seeking a ruling that various claims in <ix:nonfraction contextref="ib414aaa5a0174c7fb17ac9898d399d32_I20220930" decimals="INF" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183MC9mcmFnOjNjOWJjNzRiOGMyODRlZTQ4NThjMTM0MDBiMTE4Zjk1L3RleHRyZWdpb246M2M5YmM3NGI4YzI4NGVlNDg1OGMxMzQwMGIxMThmOTVfMzI3MA_8e971b18-a9a6-4aef-8669-427d64636547" name="lly:LossContingencyNumberOfPatents" scale="0" unitref="patent">three</ix:nonfraction> different Teva patents would be infringed by our launch and continued sales of Emgality for the prevention of migraine in adults. Trial began in October 2022. In June 2021, we were named as a defendant in a second litigation filed by Teva in the U.S. District Court for the District of Massachusetts seeking a ruling that <ix:nonfraction contextref="if274934ece0041f487b43797bc8de648_I20210630" decimals="INF" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183MC9mcmFnOjNjOWJjNzRiOGMyODRlZTQ4NThjMTM0MDBiMTE4Zjk1L3RleHRyZWdpb246M2M5YmM3NGI4YzI4NGVlNDg1OGMxMzQwMGIxMThmOTVfMzYyMQ_e7472257-8527-43b9-811f-30e96ee28ad1" name="lly:LossContingencyNumberOfPatents" scale="0" unitref="patent">two</ix:nonfraction> of Teva's patents, which are directed toward use of the active ingredient in Emgality to treat migraine, would be infringed by our continued sales of Emgality. We challenged these <ix:nonfraction contextref="ibcc5f2496e02449abe458e54c0a8a61f_I20221031" decimals="INF" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183MC9mcmFnOjNjOWJjNzRiOGMyODRlZTQ4NThjMTM0MDBiMTE4Zjk1L3RleHRyZWdpb246M2M5YmM3NGI4YzI4NGVlNDg1OGMxMzQwMGIxMThmOTVfMzI5ODUzNDkxMzc1Nw_ffd61f4e-01d0-4ed4-8e24-921cab76ceb3" name="lly:LossContingencyNumberOfPatents" scale="0" unitref="patent">two</ix:nonfraction> patents by filing requests for Inter Partes Review with the Patent Trial and Appeal Board (PTAB) and in October 2022, the PTAB granted our requests.The corresponding district court litigation is stayed while this PTAB proceeding is ongoing.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Jardiance Patent Litigation</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2018, Boehringer Ingelheim, our partner in marketing and development of Jardiance, initiated U.S. patent litigation in the U.S. District Court of Delaware alleging infringement arising from submissions of Abbreviated New Drug Applications (ANDA) by a number of generic companies seeking approval to market generic versions of Jardiance, Glyxambi, and Synjardy in accordance with the procedures set out in the Drug Price Competition and Patent Term Restoration Act of 1984 (the Hatch-Waxman Act). Particularly with respect to Jardiance, the generic companies' ANDAs seek approval to market generic versions of Jardiance prior to the expiration of the relevant patents, and allege that certain patents, including in some allegations the compound patent, are invalid or would not be infringed. We are not a party to this litigation. This litigation has been stayed. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Taltz Patent Litigation</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2021, we petitioned the High Court of Ireland to declare invalid a patent that Novartis Pharma AG (Novartis) purchased from Genentech, Inc. in 2020. Novartis responded by filing a claim against us alleging patent infringement related to our commercialization of Taltz and seeking damages for past infringement and an injunction against future infringement. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2021, Novartis petitioned the Court of Rome Intellectual Property Division for a preliminary injunction (PI) against us related to our commercialization of Taltz in Italy. In May 2021, We commenced patent revocation proceedings against Novartis before the Court of Milan&#8217;s IP Division where we also sought a declaration of non-infringement. Novartis counter-claimed for patent infringement and sought a permanent injunction. A hearing on the PI request before the Court of Rome Intellectual Property Division took place in May 2022 and in July 2022, the court rejected Novartis' request.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, Novartis petitioned the Swiss Federal Patent Court for a PI and a permanent injunction in main infringement proceedings against us related to our commercialization of Taltz in Switzerland. We petitioned the court to revoke the patent and for a declaration of non-infringement. In April 2022, Novartis withdrew its PI request.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2022, we commenced an action in the Hague District Court asking for a judgment that a Novartis Dutch patent is not infringed by our commercialization of Taltz in the Netherlands and is invalid. In October 2022, Novartis filed a counterclaim for infringement and sought a permanent injunction.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2022, we entered into a settlement and mutual release agreement with Novartis, which resolves the above-described disputes. Without any admission of liability or wrongdoing, we and Novartis have agreed to mutual releases for past claims and mutual covenants not to sue the other in relation to Taltz and the patents Novartis purchased from Genentech. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation continuedat="ie638f5bd5e9f476193a7dbaa06514ac3" id="i21ea1be77e034af49bfdae98dea849af"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Zyprexa Canada Patent Litigation</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in the mid-2000s, several generic companies in Canada challenged the validity of our Zyprexa compound patent. In 2012, the Canadian Federal Court of Appeals denied our appeal of a lower court's decision that certain patent claims were invalid for lack of utility. In 2013, Apotex Inc. and Apotex Pharmachem Inc. (collectively, Apotex) brought claims against us in the Ontario Superior Court of Justice at Toronto for damages related to our enforcement of the Zyprexa compound patent under Canadian regulations governing patented drugs. Apotex seeks compensation based on novel legal theories under the Statute of Monopolies, Trademark Act, and common law. In March 2021, the Ontario Superior Court granted our motion for summary judgment, thereby dismissing Apotex's case. Apotex appealed that ruling to the Court of Appeal for Ontario in April 2021. In August 2022, the Court dismissed the appeal and in October 2022, Apotex appealed the decision. This matter is ongoing.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Product Liability Litigation</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Byetta&#174; Product Liability</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have been named as a defendant in over <ix:nonfraction contextref="i58d8155218724e10a6956cdd38ca1bb1_I20220930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183MC9mcmFnOjNjOWJjNzRiOGMyODRlZTQ4NThjMTM0MDBiMTE4Zjk1L3RleHRyZWdpb246M2M5YmM3NGI4YzI4NGVlNDg1OGMxMzQwMGIxMThmOTVfNzE4NA_c911cb99-3c7e-4e9d-8a5e-5f4a3ac54ad6" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" unitref="lawsuit">500</ix:nonfraction> Byetta product liability lawsuits in the U.S. that were first initiated in March 2009 and involved over <ix:nonfraction contextref="i03a0a6037fc44e39af8b9a0fc87cbcbb_D20090301-20220930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183MC9mcmFnOjNjOWJjNzRiOGMyODRlZTQ4NThjMTM0MDBiMTE4Zjk1L3RleHRyZWdpb246M2M5YmM3NGI4YzI4NGVlNDg1OGMxMzQwMGIxMThmOTVfNzI5MQ_a72efacc-c27f-4e6e-8f0e-a546adfee6ab" name="us-gaap:LossContingencyNumberOfPlaintiffs" scale="0" unitref="plaintiff">800</ix:nonfraction> plaintiffs. These lawsuits have been filed in various state and federal jurisdictions, including California state court (coordinated in Los Angeles County Superior Court), and various federal courts, the majority of which are coordinated in a multi-district litigation (MDL) in the U.S. District Court for the Southern District of California. The majority of these suits contain allegations that Byetta caused or contributed to the plaintiffs' cancer (primarily pancreatic cancer or thyroid cancer). The federal MDL and coordinated California state trial courts granted summary judgment in our favor on claims pertaining to pancreatic cancer, and the plaintiffs have dismissed Lilly from their appeal of the MDL ruling (the parties still await the order of judgment in the Los Angeles County Superior Court). Most of the MDL and state court lawsuits have been dismissed as of November 2022.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Environmental Proceedings</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Comprehensive Environmental Response, Compensation, and Liability Act, commonly known as "Superfund," we have been designated as one of several potentially responsible parties with respect to the cleanup of fewer than <ix:nonfraction contextref="iedfe8e594f2d4534ba3f7d18996055ec_I20220930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183MC9mcmFnOjNjOWJjNzRiOGMyODRlZTQ4NThjMTM0MDBiMTE4Zjk1L3RleHRyZWdpb246M2M5YmM3NGI4YzI4NGVlNDg1OGMxMzQwMGIxMThmOTVfOTQwMQ_5089f719-62ae-4612-80e7-43f34070b9d0" name="lly:LossContingencyNumberOfSitesJointlyAndSeverallyLiableForCleanup" scale="0" unitref="site">10</ix:nonfraction> sites. Under Superfund, each responsible party may be jointly and severally liable for the entire amount of the cleanup.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Matters</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">340B Litigation and Investigations</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are the plaintiff in a lawsuit filed in January 2021 in the U.S. District Court for the Southern District of Indiana against the U.S. Department of Health and Human Services (HHS), the Secretary of HHS, the Health Resources and Services Administration (HRSA), and the Administrator of HRSA. The lawsuit challenges the HHS's December 30, 2020 advisory opinion stating that drug manufacturers are required to deliver discounts under the 340B program to all contract pharmacies. We seek a declaratory judgment that the defendants violated the Administrative Procedures Act and the U.S. Constitution, a preliminary injunction enjoining implementation of the administrative dispute resolution process created by defendants and, with it, their application of the advisory opinion, and other related relief. In March 2021, the court entered an order preliminarily enjoining the government's enforcement of the administrative dispute resolution process against us. In May 2021, HRSA notified us that it determined that our policy was contrary to the 340B statute. In response, in May 2021, we filed a motion for preliminary injunction and temporary restraining order requesting that the U.S. District Court for the Southern District of Indiana enjoin defendants from taking any action against us relating to the 340B drug pricing program until after the court issues a final judgment on the aforementioned litigation. In May 2021, the court denied our motion for a temporary restraining order but deferred resolution of our motion for preliminary injunction. In June 2021, the defendants withdrew the HHS December 30, 2020 advisory opinion. In July 2021, the court held oral argument on the parties' cross motions for summary judgment, the defendants' motion to dismiss, and our motion for preliminary injunction related to HRSA's May 2021 enforcement letter. In October 2021, the court denied the defendants' motion to dismiss, and granted in part and denied in part the parties' cross motions for summary judgment. Both parties filed notices of appeal related to the court's summary judgment order. Oral argument took place in October 2022 in the U.S. Court of Appeals for the Seventh Circuit. This matter is ongoing.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, we, along with other pharmaceutical manufacturers, were named as a defendant in a petition currently pending before the HHS Administrative Dispute Resolution Panel. Petitioner seeks declaratory and other injunctive relief related to the 340B program. As described above, the U.S. District Court for the Southern District of Indiana has entered a preliminary injunction enjoining the government's enforcement of this administrative dispute resolution process against us. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation continuedat="i17ff402873de46eba0376eb4da6d0c18" id="ie638f5bd5e9f476193a7dbaa06514ac3"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, we, along with Sanofi-Aventis U.S., LLC (Sanofi), Novo Nordisk Inc. (Novo Nordisk), and AstraZeneca Pharmaceuticals LP, were named as a defendant in a purported class action lawsuit filed in the U.S. District Court for the Western District of New York by Mosaic Health, Inc. alleging antitrust and unjust enrichment claims related to the defendants' 340B distribution programs. We, with Sanofi and Novo Nordisk, filed a motion to dismiss the lawsuit, which was granted in September 2022. In October 2022, the plaintiffs filed a motion for leave to amend their complaint. This matter is ongoing.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We received a civil investigative subpoena in February 2021 from the Office of the Attorney General for the State of Vermont relating to the sale of pharmaceutical products to Vermont covered entities under the 340B program. We are cooperating with this subpoena. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Branchburg Manufacturing Facility</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, we received a subpoena from the U.S. Department of Justice requesting the production of certain documents relating to our manufacturing site in Branchburg, New Jersey. We are cooperating with the subpoena.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Brazil Litigation &#8211; Cosmopolis Facility</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Labor Attorney Litigation</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">First initiated in 2008, our subsidiary in Brazil, Eli Lilly do Brasil Limitada (Lilly Brasil), is named in a Public Civil Action brought by the Labor Public Attorney (LPA) for the 15th Region in the Labor Court of Paulinia, State of Sao Paulo, Brazil, (the Labor Court) alleging possible harm to employees and former employees caused by alleged exposure to soil and groundwater contaminants at a former Lilly Brasil manufacturing facility in Cosmopolis, Brazil, operated by the company between 1977 and 2003. In May 2014, the Labor Court judge ruled against Lilly Brasil, ordering it to undertake several remedial and compensatory actions including health coverage for a class of individuals and certain of their children. In July 2018, the appeals court (TRT) generally affirmed our appeal of the Labor Court's ruling, which included a liquidated award of <ix:nonfraction contextref="i7b4e96e210ab4559a67ee97574922011_D20180701-20180731" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183MC9mcmFnOjNjOWJjNzRiOGMyODRlZTQ4NThjMTM0MDBiMTE4Zjk1L3RleHRyZWdpb246M2M5YmM3NGI4YzI4NGVlNDg1OGMxMzQwMGIxMThmOTVfMTQyMTE_d6c1f2d4-f081-4c9e-87e4-c8521a4db76d" name="us-gaap:LossContingencyDamagesAwardedValue" scale="6" unitref="brl">300</ix:nonfraction> million Brazilian real, which, when adjusted for inflation and the addition of pre and post judgment interest using the current Central Bank of Brazil's special system of clearance and custody rate, is approximately <ix:nonfraction contextref="i983baf60b46f4dc0ab264f727cff1fd1_D20220101-20220930" decimals="-9" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183MC9mcmFnOjNjOWJjNzRiOGMyODRlZTQ4NThjMTM0MDBiMTE4Zjk1L3RleHRyZWdpb246M2M5YmM3NGI4YzI4NGVlNDg1OGMxMzQwMGIxMThmOTVfMTQ0MjI_9d1ce226-be24-4fb7-88e3-a7c4b947c95a" name="us-gaap:LossContingencyDamagesAwardedValue" scale="9" unitref="brl">one</ix:nonfraction> billion Brazilian real (approximately $<ix:nonfraction contextref="i983baf60b46f4dc0ab264f727cff1fd1_D20220101-20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183MC9mcmFnOjNjOWJjNzRiOGMyODRlZTQ4NThjMTM0MDBiMTE4Zjk1L3RleHRyZWdpb246M2M5YmM3NGI4YzI4NGVlNDg1OGMxMzQwMGIxMThmOTVfMTQ0NjM_26784162-b13d-444b-a14d-98a5f9b6b865" name="us-gaap:LossContingencyDamagesAwardedValue" scale="6" unitref="usd">185</ix:nonfraction>&#160;million as of September&#160;30, 2022). In August 2019, Lilly Brasil filed an appeal to the superior labor court (TST) and in June 2021, the TRT published its decision on the admissibility of Lilly Brasil's appeal, allowing the majority of the elements, which were allowed to proceed in June 2021; elements not proceeding are subject to an interlocutory appeal to the TST that was filed in June 2021. In September 2019, the TRT stayed a number of elements of its trial court decision pending the determination of Lilly Brasil's appeal to the TST.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2019 and September 2020, the LPA filed applications in the Labor Court for enforcement of certain remedies granted by the TRT in its July 2018 decision, requested restrictions on Lilly Brasil&#8217;s assets in Brazil, and required Lilly Brasil and Antibi&#243;ticos do Brasil Ltda. (ABL) to submit a list of potential beneficiaries of the Public Civil Action. In July 2019, the Labor Court issued a ruling requiring a freeze of Lilly Brasil&#8217;s immovable property or, alternatively, a security deposit or lien of <ix:nonfraction contextref="id52423032e6747898c41a944e3038420_D20190701-20190731" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183MC9mcmFnOjNjOWJjNzRiOGMyODRlZTQ4NThjMTM0MDBiMTE4Zjk1L3RleHRyZWdpb246M2M5YmM3NGI4YzI4NGVlNDg1OGMxMzQwMGIxMThmOTVfMTU0OTI_05a6deee-589b-4dc5-a6ac-d95a9c2c06f6" name="us-gaap:LossContingencyDamagesAwardedValue" scale="6" unitref="brl">500</ix:nonfraction> million Brazilian real, which ruling was subsequently limited in scope and the security was reduced to <ix:nonfraction contextref="i098637113ce84c2f8c583d5aac35942b_D20210601-20210630" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183MC9mcmFnOjNjOWJjNzRiOGMyODRlZTQ4NThjMTM0MDBiMTE4Zjk1L3RleHRyZWdpb246M2M5YmM3NGI4YzI4NGVlNDg1OGMxMzQwMGIxMThmOTVfMTU1OTA_a0d249b9-eaa1-45da-818b-3b500a445068" name="us-gaap:LossContingencyDamagesAwardedValue" scale="6" unitref="brl">100</ix:nonfraction> million Brazilian real. ABL and LPA appealed the June 2021 Labor Court ruling to the TST, which appeal is under review. The Labor Court is currently assessing the status of Lilly Brasil&#8217;s and ABL&#8217;s compliance with such portion of the July 2018 TRT decision and an inspection in the industrial plant is expected. These matters are ongoing.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Individual Former Employee Litigation</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lilly Brasil is also named in over <ix:nonfraction contextref="i91a11e76b2844622ba08c167af2c1bbd_I20220930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183MC9mcmFnOjNjOWJjNzRiOGMyODRlZTQ4NThjMTM0MDBiMTE4Zjk1L3RleHRyZWdpb246M2M5YmM3NGI4YzI4NGVlNDg1OGMxMzQwMGIxMThmOTVfMTU5OTc_c00515b3-d3eb-4b3d-87f9-0186af61fd07" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" unitref="lawsuit">20</ix:nonfraction> pending lawsuits filed in the Labor Court by individual former employees making similar claims. These individual lawsuits are at various stages in the litigation process.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Puerto Rico Tax Matter</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2013, the Municipality of Carolina in Puerto Rico (Municipality) filed a lawsuit against us alleging noncompliance with respect to a contract with the Municipality and seeking a declaratory judgment. In December 2020, the Puerto Rico Appellate Court (AP) reversed the summary judgment previously granted by the Court of First Instance (CFI) in our favor, dismissing the Municipality's complaint in its entirety. The AP remanded the case to the CFI for trial on the merits. The trial began in May 2022; however, the Municipality filed a new motion requesting the CFI to award damages. The request was denied by the CFI in our favor and the Municipality filed for revision at the AP, which we opposed, staying the case. This matter is ongoing. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation continuedat="i29abc795a0f74b6d97f622965ea5cdaf" id="i17ff402873de46eba0376eb4da6d0c18"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Eastern District of Pennsylvania Pricing (Average Manufacturer Price) Inquiry</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2014, we, along with another pharmaceutical manufacturer, were named as co-defendants in </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States et al. ex rel. Streck v. Takeda Pharm. Am., Inc., et al.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which was filed in November 2014 and unsealed in the U.S. District Court for the Northern District of Illinois. The complaint alleges that the defendants should have treated certain credits from distributors as retroactive price increases and included such increases in calculating average manufacturer prices. Following a trial in August 2022, the jury returned a verdict in favor of the plaintiff. The case is proceeding with post-trial motions after which the court will enter final judgment in the case. This matter is ongoing.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Health Choice Alliance </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are named as a defendant in <ix:nonfraction contextref="i3fd1ac8f6fc9438cb71e216b3246793e_I20220930" decimals="INF" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183MC9mcmFnOjNjOWJjNzRiOGMyODRlZTQ4NThjMTM0MDBiMTE4Zjk1L3RleHRyZWdpb246M2M5YmM3NGI4YzI4NGVlNDg1OGMxMzQwMGIxMThmOTVfMTc1OTg_f42a9182-bf94-43fd-98b7-772f35b286c5" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" unitref="lawsuit">two</ix:nonfraction> lawsuits filed in Texas and New Jersey state courts in October 2019 seeking damages under the Texas Medicaid Fraud Prevention Act and New Jersey Medicaid False Claims Act, respectively, for certain patient support programs related to our products Humalog, Humulin, and Forteo. The Texas state court action has been stayed. The New Jersey state court action was dismissed with prejudice pending an ongoing appeal before the Appellate Division of the New Jersey Superior Court. This matter is ongoing.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Pricing Litigation</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2017 and February 2018, we, along with Sanofi and Novo Nordisk, were named as defendants in a consolidated purported class action lawsuit, In re. Insulin Pricing Litigation and in MSP Recovery Claims, Series, LLC et al. v. Sanofi Aventis U.S. LLC et al., both filed in the U.S. District Court for the District of New Jersey. The cases relate to insulin pricing and seek damages or other relief under various theories, including state consumer protection laws, common law fraud, unjust enrichment, and the Federal Racketeer Influenced and Corrupt Organization Act (federal RICO Act). In both cases, the court dismissed claims under the federal RICO Act and certain state laws. In April 2021, the plaintiffs in In re. Insulin Pricing Litigation amended their complaint to allege additional state law claims for civil conspiracy and violations of state RICO statutes. The court allowed the Arizona RICO statute and certain state civil conspiracy law claims to proceed. Additionally in 2020, we, along with Sanofi, Novo Nordisk, CVS, Express Scripts, and Optum, have been sued in a putative class action, FWK Holdings, LLC v. Novo Nordisk Inc., et al., filed in the same court, for alleged violations of the federal RICO Act as well as the New Jersey RICO Act and antitrust law. The same group of defendants, along with Medco Health and United Health Group, also have been sued in other purported class actions in the same court, Rochester Drug Co-Operative Inc. v. Eli Lilly &amp; Co. et al. and Value Drug Co. v. Eli Lilly &amp; Co. et al., which were both initiated in March 2020, with the plaintiffs seeking damages for alleged violations of the federal RICO Act. In September 2020, the U.S. District Court for the District of New Jersey granted plaintiffs' motion to consolidate FWK Holdings, LLC v. Novo Nordisk Inc., et al., Rochester Drug Co-Operative Inc. v. Eli Lilly &amp; Co. et al., and Value Drug Co. v. Eli Lilly &amp; Co. et al. In July 2021, the U.S. District Court for the District of New Jersey dismissed the <ix:nonfraction contextref="if2605d2b37d747e1b5887703c18e4963_D20210701-20210731" decimals="INF" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183MC9mcmFnOjNjOWJjNzRiOGMyODRlZTQ4NThjMTM0MDBiMTE4Zjk1L3RleHRyZWdpb246M2M5YmM3NGI4YzI4NGVlNDg1OGMxMzQwMGIxMThmOTVfMjAxODI_b508d386-d4a9-4d74-8d63-16450171d9c7" name="lly:LitigationClaimsDismissedNumber" scale="0" unitref="claim">three</ix:nonfraction> antitrust claims alleged by plaintiffs in the consolidated litigation and denied dismissal of the federal RICO Act claims.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2018, the Minnesota Attorney General's Office initiated litigation against us, Sanofi, and Novo Nordisk, State of Minnesota v. Sanofi-Aventis U.S. LLC et al., in the U.S. District Court for the District of New Jersey, seeking damages for unjust enrichment, violations of various Minnesota state consumer protection laws, and the federal RICO Act. In March 2021, the U.S. District Court for the District of New Jersey dismissed with prejudice the Minnesota Attorney General's federal RICO claims and false advertising claims under state law; the consumer fraud and other related state law claims remain ongoing. Additionally, in May 2019, the Kentucky Attorney General's Office filed a complaint against us, Sanofi, and Novo Nordisk, Commonwealth of Kentucky v. Novo Nordisk, Inc. et al., in Kentucky state court, alleging violations of the Kentucky consumer protection law, false advertising, and unjust enrichment.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, the Mississippi Attorney General's Office initiated litigation against us, Sanofi, Novo Nordisk, Evernorth/ESI, CVS/Caremark, and United/Optum in the Hinds County, Mississippi Chancery Court, alleging state law consumer protection, unjust enrichment, and civil conspiracy claims. After the case was removed to federal court, we, along with the other defendants, filed a motion to dismiss the lawsuit, which was denied. This matter is ongoing.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2022, the state of Arkansas filed suit against us Sanofi, Novo Nordisk, ESI, CVS/Caremark/Aetna, and Optum, asserting state law consumer protection, civil conspiracy, and unjust enrichment claims. The case has been removed to federal court and is ongoing.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2022, the County of Albany, New York filed a suit against us, Sanofi, Novo Nordisk, Evernorth/ESI, CVS/Caremark and United/Optum asserting violations of federal RICO statute and state law claims for deceptive trade practices, unjust enrichment, and civil conspiracy. This matter is ongoing.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i29abc795a0f74b6d97f622965ea5cdaf"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2022, the State of Montana filed a suit against us, Sanofi, Novo Nordisk, Evernorth/ESI, Medco Health Solutions, CVS/Caremark and Optum asserting violations of the Montana Unfair Practices and Consumer Protection Act, unjust enrichment, and civil conspiracy. This matter is ongoing.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Investigations, Subpoenas, and Inquiries</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the pricing and sale of our insulin and other products, we have been subject to various investigations and received subpoenas, civil investigative demand requests, information requests, interrogatories, and other inquiries from various governmental entities. These include subpoenas from the New York and Vermont Attorney General Offices, civil investigative demands from the Washington, New Mexico, Colorado, Illinois, Ohio Attorney General Offices, the Department of Justice and the Federal Trade Commission, as well as information requests from the Mississippi, Washington D.C., California, Florida, Hawaii, and Nevada Attorney General Offices. In January 2022, the Michigan Attorney General filed a petition in Michigan state court seeking authorization to investigate Lilly for potential violations of the Michigan Consumer Protection Act (MCPA), and a complaint seeking a declaratory judgment that the Attorney General has authority to investigate Lilly's sale of insulin under the MCPA. The court authorized the proposed investigation and the issuance of civil investigative subpoenas. In April 2022, the parties entered into a stipulation providing that the State will not issue any civil investigative subpoena to us under the MCPA until the declaratory judgment action is resolved. In July 2022, the court dismissed the case in its entirety. The Michigan Attorney General filed a notice of appeal and an application to obtain review by the Michigan Supreme Court, which remain pending. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We received a request in January 2019 from the House of Representatives' Committee on Oversight and Reform seeking commercial information and business records related to the pricing of insulin products, among other issues. We also received similar requests from the Senate Finance Committee and the Senate Committee on Health, Education, Labor, and Pensions, and separate requests from the House Committee on Energy and Commerce majority and minority members. In January 2021, the Senate Finance Committee released a report summarizing the findings of its investigation. In December 2021 the House of Representatives' Committee on Oversight and Reform majority and minority staffs released separate reports with findings from their investigations into drug pricing, including of insulin products.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are cooperating with all of the aforementioned investigations, subpoenas, and inquiries.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Research Corporation Technologies, Inc.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2016, we were named as a defendant in litigation filed by Research Corporation Technologies, Inc. (RCT) in the U.S. District Court for the District of Arizona. RCT is seeking damages for breach of contract, unjust enrichment, and conversion related to processes used to manufacture certain products, including Humalog and Humulin. In October 2021, the court issued a summary judgment decision finding in favor of RCT on certain issues, including with respect to a disputed royalty. Both parties filed motions for reconsideration, which were denied. We filed supplemental summary judgment motions. A trial date has not been set. Potential damages payable under the litigation, if finally awarded after an appeal, could be material but are not currently reasonably estimable. This matter is ongoing.</span></div></ix:continuation><div style="margin-top:6pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><div id="i5fed483d9c7e4f3cbba3a62c53226cd7_73"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 10: <ix:nonnumeric contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" continuedat="ife5293ddf23a4ace82a22a273c0270aa" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RleHRyZWdpb246ZTE0MjlmY2IyNjYyNDg4ZDk5MTllMTg4MGNiZTMyMTNfMTI1Ng_4177cc75-a543-4e1f-95ea-f932e4ab8da9" name="us-gaap:ComprehensiveIncomeNoteTextBlock">Other Comprehensive Income (Loss)</ix:nonnumeric></span></div><ix:continuation continuedat="i5522e96d15c7416b8ed82fcd2588116a" id="ife5293ddf23a4ace82a22a273c0270aa"><ix:nonnumeric contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" continuedat="i3587bacca65548d4a7335757e1648b25" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RleHRyZWdpb246ZTE0MjlmY2IyNjYyNDg4ZDk5MTllMTg4MGNiZTMyMTNfMTI1NA_1a2821d3-38b3-400c-bedd-744bdd5e1a5e" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the activity related to each component of other comprehensive income (loss) during the three months ended September&#160;30, 2022 and 2021:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.420%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.601%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Amounts presented net of taxes)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Foreign Currency Translation Gains&#160;(Losses)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Unrealized Net Gains (Losses) on&#160;Securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Defined Benefit Pension and Retiree&#160;Health Benefit Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Effective Portion of Cash&#160;Flow Hedges</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at July 1, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="ia44884b555f84a8bb8c051329b5b483c_I20220630" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmI0OWI3ZGUzOGIzYTRjZGE4OGU1ZDkxMzcwMDI5NmJlL3RhYmxlcmFuZ2U6YjQ5YjdkZTM4YjNhNGNkYTg4ZTVkOTEzNzAwMjk2YmVfMi0xLTEtMS0xNTk1NDA_61537d92-f2a1-4b69-a3f9-24b3bc3738a2" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" sign="-" unitref="usd">1,844.2</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="icf1cf37660ed42919d552edbdc9ddf29_I20220630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmI0OWI3ZGUzOGIzYTRjZGE4OGU1ZDkxMzcwMDI5NmJlL3RhYmxlcmFuZ2U6YjQ5YjdkZTM4YjNhNGNkYTg4ZTVkOTEzNzAwMjk2YmVfMi0zLTEtMS0xNTk1NDA_69a279ca-9089-47c0-b87e-d86d691a3181" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" sign="-" unitref="usd">27.9</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="ib07a74d7836447719291eff28ad65a22_I20220630" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmI0OWI3ZGUzOGIzYTRjZGE4OGU1ZDkxMzcwMDI5NmJlL3RhYmxlcmFuZ2U6YjQ5YjdkZTM4YjNhNGNkYTg4ZTVkOTEzNzAwMjk2YmVfMi01LTEtMS0xNTk1NDA_db7d1beb-6363-4f7f-a9d9-b2d18039afa9" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" sign="-" unitref="usd">2,443.2</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ia3f2ab912d2b47e7862abe56a92bb118_I20220630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmI0OWI3ZGUzOGIzYTRjZGE4OGU1ZDkxMzcwMDI5NmJlL3RhYmxlcmFuZ2U6YjQ5YjdkZTM4YjNhNGNkYTg4ZTVkOTEzNzAwMjk2YmVfMi03LTEtMS0xNTk1NDA_343b9422-190c-462f-8ead-daf5eeaab408" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" unitref="usd">27.6</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="ic22b2460974b4792a24b9b75e0e598d3_I20220630" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmI0OWI3ZGUzOGIzYTRjZGE4OGU1ZDkxMzcwMDI5NmJlL3RhYmxlcmFuZ2U6YjQ5YjdkZTM4YjNhNGNkYTg4ZTVkOTEzNzAwMjk2YmVfMi0xMS0xLTEtMTU5NTQw_fd980611-5e52-4a97-a798-2655f95c571e" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" sign="-" unitref="usd">4,287.7</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="ibb680e42808d41b587bffa2f35409a91_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmI0OWI3ZGUzOGIzYTRjZGE4OGU1ZDkxMzcwMDI5NmJlL3RhYmxlcmFuZ2U6YjQ5YjdkZTM4YjNhNGNkYTg4ZTVkOTEzNzAwMjk2YmVfNC0xLTEtMS0xNTk1NDA_cbc2ec7d-665e-4d72-abcf-0680f8743a62" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" sign="-" unitref="usd">165.1</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="ib423da078b9740019ae03257a6ca1320_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmI0OWI3ZGUzOGIzYTRjZGE4OGU1ZDkxMzcwMDI5NmJlL3RhYmxlcmFuZ2U6YjQ5YjdkZTM4YjNhNGNkYTg4ZTVkOTEzNzAwMjk2YmVfNC0zLTEtMS0xNTk1NDA_dd7e584d-274c-4035-a1ad-3bd934deec3d" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" sign="-" unitref="usd">24.9</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i0ddaa7c4639946b1a63ee163ebac9cda_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmI0OWI3ZGUzOGIzYTRjZGE4OGU1ZDkxMzcwMDI5NmJlL3RhYmxlcmFuZ2U6YjQ5YjdkZTM4YjNhNGNkYTg4ZTVkOTEzNzAwMjk2YmVfNC01LTEtMS0xNTk1NDA_c4468f3b-2c88-45f9-a4e2-213f55b53fe2" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" unitref="usd">47.8</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i9e78a70b50b740909d4bd5980c556e3a_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmI0OWI3ZGUzOGIzYTRjZGE4OGU1ZDkxMzcwMDI5NmJlL3RhYmxlcmFuZ2U6YjQ5YjdkZTM4YjNhNGNkYTg4ZTVkOTEzNzAwMjk2YmVfNC03LTEtMS0xNTk1NDA_591568af-3056-4f1f-88f7-e568a0207664" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" unitref="usd">63.0</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="i19fc0325c48543008ea71e1fdcf11d86_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmI0OWI3ZGUzOGIzYTRjZGE4OGU1ZDkxMzcwMDI5NmJlL3RhYmxlcmFuZ2U6YjQ5YjdkZTM4YjNhNGNkYTg4ZTVkOTEzNzAwMjk2YmVfNC0xMS0xLTEtMTU5NTQw_c31fdf97-1486-4381-9437-328a9ca94800" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" sign="-" unitref="usd">79.2</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net amount reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ibb680e42808d41b587bffa2f35409a91_D20220701-20220930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmI0OWI3ZGUzOGIzYTRjZGE4OGU1ZDkxMzcwMDI5NmJlL3RhYmxlcmFuZ2U6YjQ5YjdkZTM4YjNhNGNkYTg4ZTVkOTEzNzAwMjk2YmVfNS0xLTEtMS0xNTk1NDA_c14fa024-aa18-4392-a0f1-db43693c837a" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" unitref="usd">&#8212;</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ib423da078b9740019ae03257a6ca1320_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmI0OWI3ZGUzOGIzYTRjZGE4OGU1ZDkxMzcwMDI5NmJlL3RhYmxlcmFuZ2U6YjQ5YjdkZTM4YjNhNGNkYTg4ZTVkOTEzNzAwMjk2YmVfNS0zLTEtMS0xNTk1NDA_a4adb628-3aa8-4ae0-aa97-fc39db7ac531" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" sign="-" unitref="usd">13.5</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i0ddaa7c4639946b1a63ee163ebac9cda_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmI0OWI3ZGUzOGIzYTRjZGE4OGU1ZDkxMzcwMDI5NmJlL3RhYmxlcmFuZ2U6YjQ5YjdkZTM4YjNhNGNkYTg4ZTVkOTEzNzAwMjk2YmVfNS01LTEtMS0xNTk1NDA_c08f6e8b-84f8-4d36-abc4-42478db731bb" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" sign="-" unitref="usd">57.2</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i9e78a70b50b740909d4bd5980c556e3a_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmI0OWI3ZGUzOGIzYTRjZGE4OGU1ZDkxMzcwMDI5NmJlL3RhYmxlcmFuZ2U6YjQ5YjdkZTM4YjNhNGNkYTg4ZTVkOTEzNzAwMjk2YmVfNS03LTEtMS0xNTk1NDA_b3f01a8b-6d38-4402-93a0-821e676bc7a1" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" sign="-" unitref="usd">0.4</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i19fc0325c48543008ea71e1fdcf11d86_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmI0OWI3ZGUzOGIzYTRjZGE4OGU1ZDkxMzcwMDI5NmJlL3RhYmxlcmFuZ2U6YjQ5YjdkZTM4YjNhNGNkYTg4ZTVkOTEzNzAwMjk2YmVfNS0xMS0xLTEtMTU5NTQw_088704fe-f523-48bf-8ae4-4b227e58c298" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" sign="-" unitref="usd">71.1</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="ibb680e42808d41b587bffa2f35409a91_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmI0OWI3ZGUzOGIzYTRjZGE4OGU1ZDkxMzcwMDI5NmJlL3RhYmxlcmFuZ2U6YjQ5YjdkZTM4YjNhNGNkYTg4ZTVkOTEzNzAwMjk2YmVfNi0xLTEtMS0xNTk1NDA_3b62616a-2821-459a-a310-620633bc58e9" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" sign="-" unitref="usd">165.1</ix:nonfraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="ib423da078b9740019ae03257a6ca1320_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmI0OWI3ZGUzOGIzYTRjZGE4OGU1ZDkxMzcwMDI5NmJlL3RhYmxlcmFuZ2U6YjQ5YjdkZTM4YjNhNGNkYTg4ZTVkOTEzNzAwMjk2YmVfNi0zLTEtMS0xNTk1NDA_dc860762-cab1-407d-9227-4d943555d204" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" sign="-" unitref="usd">11.4</ix:nonfraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i0ddaa7c4639946b1a63ee163ebac9cda_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmI0OWI3ZGUzOGIzYTRjZGE4OGU1ZDkxMzcwMDI5NmJlL3RhYmxlcmFuZ2U6YjQ5YjdkZTM4YjNhNGNkYTg4ZTVkOTEzNzAwMjk2YmVfNi01LTEtMS0xNTk1NDA_7ac26987-d230-4727-8f9c-6cc3a1627cec" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" unitref="usd">105.0</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i9e78a70b50b740909d4bd5980c556e3a_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmI0OWI3ZGUzOGIzYTRjZGE4OGU1ZDkxMzcwMDI5NmJlL3RhYmxlcmFuZ2U6YjQ5YjdkZTM4YjNhNGNkYTg4ZTVkOTEzNzAwMjk2YmVfNi03LTEtMS0xNTk1NDA_fd9706f0-f0af-4046-b6c4-7bfe7b4b4acc" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" unitref="usd">63.4</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="i19fc0325c48543008ea71e1fdcf11d86_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmI0OWI3ZGUzOGIzYTRjZGE4OGU1ZDkxMzcwMDI5NmJlL3RhYmxlcmFuZ2U6YjQ5YjdkZTM4YjNhNGNkYTg4ZTVkOTEzNzAwMjk2YmVfNi0xMS0xLTEtMTU5NTQw_40cb76f4-eb16-4abc-9dad-92674aae60e4" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" sign="-" unitref="usd">8.1</ix:nonfraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2022</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="i603b413215ff4ac0860f74b6a1be9294_I20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmI0OWI3ZGUzOGIzYTRjZGE4OGU1ZDkxMzcwMDI5NmJlL3RhYmxlcmFuZ2U6YjQ5YjdkZTM4YjNhNGNkYTg4ZTVkOTEzNzAwMjk2YmVfOC0xLTEtMS0xNTk1NDA_5d3103f5-2c11-4a4b-b0bc-675cd4e76e01" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" sign="-" unitref="usd">2,009.3</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="i6105e19d65744395aeb2921c7555324a_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmI0OWI3ZGUzOGIzYTRjZGE4OGU1ZDkxMzcwMDI5NmJlL3RhYmxlcmFuZ2U6YjQ5YjdkZTM4YjNhNGNkYTg4ZTVkOTEzNzAwMjk2YmVfOC0zLTEtMS0xNTk1NDA_1a11a6ab-46f7-46ba-9882-ee81f6991b2d" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" sign="-" unitref="usd">39.3</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="i1ec1c7b3b72549149e283cdff33abeed_I20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmI0OWI3ZGUzOGIzYTRjZGE4OGU1ZDkxMzcwMDI5NmJlL3RhYmxlcmFuZ2U6YjQ5YjdkZTM4YjNhNGNkYTg4ZTVkOTEzNzAwMjk2YmVfOC01LTEtMS0xNTk1NDA_eb9fe125-efd8-45bc-9d1f-26432a65fe4b" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" sign="-" unitref="usd">2,338.2</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ifc51fbfd706a4f809013d42ddd4fef8c_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmI0OWI3ZGUzOGIzYTRjZGE4OGU1ZDkxMzcwMDI5NmJlL3RhYmxlcmFuZ2U6YjQ5YjdkZTM4YjNhNGNkYTg4ZTVkOTEzNzAwMjk2YmVfOC03LTEtMS0xNTk1NDA_fa96315f-e4ce-4976-91c5-8d39001ad233" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" unitref="usd">91.0</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="iad56c44530dd4208959b336f8d1fe8b1_I20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmI0OWI3ZGUzOGIzYTRjZGE4OGU1ZDkxMzcwMDI5NmJlL3RhYmxlcmFuZ2U6YjQ5YjdkZTM4YjNhNGNkYTg4ZTVkOTEzNzAwMjk2YmVfOC0xMS0xLTEtMTU5NTQw_0792feed-da8e-462b-b629-002325c41dda" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" sign="-" unitref="usd">4,295.8</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.420%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.601%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Amounts presented net of taxes)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Foreign Currency Translation Gains&#160;(Losses)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Unrealized Net Gains (Losses) on&#160;Securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Defined Benefit Pension and Retiree&#160;Health Benefit Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Effective Portion of Cash&#160;Flow Hedges</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at July 1, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i9b7795dc491c42cbb64812b2b99d2ac9_I20210630" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOjU0MGYzNDkzN2Y1NDQ5NWI4YzRjZjllMzUyMjZjMjY3L3RhYmxlcmFuZ2U6NTQwZjM0OTM3ZjU0NDk1YjhjNGNmOWUzNTIyNmMyNjdfMi0xLTEtMS0xNTk1NDA_9f17f11a-0fc5-43a5-8540-fc6678ec4e5c" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" sign="-" unitref="usd">1,516.2</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ideb9d32d39e441f68ba01504bca2b03c_I20210630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOjU0MGYzNDkzN2Y1NDQ5NWI4YzRjZjllMzUyMjZjMjY3L3RhYmxlcmFuZ2U6NTQwZjM0OTM3ZjU0NDk1YjhjNGNmOWUzNTIyNmMyNjdfMi0zLTEtMS0xNTk1NDA_51706b6e-854b-47d9-9a42-09fa39f7bae1" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" unitref="usd">9.1</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="iec456e1ce7794922919937b65a44561f_I20210630" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOjU0MGYzNDkzN2Y1NDQ5NWI4YzRjZjllMzUyMjZjMjY3L3RhYmxlcmFuZ2U6NTQwZjM0OTM3ZjU0NDk1YjhjNGNmOWUzNTIyNmMyNjdfMi01LTEtMS0xNTk1NDA_0e6d56b0-e95e-4911-8028-5eae3b51a9e7" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" sign="-" unitref="usd">4,569.9</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i2988484b109649f28736efa0418c49f9_I20210630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOjU0MGYzNDkzN2Y1NDQ5NWI4YzRjZjllMzUyMjZjMjY3L3RhYmxlcmFuZ2U6NTQwZjM0OTM3ZjU0NDk1YjhjNGNmOWUzNTIyNmMyNjdfMi03LTEtMS0xNTk1NDA_5e978c74-5638-4781-a4ff-865cc813ebaf" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" sign="-" unitref="usd">210.1</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="id29f7d92807d4933b0fb1e960563f81f_I20210630" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOjU0MGYzNDkzN2Y1NDQ5NWI4YzRjZjllMzUyMjZjMjY3L3RhYmxlcmFuZ2U6NTQwZjM0OTM3ZjU0NDk1YjhjNGNmOWUzNTIyNmMyNjdfMi0xMS0xLTEtMTU5NTQw_37377391-9ecb-4afc-9492-6c1eadf7fe84" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" sign="-" unitref="usd">6,287.1</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i3153def44849420f812d26d82e12f780_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOjU0MGYzNDkzN2Y1NDQ5NWI4YzRjZjllMzUyMjZjMjY3L3RhYmxlcmFuZ2U6NTQwZjM0OTM3ZjU0NDk1YjhjNGNmOWUzNTIyNmMyNjdfNC0xLTEtMS0xNTk1NDA_bc8a8610-333e-4734-8c68-4bb9f7eac143" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" sign="-" unitref="usd">8.0</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i525ab1d53cfc40b99c19c64b4d032446_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOjU0MGYzNDkzN2Y1NDQ5NWI4YzRjZjllMzUyMjZjMjY3L3RhYmxlcmFuZ2U6NTQwZjM0OTM3ZjU0NDk1YjhjNGNmOWUzNTIyNmMyNjdfNC0zLTEtMS0xNTk1NDA_69c003da-0998-4b7f-8fa6-c4c56181b78e" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" sign="-" unitref="usd">2.4</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i4b3bb220bf604c6daaf72988d3e20703_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOjU0MGYzNDkzN2Y1NDQ5NWI4YzRjZjllMzUyMjZjMjY3L3RhYmxlcmFuZ2U6NTQwZjM0OTM3ZjU0NDk1YjhjNGNmOWUzNTIyNmMyNjdfNC01LTEtMS0xNTk1NDA_db3bdeb5-0335-4d31-8f22-8dfdbf73f86c" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" unitref="usd">18.6</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i24f2b962044749c5a2936c59a2f25aa9_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOjU0MGYzNDkzN2Y1NDQ5NWI4YzRjZjllMzUyMjZjMjY3L3RhYmxlcmFuZ2U6NTQwZjM0OTM3ZjU0NDk1YjhjNGNmOWUzNTIyNmMyNjdfNC03LTEtMS0xNTk1NDA_8fcdde21-f197-47a8-bd3f-ed07e15a6bf7" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" unitref="usd">16.8</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie4fa4f6b472a4f269297591b44aba572_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOjU0MGYzNDkzN2Y1NDQ5NWI4YzRjZjllMzUyMjZjMjY3L3RhYmxlcmFuZ2U6NTQwZjM0OTM3ZjU0NDk1YjhjNGNmOWUzNTIyNmMyNjdfNC0xMS0xLTEtMTU5NTQw_343b68c5-27eb-4a31-b338-3ed735373f5a" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" unitref="usd">25.0</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net amount reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i3153def44849420f812d26d82e12f780_D20210701-20210930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOjU0MGYzNDkzN2Y1NDQ5NWI4YzRjZjllMzUyMjZjMjY3L3RhYmxlcmFuZ2U6NTQwZjM0OTM3ZjU0NDk1YjhjNGNmOWUzNTIyNmMyNjdfNS0xLTEtMS0xNTk1NDA_2a329ba9-7e50-447e-bffc-c4a69fd434f6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i525ab1d53cfc40b99c19c64b4d032446_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOjU0MGYzNDkzN2Y1NDQ5NWI4YzRjZjllMzUyMjZjMjY3L3RhYmxlcmFuZ2U6NTQwZjM0OTM3ZjU0NDk1YjhjNGNmOWUzNTIyNmMyNjdfNS0zLTEtMS0xNTk1NDA_b36cff12-8b7c-4afa-b308-583098de3ea4" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" sign="-" unitref="usd">0.1</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i4b3bb220bf604c6daaf72988d3e20703_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOjU0MGYzNDkzN2Y1NDQ5NWI4YzRjZjllMzUyMjZjMjY3L3RhYmxlcmFuZ2U6NTQwZjM0OTM3ZjU0NDk1YjhjNGNmOWUzNTIyNmMyNjdfNS01LTEtMS0xNTk1NDA_7731c7aa-8612-4961-b098-63eb8bfaf2ff" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" sign="-" unitref="usd">86.0</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i24f2b962044749c5a2936c59a2f25aa9_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOjU0MGYzNDkzN2Y1NDQ5NWI4YzRjZjllMzUyMjZjMjY3L3RhYmxlcmFuZ2U6NTQwZjM0OTM3ZjU0NDk1YjhjNGNmOWUzNTIyNmMyNjdfNS03LTEtMS0xNTk1NDA_6e152849-6097-4be8-91ea-75fa17567af1" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" sign="-" unitref="usd">3.3</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie4fa4f6b472a4f269297591b44aba572_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOjU0MGYzNDkzN2Y1NDQ5NWI4YzRjZjllMzUyMjZjMjY3L3RhYmxlcmFuZ2U6NTQwZjM0OTM3ZjU0NDk1YjhjNGNmOWUzNTIyNmMyNjdfNS0xMS0xLTEtMTU5NTQw_32339359-20c1-45a6-b833-49beea1c1a68" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" sign="-" unitref="usd">89.4</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i3153def44849420f812d26d82e12f780_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOjU0MGYzNDkzN2Y1NDQ5NWI4YzRjZjllMzUyMjZjMjY3L3RhYmxlcmFuZ2U6NTQwZjM0OTM3ZjU0NDk1YjhjNGNmOWUzNTIyNmMyNjdfNi0xLTEtMS0xNTk1NDA_8d330736-566f-4748-af15-275f24a2ecc5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" sign="-" unitref="usd">8.0</ix:nonfraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i525ab1d53cfc40b99c19c64b4d032446_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOjU0MGYzNDkzN2Y1NDQ5NWI4YzRjZjllMzUyMjZjMjY3L3RhYmxlcmFuZ2U6NTQwZjM0OTM3ZjU0NDk1YjhjNGNmOWUzNTIyNmMyNjdfNi0zLTEtMS0xNTk1NDA_974c590f-756c-4fa5-b790-400ffac0b535" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" sign="-" unitref="usd">2.3</ix:nonfraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i4b3bb220bf604c6daaf72988d3e20703_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOjU0MGYzNDkzN2Y1NDQ5NWI4YzRjZjllMzUyMjZjMjY3L3RhYmxlcmFuZ2U6NTQwZjM0OTM3ZjU0NDk1YjhjNGNmOWUzNTIyNmMyNjdfNi01LTEtMS0xNTk1NDA_14730f10-7bc8-4e8d-835f-7b995f65368e" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" unitref="usd">104.6</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i24f2b962044749c5a2936c59a2f25aa9_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOjU0MGYzNDkzN2Y1NDQ5NWI4YzRjZjllMzUyMjZjMjY3L3RhYmxlcmFuZ2U6NTQwZjM0OTM3ZjU0NDk1YjhjNGNmOWUzNTIyNmMyNjdfNi03LTEtMS0xNTk1NDA_30b23c77-6fe2-4c9c-af28-6395045b5f29" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" unitref="usd">20.1</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie4fa4f6b472a4f269297591b44aba572_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOjU0MGYzNDkzN2Y1NDQ5NWI4YzRjZjllMzUyMjZjMjY3L3RhYmxlcmFuZ2U6NTQwZjM0OTM3ZjU0NDk1YjhjNGNmOWUzNTIyNmMyNjdfNi0xMS0xLTEtMTU5NTQw_08c98961-b86f-4677-8189-af10d0ee5c84" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" unitref="usd">114.4</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2021</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="iab4358396efe4d7f92c5aab447052434_I20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOjU0MGYzNDkzN2Y1NDQ5NWI4YzRjZjllMzUyMjZjMjY3L3RhYmxlcmFuZ2U6NTQwZjM0OTM3ZjU0NDk1YjhjNGNmOWUzNTIyNmMyNjdfOC0xLTEtMS0xNTk1NDA_7b757b75-7371-4b9d-ac7a-2f1cdb45fb2e" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" sign="-" unitref="usd">1,524.2</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i5be060faaa5146e7a2bf742eb38f7bec_I20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOjU0MGYzNDkzN2Y1NDQ5NWI4YzRjZjllMzUyMjZjMjY3L3RhYmxlcmFuZ2U6NTQwZjM0OTM3ZjU0NDk1YjhjNGNmOWUzNTIyNmMyNjdfOC0zLTEtMS0xNTk1NDA_2b6b1d47-7f8a-468f-884d-6bf3a2292ee7" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" unitref="usd">6.8</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i894ae4ccbe404068bbc052f007cea48c_I20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOjU0MGYzNDkzN2Y1NDQ5NWI4YzRjZjllMzUyMjZjMjY3L3RhYmxlcmFuZ2U6NTQwZjM0OTM3ZjU0NDk1YjhjNGNmOWUzNTIyNmMyNjdfOC01LTEtMS0xNTk1NDA_b37da8f5-807c-42b1-b506-fc8dfe381b72" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" sign="-" unitref="usd">4,465.3</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="ic74e9458c4f44462a21bfd6f33c8c50d_I20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOjU0MGYzNDkzN2Y1NDQ5NWI4YzRjZjllMzUyMjZjMjY3L3RhYmxlcmFuZ2U6NTQwZjM0OTM3ZjU0NDk1YjhjNGNmOWUzNTIyNmMyNjdfOC03LTEtMS0xNTk1NDA_d4efb03b-9397-40f6-bbee-979fe8e73da5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" sign="-" unitref="usd">190.0</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i9ed755da42e84ed28970211b57db0d80_I20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOjU0MGYzNDkzN2Y1NDQ5NWI4YzRjZjllMzUyMjZjMjY3L3RhYmxlcmFuZ2U6NTQwZjM0OTM3ZjU0NDk1YjhjNGNmOWUzNTIyNmMyNjdfOC0xMS0xLTEtMTU5NTQw_f375035b-ffa1-4002-b006-f4d6d33aa64c" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" sign="-" unitref="usd">6,172.7</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the activity related to each component of other comprehensive income (loss) during the nine months ended September&#160;30, 2022 and 2021: </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.420%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.601%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Amounts presented net of taxes)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Foreign Currency Translation Gains&#160;(Losses)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Unrealized Net Gains (Losses) on&#160;Securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Defined Benefit Pension and Retiree&#160;Health Benefit Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Effective Portion of Cash&#160;Flow Hedges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="if779a9c74164409ab40929f3c1a22e08_I20211231" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmJhMWE1ZDZiZDA3YTRhN2E5MmJlMzY4ZDI1NWZkNTM3L3RhYmxlcmFuZ2U6YmExYTVkNmJkMDdhNGE3YTkyYmUzNjhkMjU1ZmQ1MzdfMS0xLTEtMS0xNTk1NDA_c57d548c-63b2-4e4c-8797-1863e9f2985c" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" sign="-" unitref="usd">1,550.2</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i15e5d118ed234a2f82b7b9a362d215d8_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmJhMWE1ZDZiZDA3YTRhN2E5MmJlMzY4ZDI1NWZkNTM3L3RhYmxlcmFuZ2U6YmExYTVkNmJkMDdhNGE3YTkyYmUzNjhkMjU1ZmQ1MzdfMS0zLTEtMS0xNTk1NDA_e16a6b1c-4be5-4d8b-9098-1d40eec27402" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" unitref="usd">3.7</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="ib7546d9d8f53446e8b4f3eed0a4210c4_I20211231" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmJhMWE1ZDZiZDA3YTRhN2E5MmJlMzY4ZDI1NWZkNTM3L3RhYmxlcmFuZ2U6YmExYTVkNmJkMDdhNGE3YTkyYmUzNjhkMjU1ZmQ1MzdfMS01LTEtMS0xNTk1NDA_3e788ceb-98ed-421e-a00e-fab504a1fe6d" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" sign="-" unitref="usd">2,583.6</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="if2ce5c439794420c8829fd223a835cd4_I20211231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmJhMWE1ZDZiZDA3YTRhN2E5MmJlMzY4ZDI1NWZkNTM3L3RhYmxlcmFuZ2U6YmExYTVkNmJkMDdhNGE3YTkyYmUzNjhkMjU1ZmQ1MzdfMS03LTEtMS0xNTk1NDA_3cc16d4d-e794-44ff-ab6d-7768cfdf83d9" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" sign="-" unitref="usd">213.0</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="ic63664fe4e074a5599837d8254019a8b_I20211231" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmJhMWE1ZDZiZDA3YTRhN2E5MmJlMzY4ZDI1NWZkNTM3L3RhYmxlcmFuZ2U6YmExYTVkNmJkMDdhNGE3YTkyYmUzNjhkMjU1ZmQ1MzdfMS05LTEtMS0xNTk1NDA_7d55d54f-0b88-4df8-85ee-b72af38d492d" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" sign="-" unitref="usd">4,343.1</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="i13abcd536a74422a91f0be2e859c5f11_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmJhMWE1ZDZiZDA3YTRhN2E5MmJlMzY4ZDI1NWZkNTM3L3RhYmxlcmFuZ2U6YmExYTVkNmJkMDdhNGE3YTkyYmUzNjhkMjU1ZmQ1MzdfMy0xLTEtMS0xNTk1NDA_4d50c7d3-123d-4020-a141-6e06010277e1" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" sign="-" unitref="usd">459.7</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="ieeda2eb9aa724c2eb2b08a110d5910ca_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmJhMWE1ZDZiZDA3YTRhN2E5MmJlMzY4ZDI1NWZkNTM3L3RhYmxlcmFuZ2U6YmExYTVkNmJkMDdhNGE3YTkyYmUzNjhkMjU1ZmQ1MzdfMy0zLTEtMS0xNTk1NDA_c6f62673-eae2-4982-b1dc-26d018ba39ac" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" sign="-" unitref="usd">55.5</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i1c0ca46f62b245baa26e2ca939e70c30_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmJhMWE1ZDZiZDA3YTRhN2E5MmJlMzY4ZDI1NWZkNTM3L3RhYmxlcmFuZ2U6YmExYTVkNmJkMDdhNGE3YTkyYmUzNjhkMjU1ZmQ1MzdfMy01LTEtMS0xNTk1NDA_1d6a8cf2-3ffa-4a8b-adbe-86525531a476" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" unitref="usd">72.9</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i698e8cd8a6e44a719d0a96611610bdf4_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmJhMWE1ZDZiZDA3YTRhN2E5MmJlMzY4ZDI1NWZkNTM3L3RhYmxlcmFuZ2U6YmExYTVkNmJkMDdhNGE3YTkyYmUzNjhkMjU1ZmQ1MzdfMy03LTEtMS0xNTk1NDA_3ee4aca4-1af3-4241-a3ad-15fa974c7eb0" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" unitref="usd">297.2</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmJhMWE1ZDZiZDA3YTRhN2E5MmJlMzY4ZDI1NWZkNTM3L3RhYmxlcmFuZ2U6YmExYTVkNmJkMDdhNGE3YTkyYmUzNjhkMjU1ZmQ1MzdfMy05LTEtMS0xNTk1NDA_f7cf9943-aa76-4bdf-b722-c3e1eaed20c4" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" sign="-" unitref="usd">145.1</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net amount reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i13abcd536a74422a91f0be2e859c5f11_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmJhMWE1ZDZiZDA3YTRhN2E5MmJlMzY4ZDI1NWZkNTM3L3RhYmxlcmFuZ2U6YmExYTVkNmJkMDdhNGE3YTkyYmUzNjhkMjU1ZmQ1MzdfNC0xLTEtMS0xNTk1NDA_e23bba7b-34de-48f1-9b60-8e15a22b59f6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" sign="-" unitref="usd">0.6</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ieeda2eb9aa724c2eb2b08a110d5910ca_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmJhMWE1ZDZiZDA3YTRhN2E5MmJlMzY4ZDI1NWZkNTM3L3RhYmxlcmFuZ2U6YmExYTVkNmJkMDdhNGE3YTkyYmUzNjhkMjU1ZmQ1MzdfNC0zLTEtMS0xNTk1NDA_9190dfd0-0744-4be9-8d39-1d232d9a7b8d" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" sign="-" unitref="usd">12.5</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i1c0ca46f62b245baa26e2ca939e70c30_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmJhMWE1ZDZiZDA3YTRhN2E5MmJlMzY4ZDI1NWZkNTM3L3RhYmxlcmFuZ2U6YmExYTVkNmJkMDdhNGE3YTkyYmUzNjhkMjU1ZmQ1MzdfNC01LTEtMS0xNTk1NDA_852c1882-c146-48a5-9450-2a666a131665" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" sign="-" unitref="usd">172.5</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i698e8cd8a6e44a719d0a96611610bdf4_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmJhMWE1ZDZiZDA3YTRhN2E5MmJlMzY4ZDI1NWZkNTM3L3RhYmxlcmFuZ2U6YmExYTVkNmJkMDdhNGE3YTkyYmUzNjhkMjU1ZmQ1MzdfNC03LTEtMS0xNTk1NDA_11893604-2bfe-48e3-81ff-2b84fa6a9b37" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" sign="-" unitref="usd">6.8</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmJhMWE1ZDZiZDA3YTRhN2E5MmJlMzY4ZDI1NWZkNTM3L3RhYmxlcmFuZ2U6YmExYTVkNmJkMDdhNGE3YTkyYmUzNjhkMjU1ZmQ1MzdfNC05LTEtMS0xNTk1NDA_43bf1dac-bccf-4c22-84b0-f7f40c953855" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" sign="-" unitref="usd">192.4</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="i13abcd536a74422a91f0be2e859c5f11_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmJhMWE1ZDZiZDA3YTRhN2E5MmJlMzY4ZDI1NWZkNTM3L3RhYmxlcmFuZ2U6YmExYTVkNmJkMDdhNGE3YTkyYmUzNjhkMjU1ZmQ1MzdfNS0xLTEtMS0xNTk1NDA_9622fa05-3684-45e2-8cf0-a244e7a249f4" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" sign="-" unitref="usd">459.1</ix:nonfraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="ieeda2eb9aa724c2eb2b08a110d5910ca_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmJhMWE1ZDZiZDA3YTRhN2E5MmJlMzY4ZDI1NWZkNTM3L3RhYmxlcmFuZ2U6YmExYTVkNmJkMDdhNGE3YTkyYmUzNjhkMjU1ZmQ1MzdfNS0zLTEtMS0xNTk1NDA_a849d495-a915-48e5-9b20-7bfed9449537" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" sign="-" unitref="usd">43.0</ix:nonfraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i1c0ca46f62b245baa26e2ca939e70c30_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmJhMWE1ZDZiZDA3YTRhN2E5MmJlMzY4ZDI1NWZkNTM3L3RhYmxlcmFuZ2U6YmExYTVkNmJkMDdhNGE3YTkyYmUzNjhkMjU1ZmQ1MzdfNS01LTEtMS0xNTk1NDA_048e54b6-f1b0-4d53-91cf-412483723899" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" unitref="usd">245.4</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i698e8cd8a6e44a719d0a96611610bdf4_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmJhMWE1ZDZiZDA3YTRhN2E5MmJlMzY4ZDI1NWZkNTM3L3RhYmxlcmFuZ2U6YmExYTVkNmJkMDdhNGE3YTkyYmUzNjhkMjU1ZmQ1MzdfNS03LTEtMS0xNTk1NDA_6a7da4af-c3b0-438f-ba1d-f8da68a1e393" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" unitref="usd">304.0</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmJhMWE1ZDZiZDA3YTRhN2E5MmJlMzY4ZDI1NWZkNTM3L3RhYmxlcmFuZ2U6YmExYTVkNmJkMDdhNGE3YTkyYmUzNjhkMjU1ZmQ1MzdfNS05LTEtMS0xNTk1NDA_79e6ae06-d612-4dc9-ab64-0b6d4d858ce1" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" unitref="usd">47.3</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2022</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="i603b413215ff4ac0860f74b6a1be9294_I20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmJhMWE1ZDZiZDA3YTRhN2E5MmJlMzY4ZDI1NWZkNTM3L3RhYmxlcmFuZ2U6YmExYTVkNmJkMDdhNGE3YTkyYmUzNjhkMjU1ZmQ1MzdfNy0xLTEtMS0xNTk1NDA_e2817971-3ce0-4f62-8b72-ec9911ed1219" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" sign="-" unitref="usd">2,009.3</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="i6105e19d65744395aeb2921c7555324a_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmJhMWE1ZDZiZDA3YTRhN2E5MmJlMzY4ZDI1NWZkNTM3L3RhYmxlcmFuZ2U6YmExYTVkNmJkMDdhNGE3YTkyYmUzNjhkMjU1ZmQ1MzdfNy0zLTEtMS0xNTk1NDA_a3b04b31-bbaf-4aa0-9a03-66bce2b7d63e" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" sign="-" unitref="usd">39.3</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="i1ec1c7b3b72549149e283cdff33abeed_I20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmJhMWE1ZDZiZDA3YTRhN2E5MmJlMzY4ZDI1NWZkNTM3L3RhYmxlcmFuZ2U6YmExYTVkNmJkMDdhNGE3YTkyYmUzNjhkMjU1ZmQ1MzdfNy01LTEtMS0xNTk1NDA_2ea540f9-5c8b-4ece-8733-2bd315bdaa84" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" sign="-" unitref="usd">2,338.2</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ifc51fbfd706a4f809013d42ddd4fef8c_I20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmJhMWE1ZDZiZDA3YTRhN2E5MmJlMzY4ZDI1NWZkNTM3L3RhYmxlcmFuZ2U6YmExYTVkNmJkMDdhNGE3YTkyYmUzNjhkMjU1ZmQ1MzdfNy03LTEtMS0xNTk1NDA_a7d3d5b8-ef0b-4c72-ac84-9259e1ecdca6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" unitref="usd">91.0</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="iad56c44530dd4208959b336f8d1fe8b1_I20220930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmJhMWE1ZDZiZDA3YTRhN2E5MmJlMzY4ZDI1NWZkNTM3L3RhYmxlcmFuZ2U6YmExYTVkNmJkMDdhNGE3YTkyYmUzNjhkMjU1ZmQ1MzdfNy05LTEtMS0xNTk1NDA_672abccd-1b4a-49ea-ae6b-39bf34e1fe61" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" sign="-" unitref="usd">4,295.8</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.420%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.601%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Amounts presented net of taxes)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Foreign Currency Translation Gains&#160;(Losses)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Unrealized Net Gains (Losses) on&#160;Securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Defined Benefit Pension and Retiree&#160;Health Benefit Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Effective Portion of Cash&#160;Flow Hedges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i4b2bb6e433df4a26acb1d1cfbcc2ce7d_I20201231" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOjZkZDI3YTI5ZjA1YzQ0YjRhMWMxOWQ2MTQ5MWFiMDRiL3RhYmxlcmFuZ2U6NmRkMjdhMjlmMDVjNDRiNGExYzE5ZDYxNDkxYWIwNGJfMS0xLTEtMS0xNTk1NDA_97951402-5497-4828-9561-5cab17c2bda8" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" sign="-" unitref="usd">1,427.5</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ic15a6784d2e64c5b9176f90a12f6b997_I20201231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOjZkZDI3YTI5ZjA1YzQ0YjRhMWMxOWQ2MTQ5MWFiMDRiL3RhYmxlcmFuZ2U6NmRkMjdhMjlmMDVjNDRiNGExYzE5ZDYxNDkxYWIwNGJfMS0zLTEtMS0xNTk1NDA_882fb8f0-8666-4ad8-b77b-3848ee4f03b4" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" unitref="usd">14.8</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="if4dbdc6b4ce3472bb83f35a58ba62009_I20201231" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOjZkZDI3YTI5ZjA1YzQ0YjRhMWMxOWQ2MTQ5MWFiMDRiL3RhYmxlcmFuZ2U6NmRkMjdhMjlmMDVjNDRiNGExYzE5ZDYxNDkxYWIwNGJfMS01LTEtMS0xNTk1NDA_c2f6e5ff-e854-4806-9340-0995d612e927" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" sign="-" unitref="usd">4,751.0</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i4084f6774b4344709f32500dfb758be3_I20201231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOjZkZDI3YTI5ZjA1YzQ0YjRhMWMxOWQ2MTQ5MWFiMDRiL3RhYmxlcmFuZ2U6NmRkMjdhMjlmMDVjNDRiNGExYzE5ZDYxNDkxYWIwNGJfMS03LTEtMS0xNTk1NDA_2da41502-b2ab-44ee-8b0f-30b72625c205" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" sign="-" unitref="usd">332.7</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i61189f333c704d8a9f0dffcd44fd0870_I20201231" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOjZkZDI3YTI5ZjA1YzQ0YjRhMWMxOWQ2MTQ5MWFiMDRiL3RhYmxlcmFuZ2U6NmRkMjdhMjlmMDVjNDRiNGExYzE5ZDYxNDkxYWIwNGJfMS05LTEtMS0xNTk1NDA_0b6c8abd-2f26-4669-9d7d-4924fbdb1bf2" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" sign="-" unitref="usd">6,496.4</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i4def4770d4c9484b9eafab55058f4c06_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOjZkZDI3YTI5ZjA1YzQ0YjRhMWMxOWQ2MTQ5MWFiMDRiL3RhYmxlcmFuZ2U6NmRkMjdhMjlmMDVjNDRiNGExYzE5ZDYxNDkxYWIwNGJfMy0xLTEtMS0xNTk1NDA_d44c05f9-6f7a-4c53-af68-0eda7919903d" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" sign="-" unitref="usd">96.7</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="if73a641a34fe4591b395573cedb1bea4_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOjZkZDI3YTI5ZjA1YzQ0YjRhMWMxOWQ2MTQ5MWFiMDRiL3RhYmxlcmFuZ2U6NmRkMjdhMjlmMDVjNDRiNGExYzE5ZDYxNDkxYWIwNGJfMy0zLTEtMS0xNTk1NDA_51e782a8-6f25-47c7-99d9-cdc918d27e6e" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" sign="-" unitref="usd">8.8</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i71a11ec78f2242498930e393cd63658b_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOjZkZDI3YTI5ZjA1YzQ0YjRhMWMxOWQ2MTQ5MWFiMDRiL3RhYmxlcmFuZ2U6NmRkMjdhMjlmMDVjNDRiNGExYzE5ZDYxNDkxYWIwNGJfMy01LTEtMS0xNTk1NDA_bcd0bbc9-ec9d-4c48-a74b-68fb8571e331" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" unitref="usd">27.2</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i314c9492fa9044c3a8d05e0fc3ad2e63_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOjZkZDI3YTI5ZjA1YzQ0YjRhMWMxOWQ2MTQ5MWFiMDRiL3RhYmxlcmFuZ2U6NmRkMjdhMjlmMDVjNDRiNGExYzE5ZDYxNDkxYWIwNGJfMy03LTEtMS0xNTk1NDA_8156c0cb-ba75-44a2-b9a5-dc9d6f619b07" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" unitref="usd">132.8</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOjZkZDI3YTI5ZjA1YzQ0YjRhMWMxOWQ2MTQ5MWFiMDRiL3RhYmxlcmFuZ2U6NmRkMjdhMjlmMDVjNDRiNGExYzE5ZDYxNDkxYWIwNGJfMy05LTEtMS0xNTk1NDA_b6d2e3de-b539-42d4-aadb-0ad48f908c1e" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" unitref="usd">54.5</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net amount reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i4def4770d4c9484b9eafab55058f4c06_D20210101-20210930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOjZkZDI3YTI5ZjA1YzQ0YjRhMWMxOWQ2MTQ5MWFiMDRiL3RhYmxlcmFuZ2U6NmRkMjdhMjlmMDVjNDRiNGExYzE5ZDYxNDkxYWIwNGJfNC0xLTEtMS0xNTk1NDA_df117ee3-063e-4522-8a2b-590a65911b29" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="if73a641a34fe4591b395573cedb1bea4_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOjZkZDI3YTI5ZjA1YzQ0YjRhMWMxOWQ2MTQ5MWFiMDRiL3RhYmxlcmFuZ2U6NmRkMjdhMjlmMDVjNDRiNGExYzE5ZDYxNDkxYWIwNGJfNC0zLTEtMS0xNTk1NDA_fc963b77-b32c-41b6-88c2-94026c36effd" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" sign="-" unitref="usd">0.8</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i71a11ec78f2242498930e393cd63658b_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOjZkZDI3YTI5ZjA1YzQ0YjRhMWMxOWQ2MTQ5MWFiMDRiL3RhYmxlcmFuZ2U6NmRkMjdhMjlmMDVjNDRiNGExYzE5ZDYxNDkxYWIwNGJfNC01LTEtMS0xNTk1NDA_3a98660b-8435-4d58-a6ce-92f902d62686" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" sign="-" unitref="usd">258.5</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i314c9492fa9044c3a8d05e0fc3ad2e63_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOjZkZDI3YTI5ZjA1YzQ0YjRhMWMxOWQ2MTQ5MWFiMDRiL3RhYmxlcmFuZ2U6NmRkMjdhMjlmMDVjNDRiNGExYzE5ZDYxNDkxYWIwNGJfNC03LTEtMS0xNTk1NDA_bfaa1d27-e9e4-443a-9975-36ed67113289" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" sign="-" unitref="usd">9.9</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOjZkZDI3YTI5ZjA1YzQ0YjRhMWMxOWQ2MTQ5MWFiMDRiL3RhYmxlcmFuZ2U6NmRkMjdhMjlmMDVjNDRiNGExYzE5ZDYxNDkxYWIwNGJfNC05LTEtMS0xNTk1NDA_f029ff4d-e8ee-4af2-aa01-c0569e36d6fc" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" sign="-" unitref="usd">269.2</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i4def4770d4c9484b9eafab55058f4c06_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOjZkZDI3YTI5ZjA1YzQ0YjRhMWMxOWQ2MTQ5MWFiMDRiL3RhYmxlcmFuZ2U6NmRkMjdhMjlmMDVjNDRiNGExYzE5ZDYxNDkxYWIwNGJfNS0xLTEtMS0xNTk1NDA_f142a863-e7ef-441c-ba12-31bddcf20883" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" sign="-" unitref="usd">96.7</ix:nonfraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="if73a641a34fe4591b395573cedb1bea4_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOjZkZDI3YTI5ZjA1YzQ0YjRhMWMxOWQ2MTQ5MWFiMDRiL3RhYmxlcmFuZ2U6NmRkMjdhMjlmMDVjNDRiNGExYzE5ZDYxNDkxYWIwNGJfNS0zLTEtMS0xNTk1NDA_fc325872-d51f-4c45-ae5b-77c883cf97bd" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" sign="-" unitref="usd">8.0</ix:nonfraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i71a11ec78f2242498930e393cd63658b_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOjZkZDI3YTI5ZjA1YzQ0YjRhMWMxOWQ2MTQ5MWFiMDRiL3RhYmxlcmFuZ2U6NmRkMjdhMjlmMDVjNDRiNGExYzE5ZDYxNDkxYWIwNGJfNS01LTEtMS0xNTk1NDA_31a06a9d-b27b-4cec-b8b2-6bbe0a72a142" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" unitref="usd">285.7</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i314c9492fa9044c3a8d05e0fc3ad2e63_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOjZkZDI3YTI5ZjA1YzQ0YjRhMWMxOWQ2MTQ5MWFiMDRiL3RhYmxlcmFuZ2U6NmRkMjdhMjlmMDVjNDRiNGExYzE5ZDYxNDkxYWIwNGJfNS03LTEtMS0xNTk1NDA_8f52c74d-d777-4d3c-9078-604c6e660b15" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" unitref="usd">142.7</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOjZkZDI3YTI5ZjA1YzQ0YjRhMWMxOWQ2MTQ5MWFiMDRiL3RhYmxlcmFuZ2U6NmRkMjdhMjlmMDVjNDRiNGExYzE5ZDYxNDkxYWIwNGJfNS05LTEtMS0xNTk1NDA_1a7b6916-95a3-4664-b1be-77f3cddfc826" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" unitref="usd">323.7</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2021</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="iab4358396efe4d7f92c5aab447052434_I20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOjZkZDI3YTI5ZjA1YzQ0YjRhMWMxOWQ2MTQ5MWFiMDRiL3RhYmxlcmFuZ2U6NmRkMjdhMjlmMDVjNDRiNGExYzE5ZDYxNDkxYWIwNGJfNy0xLTEtMS0xNTk1NDA_df686e57-acf0-4aae-8f8d-89339b78fb83" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" sign="-" unitref="usd">1,524.2</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i5be060faaa5146e7a2bf742eb38f7bec_I20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOjZkZDI3YTI5ZjA1YzQ0YjRhMWMxOWQ2MTQ5MWFiMDRiL3RhYmxlcmFuZ2U6NmRkMjdhMjlmMDVjNDRiNGExYzE5ZDYxNDkxYWIwNGJfNy0zLTEtMS0xNTk1NDA_1562e3d0-3bb8-4ee8-8ee0-5bae8ee51810" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" unitref="usd">6.8</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i894ae4ccbe404068bbc052f007cea48c_I20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOjZkZDI3YTI5ZjA1YzQ0YjRhMWMxOWQ2MTQ5MWFiMDRiL3RhYmxlcmFuZ2U6NmRkMjdhMjlmMDVjNDRiNGExYzE5ZDYxNDkxYWIwNGJfNy01LTEtMS0xNTk1NDA_080fc4e5-2651-4b0d-b0b2-3f8acc562924" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" sign="-" unitref="usd">4,465.3</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="ic74e9458c4f44462a21bfd6f33c8c50d_I20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOjZkZDI3YTI5ZjA1YzQ0YjRhMWMxOWQ2MTQ5MWFiMDRiL3RhYmxlcmFuZ2U6NmRkMjdhMjlmMDVjNDRiNGExYzE5ZDYxNDkxYWIwNGJfNy03LTEtMS0xNTk1NDA_c699214d-26ae-4453-a649-8b55feb4304b" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" sign="-" unitref="usd">190.0</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i9ed755da42e84ed28970211b57db0d80_I20210930" decimals="-5" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOjZkZDI3YTI5ZjA1YzQ0YjRhMWMxOWQ2MTQ5MWFiMDRiL3RhYmxlcmFuZ2U6NmRkMjdhMjlmMDVjNDRiNGExYzE5ZDYxNDkxYWIwNGJfNy05LTEtMS0xNTk1NDA_6b796905-b78a-40b3-a04d-9f8a7c2593f2" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" sign="-" unitref="usd">6,172.7</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonnumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i5522e96d15c7416b8ed82fcd2588116a"><ix:continuation id="i3587bacca65548d4a7335757e1648b25"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tax effects on the net activity related to each component of other comprehensive income (loss) were as follows:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.206%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Tax benefit (expense) </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation gains/losses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="ibb680e42808d41b587bffa2f35409a91_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmFhYWFkZDkyNDk1NzQ2NTM4ZTYyOWNhYmVmOTIyNDUwL3RhYmxlcmFuZ2U6YWFhYWRkOTI0OTU3NDY1MzhlNjI5Y2FiZWY5MjI0NTBfMi0xLTEtMS0xNTk1NDA_9288aeb5-bc35-4821-b372-845cc812a74b" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" unitref="usd">133.3</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i3153def44849420f812d26d82e12f780_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmFhYWFkZDkyNDk1NzQ2NTM4ZTYyOWNhYmVmOTIyNDUwL3RhYmxlcmFuZ2U6YWFhYWRkOTI0OTU3NDY1MzhlNjI5Y2FiZWY5MjI0NTBfMi0zLTEtMS0xNTk1NDA_a5ffecc2-9b51-46ac-af7b-fee5b950b93f" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" unitref="usd">39.0</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="i13abcd536a74422a91f0be2e859c5f11_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmFhYWFkZDkyNDk1NzQ2NTM4ZTYyOWNhYmVmOTIyNDUwL3RhYmxlcmFuZ2U6YWFhYWRkOTI0OTU3NDY1MzhlNjI5Y2FiZWY5MjI0NTBfMi01LTEtMS0xNTk1NDA_effcd36c-4bc5-413d-902e-1975903a5dbc" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" unitref="usd">234.2</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i4def4770d4c9484b9eafab55058f4c06_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmFhYWFkZDkyNDk1NzQ2NTM4ZTYyOWNhYmVmOTIyNDUwL3RhYmxlcmFuZ2U6YWFhYWRkOTI0OTU3NDY1MzhlNjI5Y2FiZWY5MjI0NTBfMi03LTEtMS0xNTk1NDA_cf738574-2c69-4fb7-897e-f429ae685e23" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" unitref="usd">92.3</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized net gains/losses on securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ib423da078b9740019ae03257a6ca1320_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmFhYWFkZDkyNDk1NzQ2NTM4ZTYyOWNhYmVmOTIyNDUwL3RhYmxlcmFuZ2U6YWFhYWRkOTI0OTU3NDY1MzhlNjI5Y2FiZWY5MjI0NTBfMy0xLTEtMS0xNTk1NDA_adc9b647-288e-4693-b5fd-7dd97abcc7c9" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" sign="-" unitref="usd">3.4</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i525ab1d53cfc40b99c19c64b4d032446_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmFhYWFkZDkyNDk1NzQ2NTM4ZTYyOWNhYmVmOTIyNDUwL3RhYmxlcmFuZ2U6YWFhYWRkOTI0OTU3NDY1MzhlNjI5Y2FiZWY5MjI0NTBfMy0zLTEtMS0xNTk1NDA_891e3a1c-8491-4d56-a658-a73f2948d075" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" sign="-" unitref="usd">0.8</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ieeda2eb9aa724c2eb2b08a110d5910ca_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmFhYWFkZDkyNDk1NzQ2NTM4ZTYyOWNhYmVmOTIyNDUwL3RhYmxlcmFuZ2U6YWFhYWRkOTI0OTU3NDY1MzhlNjI5Y2FiZWY5MjI0NTBfMy01LTEtMS0xNTk1NDA_b1fb0281-e508-477b-bbc4-f0903d8ca148" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" sign="-" unitref="usd">13.1</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="if73a641a34fe4591b395573cedb1bea4_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmFhYWFkZDkyNDk1NzQ2NTM4ZTYyOWNhYmVmOTIyNDUwL3RhYmxlcmFuZ2U6YWFhYWRkOTI0OTU3NDY1MzhlNjI5Y2FiZWY5MjI0NTBfMy03LTEtMS0xNTk1NDA_2d52efac-cc89-410f-a00b-9f4d7f605ae7" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" sign="-" unitref="usd">3.8</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Defined benefit pension and retiree health benefit plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="i0ddaa7c4639946b1a63ee163ebac9cda_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmFhYWFkZDkyNDk1NzQ2NTM4ZTYyOWNhYmVmOTIyNDUwL3RhYmxlcmFuZ2U6YWFhYWRkOTI0OTU3NDY1MzhlNjI5Y2FiZWY5MjI0NTBfNC0xLTEtMS0xNTk1NDA_f3500220-7318-4848-bc45-1c25ece78cb8" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" unitref="usd">22.4</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i4b3bb220bf604c6daaf72988d3e20703_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmFhYWFkZDkyNDk1NzQ2NTM4ZTYyOWNhYmVmOTIyNDUwL3RhYmxlcmFuZ2U6YWFhYWRkOTI0OTU3NDY1MzhlNjI5Y2FiZWY5MjI0NTBfNC0zLTEtMS0xNTk1NDA_c0679b86-78ff-4695-8681-9e8c61bd9da9" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" unitref="usd">28.2</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="i1c0ca46f62b245baa26e2ca939e70c30_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmFhYWFkZDkyNDk1NzQ2NTM4ZTYyOWNhYmVmOTIyNDUwL3RhYmxlcmFuZ2U6YWFhYWRkOTI0OTU3NDY1MzhlNjI5Y2FiZWY5MjI0NTBfNC01LTEtMS0xNTk1NDA_08c99a23-2aac-45a4-b919-842288032819" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" unitref="usd">73.2</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i71a11ec78f2242498930e393cd63658b_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmFhYWFkZDkyNDk1NzQ2NTM4ZTYyOWNhYmVmOTIyNDUwL3RhYmxlcmFuZ2U6YWFhYWRkOTI0OTU3NDY1MzhlNjI5Y2FiZWY5MjI0NTBfNC03LTEtMS0xNTk1NDA_4e681248-c5d8-4faf-b1e8-fd0f254e2154" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" unitref="usd">79.7</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective portion of cash flow hedges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="i9e78a70b50b740909d4bd5980c556e3a_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmFhYWFkZDkyNDk1NzQ2NTM4ZTYyOWNhYmVmOTIyNDUwL3RhYmxlcmFuZ2U6YWFhYWRkOTI0OTU3NDY1MzhlNjI5Y2FiZWY5MjI0NTBfNS0xLTEtMS0xNTk1NDA_d196d5d1-d157-4ec3-a972-9a43fec9dd9d" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" unitref="usd">16.9</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i24f2b962044749c5a2936c59a2f25aa9_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmFhYWFkZDkyNDk1NzQ2NTM4ZTYyOWNhYmVmOTIyNDUwL3RhYmxlcmFuZ2U6YWFhYWRkOTI0OTU3NDY1MzhlNjI5Y2FiZWY5MjI0NTBfNS0zLTEtMS0xNTk1NDA_2f573e2c-37b5-4711-86c5-3a6b173c0498" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" unitref="usd">5.4</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="i698e8cd8a6e44a719d0a96611610bdf4_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmFhYWFkZDkyNDk1NzQ2NTM4ZTYyOWNhYmVmOTIyNDUwL3RhYmxlcmFuZ2U6YWFhYWRkOTI0OTU3NDY1MzhlNjI5Y2FiZWY5MjI0NTBfNS01LTEtMS0xNTk1NDA_7a1f9e17-3ca1-424e-a357-8dbda5994062" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" unitref="usd">80.8</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i314c9492fa9044c3a8d05e0fc3ad2e63_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmFhYWFkZDkyNDk1NzQ2NTM4ZTYyOWNhYmVmOTIyNDUwL3RhYmxlcmFuZ2U6YWFhYWRkOTI0OTU3NDY1MzhlNjI5Y2FiZWY5MjI0NTBfNS03LTEtMS0xNTk1NDA_f1841f57-2300-4e86-9a53-bca575b58a79" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" unitref="usd">37.9</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit (expense) for income taxes allocated to other comprehensive income (loss) items</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="i19fc0325c48543008ea71e1fdcf11d86_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmFhYWFkZDkyNDk1NzQ2NTM4ZTYyOWNhYmVmOTIyNDUwL3RhYmxlcmFuZ2U6YWFhYWRkOTI0OTU3NDY1MzhlNjI5Y2FiZWY5MjI0NTBfNi0xLTEtMS0xNTk1NDA_b0afe6a4-7541-4944-a2d7-1fe08a907f67" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" unitref="usd">169.2</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="ie4fa4f6b472a4f269297591b44aba572_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmFhYWFkZDkyNDk1NzQ2NTM4ZTYyOWNhYmVmOTIyNDUwL3RhYmxlcmFuZ2U6YWFhYWRkOTI0OTU3NDY1MzhlNjI5Y2FiZWY5MjI0NTBfNi0zLTEtMS0xNTk1NDA_54b09372-a85d-4dce-9258-21a58b740a97" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" unitref="usd">71.8</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmFhYWFkZDkyNDk1NzQ2NTM4ZTYyOWNhYmVmOTIyNDUwL3RhYmxlcmFuZ2U6YWFhYWRkOTI0OTU3NDY1MzhlNjI5Y2FiZWY5MjI0NTBfNi01LTEtMS0xNTk1NDA_95d8e0c0-f5d8-4739-a772-b658fe2818d4" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" unitref="usd">375.1</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmFhYWFkZDkyNDk1NzQ2NTM4ZTYyOWNhYmVmOTIyNDUwL3RhYmxlcmFuZ2U6YWFhYWRkOTI0OTU3NDY1MzhlNjI5Y2FiZWY5MjI0NTBfNi03LTEtMS0xNTk1NDA_9c096cdb-f645-4bac-8c07-275cf8aa1352" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" unitref="usd">206.1</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except for the tax effects of foreign currency translation gains and losses related to our foreign currency-denominated notes, cross-currency interest rate swaps, and other foreign currency exchange contracts designated as net investment hedges (see Note 6), income taxes were not provided for foreign currency translation. Generally, the assets and liabilities of foreign operations are translated into U.S. dollars using the current exchange rate. For those operations, changes in exchange rates generally do not affect cash flows; therefore, resulting translation adjustments are made in shareholders' equity rather than in the consolidated condensed statements of operations.</span></div><ix:nonnumeric contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RleHRyZWdpb246ZTE0MjlmY2IyNjYyNDg4ZDk5MTllMTg4MGNiZTMyMTNfMTI0Ng_7fce3647-7646-46f0-b874-b42e629c05a1" name="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reclassifications out of accumulated other comprehensive loss were as follows:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.718%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.830%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Details about Accumulated Other Comprehensive Loss Components</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Affected Line Item in the Consolidated Condensed Statements of Operations</span></td></tr><tr style="height:6pt"><td colspan="30" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of retirement benefit items:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service benefits, net</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="iaaff00acdddb497fb5b94bf8d2ff771d_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmEwNDg1MGU2OTU2MjQ2ZTg4NDNjOWQzMjQ1ZGFiZDk4L3RhYmxlcmFuZ2U6YTA0ODUwZTY5NTYyNDZlODg0M2M5ZDMyNDVkYWJkOThfNC0yLTEtMS0xNTk1NDA_75d52764-47c2-4aed-9811-e009dae7063b" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" sign="-" unitref="usd">13.1</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="ia0716cc08360439bb971180db7de8214_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmEwNDg1MGU2OTU2MjQ2ZTg4NDNjOWQzMjQ1ZGFiZDk4L3RhYmxlcmFuZ2U6YTA0ODUwZTY5NTYyNDZlODg0M2M5ZDMyNDVkYWJkOThfNC00LTEtMS0xNTk1NDA_7757718b-97b7-430d-8469-2655b7c55f79" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" sign="-" unitref="usd">13.9</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="i1e81189c858b4d59b30b2380c8bf756b_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmEwNDg1MGU2OTU2MjQ2ZTg4NDNjOWQzMjQ1ZGFiZDk4L3RhYmxlcmFuZ2U6YTA0ODUwZTY5NTYyNDZlODg0M2M5ZDMyNDVkYWJkOThfNC02LTEtMS0xNTk1NDA_ab068766-f7f2-4015-aca9-d0926ab6f17a" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" sign="-" unitref="usd">39.2</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="iafe03a1322e544acb123846499dfb8f0_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmEwNDg1MGU2OTU2MjQ2ZTg4NDNjOWQzMjQ1ZGFiZDk4L3RhYmxlcmFuZ2U6YTA0ODUwZTY5NTYyNDZlODg0M2M5ZDMyNDVkYWJkOThfNC04LTEtMS0xNTk1NDA_4c80be46-a6d8-4fb5-a83b-021447ab5122" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" sign="-" unitref="usd">41.5</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other&#8211;net, (income) expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial losses, net</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="iedc64e6c0ae84f6f8f6f168b1b71f00f_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmEwNDg1MGU2OTU2MjQ2ZTg4NDNjOWQzMjQ1ZGFiZDk4L3RhYmxlcmFuZ2U6YTA0ODUwZTY5NTYyNDZlODg0M2M5ZDMyNDVkYWJkOThfNS0yLTEtMS0xNTk1NDA_b8c61d10-6692-415c-acb7-4a5f3bc9cdc1" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" unitref="usd">85.5</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i02ba7e57b97e4c15aa93cdacb3f05447_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmEwNDg1MGU2OTU2MjQ2ZTg4NDNjOWQzMjQ1ZGFiZDk4L3RhYmxlcmFuZ2U6YTA0ODUwZTY5NTYyNDZlODg0M2M5ZDMyNDVkYWJkOThfNS00LTEtMS0xNTk1NDA_4aa3e2da-7c6b-4b72-b2f6-621b543f2042" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" unitref="usd">122.7</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i8d7550b247eb4a90ac3acd3ea2eab6ad_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmEwNDg1MGU2OTU2MjQ2ZTg4NDNjOWQzMjQ1ZGFiZDk4L3RhYmxlcmFuZ2U6YTA0ODUwZTY5NTYyNDZlODg0M2M5ZDMyNDVkYWJkOThfNS02LTEtMS0xNTk1NDA_acc4c432-ea31-4b2a-af8a-cd9d50eaab77" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" unitref="usd">257.5</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="if8458e6a1b9b4239b31d01e183c0368d_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmEwNDg1MGU2OTU2MjQ2ZTg4NDNjOWQzMjQ1ZGFiZDk4L3RhYmxlcmFuZ2U6YTA0ODUwZTY5NTYyNDZlODg0M2M5ZDMyNDVkYWJkOThfNS04LTEtMS0xNTk1NDA_3323a627-a909-48fd-8e7d-0bb12bf616ab" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" unitref="usd">368.7</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other&#8211;net, (income) expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total before tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i14e2a21089594bfda05e2f482a1a9fdb_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmEwNDg1MGU2OTU2MjQ2ZTg4NDNjOWQzMjQ1ZGFiZDk4L3RhYmxlcmFuZ2U6YTA0ODUwZTY5NTYyNDZlODg0M2M5ZDMyNDVkYWJkOThfNi0yLTEtMS0xNTk1NDA_e4cca648-b540-4e36-bc46-c09b2a81efe5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" unitref="usd">72.4</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="if60b1262bf5c4116ad9ba0e69b270a48_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmEwNDg1MGU2OTU2MjQ2ZTg4NDNjOWQzMjQ1ZGFiZDk4L3RhYmxlcmFuZ2U6YTA0ODUwZTY5NTYyNDZlODg0M2M5ZDMyNDVkYWJkOThfNi00LTEtMS0xNTk1NDA_753a8d8b-c928-4c94-bf34-6b0fed64423d" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" unitref="usd">108.8</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i913335a3ccfe4b639f36db1017ae92af_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmEwNDg1MGU2OTU2MjQ2ZTg4NDNjOWQzMjQ1ZGFiZDk4L3RhYmxlcmFuZ2U6YTA0ODUwZTY5NTYyNDZlODg0M2M5ZDMyNDVkYWJkOThfNi02LTEtMS0xNTk1NDA_6b167d15-d4ac-4f22-9f2f-443e5d6874be" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" unitref="usd">218.3</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7c947211ed8b449b9617f0791f225696_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmEwNDg1MGU2OTU2MjQ2ZTg4NDNjOWQzMjQ1ZGFiZDk4L3RhYmxlcmFuZ2U6YTA0ODUwZTY5NTYyNDZlODg0M2M5ZDMyNDVkYWJkOThfNi04LTEtMS0xNTk1NDA_0350ef29-18de-4d39-86a2-c8ceb299f6e7" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" unitref="usd">327.2</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="i14e2a21089594bfda05e2f482a1a9fdb_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmEwNDg1MGU2OTU2MjQ2ZTg4NDNjOWQzMjQ1ZGFiZDk4L3RhYmxlcmFuZ2U6YTA0ODUwZTY5NTYyNDZlODg0M2M5ZDMyNDVkYWJkOThfNy0yLTEtMS0xNTk1NDA_c69e305a-591a-4070-9ec3-f9a8f7a02bc0" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" unitref="usd">15.2</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="if60b1262bf5c4116ad9ba0e69b270a48_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmEwNDg1MGU2OTU2MjQ2ZTg4NDNjOWQzMjQ1ZGFiZDk4L3RhYmxlcmFuZ2U6YTA0ODUwZTY5NTYyNDZlODg0M2M5ZDMyNDVkYWJkOThfNy00LTEtMS0xNTk1NDA_2f77d614-038e-490f-b2ef-544ac03182a9" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" unitref="usd">22.8</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="i913335a3ccfe4b639f36db1017ae92af_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmEwNDg1MGU2OTU2MjQ2ZTg4NDNjOWQzMjQ1ZGFiZDk4L3RhYmxlcmFuZ2U6YTA0ODUwZTY5NTYyNDZlODg0M2M5ZDMyNDVkYWJkOThfNy02LTEtMS0xNTk1NDA_202a3d38-09bf-4207-8bf8-1aff1296d1b1" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" unitref="usd">45.8</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i7c947211ed8b449b9617f0791f225696_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmEwNDg1MGU2OTU2MjQ2ZTg4NDNjOWQzMjQ1ZGFiZDk4L3RhYmxlcmFuZ2U6YTA0ODUwZTY5NTYyNDZlODg0M2M5ZDMyNDVkYWJkOThfNy04LTEtMS0xNTk1NDA_a640bf6f-a7d1-4129-81f4-869a47fac787" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" unitref="usd">68.7</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i14e2a21089594bfda05e2f482a1a9fdb_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmEwNDg1MGU2OTU2MjQ2ZTg4NDNjOWQzMjQ1ZGFiZDk4L3RhYmxlcmFuZ2U6YTA0ODUwZTY5NTYyNDZlODg0M2M5ZDMyNDVkYWJkOThfOC0yLTEtMS0xNTk1NDA_078cf349-6ae2-4264-ba2d-cc2dc7023f74" name="us-gaap:ProfitLoss" scale="6" unitref="usd">57.2</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="if60b1262bf5c4116ad9ba0e69b270a48_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmEwNDg1MGU2OTU2MjQ2ZTg4NDNjOWQzMjQ1ZGFiZDk4L3RhYmxlcmFuZ2U6YTA0ODUwZTY5NTYyNDZlODg0M2M5ZDMyNDVkYWJkOThfOC00LTEtMS0xNTk1NDA_43f1f17d-5e6e-4e0d-9275-01fc78827701" name="us-gaap:ProfitLoss" scale="6" unitref="usd">86.0</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i913335a3ccfe4b639f36db1017ae92af_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmEwNDg1MGU2OTU2MjQ2ZTg4NDNjOWQzMjQ1ZGFiZDk4L3RhYmxlcmFuZ2U6YTA0ODUwZTY5NTYyNDZlODg0M2M5ZDMyNDVkYWJkOThfOC02LTEtMS0xNTk1NDA_024f976b-b13d-4afb-a727-247f62c054ae" name="us-gaap:ProfitLoss" scale="6" unitref="usd">172.5</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7c947211ed8b449b9617f0791f225696_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmEwNDg1MGU2OTU2MjQ2ZTg4NDNjOWQzMjQ1ZGFiZDk4L3RhYmxlcmFuZ2U6YTA0ODUwZTY5NTYyNDZlODg0M2M5ZDMyNDVkYWJkOThfOC04LTEtMS0xNTk1NDA_ee56cd72-d540-4e2e-a6aa-7aa4b9663e61" name="us-gaap:ProfitLoss" scale="6" unitref="usd">258.5</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net of tax</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="ib98dca097ce342f1856252087101e534_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmEwNDg1MGU2OTU2MjQ2ZTg4NDNjOWQzMjQ1ZGFiZDk4L3RhYmxlcmFuZ2U6YTA0ODUwZTY5NTYyNDZlODg0M2M5ZDMyNDVkYWJkOThfMTAtMi0xLTEtMTU5NTQw_f2d3ab8e-1b2b-4ff5-a7c3-5f627d0d4f55" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" unitref="usd">13.9</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="if20e319a4c3045b8b0693a8773446ca4_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmEwNDg1MGU2OTU2MjQ2ZTg4NDNjOWQzMjQ1ZGFiZDk4L3RhYmxlcmFuZ2U6YTA0ODUwZTY5NTYyNDZlODg0M2M5ZDMyNDVkYWJkOThfMTAtNC0xLTEtMTU5NTQw_cae01196-fe0d-48f1-a0a1-d5308a3751c6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" unitref="usd">3.4</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i06f2cc53bd804ced906cc353bccf23bd_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmEwNDg1MGU2OTU2MjQ2ZTg4NDNjOWQzMjQ1ZGFiZDk4L3RhYmxlcmFuZ2U6YTA0ODUwZTY5NTYyNDZlODg0M2M5ZDMyNDVkYWJkOThfMTAtNi0xLTEtMTU5NTQw_0b895ae1-2a9b-4f7c-8d41-9911ac8e0f19" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" unitref="usd">19.9</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i562107a932c943419a75d588f68a7ede_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmEwNDg1MGU2OTU2MjQ2ZTg4NDNjOWQzMjQ1ZGFiZDk4L3RhYmxlcmFuZ2U6YTA0ODUwZTY5NTYyNDZlODg0M2M5ZDMyNDVkYWJkOThfMTAtOC0xLTEtMTU5NTQw_ea3bc79b-cd71-4dcc-b0cc-66f387200de8" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" unitref="usd">10.7</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other&#8211;net, (income) expense</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total reclassifications, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i294aedf137cf40faaba28e6d98a540dc_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmEwNDg1MGU2OTU2MjQ2ZTg4NDNjOWQzMjQ1ZGFiZDk4L3RhYmxlcmFuZ2U6YTA0ODUwZTY5NTYyNDZlODg0M2M5ZDMyNDVkYWJkOThfMTItMi0xLTEtMTU5NTQw_9c895380-89ef-4bd2-9085-faf91a1e9dd5" name="us-gaap:ProfitLoss" scale="6" unitref="usd">71.1</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="id04bc0ea75e7453daeb27bfa63e91d46_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmEwNDg1MGU2OTU2MjQ2ZTg4NDNjOWQzMjQ1ZGFiZDk4L3RhYmxlcmFuZ2U6YTA0ODUwZTY5NTYyNDZlODg0M2M5ZDMyNDVkYWJkOThfMTItNC0xLTEtMTU5NTQw_dafea8ca-30c7-42dd-b875-a96517caeeaf" name="us-gaap:ProfitLoss" scale="6" unitref="usd">89.4</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="id8fcac86ddf342cf954cceefebfd7779_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmEwNDg1MGU2OTU2MjQ2ZTg4NDNjOWQzMjQ1ZGFiZDk4L3RhYmxlcmFuZ2U6YTA0ODUwZTY5NTYyNDZlODg0M2M5ZDMyNDVkYWJkOThfMTItNi0xLTEtMTU5NTQw_a52dcf8c-cf09-42ec-bb83-f8eb0ca6ac84" name="us-gaap:ProfitLoss" scale="6" unitref="usd">192.4</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i741049a232dc40728bbe8ee225522d87_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183My9mcmFnOmUxNDI5ZmNiMjY2MjQ4OGQ5OTE5ZTE4ODBjYmUzMjEzL3RhYmxlOmEwNDg1MGU2OTU2MjQ2ZTg4NDNjOWQzMjQ1ZGFiZDk4L3RhYmxlcmFuZ2U6YTA0ODUwZTY5NTYyNDZlODg0M2M5ZDMyNDVkYWJkOThfMTItOC0xLTEtMTU5NTQw_2d74a895-ec3d-48e4-aea1-6e52b6e3c7db" name="us-gaap:ProfitLoss" scale="6" unitref="usd">269.2</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div></ix:nonnumeric></ix:continuation><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div id="i5fed483d9c7e4f3cbba3a62c53226cd7_79"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 11: <ix:nonnumeric contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" continuedat="ic9967df7dda640d38cf70f17b7e0c2c9" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183OS9mcmFnOjRlODJmYzU4OGU5ZTQ1OWY4NThhZGYzYjAwN2ZhNjIxL3RleHRyZWdpb246NGU4MmZjNTg4ZTllNDU5Zjg1OGFkZjNiMDA3ZmE2MjFfMTAw_a4436a0b-790b-4f5c-89ef-5fc4fe3b6d4c" name="us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock">Other&#8211;Net, (Income) Expense</ix:nonnumeric></span></div><ix:continuation id="ic9967df7dda640d38cf70f17b7e0c2c9"><ix:nonnumeric contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183OS9mcmFnOjRlODJmYzU4OGU5ZTQ1OWY4NThhZGYzYjAwN2ZhNjIxL3RleHRyZWdpb246NGU4MmZjNTg4ZTllNDU5Zjg1OGFkZjNiMDA3ZmE2MjFfMTEw_ad46a46a-9b7c-457d-899a-6c782493986f" name="us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other&#8211;net, (income) expense consisted of the following:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.206%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i19fc0325c48543008ea71e1fdcf11d86_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183OS9mcmFnOjRlODJmYzU4OGU5ZTQ1OWY4NThhZGYzYjAwN2ZhNjIxL3RhYmxlOjJjYTIxZTlmZWFjNzRmMWQ4ZDQ2MjEzMGY2NThlYTdkL3RhYmxlcmFuZ2U6MmNhMjFlOWZlYWM3NGYxZDhkNDYyMTMwZjY1OGVhN2RfMi0xLTEtMS0xNTk1NDA_33cda92a-e46e-4aea-842b-df4b67ecd84e" name="us-gaap:InterestExpense" scale="6" unitref="usd">81.5</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie4fa4f6b472a4f269297591b44aba572_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183OS9mcmFnOjRlODJmYzU4OGU5ZTQ1OWY4NThhZGYzYjAwN2ZhNjIxL3RhYmxlOjJjYTIxZTlmZWFjNzRmMWQ4ZDQ2MjEzMGY2NThlYTdkL3RhYmxlcmFuZ2U6MmNhMjFlOWZlYWM3NGYxZDhkNDYyMTMwZjY1OGVhN2RfMi0zLTEtMS0xNTk1NDA_1eabc783-52db-4890-bb75-8406c7ee6a31" name="us-gaap:InterestExpense" scale="6" unitref="usd">83.6</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183OS9mcmFnOjRlODJmYzU4OGU5ZTQ1OWY4NThhZGYzYjAwN2ZhNjIxL3RhYmxlOjJjYTIxZTlmZWFjNzRmMWQ4ZDQ2MjEzMGY2NThlYTdkL3RhYmxlcmFuZ2U6MmNhMjFlOWZlYWM3NGYxZDhkNDYyMTMwZjY1OGVhN2RfMi01LTEtMS0xNTk1NDA_ada27b2f-3ec8-422a-aed1-25eb5ee50ea0" name="us-gaap:InterestExpense" scale="6" unitref="usd">247.6</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183OS9mcmFnOjRlODJmYzU4OGU5ZTQ1OWY4NThhZGYzYjAwN2ZhNjIxL3RhYmxlOjJjYTIxZTlmZWFjNzRmMWQ4ZDQ2MjEzMGY2NThlYTdkL3RhYmxlcmFuZ2U6MmNhMjFlOWZlYWM3NGYxZDhkNDYyMTMwZjY1OGVhN2RfMi03LTEtMS0xNTk1NDA_54fa630a-3f4d-4f04-9577-1077a69f6f70" name="us-gaap:InterestExpense" scale="6" unitref="usd">258.4</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="i19fc0325c48543008ea71e1fdcf11d86_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183OS9mcmFnOjRlODJmYzU4OGU5ZTQ1OWY4NThhZGYzYjAwN2ZhNjIxL3RhYmxlOjJjYTIxZTlmZWFjNzRmMWQ4ZDQ2MjEzMGY2NThlYTdkL3RhYmxlcmFuZ2U6MmNhMjFlOWZlYWM3NGYxZDhkNDYyMTMwZjY1OGVhN2RfMy0xLTEtMS0xNTk1NDA_75826add-d709-499e-939b-c541790eaed8" name="us-gaap:InvestmentIncomeInterest" scale="6" unitref="usd">20.1</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="ie4fa4f6b472a4f269297591b44aba572_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183OS9mcmFnOjRlODJmYzU4OGU5ZTQ1OWY4NThhZGYzYjAwN2ZhNjIxL3RhYmxlOjJjYTIxZTlmZWFjNzRmMWQ4ZDQ2MjEzMGY2NThlYTdkL3RhYmxlcmFuZ2U6MmNhMjFlOWZlYWM3NGYxZDhkNDYyMTMwZjY1OGVhN2RfMy0zLTEtMS0xNTk1NDA_f798d748-7f48-4a5f-bb59-23fd9c334244" name="us-gaap:InvestmentIncomeInterest" scale="6" unitref="usd">7.0</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183OS9mcmFnOjRlODJmYzU4OGU5ZTQ1OWY4NThhZGYzYjAwN2ZhNjIxL3RhYmxlOjJjYTIxZTlmZWFjNzRmMWQ4ZDQ2MjEzMGY2NThlYTdkL3RhYmxlcmFuZ2U6MmNhMjFlOWZlYWM3NGYxZDhkNDYyMTMwZjY1OGVhN2RfMy01LTEtMS0xNTk1NDA_d3294d53-2ec1-4008-afb9-ebd49ab57ae6" name="us-gaap:InvestmentIncomeInterest" scale="6" unitref="usd">37.3</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183OS9mcmFnOjRlODJmYzU4OGU5ZTQ1OWY4NThhZGYzYjAwN2ZhNjIxL3RhYmxlOjJjYTIxZTlmZWFjNzRmMWQ4ZDQ2MjEzMGY2NThlYTdkL3RhYmxlcmFuZ2U6MmNhMjFlOWZlYWM3NGYxZDhkNDYyMTMwZjY1OGVhN2RfMy03LTEtMS0xNTk1NDA_7af8f4a4-f340-41e1-8ffc-1f0c48f342d9" name="us-gaap:InvestmentIncomeInterest" scale="6" unitref="usd">18.0</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment (gains) losses on equity securities (Note 6)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i19fc0325c48543008ea71e1fdcf11d86_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183OS9mcmFnOjRlODJmYzU4OGU5ZTQ1OWY4NThhZGYzYjAwN2ZhNjIxL3RhYmxlOjJjYTIxZTlmZWFjNzRmMWQ4ZDQ2MjEzMGY2NThlYTdkL3RhYmxlcmFuZ2U6MmNhMjFlOWZlYWM3NGYxZDhkNDYyMTMwZjY1OGVhN2RfNC0xLTEtMS0xNTk1NDA_5cd0ac3d-1d37-4f83-919d-48c80bd2ec13" name="us-gaap:EquitySecuritiesFvNiGainLoss" scale="6" sign="-" unitref="usd">123.3</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie4fa4f6b472a4f269297591b44aba572_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183OS9mcmFnOjRlODJmYzU4OGU5ZTQ1OWY4NThhZGYzYjAwN2ZhNjIxL3RhYmxlOjJjYTIxZTlmZWFjNzRmMWQ4ZDQ2MjEzMGY2NThlYTdkL3RhYmxlcmFuZ2U6MmNhMjFlOWZlYWM3NGYxZDhkNDYyMTMwZjY1OGVhN2RfNC0zLTEtMS0xNTk1NDA_8dca2ddf-db58-412d-8364-95935d1ba64c" name="us-gaap:EquitySecuritiesFvNiGainLoss" scale="6" sign="-" unitref="usd">246.8</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183OS9mcmFnOjRlODJmYzU4OGU5ZTQ1OWY4NThhZGYzYjAwN2ZhNjIxL3RhYmxlOjJjYTIxZTlmZWFjNzRmMWQ4ZDQ2MjEzMGY2NThlYTdkL3RhYmxlcmFuZ2U6MmNhMjFlOWZlYWM3NGYxZDhkNDYyMTMwZjY1OGVhN2RfNC01LTEtMS0xNTk1NDA_2ffa2442-aa70-42f4-b1f5-332bdd49c2c8" name="us-gaap:EquitySecuritiesFvNiGainLoss" scale="6" sign="-" unitref="usd">667.6</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183OS9mcmFnOjRlODJmYzU4OGU5ZTQ1OWY4NThhZGYzYjAwN2ZhNjIxL3RhYmxlOjJjYTIxZTlmZWFjNzRmMWQ4ZDQ2MjEzMGY2NThlYTdkL3RhYmxlcmFuZ2U6MmNhMjFlOWZlYWM3NGYxZDhkNDYyMTMwZjY1OGVhN2RfNC03LTEtMS0xNTk1NDA_1ef5aaec-a5b2-49d9-b2e6-fc4bfd34c928" name="us-gaap:EquitySecuritiesFvNiGainLoss" scale="6" unitref="usd">270.1</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retirement benefit plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="i19fc0325c48543008ea71e1fdcf11d86_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183OS9mcmFnOjRlODJmYzU4OGU5ZTQ1OWY4NThhZGYzYjAwN2ZhNjIxL3RhYmxlOjJjYTIxZTlmZWFjNzRmMWQ4ZDQ2MjEzMGY2NThlYTdkL3RhYmxlcmFuZ2U6MmNhMjFlOWZlYWM3NGYxZDhkNDYyMTMwZjY1OGVhN2RfNS0xLTEtMS0xNTk1NDA_696c9a51-3037-4c44-9707-e7a4fe5990e2" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" sign="-" unitref="usd">92.4</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="ie4fa4f6b472a4f269297591b44aba572_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183OS9mcmFnOjRlODJmYzU4OGU5ZTQ1OWY4NThhZGYzYjAwN2ZhNjIxL3RhYmxlOjJjYTIxZTlmZWFjNzRmMWQ4ZDQ2MjEzMGY2NThlYTdkL3RhYmxlcmFuZ2U6MmNhMjFlOWZlYWM3NGYxZDhkNDYyMTMwZjY1OGVhN2RfNS0zLTEtMS0xNTk1NDA_108e730a-fa82-4d4a-b646-a497cd3bfe47" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" sign="-" unitref="usd">72.6</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183OS9mcmFnOjRlODJmYzU4OGU5ZTQ1OWY4NThhZGYzYjAwN2ZhNjIxL3RhYmxlOjJjYTIxZTlmZWFjNzRmMWQ4ZDQ2MjEzMGY2NThlYTdkL3RhYmxlcmFuZ2U6MmNhMjFlOWZlYWM3NGYxZDhkNDYyMTMwZjY1OGVhN2RfNS01LTEtMS0xNTk1NDA_6dd8f318-1931-4704-811b-5f43ab62d832" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" sign="-" unitref="usd">280.0</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183OS9mcmFnOjRlODJmYzU4OGU5ZTQ1OWY4NThhZGYzYjAwN2ZhNjIxL3RhYmxlOjJjYTIxZTlmZWFjNzRmMWQ4ZDQ2MjEzMGY2NThlYTdkL3RhYmxlcmFuZ2U6MmNhMjFlOWZlYWM3NGYxZDhkNDYyMTMwZjY1OGVhN2RfNS03LTEtMS0xNTk1NDA_ddc5eef9-547b-40ff-9889-d15cff937812" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" sign="-" unitref="usd">217.1</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt extinguishment loss (Note 6)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i19fc0325c48543008ea71e1fdcf11d86_D20220701-20220930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183OS9mcmFnOjRlODJmYzU4OGU5ZTQ1OWY4NThhZGYzYjAwN2ZhNjIxL3RhYmxlOjJjYTIxZTlmZWFjNzRmMWQ4ZDQ2MjEzMGY2NThlYTdkL3RhYmxlcmFuZ2U6MmNhMjFlOWZlYWM3NGYxZDhkNDYyMTMwZjY1OGVhN2RfNi0xLTEtMS0xNTk1NDA_e112022d-6846-40ce-b958-29278337cd5d" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" unitref="usd">&#8212;</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie4fa4f6b472a4f269297591b44aba572_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183OS9mcmFnOjRlODJmYzU4OGU5ZTQ1OWY4NThhZGYzYjAwN2ZhNjIxL3RhYmxlOjJjYTIxZTlmZWFjNzRmMWQ4ZDQ2MjEzMGY2NThlYTdkL3RhYmxlcmFuZ2U6MmNhMjFlOWZlYWM3NGYxZDhkNDYyMTMwZjY1OGVhN2RfNi0zLTEtMS0xNTk1NDA_94ed0a9f-b016-4c6b-8256-c4dbca145a96" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" sign="-" unitref="usd">405.2</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="-5" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183OS9mcmFnOjRlODJmYzU4OGU5ZTQ1OWY4NThhZGYzYjAwN2ZhNjIxL3RhYmxlOjJjYTIxZTlmZWFjNzRmMWQ4ZDQ2MjEzMGY2NThlYTdkL3RhYmxlcmFuZ2U6MmNhMjFlOWZlYWM3NGYxZDhkNDYyMTMwZjY1OGVhN2RfNi01LTEtMS0xNTk1NDA_6bb402b6-31d7-426c-9be9-1aaec0b9e87c" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" unitref="usd">&#8212;</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183OS9mcmFnOjRlODJmYzU4OGU5ZTQ1OWY4NThhZGYzYjAwN2ZhNjIxL3RhYmxlOjJjYTIxZTlmZWFjNzRmMWQ4ZDQ2MjEzMGY2NThlYTdkL3RhYmxlcmFuZ2U6MmNhMjFlOWZlYWM3NGYxZDhkNDYyMTMwZjY1OGVhN2RfNi03LTEtMS0xNTk1NDA_963519da-bc95-4b28-aa75-075fdb0bcf67" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" sign="-" unitref="usd">405.2</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i19fc0325c48543008ea71e1fdcf11d86_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183OS9mcmFnOjRlODJmYzU4OGU5ZTQ1OWY4NThhZGYzYjAwN2ZhNjIxL3RhYmxlOjJjYTIxZTlmZWFjNzRmMWQ4ZDQ2MjEzMGY2NThlYTdkL3RhYmxlcmFuZ2U6MmNhMjFlOWZlYWM3NGYxZDhkNDYyMTMwZjY1OGVhN2RfNy0xLTEtMS0xNTk1NDA_50be6c14-aff6-4757-847e-cfa0831e1bbb" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" sign="-" unitref="usd">18.7</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="ie4fa4f6b472a4f269297591b44aba572_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183OS9mcmFnOjRlODJmYzU4OGU5ZTQ1OWY4NThhZGYzYjAwN2ZhNjIxL3RhYmxlOjJjYTIxZTlmZWFjNzRmMWQ4ZDQ2MjEzMGY2NThlYTdkL3RhYmxlcmFuZ2U6MmNhMjFlOWZlYWM3NGYxZDhkNDYyMTMwZjY1OGVhN2RfNy0zLTEtMS0xNTk1NDA_522898d9-cf62-4b08-adbb-ed7883066ea3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" unitref="usd">20.1</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183OS9mcmFnOjRlODJmYzU4OGU5ZTQ1OWY4NThhZGYzYjAwN2ZhNjIxL3RhYmxlOjJjYTIxZTlmZWFjNzRmMWQ4ZDQ2MjEzMGY2NThlYTdkL3RhYmxlcmFuZ2U6MmNhMjFlOWZlYWM3NGYxZDhkNDYyMTMwZjY1OGVhN2RfNy01LTEtMS0xNTk1NDA_2cea1b0b-fb10-4879-86b7-123df7461cc5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" unitref="usd">17.0</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183OS9mcmFnOjRlODJmYzU4OGU5ZTQ1OWY4NThhZGYzYjAwN2ZhNjIxL3RhYmxlOjJjYTIxZTlmZWFjNzRmMWQ4ZDQ2MjEzMGY2NThlYTdkL3RhYmxlcmFuZ2U6MmNhMjFlOWZlYWM3NGYxZDhkNDYyMTMwZjY1OGVhN2RfNy03LTEtMS0xNTk1NDA_06289573-41b0-4298-95dc-9abd1048b93c" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" unitref="usd">34.1</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other&#8211;net, (income) expense</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="i19fc0325c48543008ea71e1fdcf11d86_D20220701-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183OS9mcmFnOjRlODJmYzU4OGU5ZTQ1OWY4NThhZGYzYjAwN2ZhNjIxL3RhYmxlOjJjYTIxZTlmZWFjNzRmMWQ4ZDQ2MjEzMGY2NThlYTdkL3RhYmxlcmFuZ2U6MmNhMjFlOWZlYWM3NGYxZDhkNDYyMTMwZjY1OGVhN2RfOC0xLTEtMS0xNTk1NDA_f98b9603-2aa7-4cc7-9928-490f2e31db3b" name="us-gaap:NonoperatingIncomeExpense" scale="6" sign="-" unitref="usd">111.0</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie4fa4f6b472a4f269297591b44aba572_D20210701-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183OS9mcmFnOjRlODJmYzU4OGU5ZTQ1OWY4NThhZGYzYjAwN2ZhNjIxL3RhYmxlOjJjYTIxZTlmZWFjNzRmMWQ4ZDQ2MjEzMGY2NThlYTdkL3RhYmxlcmFuZ2U6MmNhMjFlOWZlYWM3NGYxZDhkNDYyMTMwZjY1OGVhN2RfOC0zLTEtMS0xNTk1NDA_08fb8c9e-ea3f-490c-ae48-abadbe691982" name="us-gaap:NonoperatingIncomeExpense" scale="6" sign="-" unitref="usd">635.9</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonfraction contextref="if8dcfbea11824c45a6c960ab0a956d04_D20220101-20220930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183OS9mcmFnOjRlODJmYzU4OGU5ZTQ1OWY4NThhZGYzYjAwN2ZhNjIxL3RhYmxlOjJjYTIxZTlmZWFjNzRmMWQ4ZDQ2MjEzMGY2NThlYTdkL3RhYmxlcmFuZ2U6MmNhMjFlOWZlYWM3NGYxZDhkNDYyMTMwZjY1OGVhN2RfOC01LTEtMS0xNTk1NDA_56cd7490-bc22-41e8-8cc1-e23a9679190e" name="us-gaap:NonoperatingIncomeExpense" scale="6" sign="-" unitref="usd">580.9</ix:nonfraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i167ed8f67bef48c49e54fa466400cdaa_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjVmZWQ0ODNkOWM3ZTRmM2NiYmEzYTYyYzUzMjI2Y2Q3L3NlYzo1ZmVkNDgzZDljN2U0ZjNjYmJhM2E2MmM1MzIyNmNkN183OS9mcmFnOjRlODJmYzU4OGU5ZTQ1OWY4NThhZGYzYjAwN2ZhNjIxL3RhYmxlOjJjYTIxZTlmZWFjNzRmMWQ4ZDQ2MjEzMGY2NThlYTdkL3RhYmxlcmFuZ2U6MmNhMjFlOWZlYWM3NGYxZDhkNDYyMTMwZjY1OGVhN2RfOC03LTEtMS0xNTk1NDA_dcd3636f-bd7d-474a-92e7-b4e1736f410b" name="us-gaap:NonoperatingIncomeExpense" scale="6" sign="-" unitref="usd">124.3</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonnumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><div id="i5fed483d9c7e4f3cbba3a62c53226cd7_82"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Item&#160;2. Management's Discussion and Analysis of Results of Operations and Financial Condition</span></div><div id="i5fed483d9c7e4f3cbba3a62c53226cd7_85"></div><div><span><br/></span></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Results of Operations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Tables present dollars in millions, except per-share data)</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management's discussion and analysis of results of operations and financial condition is intended to assist the reader in understanding and assessing significant changes and trends related to the results of operations and financial position of our consolidated company. This discussion and analysis should be read in conjunction with the consolidated condensed financial statements and accompanying footnotes in Part I, Item 1 of this Quarterly Report on Form 10-Q. Certain statements in this Part I, Item 2 of this Quarterly Report on Form 10-Q constitute forward-looking statements. Various risks and uncertainties, including those discussed in "Forward-Looking Statements" in this Quarterly Report on Form 10-Q and "Risk Factors" in Part I, Item 1A of our Annual Report on </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/0000059478/000005947822000068/lly-20211231.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Form 10-K</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the year ended December&#160;31, 2021, may cause our actual results, financial position, and cash generated from operations to differ materially from these forward-looking statements.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Executive Overview</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This section provides an overview of our financial results, recent product and late-stage pipeline developments, and other matters affecting our company and the pharmaceutical industry. Earnings per share (EPS) data are presented on a diluted basis.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COVID-19 Pandemic</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In response to the COVID-19 pandemic, we have focused on maintaining a supply of our medicines; reducing the strain on the medical system; developing treatments for COVID-19; protecting the health, safety, and well-being of our employees; supporting our communities; and ensuring affordability of and access to our medicines, particularly insulin. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have received various regulatory authorizations, including Emergency Use Authorizations (EUA), for our COVID-19 therapies. We supplied the United States (U.S.) government approximately 810,000 doses of bebtelovimab during the nine months ended September 30, 2022. Beginning in the third quarter of 2022 and in collaboration with the U.S. government, we have made bebtelovimab commercially available for purchase by U.S. states/territories, hospitals, and certain other providers. We do not anticipate any further U.S. government orders. The U.S. Food and Drug Administration (FDA) has revised, and may in the future revise, any EUA for our COVID-19 therapies in response to the prevalence of variants against which our therapies have varying degrees of efficacy, including the new BQ variants. Based on early data, we do not believe that bebtelovimab will neutralize against the new BQ variants. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic has, and may continue to, adversely impact our business and operations. Strain on global transportation, logistics, manufacturing, and labor markets, including as aggravated by the pandemic and global unrest, the focus of resources on COVID-19, protective measures implemented to control the spread of COVID-19, and an increase in overall demand in our industry for certain resources and medicines, resulting in changed buying patterns, increased costs, and constrained supply, have negatively impacted and may continue to negatively impact the development, manufacturing, supply, distribution, and sales of our medicines. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The degree to which the COVID-19 pandemic and related challenges impact the development, manufacturing, supply, distribution, and sale of our medicines will depend on developments that are highly uncertain and beyond our knowledge or control. </span></div><div style="margin-top:6pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Product Supply </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Continued strong demand for Trulicity</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in U.S. and international markets, partially due to the ongoing limited availability of competitor therapies, has challenged, and is expected to continue to challenge, our ability to meet demand in most international markets. In the U.S., as demand for Trulicity has continued to exceed historical levels, we anticipate tight supplies will persist until additional manufacturing capacity is operationalized, and U.S. wholesalers may experience intermittent restocking delays of Trulicity orders. Outside the U.S., we have implemented certain actions to minimize the impact to existing patients, but we expect to experience intermittent disruptions in our supply of Trulicity in international markets. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the uptake of Mounjaro</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for type 2 diabetes following its launch in the U.S. has been very strong. We continue to carefully monitor demand, incretin competitor availability, and supply with a focus on access for Type 2 diabetes patients.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We anticipate that additional internal and contracted manufacturing capacity will become fully operational around the world in the next several years, with significant expansion in 2023, as part of our ongoing efforts to meet the significant demand for our incretin medicines.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See "Risk Factors" in Part I, Item 1A of our Annual Report on </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/0000059478/000005947822000068/lly-20211231.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Form 10-K</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the year ended December&#160;31, 2021 for additional information on risk factors that could impact our business and operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Results</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our key operating results:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:33.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.923%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.923%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.791%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.923%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.923%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.795%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended <br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,941.6</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,772.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">21,239.6</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,318.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross margin</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,362.5</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,342.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16,157.9</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,055.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross margin as a percent of revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">77.3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">76.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,802.9</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,705.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,194.9</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,032.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, selling, and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,614.2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,577.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,797.2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,839.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired in-process research and development (IPR&amp;D) and development milestones</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">62.4</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">668.4</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">532.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairment, restructuring, and other special charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">206.5</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">206.5</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other&#8211;net, (income) expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">111.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">635.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">580.9</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,451.7</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,110.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,307.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,855.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EPS - diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.61</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.76</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13</span></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">NM - not meaningful</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue increased for the three and nine months ended September&#160;30, 2022, driven by increased volume, partially offset by lower realized prices and the unfavorable impact of foreign exchange rates. Research and development expenses increased for the three and nine months ended September&#160;30, 2022, primarily driven by higher development expenses for late-stage assets, partially offset by lower development expenses for COVID-19 antibodies and the favorable impact of foreign exchange rates. Marketing, selling, and administrative expenses increased for the three months ended September&#160;30, 2022, primarily driven by increased costs associated with the launch of Mounjaro, partially offset by the favorable impact of foreign exchange rates. Marketing, selling, and administrative expenses decreased for the nine months ended September&#160;30, 2022, primarily driven by the favorable impact of foreign exchange rates as well as reduced marketing costs in the first half of 2022, partially offset by increased costs associated with the launch of Mounjaro. </span></div><div style="margin-top:6pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following highlighted items also affect comparisons of our financial results for the three and nine months ended September&#160;30, 2022 and 2021:</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022 </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquired IPR&amp;D and Development Milestones (See Note 3 to the consolidated condensed financial statements)</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We recognized $62.4 million and $668.4 million of acquired IPR&amp;D and development milestones for the three and nine months ended September&#160;30, 2022, respectively. The charges for the nine months ended September&#160;30, 2022 included the buy-out of substantially all future obligations that were contingent upon the occurrence of certain events linked to the success of our mutant-selective PI3k&#945; inhibitor and a purchase of a Priority Review Voucher. </span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Asset Impairment, Restructuring, and Other Special Charges (See Note 5 to the consolidated condensed financial statements)</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We recognized charges of $206.5 million for the three and nine months ended September&#160;30, 2022, primarily related to an intangible asset impairment for GBA1 Gene Therapy (PR001) due to changes in estimated launch timing.</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other-Net, (Income) Expense (See Note 11 to the consolidated condensed financial statements)</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We recognized $123.3 million and $667.6 million of net investment losses on equity securities for the three and nine months ended September&#160;30, 2022, respectively. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021 </span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of Sales (See Note 5 to the consolidated condensed financial statements)</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We recognized a net inventory impairment charge related to our COVID-19 antibodies of $435.1 million for the nine months ended September&#160;30, 2021. As part of our response to the COVID-19 pandemic, and at the request of the U.S. and international governments, we invested in large-scale manufacturing of COVID-19 antibodies at risk, in order to ensure rapid access to patients around the world. As the COVID-19 pandemic evolved during 2021, we incurred a net inventory impairment charge primarily due to the combination of changes to demand from U.S. and international governments, including changes to our agreement with the U.S. government, and near-term expiry dates of COVID-19 antibodies. </span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquired IPR&amp;D and Development Milestones (See Note 3 to the consolidated condensed financial statements)</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We recognized $177.6 million and $532.4 million of acquired IPR&amp;D and development milestones for the three and nine months ended September&#160;30, 2021, respectively. The charges for the nine months ended September&#160;30, 2021 included acquired IPR&amp;D charges resulting from business development transactions with Rigel Pharmaceuticals, Inc. (Rigel) and Precision Biosciences, Inc. (Precision).</span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Asset Impairment, Restructuring, and Other Special Charges (See Note 5 to the consolidated condensed financial statements)</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We recognized charges of $211.6 million for the nine months ended September&#160;30, 2021, primarily related to an intangible asset impairment resulting from the sale of the rights to Qbrexza</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as well as acquisition and integration costs associated with the acquisition of Prevail Therapeutics Inc. (Prevail). </span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other-Net, (Income) Expense (See Note 11 to the consolidated condensed financial statements)</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We recognized a debt extinguishment loss of $405.2 million related to the repurchase of debt for the three and nine months ended September&#160;30, 2021.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We recognized $246.8 million of net investment losses on equity securities for the three months ended September&#160;30, 2021. We recognized $270.1 million of net investment gains on equity securities for the nine months ended September&#160;30, 2021. </span></div><div style="margin-top:6pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Late-Stage Pipeline</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our long-term success depends on our ability to continually discover or acquire, develop, and commercialize innovative new medicines. We currently have approximately 45 new medicine candidates in clinical development or under regulatory review, and a larger number of projects in the discovery phase.</span></div><div style="margin-bottom:8pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following certain new molecular entities (NMEs) are currently in Phase II or Phase III clinical trials or have been submitted for regulatory review or have received regulatory approval in the U.S., Europe, or Japan. The following table reflects the status of these NMEs, including certain other developments since our Annual Report on </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/0000059478/000005947822000068/lly-20211231.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Form 10-K</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the year ended December&#160;31, 2021. </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.539%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#d8d8d8;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Compound</span></td><td colspan="3" style="background-color:#d8d8d8;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indication</span></td><td colspan="3" style="background-color:#d8d8d8;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Status </span></td><td colspan="3" style="background-color:#d8d8d8;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Developments</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="12" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diabetes</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:35pt"><td colspan="3" rowspan="5" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tirzepatide (Mounjaro)</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Type 2 diabetes</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Approved</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Approved in the U.S. in the second quarter of 2022 and in Europe and Japan in the third quarter of 2022.</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:35pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Heart failure with preserved ejection fraction</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phase III</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phase III trials are ongoing.</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:45pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Obesity</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phase III</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted FDA Fast Track designation</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> in October 2022. Announced in the second quarter of 2022 that the initial Phase III trial met co-primary and all key secondary endpoints. Phase III trials are ongoing.</span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:24pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Obstructive sleep apnea</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phase III</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phase III trial initiated in the third quarter of 2022.</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:24pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonalcoholic steatohepatitis </span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phase II</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phase II trial is ongoing. </span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basal Insulin-Fc</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Type 1 and 2 diabetes</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phase III</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phase III trials initiated in the first, second, and third quarters of 2022. </span></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Orforglipron (GLP-1R NPA)</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Obesity</span></td><td colspan="3" rowspan="2" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phase II</span></td><td colspan="3" rowspan="2" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phase II trials are ongoing.</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Type 2 diabetes</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retatrutide (GGG Tri-Agonist)</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Obesity</span></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phase II</span></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phase II trials are ongoing. </span></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Type 2 diabetes</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="12" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Immunology</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Lebrikizumab</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Atopic dermatitis</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Submitted</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted FDA Fast Track designation</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Submitted in the U.S. in the third quarter of 2022 and in Europe in October 2022. Phase III trials are ongoing. </span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:24pt"><td colspan="3" rowspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mirikizumab</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ulcerative colitis</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Submitted</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Submitted in the U.S. in first quarter of 2022 and in Europe and Japan in the second quarter of 2022.</span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Crohn's Disease</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phase III</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phase III trials are ongoing. </span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ANGPTL3 siRNA</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular disease</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phase II</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phase II trial initiated in the third quarter of 2022.</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BTLA MAB Agonist</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Systemic lupus erythematosus</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phase II</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phase II trial initiated in the second quarter of 2022.</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CXCR1/2 Ligands Monoclonal Antibody</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hidradenitis suppurativa</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phase II</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phase II trial is ongoing.</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Peresolimab (PD-1 MAB Agonist)</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Rheumatoid arthritis</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Phase II</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Phase II trial is ongoing.</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:24pt"><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rezpegaldesleukin (IL-2 Conjugate)</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Systemic lupus erythematosus</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phase II</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Phase II trial is ongoing.</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.539%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#d8d8d8;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Compound</span></td><td colspan="3" style="background-color:#d8d8d8;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indication</span></td><td colspan="3" style="background-color:#d8d8d8;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Status </span></td><td colspan="3" style="background-color:#d8d8d8;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Developments</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="12" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Neuroscience</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:54pt"><td colspan="3" rowspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Donanemab</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Early Alzheimer's disease</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Submitted</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted FDA Breakthrough Therapy designation</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Submitted in the U.S. in the second quarter of 2022. Received Priority Review designation under the accelerated approval pathway. Phase III trials are ongoing.</span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:24pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preclinical Alzheimer's disease</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phase III</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phase III trial is ongoing.</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remternetug</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Early Alzheimer's disease</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phase III</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phase III trial initiated in the third quarter of 2022.</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Solanezumab</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preclinical Alzheimer's disease</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phase III</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phase III trial is ongoing. </span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GBA1 Gene Therapy (PR001)</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Parkinson's disease </span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phase II</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted FDA Fast Track designation</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Phase II trial is ongoing. </span></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GRN Gene Therapy (PR006)</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Frontotemporal dementia</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phase II</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted FDA Fast Track designation</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Phase II trial is ongoing. </span></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">O-GlcNAcase Inh</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alzheimer's disease</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phase II</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phase II trial is ongoing.</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SSTR4 Agonist</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pain</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phase II</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phase II trials are ongoing.</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TRPA1 Antagonist</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pain</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phase II</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phase II trials are ongoing.</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PACAP38 Antibody</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Migraine</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In the third quarter of 2022 based on the results of the Phase II trial, we discontinued development.</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="12" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Oncology</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:65pt"><td colspan="3" rowspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selpercatinib (Retevmo</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lung cancer</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Approved</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phase III trials are ongoing. In the third quarter of 2022, the FDA granted accelerated approval in tumor-agnostic RET fusion-positive advanced or metastatic solid tumors and traditional approval in locally advanced or metastatic RET fusion-positive non-small cell lung cancer.</span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thyroid cancer</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Approved</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phase III trial is ongoing.</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:45pt"><td colspan="3" rowspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pirtobrutinib (LOXO-305)</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mantle cell lymphoma</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Submitted</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Submitted in the U.S. in second quarter of 2022. Received Priority Review designation under the accelerated approval pathway. Phase III trial is ongoing.</span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:24pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chronic lymphocytic leukemia</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phase III</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phase III trials are ongoing.</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">B-cell malignancies</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phase II</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phase II trial is ongoing.</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Imlunestrant</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ER+HER2- metastatic breast cancer</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phase III</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phase III trial is ongoing.</span></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Fast Track designation is designed to facilitate the development and expedite the review of medicines to treat serious conditions and fill an unmet medical need.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">In collaboration with Almirall, S.A. in Europe. </span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> Breakthrough Therapy designation is designed to expedite the development and review of potential medicines that are intended to treat a serious condition where preliminary clinical evidence indicates that the treatment may demonstrate substantial improvement over available therapy on a clinically significant endpoint. </span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> Continued approval may be contingent on verification and description of clinical benefit in confirmatory Phase III trials.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our pipeline also contains several new indication line extension (NILEX) products. The following certain NILEX products for use in the indication described are currently in Phase II or Phase III clinical trials or have been submitted for regulatory review or have received regulatory approval in the U.S., Europe, or Japan. The following table reflects the status of these NILEX products, including certain other developments since our Annual Report on </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/0000059478/000005947822000068/lly-20211231.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Form 10-K</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the year ended December&#160;31, 2021. </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.539%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#d8d8d8;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Compound</span></td><td colspan="3" style="background-color:#d8d8d8;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indication</span></td><td colspan="3" style="background-color:#d8d8d8;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Status</span></td><td colspan="3" style="background-color:#d8d8d8;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Developments</span></td></tr><tr><td colspan="12" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diabetes</span></td></tr><tr style="height:35pt"><td colspan="3" rowspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Empagliflozin (Jardiance</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Heart failure with preserved ejection fraction</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Approved</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Approved in the U.S. and Europe in the first quarter of 2022 and in Japan in the second quarter of 2022.</span></div></td></tr><tr style="height:45pt"><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chronic kidney disease</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phase III</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted FDA Fast Track designation</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. In the first quarter of 2022 the Independent Data Monitoring Committee recommended stopping the Phase III trial early due to clear positive efficacy.</span></div></td></tr><tr><td colspan="12" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Immunology</span></td></tr><tr style="height:24pt"><td colspan="3" rowspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Baricitinib (Olumiant</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alopecia areata</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Approved</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Approved in the U.S., Europe, and Japan in the second quarter of 2022. </span></div></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COVID-19</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Approved</span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Approved in the U.S. in the second quarter of 2022.</span></td></tr><tr><td colspan="12" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Oncology</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Abemaciclib (Verzenio</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:700;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">)</span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Prostate cancer</span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Phase III</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phase III trials are ongoing.</span></div></td></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">In collaboration with Boehringer Ingelheim. </span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Fast Track designation is designed to facilitate the development and expedite the review of medicines to treat serious conditions and fill an unmet medical need.</span></div><div style="margin-top:15pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Matters</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Patent Matters</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We depend on patents or other forms of intellectual property protection for most of our revenue, cash flows, and earnings. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the June 2021 loss of patent exclusivity for Alimta</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in Europe and Japan, we faced, and expect to continue to face, generic competition that has rapidly and severely eroded revenue, and we expect will continue to erode revenue from current levels. In addition, as a result of the entry of multiple generics in the U.S. following the loss of patent and pediatric exclusivity in May 2022, we began facing, and expect to continue to face, additional generic competition that has eroded revenue, and we expect will continue to rapidly and severely erode revenue from current levels. This decline in revenue has had and will have a material adverse effect on our consolidated results of operations and cash flows. See Note 9 to the consolidated condensed financial statements for a description of legal proceedings currently pending regarding certain of our patents.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our compound patents for Humalog</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (insulin lispro) have expired in the U.S. and major international markets, and we have also introduced lower-priced versions of Humalog as part of our insulin affordability solutions. A competitor has a similar version of insulin lispro in the U.S. and in certain European markets. Due to the impact of competition and pricing pressure in the U.S. and some international markets, we expect that lower revenue due to realized price decline will continue over time.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our formulation and use patents for Forteo</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> have expired in major markets. We expect further decline in revenue as a result of the entry of generic and biosimilar competition due to the loss of patent exclusivity in major markets. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Exchange Rates</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a global company, we face foreign currency risk exposure from fluctuating currency exchange rates, primarily the U.S. dollar against the euro, Japanese yen, and Chinese yuan. While we seek to manage a portion of these exposures through hedging and other risk management techniques, significant fluctuations in currency rates can have a material impact, either positive or negative, on our consolidated results of operations in any given period. During the three and nine months ended September&#160;30, 2022, revenue was unfavorably impacted by 4 percent and 3 percent, respectively, due to foreign exchange rates. While there is uncertainty in the future movements in foreign exchange rates, fluctuations in these rates have, and we currently expect in the near-term future will, adversely impact our consolidated results of operations and cash flows.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trends Affecting Pharmaceutical Pricing, Reimbursement, and Access </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Global concern over access to and affordability of pharmaceutical products continues to drive regulatory and legislative debate and action, as well as worldwide cost containment efforts by governmental authorities. Such measures include the use of mandated discounts, price reporting requirements, mandated reference prices, restrictive formularies, changes to available intellectual property protections, as well as other efforts. In August 2022, the U.S. government enacted the Inflation Reduction Act (IRA). Among other measures, the IRA will allow the U.S. Department of Health and Human Services to effectively set prices for certain single-source drugs and biologics reimbursed under Medicare Part B and Part D. Generally, these government prices apply nine (medicines approved under a New Drug Application) or thirteen (medicines approved under a Biologics License Application) years following initial FDA approval and will be capped at a statutory ceiling price that is likely to represent a significant discount from average prices to wholesalers and direct purchasers. It is too soon to tell how the U.S. government will set these prices as the law specifies a ceiling price, but not a minimum or floor price. One or more significant Lilly products may be selected, which would have the effect of accelerating revenue erosion prior to patent expiry. The effect of reducing prices and reimbursement for certain of our products could significantly impact our business and consolidated results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other of the IRA&#8217;s provisions provide for penalties on drug manufacturers that increase prices of certain Medicare Part B and Part D medicines at a rate greater than the rate of inflation and replace the Part D coverage gap discount program with a new manufacturer discounting program. Manufacturers that fail to comply with the IRA may be subject to various penalties, including civil monetary penalties. The IRA takes effect progressively starting in 2023, with the first government set prices effective in 2026. The IRA may meaningfully influence our and pharmaceutical industry business strategies. In particular it may reduce the attractiveness of investment in small molecule innovation. Provisions of the IRA may be subject to legal challenges or other reformation, and the full effect of the IRA on our business and the pharmaceutical industry remains uncertain. Additional policies, regulations, legislation, or enforcement, including those proposed and/or pursued by the U.S. Congress and executive branch of the U.S. administration and other regulatory authorities worldwide, could adversely impact our business and consolidated results of operations. </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidation of private payors in the U.S. has also significantly impacted the market for pharmaceuticals by increasing payor leverage in negotiating manufacturer price concessions and pharmacy reimbursement rates. Furthermore, restrictive or unfavorable pricing, coverage, or reimbursement determinations for our medicines or product candidates by governments, regulatory agencies, courts, or private payers, such as the Centers for Medicare &amp; Medicaid Services' National Coverage Determination for monoclonal antibodies for the treatment of Alzheimer's Disease, may adversely impact our business and consolidated results of operations. We expect that these actions may intensify and could particularly affect certain products, such as insulin, as governments manage and emerge from the COVID-19 pandemic, which could adversely affect our business. In addition, we are engaged in litigation and investigations related to our 340B program and access to insulin that, if resolved adversely to us, could negatively impact our business and consolidated results of operations. It is not currently possible to predict the overall potential adverse impact to us or the general pharmaceutical industry of continued cost containment efforts worldwide. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Evolving regulatory priorities have also intensified governmental scrutiny of our operations and our industry, including with respect to current Good Manufacturing Practices, quality assurance, and similar regulations, and increased focus on business combinations in our industry. Any regulatory issues concerning these matters could lead to regulatory and legal actions, product recalls and seizures, fines and penalties, interruption of production leading to product shortages, import bans or denials of import certifications, delays or denials in the approvals of new products or supplemental approvals of current products pending resolution of the issues, impediments to the completion of business combinations, and reputational harm, any of which would adversely affect our business.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See "Business - Regulations and Private Payer Actions Affecting Pharmaceutical Pricing, Reimbursement, and Access" in Part I, Item 1 and "Risk Factors" in Part I, Item 1A of our Annual Report on </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/0000059478/000005947822000068/lly-20211231.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Form 10-K</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the year ended December&#160;31, 2021. See also Note 9 to the consolidated condensed financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tax Matters</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to income taxes and various other taxes in the U.S. and in many foreign jurisdictions; therefore, changes in both domestic and international tax laws or regulations have affected and may affect our effective tax rate, results of operations, and cash flows. In 2017, the U.S. enacted the Tax Cuts and Jobs Act (the 2017 Tax Act), which contains a provision that requires capitalization and amortization of research and development expenses for tax purposes starting in 2022. Previously, these expenses could be deducted in the year incurred. The implementation of this provision has increased, and is expected to continue to increase, our 2022 cash payments of income taxes and subsequently decrease our cash payments of income taxes moderately over the five-year amortization period. We expect the implementation of this provision to impact our 2022 cash payments of income taxes by up to $1.50 billion. For the three and nine months ended September&#160;30, 2022, the implementation of this provision favorably impacted other tax items that decreased our effective tax rate by approximately 4 percentage points. If this provision of the 2017 Tax Act is deferred or repealed by the U.S. Congress effective for 2022, we expect our effective tax rate to be approximately 13 percent to 14 percent for 2022.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. and countries around the world are actively considering and enacting tax law changes. Tax proposals have been introduced by the U.S. Congress and the U.S. administration containing significant changes, including increases to the tax rates at which both domestic and foreign income of U.S. companies would be taxed. In addition, tax authorities in the U.S. and other jurisdictions in which we do business routinely examine our tax returns and are intensifying their scrutiny and examinations of profit allocations among jurisdictions. Further, actions taken with respect to tax-related matters by associations, such as the Organisation for Economic Co-operation and Development and the European Commission, could influence tax laws in countries in which we operate. Changes to existing tax law and increased scrutiny by tax authorities in the U.S. and other jurisdictions could adversely impact our future consolidated results of operations and cash flows.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We opportunistically invest in external research and technologies that we believe complement and strengthen our own efforts. These investments can take many forms, including acquisitions, collaborations, investments, and licensing arrangements. We view our business development activity as a way to enhance our pipeline and strengthen our business. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 3 to the consolidated condensed financial statements for further discussion regarding our recent acquisitions.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><div id="i5fed483d9c7e4f3cbba3a62c53226cd7_88"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Revenue</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our revenue activity by region:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.508%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,422.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,989.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13,531.5</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,635.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outside U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,519.4</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,783.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,708.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,683.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,941.6</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,772.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">21,239.6</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,318.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Numbers may not add due to rounding.</span></div><div><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are components of the change in revenue compared with the prior year:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022 vs. 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022 vs. 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outside U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outside U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volume</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Price</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange rates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Percent change</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Numbers may not add due to rounding.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the U.S. for the three and nine months ended September&#160;30, 2022, the increase in volume was primarily driven by COVID-19 antibodies, Trulicity, Verzenio, Jardiance, Taltz</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and Mounjaro, partially offset by decreased volume for Alimta, resulting from the entry of multiple generics in the second quarter of 2022, and for Olumiant, due to the decline in utilization for COVID-19 treatment. In the U.S. for the three and nine months ended September&#160;30, 2022, the decrease in realized prices was primarily driven by Humalog, due to a list price reduction of insulin lispro injection and unfavorable segment mix, and by Trulicity, due to unfavorable segment mix and higher contracted rebates. In the U.S. for the three months ended September 30, 2022, the decrease in realized prices for Trulicity was partially offset by changes to estimates for rebates and discounts.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outside the U.S. for the three and nine months ended September&#160;30, 2022, the increase in volume was primarily driven by Verzenio, Trulicity, Tyvyt</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Jardiance, and Taltz, partially offset by Alimta and Cymbalta</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> resulting from generic competition. Additionally outside the U.S. for the three and nine months ended September&#160;30, 2022, we recognized revenue related to a sales collaboration agreement for the right to sell and distribute Mounjaro in Japan. Outside the U.S. for the nine months ended September&#160;30, 2022, the increase in volume was also partially offset by decreased sales of COVID-19 antibodies and the sale of the rights to Cialis</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in China in the second quarter of 2021. Outside the U.S. for the three and nine months ended September&#160;30, 2022, the decrease in realized prices was primarily driven by the impact of government pricing in China from the National Reimbursement Drug List (NRDL) formulary for certain products, particularly Tyvyt and Verzenio, and volume-based procurement (VBP) for Humalog. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our revenue activity by product for the three months ended September&#160;30, 2022 and 2021: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:37.225%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.651%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" rowspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Product</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S. </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outside U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent Change</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trulicity</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,418.3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">432.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,850.4</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,600.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taltz</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">493.8</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">186.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">679.9</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">593.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Verzenio</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">414.8</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">202.9</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">617.7</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jardiance</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">350.9</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">222.4</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">573.3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Humalog</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">248.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">198.8</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">447.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">626.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COVID-19 antibodies</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">386.6</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">386.6</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Humulin</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">169.5</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">68.7</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">238.2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cyramza</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">87.5</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">144.6</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">232.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basaglar</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">124.8</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">68.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">193.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mounjaro</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">97.3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">90.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">187.3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Olumiant</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">22.9</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">160.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">182.9</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forteo</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">112.7</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">64.4</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">177.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emgality</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">114.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">54.6</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">168.5</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Erbitux</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">126.3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18.7</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">144.9</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alimta</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">64.6</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">54.8</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">119.4</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">457.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74)</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cialis</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">107.7</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">115.7</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Zyprexa</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">73.4</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">81.4</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tyvyt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">76.8</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">76.8</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cymbalta</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7.8</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">54.9</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">62.7</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">166.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">240.5</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">406.7</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">447.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,422.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,519.4</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,941.6</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,772.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Numbers may not add due to rounding.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">NM - not meaningful</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Jardiance revenue includes Glyxambi</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Synjardy</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">, and Trijardy</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> XR. </span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Humalog revenue includes insulin lispro. </span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(3) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">COVID-19 antibodies include sales for bamlanivimab administered alone, for bamlanivimab and etesevimab administered together, and for bebtelovimab and were made pursuant to EUAs or similar regulatory authorizations.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(4) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Olumiant revenue includes sales for baricitinib that were made pursuant to EUA or similar regulatory authorizations.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"> </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our revenue activity by product for the nine months ended September&#160;30, 2022 and 2021:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:37.191%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.534%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.685%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td><td colspan="3" rowspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:20pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Product</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outside U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trulicity</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,162.4</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,341.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,503.5</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,588.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COVID-19 antibodies</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,970.9</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14.7</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,985.5</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,176.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taltz</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,212.6</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">561.6</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,774.2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,565.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Verzenio</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,100.5</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">575.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,675.6</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">945.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Humalog</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">855.8</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">656.4</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,512.3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,851.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jardiance</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">831.4</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">622.4</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,453.7</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,058.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Humulin</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">562.3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">223.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">785.4</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">923.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cyramza</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">259.3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">434.3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">693.6</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">762.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alimta</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">490.5</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">200.5</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">691.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,626.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Olumiant</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">104.6</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">520.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">624.7</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">809.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basaglar</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">339.9</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">218.8</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">558.7</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cialis</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">25.8</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">454.7</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">480.4</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">538.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emgality</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">330.8</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">144.4</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">475.2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">415.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forteo</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">261.4</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">191.7</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">453.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">617.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Erbitux</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">361.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">47.4</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">408.3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">403.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Zyprexa</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">26.2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">235.5</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">261.7</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tyvyt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">235.8</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">235.8</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cymbalta</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">25.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">194.3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">219.3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">484.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mounjaro</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">109.9</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">93.3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">203.2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">501.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">743.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,244.2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,267.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13,531.5</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,708.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">21,239.6</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,318.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Numbers may not add due to rounding.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">NM - not meaningful</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">COVID-19 antibodies include sales for bamlanivimab administered alone, for bamlanivimab and etesevimab administered together, and for bebtelovimab and were made pursuant to EUAs or similar regulatory authorizations.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Humalog revenue includes insulin lispro. </span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(3) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Jardiance revenue includes Glyxambi,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Synjardy, and Trijardy XR. </span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(4) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Olumiant revenue includes sales for baricitinib that were made pursuant to EUA or similar regulatory authorizations.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"> </span></div><div><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue of Trulicity, a treatment for type 2 diabetes and to reduce the risk of major adverse cardiovascular events in adult patients with type 2 diabetes and established cardiovascular disease or multiple cardiovascular risk factors, increased 18 percent in the U.S. during the three months ended September&#160;30, 2022, driven by increased demand, partially offset by lower realized prices. The lower realized prices in the U.S. for the three months ended September&#160;30, 2022 were due to unfavorable segment mix and higher contracted rebates, partially offset by changes to estimates for rebates and discounts. Revenue in the U.S. increased 20 percent during the nine months ended September&#160;30, 2022, driven by increased demand, partially offset by lower realized prices due to unfavorable segment mix and higher contracted rebates. Revenue outside the U.S. increased 8 percent and 19 percent during the three and nine months ended September&#160;30, 2022, respectively, driven by increased demand, partially offset by the unfavorable impact of foreign exchange rates and, to a lesser extent, lower realized prices.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue of COVID-19 antibodies, treatments for mild to moderate COVID-19 for higher-risk patients and for post-exposure prophylaxis in certain individuals for the prevention of SARS-CoV-2 infection, was $386.6&#160;million and $1.97&#160;billion in the U.S. during the three and nine months ended September&#160;30, 2022, respectively. Revenue outside the U.S. was not material during the three and nine months ended September&#160;30, 2022. The availability of superior or competitive therapies, including therapies that can be administered more easily, or preventative measures, such as vaccines, coupled with the unpredictable nature of pandemics, have and could further negatively impact or eliminate demand for these COVID-19 antibodies. The FDA has revised, and may in the future revise, any EUA for our COVID-19 antibodies in response to the prevalence of variants against which our antibodies have varying degrees of efficacy, including the new BQ variants. Based on early data, we do not believe that bebtelovimab will neutralize against the new BQ variants. We supplied the U.S. government approximately 810,000 doses of bebtelovimab during the nine months ended September 30, 2022. Beginning in the third quarter of 2022 and in collaboration with the U.S. government, we have made bebtelovimab commercially available for purchase by U.S. states/territories, hospitals, and certain other providers. We do not anticipate any further U.S. government orders. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue of Taltz, a treatment for moderate-to-severe plaque psoriasis, active psoriatic arthritis, ankylosing spondylitis, and active non-radiographic axial spondyloarthritis, increased 17 percent and 13 percent in the U.S. during the three and nine months ended September&#160;30, 2022, respectively, driven by increased demand, partially offset by lower realized prices. Revenue outside the U.S. increased 9 percent and 14 percent during the three and nine months ended September&#160;30, 2022, respectively, driven by increased volume, partially offset by unfavorable impact of foreign exchange rates and lower realized prices.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue of Verzenio, a treatment for HR+, HER2- metastatic breast cancer and high risk early breast cancer, increased $215.1&#160;million and $518.4&#160;million in the U.S. during the three and nine months ended September&#160;30, 2022, respectively, primarily driven by increased demand. Revenue outside the U.S. increased 49 percent and 58 percent during the three and nine months ended September&#160;30, 2022, respectively, driven by increased demand, partially offset by lower realized prices due to the impact of the NRDL formulary in China and the unfavorable impact of foreign exchange rates.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue of Humalog, an injectable human insulin analog for the treatment of diabetes, decreased 29 percent and 15 percent in the U.S. during the three and nine months ended September&#160;30, 2022, respectively, driven by lower realized prices due to a list price reduction of insulin lispro injection and unfavorable segment mix. Revenue outside the U.S. decreased 29 percent and 22 percent during the three and nine months ended September&#160;30, 2022, respectively, driven by lower realized prices due to the impact of VBP in China and the unfavorable impact of foreign exchange rates. Due to the impact of competition and pricing pressure in the U.S. and some international markets, we expect that lower revenue due to realized price decline will continue over time. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue of Jardiance, a treatment for type 2 diabetes, to reduce the risk of cardiovascular death in adult patients with type 2 diabetes and established cardiovascular disease, and to reduce the risk of cardiovascular death and hospitalization for heart failure in adults with heart failure, regardless of left ventricular ejection fraction, increased 59 percent and 47 percent in the U.S. during the three and nine months ended September&#160;30, 2022, respectively, primarily driven by increased demand. The increase in revenue in the U.S. during the three months ended September&#160;30, 2022 was also driven by changes to estimates for rebates and discounts. Revenue outside the U.S. increased 31 percent and 26 percent during the three and nine months ended September&#160;30, 2022, respectively, primarily driven by increased demand, partially offset by the unfavorable impact of foreign exchange rates. See Note 4 to the consolidated condensed financial statements for information regarding our collaboration with Boehringer Ingelheim involving Jardiance.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue of Alimta, a treatment for various cancers, decreased 78 percent and 46 percent in the U.S. during the three and nine months ended September&#160;30, 2022, respectively, primarily driven by decreased demand due to the entry of multiple generics in the second quarter of 2022. Revenue outside the U.S. decreased 66 percent and 72 percent during the three and nine months ended September&#160;30, 2022, respectively, largely driven by decreased demand due to generic competition. Following the June 2021 loss of patent exclusivity for Alimta in Europe and Japan, we faced, and expect to continue to face, generic competition that has rapidly and severely eroded revenue, and we expect will continue to erode revenue from current levels. In addition, as a result of the entry of multiple generics in the U.S. following the loss of patent and pediatric exclusivity in May 2022, we began facing, and expect to continue to face, additional generic competition that has eroded revenue, and we expect will continue to rapidly and severely erode revenue from current levels. See "Executive Overview - Other Matters- Patent Matters" for additional information.</span></div><div style="margin-top:6pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><div id="i5fed483d9c7e4f3cbba3a62c53226cd7_94"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Gross Margin, Costs, and Expenses</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross margin as a percent of revenue decreased 1.6 percentage points to 77.3 percent and increased 2.0 percentage points to 76.1 percent for the three and nine</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">months ended September&#160;30, 2022, respectively. The decrease in the gross margin percent for the three months ended September&#160;30, 2022 was primarily driven by a benefit in the gross margin for the three months ended September&#160;30, 2021 due to the partial reversal of inventory impairment charges related to our COVID-19 antibodies that were recognized in the first and second quarters of 2021. The partial reversal of inventory impairment charges related to our COVID-19 antibodies was driven by an unexpected increase in our COVID-19 antibodies sales as the COVID-19 pandemic evolved during the third quarter of 2021. The increase in gross margin percent for the nine months ended September&#160;30, 2022 was primarily driven by a net inventory impairment charge related to our COVID-19 antibodies recognized in 2021. Additionally, for the three and nine months ended September&#160;30, 2022, lower realized prices and increased expenses due to inflation and logistics costs were offset by favorable product mix, including the impact of lower sales of Olumiant for the treatment of COVID-19, and the favorable impact of foreign exchange rates. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses increased 6 percent to $1.80 billion and 3 percent to $5.19 billion for the three and nine</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">months ended September&#160;30, 2022, respectively, primarily driven by higher development expenses for late-stage assets, partially offset by lower development expenses for COVID-19 antibodies and the favorable impact of foreign exchange rates. </span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketing, selling, and administrative expenses </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">increased</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2 percent to $1.61 billion for the three months ended September&#160;30, 2022, primarily driven by increased costs associated with the launch of Mounjaro, partially offset by the favorable impact of foreign exchange rates. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketing, selling, and administrative expenses</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> decreased 1 percent to $4.80 billion for the nine months ended September&#160;30, 2022, primarily driven by the favorable impact of foreign exchange rates as well as reduced marketing costs in the first half of 2022, partially offset by increased costs associated with the launch of Mounjaro. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We plan to take compensatory actions to improve retention and address wage inflation which will impact our costs and consolidated results of operations. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognized $62.4 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$668.4 million of acquired IPR&amp;D and development milestones for the three and nine months ended September&#160;30, 2022, respectively. The charges for the nine months ended September&#160;30, 2022 included the buy-out of substantially all future obligations that were contingent upon the occurrence of certain events linked to the success of our mutant-selective PI3k&#945; inhibitor and a purchase of a Priority Review Voucher. We recognized $177.6 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$532.4 million of acquired IPR&amp;D and development milestones for the three and nine months ended September&#160;30, 2021, respectively. The charges for the nine months ended September&#160;30, 2021 included acquired IPR&amp;D charges from business development transactions with Rigel and Precision. See Note 3 to the consolidated condensed financial statements for additional information.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognized asset impairment, restructuring, and other special charges of $206.5 million for the three and nine months ended September&#160;30, 2022, primarily related to an intangible asset impairment for GBA1 Gene Therapy (PR001) due to changes in estimated launch timing. There were no asset impairment, restructuring, and other special charges recognized for the three months ended September&#160;30, 2021. We recognized asset impairment, restructuring, and other special charges of $211.6 million for the nine months ended September&#160;30, 2021, primarily related to an intangible asset impairment resulting from the sale of the rights to Qbrexza, as well as acquisition and integration costs associated with the acquisition of Prevail. See Note 5 to the consolidated condensed financial statements for additional information.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other&#8211;net, (income) expense was expense of $111.0 million and $580.9 million for the three and nine months ended September&#160;30, 2022, respectively, compared with expense of $635.9 million and $124.3 million for the three and nine months ended September&#160;30, 2021, respectively. The decrease in other expense for the three months ended September&#160;30, 2022 was primarily driven by a debt extinguishment loss of $405.2 million related to the repurchase of debt in 2021, as well as lower net investment losses on equity securities in 2022 compared to 2021. The increase in other expense for the nine months ended September&#160;30, 2022 was primarily driven by net investment losses on equity securities in 2022 compared with net investment gains on equity securities in 2021, partially offset by a debt extinguishment loss of $405.2 million related to the repurchase of debt in 2021.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rates were 7.3 percent and 8.6 percent for the three and nine months ended September&#160;30, 2022, respectively, reflecting the favorable tax impact of the implementation of a provision in the 2017 Tax Act that requires capitalization and amortization of research and development expenses for tax purposes starting in 2022, net investment losses on equity securities, and an intangible asset impairment charge. We expect our effective tax rate to be approximately 13 percent to 14 percent for 2022 if the capitalization and amortization of research and development expenses provision of the 2017 Tax Act is deferred or repealed by the U.S. Congress effective for 2022.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rate was 10.9 percent for the three months ended September&#160;30, 2021, reflecting the favorable tax impact of a debt extinguishment loss and of net investment losses on equity securities, partially offset by a net discrete tax detriment. The effective tax rate was 10.7 percent for the nine months ended September&#160;30, 2021, reflecting the favorable tax impact of a net discrete tax benefit, a debt extinguishment loss, and a net inventory impairment charge related to our COVID-19 antibodies. </span></div><div style="margin-top:6pt"><span><br/></span></div><div id="i5fed483d9c7e4f3cbba3a62c53226cd7_100"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Financial Condition and Liquidity</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe our available cash and cash equivalents, together with our ability to generate operating cash flow and our access to short-term and long-term borrowings, are sufficient to fund our existing and planned capital requirements. For a discussion of our capital requirements, see "Management's Discussion and Analysis of Results of Operations and Financial Condition" in Part II, Item 7 of our Annual Report on </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/0000059478/000005947822000068/lly-20211231.htm" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Form 10-K</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the year ended December&#160;31, 2021.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We plan to invest more than $2 billion over several years in two new facilities in Lebanon, Indiana to manufacture existing and future products and more than $1 billion over several years in a new facility in Concord, North Carolina to manufacture parenteral (injectable) products and devices. We plan to invest more than 400 million euro over several years in a new facility in Limerick, Ireland to expand our manufacturing network for biologic active ingredients. These investments, and other capital investments that support our operations, will result in capital expenditures being higher than recent historical levels for the next several years.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents decreased to $2.62 billion as of September&#160;30, 2022, compared with $3.82 billion as of December&#160;31, 2021. Refer to the consolidated condensed statements of cash flows for additional information on the significant sources and uses of cash for the nine months ended September&#160;30, 2022 and 2021. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to our cash and cash equivalents, we held total investments of $2.70 billion and $3.30 billion as of September&#160;30, 2022 and December&#160;31, 2021, respectively. See Note 6 to the consolidated condensed financial statements for additional information. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, total debt was $15.89 billion, a decrease of $996.3 million compared with $16.88&#160;billion as of December&#160;31, 2021. See Note 6 to the consolidated condensed financial statements for additional information. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, we had a total of $7.26 billion of unused committed bank credit facilities, $7.00 billion of which is available to support our commercial paper program. We believe that amounts accessible through existing commercial paper markets should be adequate to fund short-term borrowing needs. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2022, we repurchased $1.50 billion of shares under our $5.00&#160;billion share repurchase program authorized in May 2021. As of September&#160;30, 2022, we had $3.25 billion remaining under this program. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2022, we paid dividends of $2.65&#160;billion, or $2.94 per share, to our shareholders. In October 2022, we declared a dividend for the fourth quarter of 2022 of $0.98 per share on outstanding common stock. The dividend of approximately $882 million is payable on December 9, 2022 to shareholders of record at the close of business on November 15, 2022.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See "Executive Overview - Other Matters - Patent Matters" for information regarding recent losses of patent protection.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Both domestically and abroad, we continue to monitor the potential impacts of the economic environment; the creditworthiness of our wholesalers and other customers, including foreign government-backed agencies and suppliers; the uncertain impact of health care legislation; various international government funding levels; and fluctuations in interest rates, foreign currency exchange rates (see "Executive Overview - Other Matters - Foreign Currency Exchange Rates"), and fair values of equity securities.</span></div><div style="margin-top:6pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><div id="i5fed483d9c7e4f3cbba3a62c53226cd7_103"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Critical Accounting Estimates</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of our critical accounting estimates, refer to "Management's Discussion and Analysis of Results of Operations and Financial Condition" in Part II, Item 7 and the notes to our consolidated financial statements in Part II, Item 8 of our Annual Report on </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/0000059478/000005947822000068/lly-20211231.htm" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Form 10-K</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the year ended December&#160;31, 2021. See also Note 1 to the consolidated condensed financial statements. There have been no material changes to our critical accounting estimates since our Annual Report on </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/0000059478/000005947822000068/lly-20211231.htm" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Form 10-K</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the year ended December&#160;31, 2021. </span></div><div style="margin-bottom:12pt;margin-top:6pt"><span><br/></span></div><div id="i5fed483d9c7e4f3cbba3a62c53226cd7_106"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Available Information on our Website</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We make available through our company website, free of charge, our company filings with the Securities and Exchange Commission (SEC) as soon as reasonably practicable after we electronically file them with, or furnish them to, the SEC. The reports we make available include annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, proxy statements, registration statements, and any amendments to those documents.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The website link to our SEC filings is </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">investor.lilly.com/financial-information/sec-filings</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We routinely post important information for investors in the &#8220;Investors&#8221; section of our website, www.lilly.com. We may use our website as a means of disclosing material, non-public information and for complying with our disclosure obligations under Regulation FD. Accordingly, investors should monitor the &#8220;Investors&#8221; section of our website, in addition to following our press releases, filings with the SEC, public conference calls, presentations, and webcasts. We may also use social media channels to communicate with investors and the public about our business, products and other matters, and those communications could be deemed to be material information. The information contained on, or that may be accessed through, our website or social media channels, is not incorporated by reference into, and is not a part of, this Quarterly Report on Form 10-Q.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><div id="i5fed483d9c7e4f3cbba3a62c53226cd7_109"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Item&#160;4. Controls and Procedures</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:23.78pt">Evaluation of Disclosure Controls and Procedures</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Under applicable Securities and Exchange Commission (SEC) regulations, management of a reporting company, with the participation of the principal executive officer and principal financial officer, must periodically evaluate the company's "disclosure controls and procedures," which are defined generally as controls and other procedures of a reporting company designed to ensure that information required to be disclosed by the reporting company in its periodic reports filed with the SEC (such as this Quarterly Report on Form&#160;10-Q) is recorded, processed, summarized, and reported on a timely basis.</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, with the participation of David A. Ricks, president and chief executive officer, and Anat Ashkenazi, executive vice president and chief financial officer, evaluated our disclosure controls and procedures (as such terms are defined in our Annual Report on </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/0000059478/000005947822000068/lly-20211231.htm" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Form 10-K</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the year ended December&#160;31, 2021) as of September&#160;30, 2022, and concluded that they were effective.</span></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:23.78pt">Changes in Internal Controls</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. During the third quarter of 2022, there were no changes in our internal control over financial reporting that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><div id="i5fed483d9c7e4f3cbba3a62c53226cd7_112"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:16pt;font-weight:400;line-height:120%;text-decoration:underline">PART II. Other Information</span></div><div id="i5fed483d9c7e4f3cbba3a62c53226cd7_115"></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Item&#160;1. Legal Proceedings</span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a party to various currently pending legal actions, government investigations, and environmental proceedings. See Note 9 to the consolidated condensed financial statements for information on various legal proceedings. </span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Item should be read in conjunction with "Legal Proceedings" in Part I, Item 3 of our Annual Report on </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/0000059478/000005947822000068/lly-20211231.htm" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Form 10-K</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the year ended December&#160;31, 2021.</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span><br/></span></div><div id="i5fed483d9c7e4f3cbba3a62c53226cd7_118"></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Item&#160;1A. Risk Factors</span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our material risk factors are disclosed in "Risk Factors" in Part I, Item 1A of our Annual Report on </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/0000059478/000005947822000068/lly-20211231.htm" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Form 10-K</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the year ended December&#160;31, 2021. There have been no material changes from the risk factors previously disclosed in our Annual Report on </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/0000059478/000005947822000068/lly-20211231.htm" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Form 10-K</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the year ended December&#160;31, 2021. </span></div><div style="margin-bottom:9pt;margin-top:6pt"><span><br/></span></div><div id="i5fed483d9c7e4f3cbba3a62c53226cd7_121"></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Item&#160;2. Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information relating to the principal market for our common stock and related shareholder matters is described in "Management's Discussion and Analysis of Results of Operations and Financial Condition" in Part II, Item 7 and in "Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters" in Part III, Item 12 of our Annual Report on </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/0000059478/000005947822000068/lly-20211231.htm" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Form 10-K</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the year ended December&#160;31, 2021. </span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity related to repurchases of our equity securities during the three months ended September&#160;30, 2022:</span></div><div style="margin-bottom:6pt;margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:23.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.589%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.735%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.427%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.017%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Period</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Number of<br/>Shares Purchased<br/>(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average&#160;Price Paid&#160;<br/>per Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;Number of Shares<br/>Purchased&#160;as Part of<br/>Publicly Announced<br/>Plans or Programs<br/>(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs <br/>(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,250.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,250.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,250.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended September&#160;30, 2022, we did not repurchase any shares under our $5.00 billion share repurchase program authorized in May 2021.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><div id="i5fed483d9c7e4f3cbba3a62c53226cd7_124"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Item&#160;6. Exhibits</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following documents are filed as a part of this Quarterly Report:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:16.323%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.145%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:77.232%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Description</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EXHIBIT 3.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/59478/000005947822000138/articlesofincorporationlly.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Amended Articles of Incorporation are incorporated by reference to Exhibit 3.1 to the Company's Current Report on Form 8-K filed on May 4, 2022</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EXHIBIT 3.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/59478/000005947822000138/bylaws.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Bylaws, as amended, are incorporated by reference to Exhibit 3.2 to the Company's Current Report on Form 8-K filed on May 4, 2022</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EXHIBIT 10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/0000059478/000005947822000250/lly-093022x10qexhibit101.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Form of Performance Award under the 2002 Lilly Stock Plan (with non-compete)</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EXHIBIT 10.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/0000059478/000005947822000250/lly-093022x10qexhibit102.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Form of Shareholder Value Award under the 2002 Lilly Stock Plan (with non-compete)</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EXHIBIT 10.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/0000059478/000005947822000250/lly-093022x10qexhibit103.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Form of Relative Value Award under the 2002 Lilly Stock Plan (with non-compete)</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EXHIBIT&#160;31.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/0000059478/000005947822000250/lly-09302022x10qxexhibit311.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Rule&#160;13a-14(a) Certification of David A. Ricks, Chair, President, and Chief Executive Officer</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EXHIBIT 31.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/0000059478/000005947822000250/lly-09302022x10qxexhibit312.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Rule&#160;13a-14(a) Certification of Anat Ashkenazi, </a><a href="https://www.sec.gov/Archives/edgar/data/0000059478/000005947822000250/lly-09302022x10qxexhibit312.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Executive</a><a href="https://www.sec.gov/Archives/edgar/data/0000059478/000005947822000250/lly-09302022x10qxexhibit312.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"> Vice President and Chief Financial Officer</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EXHIBIT 32.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/0000059478/000005947822000250/lly-09302022x10qxexhibit32.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Section 1350 Certification</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EXHIBIT 101.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interactive Data Files (embedded within the Inline XBRL document)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EXHIBIT 104.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> Indicates management contract or compensatory plan.</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt instruments under which the total amount of securities authorized does not exceed 10 percent of our consolidated assets are not filed as exhibits to this Quarterly Report. We will furnish a copy of these agreements to the Securities and Exchange Commission upon request.</span></div><div style="margin-top:6pt"><span><br/></span></div><div id="i5fed483d9c7e4f3cbba3a62c53226cd7_127"></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Signatures</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.747%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.467%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:74.486%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">ELI LILLY AND COMPANY</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Registrant)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 1, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Anat Ashkenazi</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Anat Ashkenazi</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 1, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Donald A. Zakrowski</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Donald A. Zakrowski</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President, Finance, and Chief Accounting Officer</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div></body></html>
